1 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000207177.1 |
0.00102081432151446 |
|
2 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A46 |
0.00102081432151446 |
|
3 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548F3 |
0.00112377991728574 |
|
4 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM232 |
0.00114942528693351 |
|
5 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMCHL1 |
0.00171418772705956 |
|
6 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN2A1 |
0.00174971112650735 |
|
7 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP230 |
0.00174971112650735 |
|
8 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL572P |
0.00178484122484157 |
|
9 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APC |
0.00185213651425553 |
|
10 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRP19 |
0.00190930632414599 |
|
11 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFNA5 |
0.0019626312163431 |
|
12 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP122 |
0.00199558924397181 |
|
13 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252337.1 |
0.00223901027644735 |
|
14 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL17 |
0.00225073929167541 |
|
15 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM9 |
0.00228454823106572 |
|
16 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC13P |
0.00228678728937326 |
|
17 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf17 |
0.002297954362104 |
|
18 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000252083.1 |
0.00235488676033624 |
|
19 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PJA2 |
0.00264616250706429 |
|
20 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL782P |
0.00274797073980981 |
|
21 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NECAB1 |
0.0027706339605742 |
|
22 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSLP |
0.00284538567340209 |
|
23 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR36 |
0.00284538567340209 |
|
24 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK4 |
0.00284538567340209 |
|
25 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD4 |
0.00284538567340209 |
|
26 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NREP |
0.00284538567340209 |
|
27 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP57 |
0.00284538567340209 |
|
28 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA13 |
0.00295102223621213 |
|
29 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM22P |
0.00309959309348962 |
|
30 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSSK1B |
0.00313748956882265 |
|
31 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD29 |
0.00322334093751886 |
|
32 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FER |
0.00323075403947715 |
|
33 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YTHDC2 |
0.00346131859741849 |
|
34 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PVR |
0.00350834190897964 |
|
35 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM16 |
0.00365298823149174 |
|
36 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPB41L4A |
0.00381182567098992 |
|
37 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIO |
0.00381528422044153 |
|
38 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ11235 |
0.00390628395642068 |
|
39 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM19 |
0.00391861038011254 |
|
40 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC69 |
0.00406074536498879 |
|
41 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4661 |
0.00406074536498879 |
|
42 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL3 |
0.00407177014196847 |
|
43 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL777P |
0.00408082568062451 |
|
44 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP273 |
0.00425409129072274 |
|
45 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A7 |
0.00448325118366799 |
|
46 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239134.1 |
0.00448325118366799 |
|
47 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM64 |
0.00449692770608179 |
|
48 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR4 |
0.00461607638784844 |
|
49 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EML2 |
0.00461607638784844 |
|
50 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR330 |
0.00461607638784844 |
|
51 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL836P |
0.00461607638784844 |
|
52 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM55A |
0.00466214775127194 |
|
53 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUD6B |
0.00466214775127194 |
|
54 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ6|ENSG00000252200.1 |
0.00484073181979794 |
|
55 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP231 |
0.00511089646860829 |
|
56 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF23 |
0.00541613587364964 |
|
57 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000253027.1 |
0.00548254328045017 |
|
58 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBLC |
0.00548254328045017 |
|
59 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMPK |
0.00554617613799813 |
|
60 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIX5 |
0.00554617613799813 |
|
61 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH10 |
0.00559939590173364 |
|
62 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BASP1 |
0.00562512010351024 |
|
63 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238674.1 |
0.0056982343425086 |
|
64 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP189 |
0.0058136796009548 |
|
65 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF622 |
0.00591855498754235 |
|
66 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM134B |
0.00591855498754235 |
|
67 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCC |
0.00598193567013572 |
|
68 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PVRL2 |
0.00619836891893644 |
|
69 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCG |
0.00639870505208795 |
|
70 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF254 |
0.00658906714775542 |
|
71 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF726 |
0.00658906714775542 |
|
72 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUSBP1 |
0.0072262641201285 |
|
73 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPP9 |
0.00725990468557658 |
|
74 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPA3 |
0.00739239517079548 |
|
75 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC61 |
0.00750585362877743 |
|
76 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF331 |
0.0075333603912302 |
|
77 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH18 |
0.00789219076075443 |
|
78 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIQK |
0.00789742993342579 |
|
79 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRD2 |
0.00792952265766866 |
|
80 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOSB |
0.00813139891360171 |
|
81 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTN2 |
0.00813139891360171 |
|
82 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1N |
0.00813139891360171 |
|
83 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VASP |
0.00813139891360171 |
|
84 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL28A1 |
0.00814212394491465 |
|
85 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFL2 |
0.0082628630928504 |
|
86 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNG7 |
0.00828247730461007 |
|
87 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYMPK |
0.00832652182561744 |
|
88 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFL3 |
0.00837411981881897 |
|
89 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM105A |
0.00841375930229182 |
|
90 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM105B |
0.00842836208856013 |
|
91 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKH |
0.00844130420591394 |
|
92 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNG8 |
0.00846312097073609 |
|
93 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNG6 |
0.00846312097073609 |
|
94 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR935 |
0.00846312097073609 |
|
95 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSTM1 |
0.00846312097073609 |
|
96 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYADM |
0.00848648447671818 |
|
97 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSCAR |
0.00849518928224002 |
|
98 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOGA1 |
0.00851808994512615 |
|
99 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL156P |
0.00851808994512615 |
|
100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLDC2 |
0.00851808994512615 |
|
101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMHD1 |
0.00851808994512615 |
|
102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIPR |
0.00866328071617539 |
|
103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPD2 |
0.00866328071617539 |
|
104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QPCTL |
0.00866328071617539 |
|
105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO46 |
0.00866328071617539 |
|
106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4637 |
0.0086806347984647 |
|
107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMXL1 |
0.00872945426341543 |
|
108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BNIP3P1 |
0.00873599170202033 |
|
109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA3 |
0.00892053458653941 |
|
110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFPT |
0.00892053458653941 |
|
111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPA3 |
0.00899954313133011 |
|
112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUN5 |
0.00904515945867346 |
|
113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFB2 |
0.00904515945867346 |
|
114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPRX |
0.00907186379308866 |
|
115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1323 |
0.00907186379308866 |
|
116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR371A |
0.00907186379308866 |
|
117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR371B |
0.00907186379308866 |
|
118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR372 |
0.00907186379308866 |
|
119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR373 |
0.00907186379308866 |
|
120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR498 |
0.00907186379308866 |
|
121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR516A1 |
0.00907186379308866 |
|
122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR516A2 |
0.00907186379308866 |
|
123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR516B1 |
0.00907186379308866 |
|
124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR516B2 |
0.00907186379308866 |
|
125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR517A |
0.00907186379308866 |
|
126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR517B |
0.00907186379308866 |
|
127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR517C |
0.00907186379308866 |
|
128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR518A1 |
0.00907186379308866 |
|
129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR518A2 |
0.00907186379308866 |
|
130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR518B |
0.00907186379308866 |
|
131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR518C |
0.00907186379308866 |
|
132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR518D |
0.00907186379308866 |
|
133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR518E |
0.00907186379308866 |
|
134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR518F |
0.00907186379308866 |
|
135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR519A1 |
0.00907186379308866 |
|
136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR519A2 |
0.00907186379308866 |
|
137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR519B |
0.00907186379308866 |
|
138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR519C |
0.00907186379308866 |
|
139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR519D |
0.00907186379308866 |
|
140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR519E |
0.00907186379308866 |
|
141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR520A |
0.00907186379308866 |
|
142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR520B |
0.00907186379308866 |
|
143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR520C |
0.00907186379308866 |
|
144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR520D |
0.00907186379308866 |
|
145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR520E |
0.00907186379308866 |
|
146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR520F |
0.00907186379308866 |
|
147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR520G |
0.00907186379308866 |
|
148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR520H |
0.00907186379308866 |
|
149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR522 |
0.00907186379308866 |
|
150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR523 |
0.00907186379308866 |
|
151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR524 |
0.00907186379308866 |
|
152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR525 |
0.00907186379308866 |
|
153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR526A1 |
0.00907186379308866 |
|
154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR526A2 |
0.00907186379308866 |
|
155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR526B |
0.00907186379308866 |
|
156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR527 |
0.00907186379308866 |
|
157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP12 |
0.00907186379308866 |
|
158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL317P |
0.00907186379308866 |
|
159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDRG3 |
0.00912306735552337 |
|
160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239067.1 |
0.00912623738801344 |
|
161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM170A |
0.00912623738801344 |
|
162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMWD |
0.00912722331600568 |
|
163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPH6A |
0.00912722331600568 |
|
164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1GALT1 |
0.00922473104407573 |
|
165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSN1 |
0.00934774969061203 |
|
166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAM |
0.00935086062571555 |
|
167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC4 |
0.009410815622238 |
|
168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf26 |
0.009410815622238 |
|
169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCP1 |
0.00958326724628911 |
|
170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL288P |
0.00958326724628911 |
|
171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC63 |
0.00958326724628911 |
|
172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238483.1 |
0.00958326724628911 |
|
173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP5 |
0.00958326724628911 |
|
174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00563 |
0.00958326724628911 |
|
175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH8 |
0.00968053738829855 |
|
176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00645 |
0.0097672333424178 |
|
177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COG3 |
0.00980471428568774 |
|
178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM194B |
0.00980471428568774 |
|
179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP27 |
0.00980471428568774 |
|
180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf87 |
0.00984214961508389 |
|
181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TARM1 |
0.0100019920283422 |
|
182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOVA2 |
0.0100082669007286 |
|
183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR642A |
0.0100720373482981 |
|
184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCFD1 |
0.0101102742788272 |
|
185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYPOP |
0.0101219408974275 |
|
186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BANK1 |
0.0102975812296787 |
|
187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NANOS2 |
0.0103092725951585 |
|
188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIOS |
0.0103535328678657 |
|
189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL58P |
0.0103805042114119 |
|
190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTH1P10 |
0.0104151215950039 |
|
191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP133 |
0.0104151215950039 |
|
192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP205 |
0.0105286108230345 |
|
193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD81|ENSG00000212278.1 |
0.0105947316128809 |
|
194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP180 |
0.0106674902458059 |
|
195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMS2CL |
0.0107276028628106 |
|
196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP190 |
0.0108084171610671 |
|
197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B4 |
0.0108084171610671 |
|
198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239084.1 |
0.0108792968559281 |
|
199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPH10B2 |
0.0109433447463888 |
|
200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKAL1 |
0.0109688743378036 |
|
201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM40 |
0.011018367898063 |
|
202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBOAT7 |
0.011053347764406 |
|
203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
G2E3 |
0.0110648162252392 |
|
204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF853 |
0.0110794210927794 |
|
205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF12 |
0.0110794210927794 |
|
206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP469 |
0.0110949380111517 |
|
207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT3 |
0.0111181234997842 |
|
208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LENG1 |
0.0111181234997842 |
|
209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMC4 |
0.0111181234997842 |
|
210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGIF2 |
0.0112442842851004 |
|
211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCZ1B |
0.0113991459965073 |
|
212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3683 |
0.0113991459965073 |
|
213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAND3 |
0.0114213598821425 |
|
214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H13 |
0.011448054620771 |
|
215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPB2 |
0.0115332697330213 |
|
216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERP2 |
0.0115353068825937 |
|
217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPERT |
0.0115593715334368 |
|
218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIAH3 |
0.0115593715334368 |
|
219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALB1 |
0.0115794498976795 |
|
220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548A1 |
0.0116049568492932 |
|
221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00534 |
0.0116609629389588 |
|
222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOVA1 |
0.0117091526989873 |
|
223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTWD2 |
0.0117766118738882 |
|
224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239011.1 |
0.0118263663068215 |
|
225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5706 |
0.0118263663068215 |
|
226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM47 |
0.01199449789836 |
|
227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00330 |
0.0120674141022302 |
|
228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUFIP1 |
0.0120674141022302 |
|
229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1704 |
0.0120674141022302 |
|
230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL49P |
0.0120674141022302 |
|
231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP3 |
0.0120674141022302 |
|
232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSEN34 |
0.0121704829790948 |
|
233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBN |
0.0122048087173219 |
|
234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DECR1 |
0.0122048087173219 |
|
235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLGAP4 |
0.0122088778743598 |
|
236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH12 |
0.0122746473901864 |
|
237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLCCI1 |
0.0124313349870613 |
|
238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf24 |
0.0124435875722567 |
|
239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLA2 |
0.0124435875722567 |
|
240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLO1 |
0.0125518207427104 |
|
241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG14 |
0.0125748990197987 |
|
242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM27 |
0.0125748990197987 |
|
243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf100 |
0.0125748990197987 |
|
244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUB1 |
0.0125884670762947 |
|
245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA6A |
0.0127023419644647 |
|
246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXA3 |
0.012760176394529 |
|
247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRXCR1 |
0.0128614529924094 |
|
248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAND1 |
0.0129959286972396 |
|
249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXPH1 |
0.0130575662462644 |
|
250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPAR6 |
0.01314262932364 |
|
251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL9 |
0.0131870616524364 |
|
252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0226L |
0.0134378670255416 |
|
253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG24 |
0.0134400752845447 |
|
254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQPEP |
0.0136625580584098 |
|
255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL14EPL |
0.0136625580584098 |
|
256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2F2 |
0.0137626687483573 |
|
257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
7SK|ENSG00000271818.1 |
0.0137626687483573 |
|
258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD4 |
0.0137626687483573 |
|
259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000253051.1 |
0.0137626687483573 |
|
260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPT1 |
0.0137626687483573 |
|
261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000199477.1 |
0.0137626687483573 |
|
262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A30 |
0.0137626687483573 |
|
263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDGFL1 |
0.0138405667457816 |
|
264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFB6 |
0.013897077032925 |
|
265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238458.1 |
0.0139755455132924 |
|
266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEM1A |
0.0140240769968789 |
|
267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF31 |
0.0140553853669905 |
|
268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRID2IP |
0.0140897673281163 |
|
269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL471P |
0.0141935443702887 |
|
270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG15 |
0.0141935443702887 |
|
271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG16 |
0.0141935443702887 |
|
272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF311 |
0.0141935443702887 |
|
273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2W1 |
0.0141935443702887 |
|
274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2B3 |
0.0141935443702887 |
|
275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARK4 |
0.0142663942054273 |
|
276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFAIP8 |
0.0144590000017045 |
|
277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL174P |
0.0144590000017045 |
|
278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAAG1 |
0.0144607115430807 |
|
279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFL1 |
0.0144764002197871 |
|
280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2J1 |
0.0144912110223552 |
|
281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2J2 |
0.0144912110223552 |
|
282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2J3 |
0.0144912110223552 |
|
283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ID4 |
0.0144930271821904 |
|
284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUNX1T1 |
0.014498103826721 |
|
285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238932.1 |
0.0145075186780865 |
|
286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOE |
0.014525522936587 |
|
287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR769 |
0.014527344048489 |
|
288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGLYRP1 |
0.014527344048489 |
|
289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFL4 |
0.014527344048489 |
|
290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSC22D1 |
0.0146169333928675 |
|
291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF180 |
0.014699271776504 |
|
292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP274 |
0.0148799498561821 |
|
293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBL1 |
0.0149614517701 |
|
294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM20 |
0.0149772011124515 |
|
295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf23 |
0.0149790260682396 |
|
296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4802 |
0.0150670476380588 |
|
297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF2BP1 |
0.0150959412984404 |
|
298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINE3 |
0.0151216644308967 |
|
299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5693 |
0.0151216644308967 |
|
300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM124A |
0.0153132673087206 |
|
301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COCH |
0.0153751134774588 |
|
302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH11 |
0.0154046410712479 |
|
303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL7 |
0.0154400703311723 |
|
304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR887 |
0.0154400703311723 |
|
305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP178 |
0.0154400703311723 |
|
306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR579 |
0.0156800116761475 |
|
307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TICAM1 |
0.0157216292266228 |
|
308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOC1 |
0.0157373517846994 |
|
309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRN3 |
0.0159537252485394 |
|
310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYSLTR2 |
0.0159774078133555 |
|
311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRS2 |
0.0159879081263126 |
|
312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED7 |
0.0160278779375039 |
|
313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDO1 |
0.01607117452749 |
|
314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG12 |
0.01607117452749 |
|
315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL465P |
0.0161008868163652 |
|
316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA8|ENSG00000212586.1 |
0.0161008868163652 |
|
317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNMT3B |
0.0162596060638185 |
|
318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIN1 |
0.0162909953210733 |
|
319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB8 |
0.0165112359158857 |
|
320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA76|ENSG00000253007.2 |
0.0166811989794396 |
|
321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPRE1 |
0.016700631210485 |
|
322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRL |
0.0167498063379213 |
|
323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00562 |
0.0167720972993763 |
|
324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUCLA2 |
0.0167720972993763 |
|
325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT15 |
0.0167720972993763 |
|
326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED4 |
0.0167720972993763 |
|
327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF6 |
0.0168398296802758 |
|
328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLASRP |
0.0169610396177375 |
|
329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK5 |
0.0170083359354019 |
|
330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A9 |
0.0174026313875658 |
|
331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEND4 |
0.0174026313875658 |
|
332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIR3DX1 |
0.0175555791076037 |
|
333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF714 |
0.0175898233881969 |
|
334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX4 |
0.0176672380527457 |
|
335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCBTB2 |
0.0177304189911824 |
|
336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT12 |
0.0177364659947741 |
|
337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOC2 |
0.0177497430154938 |
|
338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLPTM1 |
0.0177497430154938 |
|
339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC22P |
0.0178152225009027 |
|
340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS6 |
0.0178579962037707 |
|
341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOC1P1 |
0.0180003274794517 |
|
342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF144B |
0.0180293933014458 |
|
343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOC4 |
0.018030654200205 |
|
344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIP5K2 |
0.0180314636365614 |
|
345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD16A |
0.0182114948773695 |
|
346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGER |
0.0182114948773695 |
|
347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGPAT1 |
0.0182114948773695 |
|
348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIF1 |
0.0182114948773695 |
|
349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOM |
0.0182114948773695 |
|
350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF6B |
0.0182114948773695 |
|
351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1G2 |
0.0182114948773695 |
|
352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAG6 |
0.0182114948773695 |
|
353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTNL2 |
0.0182114948773695 |
|
354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2 |
0.0182114948773695 |
|
355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4A |
0.0182114948773695 |
|
356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4B |
0.0182114948773695 |
|
357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf10 |
0.0182114948773695 |
|
358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf25 |
0.0182114948773695 |
|
359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf47 |
0.0182114948773695 |
|
360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf48 |
0.0182114948773695 |
|
361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFB |
0.0182114948773695 |
|
362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIC1 |
0.0182114948773695 |
|
363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK2B |
0.0182114948773695 |
|
364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP21A1P |
0.0182114948773695 |
|
365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP21A2 |
0.0182114948773695 |
|
366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDAH2 |
0.0182114948773695 |
|
367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX39B |
0.0182114948773695 |
|
368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOM3Z |
0.0182114948773695 |
|
369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGFL8 |
0.0182114948773695 |
|
370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHMT2 |
0.0182114948773695 |
|
371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBPL |
0.0182114948773695 |
|
372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPANK1 |
0.0182114948773695 |
|
373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPSM3 |
0.0182114948773695 |
|
374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG23 |
0.0182114948773695 |
|
375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCP5 |
0.0182114948773695 |
|
376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA1A |
0.0182114948773695 |
|
377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA1B |
0.0182114948773695 |
|
378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA1L |
0.0182114948773695 |
|
379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM2 |
0.0182114948773695 |
|
380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LST1 |
0.0182114948773695 |
|
381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTA |
0.0182114948773695 |
|
382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTB |
0.0182114948773695 |
|
383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6G5B |
0.0182114948773695 |
|
384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6G5C |
0.0182114948773695 |
|
385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6G6C |
0.0182114948773695 |
|
386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6G6D |
0.0182114948773695 |
|
387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6G6E |
0.0182114948773695 |
|
388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6G6F |
0.0182114948773695 |
|
389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCCD1 |
0.0182114948773695 |
|
390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEGT1 |
0.0182114948773695 |
|
391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICA |
0.0182114948773695 |
|
392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICB |
0.0182114948773695 |
|
393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1236 |
0.0182114948773695 |
|
394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3135B |
0.0182114948773695 |
|
395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4646 |
0.0182114948773695 |
|
396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSH5 |
0.0182114948773695 |
|
397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCR3 |
0.0182114948773695 |
|
398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NELFE |
0.0182114948773695 |
|
399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEU1 |
0.0182114948773695 |
|
400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFKBIL1 |
0.0182114948773695 |
|
401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOTCH4 |
0.0182114948773695 |
|
402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBX2 |
0.0182114948773695 |
|
403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R2P1 |
0.0182114948773695 |
|
404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPT2 |
0.0182114948773695 |
|
405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRC2A |
0.0182114948773695 |
|
406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRT1 |
0.0182114948773695 |
|
407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB8 |
0.0182114948773695 |
|
408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB9 |
0.0182114948773695 |
|
409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP206 |
0.0182114948773695 |
|
410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF5 |
0.0182114948773695 |
|
411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAPCD1 |
0.0182114948773695 |
|
412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKIV2L |
0.0182114948773695 |
|
413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC44A4 |
0.0182114948773695 |
|
414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA38|ENSG00000200816.1 |
0.0182114948773695 |
|
415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD117 |
0.0182114948773695 |
|
416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD48 |
0.0182114948773695 |
|
417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD52 |
0.0182114948773695 |
|
418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD84 |
0.0182114948773695 |
|
419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK19 |
0.0182114948773695 |
|
420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAP1 |
0.0182114948773695 |
|
421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAP2 |
0.0182114948773695 |
|
422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNF |
0.0182114948773695 |
|
423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNXB |
0.0182114948773695 |
|
424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VARS |
0.0182114948773695 |
|
425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA7 |
0.0182114948773695 |
|
426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB12 |
0.0182114948773695 |
|
427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF296 |
0.0182169305183666 |
|
428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GEMIN7 |
0.0182169305183666 |
|
429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC122 |
0.0182320233409524 |
|
430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MANBAL |
0.018262700960273 |
|
431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LACC1 |
0.0182713597338012 |
|
432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf30 |
0.0183237418371498 |
|
433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK17 |
0.0183987661270346 |
|
434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK16 |
0.0183987661270346 |
|
435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD10 |
0.0184743510282674 |
|
436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GHRH |
0.0185344911759436 |
|
437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP7 |
0.0185851954580161 |
|
438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAM |
0.0186766536223357 |
|
439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00340 |
0.0187276673800352 |
|
440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000202269.1 |
0.0187818972324025 |
|
441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF208 |
0.0188491758050759 |
|
442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP153 |
0.0189032408151606 |
|
443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR2A |
0.0189241001136154 |
|
444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSGIN2 |
0.0191307589426195 |
|
445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM33 |
0.0191516294708888 |
|
446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4307 |
0.0191723971362193 |
|
447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00444 |
0.0192103833949069 |
|
448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP240 |
0.0193081551268515 |
|
449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXG1 |
0.0196923007901554 |
|
450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTCH1 |
0.0198096255612185 |
|
451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00533 |
0.0199105019065757 |
|
452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM2 |
0.0200339195143366 |
|
453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEK |
0.020094223429311 |
|
454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT13 |
0.0201279032224506 |
|
455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOG |
0.0201809038707855 |
|
456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP57 |
0.0201809038707855 |
|
457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP3S1 |
0.0202050902884545 |
|
458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHISA3 |
0.0202338654149327 |
|
459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAIR2 |
0.0202344593761477 |
|
460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf203 |
0.0202740070912354 |
|
461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD7 |
0.0204090995240845 |
|
462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF229 |
0.020699433558687 |
|
463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPR3 |
0.0209216444452456 |
|
464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP8A1 |
0.0209570649402969 |
|
465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI16 |
0.0209682889672683 |
|
466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00662 |
0.0210014679286887 |
|
467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH5A1 |
0.0210732941794662 |
|
468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF165 |
0.0211508166138268 |
|
469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN12P1 |
0.0211508166138268 |
|
470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN16 |
0.0211508166138268 |
|
471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D7 |
0.0211587096727072 |
|
472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RELB |
0.0211601983512617 |
|
473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0319 |
0.0211855389949084 |
|
474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDP2 |
0.0211855389949084 |
|
475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL255P |
0.0212918462459573 |
|
476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4462 |
0.0213942814226366 |
|
477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABBR1 |
0.0214990622534631 |
|
478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRB4 |
0.0214990857119868 |
|
479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRCH1 |
0.0215143523866881 |
|
480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCUR1 |
0.0216364065087911 |
|
481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF182 |
0.0216364065087911 |
|
482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD83 |
0.0216364065087911 |
|
483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHOX2B |
0.0216799787270875 |
|
484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPLD1 |
0.0217580803408182 |
|
485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKAP2 |
0.0217817046780392 |
|
486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00345 |
0.0217817046780392 |
|
487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRC |
0.0217869791021085 |
|
488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLP1R |
0.0218461425289677 |
|
489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR624 |
0.0219364578412434 |
|
490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MROH8 |
0.0221138488866073 |
|
491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPN2 |
0.0221138488866073 |
|
492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL691P |
0.0221466048828304 |
|
493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRA3 |
0.0221972827921176 |
|
494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRA4 |
0.0221972827921176 |
|
495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRA5 |
0.0221972827921176 |
|
496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRA6 |
0.0221972827921176 |
|
497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRB2 |
0.0221972827921176 |
|
498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRB3 |
0.0221972827921176 |
|
499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRB5 |
0.0221972827921176 |
|
500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4752 |
0.0221972827921176 |
|
501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPA1L2 |
0.0222211035227422 |
|
502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUGT1 |
0.0222211035227422 |
|
503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LECT1 |
0.0222211035227422 |
|
504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5V1 |
0.0222753146802543 |
|
505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR12D2 |
0.0222753146802543 |
|
506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR12D1P |
0.0222753146802543 |
|
507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR11A1 |
0.0222753146802543 |
|
508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10C1 |
0.0222753146802543 |
|
509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2H1 |
0.0222753146802543 |
|
510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAS1L |
0.0222753146802543 |
|
511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP42 |
0.0222897506685985 |
|
512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00371 |
0.0222971544288291 |
|
513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH7 |
0.0223167526840587 |
|
514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESD |
0.0225342385404478 |
|
515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCAR |
0.0225568260617376 |
|
516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIR2DL1 |
0.0225568260617376 |
|
517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIR2DL3 |
0.0225568260617376 |
|
518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIR2DL4 |
0.0225568260617376 |
|
519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIR2DS4 |
0.0225568260617376 |
|
520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIR3DL1 |
0.0225568260617376 |
|
521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIR3DL2 |
0.0225568260617376 |
|
522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIR3DL3 |
0.0225568260617376 |
|
523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRG1B |
0.0225741487823615 |
|
524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRA2 |
0.0226356142648722 |
|
525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRB1 |
0.0226356142648722 |
|
526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LILRA1 |
0.0226356142648722 |
|
527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF257 |
0.022639192344779 |
|
528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF676 |
0.022639192344779 |
|
529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF729 |
0.022639192344779 |
|
530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTYH1 |
0.0226392948354508 |
|
531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LENG8 |
0.0226739694400681 |
|
532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42EP5 |
0.0226739694400681 |
|
533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LENG9 |
0.0226739694400681 |
|
534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRSN1 |
0.0227349131045178 |
|
535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD46|ENSG00000251830.1 |
0.0227349131045178 |
|
536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAYSD1 |
0.0228270743527825 |
|
537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AAR2 |
0.0232511454859805 |
|
538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFOD1 |
0.0234068061132365 |
|
539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAIR1 |
0.0235159215304768 |
|
540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00284 |
0.0235560920992786 |
|
541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLCAP |
0.023561762303003 |
|
542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NNAT |
0.023561762303003 |
|
543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO10 |
0.0236285418128364 |
|
544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP179 |
0.0236285418128364 |
|
545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR14J1 |
0.0236841927428092 |
|
546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR12D3 |
0.0236841927428092 |
|
547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP204 |
0.0237230530298879 |
|
548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRT5 |
0.0237230530298879 |
|
549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL7 |
0.0237230530298879 |
|
550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANBP9 |
0.0237230530298879 |
|
551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCDC2 |
0.0237561556867458 |
|
552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHP2L1 |
0.0237771930669353 |
|
553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf46 |
0.0237771930669353 |
|
554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEI1 |
0.0237771930669353 |
|
555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R37 |
0.0238581547981521 |
|
556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00682 |
0.0238601057505284 |
|
557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AK |
0.0239677752025034 |
|
558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BN |
0.0239677752025034 |
|
559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN1A |
0.0240039437834753 |
|
560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AL |
0.0240847050332991 |
|
561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H1B |
0.0240847050332991 |
|
562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3I |
0.0240847050332991 |
|
563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4L |
0.0240847050332991 |
|
564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3J |
0.0240847050332991 |
|
565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AM |
0.0240847050332991 |
|
566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BO |
0.0240847050332991 |
|
567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2B2 |
0.0240847050332991 |
|
568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2B6 |
0.0240847050332991 |
|
569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000199851.1 |
0.0240847050332991 |
|
570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAAM2 |
0.0241246847674121 |
|
571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL285P |
0.0241647377455098 |
|
572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOCS1 |
0.024310497397526 |
|
573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000201368.1 |
0.0243419341405322 |
|
574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H1A |
0.0244010061112707 |
|
575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRLR |
0.024569302678104 |
|
576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICA1 |
0.0247059049832715 |
|
577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2L1 |
0.0247527573564618 |
|
578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT3A2 |
0.0248842311634411 |
|
579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP484 |
0.024929418626485 |
|
580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT3A1 |
0.0250019153990375 |
|
581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRN4 |
0.0250138587668146 |
|
582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF431 |
0.0250600823009297 |
|
583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTSJD2 |
0.02521311349456 |
|
584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC167 |
0.02521311349456 |
|
585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL7R |
0.0252708213266009 |
|
586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPSL |
0.0252708213266009 |
|
587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZKSCAN8 |
0.0253256772233453 |
|
588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF192P1 |
0.0253256772233453 |
|
589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN9 |
0.0253256772233453 |
|
590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf89 |
0.0253798097459083 |
|
591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE5 |
0.0254179501748233 |
|
592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF4L1 |
0.0254731017003659 |
|
593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL615P |
0.0255781493030484 |
|
594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD45|ENSG00000200706.1 |
0.0256495507684182 |
|
595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGD2 |
0.0256907000608939 |
|
596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00492 |
0.0256907163700637 |
|
597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00664 |
0.0257180195157366 |
|
598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF429 |
0.0257180195157366 |
|
599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS9 |
0.0257732137132789 |
|
600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH5 |
0.0257935540136616 |
|
601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP82 |
0.0258681030764925 |
|
602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF765 |
0.0259212473415952 |
|
603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPM3P9 |
0.0259212473415952 |
|
604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF761 |
0.0259212473415952 |
|
605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF813 |
0.0259212473415952 |
|
606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENOX1 |
0.0260971132734231 |
|
607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFB3 |
0.0260983535165253 |
|
608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFB4 |
0.0260983535165253 |
|
609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC1 |
0.026149415079825 |
|
610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCP2 |
0.0261838061591317 |
|
611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX4I2 |
0.0261866792098179 |
|
612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPB41L1 |
0.026192750226428 |
|
613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIL1 |
0.0263116386026078 |
|
614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP204 |
0.0263650763284946 |
|
615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNDC3A |
0.0264215236041183 |
|
616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC134 |
0.0264248166967476 |
|
617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R12C |
0.0265290645783045 |
|
618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB44 |
0.0265976636976532 |
|
619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF3 |
0.0266103465945898 |
|
620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPIN3 |
0.0268072763399946 |
|
621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMILIN3 |
0.0268072763399946 |
|
622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLIN3 |
0.026862905635431 |
|
623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM38 |
0.0269283705500103 |
|
624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A2 |
0.027042307921272 |
|
625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3925 |
0.0270448141048178 |
|
626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP188 |
0.0270905231138749 |
|
627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RB1 |
0.0272067395341636 |
|
628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFR |
0.027207667187153 |
|
629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANBP3L |
0.027214061699652 |
|
630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIMP2 |
0.0272604236729271 |
|
631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF20 |
0.0272827962196507 |
|
632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00441 |
0.0273528551469301 |
|
633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABP5 |
0.027434670572445 |
|
634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF43 |
0.0274796872507792 |
|
635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HM13 |
0.0275032094112397 |
|
636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCHL1 |
0.0276016403547692 |
|
637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP177 |
0.0276051251971955 |
|
638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNBD2 |
0.0276401698609441 |
|
639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1P6 |
0.0277055936872139 |
|
640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDFY2 |
0.0277055936872139 |
|
641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL413P |
0.0277055936872139 |
|
642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGBD1 |
0.0277130029456284 |
|
643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDGA1 |
0.0277137405583906 |
|
644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF285 |
0.027717049158497 |
|
645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF112 |
0.027795452148292 |
|
646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLNR |
0.0278250290540678 |
|
647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDADC1 |
0.0278250290540678 |
|
648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZKSCAN4 |
0.0278856580713046 |
|
649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKAPL |
0.0278856580713046 |
|
650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf62 |
0.0279464117658329 |
|
651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX6A1P2 |
0.0279867548846866 |
|
652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN31 |
0.0279984467912394 |
|
653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZKSCAN3 |
0.0279984467912394 |
|
654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN12 |
0.0279984467912394 |
|
655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN23 |
0.0279984467912394 |
|
656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPX6 |
0.0279984467912394 |
|
657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPX5 |
0.0279984467912394 |
|
658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAND3 |
0.0279984467912394 |
|
659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL11A2 |
0.028101699462711 |
|
660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R1 |
0.028139665319753 |
|
661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKD1 |
0.0281740619624625 |
|
662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00462 |
0.0281756540866356 |
|
663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD65|ENSG00000212229.1 |
0.0282186996416535 |
|
664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00535 |
0.0282641518169218 |
|
665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ID1 |
0.0283473386713646 |
|
666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3193 |
0.0283473386713646 |
|
667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A1 |
0.0284192563526015 |
|
668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A3 |
0.0284192563526015 |
|
669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4J |
0.0284877078090648 |
|
670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4K |
0.0284877078090648 |
|
671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AI |
0.0286214700740284 |
|
672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AJ |
0.0286214700740284 |
|
673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BL |
0.0286214700740284 |
|
674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BM |
0.0286214700740284 |
|
675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3H |
0.0286214700740284 |
|
676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS4XP16 |
0.0286355504995376 |
|
677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL320P |
0.0286355504995376 |
|
678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G4C |
0.0286392596923017 |
|
679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTO |
0.0286709042696336 |
|
680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM216B |
0.0287271555264915 |
|
681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIG1 |
0.0287488803178696 |
|
682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT49 |
0.0287818799451914 |
|
683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238694.1 |
0.028914730649284 |
|
684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM8A1 |
0.0289453807626016 |
|
685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITM2B |
0.0289720026647716 |
|
686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRG1 |
0.0291006760357246 |
|
687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00951 |
0.0291006760357246 |
|
688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00657 |
0.0291177257382936 |
|
689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA5A |
0.0291870260045275 |
|
690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB115 |
0.0292011112116439 |
|
691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00489 |
0.0292610096382222 |
|
692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD123 |
0.0293710025849376 |
|
693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH11X |
0.0293738872872134 |
|
694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNN2 |
0.0294097199472744 |
|
695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP160 |
0.029508207944408 |
|
696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZRSR1 |
0.0296257131488236 |
|
697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAFB |
0.029811693463984 |
|
698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZHX3 |
0.0298141822535921 |
|
699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTSSA |
0.0302641666780016 |
|
700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL200P |
0.0302733729953146 |
|
701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239059.1 |
0.0302733729953146 |
|
702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238484.1 |
0.0302733729953146 |
|
703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1429 |
0.0303617889971634 |
|
704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAP2 |
0.0303969090096815 |
|
705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMAHP |
0.0304151651621869 |
|
706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAB39L |
0.0304447905412536 |
|
707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCZ1 |
0.0304919831660764 |
|
708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCM |
0.0304919831660764 |
|
709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMS2 |
0.0304919831660764 |
|
710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL556P |
0.0304919831660764 |
|
711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPH10B |
0.0304919831660764 |
|
712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF815P |
0.0304919831660764 |
|
713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKH |
0.0304969182663567 |
|
714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETDB2 |
0.0305232362131321 |
|
715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF11 |
0.0305232362131321 |
|
716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCBTB1 |
0.0305232362131321 |
|
717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL334P |
0.0305363919725766 |
|
718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF708 |
0.0306775784244003 |
|
719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF738 |
0.0306775784244003 |
|
720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF493 |
0.0306775784244003 |
|
721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY5P5 |
0.030869835845767 |
|
722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL13A |
0.0308728370451713 |
|
723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM35 |
0.0308728370451713 |
|
724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT2B |
0.0308728370451713 |
|
725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XKRX |
0.0308728370451713 |
|
726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDFI |
0.0309864437615628 |
|
727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTMT |
0.0310047866293328 |
|
728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A4 |
0.0310830131296552 |
|
729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPO4 |
0.0310843739183648 |
|
730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF235 |
0.0311284379323775 |
|
731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF233 |
0.0311284379323775 |
|
732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP89 |
0.0314084819811473 |
|
733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL128P |
0.0314748549405918 |
|
734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RXRB |
0.0315648476611448 |
|
735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B8 |
0.0315648476611448 |
|
736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P10 |
0.0315648476611448 |
|
737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A7 |
0.0315648476611448 |
|
738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RING1 |
0.0315648476611448 |
|
739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG25 |
0.0315648476611448 |
|
740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS52 |
0.0315648476611448 |
|
741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL700P |
0.0315953837027287 |
|
742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GP6 |
0.0316265150427208 |
|
743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDH13 |
0.0316265150427208 |
|
744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APBA3 |
0.0316427913755244 |
|
745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL54 |
0.0316427913755244 |
|
746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAX2 |
0.0316427913755244 |
|
747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MATK |
0.0317094795195813 |
|
748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFR2 |
0.0317094795195813 |
|
749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRPX2 |
0.0317536166263388 |
|
750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYTL4 |
0.0317536166263388 |
|
751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBR2 |
0.031773997597963 |
|
752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFA2 |
0.0317870003379316 |
|
753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC8 |
0.0318143619301191 |
|
754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX4I1 |
0.0318143619301191 |
|
755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM170B |
0.0318835233886641 |
|
756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAGLB |
0.0318908803962181 |
|
757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDELR2 |
0.0318908803962181 |
|
758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ20306 |
0.0318908803962181 |
|
759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238611.1 |
0.0320609730318484 |
|
760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239089.1 |
0.032090744020674 |
|
761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR320E |
0.0321408484807498 |
|
762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RELL1 |
0.032289034423448 |
|
763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGM2 |
0.032289034423448 |
|
764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D1 |
0.032289034423448 |
|
765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTTG2 |
0.032289034423448 |
|
766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN6 |
0.0323792571777118 |
|
767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4703 |
0.0324911460445001 |
|
768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238549.1 |
0.0325413314361912 |
|
769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC15 |
0.0325938486352372 |
|
770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPSTI1 |
0.0325938486352372 |
|
771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00400 |
0.0325938486352372 |
|
772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBD |
0.0327182352590262 |
|
773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2H2 |
0.0327566853879668 |
|
774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD32B |
0.0327566853879668 |
|
775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRNAI6 |
0.0327857959004815 |
|
776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf74 |
0.0329474537853983 |
|
777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1910 |
0.0329474537853983 |
|
778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPX2 |
0.0330534152683954 |
|
779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LNPEP |
0.0331475359103459 |
|
780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEA1 |
0.0332073386481172 |
|
781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC3 |
0.0332073386481172 |
|
782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP159 |
0.0333454197348474 |
|
783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHLRC1 |
0.0335429289453415 |
|
784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPMT |
0.0335429289453415 |
|
785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM1B |
0.0335429289453415 |
|
786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF13A |
0.0335969551558193 |
|
787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSTF2 |
0.03363609239313 |
|
788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA9|ENSG00000202231.1 |
0.03363609239313 |
|
789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOX1 |
0.03363609239313 |
|
790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00491 |
0.0336538091576563 |
|
791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEM1C |
0.0336773591113371 |
|
792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REEP5 |
0.0336833262852931 |
|
793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM220A |
0.0338870117034669 |
|
794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC16A |
0.0339014752658903 |
|
795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EAPP |
0.0339139632311135 |
|
796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P2 |
0.0339179508629671 |
|
797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPN1 |
0.0339606746464847 |
|
798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP9 |
0.0339606746464847 |
|
799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00311 |
0.0340384768831721 |
|
800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5093 |
0.0340384768831721 |
|
801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG9 |
0.0341641470419838 |
|
802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL802P |
0.0342037072734668 |
|
803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAI14 |
0.0343045811787387 |
|
804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC23L |
0.0343156916745259 |
|
805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD1 |
0.0343156916745259 |
|
806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRIX1 |
0.0343156916745259 |
|
807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC21 |
0.0343156916745259 |
|
808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGXT2 |
0.0343156916745259 |
|
809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIPK2 |
0.0344213477352483 |
|
810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TICAM2 |
0.0346392767048899 |
|
811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf106 |
0.0347642363700127 |
|
812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAC2 |
0.0347732517771283 |
|
813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYTH4 |
0.0347732517771283 |
|
814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOP1 |
0.0347886734077965 |
|
815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL558P |
0.0348558564064086 |
|
816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKM |
0.0350096192904878 |
|
817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC2 |
0.0350096192904878 |
|
818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLC3 |
0.0350096192904878 |
|
819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R13L |
0.0350096192904878 |
|
820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCN1 |
0.035195756673211 |
|
821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1755 |
0.0352290869077002 |
|
822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPI |
0.0352290869077002 |
|
823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMBRD2 |
0.0352716743644766 |
|
824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR580 |
0.0352716743644766 |
|
825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR16 |
0.0352872230968506 |
|
826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IP6K3 |
0.0353317007915467 |
|
827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM92A1 |
0.0353995206628954 |
|
828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM12B |
0.0353995206628954 |
|
829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR115 |
0.0354346290404591 |
|
830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATCAY |
0.0354424477672954 |
|
831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL202P |
0.0354424477672954 |
|
832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMRK2 |
0.0354424477672954 |
|
833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAPK3 |
0.0354424477672954 |
|
834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR637 |
0.0354424477672954 |
|
835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF2 |
0.0354424477672954 |
|
836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD37|ENSG00000206775.1 |
0.0354424477672954 |
|
837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIAS4 |
0.0354424477672954 |
|
838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIF3A |
0.0354983934328963 |
|
839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP5C |
0.0354983934328963 |
|
840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKP2 |
0.0356258123284297 |
|
841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NADK2 |
0.0356258123284297 |
|
842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP68 |
0.0356275657550357 |
|
843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO6A1 |
0.0356275657550357 |
|
844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LBP |
0.0356511163656595 |
|
845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP2A1 |
0.0356718677597371 |
|
846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCYL2 |
0.0357195428898335 |
|
847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U2AF2 |
0.0358004634247615 |
|
848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMB |
0.0358050521081831 |
|
849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPY19L4 |
0.0358131440518334 |
|
850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRYD7 |
0.0358434487149082 |
|
851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLEU1 |
0.0358434487149082 |
|
852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLEU2 |
0.0358434487149082 |
|
853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLEU7 |
0.0358434487149082 |
|
854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY1B2 |
0.0358434487149082 |
|
855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNRG |
0.0358434487149082 |
|
856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3613 |
0.0358434487149082 |
|
857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP28 |
0.0358434487149082 |
|
858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP29 |
0.0358434487149082 |
|
859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASEH2B |
0.0358434487149082 |
|
860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM13 |
0.0358434487149082 |
|
861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO4C1 |
0.0359948908747112 |
|
862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCHD4 |
0.0360149399291319 |
|
863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC3L2 |
0.03628091189991 |
|
864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A8 |
0.0363154010014675 |
|
865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA4|ENSG00000202183.1 |
0.0363216076604297 |
|
866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP116 |
0.0363973155889191 |
|
867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP181 |
0.0364351308162306 |
|
868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL502P |
0.0365446295866875 |
|
869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCG1 |
0.0366526154412568 |
|
870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPD7 |
0.0366581905503329 |
|
871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK38 |
0.0366888217742501 |
|
872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL748P |
0.0366888217742501 |
|
873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR663A |
0.0367050432658084 |
|
874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCR1 |
0.0367260031456564 |
|
875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL237P |
0.0368885946590128 |
|
876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM46D |
0.0370573984732956 |
|
877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPI |
0.0370923594340864 |
|
878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRP2 |
0.0370923594340864 |
|
879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRMS1L |
0.0371121399797413 |
|
880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238351.1 |
0.0371862339750336 |
|
881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212422.1 |
0.0373309381986345 |
|
882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL11 |
0.0374557834273026 |
|
883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBPL |
0.0374557834273026 |
|
884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPNA3 |
0.0374557834273026 |
|
885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC1A3 |
0.0376046920933419 |
|
886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRFBP1 |
0.0377455212824286 |
|
887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD20 |
0.0377531599684218 |
|
888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM177A1 |
0.0377753502839209 |
|
889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPAS3 |
0.037833815278175 |
|
890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDS5A |
0.0378371469489859 |
|
891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THSD1 |
0.0380156673100587 |
|
892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P24 |
0.0380156673100587 |
|
893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS36 |
0.0380156673100587 |
|
894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEMD2 |
0.0380332943232495 |
|
895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSUN7 |
0.0380913419987202 |
|
896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXP4 |
0.0381430082865775 |
|
897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM92B |
0.0381788949339201 |
|
898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4641 |
0.0384012528535811 |
|
899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKRP |
0.0384365626333817 |
|
900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPC |
0.0385366934811999 |
|
901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF11 |
0.0385366934811999 |
|
902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UHRF1BP1 |
0.0385366934811999 |
|
903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP11 |
0.0385625953273337 |
|
904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESRP1 |
0.0385704089601091 |
|
905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD3EAP |
0.0385705108010469 |
|
906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYSF |
0.0385751483803426 |
|
907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNT1 |
0.0387634447946688 |
|
908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSTR3 |
0.0388416578405149 |
|
909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA42|ENSG00000207217.1 |
0.0388552182724392 |
|
910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2AK1 |
0.0388552182724392 |
|
911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD61 |
0.0388552182724392 |
|
912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL851P |
0.0388552182724392 |
|
913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR759 |
0.038896037283757 |
|
914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM65B |
0.0389412210895559 |
|
915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM174A |
0.0390254892012357 |
|
916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R3C |
0.0390826975272045 |
|
917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAK1 |
0.0392811890996529 |
|
918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGNBP1 |
0.0392811890996529 |
|
919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00336 |
0.0392811890996529 |
|
920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIM1 |
0.039282803165945 |
|
921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252687.1 |
0.039282803165945 |
|
922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM217 |
0.039282803165945 |
|
923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238375.1 |
0.039282803165945 |
|
924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC142 |
0.0393021620802894 |
|
925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL53 |
0.0393021620802894 |
|
926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC31 |
0.0393021620802894 |
|
927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LBX2 |
0.0393021620802894 |
|
928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCGF1 |
0.0393021620802894 |
|
929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM45A |
0.0394151743806331 |
|
930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf132 |
0.0394619068656233 |
|
931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCA1A |
0.0394619068656233 |
|
932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4636 |
0.039594354133956 |
|
933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000253059.1 |
0.0396972218777765 |
|
934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPS8L1 |
0.0397046793516316 |
|
935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAAF3 |
0.0397383329205568 |
|
936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNI3 |
0.0397383329205568 |
|
937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSBP |
0.0397560355985754 |
|
938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD54B |
0.0397560355985754 |
|
939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252434.1 |
0.0397626766682074 |
|
940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA67|ENSG00000207419.1 |
0.0398207995101119 |
|
941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBOAT1 |
0.0399751440301148 |
|
942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYTH3 |
0.0400096241624478 |
|
943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL26P |
0.0400578203759541 |
|
944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM3 |
0.0402348212069342 |
|
945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFDN6 |
0.0402705227993148 |
|
946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGL2 |
0.0402705227993148 |
|
947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAPBP |
0.0402705227993148 |
|
948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAXX |
0.0402705227993148 |
|
949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB22 |
0.0402705227993148 |
|
950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0391 |
0.0402958785691895 |
|
951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYLK2 |
0.0403528759099229 |
|
952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXS1 |
0.0403528759099229 |
|
953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPSAP58 |
0.0403571967131386 |
|
954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOX |
0.0403623672655473 |
|
955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT88 |
0.0406897569392644 |
|
956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17D |
0.0406897569392644 |
|
957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS18 |
0.0407523298564036 |
|
958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GALT4 |
0.0407523298564036 |
|
959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR46 |
0.0407523298564036 |
|
960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS8 |
0.0407645471514996 |
|
961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00152 |
0.0408071494000634 |
|
962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLGLB1 |
0.0408071494000634 |
|
963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLGLB2 |
0.0408071494000634 |
|
964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGPD1 |
0.0408071494000634 |
|
965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMNN |
0.0408582758405505 |
|
966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PACSIN1 |
0.0409625081294002 |
|
967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRC |
0.0410784723563404 |
|
968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPM4 |
0.0410784723563404 |
|
969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD7 |
0.0411035591343297 |
|
970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP62 |
0.0411396165811153 |
|
971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST8SIA4 |
0.0411396165811153 |
|
972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548P |
0.0411396165811153 |
|
973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUZ |
0.0411575310767748 |
|
974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED25 |
0.0411575310767748 |
|
975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E2F3 |
0.0412679320559861 |
|
976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC70 |
0.0412882544123463 |
|
977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNNBL1 |
0.0413199418418534 |
|
978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP5D1 |
0.0413241498459008 |
|
979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMAL2 |
0.0414221752672129 |
|
980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMCX4 |
0.0414884110804556 |
|
981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC7 |
0.0417055692999592 |
|
982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0513 |
0.0417055692999592 |
|
983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM90A27P |
0.0417915965419734 |
|
984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIRC8 |
0.0417915965419734 |
|
985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM90A28P |
0.0417915965419734 |
|
986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKD2 |
0.0417924662018303 |
|
987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS10 |
0.0417929709310739 |
|
988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP15 |
0.0418723355017342 |
|
989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRERF1 |
0.0419620701450152 |
|
990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
N6AMT2 |
0.0423448385499987 |
|
991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMYD1 |
0.0423726428856317 |
|
992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4780 |
0.0423726428856317 |
|
993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP1 |
0.0423726428856317 |
|
994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THNSL2 |
0.0423726428856317 |
|
995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PXT1 |
0.0425405939431349 |
|
996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCA1B |
0.0425443444332784 |
|
997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF7L |
0.0425741005636616 |
|
998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTK |
0.0425741005636616 |
|
999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM8A |
0.0425741005636616 |
|
1000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMCX1 |
0.0427281524889965 |
|
1001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBLAC2 |
0.0427686064187832 |
|
1002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL36A |
0.0427778062303262 |
|
1003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLA |
0.0427778062303262 |
|
1004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPH2 |
0.0427778062303262 |
|
1005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP109 |
0.0428399073602053 |
|
1006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCSK1 |
0.0429532866244705 |
|
1007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A16 |
0.0429755571454716 |
|
1008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD37 |
0.0429755571454716 |
|
1009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEAD2 |
0.0429755571454716 |
|
1010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRTM4 |
0.0430744471115386 |
|
1011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETV7 |
0.0430816147278492 |
|
1012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGN5 |
0.0432177855831858 |
|
1013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLTSCR1L |
0.0432631848656054 |
|
1014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF391 |
0.0432660283347336 |
|
1015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238718.1 |
0.0432731032611815 |
|
1016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR320D1 |
0.0433126219937009 |
|
1017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS31 |
0.0433126219937009 |
|
1018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A15 |
0.0433126219937009 |
|
1019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR621 |
0.0433126219937009 |
|
1020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPTE2P5 |
0.0433126219937009 |
|
1021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUGT1P3 |
0.0433126219937009 |
|
1022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252354.1 |
0.0433230204353368 |
|
1023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFEB |
0.0433713459304206 |
|
1024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGC |
0.0433713459304206 |
|
1025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUCO |
0.0434631105410469 |
|
1026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP4S1 |
0.0436119293796019 |
|
1027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK5 |
0.0436750568304043 |
|
1028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS16 |
0.0436792864942672 |
|
1029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POM121L2 |
0.0436792864942672 |
|
1030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF11 |
0.0436929090189878 |
|
1031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239137.1 |
0.0437137468789178 |
|
1032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT5 |
0.0437137468789178 |
|
1033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF8 |
0.0437233098718303 |
|
1034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4324 |
0.0437656781337336 |
|
1035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPIA |
0.0437658658640969 |
|
1036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD36BP2 |
0.0437658658640969 |
|
1037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNDIG1 |
0.0437991319281967 |
|
1038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX6B2 |
0.0438986928924653 |
|
1039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUV420H2 |
0.0438986928924653 |
|
1040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM71E2 |
0.0438986928924653 |
|
1041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL11 |
0.0438986928924653 |
|
1042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM190 |
0.0438986928924653 |
|
1043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM238 |
0.0438986928924653 |
|
1044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBCC |
0.0439579686686929 |
|
1045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP7B |
0.0441676872080458 |
|
1046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG11 |
0.0441676872080458 |
|
1047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP14C |
0.0441676872080458 |
|
1048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARRDC5 |
0.0442215029608513 |
|
1049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIGLA |
0.0442880404198733 |
|
1050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL443P |
0.0442916692228553 |
|
1051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX2 |
0.0442961543050351 |
|
1052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252295.1 |
0.0442961543050351 |
|
1053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMAL1 |
0.0443016750285736 |
|
1054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPARD |
0.0444530093296418 |
|
1055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GEM |
0.044471270394442 |
|
1056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRCC6 |
0.0444965134099171 |
|
1057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R15A |
0.0445459926998495 |
|
1058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TULP2 |
0.0445459926998495 |
|
1059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUCB1 |
0.0445459926998495 |
|
1060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYM2 |
0.0445674672195345 |
|
1061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPC5 |
0.0445908497674946 |
|
1062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTOV1 |
0.0445941886092516 |
|
1063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4749 |
0.0445941886092516 |
|
1064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNKP |
0.0445941886092516 |
|
1065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCE |
0.044608058455482 |
|
1066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB116 |
0.0447185582394646 |
|
1067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf112 |
0.0447349475044349 |
|
1068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRSK1 |
0.0447408120144497 |
|
1069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD180 |
0.0448086849991181 |
|
1070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL7L1 |
0.044872916966142 |
|
1071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf226 |
0.044872916966142 |
|
1072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHISA7 |
0.0448733601416461 |
|
1073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFL2 |
0.0449195647765743 |
|
1074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA4 |
0.0451635144160036 |
|
1075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR111 |
0.0452006556488143 |
|
1076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPG |
0.0454175028722977 |
|
1077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM136A |
0.0454175028722977 |
|
1078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC8 |
0.0454703058705237 |
|
1079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGIF2LX |
0.0455918876909858 |
|
1080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P30 |
0.0456127453089515 |
|
1081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P9 |
0.0456127453089515 |
|
1082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL101P |
0.045638373629619 |
|
1083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSKS |
0.0456864256315133 |
|
1084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAC1 |
0.0457136970039571 |
|
1085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM63B |
0.0457918561799602 |
|
1086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGPD2 |
0.0458213775461035 |
|
1087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238979.1 |
0.0458213775461035 |
|
1088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRCC1 |
0.0458213775461035 |
|
1089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P15 |
0.0458213775461035 |
|
1090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239049.1 |
0.0458213775461035 |
|
1091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS12 |
0.0460763017623231 |
|
1092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALM3 |
0.0461593639450383 |
|
1093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGIR |
0.0461593639450383 |
|
1094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG8 |
0.0461593639450383 |
|
1095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPN5 |
0.0462826421147162 |
|
1096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4436A |
0.0462910360642278 |
|
1097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238322.1 |
0.0463101539164795 |
|
1098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL618P |
0.0463633722680988 |
|
1099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFWD2 |
0.0464444565896216 |
|
1100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC1 |
0.0464667971910009 |
|
1101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL193P |
0.0465852689041545 |
|
1102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLC4 |
0.046661551818009 |
|
1103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AA |
0.0466864668455018 |
|
1104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BA |
0.0466864668455018 |
|
1105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGN |
0.0466864668455018 |
|
1106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK3 |
0.0467062704942242 |
|
1107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDRG1 |
0.0467875505183932 |
|
1108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL14 |
0.0467895016581683 |
|
1109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D22B |
0.0468349525530716 |
|
1110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL273P |
0.0468349525530716 |
|
1111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF8 |
0.0468349525530716 |
|
1112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDEF |
0.0468355099612883 |
|
1113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA9 |
0.0468465277624835 |
|
1114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NQO1 |
0.0468565688842882 |
|
1115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238683.1 |
0.0468565688842882 |
|
1116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf223 |
0.0470645879913741 |
|
1117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNRD1 |
0.0472206479188851 |
|
1118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R11 |
0.0472206479188851 |
|
1119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF39 |
0.0472206479188851 |
|
1120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM31 |
0.0472206479188851 |
|
1121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MNF1 |
0.0472514823797349 |
|
1122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBP1 |
0.0472514823797349 |
|
1123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3934 |
0.0472514823797349 |
|
1124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL9 |
0.0473247793696614 |
|
1125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB122 |
0.0473501647749585 |
|
1126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXK |
0.047389976696989 |
|
1127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRFN2 |
0.0474737906673193 |
|
1128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP26B1 |
0.0477003396904702 |
|
1129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3616 |
0.0477199702796182 |
|
1130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA15|ENSG00000252193.1 |
0.0477539239406538 |
|
1131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A2 |
0.0477848223760763 |
|
1132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKS1A |
0.047791869535914 |
|
1133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000252228.1 |
0.0478030809488024 |
|
1134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMBL |
0.0479002449078332 |
|
1135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB123 |
0.0479175650540425 |
|
1136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB124 |
0.0479175650540425 |
|
1137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REM1 |
0.0479175650540425 |
|
1138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFAT5 |
0.0479307946813983 |
|
1139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TST |
0.0479411962362264 |
|
1140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD6 |
0.047954703616029 |
|
1141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238651.1 |
0.047954703616029 |
|
1142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL160P |
0.0480672209209208 |
|
1143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD53 |
0.0480672209209208 |
|
1144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX261 |
0.0480672209209208 |
|
1145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR12 |
0.0480719642845321 |
|
1146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM40 |
0.0480807765129703 |
|
1147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM10 |
0.0480807765129703 |
|
1148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM15 |
0.0480807765129703 |
|
1149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM26 |
0.0480807765129703 |
|
1150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TJP3 |
0.0481519593228616 |
|
1151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRP54 |
0.0482847108348308 |
|
1152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1825 |
0.0483143369317142 |
|
1153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB121 |
0.048345276621296 |
|
1154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR33 |
0.0485542113424003 |
|
1155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISOC2 |
0.0485816886541504 |
|
1156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF628 |
0.0485816886541504 |
|
1157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT14 |
0.0485816886541504 |
|
1158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSC5D |
0.0485816886541504 |
|
1159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBK2 |
0.0485816886541504 |
|
1160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGK110 |
0.0485816886541504 |
|
1161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGM2 |
0.0487999345285489 |
|
1162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRAS |
0.0488905624531575 |
|
1163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAF1 |
0.0488905624531575 |
|
1164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00028 |
0.0489215401519105 |
|
1165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPFIA3 |
0.0489553880451365 |
|
1166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A8 |
0.0490683063754802 |
|
1167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF845 |
0.0492914367119709 |
|
1168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF525 |
0.0492914367119709 |
|
1169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCND3 |
0.0493612890595819 |
|
1170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC6A |
0.0494285649826435 |
|
1171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLOC1S3 |
0.0494285649826435 |
|
1172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP161 |
0.0494511784596985 |
|
1173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VN1R4 |
0.0495333192205579 |
|
1174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THTPA |
0.0495448481096668 |
|
1175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1G2 |
0.0495448481096668 |
|
1176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JPH4 |
0.0495448481096668 |
|
1177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221252.1 |
0.0495851470557377 |
|
1178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF638 |
0.04959661075692 |
|
1179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC4F |
0.0496251310356139 |
|
1180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD207 |
0.0496251310356139 |
|
1181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239064.1 |
0.0499462988303362 |
|
1182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAPG |
0.0499505153060844 |
|
1183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH8 |
0.0499658703962369 |
|
1184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1B1 |
0.0500884023016912 |
|
1185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APCDD1 |
0.0501049776186336 |
|
1186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMA6 |
0.0501491094341948 |
|
1187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMY1A |
0.050151672223999 |
|
1188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMY1B |
0.050151672223999 |
|
1189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMY1C |
0.050151672223999 |
|
1190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMY2A |
0.050151672223999 |
|
1191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMY2B |
0.050151672223999 |
|
1192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNPC3 |
0.050151672223999 |
|
1193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL28 |
0.0501557725913973 |
|
1194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADM5 |
0.0502320300151256 |
|
1195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2L12 |
0.0502320300151256 |
|
1196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPT1C |
0.0502320300151256 |
|
1197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF3 |
0.0502320300151256 |
|
1198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5088 |
0.0502320300151256 |
|
1199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRMT1 |
0.0502320300151256 |
|
1200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MANBA |
0.0502540815695938 |
|
1201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFKBIA |
0.0502975603839253 |
|
1202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFA4P |
0.0503490380975711 |
|
1203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFA3 |
0.0503490380975711 |
|
1204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFA1 |
0.0503490380975711 |
|
1205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG17 |
0.0504222425836461 |
|
1206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA71B |
0.0504222425836461 |
|
1207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA71A |
0.0504222425836461 |
|
1208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA71C |
0.0504222425836461 |
|
1209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA71D |
0.0504222425836461 |
|
1210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA71|ENSG00000201811.1 |
0.0504222425836461 |
|
1211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG11 |
0.0504222425836461 |
|
1212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA60 |
0.0504222425836461 |
|
1213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL364P |
0.050580067612046 |
|
1214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP2S1 |
0.0507038040413716 |
|
1215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFPL4AL1 |
0.0507515160675295 |
|
1216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFPL4A |
0.0507515160675295 |
|
1217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP11 |
0.0507515160675295 |
|
1218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFA |
0.050884143916114 |
|
1219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD9 |
0.0510190566060535 |
|
1220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT5 |
0.0510308749637934 |
|
1221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTPBP2 |
0.051219489548066 |
|
1222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAD2L1BP |
0.051219489548066 |
|
1223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTD2 |
0.051316857999107 |
|
1224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239103.1 |
0.0513221129492608 |
|
1225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC6B |
0.0513876852419964 |
|
1226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00240 |
0.0514220133683488 |
|
1227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL4 |
0.0515522229106836 |
|
1228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIFC1 |
0.0515670165207883 |
|
1229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUTA |
0.0515670165207883 |
|
1230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF1 |
0.0515670165207883 |
|
1231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5004 |
0.0515670165207883 |
|
1232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4635 |
0.0515748099479383 |
|
1233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A7 |
0.0515748099479383 |
|
1234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A18 |
0.0515748099479383 |
|
1235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A19 |
0.0515748099479383 |
|
1236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TERT |
0.0515748099479383 |
|
1237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4457 |
0.0515748099479383 |
|
1238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLPTM1L |
0.0515748099479383 |
|
1239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A3 |
0.0516753480689476 |
|
1240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL332P |
0.0517557587864979 |
|
1241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDP1 |
0.0518910102828337 |
|
1242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378D2 |
0.0518910102828337 |
|
1243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSTM2L |
0.0519344002698696 |
|
1244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEATR5A |
0.0519710437985907 |
|
1245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTI1 |
0.0519777641633526 |
|
1246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPRD1B |
0.0519777641633526 |
|
1247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM36 |
0.0520746992654879 |
|
1248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1538 |
0.0520998931032411 |
|
1249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB118 |
0.0521481128151762 |
|
1250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000212134.1 |
0.0521481128151762 |
|
1251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS5 |
0.0522232653123734 |
|
1252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD78|ENSG00000208317.1 |
0.0522232653123734 |
|
1253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB37 |
0.0522232653123734 |
|
1254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF474 |
0.0522411587043752 |
|
1255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT3 |
0.0522538170728731 |
|
1256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP164 |
0.0522613996840239 |
|
1257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGC |
0.0523917248791179 |
|
1258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABGAP1L |
0.0524246667347819 |
|
1259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP98 |
0.0524270575056619 |
|
1260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAMP4 |
0.0524886392696955 |
|
1261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA20|ENSG00000253060.1 |
0.0524886392696955 |
|
1262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL13 |
0.0524886392696955 |
|
1263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINC1 |
0.0524982359378297 |
|
1264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP67 |
0.0524982359378297 |
|
1265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP68 |
0.0524982359378297 |
|
1266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC1A5 |
0.0525198083573651 |
|
1267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM173B |
0.0525258060672869 |
|
1268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DACT3 |
0.0525556394887361 |
|
1269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf105 |
0.0525601456584512 |
|
1270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM67 |
0.0525908763916531 |
|
1271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP4 |
0.0525970694155368 |
|
1272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF404 |
0.0526277420713019 |
|
1273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF45 |
0.0526277420713019 |
|
1274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB119 |
0.0526546300474223 |
|
1275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCK |
0.0527505730825408 |
|
1276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP482 |
0.0527505730825408 |
|
1277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPXCR1 |
0.052866183077668 |
|
1278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AB |
0.0528705601522761 |
|
1279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3B |
0.0528705601522761 |
|
1280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H1C |
0.0528705601522761 |
|
1281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BB |
0.0528705601522761 |
|
1282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3C |
0.0528705601522761 |
|
1283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEIS3 |
0.0528883771028943 |
|
1284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBNDD2 |
0.0528961458227237 |
|
1285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGT |
0.0528961458227237 |
|
1286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC2 |
0.0528961458227237 |
|
1287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINT3 |
0.0528961458227237 |
|
1288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC6 |
0.0528961458227237 |
|
1289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPPIN |
0.0528961458227237 |
|
1290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP485 |
0.0528961458227237 |
|
1291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS10 |
0.0528964116459786 |
|
1292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCRA |
0.0529376213121874 |
|
1293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNPY3 |
0.0529376213121874 |
|
1294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGA1 |
0.0529394661970096 |
|
1295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHRR |
0.0529689324276336 |
|
1296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRD9 |
0.0529689324276336 |
|
1297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf55 |
0.0529689324276336 |
|
1298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC127 |
0.0529689324276336 |
|
1299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP72 |
0.0529689324276336 |
|
1300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC3 |
0.0529689324276336 |
|
1301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC14B |
0.0529689324276336 |
|
1302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4456 |
0.0529689324276336 |
|
1303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD6 |
0.0529689324276336 |
|
1304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHG4B |
0.0529689324276336 |
|
1305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDHA |
0.0529689324276336 |
|
1306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A3 |
0.0529689324276336 |
|
1307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPPP |
0.0529689324276336 |
|
1308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIP13 |
0.0529689324276336 |
|
1309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC11B |
0.0529689324276336 |
|
1310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC11 |
0.0529689324276336 |
|
1311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238312.1 |
0.0530919439542169 |
|
1312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL17 |
0.0530927373068933 |
|
1313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XKR7 |
0.0531066251800055 |
|
1314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP481 |
0.0531143064769596 |
|
1315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCM2L |
0.0531143064769596 |
|
1316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC112 |
0.0531530769568842 |
|
1317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPH2 |
0.0531709699895553 |
|
1318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP36 |
0.0532617825061529 |
|
1319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL403P |
0.0532617825061529 |
|
1320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC8 |
0.0532903619505798 |
|
1321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAZ1A |
0.0532957084857671 |
|
1322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX34 |
0.053443775869175 |
|
1323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCYOX1 |
0.0534793332660091 |
|
1324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM3OS |
0.0534829924350365 |
|
1325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR214 |
0.0534829924350365 |
|
1326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR199A2 |
0.0534829924350365 |
|
1327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPL |
0.0535456505441619 |
|
1328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239031.1 |
0.0535583913705037 |
|
1329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNCAIP |
0.0535757750414259 |
|
1330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLFM4 |
0.0535843412996148 |
|
1331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF184 |
0.0536937399858811 |
|
1332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP11 |
0.0537451071879396 |
|
1333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC10A |
0.0537865671853395 |
|
1334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROMO1 |
0.0538208499652069 |
|
1335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BJ |
0.0538352714635648 |
|
1336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AG |
0.0538352714635648 |
|
1337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BK |
0.0538352714635648 |
|
1338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4I |
0.0538352714635648 |
|
1339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AH |
0.0538352714635648 |
|
1340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3143 |
0.0538352714635648 |
|
1341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CETN3 |
0.0539158857579205 |
|
1342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDNF |
0.0540501522387028 |
|
1343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKD2 |
0.0540637812354491 |
|
1344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELF1 |
0.0540850916002238 |
|
1345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL841P |
0.054186444821344 |
|
1346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSE1 |
0.0542223498804764 |
|
1347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR70 |
0.0542321403612339 |
|
1348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VEGFA |
0.0542677247358009 |
|
1349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1275 |
0.0543106933615132 |
|
1350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRM4 |
0.0543106933615132 |
|
1351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOC |
0.0543253148642496 |
|
1352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTKN |
0.0543441410347782 |
|
1353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL10A |
0.0544092684756324 |
|
1354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEAD3 |
0.0544092684756324 |
|
1355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TULP1 |
0.0544092684756324 |
|
1356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP155 |
0.0546125041615714 |
|
1357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO9 |
0.0546411278243792 |
|
1358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATHL1 |
0.0546411278243792 |
|
1359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALNT4 |
0.0546411278243792 |
|
1360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BET1L |
0.0546411278243792 |
|
1361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFITM1 |
0.0546411278243792 |
|
1362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFITM2 |
0.0546411278243792 |
|
1363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFITM3 |
0.0546411278243792 |
|
1364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFITM5 |
0.0546411278243792 |
|
1365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP6 |
0.0546411278243792 |
|
1366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODF3 |
0.0546411278243792 |
|
1367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKP3 |
0.0546411278243792 |
|
1368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD13 |
0.0546411278243792 |
|
1369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIC8A |
0.0546411278243792 |
|
1370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL838P |
0.0546411278243792 |
|
1371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB1C1 |
0.0546411278243792 |
|
1372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGIRR |
0.0546411278243792 |
|
1373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRT3 |
0.0546411278243792 |
|
1374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH19 |
0.0546543327868552 |
|
1375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2S |
0.0548463355781716 |
|
1376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHB2 |
0.0550222246707692 |
|
1377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMG1 |
0.0550222246707692 |
|
1378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPCAT3 |
0.0550222246707692 |
|
1379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1S |
0.0550222246707692 |
|
1380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM6 |
0.0550233542540766 |
|
1381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL37P |
0.0551805420047419 |
|
1382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF3B |
0.0551838261208758 |
|
1383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA6 |
0.0551943854417607 |
|
1384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNGAP1 |
0.0552280740653575 |
|
1385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCR2 |
0.0552327104866254 |
|
1386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADTRP |
0.0552437970469148 |
|
1387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX37 |
0.0552506750140687 |
|
1388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00598 |
0.0553341634526704 |
|
1389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53RK |
0.0553738151910479 |
|
1390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5AR2 |
0.0554006932627165 |
|
1391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSM2 |
0.0554182564095623 |
|
1392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF83 |
0.0554247937890914 |
|
1393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSCN1 |
0.0554790096714274 |
|
1394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXI3 |
0.0554851359919381 |
|
1395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED10 |
0.055582550487756 |
|
1396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN11 |
0.0556367504913353 |
|
1397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC29A1 |
0.0556367504913353 |
|
1398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf19 |
0.0557149207977001 |
|
1399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRH |
0.0557376253515263 |
|
1400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPRX1 |
0.0559867994105757 |
|
1401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRX |
0.0559867994105757 |
|
1402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPRX2P |
0.0559867994105757 |
|
1403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT2A1 |
0.0559867994105757 |
|
1404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNF4A |
0.0560108190267588 |
|
1405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf62 |
0.0560108190267588 |
|
1406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AARS2 |
0.0560779802110671 |
|
1407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETFB |
0.0561425276463022 |
|
1408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRPK1 |
0.0561551977445202 |
|
1409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCD1 |
0.0561618501656911 |
|
1410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPD3 |
0.0561618501656911 |
|
1411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM211B |
0.0561618501656911 |
|
1412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGT1 |
0.0561618501656911 |
|
1413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDND2 |
0.0562559731015543 |
|
1414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKG7 |
0.0562559731015543 |
|
1415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIM2 |
0.0562559731015543 |
|
1416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPR3 |
0.0563540150764472 |
|
1417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf42 |
0.0563774462192931 |
|
1418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC9 |
0.0564482220105506 |
|
1419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR24 |
0.0564482220105506 |
|
1420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5AR1 |
0.0564482220105506 |
|
1421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUCAT1 |
0.0564810859593521 |
|
1422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP215 |
0.0565405454903128 |
|
1423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFXL1 |
0.0565405454903128 |
|
1424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF8 |
0.0565971473043659 |
|
1425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERAP1 |
0.056624221166365 |
|
1426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS2 |
0.056722808161248 |
|
1427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM9SF4 |
0.0568092750704323 |
|
1428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJA3 |
0.0568377943607286 |
|
1429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00556 |
0.0568377943607286 |
|
1430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJB2 |
0.0568377943607286 |
|
1431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS6 |
0.0568790590228203 |
|
1432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP480 |
0.0569497609175041 |
|
1433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD6 |
0.0570785692107271 |
|
1434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCSC3 |
0.0571123455040887 |
|
1435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POFUT1 |
0.0571580587307889 |
|
1436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL2RB |
0.0571584235663546 |
|
1437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH17 |
0.0571601359289243 |
|
1438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDX |
0.0571613861806511 |
|
1439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238872.1 |
0.0572158442107386 |
|
1440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPA1P30 |
0.0572530090209602 |
|
1441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LATS2 |
0.0572530090209602 |
|
1442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238893.1 |
0.0572530090209602 |
|
1443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCUBE3 |
0.0573333768868537 |
|
1444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL604P |
0.0573577720806883 |
|
1445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA36C |
0.0573577720806883 |
|
1446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP3CA |
0.0574071565611997 |
|
1447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1255A |
0.0574071565611997 |
|
1448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACIN1 |
0.0574192214161019 |
|
1449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf119 |
0.0574192214161019 |
|
1450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEBPE |
0.0574192214161019 |
|
1451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COG6 |
0.0575534934701176 |
|
1452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP6R1 |
0.0575636807336815 |
|
1453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPBP1 |
0.0577215995461908 |
|
1454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASXL1 |
0.0577272845123413 |
|
1455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELSPBP1 |
0.0577719284856877 |
|
1456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P14 |
0.0578450938153933 |
|
1457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPLA1 |
0.0579910404494655 |
|
1458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F5 |
0.057991513218804 |
|
1459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMNB1 |
0.0580053415476461 |
|
1460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIAS1 |
0.0581502253748306 |
|
1461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM150B |
0.058159782368254 |
|
1462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRPF3 |
0.0581630707523555 |
|
1463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HECTD1 |
0.0581923016081881 |
|
1464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL381P |
0.0582874249459363 |
|
1465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GINS2 |
0.0582874249459363 |
|
1466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRWD3 |
0.0583240260199691 |
|
1467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA64|ENSG00000239008.1 |
0.0583240260199691 |
|
1468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR128 |
0.0584495608955495 |
|
1469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252989.1 |
0.0584495608955495 |
|
1470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFG |
0.0584495608955495 |
|
1471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPAL1 |
0.0584564873258711 |
|
1472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNGA1 |
0.0584564873258711 |
|
1473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGC10955 |
0.0584766773771174 |
|
1474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BSPH1 |
0.0585337449743661 |
|
1475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO8 |
0.0585372966362089 |
|
1476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTPBP3 |
0.0585372966362089 |
|
1477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF216 |
0.0586496611417709 |
|
1478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPH9 |
0.0586705705774411 |
|
1479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS18A |
0.0586705705774411 |
|
1480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf81 |
0.0587230896734865 |
|
1481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR54 |
0.0587230896734865 |
|
1482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00917 |
0.0587524781575336 |
|
1483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
R3HDML |
0.0588206838446362 |
|
1484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUL9 |
0.058825195378796 |
|
1485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000272445.1 |
0.0588436503328548 |
|
1486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF40 |
0.0588594335756609 |
|
1487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF219 |
0.0588594335756609 |
|
1488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOLA3 |
0.0588903581473621 |
|
1489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOB1A |
0.0588903581473621 |
|
1490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPN1 |
0.0589185681565887 |
|
1491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE7 |
0.0590101677361308 |
|
1492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE8 |
0.0590101677361308 |
|
1493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX24 |
0.0590570652993029 |
|
1494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35F4 |
0.0590647635247913 |
|
1495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP2 |
0.0591607086999184 |
|
1496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3921 |
0.0592110192957357 |
|
1497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC9 |
0.0592335932051682 |
|
1498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP2 |
0.05925636846192 |
|
1499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC8A2 |
0.0592693532935147 |
|
1500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPTN |
0.0592693532935147 |
|
1501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAPA |
0.0592693532935147 |
|
1502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF541 |
0.0592693532935147 |
|
1503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL322P |
0.0592693532935147 |
|
1504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL20 |
0.0592993123263612 |
|
1505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP160 |
0.0592993123263612 |
|
1506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRF1 |
0.0593798703515676 |
|
1507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA16 |
0.0593798703515676 |
|
1508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPH |
0.0594246630876998 |
|
1509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS36 |
0.0594246630876998 |
|
1510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC125 |
0.0594246630876998 |
|
1511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF9 |
0.0594246630876998 |
|
1512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD17 |
0.0594246630876998 |
|
1513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RC3H1 |
0.0594555250309337 |
|
1514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B14 |
0.0594593642212676 |
|
1515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BGRL |
0.0595018473666028 |
|
1516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF160 |
0.0595151017590996 |
|
1517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF347 |
0.0595151017590996 |
|
1518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF415 |
0.0595151017590996 |
|
1519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIC |
0.0596241966945141 |
|
1520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL689P |
0.0596241966945141 |
|
1521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3191 |
0.0596412830222608 |
|
1522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERAP2 |
0.0596613539974139 |
|
1523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL711P |
0.0597865255218276 |
|
1524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKPD1 |
0.0598117601689843 |
|
1525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB11 |
0.059889651913719 |
|
1526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH24 |
0.059889651913719 |
|
1527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNMD |
0.0598942306030393 |
|
1528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM39 |
0.0599875178987449 |
|
1529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP79 |
0.0600446312696344 |
|
1530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPSB2 |
0.0600624782241241 |
|
1531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC23 |
0.0600624782241241 |
|
1532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL13P5 |
0.0600624782241241 |
|
1533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSTNP2 |
0.0600624782241241 |
|
1534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENO2 |
0.0600624782241241 |
|
1535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212224.1 |
0.0600998878002156 |
|
1536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2QL1 |
0.0601905775032286 |
|
1537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSUN2 |
0.0601905775032286 |
|
1538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRD5A1 |
0.0601905775032286 |
|
1539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK7 |
0.0602186930609119 |
|
1540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF100 |
0.0602359582698813 |
|
1541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP30 |
0.0602551492988289 |
|
1542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUL7 |
0.0602879793165407 |
|
1543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL2 |
0.0602879793165407 |
|
1544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCF4 |
0.0602924932566528 |
|
1545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAST |
0.0603486843968836 |
|
1546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DARS2 |
0.0603793222091078 |
|
1547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF18 |
0.0604010959178681 |
|
1548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF4 |
0.0604010959178681 |
|
1549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000251817.1 |
0.0604010959178681 |
|
1550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST7 |
0.0604244389960196 |
|
1551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APMAP |
0.0604244389960196 |
|
1552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTPAL |
0.0604250679890401 |
|
1553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAAF1 |
0.0604540974174492 |
|
1554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP285 |
0.0605052212880091 |
|
1555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRX4 |
0.0605702815034809 |
|
1556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPCAT1 |
0.0605702815034809 |
|
1557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4277 |
0.0605702815034809 |
|
1558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL36 |
0.0605702815034809 |
|
1559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFS6 |
0.0605702815034809 |
|
1560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDHAP3 |
0.0605702815034809 |
|
1561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF681 |
0.060624427110836 |
|
1562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA62|ENSG00000252443.1 |
0.0607457813456335 |
|
1563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP185 |
0.0608027519856466 |
|
1564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf68 |
0.0609833772873892 |
|
1565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGSM1 |
0.0610816922525992 |
|
1566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FENDRR |
0.0611885137337039 |
|
1567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXF1 |
0.0611885137337039 |
|
1568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTHFSD |
0.0611885137337039 |
|
1569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXC2 |
0.0611885137337039 |
|
1570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXL1 |
0.0611885137337039 |
|
1571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF890P |
0.0613286190069812 |
|
1572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOB1 |
0.0613508316413681 |
|
1573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf93 |
0.0613588318419142 |
|
1574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB5 |
0.0613588318419142 |
|
1575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA73|ENSG00000252114.1 |
0.0613588318419142 |
|
1576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPGRIP1L |
0.0613749664575476 |
|
1577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN7B |
0.0614076652231925 |
|
1578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf73 |
0.0614076652231925 |
|
1579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3617 |
0.0615311962756574 |
|
1580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VN1R2 |
0.0615877671293554 |
|
1581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR640 |
0.0616192691253816 |
|
1582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHACTR1 |
0.0616402673689439 |
|
1583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGB4 |
0.0616659712923141 |
|
1584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH22 |
0.0617193287928975 |
|
1585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35C2 |
0.0617193287928975 |
|
1586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELMO2 |
0.0617193287928975 |
|
1587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTE1 |
0.0617254952901644 |
|
1588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSIG10L |
0.0618089940711164 |
|
1589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3168 |
0.061830411423582 |
|
1590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL597P |
0.061830411423582 |
|
1591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf164 |
0.0618700210187977 |
|
1592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADD2 |
0.0619020557865433 |
|
1593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAX2 |
0.061942896621068 |
|
1594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FITM2 |
0.0620916995262236 |
|
1595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLX2 |
0.0621125674673838 |
|
1596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DQX1 |
0.0621125674673838 |
|
1597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AUP1 |
0.0621125674673838 |
|
1598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTRA2 |
0.0621125674673838 |
|
1599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOXL3 |
0.0621125674673838 |
|
1600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBB3 |
0.0621140218985851 |
|
1601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATN1 |
0.0623121035022752 |
|
1602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf57 |
0.0623121035022752 |
|
1603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN6 |
0.0623121035022752 |
|
1604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR141 |
0.0623121035022752 |
|
1605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR200C |
0.0623121035022752 |
|
1606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA12 |
0.0623121035022752 |
|
1607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6S1 |
0.0623246802809778 |
|
1608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP4 |
0.0623686795126803 |
|
1609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX6 |
0.0623909872355929 |
|
1610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4458 |
0.0624055867895005 |
|
1611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSP90AB1 |
0.0624145791803201 |
|
1612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4647 |
0.0624145791803201 |
|
1613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35B2 |
0.0624145791803201 |
|
1614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFKBIE |
0.0624145791803201 |
|
1615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf1 |
0.0624841005385087 |
|
1616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAIP2B |
0.0624926638220099 |
|
1617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF5 |
0.0626063525592725 |
|
1618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL4I1 |
0.0626063525592725 |
|
1619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4750 |
0.0626063525592725 |
|
1620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4751 |
0.0626063525592725 |
|
1621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP62 |
0.0626063525592725 |
|
1622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC11 |
0.0626063525592725 |
|
1623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC16 |
0.0626063525592725 |
|
1624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D17 |
0.0626063525592725 |
|
1625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221125.1 |
0.0626063525592725 |
|
1626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VRK3 |
0.0626063525592725 |
|
1627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF473 |
0.0626063525592725 |
|
1628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF334 |
0.0626662147116351 |
|
1629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPHOSPH10 |
0.0626859161909783 |
|
1630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A5 |
0.0627991799623243 |
|
1631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCTN1 |
0.0627991799623243 |
|
1632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9C2 |
0.0628669934487012 |
|
1633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD45 |
0.0628669934487012 |
|
1634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOK1 |
0.0630544730788972 |
|
1635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM133A |
0.0631962282420097 |
|
1636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAP1L3 |
0.0631962282420097 |
|
1637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDX6 |
0.0632670968780006 |
|
1638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMP2 |
0.0633195898839588 |
|
1639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP9 |
0.0633195898839588 |
|
1640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP4 |
0.0633195898839588 |
|
1641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP12 |
0.0633195898839588 |
|
1642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPY26P |
0.0633426997780986 |
|
1643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INO80B |
0.0633449256226744 |
|
1644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP1 |
0.0633449256226744 |
|
1645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOGS |
0.0633449256226744 |
|
1646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLOCK |
0.0633870546738977 |
|
1647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC11 |
0.0634277425388823 |
|
1648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC10B |
0.0634277425388823 |
|
1649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP208 |
0.0634519564618452 |
|
1650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHAF1A |
0.063492107434638 |
|
1651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf10 |
0.063492107434638 |
|
1652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDGFRP2 |
0.063492107434638 |
|
1653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRG1 |
0.063492107434638 |
|
1654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4746 |
0.063492107434638 |
|
1655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLIN4 |
0.063492107434638 |
|
1656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLIN5 |
0.063492107434638 |
|
1657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL121P |
0.063492107434638 |
|
1658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL528P |
0.063492107434638 |
|
1659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA6B |
0.063492107434638 |
|
1660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFAIP8L1 |
0.063492107434638 |
|
1661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN6 |
0.063492107434638 |
|
1662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA68|ENSG00000207166.1 |
0.0636696847485519 |
|
1663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AJUBA |
0.0637095403060987 |
|
1664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP21 |
0.0637747011263442 |
|
1665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCIF1 |
0.0637782854182294 |
|
1666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF335 |
0.0637782854182294 |
|
1667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3A |
0.0637811022059067 |
|
1668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4A |
0.0637811022059067 |
|
1669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4B |
0.0637811022059067 |
|
1670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBB2P1 |
0.0638015514180655 |
|
1671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP5L |
0.0638015514180655 |
|
1672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLTSCR1 |
0.0640135946165731 |
|
1673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMCX2 |
0.0641653682138119 |
|
1674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R3E |
0.0642205796466863 |
|
1675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2L2 |
0.0642205796466863 |
|
1676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1671 |
0.0642751796824674 |
|
1677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFU1 |
0.0643276791079861 |
|
1678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKAIN2 |
0.0643494182479323 |
|
1679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHDH |
0.0644331683031399 |
|
1680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAX |
0.0644331683031399 |
|
1681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTL |
0.0644331683031399 |
|
1682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYS1 |
0.0644331683031399 |
|
1683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK13 |
0.0645004994913513 |
|
1684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHD2 |
0.064507940063955 |
|
1685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF337 |
0.0645146245541078 |
|
1686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNMT |
0.0645828807211332 |
|
1687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX6 |
0.0645828807211332 |
|
1688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R5D |
0.0645828807211332 |
|
1689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF6 |
0.0648394259031466 |
|
1690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMCX6 |
0.0649508581307474 |
|
1691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMCX3 |
0.0649508581307474 |
|
1692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK14 |
0.0650600252264281 |
|
1693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP13 |
0.0651239598097294 |
|
1694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP8 |
0.0651239598097294 |
|
1695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM150C |
0.0651256549624258 |
|
1696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548O2 |
0.065181311595754 |
|
1697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD116|ENSG00000212553.1 |
0.0651877129155012 |
|
1698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A5 |
0.0652266993605354 |
|
1699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROSER1 |
0.0655144737939882 |
|
1700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHLRC3 |
0.0655144737939882 |
|
1701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00332 |
0.0655634935508381 |
|
1702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPI1 |
0.0655753186170644 |
|
1703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF581 |
0.06565393305746 |
|
1704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC106 |
0.06565393305746 |
|
1705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSS1 |
0.0656724851751005 |
|
1706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BST2 |
0.0657759670589145 |
|
1707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf105 |
0.0657778215926011 |
|
1708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238430.1 |
0.0657946204170291 |
|
1709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1281 |
0.0658484678608596 |
|
1710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238791.1 |
0.0658606326395351 |
|
1711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53INP1 |
0.0658606326395351 |
|
1712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC53 |
0.0658606850766 |
|
1713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL74P |
0.0658776349424069 |
|
1714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP5 |
0.0658891111678896 |
|
1715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANG |
0.0659235816038728 |
|
1716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE4 |
0.0659235816038728 |
|
1717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE1 |
0.0659922169177206 |
|
1718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFS1 |
0.0659922169177206 |
|
1719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP271 |
0.0659922169177206 |
|
1720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM12 |
0.0659922169177206 |
|
1721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIT2 |
0.0661300216800732 |
|
1722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM30C |
0.066235407865161 |
|
1723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD61|ENSG00000238377.1 |
0.066235407865161 |
|
1724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D23 |
0.066235407865161 |
|
1725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GINS1 |
0.0662791216737416 |
|
1726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1211 |
0.0663064024385327 |
|
1727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NINL |
0.0665850424110036 |
|
1728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKT1S1 |
0.0666211392286503 |
|
1729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF114 |
0.066635304715101 |
|
1730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD8 |
0.066635304715101 |
|
1731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBDC1 |
0.0667445373128068 |
|
1732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKLE1 |
0.0667532919976445 |
|
1733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD8 |
0.0667532919976445 |
|
1734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL34 |
0.0667532919976445 |
|
1735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDA1 |
0.0667532919976445 |
|
1736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRNAI2 |
0.0667571677163303 |
|
1737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC124 |
0.0668329850308121 |
|
1738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDDM3B |
0.0668573631001478 |
|
1739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE6 |
0.0668573631001478 |
|
1740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE1 |
0.0668573631001478 |
|
1741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00350 |
0.0668607311502537 |
|
1742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPHOSPH8 |
0.0668607311502537 |
|
1743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSPC1 |
0.0668607311502537 |
|
1744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL166P |
0.0668607311502537 |
|
1745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYM5 |
0.0668607311502537 |
|
1746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238665.1 |
0.0668607311502537 |
|
1747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF750 |
0.0668794814950926 |
|
1748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000212579.1 |
0.0668853909818576 |
|
1749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5690 |
0.0668853909818576 |
|
1750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE12 |
0.0669019868792838 |
|
1751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00571 |
0.0669357133028834 |
|
1752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BABAM1 |
0.0669847170740834 |
|
1753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL80P |
0.0672110564157687 |
|
1754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD27|ENSG00000252128.1 |
0.0672110564157687 |
|
1755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPAR4 |
0.0673338264159431 |
|
1756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY10 |
0.0673338264159431 |
|
1757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG17 |
0.0673721431314729 |
|
1758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A17 |
0.0674398551322077 |
|
1759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP99 |
0.0674627675305149 |
|
1760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4764 |
0.0675091210603763 |
|
1761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOMEZ |
0.0675361934760184 |
|
1762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERINC3 |
0.0675905802347523 |
|
1763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM70A |
0.0677358181131384 |
|
1764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LNP1 |
0.0677358181131384 |
|
1765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USHBP1 |
0.0677411337208822 |
|
1766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLVAP |
0.0677490230984934 |
|
1767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP468 |
0.0677519356071925 |
|
1768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARRDC2 |
0.0677519356071925 |
|
1769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPEF2 |
0.0677872644319207 |
|
1770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM221 |
0.0679184612705039 |
|
1771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF677 |
0.0679814409754649 |
|
1772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC10 |
0.0679966848454475 |
|
1773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INS |
0.0679978327232307 |
|
1774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4686 |
0.0679978327232307 |
|
1775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TH |
0.0679978327232307 |
|
1776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MVB12A |
0.0680281507644405 |
|
1777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRR |
0.0680812666998928 |
|
1778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP162 |
0.0680980543634238 |
|
1779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AASDH |
0.0680980543634238 |
|
1780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCKDHB |
0.068107441423702 |
|
1781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAD2 |
0.0681333165410278 |
|
1782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2C2 |
0.0681333165410278 |
|
1783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COTL1 |
0.0681333165410278 |
|
1784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNG4 |
0.0681333165410278 |
|
1785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL36 |
0.0681333165410278 |
|
1786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP433 |
0.0681333165410278 |
|
1787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF1C |
0.0681333165410278 |
|
1788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLDC1 |
0.0681333165410278 |
|
1789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP10 |
0.0681333165410278 |
|
1790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC1 |
0.0681333165410278 |
|
1791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT8 |
0.0681753379265067 |
|
1792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSWIM3 |
0.0681753379265067 |
|
1793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSWIM1 |
0.0681753379265067 |
|
1794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEURL2 |
0.0681753379265067 |
|
1795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA25 |
0.0681753379265067 |
|
1796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSA |
0.0681753379265067 |
|
1797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLTP |
0.0681753379265067 |
|
1798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP9 |
0.0681753379265067 |
|
1799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTHFD2 |
0.0682234050170391 |
|
1800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC8 |
0.0682358018923196 |
|
1801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM18 |
0.0682358018923196 |
|
1802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFPT1 |
0.0682399270157218 |
|
1803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF226 |
0.0683072337403859 |
|
1804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF227 |
0.0683072337403859 |
|
1805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0040 |
0.0684014262745037 |
|
1806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLRT3 |
0.0684136681536158 |
|
1807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAPA |
0.0685510595823945 |
|
1808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP450 |
0.0685510595823945 |
|
1809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXLNB |
0.0685584904498173 |
|
1810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG18 |
0.0685952206820983 |
|
1811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPP21 |
0.0685952206820983 |
|
1812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM39 |
0.0685952206820983 |
|
1813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAGL2 |
0.0687008517363019 |
|
1814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF234 |
0.0687021462392576 |
|
1815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPST |
0.0687433738397326 |
|
1816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD17 |
0.0687433738397326 |
|
1817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP214 |
0.0687433738397326 |
|
1818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYL1 |
0.0688241250216943 |
|
1819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJB6 |
0.0688241250216943 |
|
1820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4499 |
0.0688241250216943 |
|
1821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG4 |
0.068857715892894 |
|
1822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RXFP2 |
0.0690675112188333 |
|
1823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRISPLD2 |
0.0691519524450227 |
|
1824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYBL2 |
0.0692578323129405 |
|
1825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARVELD2 |
0.0692662865840595 |
|
1826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP13A1 |
0.0692709520714421 |
|
1827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF101 |
0.0692709520714421 |
|
1828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00663 |
0.0692709520714421 |
|
1829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF14 |
0.0692709520714421 |
|
1830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNBD1 |
0.0694217908593299 |
|
1831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP176 |
0.0694775847099577 |
|
1832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBCD |
0.0694832373452369 |
|
1833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBB2 |
0.069501930911843 |
|
1834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4305 |
0.0695237801649222 |
|
1835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP494 |
0.0695395605531928 |
|
1836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP293 |
0.0696042230808949 |
|
1837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXO1 |
0.0696694663258322 |
|
1838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P9 |
0.0696955453335337 |
|
1839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP8 |
0.0699398274925563 |
|
1840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHFP |
0.0699494436272121 |
|
1841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF665 |
0.0700501514388303 |
|
1842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTB |
0.070099191791496 |
|
1843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP5 |
0.0701160687236351 |
|
1844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC12 |
0.0701160687236351 |
|
1845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLPSL1 |
0.0701160687236351 |
|
1846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLPSL2 |
0.0701160687236351 |
|
1847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLPS |
0.0701160687236351 |
|
1848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHFPL5 |
0.0701160687236351 |
|
1849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST11 |
0.0701702193538249 |
|
1850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST13P |
0.0701702193538249 |
|
1851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST8 |
0.0701702193538249 |
|
1852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST9L |
0.0701702193538249 |
|
1853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSTL1 |
0.0701702193538249 |
|
1854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP100 |
0.0701706520310018 |
|
1855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC114 |
0.0701920659640041 |
|
1856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP5 |
0.0702480863367053 |
|
1857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL498P |
0.0702698388298206 |
|
1858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRLS1 |
0.0702698388298206 |
|
1859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRN4 |
0.0702698388298206 |
|
1860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE13 |
0.0703041388562889 |
|
1861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3646 |
0.0703462926283315 |
|
1862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A5 |
0.0704078257479441 |
|
1863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOA5 |
0.0704078257479441 |
|
1864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD40 |
0.0704078257479441 |
|
1865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP120 |
0.07041562043262 |
|
1866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK1G3 |
0.07041562043262 |
|
1867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHGB |
0.0704727427273921 |
|
1868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT6 |
0.0704727427273921 |
|
1869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM8 |
0.0704727427273921 |
|
1870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABI3BP |
0.0706074150955182 |
|
1871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTK7 |
0.0706311241958342 |
|
1872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRF |
0.0706367262290729 |
|
1873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2AK3 |
0.070669630207269 |
|
1874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNC2 |
0.0706804129008862 |
|
1875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX21 |
0.0706804129008862 |
|
1876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F24P |
0.070764801601312 |
|
1877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5H15 |
0.0707986620355286 |
|
1878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5H6 |
0.0707986620355286 |
|
1879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5H2 |
0.0707986620355286 |
|
1880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLN |
0.0708333497714021 |
|
1881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR174 |
0.0708494464451749 |
|
1882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITM2A |
0.0708494464451749 |
|
1883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F2 |
0.0709198110666879 |
|
1884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCA1 |
0.0709781443182063 |
|
1885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF155 |
0.0710576514847102 |
|
1886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF230 |
0.0711110991167022 |
|
1887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF222 |
0.0711110991167022 |
|
1888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF223 |
0.0711110991167022 |
|
1889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTF3 |
0.0712745135901565 |
|
1890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD56|ENSG00000199783.1 |
0.071294472063325 |
|
1891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM211 |
0.071294472063325 |
|
1892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK14 |
0.0712991761216355 |
|
1893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP475 |
0.0713706228486736 |
|
1894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA30 |
0.0714187111423819 |
|
1895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME7 |
0.07151044318303 |
|
1896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLZF1 |
0.07151044318303 |
|
1897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC181 |
0.07151044318303 |
|
1898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC19A2 |
0.07151044318303 |
|
1899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APBB2 |
0.0716166658090089 |
|
1900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTU1 |
0.071687378493732 |
|
1901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKIG |
0.0717043847790508 |
|
1902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf37 |
0.0717821581254603 |
|
1903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGGT1B |
0.0718150771370124 |
|
1904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARRDC3 |
0.0718169470546817 |
|
1905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRG2 |
0.0718919044813503 |
|
1906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR12 |
0.0718919044813503 |
|
1907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIWIL3 |
0.0719318254419489 |
|
1908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHDRBS2 |
0.0719869095892053 |
|
1909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT7 |
0.0719916999078206 |
|
1910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT8L2 |
0.0719987582934086 |
|
1911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSFY1P1 |
0.0719987582934086 |
|
1912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNMB3P1 |
0.0719987582934086 |
|
1913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR11H1 |
0.0719987582934086 |
|
1914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEH |
0.0719987582934086 |
|
1915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPTEP1 |
0.0719987582934086 |
|
1916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XKR3 |
0.0719987582934086 |
|
1917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALGAPA1 |
0.0720234880067152 |
|
1918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB7A |
0.0720300233795761 |
|
1919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX19B |
0.0720968669610813 |
|
1920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNTL1 |
0.0722082055738874 |
|
1921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METRNL |
0.0722082055738874 |
|
1922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPPA2 |
0.0724313192669465 |
|
1923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4747 |
0.0724511885868366 |
|
1924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM253 |
0.0725369719778087 |
|
1925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAGK |
0.0725583145734531 |
|
1926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG5 |
0.0725652682303387 |
|
1927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC8 |
0.0725652682303387 |
|
1928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSTR4 |
0.0725808001933405 |
|
1929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THBD |
0.0725808001933405 |
|
1930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX22 |
0.0726831395658208 |
|
1931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELP |
0.0726954040038376 |
|
1932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD65|ENSG00000238936.1 |
0.072776993619829 |
|
1933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC29A4 |
0.0727940573027321 |
|
1934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELL |
0.072824459912563 |
|
1935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELE |
0.072824459912563 |
|
1936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC17P |
0.0729246035753903 |
|
1937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NANP |
0.0729246035753903 |
|
1938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL594P |
0.0729246035753903 |
|
1939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY2 |
0.0729540860481532 |
|
1940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf49 |
0.0730918632899001 |
|
1941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FASTKD3 |
0.0730918632899001 |
|
1942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNPH1 |
0.0731472066932212 |
|
1943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC5 |
0.0731653516711819 |
|
1944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT27 |
0.0731978542814927 |
|
1945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PVALB |
0.0731978542814927 |
|
1946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADA |
0.0732923523042649 |
|
1947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC13 |
0.0732977949363425 |
|
1948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINT4 |
0.0732977949363425 |
|
1949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK1A1L |
0.0734068388827964 |
|
1950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOX2 |
0.0734217303180316 |
|
1951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACYBP |
0.0734478193104146 |
|
1952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53TG5 |
0.0736349311610537 |
|
1953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TET3 |
0.0737449596149812 |
|
1954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDRG2 |
0.0737814958589295 |
|
1955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC7 |
0.0737858016646734 |
|
1956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC9 |
0.0737858016646734 |
|
1957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFHX2 |
0.0737902803045764 |
|
1958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JPH2 |
0.0738118121949073 |
|
1959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00609 |
0.0739264465615477 |
|
1960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARGE |
0.0739404681990971 |
|
1961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF221 |
0.0739586269080799 |
|
1962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4640 |
0.0740568340691545 |
|
1963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2H4 |
0.0740568340691545 |
|
1964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL175P |
0.0740568340691545 |
|
1965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VARS2 |
0.0740568340691545 |
|
1966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFTA2 |
0.0740568340691545 |
|
1967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPCR1 |
0.0740568340691545 |
|
1968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG21 |
0.0740568340691545 |
|
1969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUSBP2 |
0.0740756136380296 |
|
1970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUPT20H |
0.0741987248145646 |
|
1971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP1 |
0.0741987248145646 |
|
1972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNE2 |
0.0742198663633791 |
|
1973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIZ1 |
0.0742982963710709 |
|
1974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF524 |
0.0742982963710709 |
|
1975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF865 |
0.0742982963710709 |
|
1976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF784 |
0.0742982963710709 |
|
1977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF580 |
0.0742982963710709 |
|
1978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10H5 |
0.0743534422675172 |
|
1979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10H1 |
0.0743534422675172 |
|
1980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5H8P |
0.0743815602869385 |
|
1981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMACR |
0.0744131788794816 |
|
1982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF3 |
0.0744131788794816 |
|
1983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC45A2 |
0.0744131788794816 |
|
1984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH6 |
0.0745415726154174 |
|
1985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYS1 |
0.0746732622617584 |
|
1986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JARID2 |
0.0748363642307983 |
|
1987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf80 |
0.074853422325393 |
|
1988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPSF4L |
0.074853422325393 |
|
1989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCL2 |
0.0749828453550078 |
|
1990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTBK1 |
0.075003323161519 |
|
1991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A7 |
0.075003323161519 |
|
1992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRIP3 |
0.075003323161519 |
|
1993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GZF1 |
0.0752018434626128 |
|
1994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAPB |
0.0752018434626128 |
|
1995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP479 |
0.0752018434626128 |
|
1996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL189P |
0.0753804998804769 |
|
1997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE2 |
0.0753804998804769 |
|
1998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE3 |
0.0753804998804769 |
|
1999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIP5K1C |
0.0754742841424288 |
|
2000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHF2 |
0.0757101119318296 |
|
2001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNGB3 |
0.075756882062704 |
|
2002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFKB1 |
0.0758408494526441 |
|
2003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WISP2 |
0.0758487961581912 |
|
2004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK15 |
0.0758487961581912 |
|
2005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPC1L |
0.0758487961581912 |
|
2006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM34 |
0.0758487961581912 |
|
2007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK4 |
0.0758487961581912 |
|
2008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUT |
0.0758637733149385 |
|
2009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A8 |
0.075917783798512 |
|
2010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL728P |
0.0759180120864632 |
|
2011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDR1 |
0.0759271897232701 |
|
2012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR486 |
0.0760305343929517 |
|
2013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5K4 |
0.0760561017516083 |
|
2014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3650 |
0.0761009712331027 |
|
2015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIFR |
0.0761316853836347 |
|
2016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT52 |
0.0761721517867913 |
|
2017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTSF1L |
0.0761721517867913 |
|
2018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL666P |
0.0763355148416559 |
|
2019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL50P |
0.0763960668957335 |
|
2020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTK |
0.0764537115639577 |
|
2021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA64|ENSG00000252016.1 |
0.0765572300330948 |
|
2022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3660 |
0.0766045205878598 |
|
2023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYGB |
0.0767087896535972 |
|
2024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD12 |
0.0767087896535972 |
|
2025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HECA |
0.0767944123140623 |
|
2026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
N4BP2 |
0.0769191580501472 |
|
2027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000201863.1 |
0.0769191580501472 |
|
2028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNR |
0.0769241768606405 |
|
2029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGFLAM |
0.0770096526215164 |
|
2030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELFN2 |
0.0770476265115824 |
|
2031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF99 |
0.0770980179119571 |
|
2032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC13A3 |
0.0771837662295118 |
|
2033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNLRB2 |
0.0772172167112406 |
|
2034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBXA2R |
0.0775010355279909 |
|
2035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACTIN |
0.0775010355279909 |
|
2036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5K1 |
0.0775153354180887 |
|
2037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDND1 |
0.0775153354180887 |
|
2038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5K2 |
0.0775153354180887 |
|
2039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPOX |
0.0775153354180887 |
|
2040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR15 |
0.0775153354180887 |
|
2041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS13B |
0.0775802496746243 |
|
2042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP42 |
0.0776026228310825 |
|
2043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC13A |
0.0776967006151341 |
|
2044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST3GAL6 |
0.0777063886130287 |
|
2045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLON5 |
0.0777146383907394 |
|
2046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPQ |
0.0777495428373646 |
|
2047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5589 |
0.077751001922053 |
|
2048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKOR1 |
0.0780296607919573 |
|
2049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF16B |
0.0780349517423762 |
|
2050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHB |
0.0780384205859532 |
|
2051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGB2 |
0.0780384205859532 |
|
2052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGB |
0.0780384205859532 |
|
2053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGB1 |
0.0780384205859532 |
|
2054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGB5 |
0.0780384205859532 |
|
2055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGB7 |
0.0780384205859532 |
|
2056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGB8 |
0.0780384205859532 |
|
2057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTF4 |
0.0780384205859532 |
|
2058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUBPL |
0.0780872152386429 |
|
2059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3150B |
0.0783679965678189 |
|
2060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASL11A |
0.0783805648464968 |
|
2061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFS |
0.0783902534092977 |
|
2062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL25 |
0.0783902534092977 |
|
2063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMTM5 |
0.0783902534092977 |
|
2064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH6 |
0.0783902534092977 |
|
2065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR208A |
0.0783902534092977 |
|
2066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH7 |
0.0783902534092977 |
|
2067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR208B |
0.0783902534092977 |
|
2068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NGDN |
0.0783902534092977 |
|
2069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLECL1 |
0.0783945120062296 |
|
2070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOH |
0.0783969829126632 |
|
2071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGT5 |
0.0784826889814503 |
|
2072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POM121L9P |
0.0784826889814503 |
|
2073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX7A2 |
0.0785104456606227 |
|
2074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf222 |
0.0785372076378519 |
|
2075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDN1 |
0.0785526584446888 |
|
2076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000252296.1 |
0.0785828882361228 |
|
2077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEE1 |
0.0785829626980394 |
|
2078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC155 |
0.0785952996399812 |
|
2079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTH2 |
0.0785952996399812 |
|
2080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A7 |
0.0785952996399812 |
|
2081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD4 |
0.0786977574254085 |
|
2082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAD1 |
0.0786977574254085 |
|
2083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4E2 |
0.0786977574254085 |
|
2084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6J1 |
0.0786977574254085 |
|
2085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAC |
0.0786977574254085 |
|
2086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ10 |
0.0786977574254085 |
|
2087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ11 |
0.0786977574254085 |
|
2088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ12 |
0.0786977574254085 |
|
2089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ13 |
0.0786977574254085 |
|
2090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ14 |
0.0786977574254085 |
|
2091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ16 |
0.0786977574254085 |
|
2092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ17 |
0.0786977574254085 |
|
2093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ18 |
0.0786977574254085 |
|
2094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ19 |
0.0786977574254085 |
|
2095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ1 |
0.0786977574254085 |
|
2096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ20 |
0.0786977574254085 |
|
2097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ21 |
0.0786977574254085 |
|
2098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ22 |
0.0786977574254085 |
|
2099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ23 |
0.0786977574254085 |
|
2100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ24 |
0.0786977574254085 |
|
2101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ25 |
0.0786977574254085 |
|
2102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ26 |
0.0786977574254085 |
|
2103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ27 |
0.0786977574254085 |
|
2104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ28 |
0.0786977574254085 |
|
2105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ29 |
0.0786977574254085 |
|
2106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ2 |
0.0786977574254085 |
|
2107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ30 |
0.0786977574254085 |
|
2108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ31 |
0.0786977574254085 |
|
2109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ32 |
0.0786977574254085 |
|
2110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ33 |
0.0786977574254085 |
|
2111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ34 |
0.0786977574254085 |
|
2112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ35 |
0.0786977574254085 |
|
2113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ36 |
0.0786977574254085 |
|
2114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ37 |
0.0786977574254085 |
|
2115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ38 |
0.0786977574254085 |
|
2116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ39 |
0.0786977574254085 |
|
2117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ3 |
0.0786977574254085 |
|
2118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ40 |
0.0786977574254085 |
|
2119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ41 |
0.0786977574254085 |
|
2120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ42 |
0.0786977574254085 |
|
2121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ43 |
0.0786977574254085 |
|
2122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ44 |
0.0786977574254085 |
|
2123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ45 |
0.0786977574254085 |
|
2124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ46 |
0.0786977574254085 |
|
2125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ47 |
0.0786977574254085 |
|
2126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ48 |
0.0786977574254085 |
|
2127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ49 |
0.0786977574254085 |
|
2128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ4 |
0.0786977574254085 |
|
2129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ50 |
0.0786977574254085 |
|
2130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ52 |
0.0786977574254085 |
|
2131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ53 |
0.0786977574254085 |
|
2132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ54 |
0.0786977574254085 |
|
2133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ56 |
0.0786977574254085 |
|
2134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ57 |
0.0786977574254085 |
|
2135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ58 |
0.0786977574254085 |
|
2136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ59 |
0.0786977574254085 |
|
2137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ5 |
0.0786977574254085 |
|
2138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ61 |
0.0786977574254085 |
|
2139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ6 |
0.0786977574254085 |
|
2140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ7 |
0.0786977574254085 |
|
2141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ8 |
0.0786977574254085 |
|
2142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAJ9 |
0.0786977574254085 |
|
2143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV10 |
0.0786977574254085 |
|
2144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV14DV4 |
0.0786977574254085 |
|
2145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV16 |
0.0786977574254085 |
|
2146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV17 |
0.0786977574254085 |
|
2147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV18 |
0.0786977574254085 |
|
2148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV19 |
0.0786977574254085 |
|
2149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV20 |
0.0786977574254085 |
|
2150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV21 |
0.0786977574254085 |
|
2151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV22 |
0.0786977574254085 |
|
2152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV23DV6 |
0.0786977574254085 |
|
2153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV24 |
0.0786977574254085 |
|
2154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV25 |
0.0786977574254085 |
|
2155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV27 |
0.0786977574254085 |
|
2156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV29DV5 |
0.0786977574254085 |
|
2157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV2 |
0.0786977574254085 |
|
2158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV30 |
0.0786977574254085 |
|
2159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV34 |
0.0786977574254085 |
|
2160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV35 |
0.0786977574254085 |
|
2161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV36DV7 |
0.0786977574254085 |
|
2162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV39 |
0.0786977574254085 |
|
2163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV3 |
0.0786977574254085 |
|
2164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV40 |
0.0786977574254085 |
|
2165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV41 |
0.0786977574254085 |
|
2166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV4 |
0.0786977574254085 |
|
2167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV5 |
0.0786977574254085 |
|
2168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV6 |
0.0786977574254085 |
|
2169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAV7 |
0.0786977574254085 |
|
2170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDC |
0.0786977574254085 |
|
2171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDD1 |
0.0786977574254085 |
|
2172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDD2 |
0.0786977574254085 |
|
2173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDD3 |
0.0786977574254085 |
|
2174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDJ1 |
0.0786977574254085 |
|
2175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDJ2 |
0.0786977574254085 |
|
2176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDJ3 |
0.0786977574254085 |
|
2177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDJ4 |
0.0786977574254085 |
|
2178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDV1 |
0.0786977574254085 |
|
2179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDV2 |
0.0786977574254085 |
|
2180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDV3 |
0.0786977574254085 |
|
2181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000206886.1 |
0.0787343017320293 |
|
2182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE3 |
0.0787583440292868 |
|
2183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP2NL |
0.0787916557057875 |
|
2184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATS1 |
0.0788144946880258 |
|
2185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXNL1 |
0.0788245332348363 |
|
2186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAE1 |
0.0788389081693595 |
|
2187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSF2RB |
0.0789105391994057 |
|
2188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239056.1 |
0.0789105391994057 |
|
2189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX33 |
0.0789105391994057 |
|
2190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKKL1 |
0.0790152335986073 |
|
2191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUSD2 |
0.0790370329985106 |
|
2192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSER1 |
0.079039773318774 |
|
2193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR361 |
0.0790828969113178 |
|
2194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNN |
0.0792547234388593 |
|
2195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFB1 |
0.0792606211539096 |
|
2196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5K3 |
0.0792632640588625 |
|
2197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL31P |
0.0792668517047849 |
|
2198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YWHAB |
0.0792668517047849 |
|
2199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FASLG |
0.0793061400313515 |
|
2200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNA7 |
0.0793067348882985 |
|
2201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL708P |
0.0793067348882985 |
|
2202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRNP70 |
0.0793067348882985 |
|
2203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAGA |
0.0793136329748013 |
|
2204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM109B |
0.0793136329748013 |
|
2205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL709P |
0.0793223928956717 |
|
2206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL511P |
0.0793495473837397 |
|
2207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK5RAP1 |
0.079503781623917 |
|
2208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNTA1 |
0.0797472443250755 |
|
2209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP25 |
0.0798096758841279 |
|
2210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPE |
0.0798234038242585 |
|
2211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5H14 |
0.0798654632428406 |
|
2212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGN3 |
0.0798942633421057 |
|
2213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD36|ENSG00000252227.1 |
0.0800274855567461 |
|
2214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CECR3 |
0.0800340645645536 |
|
2215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALGAPB |
0.0800701390756614 |
|
2216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADIG |
0.0800701390756614 |
|
2217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP40 |
0.0800701390756614 |
|
2218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBEA |
0.0801926709626559 |
|
2219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MINA |
0.0803867342786848 |
|
2220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRR3 |
0.0803867342786848 |
|
2221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5AC1 |
0.0803867342786848 |
|
2222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5AC2 |
0.0803867342786848 |
|
2223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf94 |
0.0804180770214405 |
|
2224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHFPL4 |
0.0805302938170674 |
|
2225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5H1 |
0.0806356273800959 |
|
2226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBC3 |
0.080651352322693 |
|
2227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC10 |
0.0807204830114224 |
|
2228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLK2 |
0.0807204830114224 |
|
2229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TJAP1 |
0.0807204830114224 |
|
2230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC73 |
0.0807204830114224 |
|
2231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR1C |
0.0807204830114224 |
|
2232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIPF3 |
0.0807204830114224 |
|
2233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA8 |
0.080853827037526 |
|
2234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL515P |
0.080853827037526 |
|
2235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD17 |
0.0809111058754279 |
|
2236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf77 |
0.0809111058754279 |
|
2237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD300A |
0.0809111058754279 |
|
2238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD300C |
0.0809111058754279 |
|
2239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD300E |
0.0809111058754279 |
|
2240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD300LB |
0.0809111058754279 |
|
2241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD300LD |
0.0809111058754279 |
|
2242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD300LF |
0.0809111058754279 |
|
2243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAI2 |
0.0809111058754279 |
|
2244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR142 |
0.0809111058754279 |
|
2245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRC5C |
0.0809111058754279 |
|
2246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF19 |
0.0809111058754279 |
|
2247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB37 |
0.0809111058754279 |
|
2248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP448 |
0.0809111058754279 |
|
2249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL38 |
0.0809111058754279 |
|
2250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTYH2 |
0.0809111058754279 |
|
2251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP5 |
0.0809937825187528 |
|
2252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDIT4L |
0.0810575754234868 |
|
2253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHM |
0.0811025942402086 |
|
2254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP508 |
0.081142624278313 |
|
2255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLH |
0.0811682937945337 |
|
2256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP486 |
0.0811942653168291 |
|
2257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAST3 |
0.0812175761366668 |
|
2258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNA11 |
0.0812441027583161 |
|
2259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNA15 |
0.0812441027583161 |
|
2260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S1PR4 |
0.0812441027583161 |
|
2261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCLN |
0.0812441027583161 |
|
2262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCBLD2 |
0.0814450728234476 |
|
2263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf38 |
0.081454198807545 |
|
2264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRX2 |
0.081454198807545 |
|
2265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUPT6H |
0.0816253359839192 |
|
2266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCAM1 |
0.0817173489801561 |
|
2267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTDSS1 |
0.0817389434602165 |
|
2268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDC2 |
0.0817389434602165 |
|
2269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPM |
0.0817566555480811 |
|
2270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00634 |
0.0817566555480811 |
|
2271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR33A |
0.0817566555480811 |
|
2272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378I |
0.0817566555480811 |
|
2273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT3 |
0.0817566555480811 |
|
2274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHISA8 |
0.0817566555480811 |
|
2275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF13C |
0.0817566555480811 |
|
2276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFS7 |
0.0817972250059735 |
|
2277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFAF6 |
0.0818184472994897 |
|
2278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR52 |
0.0818196434454452 |
|
2279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAPIN |
0.0818915358227394 |
|
2280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17RA |
0.081942545731827 |
|
2281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB40B |
0.0819915683286455 |
|
2282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4525 |
0.0819915683286455 |
|
2283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM86B |
0.0819965748255819 |
|
2284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC5C |
0.0820895726290025 |
|
2285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239068.1 |
0.0821540475367323 |
|
2286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10H3 |
0.0822245241354499 |
|
2287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CECR6 |
0.0822266802086015 |
|
2288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH6 |
0.0822507334889935 |
|
2289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRY |
0.0823117166383895 |
|
2290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMS4 |
0.0823230204185685 |
|
2291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR583 |
0.0823316541496454 |
|
2292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM71C |
0.0823643846433979 |
|
2293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIPC3 |
0.0824305573320926 |
|
2294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMG20B |
0.0824305573320926 |
|
2295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNA5 |
0.0824445328464301 |
|
2296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2K |
0.0824448994424708 |
|
2297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIPPLY2 |
0.0824743101770864 |
|
2298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FASN |
0.0824841129663823 |
|
2299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGB1 |
0.0825033518578507 |
|
2300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CITED2 |
0.0825514838576399 |
|
2301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD9 |
0.0825565391590555 |
|
2302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00494 |
0.0825916883228669 |
|
2303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHIP |
0.0826055673435774 |
|
2304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE11 |
0.082694504213095 |
|
2305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNB3 |
0.0827653445936415 |
|
2306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCA3 |
0.0827653445936415 |
|
2307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF608 |
0.0827824232961412 |
|
2308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB9 |
0.0828448493481073 |
|
2309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUVBL2 |
0.0828725429368378 |
|
2310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP186 |
0.0829114444340937 |
|
2311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP761J1410 |
0.0829499888721924 |
|
2312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3P1 |
0.0829710002508036 |
|
2313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD34B |
0.0830454790050202 |
|
2314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHFR |
0.0830454790050202 |
|
2315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L2 |
0.0830454790050202 |
|
2316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRBK2 |
0.0831701142809 |
|
2317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRNDE |
0.0832695081772116 |
|
2318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRX5 |
0.0832695081772116 |
|
2319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A8 |
0.0832971310148236 |
|
2320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BC |
0.0833656678248614 |
|
2321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALOX5AP |
0.0834207662542626 |
|
2322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00398 |
0.0834207662542626 |
|
2323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00545 |
0.0834207662542626 |
|
2324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC22 |
0.083436972072641 |
|
2325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10H2 |
0.0835737188658412 |
|
2326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF5OS |
0.0835761129728119 |
|
2327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF5 |
0.0835761129728119 |
|
2328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDAP1L1 |
0.0837619365007061 |
|
2329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP250 |
0.0838531796329791 |
|
2330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf173 |
0.0838531796329791 |
|
2331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERGIC3 |
0.0838531796329791 |
|
2332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FER1L4 |
0.0838531796329791 |
|
2333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR488 |
0.0838535707482612 |
|
2334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAB4 |
0.0838777136302877 |
|
2335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA3 |
0.0839579869763123 |
|
2336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPCAT2 |
0.0840316501895435 |
|
2337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPNS2 |
0.0840316501895435 |
|
2338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREM1 |
0.0840373605726882 |
|
2339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEDAG |
0.0840982156256289 |
|
2340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX26 |
0.0840982156256289 |
|
2341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX18 |
0.0841194801224512 |
|
2342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD93 |
0.0841668535578668 |
|
2343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OARD1 |
0.0844615488325255 |
|
2344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC5CL |
0.0844615488325255 |
|
2345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPO2 |
0.0844615488325255 |
|
2346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC2 |
0.0844615488325255 |
|
2347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFYA |
0.0844615488325255 |
|
2348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY10P1 |
0.0844615488325255 |
|
2349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREML1 |
0.0844615488325255 |
|
2350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREM2 |
0.0844615488325255 |
|
2351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREML2 |
0.0844615488325255 |
|
2352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREML3P |
0.0844615488325255 |
|
2353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREML4 |
0.0844615488325255 |
|
2354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP207 |
0.0844615488325255 |
|
2355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CECR7 |
0.0845435600911985 |
|
2356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC21 |
0.0845619704493569 |
|
2357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBX4 |
0.0847275765706299 |
|
2358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP11X3P |
0.0847463155278698 |
|
2359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS18 |
0.0847801849641042 |
|
2360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL52 |
0.084810878668232 |
|
2361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP14 |
0.084810878668232 |
|
2362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC4B |
0.0848154747991395 |
|
2363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS14 |
0.0849135773683717 |
|
2364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KANSL3 |
0.085086137453836 |
|
2365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A7 |
0.0851259445179502 |
|
2366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSORS1C3 |
0.0851332130703005 |
|
2367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG27 |
0.0851332130703005 |
|
2368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM182B |
0.085154598027829 |
|
2369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCSTAMP |
0.08518292655749 |
|
2370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRK5 |
0.0852088115485046 |
|
2371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1239 |
0.0852160617128761 |
|
2372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLYATL3 |
0.0852180326208272 |
|
2373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FREM2 |
0.0854150634420908 |
|
2374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNTTIP1 |
0.0854375052598588 |
|
2375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2C |
0.0854375052598588 |
|
2376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST5 |
0.0854587579610716 |
|
2377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HFE |
0.0855056159388526 |
|
2378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM138F |
0.08558771474409 |
|
2379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F17 |
0.08558771474409 |
|
2380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAP2C |
0.08558771474409 |
|
2381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASH5P |
0.08558771474409 |
|
2382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFAP1L2 |
0.0856209277105142 |
|
2383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP4C |
0.0856287809000563 |
|
2384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3615 |
0.0857036103446898 |
|
2385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A3R1 |
0.0857036103446898 |
|
2386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT9 |
0.0857036103446898 |
|
2387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRX6 |
0.0857273586307596 |
|
2388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP2 |
0.0857273586307596 |
|
2389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4C |
0.0858188197390949 |
|
2390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H1T |
0.0858188197390949 |
|
2391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4707 |
0.0858693087139309 |
|
2392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A42 |
0.0859092724218974 |
|
2393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPOLB |
0.0859476052420129 |
|
2394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIER2 |
0.0859576706797854 |
|
2395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THEG |
0.0859576706797854 |
|
2396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2CD4C |
0.0859576706797854 |
|
2397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM104A |
0.0859757531247962 |
|
2398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGRT |
0.0860378845266428 |
|
2399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCN3 |
0.0860378845266428 |
|
2400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSCN2 |
0.0860963968504349 |
|
2401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHC2 |
0.0861509765605696 |
|
2402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP462 |
0.0861509765605696 |
|
2403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODF3L2 |
0.0861509765605696 |
|
2404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MADCAM1 |
0.0861509765605696 |
|
2405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPGS1 |
0.0861509765605696 |
|
2406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC34 |
0.0861509765605696 |
|
2407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GZMM |
0.0861509765605696 |
|
2408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRAP2 |
0.0862084025617058 |
|
2409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRX3 |
0.086244774937229 |
|
2410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGK2 |
0.0862508194719854 |
|
2411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAP18 |
0.0862518976826169 |
|
2412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKA3 |
0.0862985523365958 |
|
2413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRP63 |
0.0862985523365958 |
|
2414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSH3 |
0.0863032068664786 |
|
2415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF253 |
0.0863496553453211 |
|
2416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF430 |
0.0863496553453211 |
|
2417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF486 |
0.0863496553453211 |
|
2418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF626 |
0.0863496553453211 |
|
2419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF66 |
0.0863496553453211 |
|
2420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF682 |
0.0863496553453211 |
|
2421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF737 |
0.0863496553453211 |
|
2422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF826P |
0.0863496553453211 |
|
2423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF85 |
0.0863496553453211 |
|
2424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF90 |
0.0863496553453211 |
|
2425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF93 |
0.0863496553453211 |
|
2426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMD2 |
0.0863941891134072 |
|
2427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF216P1 |
0.0863941891134072 |
|
2428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORIN |
0.0864040914969326 |
|
2429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SENP7 |
0.0864265663634556 |
|
2430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPAR2 |
0.086454356590531 |
|
2431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMIP |
0.086454356590531 |
|
2432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH3 |
0.086458280480876 |
|
2433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXTL2 |
0.086463655672812 |
|
2434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF579 |
0.0864813246943251 |
|
2435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDH8 |
0.0865710866930982 |
|
2436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COLGALT1 |
0.0866040770002421 |
|
2437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00970 |
0.0867356853456549 |
|
2438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP66 |
0.0867356853456549 |
|
2439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRAK1BP1 |
0.086894947355615 |
|
2440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMU |
0.0869127437591226 |
|
2441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2K2 |
0.0869156970518831 |
|
2442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM23 |
0.0869301972509804 |
|
2443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIN2D |
0.0869496432766313 |
|
2444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCORL |
0.0869694648452811 |
|
2445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238887.1 |
0.0869923562594037 |
|
2446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDS5B |
0.0870355735777524 |
|
2447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1244 |
0.0871429540221317 |
|
2448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LNX1 |
0.0871666820834814 |
|
2449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELOVL4 |
0.0871987687946951 |
|
2450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP1S |
0.0872021289270175 |
|
2451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf63 |
0.087203835272331 |
|
2452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS11 |
0.0872209313872164 |
|
2453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD35B |
0.0872209313872164 |
|
2454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP5Z1 |
0.0872506963363677 |
|
2455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4656 |
0.0872506963363677 |
|
2456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RADIL |
0.0872506963363677 |
|
2457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIP1L1 |
0.0872536464750674 |
|
2458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPG2 |
0.0872975466690668 |
|
2459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00421 |
0.0873027587029804 |
|
2460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLCE |
0.0873071258545035 |
|
2461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANTXR1 |
0.0873394060522756 |
|
2462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3126 |
0.0873394060522756 |
|
2463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP96 |
0.0873394060522756 |
|
2464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAT |
0.087394392531677 |
|
2465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3G |
0.0874956310093542 |
|
2466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYSMD3 |
0.0874956310093542 |
|
2467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLFM3 |
0.0875268475091211 |
|
2468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD12 |
0.087604742685838 |
|
2469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf70 |
0.0876144435955523 |
|
2470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPB |
0.08762490849236 |
|
2471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCYT2 |
0.08762490849236 |
|
2472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRT7 |
0.08762490849236 |
|
2473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAFG |
0.08762490849236 |
|
2474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYADML2 |
0.08762490849236 |
|
2475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYCR1 |
0.08762490849236 |
|
2476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A13 |
0.0876549366373603 |
|
2477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF1DP3 |
0.0877148293657906 |
|
2478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD8 |
0.0877347673592249 |
|
2479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXA1L |
0.0877423139131774 |
|
2480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD41|ENSG00000212302.1 |
0.0877423139131774 |
|
2481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRMT5 |
0.0877950980227687 |
|
2482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAUS4 |
0.0877950980227687 |
|
2483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF4L2 |
0.087817216371801 |
|
2484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM30A |
0.0878982873720663 |
|
2485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FILIP1 |
0.0878982873720663 |
|
2486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF318 |
0.088000511050032 |
|
2487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLTSCR2 |
0.0880210986899189 |
|
2488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD23|ENSG00000221803.1 |
0.0880210986899189 |
|
2489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPW1 |
0.0880210986899189 |
|
2490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF528 |
0.0880474670618595 |
|
2491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF534 |
0.0880474670618595 |
|
2492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF880 |
0.0880474670618595 |
|
2493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF91 |
0.0880657617008231 |
|
2494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM46A |
0.0880724369755586 |
|
2495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDK2 |
0.0880805497540044 |
|
2496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPO5 |
0.0880818795870798 |
|
2497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA15|ENSG00000252218.1 |
0.0880818795870798 |
|
2498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP10 |
0.088109477736046 |
|
2499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REM2 |
0.088109477736046 |
|
2500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IBTK |
0.0881104183819272 |
|
2501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHB2 |
0.0881397185754326 |
|
2502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UFM1 |
0.0881802369965192 |
|
2503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP207 |
0.0882444619128721 |
|
2504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR150 |
0.0882602463038672 |
|
2505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC5 |
0.088420344218423 |
|
2506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP5M1 |
0.088420344218423 |
|
2507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42EP4 |
0.0884457581262067 |
|
2508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEZ6L |
0.0884745114802139 |
|
2509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP495 |
0.0884745114802139 |
|
2510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WWP1 |
0.0884799321411068 |
|
2511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEAL2 |
0.0885474273645672 |
|
2512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEAL6 |
0.0885474273645672 |
|
2513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEX5 |
0.0885474273645672 |
|
2514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CECR5 |
0.0886229980946502 |
|
2515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CECR1 |
0.0886229980946502 |
|
2516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A10 |
0.0886409234526805 |
|
2517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR1H4 |
0.0886725049653712 |
|
2518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00656 |
0.0887361192629252 |
|
2519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP478 |
0.0887361192629252 |
|
2520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABT1 |
0.0888287346008523 |
|
2521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF322 |
0.0888287346008523 |
|
2522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP76 |
0.0888403416281585 |
|
2523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTO1 |
0.0891561157628259 |
|
2524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDHA2 |
0.0892061897573945 |
|
2525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR6 |
0.0892195012945277 |
|
2526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEPDC4 |
0.0892195012945277 |
|
2527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDIL3 |
0.0892657411309425 |
|
2528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC38P |
0.0893407468959426 |
|
2529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPBG |
0.0893799814989771 |
|
2530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL18A |
0.0893813682206239 |
|
2531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAZAP1 |
0.0894519626406534 |
|
2532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS15 |
0.0894519626406534 |
|
2533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PXMP4 |
0.0895463329241204 |
|
2534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000251828.1 |
0.0895628714972942 |
|
2535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPZ1 |
0.0895628714972942 |
|
2536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE16 |
0.0895628714972942 |
|
2537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM151B |
0.0895628714972942 |
|
2538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USPL1 |
0.089565404728136 |
|
2539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPB2 |
0.0902750157761639 |
|
2540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOR |
0.0902750157761639 |
|
2541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP10D |
0.0902800342926802 |
|
2542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR140 |
0.0902895420508015 |
|
2543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFESD |
0.0903938768796795 |
|
2544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XCL1 |
0.0907019254770391 |
|
2545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH9 |
0.0910026115768388 |
|
2546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPLOC4 |
0.0911401477546278 |
|
2547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTNBP1 |
0.0911652932312763 |
|
2548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP210 |
0.0911793723703545 |
|
2549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A24 |
0.091210332566289 |
|
2550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF4 |
0.091210332566289 |
|
2551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REPS1 |
0.091213302960689 |
|
2552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XCL2 |
0.091317943631366 |
|
2553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPT |
0.091317943631366 |
|
2554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00626 |
0.091317943631366 |
|
2555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LETM2 |
0.0914235572060075 |
|
2556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF6 |
0.0914471149658558 |
|
2557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
L3MBTL1 |
0.0914471149658558 |
|
2558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDGFRA |
0.0914845946766211 |
|
2559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSS2 |
0.0915282871330749 |
|
2560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXT1 |
0.0915338206556582 |
|
2561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf61 |
0.0915395119879634 |
|
2562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2K5 |
0.0915395119879634 |
|
2563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YJEFN3 |
0.0915618680594968 |
|
2564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CILP2 |
0.0915618680594968 |
|
2565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf85 |
0.0915984252375284 |
|
2566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AAK1 |
0.0916497724563159 |
|
2567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF578 |
0.091696377879035 |
|
2568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFC1 |
0.0917237967924992 |
|
2569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UHRF1 |
0.0917741537703812 |
|
2570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP16 |
0.0917893278895738 |
|
2571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA3C |
0.092096885597783 |
|
2572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF16 |
0.0921276387552806 |
|
2573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STXBP6 |
0.0921312406148115 |
|
2574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRAM1 |
0.0922545956026819 |
|
2575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DACH2 |
0.0923009399029503 |
|
2576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIX1 |
0.0923134231745351 |
|
2577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL843P |
0.0924225988324892 |
|
2578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDR |
0.0924346914008661 |
|
2579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH7A1 |
0.0924724854623549 |
|
2580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHAX |
0.0924724854623549 |
|
2581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf48 |
0.0924724854623549 |
|
2582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238408.1 |
0.0925270415657787 |
|
2583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CECR9 |
0.0926300934261938 |
|
2584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR11 |
0.0926468376382219 |
|
2585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATRX |
0.0927262565732523 |
|
2586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL16P |
0.092743074958561 |
|
2587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM33 |
0.0927603113100497 |
|
2588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEP1 |
0.0927664888546255 |
|
2589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf22 |
0.0927677063980776 |
|
2590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXK1 |
0.0928300871316156 |
|
2591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSG |
0.0928301128310696 |
|
2592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GZMH |
0.0928301128310696 |
|
2593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CWH43 |
0.0928977496671675 |
|
2594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRYL |
0.0928977496671675 |
|
2595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCIAD1 |
0.0928977496671675 |
|
2596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCIAD2 |
0.0928977496671675 |
|
2597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLAIN2 |
0.0928977496671675 |
|
2598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC10A4 |
0.0928977496671675 |
|
2599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEC |
0.0928977496671675 |
|
2600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZAR1 |
0.0928977496671675 |
|
2601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FN3K |
0.0929074833381202 |
|
2602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL8A1 |
0.0929532291501355 |
|
2603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHDC1L |
0.0929532497146603 |
|
2604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHDC1 |
0.0929532497146603 |
|
2605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPPA5 |
0.0929532497146603 |
|
2606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EN2 |
0.0930869476436487 |
|
2607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNPY1 |
0.0930869476436487 |
|
2608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL680P |
0.0931754198036373 |
|
2609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL194P |
0.0931754198036373 |
|
2610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238781.1 |
0.0931924718823118 |
|
2611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN20 |
0.0932266567123987 |
|
2612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC1 |
0.093306349163349 |
|
2613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEBP2 |
0.0933483139961355 |
|
2614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHSL1 |
0.0933483139961355 |
|
2615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3145 |
0.0933483139961355 |
|
2616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNA6 |
0.0933492521733553 |
|
2617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNA1 |
0.0933492521733553 |
|
2618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRTM1 |
0.0934335407851621 |
|
2619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA7 |
0.0935116654563179 |
|
2620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FN3KRP |
0.0935656528481272 |
|
2621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXK2 |
0.0937699681367594 |
|
2622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBOV1 |
0.0938811750954207 |
|
2623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGTLC1 |
0.0939692291124526 |
|
2624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STOML3 |
0.0941069125791902 |
|
2625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYLC1 |
0.0941228981242584 |
|
2626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KA6 |
0.0941228981242584 |
|
2627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL19A1 |
0.0942202220251959 |
|
2628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST5 |
0.094235123984348 |
|
2629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM231 |
0.094235123984348 |
|
2630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABARAPL2 |
0.094235123984348 |
|
2631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA13 |
0.0942376390886857 |
|
2632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFC3 |
0.0942589273870525 |
|
2633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX15 |
0.0943253772775685 |
|
2634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00469 |
0.0943825560259847 |
|
2635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSSK6 |
0.0944204743049798 |
|
2636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAMD3 |
0.094423925465035 |
|
2637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD45|ENSG00000200422.1 |
0.0944305542182907 |
|
2638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF1A1 |
0.0944314184306948 |
|
2639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TARS |
0.0944867794717907 |
|
2640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC5L |
0.0944941694997889 |
|
2641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP117 |
0.0944962814605588 |
|
2642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP280 |
0.0946102885832272 |
|
2643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548I4 |
0.0946784116784491 |
|
2644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTERFD1 |
0.0947363945757673 |
|
2645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCRB |
0.0947363945757673 |
|
2646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPTE2 |
0.0950003218752418 |
|
2647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA18|ENSG00000252601.1 |
0.0950553476585924 |
|
2648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABRACL |
0.0950728817644869 |
|
2649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOGA2 |
0.0950741646523846 |
|
2650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSIG1 |
0.0950742217950971 |
|
2651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLACE |
0.0950742217950971 |
|
2652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR59 |
0.0951117237975898 |
|
2653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN10 |
0.0951438770939866 |
|
2654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5000 |
0.095382777519725 |
|
2655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL149P |
0.0954216824809866 |
|
2656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMG2 |
0.0955301525172702 |
|
2657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF28 |
0.0955447130894307 |
|
2658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF320 |
0.0955447130894307 |
|
2659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF321P |
0.0955447130894307 |
|
2660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF468 |
0.0955447130894307 |
|
2661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF600 |
0.0955447130894307 |
|
2662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF611 |
0.0955447130894307 |
|
2663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF702P |
0.0955447130894307 |
|
2664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF816 |
0.0955447130894307 |
|
2665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF888 |
0.0955447130894307 |
|
2666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5R4 |
0.0956413117474884 |
|
2667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KATNAL1 |
0.0956871936098389 |
|
2668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00365 |
0.0956942887453719 |
|
2669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF808 |
0.0956944298722952 |
|
2670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF701 |
0.0956944298722952 |
|
2671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF137P |
0.0956944298722952 |
|
2672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFXN5 |
0.0957690350979561 |
|
2673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOPEY1 |
0.0957809147562131 |
|
2674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPHD2 |
0.0958401259697882 |
|
2675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPS4 |
0.0958401259697882 |
|
2676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR45B |
0.095870552328043 |
|
2677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUNX2 |
0.0959067003508767 |
|
2678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP203 |
0.095935598446371 |
|
2679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLE4 |
0.0959909436726273 |
|
2680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A5 |
0.0960272693996711 |
|
2681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPH5 |
0.0960337609824885 |
|
2682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA16|ENSG00000252765.1 |
0.0960337609824885 |
|
2683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR325 |
0.0960412973320609 |
|
2684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP509 |
0.0960412973320609 |
|
2685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGM3 |
0.0960413887602496 |
|
2686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBG3|ENSG00000080200.5 |
0.0961128968958207 |
|
2687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HELQ |
0.0961376616133564 |
|
2688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS18C |
0.0961376616133564 |
|
2689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM175A |
0.0961376616133564 |
|
2690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMAT1 |
0.0962124791166274 |
|
2691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEDD9 |
0.0962622800621238 |
|
2692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4642 |
0.0962636435695176 |
|
2693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238301.1 |
0.0963681286261298 |
|
2694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC28A |
0.0964481733270948 |
|
2695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECT2L |
0.0964481733270948 |
|
2696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERS1 |
0.0964695393213068 |
|
2697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF1 |
0.0964695393213068 |
|
2698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC20 |
0.0964887817359532 |
|
2699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH1A2 |
0.0965284186059792 |
|
2700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF341 |
0.0965586119180417 |
|
2701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TACR3 |
0.0966445623030625 |
|
2702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00427 |
0.0968279173897701 |
|
2703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00426 |
0.0968279173897701 |
|
2704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSGEP |
0.0968573861717892 |
|
2705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APEX1 |
0.0968573861717892 |
|
2706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM55B |
0.0968573861717892 |
|
2707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNP |
0.0968573861717892 |
|
2708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238498.1 |
0.0968939747607245 |
|
2709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMDT1 |
0.0968939747607245 |
|
2710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA6 |
0.0968939747607245 |
|
2711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT8 |
0.0969836068733342 |
|
2712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2D6 |
0.0970097746883348 |
|
2713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2D7P1 |
0.0970097746883348 |
|
2714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOSIP |
0.0970347992102455 |
|
2715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238296.1 |
0.0970631924486098 |
|
2716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S1PR1 |
0.0970631924486098 |
|
2717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR5A |
0.0970715686882621 |
|
2718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A7 |
0.0970736643659877 |
|
2719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR552 |
0.0971607938289559 |
|
2720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA1 |
0.0971629550477476 |
|
2721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAS1 |
0.09742478243132 |
|
2722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212165.1 |
0.0974298481396856 |
|
2723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238403.1 |
0.0974758897587692 |
|
2724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL33 |
0.0978424207928159 |
|
2725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD2AP |
0.0978429047682368 |
|
2726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00445 |
0.0978586768552802 |
|
2727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSKH2 |
0.0978747111269557 |
|
2728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM104 |
0.0978827324839584 |
|
2729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP205 |
0.0979068498089734 |
|
2730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00596 |
0.0979068498089734 |
|
2731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAMSTR |
0.0979217161376864 |
|
2732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASIP1 |
0.0979217161376864 |
|
2733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IZUMO1 |
0.0979217161376864 |
|
2734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTN2A1 |
0.097982484190722 |
|
2735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTN2A3P |
0.097982484190722 |
|
2736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTN3A3 |
0.097982484190722 |
|
2737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTN1A1 |
0.097982484190722 |
|
2738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG11 |
0.097982484190722 |
|
2739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGN4 |
0.097982484190722 |
|
2740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238577.1 |
0.0980211128376908 |
|
2741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNS1 |
0.0981279233242648 |
|
2742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC5 |
0.0981279233242648 |
|
2743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC12 |
0.0981279233242648 |
|
2744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI3 |
0.0981279233242648 |
|
2745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP427 |
0.0982224617460167 |
|
2746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238645.1 |
0.0982224617460167 |
|
2747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKTIP |
0.0982224617460167 |
|
2748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00366 |
0.0983026094325294 |
|
2749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0D2 |
0.0983074957003958 |
|
2750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSTL3 |
0.0983388905813732 |
|
2751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS57 |
0.0983388905813732 |
|
2752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP33 |
0.098351264311809 |
|
2753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00973 |
0.0983948242169156 |
|
2754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPP4 |
0.098477459005643 |
|
2755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1009 |
0.098502504030484 |
|
2756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAV3 |
0.0985461325958045 |
|
2757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLB |
0.0986157276847056 |
|
2758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5591 |
0.0986157276847056 |
|
2759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf89 |
0.0987288802800093 |
|
2760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK8 |
0.0990110746326316 |
|
2761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK9 |
0.0990110746326316 |
|
2762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROPN1L |
0.0990390287050508 |
|
2763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JOSD2 |
0.0992137580323161 |
|
2764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPDH |
0.0992137580323161 |
|
2765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNTTIP2 |
0.09932954702722 |
|
2766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCLM |
0.09932954702722 |
|
2767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEAL4 |
0.0993675664214483 |
|
2768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOOL |
0.0993966584355299 |
|
2769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POF1B |
0.0993966584355299 |
|
2770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SATL1 |
0.0993966584355299 |
|
2771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2DNL |
0.0993966584355299 |
|
2772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF711 |
0.0993966584355299 |
|
2773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE10 |
0.099517296880848 |
|
2774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STIM1 |
0.0995597091859248 |
|
2775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2D3 |
0.0996012810178748 |
|
2776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PERP |
0.0996096074375084 |
|
2777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXF5 |
0.0996400395763722 |
|
2778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf66 |
0.0996514719569555 |
|
2779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPTL6 |
0.0996514719569555 |
|
2780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD105 |
0.0996514719569555 |
|
2781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF836 |
0.099666521822466 |
|
2782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R1A |
0.099666521822466 |
|
2783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
M1AP |
0.0998074085841099 |
|
2784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORC3 |
0.100035593513396 |
|
2785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBL2 |
0.100179483515492 |
|
2786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC22P |
0.100191718053435 |
|
2787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD33 |
0.100191718053435 |
|
2788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF423 |
0.100192281434063 |
|
2789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF284 |
0.100346592298983 |
|
2790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL53P |
0.100346592298983 |
|
2791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF224 |
0.100346592298983 |
|
2792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF225 |
0.100346592298983 |
|
2793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAMT |
0.100492276144242 |
|
2794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIPF7 |
0.100550048812198 |
|
2795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DESI1 |
0.100554630468264 |
|
2796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB3D |
0.100805312409872 |
|
2797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGAP3 |
0.100838804045742 |
|
2798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNPTAB |
0.100846949404515 |
|
2799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP368 |
0.100846949404515 |
|
2800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238940.1 |
0.100846949404515 |
|
2801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP369 |
0.100846949404515 |
|
2802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF506 |
0.100926200564731 |
|
2803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC159 |
0.100934463378066 |
|
2804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM205 |
0.100934463378066 |
|
2805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRMT6 |
0.100942254555493 |
|
2806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTNG1 |
0.100942254555493 |
|
2807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5AU1 |
0.100992017977692 |
|
2808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL384P |
0.100992433985325 |
|
2809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRT |
0.100997906493898 |
|
2810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42EP1 |
0.101072504633306 |
|
2811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR14 |
0.10108465993117 |
|
2812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF12 |
0.101087320331163 |
|
2813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTN3A2 |
0.101099747215968 |
|
2814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIH1D1 |
0.101107509127312 |
|
2815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH16A1 |
0.101107509127312 |
|
2816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLT3LG |
0.101107509127312 |
|
2817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL13A |
0.101107509127312 |
|
2818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD32A |
0.101107509127312 |
|
2819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD33|ENSG00000199631.1 |
0.101107509127312 |
|
2820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD34 |
0.101107509127312 |
|
2821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD35A |
0.101107509127312 |
|
2822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS2 |
0.10111419152637 |
|
2823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOTO |
0.101137065433911 |
|
2824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMYD5 |
0.101137065433911 |
|
2825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRADC1 |
0.101137065433911 |
|
2826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSE1L |
0.101564329433919 |
|
2827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTN2A2 |
0.101581225829337 |
|
2828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTN3A1 |
0.101581225829337 |
|
2829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST13 |
0.1016234473765 |
|
2830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB7 |
0.1016234473765 |
|
2831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB11FIP1 |
0.10168404829902 |
|
2832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALB |
0.101738659658568 |
|
2833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL749P |
0.10176157670046 |
|
2834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE9 |
0.101815475152191 |
|
2835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000199196.1 |
0.101951830696334 |
|
2836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNNA2 |
0.102020150553651 |
|
2837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF766 |
0.102042015638475 |
|
2838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR643 |
0.102042015638475 |
|
2839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF480 |
0.102042015638475 |
|
2840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF610 |
0.102042015638475 |
|
2841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238630.1 |
0.102092026569367 |
|
2842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF585A |
0.102154668856864 |
|
2843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL42 |
0.102261305162202 |
|
2844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL737P |
0.102261305162202 |
|
2845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC16 |
0.102343912358544 |
|
2846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF22P |
0.102428242444998 |
|
2847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB8A |
0.102588682004018 |
|
2848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHAG |
0.102590467511587 |
|
2849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNC1LI2 |
0.102894019920219 |
|
2850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAK3 |
0.102940457124896 |
|
2851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EYS |
0.103024220300159 |
|
2852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSMCE4A |
0.103034940639524 |
|
2853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX49 |
0.103075787563071 |
|
2854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOMER3 |
0.103075787563071 |
|
2855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL70P |
0.103075787563071 |
|
2856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLGAP2 |
0.10312563070748 |
|
2857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPP5 |
0.103157425766154 |
|
2858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSTR2 |
0.103174936569005 |
|
2859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COG1 |
0.103174936569005 |
|
2860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCHO1 |
0.103353529668492 |
|
2861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI30 |
0.103370820551175 |
|
2862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST9 |
0.103377082408888 |
|
2863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST3 |
0.103377082408888 |
|
2864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM184B |
0.103431950709443 |
|
2865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGMB |
0.103461679106132 |
|
2866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD1 |
0.103461679106132 |
|
2867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST4 |
0.10352906374111 |
|
2868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST1 |
0.10352906374111 |
|
2869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST2 |
0.10352906374111 |
|
2870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIC5 |
0.103540707069012 |
|
2871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL16 |
0.103551067070816 |
|
2872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HGS |
0.103551067070816 |
|
2873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL12 |
0.103551067070816 |
|
2874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAB21L1 |
0.10355315938218 |
|
2875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDTL |
0.103599467808988 |
|
2876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDT |
0.103599467808988 |
|
2877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTT1 |
0.103599467808988 |
|
2878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTT2B |
0.103599467808988 |
|
2879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTT2 |
0.103599467808988 |
|
2880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTTP2 |
0.103599467808988 |
|
2881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REXO1L10P|ENSG00000255940.1 |
0.103617419897662 |
|
2882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REXO1L10P|ENSG00000270416.1 |
0.103617419897662 |
|
2883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REXO1L11P |
0.103617419897662 |
|
2884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REXO1L1 |
0.103617419897662 |
|
2885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPG1 |
0.103759291922477 |
|
2886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTBP1 |
0.10379792837546 |
|
2887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4745 |
0.10379792837546 |
|
2888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPPR3 |
0.10379792837546 |
|
2889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3187 |
0.10379792837546 |
|
2890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC2 |
0.103802043825104 |
|
2891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM14 |
0.103859997649053 |
|
2892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELF5 |
0.103925203547801 |
|
2893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC27A1 |
0.10398712104205 |
|
2894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD7 |
0.103992865728532 |
|
2895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SECTM1 |
0.103992865728532 |
|
2896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRRD |
0.104078775578082 |
|
2897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAT2 |
0.10410587048891 |
|
2898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFV2 |
0.10422204463645 |
|
2899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4801 |
0.104237147328337 |
|
2900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD8 |
0.10431085477418 |
|
2901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERTM1 |
0.104332581512987 |
|
2902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC14A |
0.104349375405684 |
|
2903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR88 |
0.104349375405684 |
|
2904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFP |
0.104420775526548 |
|
2905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT7 |
0.104492961461867 |
|
2906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO41 |
0.104492961461867 |
|
2907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FILIP1L |
0.104567144869161 |
|
2908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC57 |
0.104747149407594 |
|
2909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK1D |
0.104747149407594 |
|
2910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A3 |
0.104747149407594 |
|
2911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238947.1 |
0.104747149407594 |
|
2912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMSS1 |
0.104768448511642 |
|
2913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1R |
0.104805688095318 |
|
2914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1RL |
0.104805688095318 |
|
2915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBP5 |
0.104805688095318 |
|
2916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLSTN3 |
0.104805688095318 |
|
2917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX5 |
0.104805688095318 |
|
2918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIH1 |
0.104812413039577 |
|
2919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHC2 |
0.104823605922694 |
|
2920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMP5 |
0.104833603819416 |
|
2921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGLS |
0.104836768622157 |
|
2922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM129C |
0.104836768622157 |
|
2923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FER1L5 |
0.104889004275183 |
|
2924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMAN2L |
0.104889004275183 |
|
2925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLOT2 |
0.104891529636777 |
|
2926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS13 |
0.104891529636777 |
|
2927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP167 |
0.104949856655673 |
|
2928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP4R1 |
0.105201200533156 |
|
2929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF585B |
0.105218529177151 |
|
2930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SENP6 |
0.105236416514697 |
|
2931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMTM4 |
0.105286157416671 |
|
2932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238864.1 |
0.105321803754354 |
|
2933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4684 |
0.105412305500229 |
|
2934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN21 |
0.105478399175429 |
|
2935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL533P |
0.105555526413153 |
|
2936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPA1P |
0.10555722197832 |
|
2937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPA1 |
0.10555722197832 |
|
2938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPNPEP3 |
0.105557240474524 |
|
2939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP4 |
0.105566011992155 |
|
2940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC10A5 |
0.105581377347871 |
|
2941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAND1 |
0.105581377347871 |
|
2942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBAK |
0.105594362561811 |
|
2943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5006 |
0.105596601898656 |
|
2944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD1L2 |
0.105658953290206 |
|
2945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCMO1 |
0.105658953290206 |
|
2946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKIRIN2 |
0.105715030928886 |
|
2947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238628.1 |
0.105715030928886 |
|
2948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H14 |
0.1057229994306 |
|
2949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR3 |
0.105800619145499 |
|
2950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00297 |
0.10586334483477 |
|
2951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLPH3 |
0.105905278930331 |
|
2952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC6 |
0.106223370869791 |
|
2953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF6 |
0.106273157196811 |
|
2954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM83C |
0.106273157196811 |
|
2955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC8B |
0.106367154520795 |
|
2956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf84 |
0.106367154520795 |
|
2957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC36 |
0.106367154520795 |
|
2958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf62 |
0.106367154520795 |
|
2959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4271 |
0.106367154520795 |
|
2960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLPI |
0.106422149914538 |
|
2961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MATN4 |
0.106422149914538 |
|
2962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBPJL |
0.106422149914538 |
|
2963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00457 |
0.106501105840823 |
|
2964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG10 |
0.10653452381508 |
|
2965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL424P |
0.106722889484247 |
|
2966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDYL2 |
0.106757308928133 |
|
2967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNMT1 |
0.106801835207355 |
|
2968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTG2 |
0.10682799277013 |
|
2969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4253 |
0.106861310141894 |
|
2970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCGR |
0.106932158509901 |
|
2971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB12 |
0.107056247657529 |
|
2972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGCC |
0.107093775780048 |
|
2973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPS7A |
0.107155223452155 |
|
2974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLF2 |
0.107155223452155 |
|
2975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTMS |
0.107155223452155 |
|
2976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAG3 |
0.107155223452155 |
|
2977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL380P |
0.107155223452155 |
|
2978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM195B |
0.107207626314775 |
|
2979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R27 |
0.107207626314775 |
|
2980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WIPI2 |
0.107325228663344 |
|
2981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC17P |
0.107334416073692 |
|
2982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf37 |
0.107334967008026 |
|
2983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USH1G |
0.107339208855785 |
|
2984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOP2 |
0.107339208855785 |
|
2985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMTC1 |
0.107340104934801 |
|
2986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD16 |
0.107363987824674 |
|
2987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHIC2 |
0.107375750208768 |
|
2988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD4 |
0.107379040516149 |
|
2989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR162 |
0.107379040516149 |
|
2990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEPREL2 |
0.107379040516149 |
|
2991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0947 |
0.10739121347654 |
|
2992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP37 |
0.10740694622482 |
|
2993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBIP |
0.107471061832605 |
|
2994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPPA3P2 |
0.107471061832605 |
|
2995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PALM |
0.107472111426439 |
|
2996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD11 |
0.107506988788905 |
|
2997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK13 |
0.107572737866414 |
|
2998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU3F4 |
0.10779044870216 |
|
2999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLD1 |
0.107877518927612 |
|
3000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL324P |
0.107877518927612 |
|
3001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIB |
0.107877518927612 |
|
3002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYBPC2 |
0.107877518927612 |
|
3003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSS |
0.107917231382881 |
|
3004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH7B |
0.107917231382881 |
|
3005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR499A |
0.107917231382881 |
|
3006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252298.1 |
0.108081673037416 |
|
3007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4681 |
0.108106329344055 |
|
3008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFIP11 |
0.108132656987624 |
|
3009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHPT1 |
0.108214615469772 |
|
3010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCP3 |
0.108214615469772 |
|
3011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDC4 |
0.10824303100716 |
|
3012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPOR |
0.108373256603775 |
|
3013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SWSAP1 |
0.108373256603775 |
|
3014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPG2 |
0.108411999942028 |
|
3015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMDN1 |
0.108484736230706 |
|
3016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFNA2 |
0.108491781683501 |
|
3017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUM1 |
0.108491781683501 |
|
3018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A14 |
0.108639679004564 |
|
3019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A13 |
0.108639679004564 |
|
3020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A1 |
0.108639679004564 |
|
3021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHTOP |
0.108639679004564 |
|
3022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HID1 |
0.108640089831895 |
|
3023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDR2L |
0.108640089831895 |
|
3024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICT1 |
0.108640089831895 |
|
3025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR150 |
0.1086481973491 |
|
3026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA9 |
0.1086481973491 |
|
3027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOBTB3 |
0.1086481973491 |
|
3028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRX |
0.1086481973491 |
|
3029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf27 |
0.1086481973491 |
|
3030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF292 |
0.108649176733729 |
|
3031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC1P |
0.108685690427538 |
|
3032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTN5 |
0.108685690427538 |
|
3033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT2 |
0.108685690427538 |
|
3034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL345P |
0.108685690427538 |
|
3035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC4 |
0.108705270975313 |
|
3036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM182A |
0.108805944196348 |
|
3037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPSCR1 |
0.108822299797198 |
|
3038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRA13 |
0.108822299797198 |
|
3039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCXR |
0.108822299797198 |
|
3040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC45 |
0.108822299797198 |
|
3041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAC3 |
0.108822299797198 |
|
3042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP157 |
0.108825104333931 |
|
3043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOTUM |
0.10882960080196 |
|
3044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF6 |
0.108874408621014 |
|
3045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYBPC1 |
0.108908646646734 |
|
3046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3941 |
0.108951314677221 |
|
3047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL353P |
0.108979106979061 |
|
3048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG20 |
0.108979106979061 |
|
3049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1P4 |
0.108989683351213 |
|
3050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIAT1 |
0.109090770779947 |
|
3051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SASS6 |
0.109090770779947 |
|
3052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT13 |
0.109090770779947 |
|
3053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC39 |
0.109090770779947 |
|
3054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3605 |
0.109173475463269 |
|
3055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP16 |
0.109173475463269 |
|
3056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUGP2 |
0.109263395551131 |
|
3057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEE2 |
0.109289200041553 |
|
3058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPRT |
0.109289200041553 |
|
3059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC15 |
0.109289200041553 |
|
3060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOP3 |
0.109523489206191 |
|
3061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NARF |
0.10952943464287 |
|
3062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDK1 |
0.109563468965212 |
|
3063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFNG |
0.109638149768534 |
|
3064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPS1 |
0.109638149768534 |
|
3065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUS1L |
0.109638149768534 |
|
3066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf141 |
0.109688681426776 |
|
3067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC12 |
0.109713784926981 |
|
3068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC6 |
0.109713784926981 |
|
3069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFNG |
0.109753435987897 |
|
3070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYRK4 |
0.109758918217345 |
|
3071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESRRAP2 |
0.109759519236772 |
|
3072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIPEPP3 |
0.109759519236772 |
|
3073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP25 |
0.109759519236772 |
|
3074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAK7 |
0.109840564687422 |
|
3075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRWD1 |
0.109843909862382 |
|
3076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ14 |
0.109843909862382 |
|
3077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP26 |
0.109921843125996 |
|
3078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XIST |
0.110004948618379 |
|
3079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LACTBL1 |
0.110061462634368 |
|
3080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB31 |
0.110092970571277 |
|
3081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD109 |
0.110183769462309 |
|
3082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00905 |
0.110224695544023 |
|
3083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF16 |
0.1103624713487 |
|
3084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00661 |
0.110415114979211 |
|
3085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM7 |
0.110421489667302 |
|
3086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGLN3 |
0.110490180405466 |
|
3087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD38|ENSG00000207199.1 |
0.110534099019694 |
|
3088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM24 |
0.110564914843721 |
|
3089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBL3 |
0.110580598568905 |
|
3090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPPP2 |
0.110672630241817 |
|
3091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RXFP3 |
0.110689716903235 |
|
3092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAPG |
0.110746609015081 |
|
3093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBNO2 |
0.110777802936778 |
|
3094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STMND1 |
0.110817149375692 |
|
3095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPM4 |
0.110849433053433 |
|
3096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POSTN |
0.110887025396208 |
|
3097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPECC1L |
0.110900441444426 |
|
3098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLN8 |
0.110930442278896 |
|
3099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR596 |
0.110930442278896 |
|
3100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF10 |
0.110930442278896 |
|
3101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRK2 |
0.110952434051128 |
|
3102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNC3 |
0.110958469054388 |
|
3103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAPSB |
0.110958469054388 |
|
3104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR1H2 |
0.110958469054388 |
|
3105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR760 |
0.111014978708065 |
|
3106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SREBF2 |
0.111129453306352 |
|
3107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FPR1 |
0.111177285189036 |
|
3108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FPR2 |
0.111177285189036 |
|
3109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FPR3 |
0.111177285189036 |
|
3110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCCAT3 |
0.111177285189036 |
|
3111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF350 |
0.111177285189036 |
|
3112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF432 |
0.111177285189036 |
|
3113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF577 |
0.111177285189036 |
|
3114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF613 |
0.111177285189036 |
|
3115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF614 |
0.111177285189036 |
|
3116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF615 |
0.111177285189036 |
|
3117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF649 |
0.111177285189036 |
|
3118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF841 |
0.111177285189036 |
|
3119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35A3 |
0.111231959179501 |
|
3120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM151B |
0.111282554220733 |
|
3121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS35 |
0.11131930135912 |
|
3122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR19 |
0.111328479474472 |
|
3123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHDC3L |
0.111358000889911 |
|
3124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC7 |
0.111368332433183 |
|
3125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HN1 |
0.111368332433183 |
|
3126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5C |
0.111368332433183 |
|
3127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEAF1 |
0.111445450708827 |
|
3128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSBP4 |
0.111678542026385 |
|
3129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISYNA1 |
0.111678542026385 |
|
3130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT3 |
0.111691932740489 |
|
3131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238748.1 |
0.111716931123672 |
|
3132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM4 |
0.111771920258157 |
|
3133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJA4 |
0.111776486749133 |
|
3134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRD5A3 |
0.111838049078635 |
|
3135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX11 |
0.111855898254651 |
|
3136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ30594 |
0.111855898254651 |
|
3137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEA1 |
0.111946505900402 |
|
3138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJB5 |
0.112028943003652 |
|
3139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJB4 |
0.112028943003652 |
|
3140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJB3 |
0.112028943003652 |
|
3141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf81 |
0.112124116982166 |
|
3142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221332.1 |
0.11214249866735 |
|
3143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4463 |
0.11214249866735 |
|
3144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00243 |
0.112160117602171 |
|
3145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R10 |
0.112168004116564 |
|
3146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS18B |
0.112168004116564 |
|
3147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATAT1 |
0.112168004116564 |
|
3148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf136 |
0.112168004116564 |
|
3149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRFN5 |
0.112177375152546 |
|
3150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P4HB |
0.112186626435207 |
|
3151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUMO2 |
0.112259081700716 |
|
3152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM222B |
0.112361621319462 |
|
3153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf118 |
0.112368554258932 |
|
3154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARPBP |
0.112382644715693 |
|
3155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMCH |
0.112382644715693 |
|
3156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL793P |
0.112382644715693 |
|
3157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL243P |
0.112387313682453 |
|
3158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GINS4 |
0.112699570857879 |
|
3159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAV3 |
0.112724336137697 |
|
3160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSMR |
0.112750497257585 |
|
3161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF175 |
0.112794551663008 |
|
3162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNL1 |
0.112813048821359 |
|
3163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP46 |
0.112868585663461 |
|
3164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGDH |
0.112912474895868 |
|
3165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMP3 |
0.112919451447701 |
|
3166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM143 |
0.112919451447701 |
|
3167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNGR4 |
0.112919451447701 |
|
3168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDELR1 |
0.112919451447701 |
|
3169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGUOK |
0.112964719263273 |
|
3170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP163 |
0.112992362671181 |
|
3171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFTA3 |
0.113005844845682 |
|
3172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAU1 |
0.113061867014285 |
|
3173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY11 |
0.113183494820895 |
|
3174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD105B |
0.113183494820895 |
|
3175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3G |
0.113183494820895 |
|
3176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRCA2 |
0.113252380790695 |
|
3177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP10 |
0.113272349761292 |
|
3178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNT3 |
0.113283582612785 |
|
3179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC32A1 |
0.113308089442868 |
|
3180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK11 |
0.113317192256295 |
|
3181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK12 |
0.113317192256295 |
|
3182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC4AP |
0.113348998594828 |
|
3183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD56|ENSG00000201151.1 |
0.113348998594828 |
|
3184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPZL1 |
0.113382278205726 |
|
3185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4449 |
0.113401436872034 |
|
3186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212588.1 |
0.113401436872034 |
|
3187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAPSA |
0.113482975843304 |
|
3188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OVCA2 |
0.113691105535434 |
|
3189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIC1 |
0.113691105535434 |
|
3190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR132 |
0.113691105535434 |
|
3191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR212 |
0.113691105535434 |
|
3192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAC8 |
0.113707426193119 |
|
3193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ2 |
0.113707426193119 |
|
3194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPSE |
0.113707426193119 |
|
3195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSH2D |
0.113740961152765 |
|
3196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB11FIP5 |
0.113755211443802 |
|
3197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDLR |
0.113813395604963 |
|
3198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROCA1 |
0.113869167188379 |
|
3199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB34 |
0.113869167188379 |
|
3200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTDSS2 |
0.113884755628326 |
|
3201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNRC18 |
0.113979085190219 |
|
3202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADORA2A |
0.113980683864022 |
|
3203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPB1 |
0.113980683864022 |
|
3204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MISP |
0.113994068320813 |
|
3205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A5 |
0.114113765506122 |
|
3206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL23A |
0.114165034370881 |
|
3207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD42B |
0.114165034370881 |
|
3208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD42A |
0.114165034370881 |
|
3209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD4A |
0.114165034370881 |
|
3210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD4B |
0.114165034370881 |
|
3211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H1E |
0.114170489621755 |
|
3212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BD |
0.114170489621755 |
|
3213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BE |
0.114170489621755 |
|
3214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTHD1 |
0.114182516338634 |
|
3215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK10 |
0.114212660392382 |
|
3216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM45A |
0.114262112942581 |
|
3217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFXN4 |
0.114262112942581 |
|
3218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDX3 |
0.114262112942581 |
|
3219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPC24 |
0.114263713414379 |
|
3220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLCD1 |
0.114292262176423 |
|
3221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK8 |
0.114292262176423 |
|
3222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMS1 |
0.114303387827686 |
|
3223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXF2 |
0.114403017755738 |
|
3224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP11X1 |
0.114403017755738 |
|
3225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTX2 |
0.114405279973137 |
|
3226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL461P |
0.114405279973137 |
|
3227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNQ5 |
0.114505795652709 |
|
3228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPSE2 |
0.114514928094983 |
|
3229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX1 |
0.114559835670059 |
|
3230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD37|ENSG00000212270.1 |
0.114582273169999 |
|
3231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD163L1 |
0.114676972509986 |
|
3232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC11 |
0.114690312829683 |
|
3233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4639 |
0.11470938329338 |
|
3234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAD9 |
0.114746454653542 |
|
3235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WWP2 |
0.114764960493391 |
|
3236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TACR1 |
0.114772876442111 |
|
3237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARAP2 |
0.114780832852948 |
|
3238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOA |
0.114823196126232 |
|
3239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
A4GALT |
0.114834783485008 |
|
3240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BSG |
0.114862463126425 |
|
3241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WHSC1L1 |
0.114952180917576 |
|
3242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238514.1 |
0.114976565544907 |
|
3243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3A |
0.11499251697867 |
|
3244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NANOS1 |
0.11499251697867 |
|
3245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA19|ENSG00000207468.1 |
0.11499251697867 |
|
3246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA19|ENSG00000222588.1 |
0.11499251697867 |
|
3247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP11X2 |
0.115032975210123 |
|
3248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMSB15A |
0.115032975210123 |
|
3249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXF4 |
0.115032975210123 |
|
3250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMCX5 |
0.115032975210123 |
|
3251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRASP1 |
0.115032975210123 |
|
3252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM20C |
0.115047581267232 |
|
3253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDGFA |
0.115047581267232 |
|
3254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QDPR |
0.11509414063873 |
|
3255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOM2 |
0.115214253858146 |
|
3256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A16 |
0.115223878916992 |
|
3257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDDM3A |
0.115229892727366 |
|
3258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN1C |
0.115381804276659 |
|
3259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4264 |
0.115488809606539 |
|
3260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABLIM1 |
0.115537472901538 |
|
3261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPX1 |
0.115542418493912 |
|
3262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCAN2 |
0.115637692409048 |
|
3263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX36 |
0.11567627698717 |
|
3264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239186.1 |
0.11570144779774 |
|
3265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOX3 |
0.115806437993596 |
|
3266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPR |
0.115874418909023 |
|
3267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMX1 |
0.115874418909023 |
|
3268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf95 |
0.115895034017431 |
|
3269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMS2 |
0.1159017348655 |
|
3270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTRA1 |
0.1159017348655 |
|
3271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSDL1 |
0.115970169018376 |
|
3272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELL |
0.116055879838436 |
|
3273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF420 |
0.116095983844352 |
|
3274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCN2 |
0.116291128814138 |
|
3275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLRMT |
0.116291128814138 |
|
3276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF22 |
0.116291128814138 |
|
3277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF126 |
0.116291128814138 |
|
3278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAP |
0.116395298298732 |
|
3279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCEE |
0.116421135385207 |
|
3280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDHD2 |
0.116506550099544 |
|
3281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHH |
0.116569983294482 |
|
3282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZAR1L |
0.116655391853016 |
|
3283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSBP1 |
0.116660758702784 |
|
3284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLYCD |
0.116660758702784 |
|
3285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSGIN1 |
0.116660758702784 |
|
3286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NECAB2 |
0.116660758702784 |
|
3287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBTPS1 |
0.116660758702784 |
|
3288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP432 |
0.116660758702784 |
|
3289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A8 |
0.116660758702784 |
|
3290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAN |
0.116667180546959 |
|
3291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TWSG1 |
0.11683258173308 |
|
3292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR18 |
0.116866726091472 |
|
3293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIN3B |
0.116866726091472 |
|
3294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM259 |
0.116866726091472 |
|
3295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAT1L |
0.11688695263846 |
|
3296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC3A |
0.11688695263846 |
|
3297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFXAP |
0.11695047671888 |
|
3298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A11 |
0.116958968413635 |
|
3299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY10 |
0.117027541986869 |
|
3300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPC2 |
0.117027541986869 |
|
3301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAT1 |
0.117124421830939 |
|
3302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEK |
0.117204121312297 |
|
3303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF283 |
0.117270812543671 |
|
3304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYTH2 |
0.117282928217703 |
|
3305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED28 |
0.117288299640767 |
|
3306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDSN |
0.11734020428793 |
|
3307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSORS1C1 |
0.11734020428793 |
|
3308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSORS1C2 |
0.11734020428793 |
|
3309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCHCR1 |
0.11734020428793 |
|
3310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF19 |
0.11734020428793 |
|
3311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU5F1 |
0.11734020428793 |
|
3312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALBP1 |
0.117370416424961 |
|
3313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR920 |
0.1174216105757 |
|
3314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CISD2 |
0.11744236186849 |
|
3315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238948.1 |
0.11744236186849 |
|
3316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNH1 |
0.117511219747856 |
|
3317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO31 |
0.117702268489405 |
|
3318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISX |
0.117727838315823 |
|
3319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4733 |
0.117787027848711 |
|
3320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUN1 |
0.117811691207778 |
|
3321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APLF |
0.117832449398474 |
|
3322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO48 |
0.117832449398474 |
|
3323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROKR1 |
0.117832449398474 |
|
3324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMTK3 |
0.117925054092019 |
|
3325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP209 |
0.117933895020622 |
|
3326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239132.1 |
0.117933895020622 |
|
3327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF492 |
0.117939340414167 |
|
3328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf77 |
0.117963802471699 |
|
3329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOHH |
0.117963802471699 |
|
3330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL866P |
0.117963802471699 |
|
3331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZR1 |
0.117963802471699 |
|
3332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD38|ENSG00000252408.1 |
0.117963802471699 |
|
3333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHIC1 |
0.117973917774105 |
|
3334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBT |
0.117979875116873 |
|
3335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLOT1 |
0.118042795601276 |
|
3336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IER3 |
0.118042795601276 |
|
3337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX16 |
0.118057440817007 |
|
3338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0100 |
0.118086609867276 |
|
3339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238588.1 |
0.118138450247602 |
|
3340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A28 |
0.118138450247602 |
|
3341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIT |
0.118210222103544 |
|
3342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H1D |
0.118211662007882 |
|
3343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4F |
0.118211662007882 |
|
3344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4G |
0.118211662007882 |
|
3345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3F |
0.118211662007882 |
|
3346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BH |
0.118211662007882 |
|
3347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXF2B |
0.118248606001119 |
|
3348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXJ1 |
0.118324466229695 |
|
3349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA9 |
0.118339459960397 |
|
3350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN1 |
0.118459589222604 |
|
3351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL315P |
0.118591882339644 |
|
3352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG5 |
0.11860314038188 |
|
3353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF4 |
0.118778172359247 |
|
3354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3R2 |
0.11883639300547 |
|
3355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CES5A |
0.118908311277778 |
|
3356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRUB1 |
0.119020455048985 |
|
3357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf42 |
0.119060401749753 |
|
3358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIA1 |
0.119060401749753 |
|
3359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD163 |
0.11907803693094 |
|
3360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238394.1 |
0.119103896068688 |
|
3361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR589 |
0.119103896068688 |
|
3362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS19 |
0.119122490648713 |
|
3363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD79A |
0.119122490648713 |
|
3364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN16 |
0.119140892536954 |
|
3365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4728 |
0.119148201226763 |
|
3366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAMBP |
0.119164700897769 |
|
3367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTCA |
0.119179092792492 |
|
3368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR553 |
0.119179092792492 |
|
3369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UHRF1BP1L |
0.119187355105389 |
|
3370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10H4 |
0.119192438914059 |
|
3371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRISP2 |
0.119250392632642 |
|
3372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGA1 |
0.119278579673031 |
|
3373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4282 |
0.119283362630265 |
|
3374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCLC |
0.11932746000108 |
|
3375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAXIP1 |
0.119429043969562 |
|
3376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAT3 |
0.11953138460808 |
|
3377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCR7L |
0.11953138460808 |
|
3378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF4 |
0.11953138460808 |
|
3379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS19BP1 |
0.11953138460808 |
|
3380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTPD7 |
0.119591526140531 |
|
3381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUTC |
0.119591526140531 |
|
3382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX15 |
0.119591526140531 |
|
3383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC2 |
0.119591526140531 |
|
3384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNMBP |
0.119591526140531 |
|
3385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238472.1 |
0.119591526140531 |
|
3386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP7A |
0.119594075236765 |
|
3387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf234 |
0.119618154222888 |
|
3388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM1A |
0.119618154222888 |
|
3389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3115 |
0.119618154222888 |
|
3390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4419A |
0.119618154222888 |
|
3391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA2B |
0.119692984880415 |
|
3392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL176P |
0.119692984880415 |
|
3393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAR1B |
0.119709930977745 |
|
3394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC46A3 |
0.119728749190338 |
|
3395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAP1GAP |
0.11982432620695 |
|
3396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
N4BP2L1 |
0.119966000054249 |
|
3397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA16|ENSG00000212293.1 |
0.119966000054249 |
|
3398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
N4BP2L2 |
0.119966000054249 |
|
3399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GORAB |
0.11997834433882 |
|
3400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC5 |
0.120015689041301 |
|
3401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC14 |
0.120015689041301 |
|
3402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238486.1 |
0.120015689041301 |
|
3403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00085 |
0.120015689041301 |
|
3404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR125A |
0.120015689041301 |
|
3405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR99B |
0.120015689041301 |
|
3406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7E |
0.120015689041301 |
|
3407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM4 |
0.120032020280902 |
|
3408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL513P |
0.120032020280902 |
|
3409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK5 |
0.120116776296664 |
|
3410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK6 |
0.120116776296664 |
|
3411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMX2 |
0.12020418389959 |
|
3412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNO1 |
0.120230597149035 |
|
3413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSM4 |
0.12023714056985 |
|
3414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP21 |
0.120259318102085 |
|
3415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD13 |
0.120299355082554 |
|
3416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRS3 |
0.120466257977063 |
|
3417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRICKLE4 |
0.120466257977063 |
|
3418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM6 |
0.120466257977063 |
|
3419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLE2 |
0.120474254133189 |
|
3420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A1 |
0.120537405927024 |
|
3421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL438P |
0.120574205431651 |
|
3422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLE6 |
0.120937423720114 |
|
3423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD2 |
0.120941137961123 |
|
3424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5H |
0.120941137961123 |
|
3425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL573P |
0.120941137961123 |
|
3426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK7 |
0.120945621435337 |
|
3427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELOVL2 |
0.12104509191491 |
|
3428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM13 |
0.12104509191491 |
|
3429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAICS |
0.121067581967418 |
|
3430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf28 |
0.121080136311871 |
|
3431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPPED1 |
0.121085109864666 |
|
3432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEATR2 |
0.121204617515317 |
|
3433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIC |
0.121220489550674 |
|
3434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF554 |
0.121238151747466 |
|
3435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP3 |
0.12126611296298 |
|
3436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLLU1OS |
0.121332710405394 |
|
3437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLLU1 |
0.121332710405394 |
|
3438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238865.1 |
0.121332710405394 |
|
3439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NANOGP1 |
0.121394425817981 |
|
3440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A14 |
0.121394425817981 |
|
3441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A3 |
0.121394425817981 |
|
3442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDEM2 |
0.121464610969981 |
|
3443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP24 |
0.121464610969981 |
|
3444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ME1 |
0.121506621592035 |
|
3445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEF6 |
0.12161715076205 |
|
3446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF829 |
0.121640725717251 |
|
3447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATE1 |
0.121823233758712 |
|
3448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRTC1 |
0.121859667217039 |
|
3449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BI |
0.121890783224636 |
|
3450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3G |
0.121890783224636 |
|
3451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4H |
0.121890783224636 |
|
3452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRP72 |
0.121993627912328 |
|
3453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFR2 |
0.122041423794684 |
|
3454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF555 |
0.122058546088454 |
|
3455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238896.1 |
0.122085048428087 |
|
3456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR1 |
0.122151089659518 |
|
3457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3138 |
0.122151089659518 |
|
3458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCC |
0.122159373801962 |
|
3459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A3 |
0.122215004873672 |
|
3460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGTA |
0.122215004873672 |
|
3461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THOP1 |
0.122215004873672 |
|
3462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSF2 |
0.122259479455231 |
|
3463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R1B |
0.122393337109124 |
|
3464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA7|ENSG00000206976.1 |
0.122393794435324 |
|
3465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF833P |
0.12248733505783 |
|
3466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNNM1 |
0.122528527266734 |
|
3467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOT1 |
0.122528527266734 |
|
3468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID3A |
0.122538298733475 |
|
3469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFD |
0.122538298733475 |
|
3470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELANE |
0.122538298733475 |
|
3471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KISS1R |
0.122538298733475 |
|
3472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED16 |
0.122538298733475 |
|
3473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRTN3 |
0.122538298733475 |
|
3474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
R3HDM4 |
0.122538298733475 |
|
3475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAG1 |
0.122541002442485 |
|
3476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNN2 |
0.122566298630275 |
|
3477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA7 |
0.122566298630275 |
|
3478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMHA1 |
0.122566298630275 |
|
3479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD3 |
0.122636371502125 |
|
3480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCAP |
0.122636371502125 |
|
3481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMT |
0.122636371502125 |
|
3482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATRNL1 |
0.122771758296993 |
|
3483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL18 |
0.122876525922738 |
|
3484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GZMB |
0.122880012826091 |
|
3485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOCS2 |
0.122916751758776 |
|
3486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRADD |
0.122916751758776 |
|
3487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDC1 |
0.12295246238545 |
|
3488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB |
0.12295246238545 |
|
3489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2E |
0.12297780926292 |
|
3490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPX4 |
0.12297780926292 |
|
3491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00277 |
0.123029162407705 |
|
3492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF556 |
0.123040956745686 |
|
3493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF57 |
0.123040956745686 |
|
3494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF77 |
0.123040956745686 |
|
3495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F11 |
0.123085902995661 |
|
3496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSIX |
0.12312815011567 |
|
3497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICU2 |
0.123157561860329 |
|
3498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238878.1 |
0.123157561860329 |
|
3499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP382 |
0.123236542121636 |
|
3500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFDC3 |
0.123241410094313 |
|
3501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE6G |
0.123244033879051 |
|
3502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXLD1 |
0.123244033879051 |
|
3503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC137 |
0.123244033879051 |
|
3504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF616 |
0.123263010139868 |
|
3505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFWD3 |
0.123263526193418 |
|
3506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLKL |
0.123263526193418 |
|
3507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL269P |
0.123295477355741 |
|
3508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGF2 |
0.123368716184911 |
|
3509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR483 |
0.123368716184911 |
|
3510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFR1 |
0.123390695714562 |
|
3511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS20P22 |
0.123390695714562 |
|
3512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4D |
0.123406139793291 |
|
3513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO6 |
0.123480894801697 |
|
3514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAQR5 |
0.123553635679239 |
|
3515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA77|ENSG00000221376.1 |
0.123553635679239 |
|
3516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP398 |
0.123553635679239 |
|
3517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETV5 |
0.123569957246715 |
|
3518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMO2 |
0.123572499006426 |
|
3519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMO1 |
0.123572499006426 |
|
3520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMO4 |
0.123572499006426 |
|
3521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCYL3 |
0.123615771885524 |
|
3522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL333P |
0.123615771885524 |
|
3523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNLIPRP3 |
0.123705215399966 |
|
3524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP11 |
0.123773482563172 |
|
3525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf78 |
0.123773482563172 |
|
3526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPESP1 |
0.123820857441055 |
|
3527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOX5 |
0.123820857441055 |
|
3528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA4F |
0.123823754620345 |
|
3529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HK2 |
0.123823754620345 |
|
3530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX35 |
0.123850869181596 |
|
3531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL155P |
0.123974045897815 |
|
3532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL26 |
0.123974045897815 |
|
3533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRB7 |
0.123974894515468 |
|
3534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL630P |
0.123996409219726 |
|
3535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP6 |
0.124123039428869 |
|
3536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TACC2 |
0.124260079209409 |
|
3537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARS |
0.124321391858817 |
|
3538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNPDA2 |
0.124351634991787 |
|
3539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf112 |
0.124357760839069 |
|
3540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASH2L |
0.124380923959872 |
|
3541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAR |
0.124380923959872 |
|
3542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM1 |
0.124380923959872 |
|
3543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAG4 |
0.124380923959872 |
|
3544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf86 |
0.124504826661539 |
|
3545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERBB2 |
0.124736137819542 |
|
3546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIEN1 |
0.124736137819542 |
|
3547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERAL1 |
0.124864632647573 |
|
3548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4732 |
0.124864632647573 |
|
3549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAN3 |
0.124877476533418 |
|
3550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLT1 |
0.124877476533418 |
|
3551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H4 |
0.124884045550436 |
|
3552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKHD1 |
0.125046096866703 |
|
3553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6ORF165 |
0.125074112936359 |
|
3554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP97 |
0.125118453255702 |
|
3555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRC2C |
0.125148546034428 |
|
3556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM80 |
0.125188681251911 |
|
3557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGPEP1 |
0.1252982256143 |
|
3558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP3R1 |
0.125354383629531 |
|
3559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RARS2 |
0.125427489877069 |
|
3560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR573 |
0.125443115000057 |
|
3561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDHR5 |
0.125513567893659 |
|
3562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF7 |
0.125513567893659 |
|
3563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCT |
0.125513567893659 |
|
3564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAPDC1B |
0.125514045723567 |
|
3565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSX2 |
0.125556324805374 |
|
3566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238753.1 |
0.125556324805374 |
|
3567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT1 |
0.12563821696546 |
|
3568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF21 |
0.12563821696546 |
|
3569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT3 |
0.125645721454769 |
|
3570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSL3 |
0.125645721454769 |
|
3571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PACSIN2 |
0.125686417767474 |
|
3572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE3D |
0.125722887566149 |
|
3573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OOEP |
0.125792968330497 |
|
3574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX43 |
0.125792968330497 |
|
3575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238464.1 |
0.125792968330497 |
|
3576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MB21D1 |
0.125792968330497 |
|
3577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPPH1 |
0.125812580391521 |
|
3578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP2 |
0.125812580391521 |
|
3579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLT3 |
0.125885092407744 |
|
3580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUF1 |
0.125971234574402 |
|
3581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL28 |
0.126037998113783 |
|
3582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX16 |
0.126044392442945 |
|
3583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNB1IP1 |
0.126104281931975 |
|
3584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTUS2 |
0.126130206589174 |
|
3585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EP300 |
0.126152739790911 |
|
3586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1B1 |
0.126177986115096 |
|
3587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGR4 |
0.126220031418169 |
|
3588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238521.1 |
0.126360014685142 |
|
3589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AARS |
0.126402459142381 |
|
3590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIOK2 |
0.126415724865766 |
|
3591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFHX4 |
0.126490181315692 |
|
3592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP48 |
0.126513072807786 |
|
3593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL862P |
0.126593367771308 |
|
3594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP449 |
0.126593367771308 |
|
3595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL575P |
0.126599262697315 |
|
3596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAL |
0.126599262697315 |
|
3597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NANOGNB |
0.126603294748527 |
|
3598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NANOG |
0.126603294748527 |
|
3599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIT1 |
0.126694544825598 |
|
3600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf74 |
0.126804367449795 |
|
3601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHG7 |
0.126804367449795 |
|
3602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASE9 |
0.126834644112743 |
|
3603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLIP |
0.126890543365336 |
|
3604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEGF10 |
0.126905253611797 |
|
3605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICK |
0.126939698700645 |
|
3606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCG22 |
0.126947840121912 |
|
3607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf15 |
0.126947840121912 |
|
3608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD78|ENSG00000212378.1 |
0.126962393518338 |
|
3609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF76 |
0.127031329159003 |
|
3610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAPDC1A |
0.12711009236247 |
|
3611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTX3 |
0.127170138759516 |
|
3612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPV17L2 |
0.127187779441184 |
|
3613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDP1 |
0.127216249815676 |
|
3614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEDD8 |
0.127216249815676 |
|
3615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMPR2 |
0.127216249815676 |
|
3616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCF1 |
0.127256929190908 |
|
3617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR877 |
0.127256929190908 |
|
3618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAAM1 |
0.127358056233493 |
|
3619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROCR |
0.127365308957193 |
|
3620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP483 |
0.127365308957193 |
|
3621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEXDC |
0.127504005513088 |
|
3622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf62 |
0.127504005513088 |
|
3623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf165 |
0.127537000691862 |
|
3624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35A1 |
0.127537000691862 |
|
3625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX2 |
0.127692421430165 |
|
3626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239087.1 |
0.127913566226079 |
|
3627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238595.1 |
0.127915629145366 |
|
3628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO4 |
0.127919782524431 |
|
3629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS4L1 |
0.127943767702745 |
|
3630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC16B |
0.127943767702745 |
|
3631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS10 |
0.127948968459232 |
|
3632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIAL1 |
0.127948968459232 |
|
3633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F3 |
0.128009504648862 |
|
3634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F12 |
0.128009504648862 |
|
3635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA2 |
0.128014571069911 |
|
3636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPH1 |
0.128125485182523 |
|
3637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GALTL |
0.128125485182523 |
|
3638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KXD1 |
0.128223465879208 |
|
3639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf60 |
0.128223465879208 |
|
3640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM59L |
0.128223465879208 |
|
3641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAG3L4 |
0.128266464071801 |
|
3642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRGC |
0.128270783004922 |
|
3643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO18B |
0.128271418562922 |
|
3644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOR1P1 |
0.128316700798391 |
|
3645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELAVL3 |
0.128359560458543 |
|
3646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF653 |
0.128359560458543 |
|
3647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECSIT |
0.128359560458543 |
|
3648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP140 |
0.128370833518721 |
|
3649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R16B |
0.128385861817722 |
|
3650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ILF2 |
0.128443539082724 |
|
3651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPH1 |
0.12847289090577 |
|
3652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALMS1 |
0.128540748422734 |
|
3653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RWDD2A |
0.128555563922356 |
|
3654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EYA2 |
0.128634606743578 |
|
3655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA7 |
0.128772104463587 |
|
3656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MON1B |
0.128830373911569 |
|
3657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCE1L |
0.128830373911569 |
|
3658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYLIP |
0.128872528002004 |
|
3659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000251793.1 |
0.128872528002004 |
|
3660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPST2 |
0.128872577222316 |
|
3661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL6 |
0.12896273787721 |
|
3662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFAIP3 |
0.128970976870449 |
|
3663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRM1 |
0.129059012688952 |
|
3664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL18 |
0.129139371500181 |
|
3665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL2BPP3 |
0.129173803474393 |
|
3666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC18A2 |
0.129188773790565 |
|
3667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZD8 |
0.129188773790565 |
|
3668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMX2OS |
0.129188773790565 |
|
3669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MROH2B |
0.129198222394393 |
|
3670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF157 |
0.129228686184532 |
|
3671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL440P |
0.129428042070528 |
|
3672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238389.1 |
0.129428042070528 |
|
3673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL12RB1 |
0.129446246726175 |
|
3674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRLF1 |
0.129701937078604 |
|
3675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBA52 |
0.129701937078604 |
|
3676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC5P |
0.129704262136655 |
|
3677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238859.1 |
0.129842772767302 |
|
3678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL425P |
0.129842772767302 |
|
3679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM160B1 |
0.130064423431926 |
|
3680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP34 |
0.130268826732241 |
|
3681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GKN1 |
0.130382600701081 |
|
3682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIF |
0.130388612312575 |
|
3683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF724P |
0.130439409478559 |
|
3684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO9 |
0.130522977308571 |
|
3685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL244P |
0.130522977308571 |
|
3686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAB1 |
0.130589277244355 |
|
3687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL116P |
0.130625298793181 |
|
3688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM83D |
0.130625298793181 |
|
3689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARD3B |
0.130726725735738 |
|
3690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL12A1 |
0.130727962889622 |
|
3691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNCRIP |
0.130734370027169 |
|
3692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF15 |
0.130819628187021 |
|
3693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3189 |
0.130819628187021 |
|
3694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC25 |
0.130819628187021 |
|
3695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNQ1 |
0.131029649268422 |
|
3696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNA1 |
0.131143217878914 |
|
3697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM161A |
0.131257149014155 |
|
3698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGPAT9 |
0.131458296053945 |
|
3699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000251858.1 |
0.13150510363156 |
|
3700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM160 |
0.131575460145815 |
|
3701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM5 |
0.131665350414233 |
|
3702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEA |
0.131665350414233 |
|
3703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM6 |
0.131665350414233 |
|
3704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMT |
0.13174641037188 |
|
3705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NICN1 |
0.13174641037188 |
|
3706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP130 |
0.13174641037188 |
|
3707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP29 |
0.131752754408396 |
|
3708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMO3 |
0.13178905545025 |
|
3709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1295A |
0.13178905545025 |
|
3710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMO6P |
0.13178905545025 |
|
3711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULF2 |
0.131800337823399 |
|
3712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP209 |
0.131835949669531 |
|
3713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGA |
0.131835949669531 |
|
3714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0907 |
0.131867658256664 |
|
3715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00261 |
0.13194175081447 |
|
3716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A17 |
0.131945885026563 |
|
3717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4766 |
0.131945885026563 |
|
3718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPARGC1A |
0.132270592964124 |
|
3719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF3 |
0.132390451898734 |
|
3720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPPA3 |
0.132390451898734 |
|
3721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC4C |
0.132390451898734 |
|
3722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR125 |
0.132497358806962 |
|
3723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELL2 |
0.132664537074507 |
|
3724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP135 |
0.132752156734755 |
|
3725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPAS1 |
0.132897376856855 |
|
3726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIN2C |
0.133001406015578 |
|
3727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FDXR |
0.133001406015578 |
|
3728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A9 |
0.133028400359329 |
|
3729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD17 |
0.133252044632952 |
|
3730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAP91 |
0.13331334466652 |
|
3731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRASP2 |
0.133396785757493 |
|
3732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHLHB9 |
0.133396785757493 |
|
3733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AC |
0.133426425831131 |
|
3734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FERMT1 |
0.133610544394477 |
|
3735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL11B |
0.133616660530195 |
|
3736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRHDE |
0.133631390726898 |
|
3737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTN4 |
0.133660767160731 |
|
3738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTPD6 |
0.133666687865863 |
|
3739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIB3 |
0.133735325893936 |
|
3740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBFOX2 |
0.133764335969265 |
|
3741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APAF1 |
0.133871582589486 |
|
3742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3D |
0.133886111471732 |
|
3743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEURL3 |
0.133951607686654 |
|
3744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID5A |
0.133951607686654 |
|
3745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIFAP3 |
0.133955395220127 |
|
3746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBX1 |
0.134014652057361 |
|
3747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL21 |
0.134106928865489 |
|
3748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD102 |
0.134106928865489 |
|
3749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA27|ENSG00000207051.1 |
0.134106928865489 |
|
3750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSK |
0.134176863215153 |
|
3751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM69C |
0.134193479260596 |
|
3752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1841 |
0.134195378221602 |
|
3753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf74 |
0.134195378221602 |
|
3754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHSA2 |
0.134195378221602 |
|
3755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1P1 |
0.13420758533967 |
|
3756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF3A |
0.13420758533967 |
|
3757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTIF3 |
0.13420758533967 |
|
3758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LNX2 |
0.13420758533967 |
|
3759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR1D |
0.13420758533967 |
|
3760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSX1 |
0.13420758533967 |
|
3761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REG1A |
0.134266841152686 |
|
3762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REG1B |
0.134266841152686 |
|
3763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REG1P |
0.134266841152686 |
|
3764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REG3A |
0.134266841152686 |
|
3765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REG3G |
0.134266841152686 |
|
3766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVA1A |
0.134415676702744 |
|
3767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU109|ENSG00000238410.1 |
0.134415676702744 |
|
3768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252476.1 |
0.134466090052855 |
|
3769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMP |
0.134499479974803 |
|
3770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC37 |
0.134638164676629 |
|
3771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTN4RL1 |
0.134735213368215 |
|
3772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLIG3 |
0.13476602628843 |
|
3773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4279 |
0.134768052352294 |
|
3774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX18 |
0.134830979086535 |
|
3775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRD4 |
0.13490036605937 |
|
3776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4682 |
0.135065440427663 |
|
3777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KL |
0.135153226147886 |
|
3778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPF1 |
0.135160394356218 |
|
3779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTG1 |
0.135243937544142 |
|
3780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL183P |
0.135298664533149 |
|
3781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSX1 |
0.135310807761033 |
|
3782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRM |
0.135400603191411 |
|
3783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD81 |
0.135419673844682 |
|
3784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNN4 |
0.135500750194363 |
|
3785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM3 |
0.135515022004592 |
|
3786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETAA1 |
0.135616181584633 |
|
3787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548J |
0.135657152814026 |
|
3788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABIN1 |
0.135933729403682 |
|
3789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REL |
0.135978025153597 |
|
3790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37B |
0.136079886692551 |
|
3791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3GL1P1 |
0.136079886692551 |
|
3792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR210HG |
0.13616979320328 |
|
3793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR210 |
0.13616979320328 |
|
3794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHRF1 |
0.13616979320328 |
|
3795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFHC1 |
0.136261777388263 |
|
3796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAM2 |
0.136261777388263 |
|
3797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCA5 |
0.13627434877093 |
|
3798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BGRL2 |
0.13627434877093 |
|
3799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMG9 |
0.136511706939232 |
|
3800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS4 |
0.136655218530169 |
|
3801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP155 |
0.136677687154791 |
|
3802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRXN3 |
0.136761325687508 |
|
3803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUS10 |
0.136926069699525 |
|
3804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP95 |
0.136926069699525 |
|
3805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX13 |
0.136926069699525 |
|
3806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP169 |
0.13696790994008 |
|
3807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGPAT6 |
0.136982584922487 |
|
3808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR586 |
0.137102240248374 |
|
3809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGL3 |
0.137106824891953 |
|
3810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000253052.1 |
0.137150224064098 |
|
3811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNGR1 |
0.137175871472634 |
|
3812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRM |
0.137188115276544 |
|
3813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R18 |
0.137188115276544 |
|
3814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP49 |
0.137226658137323 |
|
3815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA8|ENSG00000206977.1 |
0.137226658137323 |
|
3816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED20 |
0.137226658137323 |
|
3817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGT7 |
0.13726328405383 |
|
3818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM4B |
0.137298563373591 |
|
3819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5E |
0.137332500369988 |
|
3820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB11FIP2 |
0.137467590920502 |
|
3821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5EP2 |
0.137568753342763 |
|
3822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDX2 |
0.137568753342763 |
|
3823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00543 |
0.137568753342763 |
|
3824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDX1 |
0.137568753342763 |
|
3825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
URAD |
0.137568753342763 |
|
3826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL272P |
0.137568753342763 |
|
3827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTA |
0.137637563007851 |
|
3828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL864P |
0.137662240675632 |
|
3829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMX4 |
0.137787366971668 |
|
3830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP5 |
0.137893731676208 |
|
3831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9B2 |
0.137947037406221 |
|
3832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BDH2 |
0.137947037406221 |
|
3833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPE |
0.137947037406221 |
|
3834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL624P |
0.137977001380033 |
|
3835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPRS |
0.138024489136981 |
|
3836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP6 |
0.138024489136981 |
|
3837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUZ12 |
0.138024489136981 |
|
3838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP437 |
0.138024489136981 |
|
3839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00423 |
0.138175520925636 |
|
3840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf57 |
0.138187664019157 |
|
3841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP180 |
0.138247412665373 |
|
3842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf4 |
0.138308256474023 |
|
3843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD51AP1 |
0.138308256474023 |
|
3844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHO1 |
0.138392830350788 |
|
3845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC18B |
0.138423778811596 |
|
3846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB15 |
0.138423778811596 |
|
3847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD7 |
0.138423778811596 |
|
3848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPQ |
0.138601961109324 |
|
3849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A10 |
0.138624329336172 |
|
3850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEF2B |
0.13866314948035 |
|
3851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXA2 |
0.1388247980281 |
|
3852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIVEP1 |
0.138862355369907 |
|
3853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL3 |
0.139066389037519 |
|
3854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCLK1 |
0.13920213801823 |
|
3855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB131 |
0.139212337914985 |
|
3856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM90A26 |
0.139212337914985 |
|
3857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMX1 |
0.139212337914985 |
|
3858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548I2 |
0.139212337914985 |
|
3859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP153 |
0.139212337914985 |
|
3860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L10 |
0.139212337914985 |
|
3861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L11 |
0.139212337914985 |
|
3862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L12 |
0.139212337914985 |
|
3863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L13 |
0.139212337914985 |
|
3864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L15 |
0.139212337914985 |
|
3865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L17 |
0.139212337914985 |
|
3866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L18 |
0.139212337914985 |
|
3867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L19 |
0.139212337914985 |
|
3868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L20 |
0.139212337914985 |
|
3869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L21 |
0.139212337914985 |
|
3870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L22 |
0.139212337914985 |
|
3871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L23 |
0.139212337914985 |
|
3872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L24 |
0.139212337914985 |
|
3873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L25 |
0.139212337914985 |
|
3874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L26 |
0.139212337914985 |
|
3875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L27 |
0.139212337914985 |
|
3876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L28 |
0.139212337914985 |
|
3877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L29 |
0.139212337914985 |
|
3878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L30 |
0.139212337914985 |
|
3879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L5 |
0.139212337914985 |
|
3880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFAP2B |
0.139255445173163 |
|
3881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS4L2 |
0.139278521964778 |
|
3882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUD7B |
0.139283811778318 |
|
3883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS45 |
0.139364737304924 |
|
3884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDLRAD2 |
0.139430609484126 |
|
3885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF9 |
0.139456801125271 |
|
3886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMG1 |
0.139506818381002 |
|
3887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAP3 |
0.139506993203368 |
|
3888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC28 |
0.139585842829507 |
|
3889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPR1 |
0.139625559328079 |
|
3890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPD5 |
0.139709428364613 |
|
3891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPS8L2 |
0.139811912711834 |
|
3892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNN3 |
0.140103560865229 |
|
3893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238525.1 |
0.140154423359778 |
|
3894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT10C |
0.140154423359778 |
|
3895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCNP |
0.140154423359778 |
|
3896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4323 |
0.140181501687883 |
|
3897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPBPP2 |
0.140183910888511 |
|
3898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGF1 |
0.140332927261765 |
|
3899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSSC1 |
0.14035557975519 |
|
3900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC149 |
0.140427319095878 |
|
3901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00621 |
0.140466846868992 |
|
3902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD36|ENSG00000253094.1 |
0.140466846868992 |
|
3903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP305 |
0.140487269577532 |
|
3904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRX1 |
0.14052440135342 |
|
3905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBLN1 |
0.140548093297624 |
|
3906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX13A |
0.140591282869405 |
|
3907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRN2 |
0.140666977616956 |
|
3908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTHFD2P1 |
0.14074220532818 |
|
3909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCFC2 |
0.140828198458187 |
|
3910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL19 |
0.140828198458187 |
|
3911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221638.1 |
0.140828198458187 |
|
3912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239018.1 |
0.140828198458187 |
|
3913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP8A2 |
0.140845506207575 |
|
3914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIK |
0.141064521938494 |
|
3915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCAT |
0.141064521938494 |
|
3916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPO |
0.141064521938494 |
|
3917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL12 |
0.141064521938494 |
|
3918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB7 |
0.141188470789155 |
|
3919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM71E1 |
0.141253793083048 |
|
3920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC10 |
0.141253793083048 |
|
3921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP210L |
0.141292746580539 |
|
3922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASAH1 |
0.141371960275515 |
|
3923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGDIA |
0.141448062005648 |
|
3924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALYREF |
0.141448062005648 |
|
3925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYND8 |
0.141455818541953 |
|
3926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAO1 |
0.141485651963532 |
|
3927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM5B |
0.141574370300103 |
|
3928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP367 |
0.141598518311322 |
|
3929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRRS1 |
0.141921421011838 |
|
3930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH8 |
0.141944991404099 |
|
3931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AD |
0.142007879231717 |
|
3932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BF |
0.142007879231717 |
|
3933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H4E |
0.142007879231717 |
|
3934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2BG |
0.142007879231717 |
|
3935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H2AE |
0.142007879231717 |
|
3936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST1H3E |
0.142007879231717 |
|
3937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CITED1 |
0.142149970141815 |
|
3938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK1 |
0.142227249668783 |
|
3939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CADM4 |
0.142261028631549 |
|
3940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAUR |
0.142261028631549 |
|
3941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL368P |
0.142261028631549 |
|
3942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMCH1 |
0.142275335143404 |
|
3943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPGN |
0.142423954389803 |
|
3944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EREG |
0.142423954389803 |
|
3945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTB4R |
0.142465951317098 |
|
3946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAPP1 |
0.142485909063528 |
|
3947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMTOR3 |
0.142485909063528 |
|
3948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB14 |
0.142485909063528 |
|
3949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFZ |
0.142485909063528 |
|
3950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT2B1 |
0.142550061466917 |
|
3951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM83E |
0.142550061466917 |
|
3952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPACA4 |
0.142550061466917 |
|
3953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL18 |
0.142550061466917 |
|
3954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC23IP |
0.142587293650183 |
|
3955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC1 |
0.142607128325653 |
|
3956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5685 |
0.142636153471782 |
|
3957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK11 |
0.142704293910522 |
|
3958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5D |
0.142704293910522 |
|
3959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf26 |
0.142704293910522 |
|
3960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIRBP |
0.142704293910522 |
|
3961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIDN |
0.142704293910522 |
|
3962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf24 |
0.142704293910522 |
|
3963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNRIP1 |
0.142767435762323 |
|
3964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL23 |
0.142794546292922 |
|
3965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H19 |
0.142794546292922 |
|
3966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAU2 |
0.142827874658602 |
|
3967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FADS6 |
0.14287316991401 |
|
3968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF10 |
0.142929931803431 |
|
3969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBN2 |
0.142956255696877 |
|
3970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF3 |
0.143060545554244 |
|
3971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPC |
0.143080607335804 |
|
3972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF3 |
0.143270844057372 |
|
3973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL580P |
0.143275775666588 |
|
3974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK15 |
0.143394938709989 |
|
3975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK2 |
0.143394938709989 |
|
3976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK3 |
0.143394938709989 |
|
3977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLK4 |
0.143394938709989 |
|
3978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLKP1 |
0.143394938709989 |
|
3979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX31 |
0.143413674772616 |
|
3980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP257 |
0.143451925829836 |
|
3981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX9 |
0.143451925829836 |
|
3982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIN4 |
0.143531156630317 |
|
3983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS4X |
0.143531156630317 |
|
3984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASL11B |
0.143540554486255 |
|
3985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEF2BNB |
0.14358828392079 |
|
3986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGK1 |
0.143622850100536 |
|
3987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GKN2 |
0.143696260567014 |
|
3988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGT1 |
0.143860804010906 |
|
3989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL460P |
0.143860804010906 |
|
3990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX7B |
0.143860804010906 |
|
3991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGAM4 |
0.143860804010906 |
|
3992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC19 |
0.143920858444816 |
|
3993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPACA3 |
0.144081640846168 |
|
3994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VKORC1L1 |
0.144152964465154 |
|
3995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3935 |
0.144166006353414 |
|
3996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX7C |
0.144175050074056 |
|
3997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3607 |
0.144175050074056 |
|
3998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMPR |
0.144198903565278 |
|
3999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUCLG1 |
0.144257036372444 |
|
4000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCB1 |
0.144261906321111 |
|
4001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE4C |
0.14427357903755 |
|
4002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1683 |
0.14427357903755 |
|
4003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JUND |
0.14427357903755 |
|
4004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3188 |
0.14427357903755 |
|
4005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP173 |
0.144312731719629 |
|
4006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPCPD1 |
0.144332420260426 |
|
4007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00654 |
0.144332420260426 |
|
4008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00658 |
0.144332420260426 |
|
4009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf196 |
0.144332420260426 |
|
4010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOHLH2 |
0.144364222480702 |
|
4011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF3 |
0.144577248966252 |
|
4012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNQ1DN |
0.144584083669192 |
|
4013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APC2 |
0.144597693980303 |
|
4014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf25 |
0.144597693980303 |
|
4015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCSK4 |
0.144597693980303 |
|
4016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REEP6 |
0.144597693980303 |
|
4017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTSL5 |
0.144597693980303 |
|
4018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLK5 |
0.144597693980303 |
|
4019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEX3D |
0.144597693980303 |
|
4020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00313 |
0.144751371146474 |
|
4021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD8 |
0.144849610145661 |
|
4022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYAA |
0.144867583966098 |
|
4023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00319 |
0.144867583966098 |
|
4024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00322 |
0.144867583966098 |
|
4025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIK1 |
0.144867583966098 |
|
4026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK6 |
0.145046054523332 |
|
4027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBB1 |
0.14507734757046 |
|
4028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBA4 |
0.14507734757046 |
|
4029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIAT |
0.14507734757046 |
|
4030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM165 |
0.145103833224359 |
|
4031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD3 |
0.145150369970093 |
|
4032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL477P |
0.145150369970093 |
|
4033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCR11 |
0.145150369970093 |
|
4034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOB2 |
0.145171578206227 |
|
4035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP8 |
0.145171578206227 |
|
4036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRAS |
0.145294449605031 |
|
4037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC56 |
0.145294449605031 |
|
4038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf35 |
0.145294449605031 |
|
4039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF7 |
0.145294449605031 |
|
4040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QA |
0.145390046649352 |
|
4041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QC |
0.145390046649352 |
|
4042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QB |
0.145390046649352 |
|
4043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC169 |
0.145428317273322 |
|
4044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRB1 |
0.145511369502689 |
|
4045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR575 |
0.145554802908855 |
|
4046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KANK2 |
0.145675987714609 |
|
4047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL298P |
0.145675987714609 |
|
4048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf80 |
0.145675987714609 |
|
4049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSD |
0.145923779015955 |
|
4050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM99A |
0.145923779015955 |
|
4051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM99B |
0.145923779015955 |
|
4052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFITM10 |
0.145923779015955 |
|
4053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSP1|ENSG00000130592.9 |
0.145923779015955 |
|
4054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4298 |
0.145923779015955 |
|
4055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT8 |
0.145923779015955 |
|
4056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNI2 |
0.145923779015955 |
|
4057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NYNRIN |
0.145963057791584 |
|
4058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBLN3 |
0.145963057791584 |
|
4059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMBT1 |
0.146006772192352 |
|
4060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTA3 |
0.146065117229622 |
|
4061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CECR2 |
0.146261457821284 |
|
4062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BYSL |
0.146332116143086 |
|
4063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANP32A |
0.146365976390775 |
|
4064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHNYN |
0.14647646437241 |
|
4065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDR39U1 |
0.14647646437241 |
|
4066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMA1 |
0.14647646437241 |
|
4067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLIT2 |
0.146499603625036 |
|
4068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM65C |
0.146572417111003 |
|
4069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP85 |
0.146674427408784 |
|
4070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSR2 |
0.146674427408784 |
|
4071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TINF2 |
0.146680932966965 |
|
4072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGM1 |
0.146680932966965 |
|
4073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABGGTA |
0.146680932966965 |
|
4074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPN1 |
0.146693435057956 |
|
4075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERLIN1 |
0.146693435057956 |
|
4076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4312 |
0.146709086432458 |
|
4077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F3 |
0.146903222041039 |
|
4078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TERF2IP |
0.146908433276596 |
|
4079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP12 |
0.146982518515659 |
|
4080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUNDC2P2 |
0.146994235594948 |
|
4081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VDR |
0.1470369830323 |
|
4082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BDP1 |
0.147039661374199 |
|
4083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR557 |
0.147107645208304 |
|
4084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POMP |
0.147222848803428 |
|
4085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM47E |
0.1472620412817 |
|
4086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP493 |
0.147279098395728 |
|
4087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAG1 |
0.147387378666374 |
|
4088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL474P |
0.147403342909898 |
|
4089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP35 |
0.14741341246197 |
|
4090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF728 |
0.147549796291398 |
|
4091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00906 |
0.147552918158399 |
|
4092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIDEC |
0.147651354375151 |
|
4093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMFR |
0.147664882432605 |
|
4094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MROH9 |
0.147689073582176 |
|
4095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOT1L1 |
0.147746875044206 |
|
4096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDN |
0.14777117405071 |
|
4097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAG3 |
0.147783197107643 |
|
4098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP158 |
0.147878092250272 |
|
4099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR10 |
0.147878092250272 |
|
4100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR1 |
0.147878092250272 |
|
4101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR6 |
0.147878092250272 |
|
4102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P4 |
0.1478791467095 |
|
4103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00362 |
0.1478791467095 |
|
4104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX19 |
0.147883829822905 |
|
4105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00511 |
0.148006342960709 |
|
4106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRC1 |
0.148012671847576 |
|
4107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE6 |
0.148075901283691 |
|
4108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRL |
0.148075901283691 |
|
4109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCK2 |
0.148075901283691 |
|
4110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NECAP1 |
0.148105902845855 |
|
4111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC4A |
0.148105902845855 |
|
4112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCD3 |
0.148122707625486 |
|
4113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC6L |
0.148177581194139 |
|
4114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL264P |
0.148177581194139 |
|
4115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF627 |
0.148202589225822 |
|
4116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP470 |
0.148233636361796 |
|
4117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS2 |
0.148512663886601 |
|
4118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42 |
0.148514130952164 |
|
4119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELA3A |
0.148514130952164 |
|
4120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELA3B |
0.148514130952164 |
|
4121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00339 |
0.148514130952164 |
|
4122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL186P |
0.148514130952164 |
|
4123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL386P |
0.148514130952164 |
|
4124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL421P |
0.148514130952164 |
|
4125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL768P |
0.148514130952164 |
|
4126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBG3|ENSG00000233280.2 |
0.148654331346107 |
|
4127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP8 |
0.148834933714802 |
|
4128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL12 |
0.148863459404429 |
|
4129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPYL5 |
0.148896037148256 |
|
4130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRX1 |
0.148899490956643 |
|
4131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00575 |
0.149069832457449 |
|
4132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239073.1 |
0.149125354396618 |
|
4133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT4 |
0.149125354396618 |
|
4134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2N |
0.149125354396618 |
|
4135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT21 |
0.149166897484669 |
|
4136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGFOD1 |
0.149166897484669 |
|
4137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBS2 |
0.149166897484669 |
|
4138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPC3 |
0.149269317337965 |
|
4139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD74|ENSG00000201502.1 |
0.149522682799669 |
|
4140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238361.1 |
0.149522682799669 |
|
4141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OVCH1 |
0.149553873109402 |
|
4142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUSB |
0.149628514563338 |
|
4143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL9 |
0.149689125322458 |
|
4144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP7 |
0.149728455837636 |
|
4145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NECAB3 |
0.149852220325244 |
|
4146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf144 |
0.149852220325244 |
|
4147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTL10 |
0.149852220325244 |
|
4148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS2L3 |
0.149903760680914 |
|
4149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS12 |
0.149979783258213 |
|
4150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL822P |
0.15000124389872 |
|
4151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00641 |
0.150004498222032 |
|
4152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00558 |
0.150076124424595 |
|
4153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGL |
0.150081998882924 |
|
4154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP256 |
0.150120598919017 |
|
4155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF428 |
0.150155113360899 |
|
4156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP94 |
0.150199310439268 |
|
4157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA4 |
0.150253350310903 |
|
4158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIAPH2 |
0.150307026133895 |
|
4159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPBL |
0.150313571346813 |
|
4160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A24P1 |
0.150342471527655 |
|
4161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHS1 |
0.150394512651321 |
|
4162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA17|ENSG00000212589.1 |
0.150394512651321 |
|
4163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCLRE1A |
0.150394512651321 |
|
4164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHLRC2 |
0.150394512651321 |
|
4165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCMH1 |
0.150423509737808 |
|
4166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF568 |
0.150427412730166 |
|
4167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL201P |
0.150448309040732 |
|
4168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMC4 |
0.150579383658743 |
|
4169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF546 |
0.150579383658743 |
|
4170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E2F1 |
0.150605239882721 |
|
4171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STIM2 |
0.150784552754733 |
|
4172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A18 |
0.150853516448431 |
|
4173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA2 |
0.150875831465984 |
|
4174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD46 |
0.15103240521421 |
|
4175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPOLG |
0.151068047987197 |
|
4176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212626.1 |
0.151075741862461 |
|
4177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4432 |
0.151113469296327 |
|
4178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM14A |
0.151157952768481 |
|
4179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTA2 |
0.151157952768481 |
|
4180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000200237.1 |
0.151223763439839 |
|
4181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL94P |
0.151223763439839 |
|
4182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBL5 |
0.151223763439839 |
|
4183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIN1 |
0.151223763439839 |
|
4184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF383 |
0.1512878510908 |
|
4185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF1 |
0.151375953722879 |
|
4186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPG20 |
0.151388721325125 |
|
4187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPG20OS |
0.151388721325125 |
|
4188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUZD1 |
0.15139266597973 |
|
4189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM24B |
0.15139266597973 |
|
4190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM24A |
0.15139266597973 |
|
4191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf88 |
0.15139266597973 |
|
4192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1RAPL2 |
0.151455626273739 |
|
4193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEUROD2 |
0.151547853281599 |
|
4194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGPAT3 |
0.151570963165047 |
|
4195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL11A |
0.151608397755665 |
|
4196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA24|ENSG00000252274.1 |
0.151616766701678 |
|
4197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSTK |
0.151766066615839 |
|
4198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKZF5 |
0.151766066615839 |
|
4199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACADSB |
0.151766066615839 |
|
4200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D29 |
0.151877116181463 |
|
4201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF730 |
0.151878936863664 |
|
4202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERICH1 |
0.15198582376155 |
|
4203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRF2 |
0.152082238894917 |
|
4204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD33|ENSG00000252022.1 |
0.152088403708265 |
|
4205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF21 |
0.152163931271665 |
|
4206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HABP2 |
0.152175062278135 |
|
4207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL34 |
0.152177390353447 |
|
4208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ00418 |
0.152177390353447 |
|
4209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTSS1L |
0.152177390353447 |
|
4210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANK1 |
0.152193404554685 |
|
4211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMX2 |
0.152324617390433 |
|
4212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMX3 |
0.152324617390433 |
|
4213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BUB3 |
0.152324617390433 |
|
4214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf78 |
0.152345870683213 |
|
4215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCM2 |
0.152398757045989 |
|
4216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC151 |
0.15247231762022 |
|
4217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCSH |
0.15247231762022 |
|
4218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238349.1 |
0.15247231762022 |
|
4219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL669P |
0.15247231762022 |
|
4220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINF1 |
0.152546788479136 |
|
4221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL361P |
0.152611901364197 |
|
4222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORO2B |
0.152669170524573 |
|
4223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252728.1 |
0.152825801619907 |
|
4224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYM6NB |
0.152825801619907 |
|
4225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK32B |
0.15283489005614 |
|
4226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2110 |
0.152874451028358 |
|
4227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD1 |
0.152874451028358 |
|
4228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JPX |
0.152947856780221 |
|
4229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS3 |
0.152987549872836 |
|
4230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL372P |
0.152987549872836 |
|
4231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238511.1 |
0.152987549872836 |
|
4232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf38 |
0.153010898224989 |
|
4233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPGRIP1 |
0.153126481424073 |
|
4234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP210 |
0.15313675074746 |
|
4235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELOVL5 |
0.15341535946014 |
|
4236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRS |
0.153435101123497 |
|
4237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMCN |
0.153441951647134 |
|
4238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLGAP3 |
0.153486744810841 |
|
4239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA11|ENSG00000251898.1 |
0.153612131224568 |
|
4240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDX4 |
0.15364990269202 |
|
4241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2K4P1 |
0.15364990269202 |
|
4242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLVS2 |
0.153750968577118 |
|
4243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H12A |
0.153873160299467 |
|
4244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD11 |
0.153882851225749 |
|
4245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADH1B |
0.154016613320464 |
|
4246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADH1C |
0.154016613320464 |
|
4247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRB3 |
0.154034089015475 |
|
4248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGAG4 |
0.154292979780068 |
|
4249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP194 |
0.154293174476074 |
|
4250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCMBP |
0.154312681203275 |
|
4251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DANCR |
0.154346153983102 |
|
4252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212490.1 |
0.154346153983102 |
|
4253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASEH2A |
0.154396859065787 |
|
4254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF5P |
0.154453343777931 |
|
4255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF6 |
0.154453343777931 |
|
4256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM32 |
0.154477269739864 |
|
4257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00424 |
0.154526767591602 |
|
4258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB3A |
0.154585361083222 |
|
4259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHSL2 |
0.154731906947538 |
|
4260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COG4 |
0.154876231312461 |
|
4261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD111B |
0.154876231312461 |
|
4262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD111|ENSG00000221066.1 |
0.154876231312461 |
|
4263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP8B3 |
0.155100952990622 |
|
4264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF16 |
0.155100952990622 |
|
4265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1909 |
0.155100952990622 |
|
4266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ONECUT3 |
0.155100952990622 |
|
4267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REXO1 |
0.155100952990622 |
|
4268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC24A5 |
0.155140589882803 |
|
4269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF20 |
0.155224958513605 |
|
4270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YWHAZ |
0.155293123479133 |
|
4271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3B3 |
0.15539206712623 |
|
4272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4E |
0.155403796996474 |
|
4273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METAP1 |
0.155403796996474 |
|
4274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3684 |
0.155403796996474 |
|
4275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADH5 |
0.155403796996474 |
|
4276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADH4 |
0.155403796996474 |
|
4277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCNAP1 |
0.155403796996474 |
|
4278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADH6 |
0.155403796996474 |
|
4279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP1B |
0.155467545365911 |
|
4280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRG |
0.155541956115395 |
|
4281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REC8 |
0.155606799422319 |
|
4282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPO4 |
0.155606799422319 |
|
4283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC7B |
0.15563641034483 |
|
4284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRISP3 |
0.155673080326052 |
|
4285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1251 |
0.155703639623246 |
|
4286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2B |
0.155868179977141 |
|
4287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238579.1 |
0.155868179977141 |
|
4288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4719 |
0.155883325037588 |
|
4289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAX1 |
0.155920712983893 |
|
4290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBFA2T2 |
0.155975906066161 |
|
4291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADH1A |
0.156030591878002 |
|
4292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY2F |
0.156052035398952 |
|
4293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A2 |
0.156063040438291 |
|
4294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CES1P1 |
0.156063040438291 |
|
4295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CES1 |
0.156063040438291 |
|
4296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMS2P4 |
0.15613408660642 |
|
4297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC71 |
0.156273658165406 |
|
4298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUSC3 |
0.156302899178411 |
|
4299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO1D |
0.156354460710847 |
|
4300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM98 |
0.156354460710847 |
|
4301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4K17 |
0.156416196436181 |
|
4302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1255B2 |
0.156439772110423 |
|
4303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF345 |
0.156476042074005 |
|
4304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUM1L1 |
0.156487538169919 |
|
4305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS16 |
0.156522574175836 |
|
4306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOOK2 |
0.156603400940555 |
|
4307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3182 |
0.156619732130189 |
|
4308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASL |
0.156803926216999 |
|
4309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRCP |
0.156803926216999 |
|
4310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL3 |
0.156818500463125 |
|
4311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD83B |
0.156818500463125 |
|
4312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD83A |
0.156818500463125 |
|
4313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD43|ENSG00000263764.1 |
0.156818500463125 |
|
4314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf17 |
0.156894245986382 |
|
4315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT10A |
0.156894245986382 |
|
4316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA3|ENSG00000221639.1 |
0.156955656817744 |
|
4317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX14 |
0.157068903053045 |
|
4318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT11 |
0.15709309005405 |
|
4319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00572 |
0.157129636490602 |
|
4320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00544 |
0.157129636490602 |
|
4321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJB7 |
0.157145427537366 |
|
4322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM8 |
0.157145427537366 |
|
4323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf163 |
0.157145427537366 |
|
4324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf164 |
0.157145427537366 |
|
4325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP28 |
0.157240391674706 |
|
4326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMMT |
0.157246352022878 |
|
4327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4779 |
0.157246352022878 |
|
4328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL35 |
0.157246352022878 |
|
4329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCD3 |
0.157246352022878 |
|
4330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD94 |
0.157246352022878 |
|
4331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RXFP4 |
0.157273884444256 |
|
4332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXJ2 |
0.157480436159581 |
|
4333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3AR1 |
0.157480436159581 |
|
4334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4EBP1 |
0.157508869953751 |
|
4335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUZP1 |
0.157586046713191 |
|
4336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CWF19L1 |
0.15760166635767 |
|
4337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA12|ENSG00000212464.1 |
0.15760166635767 |
|
4338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLOC1S2 |
0.15760166635767 |
|
4339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD2L1 |
0.15760166635767 |
|
4340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCD |
0.15760166635767 |
|
4341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00263 |
0.15760166635767 |
|
4342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM76B |
0.157668269810012 |
|
4343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA8 |
0.157700177129048 |
|
4344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFRA1 |
0.157721930706877 |
|
4345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGAM1P5 |
0.157728181684315 |
|
4346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCP2L |
0.157840720871404 |
|
4347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM14B |
0.157840720871404 |
|
4348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAK |
0.157840720871404 |
|
4349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM9 |
0.157914300138629 |
|
4350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAST4 |
0.157945647725067 |
|
4351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S1PR2 |
0.158051864634449 |
|
4352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4322 |
0.158051864634449 |
|
4353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF23 |
0.158099569838097 |
|
4354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAST1 |
0.158103223598107 |
|
4355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REEP1 |
0.158105112379959 |
|
4356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRA4 |
0.158163484393401 |
|
4357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSC22D3 |
0.158240508423375 |
|
4358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDOC |
0.158326173774456 |
|
4359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG5 |
0.158326173774456 |
|
4360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPF |
0.158465693196214 |
|
4361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC38 |
0.158465693196214 |
|
4362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000207215.1 |
0.158517961104641 |
|
4363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A18AS |
0.158753642620479 |
|
4364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A18 |
0.158753642620479 |
|
4365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHLDA2 |
0.158753642620479 |
|
4366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAP1L4 |
0.158753642620479 |
|
4367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA54 |
0.158753642620479 |
|
4368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000199856.1 |
0.158948669026003 |
|
4369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEAF6 |
0.159003806326056 |
|
4370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BSN |
0.15905833366558 |
|
4371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF11 |
0.159079886275841 |
|
4372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FITM1 |
0.159079886275841 |
|
4373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC9 |
0.159079886275841 |
|
4374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSME1 |
0.159079886275841 |
|
4375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSME2 |
0.159079886275841 |
|
4376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF31 |
0.159079886275841 |
|
4377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF9 |
0.159079886275841 |
|
4378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP383 |
0.159079886275841 |
|
4379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoR26 |
0.159173058552225 |
|
4380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNE1L |
0.159217671005638 |
|
4381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSL4 |
0.159217671005638 |
|
4382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD10 |
0.159232185526215 |
|
4383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFRP1 |
0.159275827784529 |
|
4384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AO |
0.159275827784529 |
|
4385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM114A1 |
0.159290968674482 |
|
4386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR574 |
0.159290968674482 |
|
4387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYGB |
0.159301485660418 |
|
4388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRCD |
0.159301485660418 |
|
4389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG16 |
0.159301485660418 |
|
4390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD1B |
0.159301485660418 |
|
4391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST6GALNAC2 |
0.159301485660418 |
|
4392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4687 |
0.15932001919064 |
|
4393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDHD |
0.159395795083543 |
|
4394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTRA4 |
0.159546519428553 |
|
4395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM2D2 |
0.159546519428553 |
|
4396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBDF2 |
0.15954685249159 |
|
4397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL5A3 |
0.159590354558318 |
|
4398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL766P |
0.159603574890633 |
|
4399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53BP2 |
0.159613435719277 |
|
4400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHUK |
0.159618507648069 |
|
4401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACO2 |
0.159692248590139 |
|
4402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST6GALNAC1 |
0.159698807680484 |
|
4403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THEGL |
0.159732164566425 |
|
4404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00479 |
0.159734031985834 |
|
4405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00112 |
0.159734031985834 |
|
4406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIPK4 |
0.159734031985834 |
|
4407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST3GAL5 |
0.159794159856743 |
|
4408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF705A |
0.1599293113199 |
|
4409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASF3 |
0.159934499652976 |
|
4410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTXN3 |
0.160035198289452 |
|
4411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PACRGL |
0.160054687162857 |
|
4412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADH7 |
0.160122585227366 |
|
4413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS1 |
0.16016134535966 |
|
4414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOP9 |
0.16016134535966 |
|
4415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIDEB |
0.16016134535966 |
|
4416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTB4R2 |
0.16016134535966 |
|
4417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10G2 |
0.160180249655502 |
|
4418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AES |
0.160238449872063 |
|
4419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A8P |
0.160303975146169 |
|
4420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP5F |
0.160334199333123 |
|
4421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL846P |
0.160334199333123 |
|
4422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK3 |
0.16038575912351 |
|
4423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNN |
0.160449602476987 |
|
4424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A13 |
0.160457779213838 |
|
4425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOX4 |
0.160565427953576 |
|
4426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF514 |
0.160584686256342 |
|
4427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSUN3 |
0.160593736512057 |
|
4428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTBP2 |
0.160624989222929 |
|
4429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL860P |
0.160704507780032 |
|
4430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP263 |
0.160756267440594 |
|
4431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXNC1 |
0.160756267440594 |
|
4432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX7B2 |
0.160774403256309 |
|
4433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT44 |
0.160904813870179 |
|
4434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRPF1 |
0.160910273893754 |
|
4435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK5R1 |
0.160982929740258 |
|
4436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC2 |
0.161038769731661 |
|
4437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXT2 |
0.161113393833512 |
|
4438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGK494 |
0.16113763944634 |
|
4439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00442 |
0.161139759154882 |
|
4440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMVK |
0.161151391218074 |
|
4441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNASE2 |
0.161209816308899 |
|
4442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEKT4 |
0.161233386269293 |
|
4443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL9A1 |
0.161270839174125 |
|
4444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNGR1 |
0.16136697958647 |
|
4445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM204A |
0.161375043775308 |
|
4446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL547P |
0.161424411857931 |
|
4447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00867 |
0.161471461290532 |
|
4448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRTC2 |
0.161575797847962 |
|
4449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A1 |
0.161575797847962 |
|
4450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREB3L4 |
0.161575797847962 |
|
4451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JTB |
0.161575797847962 |
|
4452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB13 |
0.161575797847962 |
|
4453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS27 |
0.161575797847962 |
|
4454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252669.1 |
0.161575797847962 |
|
4455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL833P |
0.161634153731178 |
|
4456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF6 |
0.161696223374044 |
|
4457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL279P |
0.161737503156658 |
|
4458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1261 |
0.161745626400665 |
|
4459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP83 |
0.16177575083605 |
|
4460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND4B |
0.16179944679192 |
|
4461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL31 |
0.161887595989839 |
|
4462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239159.1 |
0.161911615651289 |
|
4463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00485 |
0.161919996571829 |
|
4464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAH |
0.161919996571829 |
|
4465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASCL1 |
0.161919996571829 |
|
4466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT4 |
0.162046510642237 |
|
4467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC18A |
0.16207874169248 |
|
4468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC18C |
0.16207874169248 |
|
4469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDPR |
0.16207874169248 |
|
4470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDXDC2P |
0.16207874169248 |
|
4471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR383 |
0.162089783748706 |
|
4472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP231 |
0.162126961912287 |
|
4473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTRC |
0.162332928252132 |
|
4474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239091.1 |
0.162332928252132 |
|
4475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM8 |
0.162655341006086 |
|
4476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASTN1 |
0.162659488784373 |
|
4477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF123 |
0.162661681102719 |
|
4478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARD6B |
0.162775914657481 |
|
4479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN2 |
0.162814471904571 |
|
4480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRD4 |
0.162963497721188 |
|
4481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSP1|ENSG00000269099.1 |
0.162975423730279 |
|
4482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPM5 |
0.163087801909407 |
|
4483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSSC4 |
0.163087801909407 |
|
4484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL22RA2 |
0.163130133892865 |
|
4485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf120 |
0.16320488844657 |
|
4486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNLIP |
0.163259806612911 |
|
4487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENO4 |
0.163259806612911 |
|
4488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL660P |
0.163289468655155 |
|
4489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPP6 |
0.163526980799759 |
|
4490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX19 |
0.163590447525515 |
|
4491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTS2R |
0.163590447525515 |
|
4492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UROS |
0.163620201919289 |
|
4493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4484 |
0.163620201919289 |
|
4494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCCIP |
0.163620201919289 |
|
4495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRD5 |
0.163694108048622 |
|
4496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIPRL |
0.163697813711776 |
|
4497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFT2D2 |
0.163697813711776 |
|
4498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD36BP1 |
0.163697813711776 |
|
4499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL1 |
0.163715745767445 |
|
4500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCUBE1 |
0.163715745767445 |
|
4501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCB4 |
0.163717995613478 |
|
4502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP154 |
0.16378761188952 |
|
4503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM199X |
0.163792286899503 |
|
4504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00461 |
0.163792631910088 |
|
4505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACPT |
0.163965123472343 |
|
4506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf48 |
0.163965123472343 |
|
4507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD88A |
0.163965123472343 |
|
4508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD88B |
0.163965123472343 |
|
4509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD88C |
0.163965123472343 |
|
4510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238506.1 |
0.163998505895236 |
|
4511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4445 |
0.164045387519384 |
|
4512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM91A1 |
0.16407650274924 |
|
4513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548E |
0.164079024405081 |
|
4514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRA2A |
0.164079024405081 |
|
4515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD66|ENSG00000212532.1 |
0.16414634794816 |
|
4516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPA4 |
0.164149371024144 |
|
4517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU105B |
0.164218197579644 |
|
4518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4N5 |
0.16431555933779 |
|
4519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP381 |
0.16431555933779 |
|
4520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR11G2 |
0.16431555933779 |
|
4521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR11H6 |
0.16431555933779 |
|
4522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR11H7 |
0.16431555933779 |
|
4523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR11H4 |
0.16431555933779 |
|
4524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC5 |
0.16431555933779 |
|
4525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA79|ENSG00000222489.1 |
0.16431555933779 |
|
4526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD126 |
0.16431555933779 |
|
4527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF471 |
0.164335587982414 |
|
4528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF20 |
0.16441520197535 |
|
4529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICU3 |
0.16441520197535 |
|
4530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNLIPRP1 |
0.164426157964018 |
|
4531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf82 |
0.164426157964018 |
|
4532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA12A |
0.164426157964018 |
|
4533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL44P |
0.164432258715621 |
|
4534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A3 |
0.164432258715621 |
|
4535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A4 |
0.164432258715621 |
|
4536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A5 |
0.164432258715621 |
|
4537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A6 |
0.164432258715621 |
|
4538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A2 |
0.164432258715621 |
|
4539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL470P |
0.164459020193905 |
|
4540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCBP1 |
0.164459020193905 |
|
4541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10G3 |
0.164581390427148 |
|
4542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238938.1 |
0.16477494624907 |
|
4543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNLIPRP2 |
0.164936807970444 |
|
4544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABAC1 |
0.165073585539492 |
|
4545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1A3 |
0.165073585539492 |
|
4546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIRAS1 |
0.165084612305575 |
|
4547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF491 |
0.165092170505266 |
|
4548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA1 |
0.165302113551168 |
|
4549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP4B |
0.165459013423123 |
|
4550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA42|ENSG00000207475.1 |
0.165467225461623 |
|
4551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA4|ENSG00000252808.1 |
0.165467225461623 |
|
4552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC12 |
0.16559659765719 |
|
4553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB40 |
0.165618592715488 |
|
4554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
7SK|ENSG00000249352.3 |
0.16577695998396 |
|
4555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf71 |
0.165930498111384 |
|
4556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD12 |
0.165930498111384 |
|
4557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM161B |
0.16604769674361 |
|
4558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP187 |
0.16604769674361 |
|
4559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000206958.1 |
0.16604769674361 |
|
4560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PREX1 |
0.166091676604051 |
|
4561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSR1 |
0.166274806941091 |
|
4562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP264 |
0.166301724566435 |
|
4563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QRICH2 |
0.166321544964669 |
|
4564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBALD2 |
0.166321544964669 |
|
4565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHOC2 |
0.166344918387833 |
|
4566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRB1 |
0.16648866941694 |
|
4567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTNAP4 |
0.166563899540609 |
|
4568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRN2 |
0.16658123570066 |
|
4569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPLP1 |
0.166636497333891 |
|
4570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000207119.1 |
0.166636497333891 |
|
4571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTA1 |
0.166679218086944 |
|
4572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT4 |
0.166689109861703 |
|
4573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP73 |
0.166743430741034 |
|
4574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEL1L3 |
0.167051785519556 |
|
4575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARFGEF2 |
0.167505823769162 |
|
4576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYW1 |
0.167563137872135 |
|
4577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALR |
0.167584957104598 |
|
4578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD5 |
0.167739584630865 |
|
4579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESX1 |
0.167772934243371 |
|
4580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF17 |
0.167832892064356 |
|
4581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA58|ENSG00000201129.1 |
0.167951049778746 |
|
4582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSMD2 |
0.167990806472209 |
|
4583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRHL2 |
0.168176814586623 |
|
4584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF439 |
0.168241981086179 |
|
4585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF440 |
0.168241981086179 |
|
4586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMA2 |
0.168262665438717 |
|
4587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM135 |
0.168375001870305 |
|
4588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRTFDC1 |
0.168408605077864 |
|
4589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPLA5 |
0.168531756418774 |
|
4590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPLA3 |
0.168531756418774 |
|
4591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTA5 |
0.168564923697266 |
|
4592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNU1 |
0.168569605665904 |
|
4593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3186 |
0.168620657573868 |
|
4594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCAN |
0.168640528694236 |
|
4595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM12 |
0.168690334921865 |
|
4596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB2B |
0.168757935776424 |
|
4597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDF2 |
0.168792735736934 |
|
4598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK8 |
0.168835346071049 |
|
4599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIO2 |
0.168923659942102 |
|
4600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEST2 |
0.168951611504673 |
|
4601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC172 |
0.169007901236013 |
|
4602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGFOD3 |
0.169166328056824 |
|
4603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NNT |
0.169253809306469 |
|
4604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL643P |
0.169287872178957 |
|
4605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SALL2 |
0.169427171807165 |
|
4606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYSLTR1 |
0.169461354210192 |
|
4607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCSK2 |
0.169478399621941 |
|
4608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSTB |
0.169558232358359 |
|
4609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP1 |
0.169558232358359 |
|
4610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL350P |
0.169745436530785 |
|
4611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC130 |
0.169808046395726 |
|
4612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FARSA |
0.169829842199592 |
|
4613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF2P2 |
0.169876468886545 |
|
4614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP24 |
0.169876468886545 |
|
4615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF709 |
0.169885905225648 |
|
4616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDXK |
0.169900531329922 |
|
4617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf34 |
0.169932688501023 |
|
4618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL619P |
0.169935075002673 |
|
4619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOA1 |
0.170022185364426 |
|
4620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PALMD |
0.170049356364218 |
|
4621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM66C |
0.170058283969178 |
|
4622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86FP |
0.170058283969178 |
|
4623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM90A1 |
0.170058283969178 |
|
4624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00937 |
0.170058283969178 |
|
4625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC6A |
0.170058283969178 |
|
4626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC4D |
0.170058283969178 |
|
4627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC4E |
0.170058283969178 |
|
4628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP39A1 |
0.170180321425503 |
|
4629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BP1 |
0.170284147720155 |
|
4630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDXP |
0.170284147720155 |
|
4631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL385P |
0.170284147720155 |
|
4632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS1 |
0.170284147720155 |
|
4633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL12 |
0.170284147720155 |
|
4634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REST |
0.170304535423338 |
|
4635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL3 |
0.170378179456175 |
|
4636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPUSD3 |
0.170378179456175 |
|
4637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA3 |
0.170537681242976 |
|
4638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APEH |
0.170561801636665 |
|
4639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MST1 |
0.170561801636665 |
|
4640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA11|ENSG00000252727.1 |
0.170586723748158 |
|
4641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIPOL1 |
0.170709162765256 |
|
4642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASNA1 |
0.170726507411174 |
|
4643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM156 |
0.170743107357229 |
|
4644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKS1B|ENSG00000173207.8 |
0.170763311186618 |
|
4645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4258 |
0.170763311186618 |
|
4646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548M |
0.170770339455669 |
|
4647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL379P |
0.170770339455669 |
|
4648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP510 |
0.170770339455669 |
|
4649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFXANK |
0.170780214059592 |
|
4650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR2C2AP |
0.170780214059592 |
|
4651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WIZ |
0.170859008638177 |
|
4652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1470 |
0.170859008638177 |
|
4653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASAL3 |
0.170859008638177 |
|
4654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRLHR |
0.171062497212684 |
|
4655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACUL1 |
0.171062497212684 |
|
4656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000251836.1 |
0.171062497212684 |
|
4657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGG1 |
0.171139370822311 |
|
4658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHC1 |
0.171276822183922 |
|
4659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGK2 |
0.171314251840344 |
|
4660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRISP1 |
0.171314251840344 |
|
4661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIA |
0.171333425182219 |
|
4662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFM |
0.171395938957649 |
|
4663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD8 |
0.171454293066376 |
|
4664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL650P |
0.171454293066376 |
|
4665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AZU1 |
0.171519573208594 |
|
4666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSWIM4 |
0.171594267650292 |
|
4667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCUN1D4 |
0.171596501747981 |
|
4668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX32 |
0.17166104517572 |
|
4669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA10 |
0.171676763534314 |
|
4670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA6 |
0.171676763534314 |
|
4671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf53 |
0.171714210464192 |
|
4672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR632 |
0.171742873698847 |
|
4673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOL3 |
0.171783840783426 |
|
4674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOL4 |
0.171783840783426 |
|
4675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC27A3 |
0.17183182213417 |
|
4676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATAD2B |
0.17183182213417 |
|
4677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR572 |
0.171834289642415 |
|
4678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS3ST1 |
0.171834289642415 |
|
4679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP156 |
0.171834289642415 |
|
4680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLAD1 |
0.171844962928382 |
|
4681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LENEP |
0.171844962928382 |
|
4682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN8 |
0.171870999206048 |
|
4683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF564 |
0.171899188781636 |
|
4684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COBL |
0.171946326218088 |
|
4685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA1 |
0.171985207198242 |
|
4686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNN1 |
0.172056889580311 |
|
4687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP350 |
0.172085020569103 |
|
4688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUPT16H |
0.172145190429382 |
|
4689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D19 |
0.172153350359327 |
|
4690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SK |
0.172246174387813 |
|
4691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAIP1 |
0.172275489157568 |
|
4692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALML4 |
0.172322844364998 |
|
4693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLN6 |
0.172322844364998 |
|
4694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEM1B |
0.172322844364998 |
|
4695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP272 |
0.172391350432539 |
|
4696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFF4 |
0.172414892680688 |
|
4697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VRK2 |
0.172570629261206 |
|
4698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO9B |
0.17265401866782 |
|
4699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PXDNL |
0.17268110742827 |
|
4700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A1 |
0.172699252241771 |
|
4701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR161 |
0.172779457670411 |
|
4702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMSB15B |
0.172795975385916 |
|
4703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2BFM |
0.172795975385916 |
|
4704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2BFWT |
0.172795975385916 |
|
4705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL197P |
0.172910166337923 |
|
4706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMEK2 |
0.172953108766565 |
|
4707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHFRL1 |
0.173019378751383 |
|
4708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAX1 |
0.173034374472533 |
|
4709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD59|ENSG00000252682.1 |
0.173034374472533 |
|
4710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP463 |
0.173116864731444 |
|
4711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4503 |
0.173138555414375 |
|
4712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC104 |
0.173151494794409 |
|
4713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF17 |
0.173212504687953 |
|
4714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D5 |
0.173212504687953 |
|
4715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEF2C |
0.17323395267768 |
|
4716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNNM3 |
0.173235979053152 |
|
4717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL5 |
0.173237759902851 |
|
4718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRI1 |
0.173309605027847 |
|
4719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF703 |
0.173339733484819 |
|
4720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD115|ENSG00000212411.1 |
0.173383132609844 |
|
4721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR938 |
0.173383132609844 |
|
4722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFX1 |
0.173582019204894 |
|
4723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL27RA |
0.173582019204894 |
|
4724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RLN3 |
0.173582019204894 |
|
4725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIOBP |
0.17360404809331 |
|
4726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCL |
0.173704818861207 |
|
4727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD2 |
0.173728422288016 |
|
4728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM5 |
0.173843647366941 |
|
4729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX9 |
0.173999341146418 |
|
4730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FA2H |
0.174002831634898 |
|
4731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KA5 |
0.174010739310883 |
|
4732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf159 |
0.174010739310883 |
|
4733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11B |
0.174010739310883 |
|
4734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF518B |
0.174041067078484 |
|
4735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPEF2 |
0.174063294174957 |
|
4736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
G3BP2 |
0.174152441916081 |
|
4737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252077.1 |
0.174155387654801 |
|
4738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL741P |
0.174159272431022 |
|
4739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1P3 |
0.174159272431022 |
|
4740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD9 |
0.174177914787994 |
|
4741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4662B |
0.174264400504499 |
|
4742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000253028.1 |
0.174279708026616 |
|
4743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PALM3 |
0.174349816548753 |
|
4744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM3A |
0.174361666435884 |
|
4745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SVIL |
0.174396602059276 |
|
4746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3140 |
0.174422766382486 |
|
4747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNIP4 |
0.174556541836836 |
|
4748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GHR |
0.174614992570012 |
|
4749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WWC1 |
0.174688381890444 |
|
4750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAQR8 |
0.174751651560544 |
|
4751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALPL |
0.174822763796856 |
|
4752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGI2 |
0.174827163104326 |
|
4753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS1R2 |
0.174843898710227 |
|
4754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPC1L2B |
0.174884077387601 |
|
4755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPC1L2A |
0.174884077387601 |
|
4756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAP1L6 |
0.174884077387601 |
|
4757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR27A |
0.175131534557255 |
|
4758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR23A |
0.175131534557255 |
|
4759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP307 |
0.175176844459044 |
|
4760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMDHD1 |
0.175299786369019 |
|
4761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000212249.2 |
0.175392068878259 |
|
4762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A53 |
0.175542213025345 |
|
4763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IZUMO2 |
0.175592348966309 |
|
4764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4296 |
0.175602816437979 |
|
4765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS5 |
0.175751662275721 |
|
4766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPRKB |
0.175762791042423 |
|
4767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRTC1B |
0.175811750411943 |
|
4768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM226A |
0.175811750411943 |
|
4769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRTC1 |
0.175811750411943 |
|
4770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00684 |
0.175811750411943 |
|
4771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEAL5 |
0.1759242861264 |
|
4772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEX2 |
0.1759242861264 |
|
4773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEAL7 |
0.1759242861264 |
|
4774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB40A |
0.1759242861264 |
|
4775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPG |
0.176165905956474 |
|
4776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR203 |
0.176165905956474 |
|
4777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIA2 |
0.176209272373564 |
|
4778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMC2 |
0.176227739276666 |
|
4779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPN |
0.176227739276666 |
|
4780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATMIN |
0.176227739276666 |
|
4781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf46 |
0.176227739276666 |
|
4782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCSH |
0.176227739276666 |
|
4783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00487 |
0.176305251629207 |
|
4784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA4 |
0.17631623889487 |
|
4785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKSG63 |
0.176374660726831 |
|
4786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238734.1 |
0.176374660726831 |
|
4787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC6 |
0.176374660726831 |
|
4788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAPLN1 |
0.176430708832288 |
|
4789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP295 |
0.176430708832288 |
|
4790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4490 |
0.176440560360988 |
|
4791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP4 |
0.1765209771651 |
|
4792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBP |
0.176554007752959 |
|
4793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA11 |
0.176554007752959 |
|
4794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35D3 |
0.17659055764996 |
|
4795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL20RA |
0.17659055764996 |
|
4796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP251 |
0.176608056105988 |
|
4797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP192 |
0.17661636373967 |
|
4798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF9 |
0.17661636373967 |
|
4799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCRQ |
0.17661636373967 |
|
4800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEAP2 |
0.17661636373967 |
|
4801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1522 |
0.176632180502011 |
|
4802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM6SF2 |
0.176670389233918 |
|
4803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUGP1 |
0.176670389233918 |
|
4804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW9 |
0.176679045722276 |
|
4805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNPO2 |
0.176679045722276 |
|
4806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD41|ENSG00000209702.1 |
0.176679045722276 |
|
4807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf43 |
0.176679045722276 |
|
4808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL388P |
0.176686171912946 |
|
4809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AICDA |
0.176730627658672 |
|
4810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFAP5 |
0.176730627658672 |
|
4811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM135A |
0.176807287517073 |
|
4812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4453 |
0.176827068377224 |
|
4813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM154 |
0.176827068377224 |
|
4814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL672P |
0.176873781551797 |
|
4815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00349 |
0.176894944567863 |
|
4816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00387 |
0.176894944567863 |
|
4817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00388 |
0.176894944567863 |
|
4818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGLYRP2 |
0.176971844232753 |
|
4819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238507.1 |
0.17701138183122 |
|
4820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKAIN1 |
0.177044576519768 |
|
4821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRAP |
0.177169493233717 |
|
4822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT4A1 |
0.177172925169934 |
|
4823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMM50 |
0.177172925169934 |
|
4824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP365 |
0.177223326168757 |
|
4825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASA1 |
0.177280583873292 |
|
4826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL629P |
0.177280583873292 |
|
4827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ING4 |
0.177294629308536 |
|
4828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF384 |
0.177294629308536 |
|
4829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIANP |
0.177294629308536 |
|
4830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPHK2 |
0.177421750366927 |
|
4831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000202537.1 |
0.177434550926876 |
|
4832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA19|ENSG00000251974.1 |
0.177434550926876 |
|
4833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPAR5 |
0.177463053475137 |
|
4834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACRBP |
0.177463053475137 |
|
4835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT1 |
0.177580617999914 |
|
4836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL446P |
0.177737613060489 |
|
4837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCPH1 |
0.17773847358734 |
|
4838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEP1A |
0.177796657254539 |
|
4839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR116 |
0.177796657254539 |
|
4840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLE3 |
0.177813732342987 |
|
4841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INO80D |
0.177880965558829 |
|
4842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR11 |
0.17791623434004 |
|
4843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A11 |
0.177963061774155 |
|
4844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW7 |
0.178071532521329 |
|
4845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMAT4 |
0.178100489481774 |
|
4846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREG1 |
0.178144196693225 |
|
4847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1A |
0.178398518587699 |
|
4848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GET4 |
0.178437974380764 |
|
4849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAP1 |
0.178437974380764 |
|
4850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf50 |
0.178437974380764 |
|
4851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX19 |
0.178437974380764 |
|
4852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2W1 |
0.178437974380764 |
|
4853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPER |
0.178437974380764 |
|
4854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR146 |
0.178437974380764 |
|
4855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR339 |
0.178437974380764 |
|
4856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAND2A |
0.178437974380764 |
|
4857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYGM |
0.178695866785344 |
|
4858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHG4 |
0.178708893918603 |
|
4859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHISA2 |
0.178770144602101 |
|
4860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00415 |
0.178770144602101 |
|
4861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAD2 |
0.178832090282331 |
|
4862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FER1L6 |
0.178843866919842 |
|
4863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNNM4 |
0.179043720388497 |
|
4864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3127 |
0.179043720388497 |
|
4865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR7A2 |
0.179089926986854 |
|
4866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PQLC2 |
0.179089926986854 |
|
4867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL85P |
0.179089926986854 |
|
4868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPZB |
0.179089926986854 |
|
4869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBA3 |
0.179139253047995 |
|
4870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCM1 |
0.179156822290372 |
|
4871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST11 |
0.179165774489205 |
|
4872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGPRG |
0.179205787331997 |
|
4873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
Vault|ENSG00000252485.1 |
0.179232880583602 |
|
4874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM1 |
0.179243259570279 |
|
4875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPC1 |
0.179265091296664 |
|
4876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC41P |
0.179265091296664 |
|
4877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP7 |
0.17930484443374 |
|
4878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL9 |
0.179397163739786 |
|
4879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIAS |
0.179397163739786 |
|
4880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGL1 |
0.17953852991475 |
|
4881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGRP2 |
0.179682039770845 |
|
4882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3663 |
0.179868197140697 |
|
4883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK18 |
0.179868197140697 |
|
4884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOD3 |
0.17989636742152 |
|
4885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2O |
0.179950681048356 |
|
4886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRP2 |
0.18000825293242 |
|
4887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP10 |
0.180019839587665 |
|
4888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP8B2 |
0.180019839587665 |
|
4889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF217 |
0.180103119874636 |
|
4890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPSAP1 |
0.180363039348916 |
|
4891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM65 |
0.180493121335578 |
|
4892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT12 |
0.180493121335578 |
|
4893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF139 |
0.180493121335578 |
|
4894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TATDN1 |
0.180493121335578 |
|
4895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB9 |
0.180493121335578 |
|
4896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTSS1 |
0.180493121335578 |
|
4897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5L2 |
0.180499608803201 |
|
4898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB133 |
0.180539603665108 |
|
4899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB114 |
0.180539603665108 |
|
4900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB113 |
0.180539603665108 |
|
4901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP380 |
0.180581705837016 |
|
4902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POM121L12 |
0.180602803714282 |
|
4903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf137 |
0.180603004840427 |
|
4904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP21 |
0.180603004840427 |
|
4905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP152 |
0.180656428052415 |
|
4906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIK5 |
0.180671531570744 |
|
4907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP3 |
0.180837009370231 |
|
4908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF103 |
0.180837009370231 |
|
4909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL17 |
0.180922443907755 |
|
4910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR12 |
0.180944644773162 |
|
4911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF574 |
0.180978368942439 |
|
4912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP256 |
0.18120250410115 |
|
4913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACBD6 |
0.181220995552802 |
|
4914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALMS1P |
0.181284923018108 |
|
4915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT8 |
0.181284923018108 |
|
4916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNMT3L |
0.181395807487658 |
|
4917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP93 |
0.181401565023617 |
|
4918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSX1 |
0.181569790212762 |
|
4919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP178 |
0.181637037874795 |
|
4920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC9P |
0.181805305391407 |
|
4921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR110 |
0.182068730833098 |
|
4922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00516 |
0.182085351859501 |
|
4923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED15P1 |
0.182085351859501 |
|
4924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED15P6 |
0.182085351859501 |
|
4925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR11H12 |
0.182085351859501 |
|
4926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4K13 |
0.182085351859501 |
|
4927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4K14 |
0.182085351859501 |
|
4928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4K15 |
0.182085351859501 |
|
4929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4K1 |
0.182085351859501 |
|
4930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4K2 |
0.182085351859501 |
|
4931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4K5 |
0.182085351859501 |
|
4932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4M1 |
0.182085351859501 |
|
4933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4N2 |
0.182085351859501 |
|
4934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4Q2 |
0.182085351859501 |
|
4935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4Q3 |
0.182085351859501 |
|
4936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEG |
0.182085351859501 |
|
4937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEM |
0.182085351859501 |
|
4938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238492.1 |
0.182085351859501 |
|
4939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4L1 |
0.182085351859501 |
|
4940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR2F6 |
0.1821379780545 |
|
4941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL685P |
0.182147166283425 |
|
4942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD8A |
0.182155942807892 |
|
4943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238383.1 |
0.182189522517192 |
|
4944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO30 |
0.182231428278821 |
|
4945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A5 |
0.182253562735939 |
|
4946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGS1 |
0.182255614840551 |
|
4947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A5 |
0.182523268220271 |
|
4948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL103P |
0.182523268220271 |
|
4949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA50|ENSG00000220986.1 |
0.182523268220271 |
|
4950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNB1 |
0.182523268220271 |
|
4951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238334.1 |
0.182523268220271 |
|
4952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNH |
0.182526299097997 |
|
4953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MNX1 |
0.182636720143203 |
|
4954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTLC3 |
0.182744939495194 |
|
4955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMTM3 |
0.182805561114274 |
|
4956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL77P |
0.182917577833051 |
|
4957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRHL1 |
0.183004153414687 |
|
4958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4762 |
0.183010651986176 |
|
4959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F8 |
0.183088076023012 |
|
4960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM189 |
0.183150413780671 |
|
4961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5695 |
0.183176173881613 |
|
4962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR124 |
0.183184884491999 |
|
4963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252238.1 |
0.183245043157311 |
|
4964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD23 |
0.183247053001333 |
|
4965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD39 |
0.183247053001333 |
|
4966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCEL1 |
0.183339190527542 |
|
4967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USE1 |
0.183339190527542 |
|
4968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SACS |
0.183375010234193 |
|
4969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K9 |
0.183453135234986 |
|
4970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISM1 |
0.183484191979071 |
|
4971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDGFRL |
0.183484344885205 |
|
4972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548V |
0.183484344885205 |
|
4973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNC2 |
0.183510586708199 |
|
4974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPST1 |
0.183607937145711 |
|
4975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR1A |
0.183665182479333 |
|
4976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H7B |
0.183702915572439 |
|
4977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCE2 |
0.183844514738789 |
|
4978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL268P |
0.184027893454825 |
|
4979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R38 |
0.184053109790415 |
|
4980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP112 |
0.18408410113329 |
|
4981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROM1 |
0.184236034283842 |
|
4982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPRIPL1 |
0.1842474835097 |
|
4983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAPH |
0.1842474835097 |
|
4984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R3 |
0.184290220881842 |
|
4985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R4 |
0.184290220881842 |
|
4986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R5 |
0.184290220881842 |
|
4987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS37 |
0.184290220881842 |
|
4988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9A3P |
0.184290220881842 |
|
4989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9A1P |
0.184290220881842 |
|
4990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9A4 |
0.184290220881842 |
|
4991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC5A |
0.184290220881842 |
|
4992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ20373 |
0.184293467413749 |
|
4993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC9 |
0.18437794628362 |
|
4994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT11 |
0.184395127796275 |
|
4995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPRV1 |
0.18448986865887 |
|
4996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENOPH1 |
0.184524887969923 |
|
4997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17A |
0.184529061311709 |
|
4998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1I |
0.184582718601932 |
|
4999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY2GP |
0.184598471735269 |
|
5000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP10 |
0.184615468918755 |
|
5001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4695 |
0.184633319494089 |
|
5002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1290 |
0.184633319494089 |
|
5003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFFO2 |
0.184633319494089 |
|
5004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGXB4 |
0.184651147111845 |
|
5005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDOST |
0.184694569141415 |
|
5006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR216A |
0.184749278254392 |
|
5007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR217 |
0.184749278254392 |
|
5008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR216B |
0.184749278254392 |
|
5009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN1 |
0.184779763493988 |
|
5010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR645 |
0.184779763493988 |
|
5011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGCG |
0.184790658728949 |
|
5012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPS2 |
0.18481384241371 |
|
5013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLIPR1L1 |
0.18481384241371 |
|
5014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID4A |
0.18484254892129 |
|
5015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM20L |
0.18484254892129 |
|
5016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM9 |
0.18484254892129 |
|
5017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD12B |
0.184866511549314 |
|
5018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD12C |
0.184866511549314 |
|
5019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD12 |
0.184866511549314 |
|
5020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAS1 |
0.184866511549314 |
|
5021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR206 |
0.184904963578824 |
|
5022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR133B |
0.184904963578824 |
|
5023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARB2 |
0.184916204085655 |
|
5024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTUS1 |
0.184918680060386 |
|
5025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM9SF1 |
0.18496062779043 |
|
5026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP4A |
0.18496062779043 |
|
5027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSSK4 |
0.18496062779043 |
|
5028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPE |
0.184969739111993 |
|
5029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM53B |
0.185197045635066 |
|
5030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA13 |
0.185207382711235 |
|
5031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARFGAP3 |
0.185361721160501 |
|
5032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF117 |
0.185371649041417 |
|
5033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC18 |
0.185468682052179 |
|
5034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO25 |
0.185473255143696 |
|
5035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F21 |
0.185473255143696 |
|
5036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL23AP53 |
0.185473255143696 |
|
5037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRP |
0.185473255143696 |
|
5038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF596 |
0.185473255143696 |
|
5039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKIB |
0.185480855656961 |
|
5040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YARS |
0.185485481886457 |
|
5041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEGF8 |
0.18549004144064 |
|
5042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP431 |
0.185510634502257 |
|
5043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPND |
0.185576068945199 |
|
5044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3GL1 |
0.185576068945199 |
|
5045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLRN2 |
0.185585657541417 |
|
5046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238536.1 |
0.185585657541417 |
|
5047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRBOX1 |
0.185618212960397 |
|
5048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SREK1 |
0.185683931838359 |
|
5049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238400.1 |
0.185683931838359 |
|
5050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4274 |
0.185712558758644 |
|
5051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSAPL1 |
0.185712558758644 |
|
5052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL506P |
0.185762399160716 |
|
5053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WEE2 |
0.185773802284128 |
|
5054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSBP1 |
0.185773802284128 |
|
5055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00237 |
0.185796012084285 |
|
5056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKRN9P |
0.185804757316101 |
|
5057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL564P |
0.185850967334783 |
|
5058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP7 |
0.185850967334783 |
|
5059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMPDL3A |
0.185850967334783 |
|
5060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAFF |
0.185932297020534 |
|
5061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf57 |
0.186010794571157 |
|
5062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAF |
0.186010900914705 |
|
5063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTBDN |
0.186036717981934 |
|
5064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP430 |
0.186063475267808 |
|
5065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH4A1 |
0.186067945170469 |
|
5066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLNK |
0.186101789643375 |
|
5067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD4 |
0.186143888720516 |
|
5068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBIP1 |
0.186143888720516 |
|
5069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4680 |
0.186143888720516 |
|
5070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN4 |
0.186160800903789 |
|
5071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC85A |
0.186178488486463 |
|
5072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHX4 |
0.186264817938198 |
|
5073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB40AL |
0.186393463318743 |
|
5074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEX1 |
0.186393463318743 |
|
5075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXF3 |
0.186393463318743 |
|
5076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF6 |
0.186408951141205 |
|
5077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT2A |
0.186515854383174 |
|
5078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1L |
0.186515854383174 |
|
5079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1E |
0.186515854383174 |
|
5080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1M |
0.186515854383174 |
|
5081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1JP |
0.186515854383174 |
|
5082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1A |
0.186515854383174 |
|
5083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1DP |
0.186515854383174 |
|
5084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHOD1 |
0.186776510944738 |
|
5085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC14L1 |
0.186807042995853 |
|
5086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A8 |
0.186851815309368 |
|
5087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP20 |
0.186851815309368 |
|
5088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238800.1 |
0.186851815309368 |
|
5089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4316 |
0.18700512835046 |
|
5090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNFN |
0.187009216468254 |
|
5091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTA4 |
0.187053262196535 |
|
5092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KERA |
0.187086056227155 |
|
5093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYS1 |
0.187234170882903 |
|
5094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212558.1 |
0.187234170882903 |
|
5095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPHN1 |
0.187271619588663 |
|
5096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT3 |
0.187657299168786 |
|
5097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAPTM4B |
0.187683204780802 |
|
5098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCER1 |
0.187782407440869 |
|
5099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00615 |
0.187782407440869 |
|
5100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPYC |
0.187782407440869 |
|
5101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUM |
0.187782407440869 |
|
5102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORCS2 |
0.187803023877412 |
|
5103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC11A |
0.187852904603444 |
|
5104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR32 |
0.187852904603444 |
|
5105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAB2 |
0.187881086153278 |
|
5106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000212594.1 |
0.187881086153278 |
|
5107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCN |
0.187929597254565 |
|
5108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP233 |
0.187949205230751 |
|
5109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf13 |
0.18800471093288 |
|
5110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF11 |
0.188012788892745 |
|
5111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA4 |
0.188093361853091 |
|
5112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFV |
0.188097288282868 |
|
5113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00936 |
0.188100800405533 |
|
5114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TECTB |
0.188106705053342 |
|
5115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2B1 |
0.188218715769161 |
|
5116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL531P |
0.188228275276509 |
|
5117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRLF3 |
0.188298713350284 |
|
5118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37BP1 |
0.188298713350284 |
|
5119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL316P |
0.188298713350284 |
|
5120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUZ12P |
0.188298713350284 |
|
5121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1B |
0.188320813481036 |
|
5122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1F |
0.188320813481036 |
|
5123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1E1 |
0.188354695969418 |
|
5124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMG6 |
0.188368897268652 |
|
5125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO15B |
0.188422746020943 |
|
5126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXO6 |
0.188467985752877 |
|
5127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP200 |
0.188481061806766 |
|
5128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP260 |
0.188481061806766 |
|
5129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDBF2 |
0.188520153949052 |
|
5130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238708.1 |
0.188583429010087 |
|
5131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPTE2P6 |
0.188637630499643 |
|
5132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF667 |
0.188758125877908 |
|
5133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX27 |
0.188762411093389 |
|
5134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNFX1 |
0.188762411093389 |
|
5135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL5 |
0.188809831952079 |
|
5136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AXDND1 |
0.188818035652925 |
|
5137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPHS2 |
0.188818035652925 |
|
5138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF1B2 |
0.188835513114554 |
|
5139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA41|ENSG00000207406.1 |
0.188835513114554 |
|
5140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD51|ENSG00000207047.2 |
0.188835513114554 |
|
5141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR1 |
0.188835513114554 |
|
5142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238418.1 |
0.188850922411191 |
|
5143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPHK1 |
0.188850922411191 |
|
5144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP99 |
0.188855457331197 |
|
5145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX20 |
0.18894087955002 |
|
5146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOD2 |
0.18894087955002 |
|
5147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00472 |
0.189075853320186 |
|
5148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC10 |
0.189078536088136 |
|
5149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP12A |
0.189213769435791 |
|
5150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1P7 |
0.189213769435791 |
|
5151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNIP3 |
0.189252626282898 |
|
5152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252356.1 |
0.189261217693898 |
|
5153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0586 |
0.189652470808128 |
|
5154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAS2 |
0.189670208745834 |
|
5155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD8B |
0.189746167028997 |
|
5156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT6P1 |
0.189764793073623 |
|
5157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA15|ENSG00000206785.1 |
0.189764793073623 |
|
5158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA22|ENSG00000206634.1 |
0.189764793073623 |
|
5159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENKUR |
0.189767961729037 |
|
5160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THNSL1 |
0.189767961729037 |
|
5161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5DC3 |
0.189772402301552 |
|
5162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIGD4 |
0.189787309833966 |
|
5163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5698 |
0.189838868527408 |
|
5164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3173 |
0.189839080098252 |
|
5165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLMN |
0.189839080098252 |
|
5166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMPD3 |
0.189891091744193 |
|
5167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWDE |
0.189897904113506 |
|
5168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF9B |
0.190055056833082 |
|
5169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA12|ENSG00000212175.1 |
0.19012792882021 |
|
5170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKEF1 |
0.190134880592047 |
|
5171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM81B |
0.190218778151472 |
|
5172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFC2 |
0.1902469096451 |
|
5173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY4 |
0.190256189823492 |
|
5174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIPK3 |
0.190256189823492 |
|
5175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFATC4 |
0.190256189823492 |
|
5176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGCS1 |
0.190309858333091 |
|
5177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL2A1 |
0.19037519661543 |
|
5178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP1C |
0.190384003155964 |
|
5179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APBB1IP |
0.190398972170628 |
|
5180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP93 |
0.190477135530561 |
|
5181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNQ1OT1 |
0.190498453737664 |
|
5182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCSD1 |
0.190538365844865 |
|
5183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMA1 |
0.190741349191965 |
|
5184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF3 |
0.190787562875273 |
|
5185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOX3 |
0.190800736399136 |
|
5186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCM1 |
0.190815135661927 |
|
5187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000251930.1 |
0.190815135661927 |
|
5188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP8 |
0.190854784864414 |
|
5189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCBP2L |
0.190909613494501 |
|
5190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP159 |
0.190930638440706 |
|
5191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA4A |
0.190993496041121 |
|
5192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ART3 |
0.191097655336849 |
|
5193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP98 |
0.191206856101793 |
|
5194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F23P |
0.1913355937271 |
|
5195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP5 |
0.191377967053567 |
|
5196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NGFRAP1 |
0.191377967053567 |
|
5197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB1 |
0.191396309301556 |
|
5198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHDC1 |
0.19148595834406 |
|
5199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM20 |
0.191536075168627 |
|
5200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5684 |
0.191617326918753 |
|
5201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JUNB |
0.191617326918753 |
|
5202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDX2 |
0.191617326918753 |
|
5203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTRA3 |
0.191620689332642 |
|
5204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM244 |
0.191627411926213 |
|
5205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMIGO3 |
0.191746560213337 |
|
5206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMPPB |
0.191746560213337 |
|
5207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ME3 |
0.19177913910145 |
|
5208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPLA2 |
0.19195412045959 |
|
5209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD151 |
0.19195412045959 |
|
5210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB4A |
0.19195412045959 |
|
5211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2L |
0.19195412045959 |
|
5212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYLD |
0.19200821408234 |
|
5213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP426 |
0.19200821408234 |
|
5214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCALD |
0.192065230634218 |
|
5215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP36 |
0.192088595750861 |
|
5216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1X |
0.19215737731963 |
|
5217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL686P |
0.192182954792724 |
|
5218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYEF2 |
0.192253081016658 |
|
5219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP477 |
0.192267102764161 |
|
5220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLK1S1 |
0.192288350944969 |
|
5221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF727 |
0.19230138405422 |
|
5222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM106B |
0.19235275347686 |
|
5223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM127 |
0.192398207341351 |
|
5224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIAO1 |
0.192398207341351 |
|
5225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRNP200 |
0.192398207341351 |
|
5226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL383P |
0.19245643456876 |
|
5227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00566 |
0.192564048966827 |
|
5228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP218 |
0.192640252913746 |
|
5229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA11 |
0.19274746781981 |
|
5230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFEMP1 |
0.192752260400732 |
|
5231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO10 |
0.192806916130283 |
|
5232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf40 |
0.192820331796077 |
|
5233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMA3 |
0.192875041761929 |
|
5234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB28 |
0.192887057335172 |
|
5235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFPL2 |
0.193040708176039 |
|
5236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP54 |
0.193177028926563 |
|
5237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAGE5 |
0.193230840350966 |
|
5238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOR1AIP2 |
0.193328804232736 |
|
5239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFRG15 |
0.193328804232736 |
|
5240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOR1AIP1 |
0.193328804232736 |
|
5241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL230P |
0.193328804232736 |
|
5242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL520P |
0.19342472781067 |
|
5243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGSN |
0.193444401805173 |
|
5244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP208 |
0.193476993688236 |
|
5245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F22 |
0.193548718478055 |
|
5246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EML6 |
0.193572102369814 |
|
5247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF1 |
0.193636222950784 |
|
5248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPM2 |
0.193654562558715 |
|
5249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDA |
0.193686608699826 |
|
5250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PINK1 |
0.193686608699826 |
|
5251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBXIP1 |
0.193716880343605 |
|
5252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYGO2 |
0.193716880343605 |
|
5253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E2F5 |
0.193739921368106 |
|
5254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf59 |
0.193739921368106 |
|
5255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSP90AA1 |
0.193749088264611 |
|
5256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNE2 |
0.193806113621719 |
|
5257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT8B |
0.193904517094512 |
|
5258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC31B |
0.193904517094512 |
|
5259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB8 |
0.193904517094512 |
|
5260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3652 |
0.193944274341372 |
|
5261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MASTL |
0.193972154091935 |
|
5262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1G |
0.194082218240315 |
|
5263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1H |
0.194082218240315 |
|
5264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASCL2 |
0.194157915981618 |
|
5265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AANAT |
0.194164764016009 |
|
5266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf24 |
0.194302983070766 |
|
5267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERINC1 |
0.194305855865077 |
|
5268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL537P |
0.19431683755174 |
|
5269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKD1 |
0.194337597207688 |
|
5270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF542 |
0.194389117089766 |
|
5271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF582 |
0.194389117089766 |
|
5272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHPRH |
0.194415827949253 |
|
5273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM32A |
0.19441933051349 |
|
5274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GON4L |
0.19442487896807 |
|
5275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC66 |
0.194491648726449 |
|
5276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGCB |
0.194491648726449 |
|
5277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAT1 |
0.194528149517185 |
|
5278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPPA2 |
0.194528149517185 |
|
5279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCA1C |
0.194528149517185 |
|
5280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00488 |
0.194528149517185 |
|
5281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORC1 |
0.194528149517185 |
|
5282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221633.1 |
0.194528149517185 |
|
5283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPPA4 |
0.194528149517185 |
|
5284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERLIN2 |
0.194539881164263 |
|
5285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROSC |
0.194539881164263 |
|
5286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP18 |
0.194570468282435 |
|
5287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOA6 |
0.194627441158686 |
|
5288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP56 |
0.194787836989085 |
|
5289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEX4 |
0.19480131499244 |
|
5290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEAL8 |
0.19480131499244 |
|
5291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF2 |
0.194818721724673 |
|
5292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L12 |
0.194914197931818 |
|
5293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA13 |
0.194989242833347 |
|
5294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC14A |
0.19502791271766 |
|
5295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6AP1L |
0.19504316508822 |
|
5296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS30 |
0.195141510372724 |
|
5297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCMF1 |
0.195165547345983 |
|
5298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GEMIN2 |
0.19519862569229 |
|
5299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC6B |
0.19519862569229 |
|
5300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD47 |
0.195292906741592 |
|
5301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA18 |
0.195299596233131 |
|
5302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBR4 |
0.195355486734369 |
|
5303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA4|ENSG00000201133.1 |
0.195397972747675 |
|
5304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf43 |
0.195441441738302 |
|
5305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLL1 |
0.195441441738302 |
|
5306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1211L |
0.195552017276251 |
|
5307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL378P |
0.1957361731145 |
|
5308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS23 |
0.1957361731145 |
|
5309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C18orf63 |
0.195736655416415 |
|
5310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOG |
0.195839657896998 |
|
5311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFAP2D |
0.195847087492626 |
|
5312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICOSLG |
0.195973516122138 |
|
5313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC119 |
0.195981538710639 |
|
5314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGS |
0.195981538710639 |
|
5315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR22HG |
0.196152120079403 |
|
5316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLCD2 |
0.196152120079403 |
|
5317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL105P |
0.196178379440274 |
|
5318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMER2 |
0.196183828497138 |
|
5319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR6 |
0.196183828497138 |
|
5320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00458 |
0.196220957604627 |
|
5321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH15 |
0.196270910770025 |
|
5322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDIA6 |
0.196313627202804 |
|
5323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRK |
0.196536897753206 |
|
5324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNRC6C |
0.196585472659809 |
|
5325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC2 |
0.196608489492768 |
|
5326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT7 |
0.196608489492768 |
|
5327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DISC1FP1 |
0.196649244960827 |
|
5328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST15 |
0.196667027458349 |
|
5329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf42 |
0.196721665946517 |
|
5330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP4K4 |
0.197127905507995 |
|
5331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASGR1 |
0.197155667535513 |
|
5332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLG4 |
0.197155667535513 |
|
5333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACADVL |
0.197155667535513 |
|
5334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA32|ENSG00000207503.1 |
0.197204349054886 |
|
5335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf22 |
0.197227936720041 |
|
5336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf187 |
0.197299004548893 |
|
5337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPO |
0.197308273142726 |
|
5338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1256 |
0.197391788554451 |
|
5339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF1 |
0.197410356199271 |
|
5340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP4K2 |
0.197410356199271 |
|
5341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNB2 |
0.197496856972932 |
|
5342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAR |
0.197496856972932 |
|
5343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL598P |
0.197513247304315 |
|
5344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR10 |
0.197513247304315 |
|
5345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTXN2 |
0.197559916036133 |
|
5346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4418 |
0.197561932791583 |
|
5347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17F |
0.19758646884079 |
|
5348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM3 |
0.19758646884079 |
|
5349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QARS |
0.197850071476692 |
|
5350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP19 |
0.197850071476692 |
|
5351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMB2 |
0.197850071476692 |
|
5352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AZIN1 |
0.198018753090519 |
|
5353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1C1 |
0.198018753090519 |
|
5354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf56 |
0.198018753090519 |
|
5355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAALC |
0.198018753090519 |
|
5356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3151 |
0.198018753090519 |
|
5357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNEP1R1 |
0.198057265646514 |
|
5358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00352 |
0.198086384842185 |
|
5359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252071.1 |
0.198163015947477 |
|
5360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP28 |
0.198175329127792 |
|
5361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP130 |
0.198182118056239 |
|
5362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMND5A |
0.198209155074838 |
|
5363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF679 |
0.198342080306952 |
|
5364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP7 |
0.198416937804246 |
|
5365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMTC3 |
0.198543566096483 |
|
5366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA30|ENSG00000200063.1 |
0.198547681003451 |
|
5367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVC |
0.198572304565507 |
|
5368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAT5B |
0.19862922669019 |
|
5369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A1 |
0.198765440787116 |
|
5370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238925.1 |
0.198892672125465 |
|
5371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00338 |
0.198899614911136 |
|
5372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA57|ENSG00000212567.1 |
0.19892399944902 |
|
5373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL37 |
0.19892399944902 |
|
5374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD72 |
0.19892399944902 |
|
5375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD6 |
0.19892399944902 |
|
5376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7 |
0.19892399944902 |
|
5377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR603 |
0.198981233227069 |
|
5378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF98 |
0.199060252345388 |
|
5379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNH1 |
0.199091427470647 |
|
5380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ6|ENSG00000264452.1 |
0.199093573825319 |
|
5381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ6|ENSG00000266692.1 |
0.199093573825319 |
|
5382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPS1 |
0.199155518844761 |
|
5383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCDH |
0.199169376531038 |
|
5384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF32 |
0.199224442080522 |
|
5385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCL6 |
0.199355773894862 |
|
5386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP57 |
0.19936618847279 |
|
5387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR2 |
0.19936618847279 |
|
5388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP345 |
0.19936618847279 |
|
5389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYZAP |
0.19941918418844 |
|
5390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHANK1 |
0.199430892392707 |
|
5391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF3A |
0.199461279274766 |
|
5392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA3|ENSG00000251778.1 |
0.19948515107775 |
|
5393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2CD2 |
0.19948515107775 |
|
5394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGPRE |
0.199738752095254 |
|
5395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QKI |
0.199890078957174 |
|
5396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD66 |
0.199893206502062 |
|
5397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNTG1 |
0.199946764661259 |
|
5398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYTL2 |
0.199968422171501 |
|
5399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG10 |
0.199975508729929 |
|
5400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA13 |
0.199975508729929 |
|
5401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRX5 |
0.199975508729929 |
|
5402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCL1B |
0.199975508729929 |
|
5403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCL1A |
0.199975508729929 |
|
5404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00617 |
0.199975508729929 |
|
5405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR629 |
0.199982041979204 |
|
5406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO3A |
0.200012575270661 |
|
5407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYROXD2 |
0.20006736677798 |
|
5408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1287 |
0.20006736677798 |
|
5409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4685 |
0.20006736677798 |
|
5410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MN1 |
0.200155262982691 |
|
5411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIP2 |
0.200205295781322 |
|
5412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4495 |
0.200224233537268 |
|
5413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC3 |
0.200278773930628 |
|
5414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC3DN |
0.200278773930628 |
|
5415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC41 |
0.2003138305712 |
|
5416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAT2 |
0.2003398019124 |
|
5417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX3 |
0.2003398019124 |
|
5418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP221 |
0.2003398019124 |
|
5419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUCA2 |
0.2003398019124 |
|
5420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00614 |
0.200542964338989 |
|
5421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTP4A1 |
0.200610705793571 |
|
5422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWC2 |
0.200621254793303 |
|
5423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD5 |
0.200703634460589 |
|
5424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNS2 |
0.200717137564945 |
|
5425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KARS |
0.200717153201117 |
|
5426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238914.1 |
0.200764100301599 |
|
5427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM163A |
0.200764267660255 |
|
5428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A27 |
0.200781732426376 |
|
5429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD6 |
0.200781732426376 |
|
5430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G7 |
0.200781732426376 |
|
5431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P3 |
0.200823619802106 |
|
5432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252526.1 |
0.200823619802106 |
|
5433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC1 |
0.200827126317788 |
|
5434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRTO4 |
0.200827126317788 |
|
5435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR7A3 |
0.200827126317788 |
|
5436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR7L |
0.200827126317788 |
|
5437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFV3 |
0.200836668054181 |
|
5438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC2 |
0.200912468440986 |
|
5439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ART1 |
0.200912468440986 |
|
5440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ART5 |
0.200912468440986 |
|
5441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA10 |
0.200912468440986 |
|
5442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238686.1 |
0.200912468440986 |
|
5443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3TC1 |
0.200947144167119 |
|
5444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESF1 |
0.200947582294613 |
|
5445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX7 |
0.200968678645567 |
|
5446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDGFB |
0.200968678645567 |
|
5447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM248 |
0.201032659787804 |
|
5448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF195 |
0.201124920127103 |
|
5449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT57 |
0.201149400414205 |
|
5450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL4 |
0.201180486814676 |
|
5451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARRDC4 |
0.201200801825462 |
|
5452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PWP2 |
0.201201038761783 |
|
5453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFC3H1 |
0.201205733363066 |
|
5454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA17|ENSG00000212461.1 |
0.201205733363066 |
|
5455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP2 |
0.201205733363066 |
|
5456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM186B |
0.201205792508612 |
|
5457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF1 |
0.201339899390865 |
|
5458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00264 |
0.20136139291311 |
|
5459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAP1L2 |
0.201397427373406 |
|
5460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BGLAP |
0.201446908850358 |
|
5461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAQR6 |
0.201446908850358 |
|
5462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMG5 |
0.201446908850358 |
|
5463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf85 |
0.201446908850358 |
|
5464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM79 |
0.201446908850358 |
|
5465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VHLL |
0.201446908850358 |
|
5466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THSD7A |
0.201466765126947 |
|
5467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238769.1 |
0.201506219739213 |
|
5468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF14 |
0.201533828647964 |
|
5469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL1 |
0.201537240456456 |
|
5470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIN2 |
0.201557037528035 |
|
5471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA20 |
0.201557037528035 |
|
5472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRNKL1 |
0.201557037528035 |
|
5473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM18 |
0.201611664451604 |
|
5474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000199552.1 |
0.201628852808066 |
|
5475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGER4 |
0.201628852808066 |
|
5476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA75|ENSG00000212533.1 |
0.201830412336121 |
|
5477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTBN1 |
0.201921450677426 |
|
5478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00174 |
0.201946722470181 |
|
5479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252265.1 |
0.201946722470181 |
|
5480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KITLG |
0.201956078207429 |
|
5481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB47 |
0.20197478702025 |
|
5482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL567P |
0.20197478702025 |
|
5483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL40 |
0.20197478702025 |
|
5484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHATL |
0.20197478702025 |
|
5485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RICTOR |
0.202143918617129 |
|
5486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf52 |
0.202224529689949 |
|
5487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCNT6 |
0.202224529689949 |
|
5488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAK1IP1 |
0.202224529689949 |
|
5489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM14C |
0.202224529689949 |
|
5490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP203 |
0.202224529689949 |
|
5491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO33 |
0.202296679267441 |
|
5492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROM2 |
0.202538315291755 |
|
5493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPD5 |
0.202809401058661 |
|
5494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY7 |
0.202809401058661 |
|
5495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRD7 |
0.202809401058661 |
|
5496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA14 |
0.202825337959079 |
|
5497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238526.1 |
0.202825337959079 |
|
5498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APH1A |
0.202825337959079 |
|
5499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf54 |
0.202825337959079 |
|
5500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf51 |
0.202825337959079 |
|
5501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS21 |
0.202825337959079 |
|
5502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP241 |
0.202849051709984 |
|
5503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL472P |
0.202874062191142 |
|
5504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1598 |
0.202947102303521 |
|
5505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC33 |
0.202977615734089 |
|
5506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAA1 |
0.202977615734089 |
|
5507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U2AF1 |
0.202988365573934 |
|
5508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEATR3 |
0.203005680187184 |
|
5509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP113 |
0.203097460309401 |
|
5510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF436 |
0.203100843655823 |
|
5511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf213 |
0.203100843655823 |
|
5512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC7 |
0.203131990592012 |
|
5513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC6 |
0.203156315876457 |
|
5514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSL5 |
0.203177258296858 |
|
5515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFTPH |
0.203184627976242 |
|
5516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMIZ2 |
0.203225530490164 |
|
5517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELOF1 |
0.203346295882262 |
|
5518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACP5 |
0.203346295882262 |
|
5519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMC3 |
0.203500129577945 |
|
5520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239125.1 |
0.203500129577945 |
|
5521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP288 |
0.203500129577945 |
|
5522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP327 |
0.203500129577945 |
|
5523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU12 |
0.203588115154125 |
|
5524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5R3 |
0.203588115154125 |
|
5525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD26 |
0.203623399193022 |
|
5526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YME1L1 |
0.203623399193022 |
|
5527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTPS1 |
0.203646740357006 |
|
5528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLFNL1 |
0.203646740357006 |
|
5529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL636P |
0.203744054444684 |
|
5530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf42 |
0.203770291679842 |
|
5531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAP25 |
0.203844426233204 |
|
5532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZPBP |
0.204021593578633 |
|
5533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPAL2 |
0.204136795642124 |
|
5534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA5 |
0.204164505902729 |
|
5535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR81 |
0.204201144911136 |
|
5536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINF2 |
0.204201144911136 |
|
5537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC30 |
0.204224522571469 |
|
5538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL277P |
0.20437450783399 |
|
5539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239027.1 |
0.20437450783399 |
|
5540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4465 |
0.204473078618534 |
|
5541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPT1 |
0.204531722989798 |
|
5542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4714 |
0.204598936660073 |
|
5543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL21A1 |
0.204604198860137 |
|
5544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAR3 |
0.204674986988928 |
|
5545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL757P |
0.204777718032817 |
|
5546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOK |
0.204808859478197 |
|
5547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL2 |
0.204881684944197 |
|
5548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf72 |
0.204906836983563 |
|
5549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUPL1 |
0.205133210301841 |
|
5550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAPLN4 |
0.205148511414003 |
|
5551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POGK |
0.205161484030699 |
|
5552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TADA1 |
0.205161484030699 |
|
5553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HP1BP3 |
0.205329888474922 |
|
5554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf57 |
0.205335391634898 |
|
5555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA11 |
0.205381230643358 |
|
5556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252762.1 |
0.205475521863377 |
|
5557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF6 |
0.205489184556455 |
|
5558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN2 |
0.205494556481047 |
|
5559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIPPLY1 |
0.205494556481047 |
|
5560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AN |
0.205542873455962 |
|
5561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPXM2 |
0.205568160840212 |
|
5562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCHY1 |
0.205586512627724 |
|
5563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP6 |
0.205586512627724 |
|
5564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf26 |
0.205586512627724 |
|
5565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEBPB |
0.20566865463677 |
|
5566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSTR1 |
0.205742213849731 |
|
5567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDO2 |
0.205746140009242 |
|
5568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKL2 |
0.205811017962735 |
|
5569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL13 |
0.205953364521533 |
|
5570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL4 |
0.205953364521533 |
|
5571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK1 |
0.205987932969756 |
|
5572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT6P3 |
0.206021145120532 |
|
5573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS4L1 |
0.206021145120532 |
|
5574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS4L2 |
0.206021145120532 |
|
5575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA15|ENSG00000207062.1 |
0.206021145120532 |
|
5576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA22|ENSG00000207344.1 |
0.206021145120532 |
|
5577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000200130.1 |
0.206021145120532 |
|
5578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000252102.1 |
0.206021145120532 |
|
5579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF92 |
0.206021145120532 |
|
5580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1F |
0.206056908535847 |
|
5581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAN |
0.206067854238842 |
|
5582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSF2BP |
0.206093316557334 |
|
5583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAIAP2L2 |
0.206131778701772 |
|
5584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G6 |
0.206131778701772 |
|
5585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATAD5 |
0.206229595668419 |
|
5586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX5 |
0.206334754132888 |
|
5587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN5A |
0.206341367049934 |
|
5588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TADA3 |
0.206341634544316 |
|
5589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPC4 |
0.206341634544316 |
|
5590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA2 |
0.20635753848721 |
|
5591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP1 |
0.206364083975477 |
|
5592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A7L2 |
0.206503601444347 |
|
5593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A7 |
0.206503601444347 |
|
5594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf73 |
0.206600064579937 |
|
5595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL225P |
0.206600064579937 |
|
5596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC6 |
0.206709344866918 |
|
5597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF273 |
0.206720332331913 |
|
5598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA9 |
0.206736990424331 |
|
5599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA12 |
0.206736990424331 |
|
5600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA4 |
0.206736990424331 |
|
5601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA5 |
0.206736990424331 |
|
5602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA3 |
0.206736990424331 |
|
5603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB6 |
0.206830257542575 |
|
5604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFATC2 |
0.206866059424366 |
|
5605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF2 |
0.206890686734725 |
|
5606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIRE |
0.207053150066942 |
|
5607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD62 |
0.207182184692954 |
|
5608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK1 |
0.207211032213904 |
|
5609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAGN1 |
0.20722436399172 |
|
5610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17RE |
0.20722436399172 |
|
5611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17RC |
0.20722436399172 |
|
5612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRELD1 |
0.20722436399172 |
|
5613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHIPL2 |
0.207261976922503 |
|
5614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF675 |
0.207479873509165 |
|
5615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DACT1 |
0.207541383183414 |
|
5616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR2F1 |
0.207560946683935 |
|
5617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP201 |
0.207576842917859 |
|
5618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4755 |
0.207711294185513 |
|
5619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCR |
0.20772482183348 |
|
5620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CES5AP1 |
0.20772482183348 |
|
5621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGTLC2 |
0.20772482183348 |
|
5622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAZ |
0.20772482183348 |
|
5623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLC1 |
0.20772482183348 |
|
5624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLC2 |
0.20772482183348 |
|
5625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLC3 |
0.20772482183348 |
|
5626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLC7 |
0.20772482183348 |
|
5627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLJ1 |
0.20772482183348 |
|
5628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLJ2 |
0.20772482183348 |
|
5629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLJ3 |
0.20772482183348 |
|
5630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLJ4 |
0.20772482183348 |
|
5631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLJ5 |
0.20772482183348 |
|
5632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLJ6 |
0.20772482183348 |
|
5633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLJ7 |
0.20772482183348 |
|
5634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGLL5 |
0.20772482183348 |
|
5635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR650 |
0.20772482183348 |
|
5636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POM121L1P |
0.20772482183348 |
|
5637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF24P |
0.20772482183348 |
|
5638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAME |
0.20772482183348 |
|
5639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB36 |
0.20772482183348 |
|
5640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL263P |
0.20772482183348 |
|
5641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTDR1 |
0.20772482183348 |
|
5642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOP3B |
0.20772482183348 |
|
5643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPREB1 |
0.20772482183348 |
|
5644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC8P1 |
0.20772482183348 |
|
5645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF280A |
0.20772482183348 |
|
5646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF280B |
0.20772482183348 |
|
5647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239066.1 |
0.20772482183348 |
|
5648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNLY |
0.207800317082714 |
|
5649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A21 |
0.207982352259702 |
|
5650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTN1 |
0.208059543221742 |
|
5651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU2F2 |
0.208142289300004 |
|
5652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAL |
0.208359586845669 |
|
5653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EED |
0.208505357565104 |
|
5654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC88B |
0.208514268044645 |
|
5655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KA4 |
0.208514268044645 |
|
5656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1237 |
0.208514268044645 |
|
5657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF790 |
0.208585602260526 |
|
5658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS12 |
0.208690584774549 |
|
5659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA75|ENSG00000206780.1 |
0.208792704510937 |
|
5660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3L |
0.208835933206769 |
|
5661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL289P |
0.208864693922888 |
|
5662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL43P |
0.208933385101201 |
|
5663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBDS |
0.208933385101201 |
|
5664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAT1A |
0.20898536783113 |
|
5665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAMP3 |
0.209018883972655 |
|
5666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCOM1 |
0.20903473409921 |
|
5667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2M |
0.20903473409921 |
|
5668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD91A |
0.209102815780751 |
|
5669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD91B |
0.209102815780751 |
|
5670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSR1 |
0.209102815780751 |
|
5671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGSM2 |
0.209102815780751 |
|
5672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX7 |
0.209139432315113 |
|
5673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF1A |
0.209140698601984 |
|
5674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00341 |
0.209207248359789 |
|
5675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX40 |
0.209242879084954 |
|
5676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELMOD3 |
0.209281716282336 |
|
5677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUT |
0.209288348752533 |
|
5678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A7P1 |
0.209308937176291 |
|
5679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP220 |
0.209319858257861 |
|
5680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3668 |
0.209319858257861 |
|
5681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDG |
0.209362927578398 |
|
5682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNI2 |
0.20939210373624 |
|
5683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT8 |
0.20939210373624 |
|
5684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOWAHA |
0.20939210373624 |
|
5685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDSS1 |
0.209433972523832 |
|
5686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABI1 |
0.209433972523832 |
|
5687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA57|ENSG00000223027.1 |
0.209433972523832 |
|
5688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238414.1 |
0.209433972523832 |
|
5689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2V1 |
0.209459317317924 |
|
5690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP4R4 |
0.209462150170635 |
|
5691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2277 |
0.209515971459237 |
|
5692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL8 |
0.2095371751584 |
|
5693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC10 |
0.209553431516805 |
|
5694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BDKRB1 |
0.209627043234365 |
|
5695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP434O1614 |
0.209627043234365 |
|
5696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG2B |
0.209627043234365 |
|
5697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USO1 |
0.209665637728919 |
|
5698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TINCR |
0.209726358244833 |
|
5699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL16 |
0.209770949643984 |
|
5700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM114A2 |
0.209846354485621 |
|
5701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERINC5 |
0.209897752812272 |
|
5702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRNP27 |
0.209901002351265 |
|
5703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MXD1 |
0.209901002351265 |
|
5704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238465.1 |
0.209901002351265 |
|
5705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC9 |
0.209953552007556 |
|
5706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT12 |
0.209953552007556 |
|
5707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSBP2 |
0.209953552007556 |
|
5708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPM3 |
0.210054102139436 |
|
5709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL431P |
0.210054102139436 |
|
5710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR190B |
0.210054102139436 |
|
5711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf189 |
0.210054102139436 |
|
5712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf43 |
0.210054102139436 |
|
5713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBAP2L |
0.210054102139436 |
|
5714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHROOM1 |
0.210071053952185 |
|
5715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF26A |
0.21007440861962 |
|
5716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR599 |
0.210086773917005 |
|
5717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR875 |
0.210086773917005 |
|
5718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00111 |
0.210183713051557 |
|
5719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4303 |
0.210247656675075 |
|
5720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF7L2 |
0.210317519285102 |
|
5721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESRRA |
0.210342159043231 |
|
5722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDX5 |
0.210342159043231 |
|
5723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT112 |
0.210342159043231 |
|
5724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEH1L |
0.210448027826313 |
|
5725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4748 |
0.210448955105564 |
|
5726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH14 |
0.210486790534853 |
|
5727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00868 |
0.210502104833461 |
|
5728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAAA |
0.210539911357099 |
|
5729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDAD1 |
0.210539911357099 |
|
5730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP28 |
0.210598794907241 |
|
5731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00668 |
0.210598794907241 |
|
5732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf24 |
0.210608957442762 |
|
5733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC13A2 |
0.210639704158479 |
|
5734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A12 |
0.210717307954254 |
|
5735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A8 |
0.210717307954254 |
|
5736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A9 |
0.210717307954254 |
|
5737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A7A |
0.210717307954254 |
|
5738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf67 |
0.210742402645665 |
|
5739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD1 |
0.210742402645665 |
|
5740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF736 |
0.210812624817748 |
|
5741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCA4 |
0.210969211400852 |
|
5742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPAM |
0.211003436098744 |
|
5743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL179P |
0.211050251307965 |
|
5744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN7L3B |
0.211070047633233 |
|
5745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASIP |
0.21110278958514 |
|
5746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKBIP |
0.211298479109204 |
|
5747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS1 |
0.211339934593721 |
|
5748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAFK |
0.211339934593721 |
|
5749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM184A |
0.211339934593721 |
|
5750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL492P |
0.211504492019341 |
|
5751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL357P |
0.211504492019341 |
|
5752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK2 |
0.211504492019341 |
|
5753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOP1MT |
0.211539727753127 |
|
5754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHPN1 |
0.211539727753127 |
|
5755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PANX1 |
0.211599530070835 |
|
5756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR4 |
0.21161888674062 |
|
5757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC43A2 |
0.211635747325171 |
|
5758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238946.1 |
0.211635747325171 |
|
5759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE7B |
0.211663650496096 |
|
5760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX5BP2 |
0.211663650496096 |
|
5761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MNT |
0.211679061776144 |
|
5762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR78 |
0.21175015783823 |
|
5763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPZ |
0.21175015783823 |
|
5764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG7 |
0.211778220973447 |
|
5765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDYN |
0.2118268950465 |
|
5766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
L3MBTL3 |
0.211877281035153 |
|
5767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD3 |
0.211877281035153 |
|
5768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM200A |
0.211877281035153 |
|
5769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR199A1 |
0.211975525218623 |
|
5770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00327 |
0.211995665036004 |
|
5771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHLDB3 |
0.212012255375412 |
|
5772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF443 |
0.212052819629215 |
|
5773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF799 |
0.212052819629215 |
|
5774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSP90B1 |
0.212061359356452 |
|
5775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf73 |
0.212061359356452 |
|
5776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AEBP2 |
0.212069717768463 |
|
5777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A4 |
0.21207568759861 |
|
5778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNB1 |
0.212084587223685 |
|
5779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTC |
0.212113007654772 |
|
5780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMYD4 |
0.212116622600343 |
|
5781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPA1 |
0.212116622600343 |
|
5782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED1 |
0.212188057044641 |
|
5783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPS2 |
0.212437267779026 |
|
5784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALK2 |
0.212437267779026 |
|
5785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4716 |
0.212437267779026 |
|
5786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDELR3 |
0.212507989881618 |
|
5787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASAL2 |
0.212532884808781 |
|
5788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ4 |
0.212675977827736 |
|
5789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM155A |
0.212804461026627 |
|
5790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf44 |
0.212819378103141 |
|
5791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPTXR |
0.21286118146073 |
|
5792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX6 |
0.21286118146073 |
|
5793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX2 |
0.212977562133223 |
|
5794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00630 |
0.213129105921672 |
|
5795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00636 |
0.21316034118832 |
|
5796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDN2 |
0.213198994347128 |
|
5797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf62 |
0.213701259057765 |
|
5798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TINAG |
0.213712617311968 |
|
5799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZD2 |
0.213725716988189 |
|
5800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC23A |
0.2137875366264 |
|
5801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YY1AP1 |
0.213797545651082 |
|
5802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAP3 |
0.213797545651082 |
|
5803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAO1 |
0.21383842347145 |
|
5804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMNL3 |
0.213905095916691 |
|
5805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMBIM6 |
0.213905095916691 |
|
5806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E2F7 |
0.213924583666532 |
|
5807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEDD2 |
0.213944954044762 |
|
5808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRED2 |
0.21397703316039 |
|
5809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL113P |
0.213982894503827 |
|
5810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALSL |
0.214126623572346 |
|
5811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QSOX1 |
0.214162815991988 |
|
5812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf79 |
0.214234515843705 |
|
5813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTG1 |
0.214234515843705 |
|
5814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC7A |
0.214303801112344 |
|
5815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42BPG |
0.214350043127087 |
|
5816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP5B1 |
0.214350043127087 |
|
5817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL2 |
0.214350043127087 |
|
5818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG2A |
0.214350043127087 |
|
5819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BATF2 |
0.214350043127087 |
|
5820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf85 |
0.214350043127087 |
|
5821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN1 |
0.214350043127087 |
|
5822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC85B |
0.214350043127087 |
|
5823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42EP2 |
0.214350043127087 |
|
5824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCA5 |
0.214350043127087 |
|
5825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFL1 |
0.214350043127087 |
|
5826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSW |
0.214350043127087 |
|
5827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPF2 |
0.214350043127087 |
|
5828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFEMP2 |
0.214350043127087 |
|
5829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHBP1L1 |
0.214350043127087 |
|
5830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHD1 |
0.214350043127087 |
|
5831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM89B |
0.214350043127087 |
|
5832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAU |
0.214350043127087 |
|
5833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIBP |
0.214350043127087 |
|
5834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOSL1 |
0.214350043127087 |
|
5835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMD8 |
0.214350043127087 |
|
5836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPHA2 |
0.214350043127087 |
|
5837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAT5 |
0.214350043127087 |
|
5838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK7 |
0.214350043127087 |
|
5839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTBP3 |
0.214350043127087 |
|
5840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MALAT1 |
0.214350043127087 |
|
5841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K11 |
0.214350043127087 |
|
5842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR192 |
0.214350043127087 |
|
5843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4489 |
0.214350043127087 |
|
5844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4690 |
0.214350043127087 |
|
5845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL49 |
0.214350043127087 |
|
5846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUS81 |
0.214350043127087 |
|
5847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAALADL1 |
0.214350043127087 |
|
5848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEAT1 |
0.214350043127087 |
|
5849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OVOL1 |
0.214350043127087 |
|
5850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCNXL3 |
0.214350043127087 |
|
5851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLA2 |
0.214350043127087 |
|
5852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R5B |
0.214350043127087 |
|
5853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RELA |
0.214350043127087 |
|
5854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL114P |
0.214350043127087 |
|
5855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL309P |
0.214350043127087 |
|
5856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASEH2C |
0.214350043127087 |
|
5857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAC3D1 |
0.214350043127087 |
|
5858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCYL1 |
0.214350043127087 |
|
5859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIPA1 |
0.214350043127087 |
|
5860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A20 |
0.214350043127087 |
|
5861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A45 |
0.214350043127087 |
|
5862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX15 |
0.214350043127087 |
|
5863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX32 |
0.214350043127087 |
|
5864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDYC |
0.214350043127087 |
|
5865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSSCA1 |
0.214350043127087 |
|
5866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYVN1 |
0.214350043127087 |
|
5867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIGD3 |
0.214350043127087 |
|
5868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM7SF2 |
0.214350043127087 |
|
5869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS51 |
0.214350043127087 |
|
5870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFPL1 |
0.214350043127087 |
|
5871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNHIT2 |
0.214350043127087 |
|
5872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFHX3 |
0.214364438826296 |
|
5873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPPE1 |
0.214450769303057 |
|
5874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMLR1 |
0.214489141969415 |
|
5875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1294 |
0.214552155945602 |
|
5876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL655P |
0.214552155945602 |
|
5877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMOD4 |
0.214556143964298 |
|
5878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS72 |
0.214556143964298 |
|
5879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIP5K1A |
0.214556143964298 |
|
5880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSTO1 |
0.214575918018011 |
|
5881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNCX |
0.214613600369311 |
|
5882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF780B |
0.214816640803402 |
|
5883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF780A |
0.214816640803402 |
|
5884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICALL2 |
0.214895700177935 |
|
5885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVI5L |
0.214915307135587 |
|
5886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKMT2 |
0.214937089781207 |
|
5887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPH2 |
0.214943151053474 |
|
5888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMP3 |
0.214980928950697 |
|
5889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHLA2 |
0.215019729215617 |
|
5890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OFCC1 |
0.215049267709343 |
|
5891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS7 |
0.215138589111405 |
|
5892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA73|ENSG00000252531.1 |
0.215138589111405 |
|
5893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXXC4 |
0.215195520144924 |
|
5894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000201809.1 |
0.215298315611563 |
|
5895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF21 |
0.215408725725537 |
|
5896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOLLIP |
0.215409850367741 |
|
5897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRSK2 |
0.215409850367741 |
|
5898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBS |
0.21546300442948 |
|
5899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLTM |
0.215518811038939 |
|
5900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUPT3H |
0.215581902690135 |
|
5901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMG3 |
0.215610424798864 |
|
5902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DICER1 |
0.215657785402606 |
|
5903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTHFD2L |
0.215709721000263 |
|
5904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EML5 |
0.215722872508953 |
|
5905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC8 |
0.215722872508953 |
|
5906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDO1 |
0.215762602665186 |
|
5907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RETSAT |
0.216028236910393 |
|
5908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD42|ENSG00000201209.1 |
0.216094440210546 |
|
5909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA5B1 |
0.216104690751526 |
|
5910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM3A |
0.216123680044735 |
|
5911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL134P |
0.216254487928306 |
|
5912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAT2 |
0.21645277785082 |
|
5913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC81 |
0.216524880236795 |
|
5914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGR5 |
0.216643449102874 |
|
5915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM16 |
0.216682178428349 |
|
5916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf33 |
0.216713950141341 |
|
5917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEIS1 |
0.21673416777362 |
|
5918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECE1 |
0.216742983100412 |
|
5919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMCL1 |
0.216783393745638 |
|
5920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT9 |
0.216878966131035 |
|
5921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR5 |
0.216897889986602 |
|
5922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF490 |
0.216980107252596 |
|
5923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHHADH |
0.217054763269731 |
|
5924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TK2 |
0.217099417837771 |
|
5925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKLF |
0.217099417837771 |
|
5926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMTM1 |
0.217099417837771 |
|
5927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMTM2 |
0.217099417837771 |
|
5928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS6 |
0.217120748577934 |
|
5929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DALRD3 |
0.217148051141939 |
|
5930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR191 |
0.217148051141939 |
|
5931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR425 |
0.217148051141939 |
|
5932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFAF3 |
0.217148051141939 |
|
5933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPDH2 |
0.217148051141939 |
|
5934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLG1 |
0.217249725567583 |
|
5935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR9 |
0.217340473827686 |
|
5936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFKL |
0.217449623506705 |
|
5937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf2 |
0.217449623506705 |
|
5938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXN3 |
0.217468863539118 |
|
5939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPH |
0.217528495945886 |
|
5940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM106C |
0.217529255051279 |
|
5941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDB2 |
0.217560042539496 |
|
5942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSL6 |
0.217565350531424 |
|
5943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL407P |
0.21764089594442 |
|
5944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF526 |
0.217650675070174 |
|
5945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OAT |
0.217701358658251 |
|
5946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL832P |
0.217715852919404 |
|
5947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1C2 |
0.217715852919404 |
|
5948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAT3 |
0.217840054378974 |
|
5949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239086.1 |
0.217840054378974 |
|
5950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTHRC1 |
0.21790753095517 |
|
5951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A32 |
0.21790753095517 |
|
5952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF13 |
0.21790753095517 |
|
5953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOR |
0.217985109099414 |
|
5954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGLYRP3 |
0.217985109099414 |
|
5955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGLYRP4 |
0.217985109099414 |
|
5956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPPR4 |
0.21802601684427 |
|
5957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238690.1 |
0.218099639546145 |
|
5958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00908 |
0.218101928260237 |
|
5959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGAP2 |
0.218110661349117 |
|
5960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD78|ENSG00000212168.1 |
0.218247140954803 |
|
5961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC24A1 |
0.218252660907198 |
|
5962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND4A |
0.218252660907198 |
|
5963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL6R |
0.218369686480635 |
|
5964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC93B6 |
0.218414193414717 |
|
5965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCFC2 |
0.218464896372174 |
|
5966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFYB |
0.218464896372174 |
|
5967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP370 |
0.218464896372174 |
|
5968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNRD1 |
0.218464896372174 |
|
5969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL182P |
0.218496611308203 |
|
5970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPK1 |
0.218527248270281 |
|
5971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1B1P1 |
0.21869228944629 |
|
5972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFAP1 |
0.218717664727234 |
|
5973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK1E |
0.21873909522828 |
|
5974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATOH8 |
0.218798928820992 |
|
5975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYM6 |
0.218865554530432 |
|
5976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL88P |
0.218996897396027 |
|
5977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP139 |
0.21907518985203 |
|
5978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASF1B |
0.219147300502558 |
|
5979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF128 |
0.219172067995955 |
|
5980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D8B |
0.21934744648833 |
|
5981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORC4 |
0.21934744648833 |
|
5982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR644A |
0.219365737313527 |
|
5983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239072.1 |
0.219382767753993 |
|
5984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB9B |
0.219407569346012 |
|
5985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP511 |
0.219407569346012 |
|
5986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRMP1 |
0.219432094978043 |
|
5987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPS4 |
0.21943658245504 |
|
5988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MXRA7 |
0.21947126569618 |
|
5989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPG |
0.219795573432545 |
|
5990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRT3 |
0.219835758255201 |
|
5991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252771.1 |
0.219934014058414 |
|
5992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP272 |
0.219942497353189 |
|
5993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF326 |
0.219942497353189 |
|
5994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL292P |
0.21997915345464 |
|
5995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3200 |
0.219990295598662 |
|
5996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3B4 |
0.220011509885084 |
|
5997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF149 |
0.220023515834627 |
|
5998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5696 |
0.220023515834627 |
|
5999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL5 |
0.220078874891934 |
|
6000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIK3 |
0.220097598331646 |
|
6001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA4C |
0.220193547674381 |
|
6002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR2 |
0.220216245097653 |
|
6003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRG1 |
0.220364522250619 |
|
6004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOM1 |
0.220739247833662 |
|
6005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICOS |
0.220779283996192 |
|
6006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFKM |
0.220867040531497 |
|
6007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB8 |
0.220867040531497 |
|
6008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2Q1 |
0.221019265153011 |
|
6009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1217 |
0.221063599108562 |
|
6010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMPK2 |
0.221096712248115 |
|
6011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCAT |
0.22115227088119 |
|
6012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H1F0 |
0.22115227088119 |
|
6013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD54 |
0.22115227088119 |
|
6014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALR3 |
0.22115227088119 |
|
6015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR658 |
0.22115227088119 |
|
6016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR659 |
0.22115227088119 |
|
6017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YWHAH |
0.221186225609631 |
|
6018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238910.1 |
0.221186225609631 |
|
6019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM15 |
0.221222771248052 |
|
6020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTA4H |
0.2212584518811 |
|
6021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPH |
0.221471687696189 |
|
6022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAHD2A |
0.221501999854704 |
|
6023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ14082 |
0.221501999854704 |
|
6024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00342 |
0.221501999854704 |
|
6025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM43 |
0.221501999854704 |
|
6026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL307P |
0.221552769407552 |
|
6027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000199666.1 |
0.221615066028669 |
|
6028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARM1 |
0.221626763269229 |
|
6029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239146.1 |
0.221646067134581 |
|
6030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM41A |
0.221646067134581 |
|
6031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELFN1 |
0.221651071892426 |
|
6032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUK |
0.221655762348713 |
|
6033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IP6K1 |
0.221853027033913 |
|
6034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLT8D2 |
0.221909768122157 |
|
6035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EID3 |
0.221909768122157 |
|
6036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP85 |
0.221968762469065 |
|
6037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGA3 |
0.221968762469065 |
|
6038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS7 |
0.221968762469065 |
|
6039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIF4GD |
0.221968762469065 |
|
6040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A19 |
0.221968762469065 |
|
6041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFS1 |
0.221987881777307 |
|
6042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR608 |
0.222165041020821 |
|
6043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL43 |
0.222165041020821 |
|
6044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA4G |
0.222165041020821 |
|
6045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5581 |
0.222290799264927 |
|
6046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA12 |
0.222328741815535 |
|
6047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT4 |
0.222451139430778 |
|
6048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIWIL4 |
0.222451139430778 |
|
6049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMOTL1 |
0.222451139430778 |
|
6050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFAP3 |
0.222465614529115 |
|
6051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNG2 |
0.222501954425032 |
|
6052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL136P |
0.222517004587697 |
|
6053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
A3GALT2 |
0.222552207698315 |
|
6054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSK3A |
0.222566947627509 |
|
6055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERF |
0.222566947627509 |
|
6056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE3C |
0.222661419258535 |
|
6057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRR |
0.222691420640311 |
|
6058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRK |
0.22272718949616 |
|
6059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEPHL1 |
0.2228255507565 |
|
6060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF131 |
0.222903294263247 |
|
6061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TECRL |
0.222914629954885 |
|
6062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA72|ENSG00000207067.1 |
0.222990785044441 |
|
6063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf47 |
0.222990785044441 |
|
6064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRSP12 |
0.222990785044441 |
|
6065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POP1 |
0.222990785044441 |
|
6066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC10A |
0.223069912366498 |
|
6067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASGR2 |
0.223069912366498 |
|
6068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL236P |
0.22333214469326 |
|
6069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX6C |
0.223334139363372 |
|
6070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS22 |
0.223334139363372 |
|
6071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD77|ENSG00000212414.1 |
0.223334139363372 |
|
6072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1273A |
0.223334139363372 |
|
6073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238544.1 |
0.223349915201203 |
|
6074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNN3 |
0.223390196307589 |
|
6075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG14 |
0.223390196307589 |
|
6076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL454P |
0.223416519794343 |
|
6077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB6 |
0.223560478046067 |
|
6078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGL4 |
0.223587062405741 |
|
6079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPREB3 |
0.223587062405741 |
|
6080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF70 |
0.223587062405741 |
|
6081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf15 |
0.223587062405741 |
|
6082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHCHD10 |
0.223587062405741 |
|
6083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP11 |
0.223587062405741 |
|
6084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR1B |
0.223680979336197 |
|
6085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOSR1 |
0.223750848288427 |
|
6086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL480P |
0.223831379498609 |
|
6087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANP32E |
0.223831379498609 |
|
6088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPD4 |
0.22399634512731 |
|
6089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRTC2 |
0.22399634512731 |
|
6090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL626P |
0.223998033399406 |
|
6091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL192P |
0.224099994864377 |
|
6092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CC2D1A |
0.224111617679459 |
|
6093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PODNL1 |
0.224111617679459 |
|
6094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SENP1 |
0.224147791846026 |
|
6095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3194 |
0.224206175461388 |
|
6096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF9 |
0.224262758238235 |
|
6097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR6 |
0.224468127151767 |
|
6098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF1B |
0.224577032138433 |
|
6099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00898 |
0.224629258956964 |
|
6100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUAK1 |
0.224706539695351 |
|
6101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZHX1 |
0.22476254527546 |
|
6102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238422.1 |
0.22476254527546 |
|
6103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEZ6 |
0.22492520947555 |
|
6104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SENP2 |
0.225023722599993 |
|
6105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTFR2 |
0.225080136395384 |
|
6106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKSG62 |
0.225173593187128 |
|
6107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00517 |
0.225197073229762 |
|
6108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO32 |
0.225245908013868 |
|
6109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL459P |
0.225273810945616 |
|
6110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOXL4 |
0.225285390308508 |
|
6111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCDC2C |
0.225379623279351 |
|
6112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT4 |
0.22539197316552 |
|
6113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL635P |
0.225488442633319 |
|
6114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
Vault|ENSG00000251900.1 |
0.225488442633319 |
|
6115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR98 |
0.225708752672803 |
|
6116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR5 |
0.22589782880209 |
|
6117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT11 |
0.225915374011927 |
|
6118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRRM5 |
0.225943785728925 |
|
6119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF576 |
0.225943785728925 |
|
6120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABLIM2 |
0.225971157731711 |
|
6121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4295 |
0.226001236700088 |
|
6122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDYHV1 |
0.226007762307655 |
|
6123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4G3 |
0.226056739904378 |
|
6124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALT5 |
0.22608290178827 |
|
6125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL4A |
0.226106262422981 |
|
6126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA64|ENSG00000199470.1 |
0.226106262422981 |
|
6127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENDOU |
0.22614763577181 |
|
6128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB110 |
0.226212835736811 |
|
6129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MINOS1 |
0.22632443478421 |
|
6130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBL1 |
0.22632443478421 |
|
6131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR6 |
0.22632443478421 |
|
6132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCKAP5L |
0.226327101301353 |
|
6133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf65 |
0.226467976558301 |
|
6134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH11 |
0.226471761937172 |
|
6135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238722.1 |
0.226489411140533 |
|
6136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf56 |
0.22651741018696 |
|
6137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH13 |
0.226521661064659 |
|
6138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGKC |
0.226531605667542 |
|
6139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGKJ1 |
0.226531605667542 |
|
6140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGKJ2 |
0.226531605667542 |
|
6141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGKJ3 |
0.226531605667542 |
|
6142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGKJ4 |
0.226531605667542 |
|
6143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGKJ5 |
0.226531605667542 |
|
6144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP100 |
0.226531605667542 |
|
6145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9B1P2 |
0.226531605667542 |
|
6146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK2N1 |
0.226623789070934 |
|
6147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUL1 |
0.226623789070934 |
|
6148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM43B |
0.226623789070934 |
|
6149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000252236.1 |
0.226762473205319 |
|
6150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A44 |
0.226762473205319 |
|
6151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMF1 |
0.226762473205319 |
|
6152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOL6 |
0.226782282215391 |
|
6153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MB |
0.226782282215391 |
|
6154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR26 |
0.226784636457533 |
|
6155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PELI1 |
0.226794586552524 |
|
6156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICALL1 |
0.226856193813708 |
|
6157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYSMD1 |
0.226860462736389 |
|
6158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCNM1 |
0.226860462736389 |
|
6159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFAIP8L2 |
0.226860462736389 |
|
6160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR135A2 |
0.226872623977116 |
|
6161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHPP |
0.226898328249107 |
|
6162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMTC2 |
0.226922009672958 |
|
6163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX17 |
0.22692342870838 |
|
6164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9B1 |
0.227097807013677 |
|
6165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG1 |
0.227122273857344 |
|
6166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF19A |
0.227122273857344 |
|
6167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4471 |
0.227122273857344 |
|
6168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL632P |
0.227155335821738 |
|
6169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H1FNT |
0.227227567085951 |
|
6170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAPT1 |
0.22730749508996 |
|
6171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZEB2P1 |
0.22730749508996 |
|
6172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC96 |
0.227389168944942 |
|
6173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TADA2B |
0.227389168944942 |
|
6174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRPEL1 |
0.227389168944942 |
|
6175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP2 |
0.227397669980777 |
|
6176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACKR2 |
0.227398354912253 |
|
6177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
7SK|ENSG00000260682.2 |
0.227440808822415 |
|
6178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDR42E1 |
0.227440808822415 |
|
6179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B2 |
0.227440808822415 |
|
6180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPHOSPH6 |
0.227440808822415 |
|
6181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238569.1 |
0.227621887023792 |
|
6182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM126B |
0.227685626984732 |
|
6183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAP30BP |
0.22769201371045 |
|
6184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AREGB |
0.227781927534256 |
|
6185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARF1 |
0.227790417978009 |
|
6186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RILP |
0.227790417978009 |
|
6187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF8 |
0.227790417978009 |
|
6188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIF1AN |
0.227804550563943 |
|
6189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKTR |
0.228016934516174 |
|
6190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR68 |
0.22802283554447 |
|
6191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5091 |
0.228045001178703 |
|
6192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIA3 |
0.228120128970204 |
|
6193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIDA |
0.228120128970204 |
|
6194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCLAF1 |
0.22815420407723 |
|
6195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGCZ |
0.228229630452848 |
|
6196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM62 |
0.228272092462628 |
|
6197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC8D |
0.228339512270964 |
|
6198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADI1 |
0.228378834746177 |
|
6199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASEH1 |
0.228378834746177 |
|
6200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAFB2 |
0.228421866056207 |
|
6201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP228 |
0.228540782667469 |
|
6202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SECISBP2L |
0.228625472167966 |
|
6203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RECQL5 |
0.228651196704691 |
|
6204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D14 |
0.228735528698968 |
|
6205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP292 |
0.228735528698968 |
|
6206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTLA4 |
0.228826007819566 |
|
6207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGF2BP2 |
0.228854391487298 |
|
6208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP155 |
0.228936798342644 |
|
6209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMURF2P1 |
0.22895566193611 |
|
6210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPD52L1 |
0.229028447606228 |
|
6211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP104 |
0.229147885525681 |
|
6212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL223P |
0.229559793180458 |
|
6213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELK3 |
0.229603855519188 |
|
6214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251824.1 |
0.229738300487806 |
|
6215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAKMIP1 |
0.229858797634863 |
|
6216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
7SK|ENSG00000271765.1 |
0.229866942228695 |
|
6217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K5 |
0.229866942228695 |
|
6218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA27|ENSG00000201807.1 |
0.229866942228695 |
|
6219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239054.1 |
0.22991144559286 |
|
6220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEUTX |
0.22994584468146 |
|
6221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TALDO1 |
0.230070250322965 |
|
6222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDDC1 |
0.230070250322965 |
|
6223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNQ4 |
0.230153319352785 |
|
6224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALOX12P2 |
0.230163502955386 |
|
6225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALOX12 |
0.230163502955386 |
|
6226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf49 |
0.230163502955386 |
|
6227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR497HG |
0.230163502955386 |
|
6228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASEK |
0.230163502955386 |
|
6229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL6B |
0.230163502955386 |
|
6230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A11 |
0.230163502955386 |
|
6231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A13 |
0.230163502955386 |
|
6232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP92 |
0.2301751474362 |
|
6233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEGAIN |
0.2301751474362 |
|
6234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP278 |
0.230342348799642 |
|
6235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COLEC11 |
0.23035029996588 |
|
6236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL577P |
0.230357924840138 |
|
6237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP290 |
0.230364472394488 |
|
6238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAZALD1 |
0.230421836937915 |
|
6239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLX1NB |
0.230421836937915 |
|
6240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBL |
0.230448152563682 |
|
6241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM198A |
0.230457109371713 |
|
6242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNF1 |
0.230497474330339 |
|
6243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD28 |
0.230542161405791 |
|
6244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX7 |
0.230585087096297 |
|
6245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGCLL1 |
0.230590649687555 |
|
6246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPD3 |
0.230612867406917 |
|
6247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPS1 |
0.230621765295582 |
|
6248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT3 |
0.230641642001159 |
|
6249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LELP1 |
0.230650449831945 |
|
6250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEND1 |
0.230685314078032 |
|
6251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A22 |
0.230685314078032 |
|
6252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIDD |
0.230685314078032 |
|
6253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPLP2 |
0.230685314078032 |
|
6254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA52 |
0.230685314078032 |
|
6255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC16B |
0.230724076086481 |
|
6256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP6 |
0.230738399125028 |
|
6257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL38 |
0.230832732911635 |
|
6258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABI2 |
0.230919744934415 |
|
6259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPH1 |
0.230919744934415 |
|
6260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4433 |
0.230926033178968 |
|
6261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSKIP |
0.230931315502234 |
|
6262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICA1L |
0.231011698261469 |
|
6263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP8L |
0.231083809917217 |
|
6264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYRK1B |
0.231098269046792 |
|
6265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD247 |
0.231133898148169 |
|
6266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR20 |
0.231142729398285 |
|
6267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00309 |
0.231259158691164 |
|
6268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AK7 |
0.231381294657034 |
|
6269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD3 |
0.231432345955905 |
|
6270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR7 |
0.231504116360534 |
|
6271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf68 |
0.231568687744796 |
|
6272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPRP |
0.231568687744796 |
|
6273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CITED4 |
0.231696892044292 |
|
6274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HUG1 |
0.23172345142907 |
|
6275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLX1 |
0.23172345142907 |
|
6276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000206661.1 |
0.231726067187146 |
|
6277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL318P |
0.231726067187146 |
|
6278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF23 |
0.23177950999323 |
|
6279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBN1 |
0.23178225216644 |
|
6280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGCX |
0.231835085204375 |
|
6281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAMP8 |
0.231835085204375 |
|
6282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRA2B |
0.231872435893322 |
|
6283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKNOX1 |
0.231889691286437 |
|
6284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB112 |
0.231901791132615 |
|
6285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GXYLT1 |
0.231993159576238 |
|
6286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3121 |
0.232006850895648 |
|
6287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC5D |
0.232018186364853 |
|
6288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf50 |
0.232037759903617 |
|
6289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf29 |
0.232037759903617 |
|
6290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP364 |
0.232037759903617 |
|
6291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL637P |
0.232111668385126 |
|
6292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB7B |
0.232160802160458 |
|
6293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED17 |
0.232234861449367 |
|
6294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL195P |
0.232234861449367 |
|
6295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238437.1 |
0.232234861449367 |
|
6296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSTM5 |
0.232234861449367 |
|
6297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC5AC |
0.232241361310422 |
|
6298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP111 |
0.232258199521767 |
|
6299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPC6 |
0.23227240268782 |
|
6300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC44A3 |
0.232454996479648 |
|
6301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378G |
0.232456621208956 |
|
6302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBTD1 |
0.23247461590919 |
|
6303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPA2 |
0.232504276112106 |
|
6304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB21 |
0.23255630319714 |
|
6305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC28P |
0.232577638943092 |
|
6306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMST |
0.232579085742907 |
|
6307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP435 |
0.232729222936329 |
|
6308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TACC1 |
0.232759811335662 |
|
6309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR1E |
0.232771015938278 |
|
6310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL305P |
0.232786015353578 |
|
6311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCST2 |
0.232980332646418 |
|
6312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCST1 |
0.232980332646418 |
|
6313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM15 |
0.232980332646418 |
|
6314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFNA4 |
0.232980332646418 |
|
6315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC37A1 |
0.233040625001169 |
|
6316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC5B |
0.233054883382395 |
|
6317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2IRD1P1 |
0.233137689565579 |
|
6318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM13B |
0.233151248247663 |
|
6319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEN1 |
0.233179213377561 |
|
6320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA13 |
0.233275358083246 |
|
6321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238687.1 |
0.233281025188935 |
|
6322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAK1 |
0.233329289400323 |
|
6323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4778 |
0.233362797045519 |
|
6324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADC |
0.233373851210135 |
|
6325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARIH2 |
0.233395714441263 |
|
6326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf5 |
0.233429655589176 |
|
6327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALR3 |
0.233434047481957 |
|
6328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRA2B |
0.233746685367199 |
|
6329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASTL |
0.233746685367199 |
|
6330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP2 |
0.233746685367199 |
|
6331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD7 |
0.233746685367199 |
|
6332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4657 |
0.233796173444982 |
|
6333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO1G |
0.233796173444982 |
|
6334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG15 |
0.233796173444982 |
|
6335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUN2 |
0.233973105213746 |
|
6336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HUS1 |
0.233984299053816 |
|
6337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR2A |
0.234063364729909 |
|
6338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR2E |
0.234063364729909 |
|
6339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR2F |
0.234063364729909 |
|
6340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBEAL1 |
0.234178376843928 |
|
6341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA1|ENSG00000202059.1 |
0.234178376843928 |
|
6342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM17 |
0.234216478390819 |
|
6343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNDC5 |
0.234315647497347 |
|
6344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLDIP3 |
0.23435445458682 |
|
6345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf4 |
0.234395800472442 |
|
6346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPT2 |
0.23440073283243 |
|
6347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HULC |
0.234423803607341 |
|
6348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2A2 |
0.234455988016924 |
|
6349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BNIP2 |
0.234455988016924 |
|
6350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TET2 |
0.234494507394773 |
|
6351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD22 |
0.23449508462231 |
|
6352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBY1 |
0.23453990205844 |
|
6353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM22 |
0.23453990205844 |
|
6354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JOSD1 |
0.23453990205844 |
|
6355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTPBP1 |
0.23453990205844 |
|
6356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF38B |
0.234551877711318 |
|
6357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD8 |
0.234583197726666 |
|
6358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC83 |
0.234604906871779 |
|
6359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL142P |
0.234634439524134 |
|
6360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM20 |
0.234711041017791 |
|
6361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA2|ENSG00000206647.1 |
0.234871819679693 |
|
6362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR2D |
0.23487877210755 |
|
6363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf65 |
0.234978260994431 |
|
6364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL177P |
0.234999236955455 |
|
6365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MATN2 |
0.235072546530954 |
|
6366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL30 |
0.235072546530954 |
|
6367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHC4 |
0.235092545781042 |
|
6368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EID1 |
0.235092545781042 |
|
6369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP219 |
0.235148073364017 |
|
6370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf2 |
0.235155191702289 |
|
6371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LZTS2 |
0.235155191702289 |
|
6372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZD7 |
0.235155191702289 |
|
6373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFXN3 |
0.235155191702289 |
|
6374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL374P |
0.235189015752277 |
|
6375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR12 |
0.235225516399101 |
|
6376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARF |
0.235225516399101 |
|
6377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGBP |
0.235235718226724 |
|
6378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC89 |
0.235250806460847 |
|
6379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSRP2 |
0.235314068284568 |
|
6380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA13 |
0.235332253138814 |
|
6381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR648 |
0.235360882452255 |
|
6382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFTPB |
0.235408366877216 |
|
6383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAND1 |
0.235497353156899 |
|
6384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RWDD3 |
0.235550156403378 |
|
6385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA73|ENSG00000252054.1 |
0.235724446081701 |
|
6386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARFIP1 |
0.235786062014037 |
|
6387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL341P |
0.235792538636763 |
|
6388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC17 |
0.235799704096979 |
|
6389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PF4 |
0.235852107485797 |
|
6390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPBP |
0.235852107485797 |
|
6391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL5 |
0.235852107485797 |
|
6392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALM1 |
0.235936259548591 |
|
6393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00642 |
0.235936259548591 |
|
6394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf45 |
0.235956453876923 |
|
6395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH1L2 |
0.235956453876923 |
|
6396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPW |
0.23598777508848 |
|
6397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC152 |
0.236024105888329 |
|
6398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREG2 |
0.236042532028533 |
|
6399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFX8 |
0.236042532028533 |
|
6400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAM |
0.236068587977405 |
|
6401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPARGC1B |
0.236083428862222 |
|
6402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00083 |
0.23614470684593 |
|
6403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCK |
0.236149470135689 |
|
6404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF69 |
0.236254247720685 |
|
6405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD9 |
0.236275993161833 |
|
6406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL127P |
0.236288839347705 |
|
6407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00525 |
0.236289811578287 |
|
6408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSACC |
0.236337858374596 |
|
6409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBG |
0.236337858374596 |
|
6410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYN3 |
0.236338978253363 |
|
6411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF700 |
0.236389541335309 |
|
6412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF763 |
0.236389541335309 |
|
6413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP464 |
0.236389541335309 |
|
6414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A2 |
0.236394820336042 |
|
6415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LBX1 |
0.236414331898156 |
|
6416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POC1B |
0.236449586395698 |
|
6417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT4 |
0.236449586395698 |
|
6418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00593 |
0.236511491543984 |
|
6419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4798 |
0.236512446087023 |
|
6420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOPX |
0.236532660936792 |
|
6421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEF |
0.23654394649718 |
|
6422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOB2 |
0.23654394649718 |
|
6423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIVA1 |
0.236571293790954 |
|
6424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKT1 |
0.236571293790954 |
|
6425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB42 |
0.236571293790954 |
|
6426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6 |
0.236627864972221 |
|
6427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM49C |
0.236761740576796 |
|
6428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM49D1 |
0.236761740576796 |
|
6429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM49 |
0.236761740576796 |
|
6430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM64B |
0.236761740576796 |
|
6431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM77 |
0.236761740576796 |
|
6432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCDIN3D |
0.236786012649668 |
|
6433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLPX |
0.236829073716288 |
|
6434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CILP |
0.236829073716288 |
|
6435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2S2 |
0.236837631604254 |
|
6436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf26 |
0.236845717650901 |
|
6437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1033 |
0.236902576677192 |
|
6438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP106 |
0.236961015718269 |
|
6439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODC1 |
0.236986242969868 |
|
6440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA80B |
0.236986242969868 |
|
6441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL10 |
0.236986242969868 |
|
6442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL218P |
0.237096110015988 |
|
6443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL3 |
0.237096110015988 |
|
6444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD177 |
0.237100257204649 |
|
6445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAMP10 |
0.237100257204649 |
|
6446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG10P |
0.237100257204649 |
|
6447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG11 |
0.237100257204649 |
|
6448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG1 |
0.237100257204649 |
|
6449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG2 |
0.237100257204649 |
|
6450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG3 |
0.237100257204649 |
|
6451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG4 |
0.237100257204649 |
|
6452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG5 |
0.237100257204649 |
|
6453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG6 |
0.237100257204649 |
|
6454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG7 |
0.237100257204649 |
|
6455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG8 |
0.237100257204649 |
|
6456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSG9 |
0.237100257204649 |
|
6457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX101 |
0.237100257204649 |
|
6458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AREG |
0.237140165354206 |
|
6459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53INP2 |
0.237147715081809 |
|
6460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00638 |
0.237218510542409 |
|
6461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP170B |
0.237218510542409 |
|
6462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARP1 |
0.237222164574739 |
|
6463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HINT3 |
0.237287823252211 |
|
6464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP216 |
0.237287823252211 |
|
6465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF433 |
0.237309620984607 |
|
6466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP465 |
0.237309620984607 |
|
6467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOLH1B |
0.237575945956477 |
|
6468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2F |
0.237706798035533 |
|
6469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX10 |
0.237706798035533 |
|
6470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4534 |
0.237706798035533 |
|
6471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALK1 |
0.237762277844943 |
|
6472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM56 |
0.237771181690264 |
|
6473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERS2 |
0.237788921749861 |
|
6474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA9 |
0.237788921749861 |
|
6475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM63A |
0.237788921749861 |
|
6476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRUNE |
0.237788921749861 |
|
6477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAP1 |
0.23779218758626 |
|
6478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL6 |
0.237822447257508 |
|
6479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PF4V1 |
0.237822447257508 |
|
6480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL1 |
0.237822447257508 |
|
6481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPS15P1 |
0.23786851758199 |
|
6482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF2 |
0.237892916830904 |
|
6483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTDH |
0.237906015620741 |
|
6484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP142 |
0.237943981205513 |
|
6485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL231P |
0.237973868765075 |
|
6486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIG1 |
0.238004257015394 |
|
6487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMAS |
0.23803780657859 |
|
6488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRPA |
0.238121745780677 |
|
6489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC8C |
0.238123545599078 |
|
6490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIPF2 |
0.238136118408856 |
|
6491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf52 |
0.238136118408856 |
|
6492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC3P |
0.238227935376084 |
|
6493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPAP3 |
0.238264426773892 |
|
6494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LLGL2 |
0.238269621082217 |
|
6495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALR2 |
0.23830583789583 |
|
6496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZACN |
0.23830583789583 |
|
6497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VIPR1 |
0.238307243107776 |
|
6498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFAP2A |
0.238329746149532 |
|
6499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00518 |
0.238329746149532 |
|
6500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5689 |
0.238329746149532 |
|
6501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSK |
0.238365046479694 |
|
6502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARNT |
0.238365046479694 |
|
6503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00909 |
0.238392574667368 |
|
6504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOGA3 |
0.238403254921453 |
|
6505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0408 |
0.238403254921453 |
|
6506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCND2 |
0.238431213456928 |
|
6507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000212145.2 |
0.238457641696442 |
|
6508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP360 |
0.23847277235316 |
|
6509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD50|ENSG00000199857.1 |
0.238486921802957 |
|
6510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPS15L1 |
0.238597081396114 |
|
6511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL844P |
0.238597081396114 |
|
6512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR30A |
0.238626342104811 |
|
6513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR137HG |
0.238675885715084 |
|
6514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP366 |
0.238776706670429 |
|
6515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WT1 |
0.23878325799773 |
|
6516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW4 |
0.238805402706649 |
|
6517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF144A |
0.23881124854228 |
|
6518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNIP1 |
0.23882761417512 |
|
6519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNALI1 |
0.23882761417512 |
|
6520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNL2 |
0.23882761417512 |
|
6521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPO1 |
0.23882761417512 |
|
6522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX35 |
0.238918024190346 |
|
6523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1ORF220 |
0.238918024190346 |
|
6524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf220 |
0.238918024190346 |
|
6525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP69 |
0.238918024190346 |
|
6526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4424 |
0.238918024190346 |
|
6527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VTI1A |
0.238969718736514 |
|
6528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX13B |
0.239006483087009 |
|
6529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSIG1 |
0.239006483087009 |
|
6530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD10 |
0.239006483087009 |
|
6531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG4A |
0.239006483087009 |
|
6532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDH1 |
0.239099795790762 |
|
6533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS4XP5 |
0.239099795790762 |
|
6534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DROSHA |
0.239168390513589 |
|
6535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETDB1 |
0.239217385747687 |
|
6536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNG1 |
0.239236606448579 |
|
6537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00683 |
0.239274511281003 |
|
6538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF15 |
0.239295613356933 |
|
6539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP388 |
0.239468898497798 |
|
6540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM178B |
0.239475318879097 |
|
6541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238566.1 |
0.239479742691499 |
|
6542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC82 |
0.239581925915808 |
|
6543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TASP1 |
0.239652839414198 |
|
6544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QRICH1 |
0.239737771257868 |
|
6545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MANEAL |
0.239804362993677 |
|
6546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YRDC |
0.239804362993677 |
|
6547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf122 |
0.239804362993677 |
|
6548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NANOS3 |
0.239939108132672 |
|
6549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR181C |
0.239939108132672 |
|
6550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR181D |
0.239939108132672 |
|
6551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGRF2 |
0.24002904014967 |
|
6552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf23 |
0.240076315015025 |
|
6553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UMODL1 |
0.240167884572873 |
|
6554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL11A1 |
0.240180750509641 |
|
6555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP294 |
0.240216333694603 |
|
6556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DFFB |
0.24026935450879 |
|
6557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf174 |
0.24026935450879 |
|
6558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL439P |
0.240301809087173 |
|
6559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOXD2P |
0.240401059078364 |
|
6560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS58 |
0.240401059078364 |
|
6561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC9 |
0.240418470133836 |
|
6562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF5B |
0.240418470133836 |
|
6563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRGAP3 |
0.240495205849156 |
|
6564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFBP7 |
0.240525258019716 |
|
6565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238541.1 |
0.240525258019716 |
|
6566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL371P |
0.240609143847909 |
|
6567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL126P |
0.240763951533466 |
|
6568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAMP5 |
0.240763951533466 |
|
6569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF181 |
0.240763951533466 |
|
6570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf68 |
0.240763951533466 |
|
6571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM150A |
0.240763951533466 |
|
6572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP39 |
0.240763951533466 |
|
6573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTX |
0.240779740917187 |
|
6574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALP |
0.240840685980629 |
|
6575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239176.1 |
0.240871836842215 |
|
6576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCIN |
0.240930968400148 |
|
6577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC47 |
0.240977243432037 |
|
6578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL574P |
0.240977243432037 |
|
6579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFIC |
0.240996689749185 |
|
6580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNIH3 |
0.240996847507735 |
|
6581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PICK1 |
0.241017148534087 |
|
6582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A8 |
0.241017148534087 |
|
6583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRCC1 |
0.241043477206543 |
|
6584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHID1 |
0.241105594797797 |
|
6585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFAM1 |
0.241125305880781 |
|
6586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP80 |
0.241125305880781 |
|
6587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP7A |
0.241125305880781 |
|
6588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP7B |
0.241125305880781 |
|
6589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERHL2 |
0.241125305880781 |
|
6590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERHL |
0.241125305880781 |
|
6591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2B5 |
0.241135361816713 |
|
6592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM126A |
0.24117866226719 |
|
6593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREBZF |
0.24117866226719 |
|
6594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC21P |
0.241204694259974 |
|
6595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNDP2 |
0.241244647074371 |
|
6596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNDP1 |
0.241244647074371 |
|
6597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1303 |
0.241257290906738 |
|
6598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAT1 |
0.241324613603082 |
|
6599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMSB10 |
0.241354348570618 |
|
6600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT19P2 |
0.241397033105617 |
|
6601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR492 |
0.241397033105617 |
|
6602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNC1H1 |
0.24146544472379 |
|
6603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESR2 |
0.241481431117157 |
|
6604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK3 |
0.241487159738924 |
|
6605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVPL |
0.241487159738924 |
|
6606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A10 |
0.2414987633597 |
|
6607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST18 |
0.241579396320024 |
|
6608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDDC2 |
0.241614560589507 |
|
6609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METAP2 |
0.242010679517934 |
|
6610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFAF5 |
0.242065658816639 |
|
6611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QL4 |
0.242127262812169 |
|
6612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TROAP |
0.242127262812169 |
|
6613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFFL |
0.24220558464429 |
|
6614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238858.1 |
0.24220558464429 |
|
6615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf128 |
0.242237725275007 |
|
6616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP73 |
0.242279853549556 |
|
6617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC27 |
0.242279853549556 |
|
6618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM1 |
0.242279853549556 |
|
6619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARK1 |
0.242281910899904 |
|
6620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL464P |
0.242281910899904 |
|
6621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC1P2 |
0.242281910899904 |
|
6622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74|ENSG00000272025.1 |
0.242341603979704 |
|
6623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL524P |
0.242352007257512 |
|
6624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO2 |
0.242435440888355 |
|
6625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP44 |
0.242472666023891 |
|
6626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF830 |
0.242496447401725 |
|
6627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIG3 |
0.242496447401725 |
|
6628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252844.1 |
0.242504292775004 |
|
6629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D6 |
0.242504396545346 |
|
6630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CC2D2A |
0.242532905526931 |
|
6631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERTAD2 |
0.242550800842007 |
|
6632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM184B |
0.24258135741193 |
|
6633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL704P |
0.24258135741193 |
|
6634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARC1 |
0.242817030819852 |
|
6635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC35P |
0.242817030819852 |
|
6636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HLX |
0.242817030819852 |
|
6637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P4HA2 |
0.242824981354411 |
|
6638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDLIM4 |
0.242824981354411 |
|
6639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A4 |
0.242824981354411 |
|
6640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA42|ENSG00000200385.1 |
0.242825276141496 |
|
6641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMBR1 |
0.242896678688421 |
|
6642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIM1 |
0.243006765898167 |
|
6643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWF |
0.243011889429342 |
|
6644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS37A |
0.243088605946084 |
|
6645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM5 |
0.243108981802756 |
|
6646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM6 |
0.243108981802756 |
|
6647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD74|ENSG00000200999.1 |
0.243191759379191 |
|
6648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM19 |
0.243195446808498 |
|
6649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB21 |
0.243195446808498 |
|
6650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DVL2 |
0.243343092662555 |
|
6651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR324 |
0.243343092662555 |
|
6652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D31 |
0.24340532755492 |
|
6653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221461.1 |
0.24340532755492 |
|
6654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPH1 |
0.243596318860422 |
|
6655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPCD |
0.243692847475901 |
|
6656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLL |
0.243692847475901 |
|
6657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF787 |
0.243713041721587 |
|
6658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPSECS |
0.243943042982363 |
|
6659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SALL1 |
0.243996010331858 |
|
6660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHADL |
0.244031244122692 |
|
6661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC158 |
0.244034542678201 |
|
6662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD2L2 |
0.244145187373647 |
|
6663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL330P |
0.244176632830189 |
|
6664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCC3 |
0.244176632830189 |
|
6665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPA1P48 |
0.244220099389365 |
|
6666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221345.1 |
0.244258778639368 |
|
6667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf115 |
0.244316867092907 |
|
6668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARC2 |
0.244316867092907 |
|
6669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL483P |
0.244349332796776 |
|
6670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL5 |
0.244483273937076 |
|
6671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB3GAP2 |
0.244500613410393 |
|
6672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA36B |
0.244500613410393 |
|
6673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF5A |
0.244580940239783 |
|
6674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AJ1 |
0.24465576266446 |
|
6675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOXD1 |
0.24465576266446 |
|
6676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEA3 |
0.24465669375999 |
|
6677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP5 |
0.244681991908799 |
|
6678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHE |
0.244684273575632 |
|
6679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD10 |
0.244684273575632 |
|
6680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POGZ |
0.244700293897213 |
|
6681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP62CL |
0.244790377120268 |
|
6682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIH1D3 |
0.244790377120268 |
|
6683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM41 |
0.244790377120268 |
|
6684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP9L |
0.244853158651897 |
|
6685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT14 |
0.244853158651897 |
|
6686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL67P |
0.244900210212277 |
|
6687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKB |
0.244910917353873 |
|
6688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD1L1 |
0.245120969129253 |
|
6689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WWOX |
0.245153519430021 |
|
6690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADNP |
0.245163610491438 |
|
6691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRAGC |
0.245212314898006 |
|
6692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYCBP |
0.245212314898006 |
|
6693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJA9 |
0.245212314898006 |
|
6694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBDL2 |
0.245212314898006 |
|
6695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSDC2 |
0.245234160270306 |
|
6696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMM1 |
0.245234160270306 |
|
6697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
Vault|ENSG00000252328.1 |
0.245251384021423 |
|
6698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHD |
0.24535808343902 |
|
6699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMIGD2 |
0.24535808343902 |
|
6700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSD1 |
0.24535808343902 |
|
6701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAP2 |
0.24535808343902 |
|
6702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTNR1B |
0.245411691560457 |
|
6703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDST1 |
0.245416915532288 |
|
6704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BROX |
0.245461901734186 |
|
6705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL276P |
0.245461901734186 |
|
6706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM177B |
0.245461901734186 |
|
6707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0195 |
0.245512117841736 |
|
6708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNRF4 |
0.245630380527939 |
|
6709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGF1R |
0.245653820488485 |
|
6710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00964 |
0.245664126526377 |
|
6711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1252 |
0.245864484561748 |
|
6712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL696P |
0.245864484561748 |
|
6713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXA1 |
0.245893881574011 |
|
6714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LANCL2 |
0.245956074641334 |
|
6715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DERL3 |
0.245974528039776 |
|
6716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSTM2A |
0.245980853666211 |
|
6717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS23 |
0.246155617145905 |
|
6718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFS5 |
0.246176599308893 |
|
6719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL830P |
0.246274454479925 |
|
6720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAT2A |
0.246274454479925 |
|
6721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCNX |
0.246293594020061 |
|
6722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRABD2A |
0.246344696052709 |
|
6723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRM2 |
0.246527963715091 |
|
6724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf48 |
0.246527963715091 |
|
6725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF878 |
0.246571853760876 |
|
6726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP466 |
0.246571853760876 |
|
6727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUSD4 |
0.24658479530084 |
|
6728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000202379.1 |
0.24666132717945 |
|
6729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSSC2 |
0.246708536018907 |
|
6730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS54 |
0.246775548688726 |
|
6731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP249 |
0.246782773896793 |
|
6732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF706 |
0.246782773896793 |
|
6733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P4HTM |
0.246825007506288 |
|
6734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD1 |
0.2468404531744 |
|
6735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPJ |
0.24692913604083 |
|
6736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPTE2P1 |
0.24692913604083 |
|
6737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNRF1 |
0.246952007201022 |
|
6738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEDD1 |
0.246962655908139 |
|
6739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDCBP2 |
0.246972181300108 |
|
6740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP1A |
0.246972181300108 |
|
6741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSFL1C |
0.246972181300108 |
|
6742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL9 |
0.247029495538569 |
|
6743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL10 |
0.247029495538569 |
|
6744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL11 |
0.247029495538569 |
|
6745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF844 |
0.247050895120889 |
|
6746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PURB |
0.247068383642543 |
|
6747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKIRIN1 |
0.247235336064902 |
|
6748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD6 |
0.247333316792449 |
|
6749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5700 |
0.247477542581388 |
|
6750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHX3 |
0.247545808815167 |
|
6751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO18A |
0.247569872349251 |
|
6752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLX4IP |
0.247616110429042 |
|
6753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPR |
0.247670194349211 |
|
6754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf144 |
0.247915748407719 |
|
6755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ45079 |
0.248071935574587 |
|
6756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGP2 |
0.248147232180562 |
|
6757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA59|ENSG00000251775.1 |
0.248147232180562 |
|
6758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM179 |
0.248347706098524 |
|
6759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD33B |
0.24846185291894 |
|
6760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCNT2 |
0.24846853289652 |
|
6761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCH |
0.248617973876953 |
|
6762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGT |
0.248618496009058 |
|
6763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACRC |
0.248618496009058 |
|
6764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCR3 |
0.248618496009058 |
|
6765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB4 |
0.24862962071333 |
|
6766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1M1 |
0.248643922870815 |
|
6767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPRG1L |
0.248877110539251 |
|
6768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCD5 |
0.248916139098144 |
|
6769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WRAP73 |
0.248953795790544 |
|
6770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD17A |
0.24902933513498 |
|
6771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAT3 |
0.24902933513498 |
|
6772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAMP4 |
0.24902933513498 |
|
6773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPX3 |
0.249097180163014 |
|
6774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKS1B |
0.249117131717737 |
|
6775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BNIPL |
0.249269682343339 |
|
6776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf56 |
0.249269682343339 |
|
6777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42SE1 |
0.249269682343339 |
|
6778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLLT11 |
0.249269682343339 |
|
6779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABPB2 |
0.249269682343339 |
|
6780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU5F2 |
0.2493793023504 |
|
6781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC8B |
0.249382908819966 |
|
6782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF1 |
0.249405951788909 |
|
6783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFRA4 |
0.249416703211343 |
|
6784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM33 |
0.249416703211343 |
|
6785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC1 |
0.249416703211343 |
|
6786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYTL1 |
0.249507253093561 |
|
6787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKK4 |
0.249609600383916 |
|
6788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COA1 |
0.249632653886279 |
|
6789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239035.1 |
0.249653412952299 |
|
6790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00926 |
0.249653412952299 |
|
6791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1D |
0.249689839135624 |
|
6792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXCT1 |
0.249778921588985 |
|
6793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA1C |
0.249902298280692 |
|
6794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTX1 |
0.249997693150088 |
|
6795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBAP1 |
0.249997693150088 |
|
6796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBA |
0.249997693150088 |
|
6797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM189B |
0.249997693150088 |
|
6798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAMP3 |
0.249997693150088 |
|
6799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICAL3 |
0.250099691653679 |
|
6800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTL8 |
0.250246723731256 |
|
6801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEGF6 |
0.25043047795072 |
|
6802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5096 |
0.250468661755475 |
|
6803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNDC7 |
0.250565608672648 |
|
6804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAP3 |
0.250574490267796 |
|
6805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTRT2 |
0.250574490267796 |
|
6806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGRN |
0.250574490267796 |
|
6807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD65 |
0.250574490267796 |
|
6808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATAD3A |
0.250574490267796 |
|
6809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATAD3B |
0.250574490267796 |
|
6810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATAD3C |
0.250574490267796 |
|
6811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AURKAIP1 |
0.250574490267796 |
|
6812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GALT6 |
0.250574490267796 |
|
6813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf159 |
0.250574490267796 |
|
6814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf170 |
0.250574490267796 |
|
6815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf222 |
0.250574490267796 |
|
6816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf233 |
0.250574490267796 |
|
6817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf86 |
0.250574490267796 |
|
6818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALML6 |
0.250574490267796 |
|
6819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNL2 |
0.250574490267796 |
|
6820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK11A |
0.250574490267796 |
|
6821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK11B |
0.250574490267796 |
|
6822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPSF3L |
0.250574490267796 |
|
6823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX11L1 |
0.250574490267796 |
|
6824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DVL1 |
0.250574490267796 |
|
6825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM132A |
0.250574490267796 |
|
6826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM138A |
0.250574490267796 |
|
6827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM213B |
0.250574490267796 |
|
6828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM41C |
0.250574490267796 |
|
6829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM87B |
0.250574490267796 |
|
6830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRD |
0.250574490267796 |
|
6831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLTPD1 |
0.250574490267796 |
|
6832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNB1 |
0.250574490267796 |
|
6833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HES4 |
0.250574490267796 |
|
6834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HES5 |
0.250574490267796 |
|
6835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISG15 |
0.250574490267796 |
|
6836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL17 |
0.250574490267796 |
|
6837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00115 |
0.250574490267796 |
|
6838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00982 |
0.250574490267796 |
|
6839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIB2 |
0.250574490267796 |
|
6840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR200A |
0.250574490267796 |
|
6841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR200B |
0.250574490267796 |
|
6842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR429 |
0.250574490267796 |
|
6843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMEL1 |
0.250574490267796 |
|
6844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP23B |
0.250574490267796 |
|
6845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORN1 |
0.250574490267796 |
|
6846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL20 |
0.250574490267796 |
|
6847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MXRA8 |
0.250574490267796 |
|
6848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NADK |
0.250574490267796 |
|
6849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOC2L |
0.250574490267796 |
|
6850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F16 |
0.250574490267796 |
|
6851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F29 |
0.250574490267796 |
|
6852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F5 |
0.250574490267796 |
|
6853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PANK4 |
0.250574490267796 |
|
6854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX10 |
0.250574490267796 |
|
6855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCH2 |
0.250574490267796 |
|
6856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHN1 |
0.250574490267796 |
|
6857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCZ |
0.250574490267796 |
|
6858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUSL1 |
0.250574490267796 |
|
6859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RER1 |
0.250574490267796 |
|
6860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL657P |
0.250574490267796 |
|
6861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF223 |
0.250574490267796 |
|
6862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD11 |
0.250574490267796 |
|
6863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCNN1D |
0.250574490267796 |
|
6864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDF4 |
0.250574490267796 |
|
6865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKI |
0.250574490267796 |
|
6866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35E2B |
0.250574490267796 |
|
6867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35E2 |
0.250574490267796 |
|
6868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSU72 |
0.250574490267796 |
|
6869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS1R3 |
0.250574490267796 |
|
6870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM240 |
0.250574490267796 |
|
6871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM52 |
0.250574490267796 |
|
6872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM88B |
0.250574490267796 |
|
6873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF14 |
0.250574490267796 |
|
6874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF18 |
0.250574490267796 |
|
6875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF4 |
0.250574490267796 |
|
6876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC34 |
0.250574490267796 |
|
6877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL10 |
0.250574490267796 |
|
6878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2J2 |
0.250574490267796 |
|
6879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA1 |
0.250574490267796 |
|
6880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF16 |
0.250574490267796 |
|
6881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR551A |
0.250574490267796 |
|
6882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCXD3 |
0.250594271991081 |
|
6883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKSG48 |
0.250633821426696 |
|
6884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AK2 |
0.250633821426696 |
|
6885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPIHBP1 |
0.250670323959997 |
|
6886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM83B |
0.250716587736423 |
|
6887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFA6 |
0.250734226672261 |
|
6888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFA4 |
0.250734226672261 |
|
6889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASKIN2 |
0.250744985634493 |
|
6890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSEN54 |
0.250744985634493 |
|
6891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAFAH1B3 |
0.250778462386129 |
|
6892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR19 |
0.250778462386129 |
|
6893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM145 |
0.250778462386129 |
|
6894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF7 |
0.250958577814268 |
|
6895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNE3 |
0.251204495534284 |
|
6896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF583 |
0.251205275924359 |
|
6897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF19B |
0.251218983252345 |
|
6898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR30C2 |
0.251248653698109 |
|
6899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRPB2 |
0.251297148065218 |
|
6900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRPD |
0.251297148065218 |
|
6901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRPB1 |
0.251297148065218 |
|
6902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRPG |
0.251297148065218 |
|
6903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL561P |
0.251297148065218 |
|
6904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf51 |
0.251310527487863 |
|
6905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO4 |
0.251310527487863 |
|
6906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM200B |
0.251322152890631 |
|
6907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEN1 |
0.251369863864079 |
|
6908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST8SIA1 |
0.25144067341557 |
|
6909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFKBIB |
0.251517006340606 |
|
6910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548H1 |
0.25159360145117 |
|
6911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHCY |
0.251731544475359 |
|
6912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1731 |
0.251854540773737 |
|
6913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35G3 |
0.251879385453623 |
|
6914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLFN5 |
0.251879385453623 |
|
6915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR4 |
0.251886203358365 |
|
6916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR1A |
0.251886203358365 |
|
6917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR3 |
0.251886203358365 |
|
6918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMUR2 |
0.25190795181031 |
|
6919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC3A |
0.252040279430161 |
|
6920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC3B |
0.252040279430161 |
|
6921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARVELD1 |
0.252087198548056 |
|
6922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT1 |
0.252170015388134 |
|
6923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XKR5 |
0.252213680262461 |
|
6924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB1 |
0.252213680262461 |
|
6925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFBR3L |
0.252253404352913 |
|
6926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRPK2 |
0.252311149738137 |
|
6927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD21L1 |
0.252326660247957 |
|
6928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNPH |
0.252326660247957 |
|
6929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RLIM |
0.252500406762194 |
|
6930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA2022 |
0.252500406762194 |
|
6931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM169B |
0.252510557842228 |
|
6932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK2A1 |
0.252647343632303 |
|
6933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL552P |
0.25267044330977 |
|
6934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN5B |
0.252867822096465 |
|
6935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC13 |
0.252969295121693 |
|
6936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIGD1A |
0.252969295121693 |
|
6937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPM1 |
0.253058354168441 |
|
6938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAS4 |
0.253074121722608 |
|
6939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239136.1 |
0.253111898914453 |
|
6940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF823 |
0.253128552125668 |
|
6941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM260 |
0.253182248809023 |
|
6942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOCS3 |
0.253316324479521 |
|
6943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC8E |
0.253353523773829 |
|
6944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2K7 |
0.253353523773829 |
|
6945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL115P |
0.253353523773829 |
|
6946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP474 |
0.253464755549348 |
|
6947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM230 |
0.253464755549348 |
|
6948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCNA |
0.253464755549348 |
|
6949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212517.1 |
0.253464755549348 |
|
6950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BFSP1 |
0.253554497729339 |
|
6951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAFB |
0.253700954370867 |
|
6952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf69 |
0.25379958857944 |
|
6953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D15 |
0.253846315999988 |
|
6954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1524 |
0.254016926795236 |
|
6955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL514P |
0.254053202362545 |
|
6956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AVEN |
0.254057563525308 |
|
6957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP152 |
0.254181052567024 |
|
6958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP17A1 |
0.254253718046116 |
|
6959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM175B |
0.25429914956868 |
|
6960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4261 |
0.254404589794909 |
|
6961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL66P |
0.254404589794909 |
|
6962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000206898.1 |
0.254404589794909 |
|
6963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPCAL1 |
0.254404589794909 |
|
6964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPRD2 |
0.254469994192544 |
|
6965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TARS2 |
0.254469994192544 |
|
6966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECM1 |
0.254469994192544 |
|
6967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00568 |
0.254469994192544 |
|
6968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000201346.1 |
0.25463833822407 |
|
6969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLFN12L |
0.254669623038913 |
|
6970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLFN14 |
0.254669623038913 |
|
6971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP2B1 |
0.254669623038913 |
|
6972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX12 |
0.254669623038913 |
|
6973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD7 |
0.254669623038913 |
|
6974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL51P |
0.254698548259013 |
|
6975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238809.1 |
0.254698548259013 |
|
6976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252525.1 |
0.254752240242049 |
|
6977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFRAL |
0.254816464819943 |
|
6978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCFD2 |
0.254819342546895 |
|
6979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRP68 |
0.254955065573394 |
|
6980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTRN |
0.254989352612556 |
|
6981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS9 |
0.255145683670317 |
|
6982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMNB2 |
0.255145683670317 |
|
6983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM13 |
0.255145683670317 |
|
6984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GADD45B |
0.255145683670317 |
|
6985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD42|ENSG00000202440.1 |
0.255185173851041 |
|
6986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAIM2 |
0.255195946442387 |
|
6987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGFRL1 |
0.255469109426322 |
|
6988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSF2 |
0.255674882105544 |
|
6989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ6|ENSG00000253067.1 |
0.255674882105544 |
|
6990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHNAK |
0.255739582781728 |
|
6991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT2 |
0.255770238528183 |
|
6992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BANF2 |
0.255846294597903 |
|
6993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGK |
0.255850968335644 |
|
6994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1147 |
0.255850968335644 |
|
6995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC6P |
0.255863517399396 |
|
6996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAMBI |
0.255863517399396 |
|
6997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100PBP |
0.256038964639824 |
|
6998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL634P |
0.256068378794785 |
|
6999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEPDC5 |
0.256076548991609 |
|
7000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1R2 |
0.256135561200353 |
|
7001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUM1 |
0.256164378876276 |
|
7002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP1B |
0.256247102010372 |
|
7003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZEB1 |
0.25629801855156 |
|
7004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHACTR2 |
0.256338793522537 |
|
7005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYR |
0.256423890306442 |
|
7006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA6 |
0.256610610889496 |
|
7007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA10 |
0.256610610889496 |
|
7008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIA1 |
0.256778295281733 |
|
7009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2CD5 |
0.25678636343387 |
|
7010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLG2 |
0.256811941772135 |
|
7011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS17 |
0.256830536046673 |
|
7012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF713 |
0.256830536046673 |
|
7013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL64P |
0.256830536046673 |
|
7014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3RF2 |
0.256837462551957 |
|
7015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPB41L2 |
0.256884068077906 |
|
7016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC10A1 |
0.256945488925581 |
|
7017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF442 |
0.257065594241237 |
|
7018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00523 |
0.257164719189781 |
|
7019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLK1 |
0.257164719189781 |
|
7020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEG3 |
0.257164719189781 |
|
7021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2392 |
0.257164719189781 |
|
7022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR770 |
0.257164719189781 |
|
7023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR493 |
0.257164719189781 |
|
7024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR337 |
0.257164719189781 |
|
7025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR431 |
0.257164719189781 |
|
7026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR433 |
0.257164719189781 |
|
7027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR665 |
0.257164719189781 |
|
7028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTL1 |
0.257164719189781 |
|
7029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR127 |
0.257164719189781 |
|
7030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR136 |
0.257164719189781 |
|
7031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR432 |
0.257164719189781 |
|
7032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEG8 |
0.257164719189781 |
|
7033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR370 |
0.257164719189781 |
|
7034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251769.1 |
0.257164719189781 |
|
7035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252873.1 |
0.257164719189781 |
|
7036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251949.1 |
0.257164719189781 |
|
7037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252144.1 |
0.257164719189781 |
|
7038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251918.1 |
0.257164719189781 |
|
7039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL207P |
0.257188814588784 |
|
7040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB1 |
0.257219933115972 |
|
7041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BDKRB2 |
0.257247084708284 |
|
7042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238776.1 |
0.257247084708284 |
|
7043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3678 |
0.257535933097778 |
|
7044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSR2 |
0.257553167107151 |
|
7045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf109 |
0.257582759200621 |
|
7046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCA8 |
0.257582759200621 |
|
7047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA10 |
0.257582759200621 |
|
7048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR1D |
0.257668243651606 |
|
7049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA4 |
0.257838158677062 |
|
7050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP120 |
0.257882382202864 |
|
7051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICAM1 |
0.25813189784209 |
|
7052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICAM4 |
0.25813189784209 |
|
7053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICAM5 |
0.25813189784209 |
|
7054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNK |
0.258159770587343 |
|
7055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf72 |
0.258159770587343 |
|
7056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD97 |
0.258381295651606 |
|
7057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf75 |
0.258425649916961 |
|
7058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF207 |
0.258425649916961 |
|
7059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROKR2 |
0.258470776831257 |
|
7060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HFM1 |
0.258496013174499 |
|
7061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMRPP5 |
0.258497372384415 |
|
7062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYZL4 |
0.258529061708374 |
|
7063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP275 |
0.258584018841664 |
|
7064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf6 |
0.258584018841664 |
|
7065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM178A |
0.258628853146021 |
|
7066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A10 |
0.25862973164892 |
|
7067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A6 |
0.258633807586082 |
|
7068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOP10 |
0.258633807586082 |
|
7069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUTM1 |
0.258633807586082 |
|
7070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A5 |
0.258690859557449 |
|
7071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL670P |
0.25873038971357 |
|
7072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBAP1L |
0.258738238365372 |
|
7073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252009.1 |
0.258771081989599 |
|
7074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD113|ENSG00000222185.1 |
0.258771081989599 |
|
7075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR379 |
0.258771081989599 |
|
7076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR411 |
0.258771081989599 |
|
7077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR299 |
0.258771081989599 |
|
7078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR380 |
0.258771081989599 |
|
7079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1197 |
0.258771081989599 |
|
7080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR323A |
0.258771081989599 |
|
7081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR758 |
0.258771081989599 |
|
7082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1193 |
0.258771081989599 |
|
7083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR494 |
0.258771081989599 |
|
7084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR495 |
0.258771081989599 |
|
7085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR543 |
0.258771081989599 |
|
7086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATAD2A |
0.258873979572448 |
|
7087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF114 |
0.258921186746879 |
|
7088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239157.1 |
0.258921186746879 |
|
7089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAI1 |
0.258921186746879 |
|
7090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL235P |
0.259021520788786 |
|
7091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP328 |
0.259200834453286 |
|
7092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGIF1 |
0.259287400875376 |
|
7093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238863.1 |
0.259287400875376 |
|
7094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM54 |
0.2595621012969 |
|
7095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA22|ENSG00000199571.1 |
0.25964849870479 |
|
7096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLVRA |
0.259673808465208 |
|
7097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED6 |
0.259787984195313 |
|
7098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP76 |
0.259791883723721 |
|
7099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITPNA |
0.259841487277527 |
|
7100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF7 |
0.25987352533383 |
|
7101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00604 |
0.259929130837725 |
|
7102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUN3 |
0.260000114933594 |
|
7103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf180 |
0.260044413732396 |
|
7104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA2R |
0.260082724580735 |
|
7105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A2 |
0.260149021204376 |
|
7106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP1LC3B |
0.26015465379707 |
|
7107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC8 |
0.260168090072943 |
|
7108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35E1 |
0.260194704677384 |
|
7109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238354.1 |
0.260254019302606 |
|
7110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPA2 |
0.26037377981818 |
|
7111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPPR5 |
0.260430098212167 |
|
7112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238790.1 |
0.260635682775787 |
|
7113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP101 |
0.260675961012664 |
|
7114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP192 |
0.260951013233376 |
|
7115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DISP1 |
0.261028783442944 |
|
7116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221673.1 |
0.261070479291094 |
|
7117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPRS |
0.261070479291094 |
|
7118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238798.1 |
0.261070479291094 |
|
7119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPSF2 |
0.261104472817999 |
|
7120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35E4 |
0.261206521200545 |
|
7121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP18 |
0.261206521200545 |
|
7122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP34 |
0.261237829288954 |
|
7123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4280 |
0.261237829288954 |
|
7124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE1F |
0.261291080568405 |
|
7125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD24 |
0.261519069600158 |
|
7126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL84P |
0.261519069600158 |
|
7127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBI3 |
0.261519069600158 |
|
7128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10ORF32 |
0.2615233679046 |
|
7129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AS3MT |
0.2615233679046 |
|
7130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1D2 |
0.261581308245163 |
|
7131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1D5 |
0.261581308245163 |
|
7132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1G1 |
0.261581308245163 |
|
7133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD11 |
0.261601308967573 |
|
7134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL38P |
0.261639483596872 |
|
7135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK10 |
0.261648032933204 |
|
7136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM117 |
0.26165953305854 |
|
7137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf32 |
0.261666975299649 |
|
7138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL517P |
0.261751687135688 |
|
7139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR215 |
0.261911416640584 |
|
7140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238576.1 |
0.261911416640584 |
|
7141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE1C |
0.261929218533899 |
|
7142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE1D |
0.261929218533899 |
|
7143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE1E |
0.261929218533899 |
|
7144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252920.1 |
0.261929218533899 |
|
7145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR1B |
0.261929218533899 |
|
7146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL18P |
0.261960657719338 |
|
7147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf78 |
0.261966874646597 |
|
7148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCP2D1 |
0.261966874646597 |
|
7149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF21A |
0.262135771758549 |
|
7150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC37P |
0.262166402075358 |
|
7151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WARS |
0.262311137683084 |
|
7152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR25 |
0.262311137683084 |
|
7153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HORMAD1 |
0.262382932465403 |
|
7154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSS |
0.262382932465403 |
|
7155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF563 |
0.262492054394643 |
|
7156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLC |
0.262575627142345 |
|
7157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR14L |
0.262672655232143 |
|
7158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF441 |
0.2627181949161 |
|
7159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf21 |
0.262776448999429 |
|
7160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN32 |
0.262776448999429 |
|
7161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL26P30 |
0.262776448999429 |
|
7162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMO3 |
0.262813571221883 |
|
7163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDS2 |
0.262887479330225 |
|
7164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5007 |
0.262905267826107 |
|
7165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFX5 |
0.263034050924142 |
|
7166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000200693.1 |
0.263035387254028 |
|
7167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGPP1 |
0.263035387254028 |
|
7168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNIP1 |
0.263048303181199 |
|
7169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA9 |
0.263068218560078 |
|
7170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000207112.1 |
0.263068218560078 |
|
7171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA1|ENSG00000206834.1 |
0.263068218560078 |
|
7172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA32|ENSG00000206799.1 |
0.263068218560078 |
|
7173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA8|ENSG00000207304.1 |
0.263068218560078 |
|
7174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD6 |
0.263068218560078 |
|
7175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1304 |
0.263068218560078 |
|
7176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA18|ENSG00000207145.1 |
0.263068218560078 |
|
7177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD5|ENSG00000239195.1 |
0.263068218560078 |
|
7178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000210825.1 |
0.263068218560078 |
|
7179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMHB1 |
0.263147009690106 |
|
7180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC34A2 |
0.263199518727181 |
|
7181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARVB |
0.263237430076322 |
|
7182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARVG |
0.263237430076322 |
|
7183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1644 |
0.263237430076322 |
|
7184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM22 |
0.263274938773358 |
|
7185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCTN4 |
0.263274938773358 |
|
7186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM3 |
0.263274938773358 |
|
7187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRGM |
0.263274938773358 |
|
7188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLIPR1L2 |
0.263313185066077 |
|
7189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK17 |
0.263432246239841 |
|
7190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP11 |
0.263432246239841 |
|
7191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF1D |
0.263655240611308 |
|
7192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf54 |
0.263655240611308 |
|
7193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL14 |
0.26366116923021 |
|
7194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP5 |
0.263682431883875 |
|
7195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB1 |
0.263682431883875 |
|
7196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA2 |
0.263682431883875 |
|
7197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R36 |
0.263682431883875 |
|
7198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAG1 |
0.263724219300229 |
|
7199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP199 |
0.263785714593548 |
|
7200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFBP1 |
0.263789491030175 |
|
7201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFBP2 |
0.263789491030175 |
|
7202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1I1 |
0.263836781665514 |
|
7203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYDE1 |
0.263836781665514 |
|
7204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ILVBL |
0.263836781665514 |
|
7205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXN1 |
0.263863419253828 |
|
7206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AZI1 |
0.263875214284542 |
|
7207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTHD2 |
0.263875214284542 |
|
7208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf89 |
0.263875214284542 |
|
7209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM2 |
0.263889224884214 |
|
7210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4ENIF1 |
0.263957216330164 |
|
7211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN11 |
0.263999254446002 |
|
7212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRDE2 |
0.264025438335369 |
|
7213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOGA1 |
0.264036461591129 |
|
7214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI4K2A |
0.264036461591129 |
|
7215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORN4 |
0.264036461591129 |
|
7216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AVPI1 |
0.264036461591129 |
|
7217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFCP2 |
0.264044528635035 |
|
7218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU6F1 |
0.264044528635035 |
|
7219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF300 |
0.264063517025677 |
|
7220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF300P1 |
0.264063517025677 |
|
7221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF699 |
0.264104934462768 |
|
7222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A10 |
0.264137405336789 |
|
7223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00482 |
0.264137405336789 |
|
7224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM105 |
0.264137405336789 |
|
7225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4740 |
0.264137405336789 |
|
7226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX19A |
0.26418271615785 |
|
7227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST3GAL2 |
0.26418271615785 |
|
7228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7A10 |
0.264190766160888 |
|
7229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTHFD1 |
0.264198507263506 |
|
7230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB25 |
0.264198507263506 |
|
7231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF839 |
0.264325482195513 |
|
7232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4A2 |
0.264367011354232 |
|
7233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD2|ENSG00000238942.1 |
0.264367011354232 |
|
7234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFC4 |
0.264367011354232 |
|
7235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA4|ENSG00000263776.1 |
0.264367011354232 |
|
7236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000200320.1 |
0.264367011354232 |
|
7237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000200418.1 |
0.264367011354232 |
|
7238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA81|ENSG00000221420.2 |
0.264367011354232 |
|
7239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP5 |
0.264399770027595 |
|
7240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000251737.1 |
0.264430444380894 |
|
7241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEAL3 |
0.264670389466906 |
|
7242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEAL1 |
0.264670389466906 |
|
7243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7A5 |
0.264688086856333 |
|
7244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTNR1A |
0.264890509041395 |
|
7245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR83 |
0.264973470853722 |
|
7246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRE11A |
0.264973470853722 |
|
7247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548L |
0.264973470853722 |
|
7248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD49 |
0.264973470853722 |
|
7249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC14 |
0.265097699895423 |
|
7250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNND2 |
0.265103467691566 |
|
7251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKKS |
0.26523641795162 |
|
7252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB1P |
0.26530958078347 |
|
7253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKIA |
0.265385797071399 |
|
7254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOLR4 |
0.265453686654864 |
|
7255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF10L |
0.265480611762437 |
|
7256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRCC4 |
0.265490561124744 |
|
7257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNR1 |
0.265493206854778 |
|
7258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKT2 |
0.265506358426213 |
|
7259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT74 |
0.265659328479578 |
|
7260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2L13 |
0.265759369259997 |
|
7261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM167A |
0.265889220841561 |
|
7262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA18|ENSG00000238835.1 |
0.265889220841561 |
|
7263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VOPP1 |
0.265986330879861 |
|
7264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00477 |
0.266012824053298 |
|
7265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOA3 |
0.266046404467039 |
|
7266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOX4 |
0.266061090735132 |
|
7267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC6 |
0.266238900354286 |
|
7268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRM5 |
0.266267430640003 |
|
7269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC7 |
0.266267430640003 |
|
7270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGBD4 |
0.266267430640003 |
|
7271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTSJ2 |
0.266282957531621 |
|
7272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT1 |
0.266282957531621 |
|
7273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000200318.1 |
0.266322630156933 |
|
7274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM63B |
0.266322630156933 |
|
7275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBASH3A |
0.266329871804253 |
|
7276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM227A |
0.266340846077542 |
|
7277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NONO |
0.266528018712059 |
|
7278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDOC1L |
0.266549928430291 |
|
7279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00687 |
0.266558259743741 |
|
7280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLECP3 |
0.266673925730564 |
|
7281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239191.1 |
0.266687439859847 |
|
7282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA5 |
0.266718935159409 |
|
7283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR92B |
0.266879512329613 |
|
7284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC1 |
0.266879512329613 |
|
7285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THBS3 |
0.266879512329613 |
|
7286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLK2 |
0.266879512329613 |
|
7287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNRC6B |
0.267011270975253 |
|
7288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD89 |
0.26702580074957 |
|
7289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLFN11 |
0.267028386912948 |
|
7290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLFN12 |
0.267028386912948 |
|
7291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLFN13 |
0.267028386912948 |
|
7292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPACA1 |
0.267047621236183 |
|
7293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378H |
0.267056309088581 |
|
7294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ILDR2 |
0.267104428861008 |
|
7295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAEL |
0.267104428861008 |
|
7296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP65 |
0.267104428861008 |
|
7297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPA33 |
0.267104428861008 |
|
7298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP27 |
0.267104428861008 |
|
7299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU2F1 |
0.267104428861008 |
|
7300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITPNB |
0.26722696866729 |
|
7301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF107 |
0.267354083502749 |
|
7302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL1 |
0.267443542987379 |
|
7303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9 |
0.267467416406285 |
|
7304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAB2 |
0.267467416406285 |
|
7305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR83OS |
0.267473569848008 |
|
7306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR83 |
0.267473569848008 |
|
7307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHPS |
0.267473569848008 |
|
7308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGSM3 |
0.267482463402266 |
|
7309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP15 |
0.267495015323655 |
|
7310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC3C |
0.267515753851424 |
|
7311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC3D |
0.267515753851424 |
|
7312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC3F |
0.267515753851424 |
|
7313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC3G |
0.267515753851424 |
|
7314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP41 |
0.267526465431728 |
|
7315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLI4 |
0.267526465431728 |
|
7316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF696 |
0.267526465431728 |
|
7317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A2 |
0.267548965490542 |
|
7318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIVEP3 |
0.267659431327731 |
|
7319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212610.1 |
0.267735084740458 |
|
7320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCCC2 |
0.267853872010215 |
|
7321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMC1 |
0.267918169873129 |
|
7322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALLC |
0.268158500843923 |
|
7323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTD2 |
0.268175341964225 |
|
7324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK17A |
0.268360270337551 |
|
7325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC3H |
0.268405377093461 |
|
7326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSMD1 |
0.268419237648293 |
|
7327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3936 |
0.268500618623302 |
|
7328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN2B1 |
0.268533426743553 |
|
7329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAP1GDS1 |
0.268617199916101 |
|
7330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR92 |
0.268642763950038 |
|
7331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN8 |
0.268665041969188 |
|
7332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238325.1 |
0.268773391949608 |
|
7333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNPO |
0.268823068481387 |
|
7334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOZ3 |
0.268823068481387 |
|
7335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRELID1P1 |
0.268985065211625 |
|
7336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD16 |
0.268988732509209 |
|
7337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRBV30 |
0.269062396971683 |
|
7338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHB6 |
0.269062396971683 |
|
7339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPV6 |
0.269062396971683 |
|
7340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRTAC1 |
0.269127828345612 |
|
7341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYG1 |
0.269187012345413 |
|
7342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYG2 |
0.269187012345413 |
|
7343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB18 |
0.269243465887567 |
|
7344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAC14 |
0.269271141307299 |
|
7345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD11 |
0.269324557278909 |
|
7346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
R3HCC1L |
0.269386774166976 |
|
7347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCO4 |
0.269393170743604 |
|
7348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP4 |
0.269471351364319 |
|
7349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNB3 |
0.269471351364319 |
|
7350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYM1 |
0.269500156111903 |
|
7351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDPCP |
0.269550504645584 |
|
7352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF111 |
0.269662229742131 |
|
7353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNB2 |
0.269662229742131 |
|
7354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIO3OS |
0.269692928964384 |
|
7355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIO3 |
0.269692928964384 |
|
7356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPD4 |
0.26989810334156 |
|
7357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMYA5 |
0.26989810334156 |
|
7358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF5 |
0.269951699502212 |
|
7359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DZIP3 |
0.269961459194133 |
|
7360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RETNLB |
0.269961459194133 |
|
7361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP9 |
0.270069456194573 |
|
7362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP255 |
0.270092848534994 |
|
7363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB11 |
0.270092848534994 |
|
7364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOA7 |
0.270097624812072 |
|
7365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPCA |
0.270126373497246 |
|
7366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCRTR2 |
0.270127077457884 |
|
7367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC94 |
0.270140749048188 |
|
7368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD18 |
0.270490258553935 |
|
7369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00504 |
0.270574950741602 |
|
7370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL855P |
0.270624296780545 |
|
7371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF733P |
0.270624296780545 |
|
7372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
L3MBTL2 |
0.270635215257513 |
|
7373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOCS3 |
0.270680623190908 |
|
7374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE5A |
0.270727544346069 |
|
7375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRCT1 |
0.270727544346069 |
|
7376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE3B |
0.270727544346069 |
|
7377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE3C |
0.270727544346069 |
|
7378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE3D |
0.270727544346069 |
|
7379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE3E |
0.270727544346069 |
|
7380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE3A |
0.270727544346069 |
|
7381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ID2 |
0.27077974477546 |
|
7382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VTA1 |
0.270841818192264 |
|
7383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4H |
0.270841985539766 |
|
7384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR590 |
0.270841985539766 |
|
7385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM20A |
0.270878899756522 |
|
7386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGPAT5 |
0.270890480405355 |
|
7387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4659A |
0.270890480405355 |
|
7388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FYB |
0.271129770751668 |
|
7389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISL1 |
0.271145665262569 |
|
7390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM17 |
0.271160037241838 |
|
7391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD4 |
0.271211073491244 |
|
7392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP7B1 |
0.271336441656623 |
|
7393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRNN |
0.271343880759292 |
|
7394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00837 |
0.2714243106306 |
|
7395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf126 |
0.2714243106306 |
|
7396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNGR2 |
0.271474744997964 |
|
7397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TK1 |
0.271474744997964 |
|
7398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPM2A |
0.271536517567642 |
|
7399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT6A |
0.271623545226545 |
|
7400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA15|ENSG00000207168.1 |
0.271623545226545 |
|
7401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA22|ENSG00000206603.1 |
0.271623545226545 |
|
7402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUMF2 |
0.271623545226545 |
|
7403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHKG1 |
0.271623545226545 |
|
7404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHCHD2 |
0.271623545226545 |
|
7405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238673.1 |
0.271623545226545 |
|
7406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP8B1 |
0.271706412124327 |
|
7407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPP1 |
0.27171122026478 |
|
7408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN5 |
0.271792936379517 |
|
7409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARP4 |
0.271804606166554 |
|
7410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A11 |
0.27210828880751 |
|
7411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf194 |
0.27210828880751 |
|
7412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL839P |
0.27210828880751 |
|
7413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA16|ENSG00000251942.1 |
0.272199587512364 |
|
7414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BARHL2 |
0.272423662675267 |
|
7415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA13P |
0.272445919462939 |
|
7416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSC |
0.272445919462939 |
|
7417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCK |
0.272451541832949 |
|
7418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC1 |
0.272451541832949 |
|
7419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALY |
0.272466497128951 |
|
7420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf55 |
0.272642507456515 |
|
7421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB1A |
0.272657656039443 |
|
7422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP35 |
0.272721041026258 |
|
7423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS4A |
0.2728365670288 |
|
7424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COG8 |
0.2728365670288 |
|
7425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDF |
0.272853435151592 |
|
7426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIP7 |
0.272853435151592 |
|
7427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED6 |
0.272853435151592 |
|
7428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TERF2 |
0.272853435151592 |
|
7429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGIS |
0.272904033954933 |
|
7430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THEMIS |
0.272933777839247 |
|
7431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX8 |
0.272937458698983 |
|
7432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R5C |
0.273007602789815 |
|
7433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDRGK1 |
0.273033194381835 |
|
7434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPA |
0.273033194381835 |
|
7435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO38 |
0.273073067331973 |
|
7436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT10 |
0.273091824441788 |
|
7437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAP30L |
0.273091824441788 |
|
7438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD56|ENSG00000207299.1 |
0.273116119059424 |
|
7439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAALAD2 |
0.273116119059424 |
|
7440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHORDC1 |
0.273116119059424 |
|
7441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF644 |
0.273261029212369 |
|
7442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP233 |
0.273327443989428 |
|
7443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN4 |
0.273481325996134 |
|
7444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF551 |
0.273481325996134 |
|
7445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF154 |
0.273481325996134 |
|
7446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF671 |
0.273481325996134 |
|
7447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238702.1 |
0.273552275096414 |
|
7448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5192 |
0.273557428992606 |
|
7449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPLAD2 |
0.273647860283595 |
|
7450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS12 |
0.273704110236779 |
|
7451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA33|ENSG00000200534.1 |
0.273704110236779 |
|
7452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD100 |
0.273704110236779 |
|
7453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD101 |
0.273704110236779 |
|
7454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD50 |
0.273753797035379 |
|
7455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDLRAD4 |
0.273790480981018 |
|
7456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STPG2 |
0.273891889122827 |
|
7457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAT4A |
0.274015812574854 |
|
7458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC22 |
0.274041826395344 |
|
7459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATS2 |
0.274041826395344 |
|
7460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD74 |
0.274070270105955 |
|
7461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf63 |
0.274082957402114 |
|
7462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGEF1B |
0.274129166827552 |
|
7463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA2 |
0.27414774113292 |
|
7464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL7 |
0.274148605042972 |
|
7465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG10B |
0.27415896276933 |
|
7466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG10 |
0.27415896276933 |
|
7467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP358 |
0.27415896276933 |
|
7468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP359 |
0.27415896276933 |
|
7469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT10 |
0.27415896276933 |
|
7470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4710 |
0.274163056577406 |
|
7471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INF2 |
0.274163056577406 |
|
7472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADSSL1 |
0.274163056577406 |
|
7473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMC1 |
0.274220459615612 |
|
7474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ2 |
0.27425049434926 |
|
7475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REV1 |
0.274344814412928 |
|
7476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUSBP11 |
0.274392802951561 |
|
7477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf58 |
0.27451253264962 |
|
7478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX8 |
0.274516467359475 |
|
7479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRXN2 |
0.274521404933864 |
|
7480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D8 |
0.274539838543918 |
|
7481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSGA10 |
0.274601479212102 |
|
7482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR568 |
0.274612706216326 |
|
7483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPEB2 |
0.274622393258261 |
|
7484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AB |
0.274830417421345 |
|
7485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70B |
0.274866977316096 |
|
7486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPO1 |
0.274866977316096 |
|
7487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP20A1 |
0.274905819538193 |
|
7488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YWHAQ |
0.274945743604155 |
|
7489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LBR |
0.274948609993558 |
|
7490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS14 |
0.275020958549602 |
|
7491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KATNBL1 |
0.275034641061039 |
|
7492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP107 |
0.275047409361969 |
|
7493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC41A2 |
0.27511648670686 |
|
7494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SV2A |
0.275119809009805 |
|
7495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCOF1 |
0.275155739138384 |
|
7496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52B4 |
0.275222802233111 |
|
7497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRDT |
0.275238676780323 |
|
7498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL3 |
0.275298813082204 |
|
7499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX26 |
0.27539332331512 |
|
7500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA8 |
0.27539332331512 |
|
7501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC22C |
0.275453001222233 |
|
7502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SS18L2 |
0.275453001222233 |
|
7503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf15 |
0.275486897682328 |
|
7504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRA4 |
0.275572783796626 |
|
7505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM31 |
0.275572783796626 |
|
7506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE27 |
0.275674278763727 |
|
7507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA8 |
0.275676781084999 |
|
7508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA9 |
0.275676781084999 |
|
7509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4524B |
0.275676781084999 |
|
7510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKBKB |
0.275688939904648 |
|
7511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF444 |
0.27570248259569 |
|
7512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZIM2 |
0.275800842385451 |
|
7513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GEMIN5 |
0.275805111897611 |
|
7514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL22 |
0.275805111897611 |
|
7515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCSTAMP |
0.275805648978781 |
|
7516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP170 |
0.275908936215264 |
|
7517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL548P |
0.276009906063677 |
|
7518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACP1 |
0.276024168004976 |
|
7519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM110C |
0.276024168004976 |
|
7520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM150B |
0.276024168004976 |
|
7521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3YL1 |
0.276024168004976 |
|
7522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR300 |
0.276100248070758 |
|
7523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR376A1 |
0.276100248070758 |
|
7524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR376C |
0.276100248070758 |
|
7525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR654 |
0.276100248070758 |
|
7526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR381HG |
0.276100248070758 |
|
7527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR381 |
0.276100248070758 |
|
7528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR487B |
0.276100248070758 |
|
7529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR539 |
0.276100248070758 |
|
7530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR889 |
0.276100248070758 |
|
7531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR544A |
0.276100248070758 |
|
7532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR655 |
0.276100248070758 |
|
7533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR487A |
0.276100248070758 |
|
7534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR134 |
0.276100248070758 |
|
7535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR382 |
0.276100248070758 |
|
7536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR485 |
0.276100248070758 |
|
7537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR323B |
0.276100248070758 |
|
7538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR154 |
0.276100248070758 |
|
7539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR377 |
0.276100248070758 |
|
7540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR496 |
0.276100248070758 |
|
7541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR369 |
0.276100248070758 |
|
7542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR409 |
0.276100248070758 |
|
7543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR410 |
0.276100248070758 |
|
7544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR412 |
0.276100248070758 |
|
7545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR541 |
0.276100248070758 |
|
7546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR656 |
0.276100248070758 |
|
7547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEG9 |
0.276100248070758 |
|
7548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBPJ |
0.276104437100208 |
|
7549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE3A |
0.276153914268018 |
|
7550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A19P |
0.276258236258639 |
|
7551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF9B |
0.276258236258639 |
|
7552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIPEP |
0.276258236258639 |
|
7553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF19 |
0.276258236258639 |
|
7554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK35 |
0.276259341921371 |
|
7555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG14 |
0.276316140656319 |
|
7556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBPL2 |
0.276316140656319 |
|
7557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF516 |
0.276330538932397 |
|
7558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCE |
0.276395675927922 |
|
7559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPD |
0.276439345164204 |
|
7560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORF4L2 |
0.276541983634222 |
|
7561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF7L1 |
0.276569872563863 |
|
7562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF846 |
0.276602726430894 |
|
7563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMNA |
0.276663648810667 |
|
7564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB6 |
0.276706772155688 |
|
7565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSPH |
0.276820551614366 |
|
7566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G2F |
0.276830686257667 |
|
7567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G2C |
0.276830686257667 |
|
7568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN10 |
0.276830686257667 |
|
7569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DST |
0.27688800830372 |
|
7570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPDL |
0.276917539847268 |
|
7571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHG6 |
0.276922515698999 |
|
7572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF1A |
0.276922515698999 |
|
7573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBF1 |
0.276958801669979 |
|
7574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD23A |
0.27701715854104 |
|
7575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GADD45GIP1 |
0.27701715854104 |
|
7576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRAS1 |
0.27702846595593 |
|
7577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALKBH1 |
0.277144393281452 |
|
7578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD11|ENSG00000238819.1 |
0.27714456036961 |
|
7579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAPC2 |
0.277281487565056 |
|
7580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL87P |
0.277378829127396 |
|
7581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIPF5 |
0.277378829127396 |
|
7582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK7 |
0.27739922060403 |
|
7583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK9 |
0.27739922060403 |
|
7584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf132 |
0.277428111353806 |
|
7585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD1 |
0.277445564714149 |
|
7586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK13 |
0.277451428838402 |
|
7587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF461 |
0.27749211888631 |
|
7588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD4 |
0.277542437895781 |
|
7589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNH3 |
0.277658405453013 |
|
7590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCRS1 |
0.277658405453013 |
|
7591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF40B |
0.277658405453013 |
|
7592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST12 |
0.277806974949057 |
|
7593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3B |
0.277806974949057 |
|
7594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPOCK2 |
0.277809272651577 |
|
7595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGMN |
0.277850361781457 |
|
7596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSAD2 |
0.277863544525949 |
|
7597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KREMEN1 |
0.277871393620567 |
|
7598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYM3 |
0.277873592492676 |
|
7599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A1 |
0.277891185398592 |
|
7600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf68 |
0.277980057393622 |
|
7601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP779L1853 |
0.277980057393622 |
|
7602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB1BP2 |
0.277993795831602 |
|
7603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMBRD1 |
0.278010113669153 |
|
7604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFRP5 |
0.278248802818717 |
|
7605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF3 |
0.278359724857707 |
|
7606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA72|ENSG00000207084.1 |
0.278390005344509 |
|
7607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMO9P |
0.27876192632768 |
|
7608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARTPT |
0.27880159972881 |
|
7609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL162P |
0.278884426988256 |
|
7610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIDEA |
0.278942680231855 |
|
7611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF362 |
0.279038958461501 |
|
7612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC1A4 |
0.279057672694897 |
|
7613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP68 |
0.279057672694897 |
|
7614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF382 |
0.279119273250806 |
|
7615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD51D |
0.279321323610415 |
|
7616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNDC8 |
0.279321323610415 |
|
7617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLE1 |
0.279321323610415 |
|
7618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC45B |
0.279321323610415 |
|
7619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM132B |
0.279358994178591 |
|
7620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RINL |
0.279377935509569 |
|
7621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRT2 |
0.279377935509569 |
|
7622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETNK1 |
0.279409420686872 |
|
7623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF138 |
0.279419806856971 |
|
7624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL69P |
0.279445953802855 |
|
7625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00652 |
0.2794644337357 |
|
7626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAI2 |
0.279499324312287 |
|
7627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTDC2 |
0.279524546601309 |
|
7628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPNA4 |
0.279572758520546 |
|
7629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT8P12 |
0.279572758520546 |
|
7630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR52 |
0.279586918571898 |
|
7631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPS8 |
0.279613348656876 |
|
7632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRAP |
0.279613348656876 |
|
7633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAL4 |
0.279655559924293 |
|
7634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYGO1 |
0.279685822018161 |
|
7635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238309.1 |
0.279719883373226 |
|
7636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA6D |
0.279850969073356 |
|
7637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP76 |
0.279873245587028 |
|
7638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00651 |
0.279883600530552 |
|
7639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIAF1 |
0.280135655277716 |
|
7640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCG1 |
0.280345671537802 |
|
7641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP492 |
0.280345671537802 |
|
7642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRELID2 |
0.280388675726088 |
|
7643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf59 |
0.280543629428193 |
|
7644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3676 |
0.280543629428193 |
|
7645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP101 |
0.28054444932723 |
|
7646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF529 |
0.280546003665086 |
|
7647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPRK1 |
0.280569790586526 |
|
7648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF662 |
0.28067027748004 |
|
7649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPO3 |
0.280789343494274 |
|
7650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF146 |
0.280789343494274 |
|
7651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECHDC1 |
0.280789343494274 |
|
7652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP217 |
0.280789343494274 |
|
7653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM102B |
0.28087374143295 |
|
7654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HENMT1 |
0.28087374143295 |
|
7655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRNP40 |
0.280978049751299 |
|
7656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BID |
0.281099634432544 |
|
7657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1260B |
0.281127262044866 |
|
7658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEGS1 |
0.281168461143892 |
|
7659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA72|ENSG00000201898.1 |
0.281168461143892 |
|
7660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOL5 |
0.281197433336629 |
|
7661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00879 |
0.281282871004361 |
|
7662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR2B |
0.281291550811901 |
|
7663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRR2G |
0.281291550811901 |
|
7664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAXDC2 |
0.281310603311739 |
|
7665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT8 |
0.281310603311739 |
|
7666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFF3 |
0.281337244098637 |
|
7667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC2 |
0.281397104135647 |
|
7668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH17 |
0.281518556480701 |
|
7669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFG3L2 |
0.281520153512239 |
|
7670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR132 |
0.281527276370086 |
|
7671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP45 |
0.281552775262822 |
|
7672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPT4 |
0.281568464346292 |
|
7673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf202 |
0.281568464346292 |
|
7674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMF1 |
0.281568464346292 |
|
7675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM74B |
0.281568464346292 |
|
7676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF791 |
0.281703121501876 |
|
7677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD118 |
0.281782604947812 |
|
7678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM107 |
0.281782604947812 |
|
7679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf90 |
0.281824970788513 |
|
7680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00528 |
0.281868573740823 |
|
7681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AG1 |
0.281947843774072 |
|
7682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEKT1 |
0.282015872307183 |
|
7683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGDCC4 |
0.282087070013792 |
|
7684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPP8 |
0.282087070013792 |
|
7685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPLAD1 |
0.282087070013792 |
|
7686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238715.1 |
0.282087070013792 |
|
7687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA9 |
0.282087070013792 |
|
7688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378D1 |
0.282273797662304 |
|
7689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf50 |
0.282273797662304 |
|
7690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP191 |
0.282336793661722 |
|
7691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP429 |
0.282590721985354 |
|
7692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPL |
0.282653077942362 |
|
7693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHX4 |
0.282683802868218 |
|
7694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE8 |
0.282712231025665 |
|
7695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTNAP2 |
0.282765646925362 |
|
7696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP49 |
0.282772177828138 |
|
7697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO28 |
0.282772177828138 |
|
7698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCG2 |
0.282776157243672 |
|
7699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF18P |
0.282818833786183 |
|
7700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100A11 |
0.282818833786183 |
|
7701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIF |
0.282947863365203 |
|
7702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGC20647 |
0.282947863365203 |
|
7703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf49 |
0.283017940050146 |
|
7704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf49B |
0.283017940050146 |
|
7705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH1 |
0.283154332195361 |
|
7706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEY2 |
0.283220091954461 |
|
7707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOL1 |
0.283240650832033 |
|
7708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOL2 |
0.283240650832033 |
|
7709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL349P |
0.283240650832033 |
|
7710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHI1 |
0.283448153502796 |
|
7711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFPQ |
0.283461950470097 |
|
7712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR4A1 |
0.283537296892216 |
|
7713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00866 |
0.28354915774615 |
|
7714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA7B |
0.28354915774615 |
|
7715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF776 |
0.283549366751747 |
|
7716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF586 |
0.283549366751747 |
|
7717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF552 |
0.283549366751747 |
|
7718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRA1 |
0.28360239240716 |
|
7719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP198 |
0.28360239240716 |
|
7720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASH1L |
0.283610914449459 |
|
7721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR555 |
0.283610914449459 |
|
7722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238805.1 |
0.283610914449459 |
|
7723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D4A |
0.283641318094923 |
|
7724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P17 |
0.283688406525628 |
|
7725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THEM4 |
0.283703816179101 |
|
7726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPAT2 |
0.283788086122676 |
|
7727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYM4 |
0.283815724772069 |
|
7728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN3 |
0.283816826413606 |
|
7729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIPA1L1 |
0.283820607557895 |
|
7730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STON2 |
0.283830029822846 |
|
7731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL211P |
0.283844340861409 |
|
7732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238696.1 |
0.283844340861409 |
|
7733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO43 |
0.28398012844477 |
|
7734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2K |
0.28398012844477 |
|
7735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC36A3 |
0.284006967785066 |
|
7736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf26 |
0.284046499443869 |
|
7737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRB2 |
0.28429431639621 |
|
7738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO1B1 |
0.284359654319318 |
|
7739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R2C |
0.284407583674508 |
|
7740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC19 |
0.284433405053489 |
|
7741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP361 |
0.284558705848255 |
|
7742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NWD1 |
0.284646525340875 |
|
7743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIN3B |
0.284646525340875 |
|
7744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F2RL3 |
0.284646525340875 |
|
7745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF606 |
0.284684708060465 |
|
7746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLD4 |
0.284718335418602 |
|
7747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHNAK2 |
0.284718335418602 |
|
7748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAL |
0.284739413249413 |
|
7749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEPD1 |
0.284750642878868 |
|
7750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H3F3B |
0.284840363709741 |
|
7751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4738 |
0.284840363709741 |
|
7752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX5 |
0.28485458813355 |
|
7753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP326 |
0.28486696702396 |
|
7754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPV5 |
0.284868330263185 |
|
7755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBQLN4 |
0.285054142984135 |
|
7756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMTOR2 |
0.285054142984135 |
|
7757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB25 |
0.285054142984135 |
|
7758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEX3A |
0.285054142984135 |
|
7759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM186A |
0.285099553289514 |
|
7760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR3B |
0.285104021990025 |
|
7761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3619 |
0.285160238475437 |
|
7762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC7 |
0.285340520303498 |
|
7763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf96 |
0.285497632311256 |
|
7764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB125 |
0.285497632311256 |
|
7765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB126 |
0.285497632311256 |
|
7766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB127 |
0.285497632311256 |
|
7767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB128 |
0.285497632311256 |
|
7768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB129 |
0.285497632311256 |
|
7769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB132 |
0.285497632311256 |
|
7770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRSN2 |
0.285497632311256 |
|
7771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBCK1 |
0.285497632311256 |
|
7772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX12 |
0.285497632311256 |
|
7773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D20 |
0.285497632311256 |
|
7774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIB3 |
0.285497632311256 |
|
7775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC3 |
0.285497632311256 |
|
7776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2CD4D |
0.285532687630554 |
|
7777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THEM5 |
0.285532687630554 |
|
7778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4713 |
0.285704725838659 |
|
7779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCB1 |
0.285969307483032 |
|
7780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238901.1 |
0.285984488029506 |
|
7781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P5 |
0.285984488029506 |
|
7782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATSL1 |
0.286013533373469 |
|
7783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBSCR16 |
0.286013533373469 |
|
7784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2IRD2B |
0.286013533373469 |
|
7785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNIP1 |
0.286044038527092 |
|
7786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA6 |
0.286044038527092 |
|
7787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC69 |
0.286044038527092 |
|
7788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GM2A |
0.286044038527092 |
|
7789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IARS2 |
0.286200251992606 |
|
7790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEG3 |
0.286235019315767 |
|
7791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA8P1 |
0.286251312522511 |
|
7792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf76 |
0.286256160563346 |
|
7793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTSL4 |
0.286339592133177 |
|
7794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4257 |
0.286339592133177 |
|
7795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf138 |
0.286339592133177 |
|
7796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL473P |
0.286339592133177 |
|
7797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL600P |
0.286339592133177 |
|
7798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCL1 |
0.286339592133177 |
|
7799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENSA |
0.286339592133177 |
|
7800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000253047.1 |
0.286339592133177 |
|
7801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL872P |
0.286375306725745 |
|
7802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJA1 |
0.286388079898751 |
|
7803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238372.1 |
0.286439294181648 |
|
7804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKZF3 |
0.286458129213121 |
|
7805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STMN2 |
0.286518954527651 |
|
7806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD38 |
0.286526757441658 |
|
7807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCHHL1 |
0.286544069393806 |
|
7808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCHH |
0.286544069393806 |
|
7809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ27365 |
0.286582815866749 |
|
7810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLDN |
0.286620928871339 |
|
7811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AS |
0.286854132047579 |
|
7812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABR |
0.286908557449683 |
|
7813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S1PR5 |
0.286972798552247 |
|
7814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLK |
0.287063268537581 |
|
7815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5680 |
0.287171782625318 |
|
7816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPA6 |
0.287191681704539 |
|
7817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR135 |
0.287322634741002 |
|
7818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOB3B |
0.287410667534297 |
|
7819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR95 |
0.287566277466507 |
|
7820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC52A3 |
0.287616857262681 |
|
7821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMA1 |
0.287632950461681 |
|
7822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF135 |
0.287800541895729 |
|
7823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN18 |
0.287800541895729 |
|
7824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSTN |
0.28795334728977 |
|
7825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHLHE22 |
0.287959378308832 |
|
7826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKACA |
0.288003063317723 |
|
7827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD5 |
0.288015852552911 |
|
7828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPT1 |
0.28804252687081 |
|
7829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL30 |
0.28804252687081 |
|
7830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MITD1 |
0.28804252687081 |
|
7831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMG2 |
0.288050379660979 |
|
7832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRCC2 |
0.288082257912831 |
|
7833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL811P |
0.288082257912831 |
|
7834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL845P |
0.288082257912831 |
|
7835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DERA |
0.288166978729496 |
|
7836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSHZ2 |
0.288221931568388 |
|
7837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF8 |
0.288277484255666 |
|
7838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42SE2 |
0.288310083412379 |
|
7839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPGEF6 |
0.288310083412379 |
|
7840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238841.1 |
0.288388231978476 |
|
7841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSTL4 |
0.288409919826776 |
|
7842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP308 |
0.288431121200216 |
|
7843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CWC15 |
0.288447131164328 |
|
7844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM4D |
0.288447131164328 |
|
7845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM4E |
0.288447131164328 |
|
7846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJB1 |
0.288579066505002 |
|
7847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFF2 |
0.288603274926466 |
|
7848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFF1 |
0.288603274926466 |
|
7849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS3 |
0.288603274926466 |
|
7850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARS |
0.28861255573666 |
|
7851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GAT2 |
0.288612626795491 |
|
7852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS7B |
0.288678271966001 |
|
7853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACBD5 |
0.288814923801976 |
|
7854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A6P |
0.288814923801976 |
|
7855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM172A |
0.288886045303725 |
|
7856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCTP1 |
0.289085632836704 |
|
7857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3166 |
0.289213189656992 |
|
7858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238871.1 |
0.289241357234304 |
|
7859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000202482.1 |
0.289339223570689 |
|
7860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF470 |
0.28935675367761 |
|
7861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRO |
0.289375431282584 |
|
7862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00639 |
0.289426553755144 |
|
7863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC67 |
0.289691024688301 |
|
7864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC36A4 |
0.289691024688301 |
|
7865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDP1 |
0.289962120344436 |
|
7866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARG1 |
0.290061382854145 |
|
7867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB38 |
0.290122487175279 |
|
7868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPO4 |
0.290211045650344 |
|
7869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR374B |
0.290269628593749 |
|
7870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR421 |
0.290269628593749 |
|
7871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL648P |
0.290269628593749 |
|
7872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR374A |
0.290269628593749 |
|
7873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR545 |
0.290269628593749 |
|
7874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC13 |
0.290269628593749 |
|
7875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP497 |
0.290331338661854 |
|
7876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00207 |
0.290336116837703 |
|
7877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00229 |
0.290336116837703 |
|
7878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED23 |
0.290363624598318 |
|
7879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A4 |
0.290363624598318 |
|
7880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBAS |
0.290539222902925 |
|
7881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAC8L1 |
0.290747250508841 |
|
7882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAAP1 |
0.29075012415469 |
|
7883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CINP |
0.29086010606293 |
|
7884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM47 |
0.290895246562198 |
|
7885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM65 |
0.290895246562198 |
|
7886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL38 |
0.290895246562198 |
|
7887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM131 |
0.290916019183526 |
|
7888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL39P |
0.29094320113154 |
|
7889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238445.1 |
0.29094320113154 |
|
7890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCKAR |
0.290999465778582 |
|
7891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G2D |
0.291020924473226 |
|
7892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000206761.1 |
0.291176059313508 |
|
7893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIC |
0.291287512332799 |
|
7894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS28 |
0.291450747604931 |
|
7895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PICALM |
0.291561441332579 |
|
7896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4431 |
0.291604956390395 |
|
7897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XKR4 |
0.291630890595195 |
|
7898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENDOD1 |
0.291691123135431 |
|
7899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1614 |
0.291904986333502 |
|
7900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA53 |
0.291954529778963 |
|
7901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP50 |
0.292011890580372 |
|
7902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0930 |
0.292011890580372 |
|
7903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1249 |
0.292011890580372 |
|
7904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF38 |
0.292057493177365 |
|
7905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERMP1 |
0.292067107071424 |
|
7906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS4 |
0.292106953722628 |
|
7907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECH1 |
0.292106953722628 |
|
7908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS12 |
0.292156659172331 |
|
7909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTCD |
0.292156659172331 |
|
7910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAWR |
0.292158300484894 |
|
7911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THUMPD3 |
0.292189945048478 |
|
7912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN2 |
0.292193397221509 |
|
7913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR89 |
0.292510247394705 |
|
7914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO7 |
0.292534448395976 |
|
7915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPK3A |
0.292654155058762 |
|
7916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXYD6 |
0.292666479286202 |
|
7917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIFM3 |
0.292690386090572 |
|
7918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARVCF |
0.292690386090572 |
|
7919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCRP2 |
0.292690386090572 |
|
7920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf29 |
0.292690386090572 |
|
7921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf39 |
0.292690386090572 |
|
7922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC116 |
0.292690386090572 |
|
7923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC45 |
0.292690386090572 |
|
7924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN5 |
0.292690386090572 |
|
7925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLTCL1 |
0.292690386090572 |
|
7926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMT |
0.292690386090572 |
|
7927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRKL |
0.292690386090572 |
|
7928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGCR14 |
0.292690386090572 |
|
7929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGCR2 |
0.292690386090572 |
|
7930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGCR5 |
0.292690386090572 |
|
7931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGCR6L |
0.292690386090572 |
|
7932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGCR6 |
0.292690386090572 |
|
7933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGCR8 |
0.292690386090572 |
|
7934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM230A |
0.292690386090572 |
|
7935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM230B |
0.292690386090572 |
|
7936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM230C |
0.292690386090572 |
|
7937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGT2 |
0.292690386090572 |
|
7938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGT3P |
0.292690386090572 |
|
7939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGTLC3 |
0.292690386090572 |
|
7940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNB1L |
0.292690386090572 |
|
7941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GP1BB |
0.292690386090572 |
|
7942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSC2 |
0.292690386090572 |
|
7943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIC2 |
0.292690386090572 |
|
7944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIRA |
0.292690386090572 |
|
7945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL22 |
0.292690386090572 |
|
7946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LZTR1 |
0.292690386090572 |
|
7947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED15 |
0.292690386090572 |
|
7948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1286 |
0.292690386090572 |
|
7949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1306 |
0.292690386090572 |
|
7950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR130B |
0.292690386090572 |
|
7951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR185 |
0.292690386090572 |
|
7952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR301B |
0.292690386090572 |
|
7953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3618 |
0.292690386090572 |
|
7954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4761 |
0.292690386090572 |
|
7955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR649 |
0.292690386090572 |
|
7956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL40 |
0.292690386090572 |
|
7957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RX6P |
0.292690386090572 |
|
7958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RX6 |
0.292690386090572 |
|
7959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI4KAP1 |
0.292690386090572 |
|
7960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI4KAP2 |
0.292690386090572 |
|
7961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI4KA |
0.292690386090572 |
|
7962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POM121L4P |
0.292690386090572 |
|
7963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POM121L7 |
0.292690386090572 |
|
7964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIL2 |
0.292690386090572 |
|
7965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRODH |
0.292690386090572 |
|
7966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANBP1 |
0.292690386090572 |
|
7967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMBP3B |
0.292690386090572 |
|
7968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMBP3C |
0.292690386090572 |
|
7969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMBP3 |
0.292690386090572 |
|
7970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP131 |
0.292690386090572 |
|
7971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP221 |
0.292690386090572 |
|
7972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP63 |
0.292690386090572 |
|
7973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL168P |
0.292690386090572 |
|
7974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL280P |
0.292690386090572 |
|
7975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL389P |
0.292690386090572 |
|
7976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL812P |
0.292690386090572 |
|
7977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTN4R |
0.292690386090572 |
|
7978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARF2 |
0.292690386090572 |
|
7979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA17|ENSG00000252020.1 |
0.292690386090572 |
|
7980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA17|ENSG00000252143.1 |
0.292690386090572 |
|
7981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA17|ENSG00000252571.1 |
0.292690386090572 |
|
7982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA18|ENSG00000252024.1 |
0.292690386090572 |
|
7983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA18|ENSG00000252314.1 |
0.292690386090572 |
|
7984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA18|ENSG00000252605.1 |
0.292690386090572 |
|
7985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDF2L1 |
0.292690386090572 |
|
7986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT5 |
0.292690386090572 |
|
7987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPIND1 |
0.292690386090572 |
|
7988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A1 |
0.292690386090572 |
|
7989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A4 |
0.292690386090572 |
|
7990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMPD4P1 |
0.292690386090572 |
|
7991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAP29 |
0.292690386090572 |
|
7992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA15|ENSG00000251940.1 |
0.292690386090572 |
|
7993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA77|ENSG00000264346.1 |
0.292690386090572 |
|
7994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TANGO2 |
0.292690386090572 |
|
7995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX1 |
0.292690386090572 |
|
7996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP7 |
0.292690386090572 |
|
7997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM191A |
0.292690386090572 |
|
7998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM191C |
0.292690386090572 |
|
7999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT2A |
0.292690386090572 |
|
8000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSSK2 |
0.292690386090572 |
|
8001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA3FP |
0.292690386090572 |
|
8002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNRD2 |
0.292690386090572 |
|
8003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2L3 |
0.292690386090572 |
|
8004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UFD1L |
0.292690386090572 |
|
8005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP18 |
0.292690386090572 |
|
8006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP41 |
0.292690386090572 |
|
8007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YDJC |
0.292690386090572 |
|
8008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YPEL1 |
0.292690386090572 |
|
8009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC8 |
0.292690386090572 |
|
8010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF74 |
0.292690386090572 |
|
8011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252402.1 |
0.292690386090572 |
|
8012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252799.1 |
0.292690386090572 |
|
8013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000271796.1 |
0.292690386090572 |
|
8014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD7 |
0.292777696806844 |
|
8015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE9A |
0.292883988019332 |
|
8016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OBFC1 |
0.292947161147496 |
|
8017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238856.1 |
0.29301863821895 |
|
8018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNIH4 |
0.29301863821895 |
|
8019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR26 |
0.29301863821895 |
|
8020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4742 |
0.29301863821895 |
|
8021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF4B |
0.293020180920286 |
|
8022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTF1 |
0.293090066991859 |
|
8023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP9 |
0.293126757163863 |
|
8024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN54 |
0.293126757163863 |
|
8025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoR442|ENSG00000252834.1 |
0.293126757163863 |
|
8026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF71 |
0.293364901676196 |
|
8027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLG2 |
0.293375644623634 |
|
8028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKRIP1 |
0.293449720745728 |
|
8029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548O |
0.293449720745728 |
|
8030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELAVL2 |
0.293478323975057 |
|
8031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC31A |
0.293539334827638 |
|
8032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf50 |
0.293626530971866 |
|
8033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PQLC3 |
0.293626530971866 |
|
8034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP44 |
0.294148583316266 |
|
8035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCNN1A |
0.294387748479846 |
|
8036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCN5 |
0.294392898965872 |
|
8037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAZAP2 |
0.294441854077646 |
|
8038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAGP |
0.294441854077646 |
|
8039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF329 |
0.294613497877521 |
|
8040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLPH3L |
0.294659929392605 |
|
8041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf35 |
0.294889162773227 |
|
8042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OAZ1 |
0.294889162773227 |
|
8043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINGO3 |
0.294889162773227 |
|
8044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLP1 |
0.294915366979916 |
|
8045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548A2 |
0.295145186402881 |
|
8046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOD1L1 |
0.295177217642777 |
|
8047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXF1 |
0.29517819905321 |
|
8048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NF2 |
0.295197466566471 |
|
8049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAGE4 |
0.295237606579597 |
|
8050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP27X |
0.295237606579597 |
|
8051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM2 |
0.295282172826406 |
|
8052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHF1 |
0.295287820067008 |
|
8053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238666.1 |
0.295357751641492 |
|
8054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFXN2 |
0.295457811444042 |
|
8055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USH2A |
0.295844163293209 |
|
8056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGFR |
0.295863871378027 |
|
8057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYB |
0.295894450927525 |
|
8058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUFIP2 |
0.29594141340956 |
|
8059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00299 |
0.296121532772575 |
|
8060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000253065.1 |
0.296134550664072 |
|
8061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIT1 |
0.296163591828128 |
|
8062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYCL |
0.296163591828128 |
|
8063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3141 |
0.296239091365751 |
|
8064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH6 |
0.296345707979127 |
|
8065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP309 |
0.296402170465463 |
|
8066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ16 |
0.296496016876067 |
|
8067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4470 |
0.296532728610231 |
|
8068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM7 |
0.296536266681136 |
|
8069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPPL2B |
0.296536266681136 |
|
8070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP14 |
0.296615680080377 |
|
8071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZGLP1 |
0.296675971487116 |
|
8072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FDX1L |
0.296675971487116 |
|
8073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCO4 |
0.296700825540745 |
|
8074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB4 |
0.296718911912918 |
|
8075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELENBP1 |
0.296718911912918 |
|
8076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P25 |
0.296718911912918 |
|
8077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIRE1 |
0.296816694224431 |
|
8078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETHE1 |
0.29684703928908 |
|
8079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF575 |
0.29684703928908 |
|
8080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRCC1 |
0.29684703928908 |
|
8081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PINLYP |
0.29684703928908 |
|
8082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRGQ |
0.29684703928908 |
|
8083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS2L2 |
0.296851726280277 |
|
8084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf50 |
0.296851726280277 |
|
8085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE2D |
0.296855900761494 |
|
8086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00302 |
0.296855900761494 |
|
8087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE2B |
0.296855900761494 |
|
8088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE2C |
0.296855900761494 |
|
8089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE2A |
0.296855900761494 |
|
8090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE4A |
0.296855900761494 |
|
8091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLMO1 |
0.297010502652766 |
|
8092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINGO4 |
0.297099180158044 |
|
8093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RORC |
0.297099180158044 |
|
8094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KNG1 |
0.297131325826081 |
|
8095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252580.1 |
0.297140729327754 |
|
8096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCBP3 |
0.297213820555627 |
|
8097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREB3L3 |
0.297221517941064 |
|
8098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRT6 |
0.297221517941064 |
|
8099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL31 |
0.297283882919159 |
|
8100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFI1 |
0.297297917009542 |
|
8101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH14 |
0.297338404652406 |
|
8102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLG |
0.297400585704886 |
|
8103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGH |
0.297543425626786 |
|
8104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTPA |
0.297543425626786 |
|
8105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YTHDF3 |
0.297543425626786 |
|
8106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL135P |
0.297543425626786 |
|
8107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4440 |
0.297671276997754 |
|
8108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4441 |
0.297671276997754 |
|
8109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TWIST2 |
0.297671276997754 |
|
8110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCP |
0.297696861392405 |
|
8111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IVL |
0.297696861392405 |
|
8112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL551P |
0.297752588163439 |
|
8113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5A |
0.297752588163439 |
|
8114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOT1 |
0.297802938859359 |
|
8115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF426 |
0.297860330480802 |
|
8116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM38A |
0.297903087182597 |
|
8117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCN3 |
0.297965157139657 |
|
8118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKLR |
0.297965157139657 |
|
8119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238760.1 |
0.298092764630031 |
|
8120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABGEF1 |
0.298137788484099 |
|
8121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH3A2 |
0.298208492734116 |
|
8122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7A17 |
0.298337862041984 |
|
8123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLFM2 |
0.298407820346685 |
|
8124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLDIP2 |
0.298460391438624 |
|
8125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM199 |
0.298460391438624 |
|
8126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4723 |
0.298460391438624 |
|
8127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SARM1 |
0.298460391438624 |
|
8128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEBOX |
0.298460391438624 |
|
8129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VTN |
0.298460391438624 |
|
8130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC46A1 |
0.298460391438624 |
|
8131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2S1 |
0.29847411861594 |
|
8132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL718P |
0.29847411861594 |
|
8133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSGALNACT1 |
0.298547167701818 |
|
8134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMC8 |
0.298590905227679 |
|
8135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf99 |
0.298590905227679 |
|
8136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A12 |
0.298602374204197 |
|
8137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL20P |
0.298626244749152 |
|
8138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD36C |
0.298636877869014 |
|
8139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf194 |
0.298657298571064 |
|
8140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA2 |
0.298657298571064 |
|
8141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM167B |
0.298657298571064 |
|
8142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC4 |
0.298696552990242 |
|
8143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD85 |
0.298727402439971 |
|
8144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM110A |
0.298843922644459 |
|
8145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSL24D1 |
0.298883236602452 |
|
8146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARM1 |
0.298905488246676 |
|
8147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI27L1 |
0.298964723972246 |
|
8148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI27 |
0.298964723972246 |
|
8149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI27L2 |
0.298964723972246 |
|
8150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM21 |
0.299000262281961 |
|
8151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM10 |
0.299026751248529 |
|
8152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCHR1 |
0.299213019728723 |
|
8153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF625 |
0.299215345780566 |
|
8154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRIM2 |
0.299227091100143 |
|
8155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf146 |
0.299231965485344 |
|
8156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTBP12 |
0.299231965485344 |
|
8157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLMN |
0.299231965485344 |
|
8158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCD2 |
0.299237177663719 |
|
8159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF530 |
0.299246202862845 |
|
8160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF134 |
0.299246202862845 |
|
8161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF211 |
0.299246202862845 |
|
8162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRG1 |
0.299252893555529 |
|
8163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00612 |
0.299252893555529 |
|
8164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PZP |
0.299252893555529 |
|
8165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4655 |
0.299348186375772 |
|
8166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO6 |
0.299372654576668 |
|
8167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPK1 |
0.299564444884935 |
|
8168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FDPS |
0.299635020807165 |
|
8169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUSC1 |
0.299635020807165 |
|
8170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBDL3 |
0.299676042834535 |
|
8171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANP32D |
0.299689544382907 |
|
8172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf54 |
0.299689544382907 |
|
8173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8S1 |
0.299689544382907 |
|
8174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LALBA |
0.299689544382907 |
|
8175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4492 |
0.299691033847447 |
|
8176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPK2 |
0.299691033847447 |
|
8177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL688P |
0.299691033847447 |
|
8178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXR1 |
0.299691033847447 |
|
8179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL529P |
0.299691033847447 |
|
8180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC84 |
0.299691033847447 |
|
8181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS25 |
0.299691033847447 |
|
8182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3656 |
0.299691033847447 |
|
8183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC4 |
0.299691033847447 |
|
8184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC37A4 |
0.299691033847447 |
|
8185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRXN1 |
0.299825644939507 |
|
8186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCRT2 |
0.299825644939507 |
|
8187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO1E |
0.299843641755693 |
|
8188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRXCR2 |
0.299869458071941 |
|
8189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A12 |
0.300013139992063 |
|
8190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD103A |
0.300063508150228 |
|
8191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD103B |
0.300063508150228 |
|
8192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRASP |
0.300176759321102 |
|
8193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMXL2 |
0.30022409828873 |
|
8194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAF1 |
0.300228963683218 |
|
8195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO39 |
0.300228963683218 |
|
8196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN5C |
0.300286659870805 |
|
8197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN5D |
0.300286659870805 |
|
8198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHANK2 |
0.30032844326102 |
|
8199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA6C |
0.300340427673807 |
|
8200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA12B |
0.300399022752197 |
|
8201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAUS8 |
0.300409799504064 |
|
8202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNK |
0.300429267694254 |
|
8203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC13D |
0.300429267694254 |
|
8204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JMJD6 |
0.300460195049756 |
|
8205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL23 |
0.300460195049756 |
|
8206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR636 |
0.300460195049756 |
|
8207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF2 |
0.300460195049756 |
|
8208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA11 |
0.3005120504113 |
|
8209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF5AL1 |
0.3005120504113 |
|
8210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00857 |
0.3005120504113 |
|
8211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBL1P |
0.3005120504113 |
|
8212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUTM2B |
0.3005120504113 |
|
8213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUTM2E |
0.3005120504113 |
|
8214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAC9 |
0.3005120504113 |
|
8215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFTPA1 |
0.3005120504113 |
|
8216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFTPA2 |
0.3005120504113 |
|
8217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFTPD |
0.3005120504113 |
|
8218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM254 |
0.3005120504113 |
|
8219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3A1 |
0.300531946720608 |
|
8220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC157 |
0.300531946720608 |
|
8221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF215 |
0.300531946720608 |
|
8222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCLY |
0.300629318612485 |
|
8223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESPNL |
0.300629318612485 |
|
8224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL30 |
0.300629318612485 |
|
8225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA2A |
0.300667815882861 |
|
8226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA2B |
0.300667815882861 |
|
8227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A3 |
0.300751386737174 |
|
8228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASIC2 |
0.300844404666988 |
|
8229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf102 |
0.300844404666988 |
|
8230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL11 |
0.300844404666988 |
|
8231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL13 |
0.300844404666988 |
|
8232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL1 |
0.300844404666988 |
|
8233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL2 |
0.300844404666988 |
|
8234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL7 |
0.300844404666988 |
|
8235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL8 |
0.300844404666988 |
|
8236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP438 |
0.300844404666988 |
|
8237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTB |
0.30090564606315 |
|
8238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
A2M |
0.30102227650836 |
|
8239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPTN |
0.301048536702294 |
|
8240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRNR |
0.301048536702294 |
|
8241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1107 |
0.301097714942499 |
|
8242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHERP |
0.301226144538211 |
|
8243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMC6 |
0.301247350586972 |
|
8244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF469 |
0.301247982177622 |
|
8245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSTM2B |
0.301264594270927 |
|
8246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE6A |
0.30126978461796 |
|
8247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A2 |
0.30126978461796 |
|
8248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIGD6 |
0.30126978461796 |
|
8249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCMTD1 |
0.301451496984444 |
|
8250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIP2B |
0.301567754721335 |
|
8251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239015.1 |
0.301568699221126 |
|
8252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FYN |
0.30159103593863 |
|
8253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF44 |
0.30160397270894 |
|
8254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL100P |
0.30161396936791 |
|
8255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAA |
0.30161396936791 |
|
8256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KANSL2 |
0.301717559049863 |
|
8257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA34 |
0.301717559049863 |
|
8258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLGN3 |
0.301721823855773 |
|
8259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4739 |
0.301867595888588 |
|
8260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK13 |
0.301929998462022 |
|
8261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252888.1 |
0.301992267200281 |
|
8262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST6 |
0.302030885911858 |
|
8263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA59B |
0.302038841784478 |
|
8264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252349.1 |
0.302038841784478 |
|
8265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC39P |
0.302114831869032 |
|
8266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCAM |
0.302136367623309 |
|
8267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA64|ENSG00000252119.1 |
0.302136367623309 |
|
8268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF26 |
0.302136367623309 |
|
8269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF5 |
0.302136367623309 |
|
8270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFRP |
0.302136367623309 |
|
8271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF3IP2 |
0.302167457293988 |
|
8272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf3 |
0.302167457293988 |
|
8273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MID2 |
0.30221415945851 |
|
8274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR641 |
0.30228275786542 |
|
8275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMA5 |
0.3022982956291 |
|
8276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALCAM |
0.302348506203692 |
|
8277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPR1 |
0.302380362756043 |
|
8278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL683P |
0.302400540565717 |
|
8279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNRH2 |
0.302424317971518 |
|
8280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS26 |
0.302424317971518 |
|
8281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBOX5 |
0.302424317971518 |
|
8282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FASTKD5 |
0.302424317971518 |
|
8283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LZTS3 |
0.302424317971518 |
|
8284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRA2 |
0.302597771375651 |
|
8285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM117B |
0.302598184239918 |
|
8286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NF1 |
0.302946184058207 |
|
8287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL835P |
0.302972301776422 |
|
8288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL823P |
0.302972301776422 |
|
8289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPAMD8 |
0.302998416214666 |
|
8290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPNT1 |
0.303024226063121 |
|
8291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD4 |
0.303088014683779 |
|
8292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP467 |
0.303120876005031 |
|
8293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1RL2 |
0.303177586034531 |
|
8294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC47A1 |
0.303196171408629 |
|
8295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR5 |
0.303196222940602 |
|
8296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf97 |
0.303206323872667 |
|
8297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBIL5P |
0.303206323872667 |
|
8298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOC2B |
0.303206323872667 |
|
8299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM101B |
0.303206323872667 |
|
8300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM57A |
0.303206323872667 |
|
8301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GEMIN4 |
0.303206323872667 |
|
8302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLOD4 |
0.303206323872667 |
|
8303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3183 |
0.303206323872667 |
|
8304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXN |
0.303206323872667 |
|
8305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNMTL1 |
0.303206323872667 |
|
8306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPH3AL |
0.303206323872667 |
|
8307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM22 |
0.303206323872667 |
|
8308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS53 |
0.303206323872667 |
|
8309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF136 |
0.3032096025301 |
|
8310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABP7 |
0.30323912701479 |
|
8311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAD1L1 |
0.303317098438117 |
|
8312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF788 |
0.303559681848299 |
|
8313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF20 |
0.303559681848299 |
|
8314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR75 |
0.303581751104957 |
|
8315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSME4 |
0.303581751104957 |
|
8316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00603 |
0.303660455821946 |
|
8317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252932.1 |
0.303706762139104 |
|
8318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INGX |
0.303707971631034 |
|
8319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRDL1 |
0.303813946457445 |
|
8320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D16 |
0.303831090364501 |
|
8321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HINFP |
0.303908646273877 |
|
8322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCG4 |
0.303908646273877 |
|
8323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRX1 |
0.303908646273877 |
|
8324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZD3 |
0.303908646273877 |
|
8325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC153 |
0.303908646273877 |
|
8326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBL |
0.303908646273877 |
|
8327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF559 |
0.30407721229879 |
|
8328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PATZ1 |
0.30413537246582 |
|
8329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPOLA |
0.304154135623792 |
|
8330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPGEF3 |
0.304193252674512 |
|
8331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC48A1 |
0.304193252674512 |
|
8332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEFM |
0.30427593917929 |
|
8333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAP2 |
0.30427593917929 |
|
8334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP2 |
0.304284022326588 |
|
8335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP5 |
0.304284022326588 |
|
8336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP6 |
0.304284022326588 |
|
8337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG4D |
0.304291012949378 |
|
8338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1238 |
0.304291012949378 |
|
8339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRI1 |
0.304291012949378 |
|
8340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1M2 |
0.304291012949378 |
|
8341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN2D |
0.304291012949378 |
|
8342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMAT5 |
0.304295154753241 |
|
8343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH9 |
0.304501194865616 |
|
8344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00460 |
0.304541968682638 |
|
8345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEL1L |
0.304603414344054 |
|
8346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR936 |
0.304626466009027 |
|
8347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASD2 |
0.3046479190764 |
|
8348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIEZO2 |
0.304768241562419 |
|
8349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBP2 |
0.304807125154875 |
|
8350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHCR7 |
0.304894127598262 |
|
8351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NADSYN1 |
0.304894127598262 |
|
8352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP280 |
0.305039723624293 |
|
8353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPHN3 |
0.305107432025227 |
|
8354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCK1 |
0.305267615500792 |
|
8355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf47 |
0.305403155353785 |
|
8356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A15 |
0.305489362824801 |
|
8357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANGAP1 |
0.30551168532956 |
|
8358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF687 |
0.305516119284749 |
|
8359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI4KB |
0.305516119284749 |
|
8360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL444P |
0.305516119284749 |
|
8361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGEA5 |
0.305614292615382 |
|
8362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H6PD |
0.305794052546126 |
|
8363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPSB1 |
0.305835167574688 |
|
8364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35B3 |
0.305879521974351 |
|
8365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDFY3 |
0.305998752844025 |
|
8366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf82 |
0.306049176632703 |
|
8367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AURKB |
0.306140614395852 |
|
8368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED12 |
0.306154148125848 |
|
8369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGPEP1L |
0.306185139240649 |
|
8370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP174 |
0.306191731337763 |
|
8371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf79 |
0.306195788767268 |
|
8372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM83F |
0.306270212809443 |
|
8373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JPH3 |
0.306346284090831 |
|
8374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKG |
0.306478402982109 |
|
8375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP14 |
0.306480139672907 |
|
8376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD113|ENSG00000200150.1 |
0.306516863486987 |
|
8377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD113|ENSG00000201036.1 |
0.306516863486987 |
|
8378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD113|ENSG00000201500.1 |
0.306516863486987 |
|
8379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD113|ENSG00000201710.1 |
0.306516863486987 |
|
8380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOM3 |
0.306590538825579 |
|
8381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL22RA1 |
0.306590538825579 |
|
8382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHIT |
0.306644326338095 |
|
8383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP2 |
0.306736259405461 |
|
8384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4285 |
0.306753286021615 |
|
8385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2B2 |
0.306753286021615 |
|
8386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS33 |
0.306906820189158 |
|
8387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR3C2 |
0.306962138219465 |
|
8388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZADH2 |
0.307104984921549 |
|
8389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSHZ1 |
0.307104984921549 |
|
8390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM21 |
0.307104984921549 |
|
8391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIDINS220 |
0.307202973587506 |
|
8392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBOAT2 |
0.307202973587506 |
|
8393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239061.1 |
0.307216532882711 |
|
8394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10AD1 |
0.307247850921043 |
|
8395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VEZT |
0.307289271469513 |
|
8396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR331 |
0.307289271469513 |
|
8397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3685 |
0.307289271469513 |
|
8398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00271 |
0.307304586027833 |
|
8399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL251P |
0.307344959116668 |
|
8400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP232 |
0.307448548797978 |
|
8401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM83A |
0.307736956215446 |
|
8402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4663 |
0.307736956215446 |
|
8403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC105 |
0.307851241304025 |
|
8404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAFA |
0.307980843107222 |
|
8405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H3 |
0.307980843107222 |
|
8406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
7SK|ENSG00000254144.2 |
0.307980843107222 |
|
8407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSDMD |
0.307980843107222 |
|
8408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MROH6 |
0.307980843107222 |
|
8409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAPRT1 |
0.307980843107222 |
|
8410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAHM |
0.308043421487182 |
|
8411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICAM3 |
0.308089583409775 |
|
8412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF418 |
0.308102663156175 |
|
8413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF256 |
0.308102663156175 |
|
8414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf18 |
0.308102663156175 |
|
8415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL790P |
0.308104228198406 |
|
8416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL641P |
0.308104228198406 |
|
8417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRBP1 |
0.308116773507216 |
|
8418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR320B2 |
0.308146766431891 |
|
8419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD113|ENSG00000222095.1 |
0.308331004049505 |
|
8420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAVER1 |
0.308412786108453 |
|
8421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A8 |
0.308538214603157 |
|
8422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF587B |
0.308565714147128 |
|
8423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMID1 |
0.308620749693174 |
|
8424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB20 |
0.308666554231157 |
|
8425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE1B |
0.308687651691734 |
|
8426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE1A |
0.308687651691734 |
|
8427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCE6A |
0.308687651691734 |
|
8428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPFIA2 |
0.308739709180509 |
|
8429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOM1 |
0.308753654604728 |
|
8430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3909 |
0.308753654604728 |
|
8431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238888.1 |
0.308759947904088 |
|
8432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL18R1 |
0.308865897560064 |
|
8433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1RL1 |
0.308865897560064 |
|
8434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238978.1 |
0.308975434825166 |
|
8435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGNL1 |
0.309177165651219 |
|
8436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN8A |
0.309282521902374 |
|
8437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K10 |
0.309375377644677 |
|
8438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC9B |
0.309375377644677 |
|
8439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGXB3 |
0.30938752688507 |
|
8440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238369.1 |
0.30938752688507 |
|
8441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSF1R |
0.30938752688507 |
|
8442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP2 |
0.30940295562588 |
|
8443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL33 |
0.309448126352113 |
|
8444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf38 |
0.309448126352113 |
|
8445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLDC |
0.309448126352113 |
|
8446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM4C |
0.309448126352113 |
|
8447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL123P |
0.309448126352113 |
|
8448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL25P |
0.309448126352113 |
|
8449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPD52L3 |
0.309448126352113 |
|
8450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UHRF2 |
0.309448126352113 |
|
8451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252110.1 |
0.309448126352113 |
|
8452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOL1 |
0.309485635165748 |
|
8453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RACGAP1 |
0.309512573328483 |
|
8454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00899 |
0.309626316349896 |
|
8455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOX1 |
0.309840992420362 |
|
8456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF562 |
0.31002335290327 |
|
8457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC27A6 |
0.310265448022224 |
|
8458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM21 |
0.310290295542902 |
|
8459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD70|ENSG00000212534.1 |
0.310316654096528 |
|
8460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD70|ENSG00000212309.1 |
0.310316654096528 |
|
8461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB3A2 |
0.310470672426359 |
|
8462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf46 |
0.310470672426359 |
|
8463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM170A |
0.310569181384149 |
|
8464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC17 |
0.31071388816194 |
|
8465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOTCH3 |
0.310773951730748 |
|
8466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A2 |
0.310873396918035 |
|
8467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRKH |
0.311000046855059 |
|
8468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP325 |
0.311029860585882 |
|
8469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBLB |
0.311067122612417 |
|
8470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D10A |
0.311121545663501 |
|
8471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC61G |
0.311172771895898 |
|
8472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBX2 |
0.311258601099632 |
|
8473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THY1 |
0.311301250776206 |
|
8474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTBP4 |
0.311305731973485 |
|
8475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL758P |
0.311305731973485 |
|
8476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHKBP1 |
0.311305731973485 |
|
8477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD7 |
0.311329539138854 |
|
8478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCP1 |
0.311435040580661 |
|
8479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLI3 |
0.311454887772566 |
|
8480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAHD2CP |
0.311533794728662 |
|
8481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL210P |
0.311533794728662 |
|
8482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGM3 |
0.311554229309622 |
|
8483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC1A6 |
0.311556265538156 |
|
8484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF417 |
0.311632947322202 |
|
8485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THBS4 |
0.311807967664774 |
|
8486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4269 |
0.311936271833899 |
|
8487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2467 |
0.311936271833899 |
|
8488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1293 |
0.312008903641208 |
|
8489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK14 |
0.312091584778426 |
|
8490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM185A |
0.312092946822323 |
|
8491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E2F2 |
0.312133640745312 |
|
8492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BST1 |
0.312211384311679 |
|
8493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE2A |
0.312280196105657 |
|
8494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11|ENSG00000221060.1 |
0.312674326018504 |
|
8495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAMP1 |
0.312824165955256 |
|
8496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF23 |
0.31282452985383 |
|
8497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABARAP |
0.31282452985383 |
|
8498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTDNEP1 |
0.31282452985383 |
|
8499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELP5 |
0.31282452985383 |
|
8500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCO3 |
0.312835026362621 |
|
8501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IAH1 |
0.312909383951711 |
|
8502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A6 |
0.312918595215976 |
|
8503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0196 |
0.313080203683656 |
|
8504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR3 |
0.313095023858673 |
|
8505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF641 |
0.313153114170446 |
|
8506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDHAL6B |
0.313180365593807 |
|
8507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDGFRB |
0.313181329582273 |
|
8508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAKMIP2 |
0.313209285658291 |
|
8509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GALNT1 |
0.313217273430904 |
|
8510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPYD |
0.313294829495106 |
|
8511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMYD2 |
0.313414253000381 |
|
8512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALA |
0.313424591065846 |
|
8513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK5 |
0.313431521979562 |
|
8514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATAD2 |
0.313531027192047 |
|
8515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AA1 |
0.313531027192047 |
|
8516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM21P1 |
0.31356468138838 |
|
8517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AATK |
0.313582338053076 |
|
8518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF835 |
0.313656718201525 |
|
8519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC36A2 |
0.313672401072634 |
|
8520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP476 |
0.313748629371361 |
|
8521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL791P |
0.31380631880752 |
|
8522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTLC2 |
0.313819210889831 |
|
8523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX16 |
0.314048174228523 |
|
8524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNJ2BP |
0.314048174228523 |
|
8525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYRM5 |
0.314086117551933 |
|
8526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRAS |
0.314086117551933 |
|
8527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1269A |
0.314131750056868 |
|
8528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHAC2 |
0.314202173858385 |
|
8529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERLEC1 |
0.314202173858385 |
|
8530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA25 |
0.314248138145315 |
|
8531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM19 |
0.314485519303366 |
|
8532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCED1B |
0.314579314037159 |
|
8533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX4 |
0.314633215126944 |
|
8534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK6 |
0.314690274622487 |
|
8535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238756.1 |
0.314748105299982 |
|
8536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3682 |
0.314748105299982 |
|
8537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD39|ENSG00000263723.1 |
0.314854135564493 |
|
8538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBS10 |
0.314854312968956 |
|
8539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IAPP |
0.314870109127674 |
|
8540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC14L2 |
0.314913126835964 |
|
8541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1658 |
0.314913126835964 |
|
8542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTFP1 |
0.314913126835964 |
|
8543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPP1 |
0.314998436117625 |
|
8544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMZ1 |
0.315250002202512 |
|
8545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK4 |
0.315313547007089 |
|
8546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL496P |
0.315337232301257 |
|
8547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP58 |
0.315339425958636 |
|
8548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL241P |
0.315508018341823 |
|
8549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K8 |
0.315508018341823 |
|
8550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKI |
0.315535981443432 |
|
8551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTGF |
0.315584223063713 |
|
8552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf47 |
0.315636623359875 |
|
8553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A7 |
0.315769001736102 |
|
8554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOP58 |
0.315973607804815 |
|
8555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD11B |
0.315973607804815 |
|
8556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD11|ENSG00000238317.1 |
0.315973607804815 |
|
8557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PISD |
0.316184145810306 |
|
8558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRM2B |
0.316188488535887 |
|
8559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548H5 |
0.316208955724519 |
|
8560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP245 |
0.316208955724519 |
|
8561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNLRB1 |
0.316287284941591 |
|
8562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP1LC3A |
0.316287284941591 |
|
8563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGU |
0.316287284941591 |
|
8564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP12 |
0.316374070069693 |
|
8565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ00104 |
0.316428868084134 |
|
8566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC4 |
0.316428868084134 |
|
8567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR1B |
0.316457821646105 |
|
8568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD36B |
0.316457821646105 |
|
8569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD36 |
0.316457821646105 |
|
8570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX5B |
0.316457821646105 |
|
8571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAHD2B |
0.316457821646105 |
|
8572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL313P |
0.316457821646105 |
|
8573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCNKA |
0.316525466438025 |
|
8574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCNKB |
0.316525466438025 |
|
8575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM131C |
0.316525466438025 |
|
8576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APPL2 |
0.316537720266791 |
|
8577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf86 |
0.316597152202883 |
|
8578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252709.1 |
0.316597152202883 |
|
8579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAB21L2 |
0.316710813128811 |
|
8580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF680 |
0.316741453819035 |
|
8581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BSDC1 |
0.316765242778336 |
|
8582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00966 |
0.316783266305581 |
|
8583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELP2 |
0.316859711070081 |
|
8584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOCOS |
0.316859711070081 |
|
8585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR30E |
0.316881309284059 |
|
8586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF814 |
0.316934727001109 |
|
8587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF587 |
0.316934727001109 |
|
8588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CWC25 |
0.316963781875065 |
|
8589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4727 |
0.316963781875065 |
|
8590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf98 |
0.316963781875065 |
|
8591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC4 |
0.316972214028218 |
|
8592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACYP2 |
0.316984044527067 |
|
8593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf73 |
0.316984044527067 |
|
8594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPYL6 |
0.316984044527067 |
|
8595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF11 |
0.31701276782716 |
|
8596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR765 |
0.31701276782716 |
|
8597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKN1 |
0.31702403681063 |
|
8598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP250 |
0.317039595682825 |
|
8599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238557.1 |
0.317039595682825 |
|
8600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212590.1 |
0.317039595682825 |
|
8601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB1 |
0.317161352530293 |
|
8602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR639 |
0.317161352530293 |
|
8603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TECR |
0.317161352530293 |
|
8604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB7 |
0.317161352530293 |
|
8605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPYS |
0.317196211767269 |
|
8606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548A3 |
0.317196211767269 |
|
8607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL18A1 |
0.317297242903696 |
|
8608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00205 |
0.317297242903696 |
|
8609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00315 |
0.317297242903696 |
|
8610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00316 |
0.317297242903696 |
|
8611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00334 |
0.317297242903696 |
|
8612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POFUT2 |
0.317297242903696 |
|
8613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC19A1 |
0.317297242903696 |
|
8614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYT1L |
0.317308000468861 |
|
8615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEY1 |
0.317322430072242 |
|
8616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL337P |
0.317325956708583 |
|
8617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL842P |
0.317325956708583 |
|
8618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFNA1 |
0.317334132540538 |
|
8619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPM3 |
0.317334132540538 |
|
8620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC50A1 |
0.317334132540538 |
|
8621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1R1 |
0.317382954674932 |
|
8622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PELI2 |
0.317422625851301 |
|
8623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INHBA |
0.317459438365937 |
|
8624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDX1 |
0.317472357690274 |
|
8625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST3 |
0.317603425509126 |
|
8626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A4 |
0.317649954598442 |
|
8627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF35 |
0.31773170706304 |
|
8628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF5 |
0.31773170706304 |
|
8629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAGE4 |
0.31773170706304 |
|
8630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAGE8 |
0.31773170706304 |
|
8631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOBOX |
0.31773170706304 |
|
8632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A1 |
0.31773170706304 |
|
8633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A20P |
0.31773170706304 |
|
8634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A42 |
0.31773170706304 |
|
8635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A7 |
0.31773170706304 |
|
8636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A9P |
0.31773170706304 |
|
8637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC40P |
0.31773170706304 |
|
8638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSSK3 |
0.317817891640652 |
|
8639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM229A |
0.317817891640652 |
|
8640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NACAD |
0.317903337315225 |
|
8641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBRG4 |
0.317903337315225 |
|
8642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA5A |
0.317903337315225 |
|
8643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA5B |
0.317903337315225 |
|
8644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA5C |
0.317903337315225 |
|
8645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAMP3 |
0.317903337315225 |
|
8646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALE |
0.318002436967805 |
|
8647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPLA2 |
0.318002436967805 |
|
8648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSC |
0.318076313937305 |
|
8649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KREMEN2 |
0.318077678236595 |
|
8650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAQR4 |
0.318077678236595 |
|
8651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKMYT1 |
0.318077678236595 |
|
8652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GAT3 |
0.318115916560798 |
|
8653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GANAB |
0.318115916560798 |
|
8654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIMT1 |
0.318180357410223 |
|
8655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5692B |
0.318406364754555 |
|
8656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX12 |
0.318433396155036 |
|
8657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL746P |
0.318433396155036 |
|
8658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRK |
0.318456476983493 |
|
8659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5DC1 |
0.318456476983493 |
|
8660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238796.1 |
0.31846457852992 |
|
8661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL603P |
0.31847928184584 |
|
8662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZHX2 |
0.3187078060799 |
|
8663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EML3 |
0.318723219840562 |
|
8664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROM1 |
0.318723219840562 |
|
8665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNLR1 |
0.318814607449658 |
|
8666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP306 |
0.318865064665691 |
|
8667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL753P |
0.318901691294746 |
|
8668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL40P |
0.318901691294746 |
|
8669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD9 |
0.318926057189445 |
|
8670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NACAP1 |
0.318934798912683 |
|
8671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL563P |
0.318934798912683 |
|
8672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSM |
0.318985778734424 |
|
8673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf65 |
0.319036906769566 |
|
8674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXO4 |
0.319036906769566 |
|
8675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL2RG |
0.319036906769566 |
|
8676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSCB |
0.319237766935824 |
|
8677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPC5 |
0.319354981469335 |
|
8678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIP4K2B |
0.319402822568186 |
|
8679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
G3BP1 |
0.319518984254732 |
|
8680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS17A |
0.319560410486631 |
|
8681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS14 |
0.319560410486631 |
|
8682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD17 |
0.319581812572884 |
|
8683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGK3 |
0.319605116078822 |
|
8684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A11P |
0.31963394006439 |
|
8685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLIPR1 |
0.319711570372812 |
|
8686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRR1 |
0.319711570372812 |
|
8687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf57 |
0.31975328585955 |
|
8688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPY19L2P2 |
0.319765060763891 |
|
8689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MELK |
0.319868936200176 |
|
8690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDHB |
0.319883415935078 |
|
8691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ8 |
0.319883415935078 |
|
8692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC9 |
0.319883415935078 |
|
8693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATSL3 |
0.319886208182369 |
|
8694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK1G2 |
0.320119604599392 |
|
8695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMGDH |
0.320138437207425 |
|
8696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7C1 |
0.32016113302452 |
|
8697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL246P |
0.320220512177655 |
|
8698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AAGAB |
0.320229241084065 |
|
8699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDS2 |
0.320285305554235 |
|
8700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIP11 |
0.320314177909561 |
|
8701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf80 |
0.320454180393372 |
|
8702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT80 |
0.320454180393372 |
|
8703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMPR1B |
0.320559552114771 |
|
8704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAML2 |
0.320664706994352 |
|
8705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCA2B |
0.320689688835704 |
|
8706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCA2A |
0.320689688835704 |
|
8707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA21|ENSG00000252699.1 |
0.32072873661713 |
|
8708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2A1 |
0.320730573351332 |
|
8709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMPR2 |
0.320798440562589 |
|
8710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP38 |
0.320803998824781 |
|
8711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPH |
0.320875186848918 |
|
8712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBLN5 |
0.320889239066717 |
|
8713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGCL |
0.320914012516696 |
|
8714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP97 |
0.320949416843868 |
|
8715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP64 |
0.321102960187653 |
|
8716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA1A |
0.321170799361232 |
|
8717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL259P |
0.321244456756717 |
|
8718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOP2 |
0.321283495907433 |
|
8719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIPOX |
0.321397986756673 |
|
8720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF135 |
0.321417795972234 |
|
8721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ID3 |
0.321421332071573 |
|
8722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB3 |
0.321438383293008 |
|
8723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACKR6 |
0.321501119687833 |
|
8724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINA7 |
0.321670151147028 |
|
8725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYPL2 |
0.321684731416495 |
|
8726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A24 |
0.321704540347041 |
|
8727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A25 |
0.321704540347041 |
|
8728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAR1A |
0.321790234236229 |
|
8729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTS |
0.321793963670877 |
|
8730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HINT1 |
0.321800640609841 |
|
8731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYRM7 |
0.321800640609841 |
|
8732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA79|ENSG00000221303.1 |
0.321874745668216 |
|
8733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5197 |
0.322077097972127 |
|
8734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRFAP1 |
0.322085600207645 |
|
8735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIPC1 |
0.32213326007529 |
|
8736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGER1 |
0.32213326007529 |
|
8737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLIS2 |
0.322199110970016 |
|
8738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAM16 |
0.322199110970016 |
|
8739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VASN |
0.322199110970016 |
|
8740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLYWCH1 |
0.322334375109374 |
|
8741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000252550.1 |
0.322345244546073 |
|
8742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS12 |
0.322369577460576 |
|
8743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP182 |
0.322375862185521 |
|
8744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F11 |
0.322377234207747 |
|
8745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4450 |
0.322390037495675 |
|
8746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AH |
0.322390037495675 |
|
8747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPCAT4 |
0.322394633998537 |
|
8748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8A |
0.322394633998537 |
|
8749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8B |
0.322394633998537 |
|
8750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA18|ENSG00000252425.1 |
0.322394633998537 |
|
8751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMEK1 |
0.322398803967446 |
|
8752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLIRP |
0.322470093553665 |
|
8753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNW1 |
0.322470093553665 |
|
8754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFNB2 |
0.322518753175343 |
|
8755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCAT2 |
0.322605629885792 |
|
8756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCAT1 |
0.322605629885792 |
|
8757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZRN4 |
0.322621152340241 |
|
8758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238311.1 |
0.322671330532563 |
|
8759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4511 |
0.322671330532563 |
|
8760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB11A |
0.322671330532563 |
|
8761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSCAML1 |
0.322784243629396 |
|
8762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RORA |
0.322790451723054 |
|
8763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM4 |
0.322901866733225 |
|
8764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4474 |
0.32293072578753 |
|
8765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAQR3 |
0.322955192711003 |
|
8766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE3A |
0.322964298350884 |
|
8767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELN |
0.3230447010006 |
|
8768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTBN4 |
0.323113771327402 |
|
8769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSCC1 |
0.32316065021832 |
|
8770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL396P |
0.32316065021832 |
|
8771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP277 |
0.32316065021832 |
|
8772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZIK1 |
0.3232242455363 |
|
8773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP4A |
0.323394018627524 |
|
8774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R5E |
0.323395753607384 |
|
8775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL540P |
0.323395753607384 |
|
8776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA20|ENSG00000252800.1 |
0.323395753607384 |
|
8777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGDH |
0.323413908372428 |
|
8778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP2A2 |
0.323498024608139 |
|
8779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC91 |
0.323539740710825 |
|
8780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM14 |
0.323555828430525 |
|
8781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTT |
0.323592333924921 |
|
8782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P1 |
0.323838962147713 |
|
8783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA18|ENSG00000206592.1 |
0.323838962147713 |
|
8784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JMY |
0.323838962147713 |
|
8785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00907 |
0.323911532645145 |
|
8786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR584 |
0.323948936915754 |
|
8787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7C2 |
0.323960183688425 |
|
8788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf47 |
0.324009368337594 |
|
8789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5586 |
0.324015400094728 |
|
8790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPP1 |
0.324149936185455 |
|
8791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX5 |
0.324273931420778 |
|
8792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASL10B |
0.324292940378 |
|
8793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP28 |
0.324292940378 |
|
8794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF15 |
0.324292940378 |
|
8795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf66 |
0.324292940378 |
|
8796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL5 |
0.324292940378 |
|
8797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP274 |
0.324292940378 |
|
8798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OVOL2 |
0.324524329945658 |
|
8799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DERL1 |
0.324545812530926 |
|
8800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCR10 |
0.324618202742927 |
|
8801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC88C |
0.324624529977201 |
|
8802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ILKAP |
0.324813443886316 |
|
8803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL613P |
0.324889299612076 |
|
8804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0247 |
0.324894202855869 |
|
8805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS37D |
0.324949070517754 |
|
8806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0895 |
0.324950647830429 |
|
8807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANLN |
0.324950647830429 |
|
8808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRHL3 |
0.324964581953029 |
|
8809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STPG1 |
0.324964581953029 |
|
8810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP396 |
0.324967727548046 |
|
8811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCNT3 |
0.324967727548046 |
|
8812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF3IP3 |
0.325000992881623 |
|
8813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf74 |
0.325000992881623 |
|
8814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2116 |
0.325006020663304 |
|
8815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A5 |
0.325111636849991 |
|
8816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA5A |
0.325111636849991 |
|
8817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTTP |
0.325266812863684 |
|
8818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LASP1 |
0.325440974203656 |
|
8819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00672 |
0.325440974203656 |
|
8820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO47 |
0.325440974203656 |
|
8821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS18 |
0.325608025875314 |
|
8822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf64 |
0.325680766639787 |
|
8823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPB7 |
0.325680766639787 |
|
8824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMC4 |
0.325763027280048 |
|
8825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR15B |
0.325763027280048 |
|
8826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM59 |
0.325763027280048 |
|
8827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA7 |
0.325763027280048 |
|
8828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SESN3 |
0.325774862933293 |
|
8829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADK |
0.325801435427152 |
|
8830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX9 |
0.325823258698389 |
|
8831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MNS1 |
0.325823258698389 |
|
8832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF21B |
0.325840670641245 |
|
8833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
A2MP1 |
0.325975119878941 |
|
8834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00987 |
0.325975119878941 |
|
8835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA75|ENSG00000212432.1 |
0.325975119878941 |
|
8836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA75|ENSG00000212440.1 |
0.325975119878941 |
|
8837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0825 |
0.325996816601687 |
|
8838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238767.1 |
0.326028673122966 |
|
8839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSRP2BP |
0.326035626773867 |
|
8840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PXDN |
0.326065745650294 |
|
8841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNTG2 |
0.326065745650294 |
|
8842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPO |
0.326065745650294 |
|
8843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORC2 |
0.326098239525609 |
|
8844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC51B |
0.326115505965707 |
|
8845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASL12 |
0.326115505965707 |
|
8846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD13 |
0.326115505965707 |
|
8847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCKSL1 |
0.326140343893965 |
|
8848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP355 |
0.326181815665557 |
|
8849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP6 |
0.326359081481561 |
|
8850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP8 |
0.326361412538291 |
|
8851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAP1 |
0.326432126773025 |
|
8852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBA6 |
0.326432126773025 |
|
8853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC24A4 |
0.326495701959755 |
|
8854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIPIN |
0.326514420521778 |
|
8855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC2HC1A |
0.3266067184423 |
|
8856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRA |
0.326658187080539 |
|
8857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15ORF31 |
0.326669407338811 |
|
8858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGDCC3 |
0.326698603803322 |
|
8859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PET117 |
0.326736541556143 |
|
8860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP12A |
0.326746115855064 |
|
8861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP12B |
0.326746115855064 |
|
8862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF1A |
0.326746115855064 |
|
8863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMK1 |
0.326846527095954 |
|
8864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGK1 |
0.326853028556371 |
|
8865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3TC2 |
0.326888404150606 |
|
8866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD56B |
0.326954104062199 |
|
8867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2276 |
0.326957258792973 |
|
8868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA5 |
0.326987295828068 |
|
8869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000252352.1 |
0.326987295828068 |
|
8870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2K6 |
0.326987295828068 |
|
8871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASA4CP |
0.327009311396685 |
|
8872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00957 |
0.327009311396685 |
|
8873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP135 |
0.327086264165283 |
|
8874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP145 |
0.327119181178948 |
|
8875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABLIM3 |
0.327119181178948 |
|
8876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP184 |
0.3271970601782 |
|
8877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A2 |
0.327197983712872 |
|
8878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3912 |
0.327199722449643 |
|
8879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C18orf21 |
0.327213731310295 |
|
8880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPRD1A |
0.327213731310295 |
|
8881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAIAP2 |
0.327410487501005 |
|
8882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRMT8 |
0.327468479684481 |
|
8883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP40 |
0.327470310369893 |
|
8884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf96 |
0.327624736338004 |
|
8885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4734 |
0.327624736338004 |
|
8886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLLT6 |
0.327624736338004 |
|
8887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC177|ENSG00000255994.1 |
0.327796448103747 |
|
8888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC177|ENSG00000267909.1 |
0.327796448103747 |
|
8889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF773 |
0.327939975802521 |
|
8890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCGF6 |
0.328011839747744 |
|
8891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF5 |
0.328011839747744 |
|
8892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF274 |
0.328017172811679 |
|
8893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SARS2 |
0.328170548563677 |
|
8894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO17 |
0.328170548563677 |
|
8895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN9 |
0.328211566021905 |
|
8896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP169 |
0.328271147016889 |
|
8897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF879 |
0.328284473067491 |
|
8898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF354C |
0.328284473067491 |
|
8899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA2026 |
0.328428294251533 |
|
8900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA36|ENSG00000200294.1 |
0.328435682298576 |
|
8901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC15P |
0.328449731541876 |
|
8902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPEAR |
0.328503830361145 |
|
8903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD1 |
0.328617508950508 |
|
8904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAPEPLD |
0.328658079794721 |
|
8905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf63 |
0.328658299550616 |
|
8906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHCE |
0.328658299550616 |
|
8907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHD |
0.328658299550616 |
|
8908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYF2 |
0.328658299550616 |
|
8909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM50A |
0.328658299550616 |
|
8910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238889.1 |
0.328658299550616 |
|
8911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAFD1 |
0.328855180235259 |
|
8912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL391P |
0.328969004035442 |
|
8913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5683 |
0.329162425858064 |
|
8914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COA5 |
0.329163523727188 |
|
8915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC50 |
0.329163523727188 |
|
8916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP5P3 |
0.329191779155986 |
|
8917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUCA1 |
0.329431882766677 |
|
8918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNR2 |
0.329431882766677 |
|
8919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL24P |
0.329431882766677 |
|
8920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238538.1 |
0.329431882766677 |
|
8921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTYH3 |
0.329533458347301 |
|
8922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORT1 |
0.329553513452109 |
|
8923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL102P |
0.329643760142674 |
|
8924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTA2 |
0.329795090272867 |
|
8925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNIP1 |
0.329913437223973 |
|
8926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F13A1 |
0.330109337469198 |
|
8927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERC1 |
0.330121071758255 |
|
8928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAV3 |
0.330141642825061 |
|
8929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238654.1 |
0.33017397579166 |
|
8930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTP1 |
0.330214418641935 |
|
8931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MASP1 |
0.330214418641935 |
|
8932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBK |
0.330238014755888 |
|
8933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX39A |
0.330328906981499 |
|
8934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXTR |
0.330334625282418 |
|
8935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTP4 |
0.330437845120827 |
|
8936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP69 |
0.330515504782004 |
|
8937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTCB |
0.330569177002597 |
|
8938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM178B |
0.330706579835556 |
|
8939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCM2 |
0.330764089782519 |
|
8940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238714.1 |
0.330823324876203 |
|
8941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLANA |
0.330847246483671 |
|
8942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239093.1 |
0.330908756255328 |
|
8943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KMT2E |
0.330913778079439 |
|
8944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM132E |
0.330922296887245 |
|
8945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL14A1 |
0.331004350577563 |
|
8946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52K2 |
0.331043165700526 |
|
8947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52K1 |
0.331043165700526 |
|
8948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXN2 |
0.331082483691695 |
|
8949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR595 |
0.331132215829606 |
|
8950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5707 |
0.331132215829606 |
|
8951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESYT2 |
0.331132215829606 |
|
8952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00689 |
0.331132215829606 |
|
8953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAPG2 |
0.331132215829606 |
|
8954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VIPR2 |
0.331132215829606 |
|
8955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR60 |
0.331132215829606 |
|
8956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCN2 |
0.331171144732895 |
|
8957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF416 |
0.331282177133541 |
|
8958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239173.1 |
0.331287132471991 |
|
8959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00032 |
0.331437001206226 |
|
8960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EQTN |
0.331437001206226 |
|
8961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTN1 |
0.33144179697305 |
|
8962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPP7 |
0.331555105512411 |
|
8963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX2 |
0.331555105512411 |
|
8964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM21 |
0.331585729577572 |
|
8965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM20P1 |
0.331585729577572 |
|
8966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM20 |
0.331585729577572 |
|
8967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221043.1 |
0.331615054345972 |
|
8968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALHM1 |
0.33172433169069 |
|
8969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALHM2 |
0.33172433169069 |
|
8970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1307 |
0.33172433169069 |
|
8971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD11 |
0.33172433169069 |
|
8972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USMG5 |
0.33172433169069 |
|
8973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALHM3 |
0.33172433169069 |
|
8974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEURL |
0.33172433169069 |
|
8975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP346 |
0.331728891207446 |
|
8976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF6 |
0.331733682797099 |
|
8977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP162 |
0.331864105274842 |
|
8978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF10 |
0.332009827811064 |
|
8979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP172 |
0.332045704032227 |
|
8980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PELO |
0.332067052274313 |
|
8981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPPK1 |
0.332257351510417 |
|
8982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRAF |
0.332262213590943 |
|
8983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000271932.1 |
0.332262213590943 |
|
8984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKP1 |
0.332311711281892 |
|
8985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRK |
0.332321186639012 |
|
8986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP19A1 |
0.332333367939518 |
|
8987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POP4 |
0.332469436220537 |
|
8988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL138P |
0.332511347376151 |
|
8989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNNM2 |
0.332523798325561 |
|
8990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPP3 |
0.332655561044699 |
|
8991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5C2 |
0.332713162566185 |
|
8992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INA |
0.332713162566185 |
|
8993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK2A |
0.332759989523344 |
|
8994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSI |
0.332759989523344 |
|
8995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RYR1 |
0.332769848251085 |
|
8996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYTH1 |
0.333056687264545 |
|
8997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP347 |
0.333057068669156 |
|
8998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSHR |
0.333077020047782 |
|
8999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATRN |
0.333108790161398 |
|
9000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFB2 |
0.33314576049765 |
|
9001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP16 |
0.333146142585703 |
|
9002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNMT |
0.333155755020625 |
|
9003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTSSB |
0.333201442549804 |
|
9004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1250 |
0.333210233050415 |
|
9005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR338 |
0.333210233050415 |
|
9006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR657 |
0.333210233050415 |
|
9007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP1 |
0.333259127782539 |
|
9008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHYHIP |
0.333259127782539 |
|
9009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR320A |
0.333259127782539 |
|
9010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3D |
0.333259127782539 |
|
9011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIVEP2 |
0.33335142809321 |
|
9012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS7 |
0.333396984211764 |
|
9013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00923 |
0.333421026404225 |
|
9014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGME1 |
0.333497573811039 |
|
9015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPTOR |
0.333570352698541 |
|
9016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP4K1 |
0.333738327470563 |
|
9017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO1B3 |
0.333743433457983 |
|
9018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LST3 |
0.333743433457983 |
|
9019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO1B7 |
0.333743433457983 |
|
9020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB27A |
0.333784216248141 |
|
9021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGB |
0.333784216248141 |
|
9022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCPG1 |
0.333784216248141 |
|
9023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR628 |
0.333784216248141 |
|
9024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf65 |
0.333784216248141 |
|
9025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYX1C1 |
0.333784216248141 |
|
9026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF333 |
0.333876427932187 |
|
9027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK1 |
0.333904585955082 |
|
9028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KEAP1 |
0.333911986978233 |
|
9029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00514 |
0.333916425463269 |
|
9030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP5B |
0.333959975221599 |
|
9031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000252448.1 |
0.333959975221599 |
|
9032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP39 |
0.334076575688682 |
|
9033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYC |
0.334192715824418 |
|
9034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC18 |
0.334193463466304 |
|
9035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238983.1 |
0.334193463466304 |
|
9036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIG4 |
0.334233184915748 |
|
9037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD13 |
0.334233184915748 |
|
9038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF13B |
0.334233184915748 |
|
9039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM27 |
0.334243627732536 |
|
9040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASL10A |
0.334283918270045 |
|
9041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD125 |
0.334283918270045 |
|
9042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARS2 |
0.334305346326887 |
|
9043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM116 |
0.334379742676253 |
|
9044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERP29 |
0.334379742676253 |
|
9045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3657 |
0.334379742676253 |
|
9046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00524 |
0.334618484334229 |
|
9047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TADA2A |
0.334723599292074 |
|
9048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3922 |
0.334730478777401 |
|
9049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPSF3 |
0.334755070726086 |
|
9050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2H2B |
0.334853322489718 |
|
9051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2H2C |
0.334853322489718 |
|
9052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2H2 |
0.334853322489718 |
|
9053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUSBP3 |
0.334853322489718 |
|
9054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAIP |
0.334853322489718 |
|
9055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCLN |
0.334853322489718 |
|
9056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL476P |
0.334853322489718 |
|
9057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL616P |
0.334853322489718 |
|
9058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL9P |
0.334853322489718 |
|
9059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERF1A |
0.334853322489718 |
|
9060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERF1B |
0.334853322489718 |
|
9061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMN1 |
0.334853322489718 |
|
9062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMN2 |
0.334853322489718 |
|
9063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238451.1 |
0.334853322489718 |
|
9064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238740.1 |
0.334853322489718 |
|
9065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEK |
0.335001329467847 |
|
9066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL532P |
0.335003126742255 |
|
9067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf143 |
0.335033974495122 |
|
9068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPZA3 |
0.33512530142265 |
|
9069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS11B |
0.335125607209274 |
|
9070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUX1 |
0.335276832230301 |
|
9071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTX1 |
0.335387687128837 |
|
9072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBIL5P2 |
0.335387687128837 |
|
9073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THRAP3 |
0.335484694816448 |
|
9074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL8P |
0.335520094146253 |
|
9075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3F |
0.335527763737131 |
|
9076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3192 |
0.335527763737131 |
|
9077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS5 |
0.335652916703359 |
|
9078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL326P |
0.335711169400492 |
|
9079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTNL8 |
0.335720631273966 |
|
9080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTNL3 |
0.335720631273966 |
|
9081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTNL9 |
0.335720631273966 |
|
9082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNB2L1 |
0.335720631273966 |
|
9083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4638 |
0.335720631273966 |
|
9084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2V1 |
0.335720631273966 |
|
9085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2V2 |
0.335720631273966 |
|
9086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F3 |
0.335720631273966 |
|
9087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD95|ENSG00000264549.1 |
0.335720631273966 |
|
9088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD96A |
0.335720631273966 |
|
9089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM41 |
0.335720631273966 |
|
9090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM52 |
0.335720631273966 |
|
9091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM7 |
0.335720631273966 |
|
9092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFX7 |
0.335783894968026 |
|
9093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf100 |
0.335789104094983 |
|
9094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4520B |
0.335789104094983 |
|
9095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RB1CC1 |
0.33589741225188 |
|
9096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM182 |
0.336066763496531 |
|
9097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKDC |
0.33624846928428 |
|
9098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR588 |
0.336404351331934 |
|
9099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL19 |
0.336520169652777 |
|
9100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHEK2 |
0.3366136606754 |
|
9101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKZF1 |
0.336704517913052 |
|
9102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIGNL1 |
0.336704517913052 |
|
9103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDC |
0.336704517913052 |
|
9104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL23 |
0.33674683047615 |
|
9105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA21|ENSG00000199293.1 |
0.33674683047615 |
|
9106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC4 |
0.336836508132737 |
|
9107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAG2 |
0.336838817947448 |
|
9108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND3 |
0.336882272743819 |
|
9109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP397 |
0.336940080164051 |
|
9110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEB3 |
0.337002090539519 |
|
9111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL10P |
0.337237175155864 |
|
9112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NELL2 |
0.337297240094574 |
|
9113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT12 |
0.337434656252001 |
|
9114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR2C1 |
0.337443359432019 |
|
9115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGD6 |
0.337443359432019 |
|
9116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE10 |
0.337459479107792 |
|
9117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12B |
0.337459479107792 |
|
9118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12C |
0.337459479107792 |
|
9119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12D |
0.337459479107792 |
|
9120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12E |
0.337459479107792 |
|
9121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12F |
0.337459479107792 |
|
9122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12G |
0.337459479107792 |
|
9123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12H |
0.337459479107792 |
|
9124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12I |
0.337459479107792 |
|
9125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE12J |
0.337459479107792 |
|
9126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE13 |
0.337459479107792 |
|
9127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE2B |
0.337459479107792 |
|
9128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE2C |
0.337459479107792 |
|
9129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE2D |
0.337459479107792 |
|
9130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE2E |
0.337459479107792 |
|
9131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPB |
0.337490399119626 |
|
9132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD119 |
0.337490399119626 |
|
9133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF343 |
0.337490399119626 |
|
9134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHLHA9 |
0.337665224034659 |
|
9135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUSC5 |
0.337665224034659 |
|
9136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB4B |
0.337845622040415 |
|
9137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFBP3 |
0.33786180355437 |
|
9138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBS1L |
0.337873125951066 |
|
9139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTXN1 |
0.33787882713361 |
|
9140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0D1 |
0.337960675262209 |
|
9141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA62|ENSG00000201157.1 |
0.338089187823342 |
|
9142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEDD4 |
0.33821382078876 |
|
9143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238513.1 |
0.33821382078876 |
|
9144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL568P |
0.33821382078876 |
|
9145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL14 |
0.338231023786585 |
|
9146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF619 |
0.338231023786585 |
|
9147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF620 |
0.338231023786585 |
|
9148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF621 |
0.338231023786585 |
|
9149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCZ1 |
0.338269885571478 |
|
9150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP118 |
0.3382715310338 |
|
9151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC36 |
0.3382715310338 |
|
9152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPPP3 |
0.3382715310338 |
|
9153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC1 |
0.3382715310338 |
|
9154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD11B2 |
0.3382715310338 |
|
9155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUNX3 |
0.338388891346197 |
|
9156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSP |
0.338397784944836 |
|
9157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM180 |
0.338536453081478 |
|
9158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF266 |
0.33857928010565 |
|
9159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB16 |
0.338736547960865 |
|
9160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB8 |
0.338736547960865 |
|
9161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP246 |
0.339010742293938 |
|
9162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L9 |
0.339036922587393 |
|
9163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS16 |
0.339208008148108 |
|
9164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN12 |
0.339211659167662 |
|
9165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTPD3 |
0.339228980343824 |
|
9166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLYWCH2 |
0.339234602230462 |
|
9167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STXBP3 |
0.339296143701122 |
|
9168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZRANB1 |
0.339416810470664 |
|
9169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMOC1 |
0.339514205856551 |
|
9170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED1 |
0.339574413136487 |
|
9171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MACROD2 |
0.339593438640499 |
|
9172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLOC1S5 |
0.339627170439334 |
|
9173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF1E1 |
0.339627170439334 |
|
9174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC23A2 |
0.339661247057728 |
|
9175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BANP |
0.339695647801794 |
|
9176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY86 |
0.33973389447866 |
|
9177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASAP3 |
0.339738562602736 |
|
9178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAI3 |
0.339743126653971 |
|
9179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPUL1 |
0.339763728598498 |
|
9180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGM6 |
0.339777508931143 |
|
9181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHMT2 |
0.339876423516724 |
|
9182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHMT |
0.339876423516724 |
|
9183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOC |
0.339920149537384 |
|
9184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGOLN2 |
0.339980860204424 |
|
9185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS11 |
0.340010027576211 |
|
9186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMBS |
0.340010027576211 |
|
9187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPAGT1 |
0.340010027576211 |
|
9188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFX |
0.340010027576211 |
|
9189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMOX1 |
0.340035408496282 |
|
9190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf33 |
0.340060198791944 |
|
9191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC33A1 |
0.340060198791944 |
|
9192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMPS |
0.340060198791944 |
|
9193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTF3 |
0.340178774235669 |
|
9194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRA2 |
0.340178774235669 |
|
9195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP15 |
0.340178774235669 |
|
9196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISOC1 |
0.340182025609929 |
|
9197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4633 |
0.340182025609929 |
|
9198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPCDR1 |
0.34021700846938 |
|
9199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212211.1 |
0.34021700846938 |
|
9200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP190 |
0.340305136017623 |
|
9201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238321.1 |
0.340305136017623 |
|
9202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMR2 |
0.340372926935535 |
|
9203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL824P |
0.340418483405928 |
|
9204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTN4 |
0.340426479582014 |
|
9205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4701 |
0.340490137138924 |
|
9206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHEBL1 |
0.340546997761316 |
|
9207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHH |
0.340546997761316 |
|
9208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMBR1L |
0.340546997761316 |
|
9209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP12 |
0.340651288375331 |
|
9210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCH1 |
0.34068474355057 |
|
9211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC9P |
0.34068474355057 |
|
9212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4308 |
0.34068474355057 |
|
9213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFNA3 |
0.340691728876611 |
|
9214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP82 |
0.340715934936143 |
|
9215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOAT1 |
0.340746702990841 |
|
9216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3D21 |
0.34079214772759 |
|
9217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VDAC3 |
0.340849287595234 |
|
9218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL25 |
0.341017393235586 |
|
9219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2CD2L |
0.341070868819517 |
|
9220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf46 |
0.341115285192186 |
|
9221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4692 |
0.341165265413832 |
|
9222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUT1 |
0.341175259817666 |
|
9223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAGE9 |
0.341177220424072 |
|
9224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3163 |
0.34135530875745 |
|
9225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAD3 |
0.341402497439063 |
|
9226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCA4 |
0.341412917735487 |
|
9227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBP1 |
0.341440647532496 |
|
9228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDN |
0.34144606515435 |
|
9229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAG1 |
0.34144606515435 |
|
9230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KMT2D |
0.34144606515435 |
|
9231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VDAC1 |
0.341520014903075 |
|
9232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1432 |
0.341656942585709 |
|
9233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM18 |
0.341752651755057 |
|
9234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF1G |
0.341867789804609 |
|
9235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3654 |
0.341867789804609 |
|
9236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSB |
0.341899174637721 |
|
9237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P11 |
0.341915726516806 |
|
9238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00851 |
0.341915726516806 |
|
9239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD11B1 |
0.341950153654292 |
|
9240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOCAD |
0.341957461464325 |
|
9241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX6 |
0.342225993382091 |
|
9242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238462.1 |
0.342306265099604 |
|
9243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf15 |
0.342351858683681 |
|
9244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMCHL2 |
0.34253751919228 |
|
9245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA42 |
0.342733051799393 |
|
9246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AUNIP |
0.342750236396537 |
|
9247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAQR7 |
0.342750236396537 |
|
9248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEND6 |
0.342754735775163 |
|
9249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1586 |
0.342754735775163 |
|
9250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF451 |
0.342754735775163 |
|
9251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC6 |
0.342923082023756 |
|
9252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR130A |
0.343012661371402 |
|
9253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YPEL4 |
0.343012661371402 |
|
9254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX4 |
0.343032944026136 |
|
9255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPAP2 |
0.343169756887599 |
|
9256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM158 |
0.343224712257438 |
|
9257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SST |
0.343304823172819 |
|
9258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTP2 |
0.343304823172819 |
|
9259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL6 |
0.343304823172819 |
|
9260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD19 |
0.343345495516071 |
|
9261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2L6 |
0.343422625712058 |
|
9262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPING1 |
0.343422625712058 |
|
9263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP5 |
0.343479514255715 |
|
9264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000199370.1 |
0.343612308863876 |
|
9265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUV420H1 |
0.343683808163025 |
|
9266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF8 |
0.343721054683446 |
|
9267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPM3 |
0.343721054683446 |
|
9268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf34 |
0.343732506768449 |
|
9269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KEL |
0.343732506768449 |
|
9270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRTCAP2 |
0.343741241727824 |
|
9271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM46 |
0.343741241727824 |
|
9272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRM1 |
0.343764516830744 |
|
9273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH3B1 |
0.34384851998111 |
|
9274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFS8 |
0.34384851998111 |
|
9275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4691 |
0.34384851998111 |
|
9276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCIRG1 |
0.34384851998111 |
|
9277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238463.1 |
0.343858250638663 |
|
9278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHD1 |
0.343933425884569 |
|
9279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf36 |
0.344054836312667 |
|
9280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP353 |
0.344054836312667 |
|
9281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1324 |
0.344217390401683 |
|
9282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAS1 |
0.344309341530023 |
|
9283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4756 |
0.344309341530023 |
|
9284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100P |
0.344319683701268 |
|
9285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRFAP1L1 |
0.344319683701268 |
|
9286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLOC1S4 |
0.344319683701268 |
|
9287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL10A1 |
0.344341541939647 |
|
9288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXYD2 |
0.34443103382733 |
|
9289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP132 |
0.34449169214498 |
|
9290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA21|ENSG00000252409.1 |
0.344535738887499 |
|
9291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000272292.1 |
0.344689893331442 |
|
9292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULK4 |
0.344704768645911 |
|
9293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NVL |
0.344722961227951 |
|
9294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMBR |
0.344822396850077 |
|
9295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMS3 |
0.344944326389784 |
|
9296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C18orf42 |
0.345044493606005 |
|
9297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROCK2 |
0.34515514626201 |
|
9298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf75 |
0.345208130882721 |
|
9299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL554P |
0.345284797983287 |
|
9300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000251762.1 |
0.345284797983287 |
|
9301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI4K2B |
0.345299544451168 |
|
9302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM210A |
0.345315568805885 |
|
9303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL362P |
0.345315568805885 |
|
9304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHBP1 |
0.345434425472739 |
|
9305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYOU1 |
0.345510678646057 |
|
9306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMAIP1 |
0.34562182242258 |
|
9307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL342P |
0.34562182242258 |
|
9308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM179B |
0.345755076493815 |
|
9309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHKA |
0.345758429475744 |
|
9310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN2B2 |
0.345794341787794 |
|
9311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF6L |
0.345895778023575 |
|
9312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM223 |
0.345895778023575 |
|
9313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX56 |
0.345962765338187 |
|
9314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED4 |
0.345962765338187 |
|
9315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED19 |
0.346039504330741 |
|
9316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC37 |
0.346098404313593 |
|
9317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1181 |
0.346098404313593 |
|
9318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP196 |
0.346199526681334 |
|
9319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD2A |
0.346231355375599 |
|
9320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238631.1 |
0.346289705185731 |
|
9321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP218 |
0.346289705185731 |
|
9322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM4B |
0.346309832962562 |
|
9323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTBN2 |
0.346309832962562 |
|
9324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL12P |
0.346309832962562 |
|
9325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf80 |
0.346309832962562 |
|
9326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBDD3 |
0.346341949444032 |
|
9327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL348P |
0.346388862006751 |
|
9328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKDD1A |
0.346388862006751 |
|
9329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALYL |
0.346415665302455 |
|
9330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCJ |
0.346481949985217 |
|
9331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFB1 |
0.346492071924847 |
|
9332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIC4 |
0.346499357218384 |
|
9333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TJP2 |
0.346535457716411 |
|
9334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
L3MBTL4 |
0.346600068159997 |
|
9335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL282P |
0.346600068159997 |
|
9336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL723P |
0.346600068159997 |
|
9337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL6P27 |
0.346600068159997 |
|
9338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUPR1L |
0.346770628736269 |
|
9339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFI1 |
0.346814542309792 |
|
9340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCA2 |
0.346836918850362 |
|
9341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLVS1 |
0.346857205614837 |
|
9342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPD52 |
0.346964508883175 |
|
9343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFLR1 |
0.347021780035354 |
|
9344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN37 |
0.347021780035354 |
|
9345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSENEN |
0.347021780035354 |
|
9346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U2AF1L4 |
0.347021780035354 |
|
9347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf55 |
0.347021780035354 |
|
9348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPB6 |
0.347021780035354 |
|
9349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP33 |
0.347021780035354 |
|
9350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELV |
0.347056051363059 |
|
9351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARGLU1 |
0.347170579483462 |
|
9352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF561 |
0.347462504638125 |
|
9353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R2B |
0.34754735657546 |
|
9354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORAI2 |
0.347566430414877 |
|
9355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL97P |
0.347590174671058 |
|
9356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC22 |
0.347723210670693 |
|
9357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EYA4 |
0.347830523095442 |
|
9358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALKBH4 |
0.347897483252047 |
|
9359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRWD1 |
0.347897483252047 |
|
9360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4467 |
0.347897483252047 |
|
9361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5090 |
0.347897483252047 |
|
9362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2J2 |
0.347897483252047 |
|
9363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2J3 |
0.347897483252047 |
|
9364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2J |
0.347897483252047 |
|
9365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASA4B |
0.347897483252047 |
|
9366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASA4 |
0.347897483252047 |
|
9367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDYE2B |
0.347897483252047 |
|
9368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDYE2 |
0.347897483252047 |
|
9369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPK3BL |
0.347897483252047 |
|
9370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED26 |
0.347911342888175 |
|
9371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM7 |
0.347911342888175 |
|
9372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM17 |
0.347913635292205 |
|
9373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP11 |
0.347922355848934 |
|
9374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS24 |
0.347931173262521 |
|
9375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
URGCP |
0.347931173262521 |
|
9376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2D4 |
0.347931173262521 |
|
9377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2J4 |
0.347931173262521 |
|
9378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE4A |
0.347936891982319 |
|
9379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRTA1 |
0.347977752484977 |
|
9380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGRN1 |
0.347980774485392 |
|
9381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARCN1 |
0.347980907924956 |
|
9382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHLDB1 |
0.347980907924956 |
|
9383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREH |
0.347980907924956 |
|
9384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR26A1 |
0.348073591035285 |
|
9385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VILL |
0.348073591035285 |
|
9386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLKB1 |
0.34812659547446 |
|
9387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PACRG |
0.348276028485582 |
|
9388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS13 |
0.34830928071008 |
|
9389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNM |
0.348356112415144 |
|
9390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A20 |
0.348542018842555 |
|
9391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARIH2OS |
0.348542018842555 |
|
9392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3919 |
0.348552818503739 |
|
9393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGP |
0.348669151960106 |
|
9394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RREB1 |
0.348672822218218 |
|
9395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMX2 |
0.348710678902869 |
|
9396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC5 |
0.348901334900375 |
|
9397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT8 |
0.348901334900375 |
|
9398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5SL |
0.348901334900375 |
|
9399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf69 |
0.348901334900375 |
|
9400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CADPS |
0.348919344961698 |
|
9401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0753 |
0.349099444772368 |
|
9402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED31 |
0.349099444772368 |
|
9403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC17 |
0.349099444772368 |
|
9404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRAK4 |
0.34916015826511 |
|
9405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4720 |
0.34933994223987 |
|
9406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSCP1 |
0.349371980726517 |
|
9407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000201448.1 |
0.349371980726517 |
|
9408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS15 |
0.349371980726517 |
|
9409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSF3R |
0.349371980726517 |
|
9410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC15A5 |
0.349412201705106 |
|
9411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP4E1 |
0.34949048852445 |
|
9412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZPLD1 |
0.349495702236668 |
|
9413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP91 |
0.349558513183732 |
|
9414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR103A1 |
0.349602531153932 |
|
9415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFMBT2 |
0.349622705460439 |
|
9416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
A2ML1 |
0.349733870436494 |
|
9417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKX |
0.349739961640017 |
|
9418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAG2 |
0.349783552247114 |
|
9419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB23 |
0.349783552247114 |
|
9420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS11D |
0.349793900980308 |
|
9421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS11A |
0.349793900980308 |
|
9422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KMT2C |
0.349794443481336 |
|
9423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCD1 |
0.349812912071565 |
|
9424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSAP |
0.349841122756069 |
|
9425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP10 |
0.350026282042417 |
|
9426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATC1 |
0.350026282042417 |
|
9427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLD3 |
0.350207790356323 |
|
9428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPS8 |
0.350212945044855 |
|
9429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX6 |
0.350263423047808 |
|
9430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR180 |
0.350280968684975 |
|
9431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP36 |
0.350280968684975 |
|
9432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL585P |
0.350280968684975 |
|
9433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00391 |
0.350280968684975 |
|
9434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX21 |
0.350280968684975 |
|
9435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADIPOQ |
0.350380491572479 |
|
9436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0232 |
0.350526417372744 |
|
9437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL10RA |
0.350612198644219 |
|
9438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCR5 |
0.350647263004234 |
|
9439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL9L |
0.350647263004234 |
|
9440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP11 |
0.350706854268525 |
|
9441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCO3 |
0.350706854268525 |
|
9442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ART4 |
0.350706854268525 |
|
9443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD9 |
0.350745998922883 |
|
9444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GREM1 |
0.350861232238366 |
|
9445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3K |
0.350939299686093 |
|
9446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOMER1 |
0.350973182961506 |
|
9447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000251735.1 |
0.350996094709897 |
|
9448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B9D2 |
0.35105022925632 |
|
9449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCKDHA |
0.35105022925632 |
|
9450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM91 |
0.35105022925632 |
|
9451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9A2 |
0.351162894248225 |
|
9452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBNL |
0.351193162612611 |
|
9453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGAM2 |
0.351193162612611 |
|
9454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLM |
0.351193162612611 |
|
9455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L6 |
0.351251244286632 |
|
9456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS1 |
0.351251244286632 |
|
9457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS3P2 |
0.351251244286632 |
|
9458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS3P3 |
0.351251244286632 |
|
9459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRBC2 |
0.351251244286632 |
|
9460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRBV19 |
0.351251244286632 |
|
9461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRBV27 |
0.351251244286632 |
|
9462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRBV28 |
0.351251244286632 |
|
9463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRBV2 |
0.351251244286632 |
|
9464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRBV9 |
0.351251244286632 |
|
9465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO27 |
0.351264938410369 |
|
9466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf12 |
0.35127127099903 |
|
9467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LFNG |
0.351293486151024 |
|
9468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4648 |
0.351293486151024 |
|
9469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRAT1 |
0.351293486151024 |
|
9470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238857.1 |
0.351293486151024 |
|
9471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFDN4 |
0.351437996960519 |
|
9472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC17 |
0.35147571061314 |
|
9473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC36A1 |
0.35154609843114 |
|
9474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM150A |
0.351594757828705 |
|
9475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3H |
0.351623801855098 |
|
9476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFAIP8L3 |
0.351633675022341 |
|
9477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RERG |
0.35178102635022 |
|
9478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPBWR1 |
0.351847450359807 |
|
9479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL366P |
0.351904184678412 |
|
9480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RARS |
0.351915537624107 |
|
9481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBLL1 |
0.351915537624107 |
|
9482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PANK3 |
0.351915537624107 |
|
9483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM12 |
0.351925309199987 |
|
9484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHFPL3 |
0.351941004675374 |
|
9485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P29 |
0.352042799183392 |
|
9486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORCS1 |
0.352046338583827 |
|
9487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JRKL |
0.352132595469194 |
|
9488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM25 |
0.352145431415047 |
|
9489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC36 |
0.352145431415047 |
|
9490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT46 |
0.352145431415047 |
|
9491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBA1 |
0.352293891956817 |
|
9492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCC2 |
0.352428738751857 |
|
9493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239020.1 |
0.352428738751857 |
|
9494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDM1 |
0.352456721587708 |
|
9495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYZL6 |
0.352456721587708 |
|
9496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL16 |
0.352456721587708 |
|
9497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL14 |
0.352456721587708 |
|
9498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL15 |
0.352456721587708 |
|
9499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00326 |
0.352536891386197 |
|
9500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF15 |
0.352705727321125 |
|
9501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMOX2 |
0.352888197256314 |
|
9502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDIP1 |
0.352888197256314 |
|
9503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC4G |
0.353023521816957 |
|
9504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD209 |
0.353023521816957 |
|
9505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL448P |
0.353024644972035 |
|
9506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRA2C |
0.353172007391246 |
|
9507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAP2 |
0.353217745628364 |
|
9508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
M6PR |
0.353290419010568 |
|
9509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIFIN |
0.353401488210083 |
|
9510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL23 |
0.353455145191532 |
|
9511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF438 |
0.353538750797172 |
|
9512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK1G |
0.353643180093429 |
|
9513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARD3 |
0.353777236147811 |
|
9514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA24|ENSG00000206903.1 |
0.353979520250937 |
|
9515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEL1L2 |
0.354056810203359 |
|
9516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP26 |
0.354147525891669 |
|
9517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBP |
0.354148029051705 |
|
9518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52M1 |
0.354183303229599 |
|
9519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf40 |
0.354183303229599 |
|
9520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52I2 |
0.354183303229599 |
|
9521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52I1 |
0.354183303229599 |
|
9522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM68 |
0.354183303229599 |
|
9523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51D1 |
0.354183303229599 |
|
9524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51E1 |
0.354183303229599 |
|
9525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51E2 |
0.354183303229599 |
|
9526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51C1P |
0.354183303229599 |
|
9527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN6 |
0.354359306441253 |
|
9528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN9 |
0.354359306441253 |
|
9529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC64B |
0.354359306441253 |
|
9530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCFC1R1 |
0.354359306441253 |
|
9531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THOC6 |
0.354359306441253 |
|
9532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF12A |
0.354359306441253 |
|
9533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJE1 |
0.354375662697253 |
|
9534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADARB1 |
0.354411135613647 |
|
9535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEC |
0.354553364302468 |
|
9536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR661 |
0.354553364302468 |
|
9537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRINA |
0.354553364302468 |
|
9538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG16L2 |
0.354572179463525 |
|
9539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC7 |
0.354624695661987 |
|
9540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPD1 |
0.354643518800574 |
|
9541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADHFE1 |
0.354942897960898 |
|
9542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRS1 |
0.354942897960898 |
|
9543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRL |
0.355012073822773 |
|
9544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D22A |
0.355045263681728 |
|
9545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYBL1 |
0.355056109867447 |
|
9546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA62|ENSG00000201980.1 |
0.355106138914285 |
|
9547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51F1 |
0.355106138914285 |
|
9548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX8C |
0.35520246650793 |
|
9549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF1 |
0.35523427964045 |
|
9550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXRED2 |
0.355272446500448 |
|
9551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf97 |
0.355275963269619 |
|
9552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00919 |
0.355275963269619 |
|
9553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP50 |
0.355287946738227 |
|
9554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL519P |
0.355391138510847 |
|
9555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRB10 |
0.355392663280159 |
|
9556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TC2N |
0.355407504340221 |
|
9557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN7L2 |
0.355470079771999 |
|
9558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB561D1 |
0.355470079771999 |
|
9559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMIGO1 |
0.355470079771999 |
|
9560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3D |
0.355487352614669 |
|
9561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTWD1 |
0.355490795010046 |
|
9562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS12 |
0.355548749548289 |
|
9563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00935 |
0.355565732062899 |
|
9564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO1A2 |
0.355574927303269 |
|
9565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYROXD1 |
0.355574927303269 |
|
9566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RECQL |
0.355574927303269 |
|
9567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPP7 |
0.3555767427557 |
|
9568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF407 |
0.355632695191894 |
|
9569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00648 |
0.355660728468273 |
|
9570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548Y |
0.355660728468273 |
|
9571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXT |
0.355702839845596 |
|
9572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AVP |
0.355702839845596 |
|
9573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL555P |
0.355702839845596 |
|
9574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA8 |
0.355708652807015 |
|
9575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC24A3 |
0.35576270716586 |
|
9576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB1 |
0.355875094348217 |
|
9577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL8 |
0.355951510098699 |
|
9578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6V1 |
0.35607144860319 |
|
9579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6W1P |
0.35607144860319 |
|
9580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2F1 |
0.356200921690627 |
|
9581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1292 |
0.356392017335397 |
|
9582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOP56 |
0.356392017335397 |
|
9583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000271798.1 |
0.356392017335397 |
|
9584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD110 |
0.356392017335397 |
|
9585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD86 |
0.356392017335397 |
|
9586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD56|ENSG00000229686.1 |
0.356392017335397 |
|
9587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD57 |
0.356392017335397 |
|
9588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDH3B |
0.356392017335397 |
|
9589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF704 |
0.356612513796722 |
|
9590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN22 |
0.356645170864596 |
|
9591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
A1BG |
0.356645170864596 |
|
9592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP13A2 |
0.356722390371787 |
|
9593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAD6 |
0.356755137714783 |
|
9594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITHD1 |
0.356767319428109 |
|
9595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2IRD2 |
0.356834753746027 |
|
9596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCF1 |
0.356834753746027 |
|
9597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALNT3 |
0.356880181311216 |
|
9598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC77 |
0.356880181311216 |
|
9599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM138D |
0.356880181311216 |
|
9600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQSEC3 |
0.356880181311216 |
|
9601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM5A |
0.356880181311216 |
|
9602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NINJ2 |
0.356880181311216 |
|
9603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC16P |
0.356880181311216 |
|
9604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A12 |
0.356880181311216 |
|
9605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A13 |
0.356880181311216 |
|
9606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNK1 |
0.356880181311216 |
|
9607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCHSD2 |
0.356980347794108 |
|
9608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF10 |
0.357039959723541 |
|
9609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB3 |
0.357147328343373 |
|
9610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YAE1D1 |
0.357239028013452 |
|
9611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP269 |
0.357308994790536 |
|
9612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378F |
0.357388284705795 |
|
9613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNRC2 |
0.357388284705795 |
|
9614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM235 |
0.357451626713571 |
|
9615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF8 |
0.357483000512753 |
|
9616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC10 |
0.357541339830648 |
|
9617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACVRL1 |
0.357605118035456 |
|
9618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD33 |
0.357605118035456 |
|
9619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL7 |
0.357707134937656 |
|
9620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF497 |
0.357766855415379 |
|
9621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP473 |
0.357766855415379 |
|
9622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP2A |
0.357766855415379 |
|
9623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4754 |
0.357766855415379 |
|
9624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MZF1 |
0.357766855415379 |
|
9625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL525P |
0.357766855415379 |
|
9626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL693P |
0.357766855415379 |
|
9627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL23AP79 |
0.357766855415379 |
|
9628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS5 |
0.357766855415379 |
|
9629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC27A5 |
0.357766855415379 |
|
9630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM28 |
0.357766855415379 |
|
9631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2M |
0.357766855415379 |
|
9632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB45 |
0.357766855415379 |
|
9633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF132 |
0.357766855415379 |
|
9634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF324B |
0.357766855415379 |
|
9635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF324 |
0.357766855415379 |
|
9636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF446 |
0.357766855415379 |
|
9637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF584 |
0.357766855415379 |
|
9638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF837 |
0.357766855415379 |
|
9639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL14 |
0.357792644192374 |
|
9640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00942 |
0.357792644192374 |
|
9641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3649 |
0.357792644192374 |
|
9642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT5B |
0.357792644192374 |
|
9643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUS7L |
0.357803846830152 |
|
9644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YWHAE |
0.357860647423648 |
|
9645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC4P1 |
0.357899357346572 |
|
9646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCHD3 |
0.357899357346572 |
|
9647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXP3 |
0.358373288662974 |
|
9648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL3L1 |
0.358656616966226 |
|
9649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL3L3 |
0.358656616966226 |
|
9650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL3 |
0.358656616966226 |
|
9651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL4L1 |
0.358656616966226 |
|
9652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL4L2 |
0.358656616966226 |
|
9653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL4 |
0.358656616966226 |
|
9654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGNBP2 |
0.358656616966226 |
|
9655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO19 |
0.358656616966226 |
|
9656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGW |
0.358656616966226 |
|
9657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL301P |
0.358656616966226 |
|
9658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP439 |
0.358656616966226 |
|
9659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D3B |
0.358656616966226 |
|
9660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D3C |
0.358656616966226 |
|
9661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D3G |
0.358656616966226 |
|
9662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D3H |
0.358656616966226 |
|
9663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNHIT3 |
0.358656616966226 |
|
9664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORCS3 |
0.358681092619999 |
|
9665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOH12CR1 |
0.358702245109414 |
|
9666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT77 |
0.358749385698598 |
|
9667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL4 |
0.358784033180405 |
|
9668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZWILCH |
0.358784033180405 |
|
9669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCTL |
0.358784033180405 |
|
9670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3C2G |
0.3589612694777 |
|
9671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMKLB |
0.358961305397289 |
|
9672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHC1 |
0.358961305397289 |
|
9673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IZUMO3 |
0.359043839209299 |
|
9674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AEBP1 |
0.359053797841494 |
|
9675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4649 |
0.359053797841494 |
|
9676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLD2 |
0.359053797841494 |
|
9677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP230 |
0.359053797841494 |
|
9678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL7 |
0.359053797841494 |
|
9679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCK |
0.359053797841494 |
|
9680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf59 |
0.359124709083103 |
|
9681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC5 |
0.359124709083103 |
|
9682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCER2 |
0.359124709083103 |
|
9683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFMID |
0.359151876981654 |
|
9684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIRC5 |
0.359151876981654 |
|
9685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCD1 |
0.359172721041516 |
|
9686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX14 |
0.359172721041516 |
|
9687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPD1 |
0.359172721041516 |
|
9688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERS5 |
0.359172721041516 |
|
9689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC4 |
0.359178336612807 |
|
9690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0754 |
0.359179726292717 |
|
9691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASIC1 |
0.359427452678683 |
|
9692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CISD3 |
0.359459100510114 |
|
9693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4726 |
0.359459100510114 |
|
9694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP440 |
0.359459100510114 |
|
9695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCGF2 |
0.359459100510114 |
|
9696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERTAD1 |
0.359606063499936 |
|
9697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf44 |
0.359675751752918 |
|
9698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAS3 |
0.359764573987032 |
|
9699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFS1 |
0.359775004889181 |
|
9700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000253091.1 |
0.359801662810127 |
|
9701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL690P |
0.359942118667664 |
|
9702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRFN3 |
0.360062182384235 |
|
9703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSRC1 |
0.360181053101686 |
|
9704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNIP2 |
0.360192280537467 |
|
9705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MX2 |
0.360252085141437 |
|
9706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMD3 |
0.360253520337221 |
|
9707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MANSC1 |
0.360543823131358 |
|
9708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOH12CR2 |
0.360543823131358 |
|
9709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf60 |
0.360602298008006 |
|
9710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEF2D |
0.360632411580645 |
|
9711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT7P2 |
0.360643807632781 |
|
9712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFBP1 |
0.360643807632781 |
|
9713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF567 |
0.360734566486501 |
|
9714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC1 |
0.360736619767498 |
|
9715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AXL |
0.360806585743566 |
|
9716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRY4 |
0.360978190278985 |
|
9717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MACF1 |
0.361002398259369 |
|
9718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4255 |
0.361024522594319 |
|
9719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRB1 |
0.361030142316659 |
|
9720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC20A2 |
0.361057303137649 |
|
9721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STXBP2 |
0.361123302968215 |
|
9722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RETN |
0.361123302968215 |
|
9723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMTNL1 |
0.361200266380672 |
|
9724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52R1 |
0.361264498798839 |
|
9725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51F2 |
0.361264498798839 |
|
9726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51S1 |
0.361264498798839 |
|
9727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51H1P |
0.361264498798839 |
|
9728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51T1 |
0.361264498798839 |
|
9729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51A7 |
0.361264498798839 |
|
9730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51G2 |
0.361264498798839 |
|
9731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51G1 |
0.361264498798839 |
|
9732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51A2 |
0.361264498798839 |
|
9733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51A4 |
0.361264498798839 |
|
9734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTDSPL |
0.361272019237723 |
|
9735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF133 |
0.361281585117314 |
|
9736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP74 |
0.361281585117314 |
|
9737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DZANK1 |
0.361281585117314 |
|
9738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HECW1 |
0.361593836133859 |
|
9739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS11E |
0.361605572698028 |
|
9740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2A3 |
0.361605572698028 |
|
9741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2B10 |
0.361605572698028 |
|
9742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2B11 |
0.361605572698028 |
|
9743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2B15 |
0.361605572698028 |
|
9744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2B17 |
0.361605572698028 |
|
9745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2B28 |
0.361605572698028 |
|
9746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2B7 |
0.361605572698028 |
|
9747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMPD1 |
0.361805166786897 |
|
9748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL17A1 |
0.361811340025303 |
|
9749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4475 |
0.361859470052396 |
|
9750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4540 |
0.361859470052396 |
|
9751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL36 |
0.361927021464971 |
|
9752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MME |
0.362051876070221 |
|
9753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEACAM21 |
0.362086859416786 |
|
9754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00557 |
0.362109611412579 |
|
9755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf27 |
0.362131919738267 |
|
9756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPEF1 |
0.362131919738267 |
|
9757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC25B |
0.362131919738267 |
|
9758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPB |
0.362131919738267 |
|
9759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD9 |
0.362184606333679 |
|
9760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD8 |
0.362184606333679 |
|
9761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD4 |
0.362184606333679 |
|
9762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR10B |
0.362184606333679 |
|
9763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUB1 |
0.3621862459533 |
|
9764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR86 |
0.3621862459533 |
|
9765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYGN |
0.3621862459533 |
|
9766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3907 |
0.3621862459533 |
|
9767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPAB |
0.362204658530857 |
|
9768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHYKPL |
0.362204658530857 |
|
9769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3929 |
0.362249038114397 |
|
9770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAOA |
0.362256781762709 |
|
9771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00343 |
0.362256781762709 |
|
9772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00344 |
0.362256781762709 |
|
9773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PREX2 |
0.362297888988461 |
|
9774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF177 |
0.362342660348377 |
|
9775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPICE1 |
0.362385739196565 |
|
9776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCH1 |
0.362392280430573 |
|
9777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDC3 |
0.362396974127165 |
|
9778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUFT1 |
0.36269335404121 |
|
9779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SARS |
0.362696927666192 |
|
9780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238620.1 |
0.362718205028604 |
|
9781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAGE1 |
0.362747701100519 |
|
9782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFF3 |
0.362813903007536 |
|
9783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G2E |
0.362843019883574 |
|
9784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G2A |
0.362843019883574 |
|
9785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL304P |
0.362843019883574 |
|
9786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G5 |
0.362843019883574 |
|
9787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC5B |
0.362880301680339 |
|
9788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGTB |
0.362976113503089 |
|
9789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD30BL |
0.363107298105452 |
|
9790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR39 |
0.363107298105452 |
|
9791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR663B |
0.363107298105452 |
|
9792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP103 |
0.363107298105452 |
|
9793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP36 |
0.36316916721766 |
|
9794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDYE1 |
0.363244135278533 |
|
9795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT6L |
0.363428657510919 |
|
9796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ILF3 |
0.363437882316252 |
|
9797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPG21 |
0.363457710035721 |
|
9798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTFMT |
0.363457710035721 |
|
9799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4476 |
0.363710399624235 |
|
9800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PADI4 |
0.363787830364987 |
|
9801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RELN |
0.363817286912665 |
|
9802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238843.1 |
0.364026569398418 |
|
9803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGN |
0.364171481224666 |
|
9804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA44 |
0.364171481224666 |
|
9805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR554 |
0.364171481224666 |
|
9806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH8A1 |
0.364241117402754 |
|
9807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R3F |
0.364432579834223 |
|
9808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA11|ENSG00000252992.1 |
0.364461696868969 |
|
9809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BACE1 |
0.364461696868969 |
|
9810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP5S1 |
0.364467745101437 |
|
9811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAVS |
0.364467745101437 |
|
9812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR103A2 |
0.364467745101437 |
|
9813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PANK2 |
0.364467745101437 |
|
9814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF24 |
0.364467745101437 |
|
9815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF13 |
0.36457126966241 |
|
9816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC43A1 |
0.364637126424628 |
|
9817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM10 |
0.364637126424628 |
|
9818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRTG |
0.364720051999332 |
|
9819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf14 |
0.364763686226399 |
|
9820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEZF2 |
0.364763686226399 |
|
9821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZG16B |
0.3647707516872 |
|
9822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS30P |
0.3647707516872 |
|
9823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS22 |
0.3647707516872 |
|
9824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC19 |
0.364772516657512 |
|
9825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELAVL1 |
0.364786757004502 |
|
9826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf178 |
0.364834285004461 |
|
9827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB32 |
0.364940399083954 |
|
9828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KMT2B |
0.364940399083954 |
|
9829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP7 |
0.364940399083954 |
|
9830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PC |
0.364949805681796 |
|
9831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCE1 |
0.364949805681796 |
|
9832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRFN4 |
0.364949805681796 |
|
9833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUG1 |
0.364957914187834 |
|
9834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY1 |
0.3650087448482 |
|
9835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPHS1 |
0.365142920637792 |
|
9836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIRREL2 |
0.365142920637792 |
|
9837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APLP1 |
0.365142920637792 |
|
9838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR34A |
0.365175084922819 |
|
9839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP8A |
0.365260639840866 |
|
9840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGM4 |
0.365271313294183 |
|
9841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPYSL3 |
0.365401777106578 |
|
9842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf96 |
0.365406165680476 |
|
9843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBALD1 |
0.365406165680476 |
|
9844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMKLA |
0.365499983816625 |
|
9845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD7 |
0.365590439318817 |
|
9846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAPC5 |
0.365606369669669 |
|
9847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4512 |
0.365606369669669 |
|
9848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD18C |
0.365606369669669 |
|
9849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD16 |
0.365606369669669 |
|
9850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD18A |
0.365606369669669 |
|
9851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD18B |
0.365606369669669 |
|
9852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP13 |
0.365613189059107 |
|
9853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2CA |
0.365710193034174 |
|
9854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3661 |
0.365710193034174 |
|
9855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMRAL1 |
0.365791688971972 |
|
9856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PVRL1 |
0.365826686255518 |
|
9857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF544 |
0.36587587190967 |
|
9858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCRFS1 |
0.365909421173263 |
|
9859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL217P |
0.366010612978414 |
|
9860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM6 |
0.366027668186693 |
|
9861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF547 |
0.366090064496617 |
|
9862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL408P |
0.366093586479783 |
|
9863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF37BP |
0.366125578222166 |
|
9864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP2K |
0.366245929708198 |
|
9865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR30C1 |
0.366261710031948 |
|
9866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADSL |
0.366280813479534 |
|
9867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC3 |
0.366329997270416 |
|
9868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF10 |
0.366329997270416 |
|
9869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMB3 |
0.366346823884342 |
|
9870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4260 |
0.366346823884342 |
|
9871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEYL |
0.366389693886705 |
|
9872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPCAL4 |
0.366389693886705 |
|
9873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5C1A |
0.366389693886705 |
|
9874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf61 |
0.366398124251298 |
|
9875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHEB |
0.366447323947285 |
|
9876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL76P |
0.366447323947285 |
|
9877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2K1 |
0.366450203485191 |
|
9878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MACROD1 |
0.366613152804185 |
|
9879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51L1 |
0.366659873012721 |
|
9880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52J3 |
0.366659873012721 |
|
9881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52E2 |
0.366659873012721 |
|
9882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK12 |
0.366731128024201 |
|
9883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM22 |
0.366763761612621 |
|
9884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROGDI |
0.366763761612621 |
|
9885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR609 |
0.366807022447845 |
|
9886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTO1 |
0.366807022447845 |
|
9887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IK |
0.366988105586234 |
|
9888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3655 |
0.366988105586234 |
|
9889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR55 |
0.366988105586234 |
|
9890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DND1 |
0.366988105586234 |
|
9891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HARS |
0.366988105586234 |
|
9892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HARS2 |
0.366988105586234 |
|
9893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMAT2 |
0.366988105586234 |
|
9894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00882 |
0.36701332094799 |
|
9895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLT1B |
0.367034304766703 |
|
9896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf39 |
0.367034304766703 |
|
9897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYS2 |
0.367034304766703 |
|
9898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSANTD1 |
0.367235003197706 |
|
9899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCERG1 |
0.36729337024014 |
|
9900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB11 |
0.367309085907805 |
|
9901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL24 |
0.367309085907805 |
|
9902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP97 |
0.367309085907805 |
|
9903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXPE3 |
0.367309085907805 |
|
9904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL677P |
0.367442601068538 |
|
9905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD11 |
0.367456297575849 |
|
9906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM153C |
0.367490388584451 |
|
9907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELP3 |
0.367567656485071 |
|
9908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPC4 |
0.367592796704994 |
|
9909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA55 |
0.367592796704994 |
|
9910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000253076.1 |
0.36759515729701 |
|
9911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR187 |
0.367659503164614 |
|
9912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD75|ENSG00000221711.1 |
0.367681436022038 |
|
9913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4S1 |
0.367697963272776 |
|
9914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C3 |
0.367697963272776 |
|
9915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD18 |
0.367734598264062 |
|
9916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf31 |
0.367734598264062 |
|
9917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAN |
0.36794392552093 |
|
9918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN1C1 |
0.368028688697593 |
|
9919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SALL4 |
0.368072723832894 |
|
9920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR20 |
0.368149450926704 |
|
9921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00051 |
0.368149450926704 |
|
9922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MROH5 |
0.368149450926704 |
|
9923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTP4A3 |
0.368149450926704 |
|
9924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD5|ENSG00000238854.1 |
0.368149450926704 |
|
9925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSNARE1 |
0.368149450926704 |
|
9926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD32 |
0.368233913374501 |
|
9927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASCC2 |
0.36825888861821 |
|
9928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR4 |
0.368284618698563 |
|
9929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF12 |
0.368465623504201 |
|
9930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PES1 |
0.368549112404151 |
|
9931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC13C |
0.368583152350167 |
|
9932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PADI6 |
0.368619161266365 |
|
9933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP3CC |
0.368642021456989 |
|
9934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORBS3 |
0.368642021456989 |
|
9935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDLIM2 |
0.368642021456989 |
|
9936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf58 |
0.368642021456989 |
|
9937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1967 |
0.368642021456989 |
|
9938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIN3 |
0.368642021456989 |
|
9939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP12 |
0.368651336278342 |
|
9940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP4 |
0.368651336278342 |
|
9941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF572 |
0.368662899103315 |
|
9942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SQLE |
0.368662899103315 |
|
9943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM196B |
0.368668796948589 |
|
9944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORO7 |
0.368715596068453 |
|
9945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251911.1 |
0.368751794849109 |
|
9946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3609 |
0.368756910326918 |
|
9947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM130 |
0.368756910326918 |
|
9948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRRAP |
0.368756910326918 |
|
9949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238459.1 |
0.368756910326918 |
|
9950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYRM4 |
0.368808518688532 |
|
9951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOD |
0.368849651956292 |
|
9952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF7 |
0.368921182817567 |
|
9953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239045.1 |
0.368927419061878 |
|
9954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL221P |
0.368932661406097 |
|
9955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU4F3 |
0.368978407201372 |
|
9956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX6B1 |
0.369073401531353 |
|
9957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL765P |
0.369073401531353 |
|
9958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPK1A |
0.369073401531353 |
|
9959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKAP4 |
0.369111368839936 |
|
9960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL18RAP |
0.369172755760721 |
|
9961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4772 |
0.369172755760721 |
|
9962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIE |
0.369216031654426 |
|
9963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMS19 |
0.369448829777941 |
|
9964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR532 |
0.369530084043112 |
|
9965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR188 |
0.369530084043112 |
|
9966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR362 |
0.369530084043112 |
|
9967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR500A |
0.369530084043112 |
|
9968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR500B |
0.369530084043112 |
|
9969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR501 |
0.369530084043112 |
|
9970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR660 |
0.369530084043112 |
|
9971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR502 |
0.369530084043112 |
|
9972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OVOL3 |
0.369535212960647 |
|
9973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2I |
0.369535212960647 |
|
9974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBCB |
0.369535212960647 |
|
9975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLB |
0.369585764831249 |
|
9976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TANC2 |
0.369607613762645 |
|
9977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC44A2 |
0.369833918471708 |
|
9978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCPIP1 |
0.369845579408383 |
|
9979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAC2 |
0.370232664353948 |
|
9980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRN1 |
0.370311946830049 |
|
9981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC10P |
0.370378535510969 |
|
9982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA20|ENSG00000251818.1 |
0.370390392212498 |
|
9983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000202389.1 |
0.370390392212498 |
|
9984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
Vault|ENSG00000252283.1 |
0.370390392212498 |
|
9985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCF |
0.370391954416937 |
|
9986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf33 |
0.37042918044669 |
|
9987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D32 |
0.370436044553846 |
|
9988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5699 |
0.370672098901334 |
|
9989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR26 |
0.370672098901334 |
|
9990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC13A5 |
0.370684669043254 |
|
9991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPYL1 |
0.370695904598786 |
|
9992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP14 |
0.370720240348144 |
|
9993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN1 |
0.370772630549981 |
|
9994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL526P |
0.370772630549981 |
|
9995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM14B |
0.370786232968233 |
|
9996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF549 |
0.370946167022519 |
|
9997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF550 |
0.370946167022519 |
|
9998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPYL4 |
0.371074465137798 |
|
9999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000201791.1 |
0.371114006057198 |
|
10000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST6GAL1 |
0.371140050438148 |
|
10001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP9A |
0.371204920823447 |
|
10002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFAP1L1 |
0.371235288488951 |
|
10003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252136.1 |
0.371401041382038 |
|
10004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM63C |
0.37164172404668 |
|
10005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1L |
0.371659131087258 |
|
10006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF684 |
0.371729202218181 |
|
10007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FICD |
0.371758152338183 |
|
10008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4287 |
0.371856907802991 |
|
10009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDN1 |
0.37189576001608 |
|
10010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB2 |
0.371993488780778 |
|
10011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB3 |
0.371993488780778 |
|
10012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB17 |
0.371993488780778 |
|
10013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB4 |
0.371993488780778 |
|
10014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB5 |
0.371993488780778 |
|
10015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB6 |
0.371993488780778 |
|
10016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP454 |
0.372077462751196 |
|
10017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3C3 |
0.372091139260714 |
|
10018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPC |
0.372106165124952 |
|
10019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA9 |
0.372162464254319 |
|
10020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA10 |
0.372162464254319 |
|
10021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA11 |
0.372162464254319 |
|
10022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGB6 |
0.372162464254319 |
|
10023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGB7 |
0.372162464254319 |
|
10024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA12 |
0.372162464254319 |
|
10025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPIFC |
0.372188151735728 |
|
10026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT10B |
0.372201099953552 |
|
10027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP8AP2 |
0.372242743221573 |
|
10028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35A5 |
0.372341330418032 |
|
10029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238642.1 |
0.37236071012059 |
|
10030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238345.1 |
0.37236071012059 |
|
10031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFPL3 |
0.372505305653854 |
|
10032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFPL3S |
0.372505305653854 |
|
10033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC2D |
0.372509807337724 |
|
10034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHX2 |
0.372552690541268 |
|
10035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF213 |
0.372589295074863 |
|
10036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNMB1 |
0.372590109800908 |
|
10037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL587P |
0.372606338709386 |
|
10038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMD1 |
0.372704290650833 |
|
10039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4311 |
0.372769104887213 |
|
10040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239100.1 |
0.372821591803086 |
|
10041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP95 |
0.372821591803086 |
|
10042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3IP1 |
0.372827129533846 |
|
10043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP496 |
0.372827129533846 |
|
10044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABS1 |
0.372930599685282 |
|
10045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS2L1 |
0.372934789010594 |
|
10046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK40 |
0.373009566461605 |
|
10047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM10 |
0.373009566461605 |
|
10048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIPK4 |
0.373053442276452 |
|
10049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRX |
0.373053442276452 |
|
10050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSD3 |
0.373092812116972 |
|
10051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETV1 |
0.373127269931273 |
|
10052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR491 |
0.373140654336215 |
|
10053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA30|ENSG00000202189.1 |
0.373140654336215 |
|
10054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR652 |
0.373142290633402 |
|
10055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3978 |
0.373142290633402 |
|
10056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG1L13P |
0.373432155563962 |
|
10057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFA1B |
0.373432155563962 |
|
10058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFA1 |
0.373432155563962 |
|
10059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFA3 |
0.373432155563962 |
|
10060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFA5 |
0.373432155563962 |
|
10061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB103A |
0.373432155563962 |
|
10062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB103B |
0.373432155563962 |
|
10063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB104A |
0.373432155563962 |
|
10064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB104B |
0.373432155563962 |
|
10065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB105A |
0.373432155563962 |
|
10066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB105B |
0.373432155563962 |
|
10067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB106A |
0.373432155563962 |
|
10068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB106B |
0.373432155563962 |
|
10069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB107A |
0.373432155563962 |
|
10070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB107B |
0.373432155563962 |
|
10071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB4A |
0.373432155563962 |
|
10072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB4B |
0.373432155563962 |
|
10073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM66B |
0.373432155563962 |
|
10074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM66E |
0.373432155563962 |
|
10075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM85B |
0.373432155563962 |
|
10076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86B3P |
0.373432155563962 |
|
10077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM90A24P |
0.373432155563962 |
|
10078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRLE1 |
0.373432155563962 |
|
10079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548I3 |
0.373432155563962 |
|
10080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGK223 |
0.373432155563962 |
|
10081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG11A |
0.373432155563962 |
|
10082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG11B |
0.373432155563962 |
|
10083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF705B |
0.373432155563962 |
|
10084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF705G |
0.373432155563962 |
|
10085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALGPS2 |
0.373472102828824 |
|
10086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOAP1 |
0.3735537347062 |
|
10087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM251 |
0.3735537347062 |
|
10088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf142 |
0.3735537347062 |
|
10089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBR7 |
0.3735537347062 |
|
10090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP198 |
0.373570881103205 |
|
10091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR96 |
0.373577953388447 |
|
10092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL107P |
0.373622948469142 |
|
10093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL14P |
0.37366030530214 |
|
10094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMNDC1 |
0.373694176485922 |
|
10095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL20 |
0.373709932294151 |
|
10096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF217 |
0.373804694607682 |
|
10097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1024L |
0.373820413378131 |
|
10098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUZP6 |
0.373824208099174 |
|
10099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTPN |
0.373824208099174 |
|
10100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMC2 |
0.373834545951756 |
|
10101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC11A2 |
0.373883546480471 |
|
10102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000272028.1 |
0.373883546480471 |
|
10103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LETMD1 |
0.373883546480471 |
|
10104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSRNP2 |
0.373883546480471 |
|
10105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF1D |
0.373909516266022 |
|
10106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH17 |
0.373927411305397 |
|
10107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRPEL2 |
0.373941290599783 |
|
10108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCYOX1L |
0.373941290599783 |
|
10109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS10 |
0.373970888585674 |
|
10110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EWSR1 |
0.373987067549758 |
|
10111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK32A |
0.373993779234822 |
|
10112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378E |
0.374117061702131 |
|
10113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXI1 |
0.374117061702131 |
|
10114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf58 |
0.374117061702131 |
|
10115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCP2 |
0.374117061702131 |
|
10116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEC |
0.374131249277804 |
|
10117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC16 |
0.374397496839718 |
|
10118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WAC |
0.374591179729564 |
|
10119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDGF |
0.374661972083884 |
|
10120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRCC |
0.374661972083884 |
|
10121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D2A |
0.374661972083884 |
|
10122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTRK1 |
0.374661972083884 |
|
10123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSRR |
0.374661972083884 |
|
10124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEAR1 |
0.374661972083884 |
|
10125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD9 |
0.374761465055391 |
|
10126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf112 |
0.374806906281439 |
|
10127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS4 |
0.374856134197558 |
|
10128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS5 |
0.374856134197558 |
|
10129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP44 |
0.374945020796538 |
|
10130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL550P |
0.374945020796538 |
|
10131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAI1 |
0.375015504027416 |
|
10132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARC |
0.375015504027416 |
|
10133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JRK |
0.375015504027416 |
|
10134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSCA |
0.375015504027416 |
|
10135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6K |
0.375015504027416 |
|
10136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THEM6 |
0.375015504027416 |
|
10137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLURP1 |
0.375015504027416 |
|
10138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPD2 |
0.375015504027416 |
|
10139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6D |
0.375015504027416 |
|
10140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYNX1 |
0.375015504027416 |
|
10141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GML |
0.375015504027416 |
|
10142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP11B1 |
0.375015504027416 |
|
10143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP11B2 |
0.375015504027416 |
|
10144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT2 |
0.375103486509407 |
|
10145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMRPP2 |
0.375164326647187 |
|
10146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIF1 |
0.3751753158563 |
|
10147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHO2 |
0.3751753158563 |
|
10148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERP27 |
0.37521235880481 |
|
10149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCA1 |
0.375249268185177 |
|
10150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS48 |
0.375337453125312 |
|
10151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5B |
0.375493178432143 |
|
10152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA7|ENSG00000201316.1 |
0.375532811317704 |
|
10153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTPAP |
0.375573348784881 |
|
10154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238853.1 |
0.37569353207657 |
|
10155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMOD3 |
0.375704746083829 |
|
10156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSN3 |
0.375715767410871 |
|
10157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITCH |
0.375719284736257 |
|
10158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSN2 |
0.375730419782022 |
|
10159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STATH |
0.375730419782022 |
|
10160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTN3 |
0.375730419782022 |
|
10161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTN1 |
0.375730419782022 |
|
10162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSN1S2AP |
0.375730419782022 |
|
10163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SVILP1 |
0.37573443901524 |
|
10164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGB8P |
0.375751330490399 |
|
10165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1205 |
0.376069477406605 |
|
10166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00443 |
0.376071937489606 |
|
10167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRK |
0.376103733451691 |
|
10168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN1 |
0.376270285160693 |
|
10169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRN4CL |
0.376270285160693 |
|
10170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZWINT |
0.376333492773187 |
|
10171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC3 |
0.376408973010422 |
|
10172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PVT1 |
0.37679911390416 |
|
10173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF560 |
0.376801757052486 |
|
10174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF186 |
0.376819744679862 |
|
10175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPARC |
0.376835877009253 |
|
10176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRED58 |
0.376865275657388 |
|
10177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACKR5 |
0.376886216605033 |
|
10178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD10 |
0.376888254932557 |
|
10179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP3 |
0.376898581104684 |
|
10180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRM1 |
0.376967676082202 |
|
10181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00595 |
0.376979418968183 |
|
10182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE4A |
0.377054123977986 |
|
10183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUD3 |
0.377107790231541 |
|
10184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIGD1C |
0.377108536572223 |
|
10185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL308P |
0.377109207758918 |
|
10186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD2 |
0.377112577349685 |
|
10187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL226P |
0.377112577349685 |
|
10188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL39L |
0.37711914714228 |
|
10189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRISPLD1 |
0.377154667746001 |
|
10190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R13B |
0.377220951266534 |
|
10191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT16L1 |
0.377244942134077 |
|
10192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKS3 |
0.377244942134077 |
|
10193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf71 |
0.377244942134077 |
|
10194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF500 |
0.377244942134077 |
|
10195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA67|ENSG00000201619.1 |
0.377311521421977 |
|
10196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA67|ENSG00000212338.1 |
0.377311521421977 |
|
10197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1A2 |
0.37738807985515 |
|
10198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1A1 |
0.37738807985515 |
|
10199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1D4 |
0.37738807985515 |
|
10200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR3A2 |
0.37738807985515 |
|
10201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR3A1 |
0.37738807985515 |
|
10202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HGSNAT |
0.377390313027091 |
|
10203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEA |
0.377390313027091 |
|
10204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP41 |
0.377390313027091 |
|
10205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGK196 |
0.377390313027091 |
|
10206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000201329.1 |
0.377390313027091 |
|
10207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00551 |
0.377557735174344 |
|
10208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM8 |
0.377571318667475 |
|
10209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL3 |
0.377571318667475 |
|
10210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF540 |
0.377580080038575 |
|
10211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF571 |
0.377580080038575 |
|
10212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINGO2 |
0.3775805933678 |
|
10213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4309 |
0.37759367720218 |
|
10214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000251749.1 |
0.377661834794845 |
|
10215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC10 |
0.377661834794845 |
|
10216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1915 |
0.377661834794845 |
|
10217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKIDA1 |
0.377661834794845 |
|
10218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM84B |
0.377671817100231 |
|
10219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD31 |
0.37781188815738 |
|
10220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLUAP1 |
0.377853187050946 |
|
10221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRC3 |
0.377853187050946 |
|
10222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB11 |
0.377893247721655 |
|
10223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUB2 |
0.377920969759193 |
|
10224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX24 |
0.377920969759193 |
|
10225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4460 |
0.37797682640599 |
|
10226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YTHDC1 |
0.378072281913583 |
|
10227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP1L |
0.378166124184052 |
|
10228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP401 |
0.378203783967822 |
|
10229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYW5 |
0.378398890345175 |
|
10230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf25 |
0.378475198486139 |
|
10231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3943 |
0.378475198486139 |
|
10232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL32 |
0.378475198486139 |
|
10233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMA2 |
0.378475198486139 |
|
10234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODAM |
0.378503630775508 |
|
10235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT1 |
0.378541819297239 |
|
10236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000272337.1 |
0.378558991135361 |
|
10237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK2 |
0.378583559647019 |
|
10238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM98C |
0.378652027347066 |
|
10239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGRP4 |
0.378652027347066 |
|
10240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL11 |
0.378673194082263 |
|
10241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP171 |
0.378709991964081 |
|
10242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNBP1L |
0.378711197830733 |
|
10243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN7 |
0.378801684619908 |
|
10244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM35 |
0.37885806875264 |
|
10245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTK2B |
0.37885806875264 |
|
10246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXADRP3 |
0.379039728947321 |
|
10247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR1H3 |
0.379062422564295 |
|
10248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP26 |
0.379323749638932 |
|
10249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA71|ENSG00000201393.1 |
0.379396711342854 |
|
10250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRED60 |
0.379413810409497 |
|
10251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDCD3 |
0.379527319832887 |
|
10252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPSNAP1 |
0.379601337574137 |
|
10253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM75 |
0.37968660496114 |
|
10254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL18 |
0.379757499397848 |
|
10255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC45A4 |
0.379797007912188 |
|
10256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR48 |
0.379835716810404 |
|
10257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GORASP1 |
0.379835716810404 |
|
10258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC87 |
0.379941389443667 |
|
10259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCS |
0.379941389443667 |
|
10260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL26 |
0.379962817768436 |
|
10261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPHB5 |
0.380010787348646 |
|
10262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZAP70 |
0.380033417571138 |
|
10263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6E |
0.380122889156539 |
|
10264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf31 |
0.380122889156539 |
|
10265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY6H |
0.380122889156539 |
|
10266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM71 |
0.380203053574638 |
|
10267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4510 |
0.380343293579189 |
|
10268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD3 |
0.38034668748178 |
|
10269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STIP1 |
0.380400747041565 |
|
10270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP37 |
0.380443723958061 |
|
10271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF2 |
0.380453600314647 |
|
10272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252096.1 |
0.380453600314647 |
|
10273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252058.1 |
0.380453600314647 |
|
10274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238455.1 |
0.380586051147868 |
|
10275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASAP2 |
0.380648049883376 |
|
10276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB1BP1 |
0.380648049883376 |
|
10277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFFO1 |
0.380743277665059 |
|
10278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFR1 |
0.380809409460515 |
|
10279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLLT10 |
0.380847995312576 |
|
10280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABL2 |
0.380973273895631 |
|
10281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL734P |
0.380998787435073 |
|
10282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHLDA1 |
0.380998787435073 |
|
10283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELF1 |
0.381008789992056 |
|
10284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYN |
0.381041236934008 |
|
10285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA1|ENSG00000199405.1 |
0.381041236934008 |
|
10286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENAH |
0.381071265960045 |
|
10287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1210 |
0.381076181569762 |
|
10288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNOC |
0.381159654106823 |
|
10289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FDCSP |
0.381290751107981 |
|
10290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFKBIZ |
0.381302084709812 |
|
10291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARK2 |
0.381324608519288 |
|
10292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNH2 |
0.381365117161646 |
|
10293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00680 |
0.38158436068641 |
|
10294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548U |
0.38158436068641 |
|
10295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERTAD3 |
0.381670012139683 |
|
10296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLVRB |
0.381670012139683 |
|
10297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTRB2 |
0.381679941910199 |
|
10298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAP1L1 |
0.381716907259359 |
|
10299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLLT3 |
0.38188317323874 |
|
10300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4473 |
0.38188317323874 |
|
10301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf40 |
0.381899561228112 |
|
10302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR151 |
0.381932147430796 |
|
10303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GC |
0.382017479417119 |
|
10304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPNT |
0.382070155179745 |
|
10305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL652P |
0.382155374752445 |
|
10306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB7 |
0.382170575242255 |
|
10307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR74 |
0.382287753689313 |
|
10308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADD3 |
0.382373579121427 |
|
10309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIGIT |
0.382383472497004 |
|
10310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUGGC |
0.382437845845362 |
|
10311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAG1 |
0.382442849881216 |
|
10312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX5 |
0.3824549429395 |
|
10313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPM2 |
0.38247131155727 |
|
10314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238466.1 |
0.38247131155727 |
|
10315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF17 |
0.38247131155727 |
|
10316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMTN |
0.38247131155727 |
|
10317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM160B2 |
0.38247131155727 |
|
10318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1B1 |
0.382486001838482 |
|
10319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS10 |
0.382547991856478 |
|
10320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVC2 |
0.38260041577679 |
|
10321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHSY3 |
0.382663816297875 |
|
10322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT10B |
0.382666369932864 |
|
10323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP163 |
0.382746292033974 |
|
10324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREBBP |
0.382814586157205 |
|
10325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMRN1 |
0.383162454625172 |
|
10326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP6 |
0.383167079408088 |
|
10327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC9 |
0.383234993443778 |
|
10328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROP1 |
0.383293882654743 |
|
10329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YAF2 |
0.38332604336789 |
|
10330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAPD2 |
0.383347026506701 |
|
10331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAPDH |
0.383347026506701 |
|
10332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP181 |
0.383354210990283 |
|
10333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAE1 |
0.38344087897253 |
|
10334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST5 |
0.383633059938006 |
|
10335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00635 |
0.38421307885887 |
|
10336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS16 |
0.384298875197383 |
|
10337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNA12 |
0.384339219720467 |
|
10338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238747.1 |
0.384384688231717 |
|
10339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL119P |
0.384474950751506 |
|
10340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG1 |
0.38458398083871 |
|
10341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC3A2 |
0.38458398083871 |
|
10342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SS18 |
0.384593718491728 |
|
10343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRODH2 |
0.384595677222446 |
|
10344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP330 |
0.384625700571514 |
|
10345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERC2 |
0.38470024000582 |
|
10346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC25P |
0.384769204382193 |
|
10347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251700.1 |
0.384769204382193 |
|
10348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALGAPA2 |
0.384914375984925 |
|
10349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDM1 |
0.384928439169456 |
|
10350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL7A |
0.384977509819735 |
|
10351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL7 |
0.385039978227133 |
|
10352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX7 |
0.385085199864898 |
|
10353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAAR9 |
0.385085199864898 |
|
10354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMS2 |
0.385099053517305 |
|
10355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3659 |
0.38559694167171 |
|
10356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC65 |
0.385602953105508 |
|
10357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP43 |
0.385758496887901 |
|
10358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOT |
0.385795068471876 |
|
10359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00323 |
0.385805670182399 |
|
10360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3197 |
0.385805670182399 |
|
10361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO15 |
0.385823486325454 |
|
10362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSCB |
0.385906859804993 |
|
10363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYK2 |
0.385921035944709 |
|
10364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB17 |
0.385961152468516 |
|
10365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSM1 |
0.385991209925615 |
|
10366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD45|ENSG00000200051.1 |
0.386059021304058 |
|
10367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP7D1 |
0.38619486587344 |
|
10368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL131P |
0.38619486587344 |
|
10369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL23A1 |
0.386297404935188 |
|
10370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL868P |
0.386465364747917 |
|
10371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378A |
0.386465364747917 |
|
10372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1H |
0.386512677348517 |
|
10373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSTA3 |
0.386818631072783 |
|
10374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF623 |
0.386818631072783 |
|
10375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNB1 |
0.386926937152681 |
|
10376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB8OS |
0.386929973682393 |
|
10377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBBP4 |
0.386929973682393 |
|
10378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNC |
0.386929973682393 |
|
10379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf51 |
0.387254544622953 |
|
10380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA64|ENSG00000202517.1 |
0.387260503235681 |
|
10381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFIX |
0.38734179862451 |
|
10382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAAR8 |
0.387385557752929 |
|
10383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLHC1 |
0.387428816561728 |
|
10384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS27A |
0.387428816561728 |
|
10385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTIF2 |
0.387428816561728 |
|
10386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HORMAD2 |
0.387436115357438 |
|
10387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEF1 |
0.387512377337557 |
|
10388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS8 |
0.387512377337557 |
|
10389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf70 |
0.387512377337557 |
|
10390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000202449.1 |
0.387522265447593 |
|
10391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP164 |
0.387588111824709 |
|
10392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC7 |
0.387598716785168 |
|
10393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSE |
0.387619424597962 |
|
10394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00922 |
0.387685340980248 |
|
10395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED7 |
0.387729785346144 |
|
10396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITK |
0.387729785346144 |
|
10397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM71B |
0.387729785346144 |
|
10398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF1B |
0.387909115836156 |
|
10399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL33P |
0.387911749242577 |
|
10400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF521 |
0.387933202861323 |
|
10401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAP1 |
0.387954232047394 |
|
10402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL146P |
0.387963421463458 |
|
10403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCBE1 |
0.388046029948647 |
|
10404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX7 |
0.388047422830898 |
|
10405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TECPR2 |
0.388212985098255 |
|
10406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF414 |
0.388324446889747 |
|
10407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RERGL |
0.388326714746247 |
|
10408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD2|ENSG00000238707.1 |
0.388374838700745 |
|
10409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00293 |
0.388401025813307 |
|
10410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRB1 |
0.388423072798635 |
|
10411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
G0S2 |
0.388465777800043 |
|
10412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAAR6 |
0.388478724539632 |
|
10413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAAR5 |
0.388478724539632 |
|
10414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAAR3 |
0.388478724539632 |
|
10415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAAR2 |
0.388478724539632 |
|
10416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAAR1 |
0.388478724539632 |
|
10417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CES2 |
0.388496733993224 |
|
10418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM227B |
0.388535720958777 |
|
10419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCD2 |
0.388626266737186 |
|
10420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL12A |
0.388653563991983 |
|
10421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK4 |
0.388700503241508 |
|
10422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM5 |
0.388734034228635 |
|
10423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAGL1 |
0.388911380617975 |
|
10424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3B5 |
0.388911380617975 |
|
10425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHMBP2 |
0.388993786259711 |
|
10426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMPCB |
0.389045618900711 |
|
10427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC2 |
0.389045618900711 |
|
10428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTHD1 |
0.389068469990615 |
|
10429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL653P |
0.389090840326777 |
|
10430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM44 |
0.389140493014601 |
|
10431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYFIP2 |
0.389151401763473 |
|
10432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNDC9 |
0.389151401763473 |
|
10433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB10 |
0.389209970343196 |
|
10434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00911 |
0.38922420850416 |
|
10435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF33B |
0.389264308034342 |
|
10436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NACA2 |
0.389264618074051 |
|
10437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTV1 |
0.38944896415916 |
|
10438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC2HC1B |
0.38944896415916 |
|
10439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX11 |
0.38944896415916 |
|
10440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000251893.2 |
0.389464573472897 |
|
10441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBLCP1 |
0.389492184956506 |
|
10442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF827 |
0.389518132893801 |
|
10443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD3 |
0.389533786244689 |
|
10444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD1 |
0.389533786244689 |
|
10445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPN1 |
0.389575280537419 |
|
10446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARA5 |
0.389585238294948 |
|
10447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO1C |
0.389712078066259 |
|
10448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB7 |
0.389743443381292 |
|
10449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB11 |
0.389743443381292 |
|
10450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB12 |
0.389743443381292 |
|
10451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB13 |
0.389743443381292 |
|
10452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB14 |
0.389743443381292 |
|
10453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB18 |
0.389743443381292 |
|
10454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3164 |
0.389844362718365 |
|
10455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAAT |
0.389905963890684 |
|
10456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL50 |
0.389905963890684 |
|
10457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF189 |
0.389905963890684 |
|
10458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARF3 |
0.389922906796668 |
|
10459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF705E |
0.389971281975969 |
|
10460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB108B |
0.389971281975969 |
|
10461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP342 |
0.389971281975969 |
|
10462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP5K |
0.389972005794941 |
|
10463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUSC1 |
0.39003145466013 |
|
10464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAM1 |
0.390126523677097 |
|
10465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF121 |
0.390128777935731 |
|
10466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF1 |
0.390301086021036 |
|
10467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTLP10 |
0.390359351585981 |
|
10468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA5 |
0.390374715579621 |
|
10469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHGA |
0.390374715579621 |
|
10470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU3P3 |
0.390398594268833 |
|
10471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRNP48 |
0.390399832747788 |
|
10472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP6 |
0.390399832747788 |
|
10473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRB3 |
0.390458769883631 |
|
10474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRB4 |
0.390458769883631 |
|
10475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD3E |
0.390476593414769 |
|
10476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD3D |
0.390476593414769 |
|
10477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD3G |
0.390476593414769 |
|
10478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOR3A |
0.39053208946039 |
|
10479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP394 |
0.390681026899349 |
|
10480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB3 |
0.390687388857269 |
|
10481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR62 |
0.390699137558597 |
|
10482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL816P |
0.390762087574626 |
|
10483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF479 |
0.390762087574626 |
|
10484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4786 |
0.390776604923118 |
|
10485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY6 |
0.390883149721834 |
|
10486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL4A5 |
0.39093610426013 |
|
10487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00667 |
0.391020054963519 |
|
10488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00526 |
0.391020054963519 |
|
10489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB14 |
0.391020054963519 |
|
10490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF781 |
0.391131415689113 |
|
10491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL607P |
0.391249796267656 |
|
10492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORC5 |
0.391310338568355 |
|
10493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR3A4P |
0.391374315645498 |
|
10494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPZL2 |
0.391472662577471 |
|
10495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC5 |
0.391536236253161 |
|
10496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT12 |
0.391542122277855 |
|
10497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR3C |
0.391601608511396 |
|
10498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC61 |
0.391601608511396 |
|
10499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBED6CL |
0.391601608511396 |
|
10500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RARRES2 |
0.391601608511396 |
|
10501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REPIN1 |
0.391601608511396 |
|
10502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBF4 |
0.391622836092209 |
|
10503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPXM1 |
0.391622836092209 |
|
10504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf141 |
0.391622836092209 |
|
10505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM239 |
0.391622836092209 |
|
10506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAT4C |
0.391660707965034 |
|
10507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPD |
0.391679799493803 |
|
10508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL411P |
0.391689622900868 |
|
10509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WISP3 |
0.391790250235654 |
|
10510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBE1 |
0.391790250235654 |
|
10511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC30 |
0.391860633058416 |
|
10512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBSCR22 |
0.391860633058416 |
|
10513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX1A |
0.391860633058416 |
|
10514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4284 |
0.391860633058416 |
|
10515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD11 |
0.391860633058416 |
|
10516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00035 |
0.391860633058416 |
|
10517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL265P |
0.391860633058416 |
|
10518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN3 |
0.391860633058416 |
|
10519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVA1B |
0.391997572728256 |
|
10520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS20 |
0.392083858226778 |
|
10521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD54 |
0.392083858226778 |
|
10522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD200R1 |
0.392102224830936 |
|
10523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MX1 |
0.39215624969309 |
|
10524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC34 |
0.392231141567778 |
|
10525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACVR1B |
0.392232074682364 |
|
10526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL6A1 |
0.392285733517847 |
|
10527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA7 |
0.392313731787901 |
|
10528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSS51 |
0.392313731787901 |
|
10529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP86 |
0.392321191005084 |
|
10530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00433 |
0.392351314179351 |
|
10531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNE4 |
0.392379931850119 |
|
10532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALKBH6 |
0.392379931850119 |
|
10533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBF1 |
0.392426981418687 |
|
10534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF145 |
0.392426981418687 |
|
10535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA68|ENSG00000252458.1 |
0.392426981418687 |
|
10536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD226 |
0.392470021781259 |
|
10537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDP2 |
0.392508255292518 |
|
10538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH16 |
0.392508255292518 |
|
10539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRAD |
0.392508255292518 |
|
10540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM96B |
0.392508255292518 |
|
10541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC17A |
0.392627867728041 |
|
10542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRED62 |
0.392682818338461 |
|
10543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPFIBP1 |
0.392699384166542 |
|
10544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A6 |
0.392804835668813 |
|
10545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A9 |
0.392888604786226 |
|
10546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMR3 |
0.392897336124198 |
|
10547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA3B |
0.392966744496325 |
|
10548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX11 |
0.39299136552174 |
|
10549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLRT2 |
0.393096527562635 |
|
10550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC16 |
0.393133207213443 |
|
10551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHAMP1 |
0.393133207213443 |
|
10552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4502 |
0.393133207213443 |
|
10553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AR |
0.393133207213443 |
|
10554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPF3A |
0.393133207213443 |
|
10555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRG1 |
0.39320759542274 |
|
10556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPHLN1 |
0.393213295208072 |
|
10557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCRB1 |
0.393213295208072 |
|
10558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC14L3 |
0.393250848556516 |
|
10559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM180A |
0.393262361217508 |
|
10560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPM |
0.393445224524888 |
|
10561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1737 |
0.393549526474806 |
|
10562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDGF1 |
0.393604067382787 |
|
10563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRB2 |
0.393650726696294 |
|
10564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP10 |
0.39366702734937 |
|
10565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF236 |
0.393708248001263 |
|
10566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP255 |
0.393709136616489 |
|
10567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf48 |
0.393709136616489 |
|
10568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP30 |
0.393712855465103 |
|
10569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF775 |
0.393746226355492 |
|
10570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAR2 |
0.393779336232006 |
|
10571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP128 |
0.393864184084614 |
|
10572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGRP |
0.393957659150503 |
|
10573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRID2 |
0.394017820385659 |
|
10574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP3M2 |
0.394055068119757 |
|
10575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIC8B |
0.394093571422178 |
|
10576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL491P |
0.394362684690822 |
|
10577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC175 |
0.394376371757471 |
|
10578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN14 |
0.39440751766826 |
|
10579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA3|ENSG00000221148.1 |
0.394418908569583 |
|
10580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF2 |
0.394443758649038 |
|
10581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP197 |
0.394501946057846 |
|
10582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS3 |
0.394502016920506 |
|
10583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R14D |
0.394554576002247 |
|
10584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMC2 |
0.394574358509235 |
|
10585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A5 |
0.394574358509235 |
|
10586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXJ3 |
0.394718061972383 |
|
10587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM65A |
0.394811688305394 |
|
10588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFAP4 |
0.394833307997336 |
|
10589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL89P |
0.394850371966333 |
|
10590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf44 |
0.394876872280576 |
|
10591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC4 |
0.394993795008325 |
|
10592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISM2 |
0.395086418856457 |
|
10593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00886 |
0.395099378001881 |
|
10594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT6B |
0.395203365170106 |
|
10595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME5 |
0.395246069351948 |
|
10596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM19 |
0.395353422086508 |
|
10597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADIPOR2 |
0.395367307518118 |
|
10598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT16 |
0.3954539447752 |
|
10599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFYC |
0.395497877698699 |
|
10600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMICA1 |
0.395505902687846 |
|
10601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPZL3 |
0.395505902687846 |
|
10602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL63P |
0.395522343526176 |
|
10603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYZL2 |
0.395522343526176 |
|
10604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSR4P1 |
0.395626260425161 |
|
10605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP384 |
0.395638754763537 |
|
10606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00847 |
0.395648962916438 |
|
10607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP62 |
0.395648962916438 |
|
10608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00560 |
0.395684023779678 |
|
10609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5196 |
0.395709565194271 |
|
10610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF214 |
0.395721674165773 |
|
10611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL646P |
0.395834967013238 |
|
10612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLK4 |
0.395834967013238 |
|
10613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP70 |
0.395834967013238 |
|
10614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS4 |
0.395938906614381 |
|
10615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN4B |
0.395938906614381 |
|
10616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN2B |
0.395938906614381 |
|
10617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf70 |
0.395977528189683 |
|
10618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FARS2 |
0.396023955541885 |
|
10619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRM5 |
0.396065315210783 |
|
10620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EID2B |
0.396084360026517 |
|
10621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EID2 |
0.396084360026517 |
|
10622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR2 |
0.3962380350545 |
|
10623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR5 |
0.3962380350545 |
|
10624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPC1L1 |
0.396351601357866 |
|
10625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL12B |
0.396363365123811 |
|
10626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC2P |
0.396363365123811 |
|
10627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
L3HYPDH |
0.39649723141175 |
|
10628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JKAMP |
0.39649723141175 |
|
10629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFPL1S |
0.396685967075713 |
|
10630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEFH |
0.396685967075713 |
|
10631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRAT1 |
0.396714587672225 |
|
10632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRAT2 |
0.396714587672225 |
|
10633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000251709.1 |
0.396741966069127 |
|
10634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFX4 |
0.396811440328534 |
|
10635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEBPD |
0.396836583978405 |
|
10636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000207244.1 |
0.396928654047506 |
|
10637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPL |
0.396976899311703 |
|
10638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUPT5H |
0.397025996030352 |
|
10639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLL3 |
0.397025996030352 |
|
10640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM50 |
0.397025996030352 |
|
10641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRMP |
0.397118879085521 |
|
10642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7E47P |
0.397218948354296 |
|
10643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAT |
0.397229851917241 |
|
10644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERH |
0.397313771858426 |
|
10645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC1 |
0.397315464877925 |
|
10646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDHAF1 |
0.397327610033821 |
|
10647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00265 |
0.397431366293719 |
|
10648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP10B |
0.397462979631807 |
|
10649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLX4 |
0.397469769137333 |
|
10650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA1B |
0.397593059328477 |
|
10651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS3A |
0.397764918066184 |
|
10652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD73A |
0.397764918066184 |
|
10653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD73 |
0.397764918066184 |
|
10654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID2 |
0.397867099220806 |
|
10655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAF11 |
0.397867099220806 |
|
10656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL340P |
0.397878802220016 |
|
10657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC79 |
0.397940740308634 |
|
10658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP9 |
0.39801091160959 |
|
10659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR18 |
0.39801091160959 |
|
10660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRED57 |
0.398012877269672 |
|
10661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE6H |
0.398038037957748 |
|
10662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000252824.1 |
0.398070966963651 |
|
10663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPAL4 |
0.398085138030666 |
|
10664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDOB |
0.398112330442316 |
|
10665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM246 |
0.398112330442316 |
|
10666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF20 |
0.398112330442316 |
|
10667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP3R2 |
0.398112330442316 |
|
10668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548B |
0.39812121233452 |
|
10669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARAP1 |
0.398148672647646 |
|
10670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNASE1 |
0.398192764731315 |
|
10671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VHL |
0.398210574819892 |
|
10672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCC1 |
0.398262227278571 |
|
10673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM11 |
0.398300002432754 |
|
10674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLINT1 |
0.398300002432754 |
|
10675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC17 |
0.398348925110067 |
|
10676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIN3 |
0.398381090562834 |
|
10677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGR4 |
0.398392459825096 |
|
10678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASF1A |
0.398426242555707 |
|
10679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL60P |
0.398492225076144 |
|
10680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM149B1 |
0.398607726434678 |
|
10681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUMO1 |
0.39877802403768 |
|
10682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239166.1 |
0.398896098058378 |
|
10683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDLIM5 |
0.399254209456345 |
|
10684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIDECP |
0.399278436744846 |
|
10685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANK1 |
0.399361543658415 |
|
10686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LONP1 |
0.399418167076064 |
|
10687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC54 |
0.399477155714459 |
|
10688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP177 |
0.399658593479981 |
|
10689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD27 |
0.399700675977955 |
|
10690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE19 |
0.39973203564931 |
|
10691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTRB1 |
0.399797513057044 |
|
10692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAR1 |
0.399797513057044 |
|
10693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11|ENSG00000221164.1 |
0.399899565063294 |
|
10694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECD |
0.399899565063294 |
|
10695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VIPAS39 |
0.400009477162277 |
|
10696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKNAD1 |
0.400083583568625 |
|
10697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD22 |
0.400121449084499 |
|
10698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FFAR1 |
0.400121449084499 |
|
10699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUX4L2 |
0.400233164826234 |
|
10700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUX4L3 |
0.400233164826234 |
|
10701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUX4L4 |
0.400233164826234 |
|
10702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUX4L5 |
0.400233164826234 |
|
10703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUX4L6 |
0.400233164826234 |
|
10704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUX4L7 |
0.400233164826234 |
|
10705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUX4 |
0.400233164826234 |
|
10706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRG1 |
0.400233164826234 |
|
10707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRG2 |
0.400233164826234 |
|
10708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSP90AA4P |
0.400233164826234 |
|
10709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP174 |
0.400233164826234 |
|
10710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP175 |
0.400233164826234 |
|
10711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIML1 |
0.400233164826234 |
|
10712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIML2 |
0.400233164826234 |
|
10713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP42 |
0.400233164826234 |
|
10714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A2 |
0.400328556895224 |
|
10715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNGA3 |
0.400361958534772 |
|
10716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS2 |
0.40050236132346 |
|
10717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM5 |
0.400564518070907 |
|
10718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGMT |
0.400638833560526 |
|
10719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPC |
0.400654418335145 |
|
10720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA9 |
0.400692762079289 |
|
10721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF280D |
0.400763039102319 |
|
10722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXB1 |
0.400827791254777 |
|
10723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYF6 |
0.400996771289245 |
|
10724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYF5 |
0.400996771289245 |
|
10725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPNA7 |
0.401072157923061 |
|
10726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2IRD1 |
0.401164555418033 |
|
10727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJA10 |
0.401237508080246 |
|
10728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP110 |
0.401237508080246 |
|
10729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRA1D |
0.401288922232856 |
|
10730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIAPH1 |
0.401292580526277 |
|
10731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPP7P8 |
0.401321759549154 |
|
10732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86C1 |
0.401321759549154 |
|
10733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238563.1 |
0.4013562701433 |
|
10734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R32 |
0.401429774853766 |
|
10735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPT1A |
0.401666272082278 |
|
10736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf91 |
0.401712919878326 |
|
10737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGST1 |
0.401767976688161 |
|
10738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPP40 |
0.401809777529018 |
|
10739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R3G |
0.401809777529018 |
|
10740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPTX1 |
0.4020941677018 |
|
10741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRA1 |
0.402286630687412 |
|
10742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4EBP3 |
0.402286630687412 |
|
10743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APBB3 |
0.402286630687412 |
|
10744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35A4 |
0.402286630687412 |
|
10745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA27|ENSG00000200235.1 |
0.402286630687412 |
|
10746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD14 |
0.402286630687412 |
|
10747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA2 |
0.402286630687412 |
|
10748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCO6 |
0.402286630687412 |
|
10749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OAZ3 |
0.402338182593039 |
|
10750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR933 |
0.402394432283852 |
|
10751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5G3 |
0.402394432283852 |
|
10752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM68 |
0.402460585115896 |
|
10753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP265 |
0.402460585115896 |
|
10754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGS1 |
0.402460585115896 |
|
10755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM118A |
0.402467025089223 |
|
10756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASCC1 |
0.402487378645867 |
|
10757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC16 |
0.402487378645867 |
|
10758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL850P |
0.402494935177329 |
|
10759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP214 |
0.402558604303329 |
|
10760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBLIM1 |
0.402671572477422 |
|
10761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A8 |
0.402743108161433 |
|
10762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT1 |
0.402919383824994 |
|
10763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7E19P |
0.403165332030526 |
|
10764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM5 |
0.403234856337122 |
|
10765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4425 |
0.403320298908498 |
|
10766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL51 |
0.403338267870395 |
|
10767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA10 |
0.403338267870395 |
|
10768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPM1 |
0.403484692763557 |
|
10769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTBR |
0.403536523950917 |
|
10770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00883 |
0.403587903113888 |
|
10771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf60 |
0.4036842713658 |
|
10772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAL |
0.403724772777543 |
|
10773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTL5 |
0.403724772777543 |
|
10774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP356 |
0.403882920369164 |
|
10775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL22 |
0.403996870339338 |
|
10776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF18 |
0.40406892830236 |
|
10777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINT1 |
0.404174082707675 |
|
10778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOV |
0.404174082707675 |
|
10779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTBP2 |
0.404290022859453 |
|
10780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC166 |
0.404392359537154 |
|
10781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM83H |
0.404392359537154 |
|
10782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK15 |
0.404392359537154 |
|
10783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4664 |
0.404392359537154 |
|
10784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF707 |
0.404392359537154 |
|
10785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf22 |
0.404441164150863 |
|
10786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS18 |
0.404477217204406 |
|
10787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUFU |
0.404512229086571 |
|
10788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR1A |
0.40453539909449 |
|
10789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTO2 |
0.404584876620455 |
|
10790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF573 |
0.404655000089441 |
|
10791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf48 |
0.40476759469458 |
|
10792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf83 |
0.40476759469458 |
|
10793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL12 |
0.40476759469458 |
|
10794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA57|ENSG00000206597.1 |
0.40476759469458 |
|
10795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP6R3 |
0.40478087071673 |
|
10796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN19 |
0.404898376738461 |
|
10797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOS |
0.40504131046613 |
|
10798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA3|ENSG00000221093.1 |
0.40504131046613 |
|
10799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
N4BP3 |
0.405053144632308 |
|
10800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF607 |
0.405196867729838 |
|
10801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN10A |
0.405276530783209 |
|
10802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM3AP |
0.40529153927941 |
|
10803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf58 |
0.40529153927941 |
|
10804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIP2A |
0.40529153927941 |
|
10805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCNT |
0.40529153927941 |
|
10806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRMT2 |
0.40529153927941 |
|
10807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100B |
0.40529153927941 |
|
10808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YBEY |
0.40529153927941 |
|
10809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCG3 |
0.405324739878743 |
|
10810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYSMD2 |
0.405324739878743 |
|
10811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMOD2 |
0.405324739878743 |
|
10812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10A4 |
0.405354851054473 |
|
10813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2D2 |
0.405354851054473 |
|
10814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2D3 |
0.405354851054473 |
|
10815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF215 |
0.405354851054473 |
|
10816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPB41L3 |
0.40538750400334 |
|
10817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL831P |
0.405427907821589 |
|
10818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP270 |
0.405427907821589 |
|
10819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM55 |
0.405443960948017 |
|
10820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRH |
0.405443960948017 |
|
10821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00967 |
0.405443960948017 |
|
10822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRIQ1 |
0.405445564342004 |
|
10823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MVK |
0.405493210590475 |
|
10824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP250 |
0.405493210590475 |
|
10825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPV4 |
0.405493210590475 |
|
10826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4497 |
0.405493210590475 |
|
10827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLTP |
0.405493210590475 |
|
10828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL441P |
0.405493210590475 |
|
10829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VIMP |
0.405577125394213 |
|
10830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPA1 |
0.405577125394213 |
|
10831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCSK6 |
0.405577125394213 |
|
10832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC9 |
0.405592795056441 |
|
10833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL21P |
0.405702050388854 |
|
10834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPS |
0.40571819573516 |
|
10835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2F |
0.405783175209624 |
|
10836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5L |
0.405914768710433 |
|
10837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT64 |
0.406251591681402 |
|
10838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TENM2 |
0.406336660336896 |
|
10839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHURC1 |
0.406343792834941 |
|
10840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD74|ENSG00000200897.1 |
0.406365532126008 |
|
10841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A3 |
0.40636813387999 |
|
10842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4530 |
0.406377974993101 |
|
10843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHG2 |
0.406377974993101 |
|
10844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP36 |
0.406377974993101 |
|
10845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS16 |
0.406377974993101 |
|
10846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM229B |
0.40642767528477 |
|
10847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNRHR |
0.406437749134217 |
|
10848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA62|ENSG00000202374.1 |
0.406437749134217 |
|
10849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCE1 |
0.406452838668975 |
|
10850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNB2 |
0.406461493617255 |
|
10851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC1 |
0.406496309883436 |
|
10852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMN1 |
0.406525042677772 |
|
10853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP298 |
0.40653225489636 |
|
10854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00637 |
0.406601497804521 |
|
10855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf2 |
0.406601497804521 |
|
10856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RD3L |
0.406601497804521 |
|
10857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3A3 |
0.406756827205237 |
|
10858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHL3 |
0.406756827205237 |
|
10859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP11L |
0.406756827205237 |
|
10860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU3F1 |
0.406756827205237 |
|
10861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL22 |
0.406951511700844 |
|
10862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMKV |
0.406962304415416 |
|
10863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAF1 |
0.407019722037635 |
|
10864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED29 |
0.407019722037635 |
|
10865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A10 |
0.407056997715582 |
|
10866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1919 |
0.407056997715582 |
|
10867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3147 |
0.407058060327892 |
|
10868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF716 |
0.407058060327892 |
|
10869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM193B |
0.407189297660358 |
|
10870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP25 |
0.407295150055898 |
|
10871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL32 |
0.407295150055898 |
|
10872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPEN |
0.407361745037276 |
|
10873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRIMA1 |
0.407462747149547 |
|
10874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRM2 |
0.407578377037248 |
|
10875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC37A3 |
0.407613928388419 |
|
10876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB19 |
0.407613928388419 |
|
10877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP247 |
0.407613928388419 |
|
10878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP248 |
0.407613928388419 |
|
10879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238868.1 |
0.407613928388419 |
|
10880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPC1 |
0.407694589149713 |
|
10881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKMY1 |
0.407694589149713 |
|
10882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP28 |
0.407694589149713 |
|
10883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNPEPL1 |
0.407694589149713 |
|
10884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN10 |
0.407694589149713 |
|
10885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR35 |
0.407694589149713 |
|
10886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD200R1L |
0.407694911415112 |
|
10887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2CD4B |
0.407832616741844 |
|
10888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACR |
0.407854323748254 |
|
10889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADM2 |
0.407854323748254 |
|
10890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG12 |
0.407854323748254 |
|
10891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSA |
0.407854323748254 |
|
10892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRD1 |
0.407854323748254 |
|
10893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf34 |
0.407854323748254 |
|
10894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHKB |
0.407854323748254 |
|
10895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPT1B |
0.407854323748254 |
|
10896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRELD2 |
0.407854323748254 |
|
10897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND6B |
0.407854323748254 |
|
10898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC10 |
0.407854323748254 |
|
10899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17REL |
0.407854323748254 |
|
10900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC7B |
0.407854323748254 |
|
10901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMF2 |
0.407854323748254 |
|
10902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK11 |
0.407854323748254 |
|
10903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK12 |
0.407854323748254 |
|
10904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK8IP2 |
0.407854323748254 |
|
10905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIOX |
0.407854323748254 |
|
10906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3667 |
0.407854323748254 |
|
10907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLC1 |
0.407854323748254 |
|
10908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOV10L1 |
0.407854323748254 |
|
10909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAPH2 |
0.407854323748254 |
|
10910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODF3B |
0.407854323748254 |
|
10911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PANX2 |
0.407854323748254 |
|
10912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIM3 |
0.407854323748254 |
|
10913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXNB2 |
0.407854323748254 |
|
10914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP6R2 |
0.407854323748254 |
|
10915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABL2B |
0.407854323748254 |
|
10916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP252 |
0.407854323748254 |
|
10917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL500P |
0.407854323748254 |
|
10918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBF1 |
0.407854323748254 |
|
10919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCO2 |
0.407854323748254 |
|
10920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHANK3 |
0.407854323748254 |
|
10921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCE3 |
0.407854323748254 |
|
10922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRABD |
0.407854323748254 |
|
10923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL8 |
0.407854323748254 |
|
10924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBGCP6 |
0.407854323748254 |
|
10925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYMP |
0.407854323748254 |
|
10926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBED4 |
0.407854323748254 |
|
10927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETV3L |
0.407894769099416 |
|
10928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETV3 |
0.407894769099416 |
|
10929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIP3 |
0.407918963311627 |
|
10930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP8 |
0.407918963311627 |
|
10931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRB2 |
0.407947852412342 |
|
10932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TWF1 |
0.4079489022008 |
|
10933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLRT1 |
0.407973943647757 |
|
10934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH16 |
0.407987425218493 |
|
10935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPC1A |
0.407987425218493 |
|
10936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000222666.1 |
0.408064446886976 |
|
10937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP39 |
0.408064446886976 |
|
10938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGBL2 |
0.408073109687261 |
|
10939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP5 |
0.408210234276835 |
|
10940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFX1 |
0.408210234276835 |
|
10941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP7 |
0.408210234276835 |
|
10942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS6 |
0.408217294248802 |
|
10943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRK1 |
0.408217294248802 |
|
10944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM255B |
0.408217294248802 |
|
10945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM57 |
0.408241183145127 |
|
10946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDLRAP1 |
0.408241183145127 |
|
10947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMURF1 |
0.408449708304328 |
|
10948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XBP1 |
0.408474404606167 |
|
10949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL608P |
0.408480633129864 |
|
10950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR126 |
0.408531199766791 |
|
10951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYND12 |
0.40858522987422 |
|
10952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPCS |
0.40858522987422 |
|
10953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLU |
0.408741711785763 |
|
10954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERKL |
0.408840225707898 |
|
10955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLEC1 |
0.408867575852339 |
|
10956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAA1 |
0.408867575852339 |
|
10957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMH |
0.408894382211511 |
|
10958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JSRP1 |
0.408894382211511 |
|
10959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4321 |
0.408894382211511 |
|
10960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR149 |
0.408966631792322 |
|
10961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS20 |
0.409253360216976 |
|
10962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEA1 |
0.409253360216976 |
|
10963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252387.1 |
0.409256120551858 |
|
10964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAA |
0.409356359841513 |
|
10965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA2 |
0.409362800878887 |
|
10966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF501 |
0.409363398139582 |
|
10967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1143 |
0.409363398139582 |
|
10968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP3 |
0.409363532357577 |
|
10969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA10 |
0.409407546174712 |
|
10970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6B2 |
0.409407546174712 |
|
10971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR21 |
0.409407546174712 |
|
10972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6B3 |
0.409407546174712 |
|
10973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYEOV2 |
0.409407546174712 |
|
10974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOS |
0.409407546174712 |
|
10975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMX3 |
0.409521799215421 |
|
10976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTF |
0.409602856351894 |
|
10977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTP3 |
0.409602856351894 |
|
10978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP10A |
0.409650216408173 |
|
10979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL267P |
0.409670137667897 |
|
10980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL10 |
0.409782627376647 |
|
10981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP40 |
0.409812797038001 |
|
10982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX11L9 |
0.410062919974863 |
|
10983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM1P47 |
0.410062919974863 |
|
10984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM138E |
0.410062919974863 |
|
10985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F13P |
0.410062919974863 |
|
10986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F15 |
0.410062919974863 |
|
10987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F4 |
0.410062919974863 |
|
10988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4F6 |
0.410062919974863 |
|
10989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL209P |
0.410062919974863 |
|
10990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TARSL2 |
0.410062919974863 |
|
10991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM2D3 |
0.410062919974863 |
|
10992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASH3P |
0.410062919974863 |
|
10993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238502.1 |
0.410062919974863 |
|
10994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS11BNL |
0.410097278079552 |
|
10995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL13 |
0.410151763174079 |
|
10996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCAIM |
0.410159019823686 |
|
10997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL34P |
0.410214426153267 |
|
10998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAT1 |
0.410428166514112 |
|
10999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf77 |
0.410428166514112 |
|
11000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERINC2 |
0.410483564895813 |
|
11001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC79 |
0.410492219129292 |
|
11002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52N1 |
0.410529113616271 |
|
11003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52N5 |
0.410529113616271 |
|
11004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52N2 |
0.410529113616271 |
|
11005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNB3 |
0.410573321052088 |
|
11006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX23 |
0.410573321052088 |
|
11007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAK4 |
0.410586665398338 |
|
11008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKL1 |
0.410596173728431 |
|
11009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS26 |
0.410651001060138 |
|
11010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYP |
0.410676755449149 |
|
11011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1F |
0.410676755449149 |
|
11012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC22 |
0.410676755449149 |
|
11013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FST |
0.410704413012148 |
|
11014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NECAP2 |
0.410777969080892 |
|
11015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIN3A |
0.411110949058317 |
|
11016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC7 |
0.411163915697113 |
|
11017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC3B |
0.411163915697113 |
|
11018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS13 |
0.411164214036351 |
|
11019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51I2 |
0.411184677852194 |
|
11020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRRM1 |
0.411189345860861 |
|
11021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238986.1 |
0.411189345860861 |
|
11022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC11 |
0.411323376957862 |
|
11023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDNRA |
0.411327953295246 |
|
11024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM184C |
0.411327953295246 |
|
11025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRMT10 |
0.411327953295246 |
|
11026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC15A1 |
0.411344394151442 |
|
11027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52D1 |
0.411477000238471 |
|
11028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBQLN3 |
0.411477000238471 |
|
11029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBQLNL |
0.411477000238471 |
|
11030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52H1 |
0.411477000238471 |
|
11031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM1A |
0.41152505588003 |
|
11032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRICKLE3 |
0.411665540654637 |
|
11033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RND1 |
0.411745492643594 |
|
11034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf82 |
0.411768258687929 |
|
11035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKK |
0.411826729804367 |
|
11036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC2P1 |
0.41191175316064 |
|
11037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFM1 |
0.411922402285726 |
|
11038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LXN |
0.411922402285726 |
|
11039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RARRES1 |
0.411922402285726 |
|
11040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A14 |
0.412124357054169 |
|
11041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2A13 |
0.412136864926827 |
|
11042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENDOV |
0.412137373054782 |
|
11043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4730 |
0.412137373054782 |
|
11044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKZF4 |
0.412200038308868 |
|
11045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA40 |
0.41223049798937 |
|
11046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX8A |
0.41223049798937 |
|
11047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUB1 |
0.41223049798937 |
|
11048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX2 |
0.41230831839451 |
|
11049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R19 |
0.412347646069386 |
|
11050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R30 |
0.412347646069386 |
|
11051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R31 |
0.412347646069386 |
|
11052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R42 |
0.412347646069386 |
|
11053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R43 |
0.412347646069386 |
|
11054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R46 |
0.412347646069386 |
|
11055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R64P |
0.412347646069386 |
|
11056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCAN3 |
0.412420875802501 |
|
11057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL857P |
0.412420875802501 |
|
11058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCMAP |
0.412420875802501 |
|
11059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUD1 |
0.41245203001376 |
|
11060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS21 |
0.412543035261949 |
|
11061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFJ |
0.412590330867948 |
|
11062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST4H4 |
0.412590330867948 |
|
11063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPLAL1 |
0.412636684257866 |
|
11064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WIPI1 |
0.412758623566539 |
|
11065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf68 |
0.412952522937494 |
|
11066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG14 |
0.413077101141074 |
|
11067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNW1 |
0.413151396778482 |
|
11068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3201 |
0.413326236227127 |
|
11069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB10 |
0.413376687666321 |
|
11070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA2 |
0.413404359612266 |
|
11071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBG2 |
0.41342020704365 |
|
11072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBE1 |
0.41342020704365 |
|
11073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRORSD1P |
0.413445798618617 |
|
11074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC88A |
0.413445798618617 |
|
11075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAR2A |
0.413564691100812 |
|
11076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHOX2 |
0.413731383698361 |
|
11077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE3B |
0.413869522653878 |
|
11078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4535 |
0.413908022536679 |
|
11079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIN2 |
0.414016178725706 |
|
11080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELA1 |
0.414016178725706 |
|
11081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPUL2 |
0.414138000432144 |
|
11082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC9C |
0.414138000432144 |
|
11083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
URI1 |
0.41414559565659 |
|
11084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATM |
0.414160361310631 |
|
11085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf10 |
0.41417845580043 |
|
11086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA17 |
0.414212529719185 |
|
11087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC80 |
0.414301292606723 |
|
11088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5190 |
0.414321665377602 |
|
11089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239034.1 |
0.414341994993943 |
|
11090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM149A |
0.414341994993943 |
|
11091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000253013.1 |
0.414341994993943 |
|
11092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4V2 |
0.414341994993943 |
|
11093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF260 |
0.414359116940393 |
|
11094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1267 |
0.41443887167316 |
|
11095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FFAR3 |
0.414502404279396 |
|
11096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR42 |
0.414502404279396 |
|
11097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL24 |
0.414572180030364 |
|
11098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFPL1 |
0.41458033796378 |
|
11099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BSCL2 |
0.414600598379647 |
|
11100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG3 |
0.414600598379647 |
|
11101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NODAL |
0.414657735053567 |
|
11102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR604 |
0.414747183590266 |
|
11103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOB1B |
0.414773105693306 |
|
11104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCK |
0.414773105693306 |
|
11105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGAM1 |
0.414971392586279 |
|
11106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC1 |
0.414971392586279 |
|
11107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000252138.1 |
0.414992029391882 |
|
11108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00601 |
0.415066064133262 |
|
11109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf65 |
0.415098090468621 |
|
11110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYRIP |
0.415191111183098 |
|
11111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT10 |
0.415387513621762 |
|
11112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFDP1 |
0.415430756767375 |
|
11113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YOD1 |
0.415710143956445 |
|
11114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFKFB2 |
0.415710143956445 |
|
11115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4BPB |
0.415710143956445 |
|
11116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4BPA |
0.415710143956445 |
|
11117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00861 |
0.415795697103548 |
|
11118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPK |
0.415802247738044 |
|
11119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGIX |
0.415835051907186 |
|
11120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCCAT5 |
0.415886416007133 |
|
11121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACKR3 |
0.415921648691054 |
|
11122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPAL3 |
0.415969916141071 |
|
11123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00210 |
0.416008264456025 |
|
11124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP8B |
0.416174495944941 |
|
11125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXCT2 |
0.416174495944941 |
|
11126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51I1 |
0.416221093224604 |
|
11127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMAB |
0.416381112091409 |
|
11128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3122 |
0.416383970334031 |
|
11129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNS3 |
0.416479522751464 |
|
11130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAT2 |
0.416517368376704 |
|
11131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POM121C |
0.416567152082026 |
|
11132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXI2 |
0.416598045208411 |
|
11133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLRN3 |
0.416598045208411 |
|
11134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX2IP |
0.416697480484947 |
|
11135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR490 |
0.416807067200088 |
|
11136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLP2 |
0.416834683120173 |
|
11137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARA3 |
0.417067438002906 |
|
11138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YBX1 |
0.417107842669361 |
|
11139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISG20L2 |
0.417287165461504 |
|
11140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRNAD1 |
0.417287165461504 |
|
11141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INO80C |
0.417304119955045 |
|
11142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF3 |
0.417311614019921 |
|
11143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCOR2 |
0.417369032142544 |
|
11144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP154 |
0.417478672614371 |
|
11145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP7 |
0.417605845894274 |
|
11146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC71 |
0.417627730551359 |
|
11147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAVCR1 |
0.417637151934147 |
|
11148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAVCR2 |
0.417637151934147 |
|
11149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3691 |
0.417752034839237 |
|
11150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP213 |
0.417761317348033 |
|
11151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC4M |
0.417967924237039 |
|
11152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN10 |
0.417977533324602 |
|
11153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF205 |
0.417977533324602 |
|
11154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF213 |
0.417977533324602 |
|
11155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP16 |
0.417977533324602 |
|
11156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTX2 |
0.418041944406322 |
|
11157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK9 |
0.418073731957838 |
|
11158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKNK2 |
0.418079169332584 |
|
11159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTN4 |
0.418088381602941 |
|
11160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF7 |
0.418106953939156 |
|
11161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR633 |
0.418124333620338 |
|
11162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLPB |
0.418124528283242 |
|
11163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL450P |
0.418171105888983 |
|
11164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NARG2 |
0.418180114219386 |
|
11165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND2A |
0.418354068229947 |
|
11166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL262P |
0.418375544353941 |
|
11167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB1 |
0.418623561611135 |
|
11168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238398.1 |
0.418748275044074 |
|
11169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLF1 |
0.418797318284485 |
|
11170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC40 |
0.418809719485498 |
|
11171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBFOX1 |
0.418810378057226 |
|
11172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A47 |
0.41896831940621 |
|
11173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYDC1 |
0.418992050937211 |
|
11174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRE |
0.41900006017208 |
|
11175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB4 |
0.419046361877231 |
|
11176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR10A |
0.419046361877231 |
|
11177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL771P |
0.419223777752115 |
|
11178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238816.1 |
0.419471245866744 |
|
11179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52N4 |
0.41949938679294 |
|
11180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLIM4 |
0.419539201053348 |
|
11181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238488.1 |
0.419695321679077 |
|
11182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPWD1 |
0.419749415907368 |
|
11183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKRN1 |
0.419787090732245 |
|
11184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LONRF2 |
0.4198165831696 |
|
11185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP4B |
0.419877963429952 |
|
11186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKI67 |
0.419885782575352 |
|
11187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPRIP |
0.419952535221077 |
|
11188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52B6 |
0.420057392184584 |
|
11189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHOD3 |
0.420166321089481 |
|
11190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MC4R |
0.420217113777799 |
|
11191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA1 |
0.420337379442088 |
|
11192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA2 |
0.420337379442088 |
|
11193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA3 |
0.420337379442088 |
|
11194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGB1 |
0.420337379442088 |
|
11195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA4 |
0.420337379442088 |
|
11196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGB2 |
0.420337379442088 |
|
11197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA5 |
0.420337379442088 |
|
11198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGB3 |
0.420337379442088 |
|
11199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA6 |
0.420337379442088 |
|
11200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA7 |
0.420337379442088 |
|
11201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGB4 |
0.420337379442088 |
|
11202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGA8 |
0.420337379442088 |
|
11203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBPL1 |
0.420366087129828 |
|
11204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMP2 |
0.42036647921989 |
|
11205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOK5 |
0.420442975301132 |
|
11206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF4B |
0.42049010649503 |
|
11207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT6 |
0.420514026657078 |
|
11208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A8 |
0.420514026657078 |
|
11209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPS5 |
0.420570867977476 |
|
11210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP268 |
0.420570867977476 |
|
11211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMFG |
0.420825363322049 |
|
11212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD4B |
0.420825363322049 |
|
11213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH8 |
0.420852485866931 |
|
11214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL24 |
0.420957883182476 |
|
11215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAIM3 |
0.420957883182476 |
|
11216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF812 |
0.420968044390611 |
|
11217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIDR |
0.420986820380064 |
|
11218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB8B |
0.420991889450182 |
|
11219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF3IP1 |
0.42100272037634 |
|
11220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A4 |
0.421023213956932 |
|
11221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA7 |
0.421090169269085 |
|
11222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSP90AB2P |
0.421121092773736 |
|
11223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTFR1L |
0.421237060132695 |
|
11224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STMN1 |
0.421237060132695 |
|
11225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3917 |
0.421237060132695 |
|
11226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA14 |
0.421263396117789 |
|
11227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSG1 |
0.421524124426004 |
|
11228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOCS4 |
0.421578202486303 |
|
11229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR151A |
0.421686161859974 |
|
11230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTK2 |
0.421686161859974 |
|
11231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP278 |
0.421686161859974 |
|
11232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKL3 |
0.421743656218331 |
|
11233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAUS5 |
0.421820153953194 |
|
11234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC19P |
0.421833426254363 |
|
11235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP4 |
0.421864267427905 |
|
11236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQSEC1 |
0.421909246883389 |
|
11237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR183 |
0.421930853969214 |
|
11238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR623 |
0.421930853969214 |
|
11239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNB1 |
0.42196612547172 |
|
11240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIPARP |
0.421999143618895 |
|
11241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAND5 |
0.422057272169921 |
|
11242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT80 |
0.422114170123877 |
|
11243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPLAH |
0.422169020510346 |
|
11244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC4 |
0.422169020510346 |
|
11245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPAA1 |
0.422169020510346 |
|
11246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYC1 |
0.422169020510346 |
|
11247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHARPIN |
0.422169020510346 |
|
11248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1875 |
0.422169020510346 |
|
11249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAF1 |
0.422169020510346 |
|
11250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHM2 |
0.422187574243444 |
|
11251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A34 |
0.422187574243444 |
|
11252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM82 |
0.422187574243444 |
|
11253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE2A |
0.422347354793477 |
|
11254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF6 |
0.4224334418667 |
|
11255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1462 |
0.422482439261139 |
|
11256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC14P |
0.422604026718441 |
|
11257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC8A3 |
0.422675831731486 |
|
11258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF21 |
0.42272588555592 |
|
11259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGXT |
0.422745213991397 |
|
11260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf54 |
0.422745213991397 |
|
11261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTA3 |
0.422831460162538 |
|
11262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CANT1 |
0.422849167645437 |
|
11263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AACSP1 |
0.422855945404232 |
|
11264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF354A |
0.422885996769317 |
|
11265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM42 |
0.423037102035346 |
|
11266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETV2 |
0.423037102035346 |
|
11267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0E1 |
0.423078223917417 |
|
11268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74B |
0.423078223917417 |
|
11269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRD8 |
0.423087791402752 |
|
11270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQGAP3 |
0.423109964350835 |
|
11271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000202268.1 |
0.423131522021902 |
|
11272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDH10 |
0.423210793767439 |
|
11273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf90 |
0.423263500123823 |
|
11274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD77|ENSG00000251967.1 |
0.423370318153508 |
|
11275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALS2CL |
0.423370318153508 |
|
11276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMIE |
0.423370318153508 |
|
11277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS17 |
0.423409658314962 |
|
11278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA21 |
0.423555960592187 |
|
11279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTN3 |
0.423594274929909 |
|
11280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf95 |
0.423594274929909 |
|
11281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL596P |
0.423594274929909 |
|
11282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf84 |
0.423594274929909 |
|
11283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARK2 |
0.423594274929909 |
|
11284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP53 |
0.423742606125125 |
|
11285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PWP1 |
0.423890862944465 |
|
11286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM4 |
0.423890862944465 |
|
11287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASCL4 |
0.423890862944465 |
|
11288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YKT6 |
0.423973256204192 |
|
11289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK2B |
0.423973256204192 |
|
11290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP85L |
0.423975542441568 |
|
11291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLN |
0.423975542441568 |
|
11292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHKA1 |
0.423982993793695 |
|
11293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM44 |
0.423993809931729 |
|
11294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESRRG |
0.423999685311788 |
|
11295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTN5 |
0.424248932815004 |
|
11296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRBA1 |
0.424265329820993 |
|
11297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF467 |
0.424265329820993 |
|
11298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF445 |
0.424296096306426 |
|
11299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOLD1 |
0.424426908501966 |
|
11300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP30 |
0.424430365360849 |
|
11301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP11 |
0.424442107815233 |
|
11302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCKAP5 |
0.424483642118964 |
|
11303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALOX5 |
0.424596928292346 |
|
11304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP201 |
0.424725568195018 |
|
11305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP24 |
0.424790445912438 |
|
11306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSRC1 |
0.424795921946599 |
|
11307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYBPHL |
0.424795921946599 |
|
11308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS2 |
0.424813789136621 |
|
11309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXLNA |
0.424829250211101 |
|
11310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3924 |
0.425039978351978 |
|
11311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTN |
0.425054623724497 |
|
11312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD81|ENSG00000202023.1 |
0.425054623724497 |
|
11313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf105 |
0.425110241271103 |
|
11314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF15 |
0.425507174793744 |
|
11315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMU1 |
0.425534191608786 |
|
11316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM81A |
0.425596749134426 |
|
11317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM6 |
0.425615242204304 |
|
11318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM34 |
0.425615242204304 |
|
11319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM22 |
0.425615242204304 |
|
11320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR56B1 |
0.425615242204304 |
|
11321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCMDC2 |
0.425695027470984 |
|
11322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG6 |
0.425695027470984 |
|
11323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD87 |
0.425695027470984 |
|
11324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF24 |
0.425695027470984 |
|
11325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIPK1 |
0.425787189998878 |
|
11326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1227 |
0.425795463658524 |
|
11327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHJ1 |
0.425795463658524 |
|
11328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3A2 |
0.425795463658524 |
|
11329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00839 |
0.425811482720566 |
|
11330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCOR1 |
0.425812839352541 |
|
11331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF9 |
0.42595451658495 |
|
11332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC147 |
0.42601980512363 |
|
11333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA43|ENSG00000199815.1 |
0.426056704492393 |
|
11334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF15 |
0.426121970804218 |
|
11335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP11L2 |
0.426257204010225 |
|
11336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROS1 |
0.426259319789472 |
|
11337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP18 |
0.426259319789472 |
|
11338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP51 |
0.426259319789472 |
|
11339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT18P55 |
0.426371594699436 |
|
11340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM97 |
0.426371594699436 |
|
11341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT20 |
0.426371594699436 |
|
11342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFAIP1 |
0.426371594699436 |
|
11343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP205 |
0.426373130921588 |
|
11344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRAK2 |
0.426419607137469 |
|
11345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM4 |
0.42643368400846 |
|
11346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOPAZ1 |
0.426471849182294 |
|
11347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf73 |
0.426489572381185 |
|
11348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC13A4 |
0.426489572381185 |
|
11349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC2 |
0.426574734871487 |
|
11350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUZPP1 |
0.426574734871487 |
|
11351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANBP6 |
0.426579800280107 |
|
11352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENY2 |
0.426712273352083 |
|
11353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBP6 |
0.426842969278072 |
|
11354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBP1P1 |
0.426842969278072 |
|
11355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERS3 |
0.426851877817607 |
|
11356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA41 |
0.426851877817607 |
|
11357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF282 |
0.426909753653269 |
|
11358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252557.1 |
0.427014165807954 |
|
11359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF777 |
0.427014165807954 |
|
11360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF746 |
0.427014165807954 |
|
11361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPHL |
0.427181586604669 |
|
11362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB2A |
0.427181586604669 |
|
11363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB2B |
0.427181586604669 |
|
11364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA2 |
0.427406707945391 |
|
11365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC12 |
0.427442199720662 |
|
11366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP371 |
0.427478571864913 |
|
11367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MR1 |
0.427567716704297 |
|
11368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAR1B |
0.42758446816196 |
|
11369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM184A |
0.427703962672413 |
|
11370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51Q1 |
0.427760354849169 |
|
11371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF850 |
0.427847381378041 |
|
11372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK13 |
0.427951856684449 |
|
11373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTRT3 |
0.427954967261574 |
|
11374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TERC |
0.427954967261574 |
|
11375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYNN |
0.427954967261574 |
|
11376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC34 |
0.427954967261574 |
|
11377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRIQ4 |
0.427954967261574 |
|
11378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC31 |
0.427954967261574 |
|
11379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4665 |
0.42799957180061 |
|
11380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52A4 |
0.428138073404339 |
|
11381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52A5 |
0.428138073404339 |
|
11382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51B4 |
0.428138073404339 |
|
11383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51B2 |
0.428138073404339 |
|
11384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51B5 |
0.428138073404339 |
|
11385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51B6 |
0.428138073404339 |
|
11386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52A1 |
0.428267628072905 |
|
11387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51V1 |
0.428267628072905 |
|
11388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBB |
0.428267628072905 |
|
11389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBD |
0.428267628072905 |
|
11390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBBP1 |
0.428267628072905 |
|
11391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBG1 |
0.428267628072905 |
|
11392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL18BP |
0.428395320273327 |
|
11393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PI15 |
0.428403196156717 |
|
11394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGR |
0.428451489512814 |
|
11395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCAMR |
0.428451489512814 |
|
11396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BP4 |
0.428467076751024 |
|
11397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSR1 |
0.428536947948543 |
|
11398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAGE1 |
0.428536947948543 |
|
11399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf52 |
0.428621646988665 |
|
11400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCSAM |
0.428621646988665 |
|
11401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM189A2 |
0.428759111869136 |
|
11402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMS1P4 |
0.428778961910663 |
|
11403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLUD1P3 |
0.428778961910663 |
|
11404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEB2 |
0.428787160841741 |
|
11405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS33 |
0.428787160841741 |
|
11406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238395.1 |
0.428926102837702 |
|
11407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAFAH1B1 |
0.429053495682051 |
|
11408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239024.1 |
0.429053495682051 |
|
11409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL521P |
0.429141497054121 |
|
11410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF398 |
0.429141497054121 |
|
11411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKG2 |
0.42916081982104 |
|
11412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1277 |
0.429265812815655 |
|
11413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BNC2 |
0.429311872008207 |
|
11414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALX1 |
0.42935857239745 |
|
11415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNAB1 |
0.42954566232343 |
|
11416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC24 |
0.429598593491245 |
|
11417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCD2OS |
0.429621910531439 |
|
11418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNT1 |
0.429622970401233 |
|
11419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CROCCP2 |
0.429624406869726 |
|
11420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CROCC |
0.429624406869726 |
|
11421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESPNP |
0.429624406869726 |
|
11422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFAP2 |
0.429624406869726 |
|
11423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3675 |
0.429624406869726 |
|
11424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MST1L |
0.429624406869726 |
|
11425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF1 |
0.429624406869726 |
|
11426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U1|ENSG00000228549.2 |
0.429624406869726 |
|
11427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U1|ENSG00000233421.3 |
0.429624406869726 |
|
11428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTCH2 |
0.429625078836586 |
|
11429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA72|ENSG00000207249.1 |
0.429683163428834 |
|
11430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS9 |
0.429695442647074 |
|
11431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IER5 |
0.429704541624977 |
|
11432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA76|ENSG00000252122.1 |
0.429804941210427 |
|
11433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD7 |
0.429892820012728 |
|
11434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC62 |
0.429892820012728 |
|
11435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCHD3P1 |
0.429897165180392 |
|
11436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF519 |
0.429911994761226 |
|
11437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A5P |
0.429911994761226 |
|
11438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F35P |
0.429911994761226 |
|
11439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUMBL |
0.429986437827344 |
|
11440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCK4 |
0.429986437827344 |
|
11441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBS1 |
0.429997257271285 |
|
11442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMSAP3 |
0.430024809409069 |
|
11443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAB2 |
0.430024809409069 |
|
11444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCP2 |
0.430024809409069 |
|
11445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PET100 |
0.430024809409069 |
|
11446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTN3 |
0.430045511830536 |
|
11447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSF |
0.430045511830536 |
|
11448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAG1 |
0.430107592029058 |
|
11449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAT6A |
0.430132606838173 |
|
11450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000238966.1 |
0.430132606838173 |
|
11451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CATSPERB |
0.43014071682195 |
|
11452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000200042.1 |
0.43014071682195 |
|
11453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR44 |
0.430278474699089 |
|
11454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNPO2L |
0.430281478489818 |
|
11455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYCRL |
0.430298654658697 |
|
11456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKHD1L1 |
0.430336487660076 |
|
11457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM9 |
0.430337679448836 |
|
11458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFS3 |
0.430429103465683 |
|
11459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPMT1 |
0.430429103465683 |
|
11460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD4 |
0.430429103465683 |
|
11461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF4 |
0.430429103465683 |
|
11462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM180B |
0.430429103465683 |
|
11463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3664 |
0.430437586411457 |
|
11464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT14 |
0.430475537379631 |
|
11465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR342 |
0.430494571138785 |
|
11466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPF1 |
0.430532761370333 |
|
11467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG5 |
0.430532761370333 |
|
11468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF121 |
0.430615004639185 |
|
11469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL4C |
0.430663042581687 |
|
11470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCO2 |
0.430760696651489 |
|
11471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHCHD7 |
0.430879719172826 |
|
11472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDR16C5 |
0.430879719172826 |
|
11473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNND1 |
0.430932481376659 |
|
11474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRC5A |
0.430993215516403 |
|
11475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRC5D |
0.430993215516403 |
|
11476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSG1 |
0.430993215516403 |
|
11477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEBP1 |
0.430993215516403 |
|
11478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR7P1 |
0.430993215516403 |
|
11479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1467 |
0.430993215516403 |
|
11480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR614 |
0.430993215516403 |
|
11481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD88 |
0.430993215516403 |
|
11482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000199769.1 |
0.431000006762745 |
|
11483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL798P |
0.431026214045652 |
|
11484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL566P |
0.431029850279132 |
|
11485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIAPH3 |
0.431031195720759 |
|
11486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL13 |
0.431074699943029 |
|
11487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD45|ENSG00000252438.1 |
0.431075672528012 |
|
11488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C22orf31 |
0.43131336324938 |
|
11489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC14L6 |
0.431458558153824 |
|
11490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAL3ST1 |
0.431458558153824 |
|
11491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRIP1 |
0.431461846937372 |
|
11492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BACH2 |
0.431602907478163 |
|
11493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4464 |
0.431602907478163 |
|
11494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35F1 |
0.431629913278864 |
|
11495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS3BP |
0.431653780055077 |
|
11496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHSA1 |
0.431705900474962 |
|
11497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA46|ENSG00000212371.1 |
0.431705900474962 |
|
11498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL17A |
0.431978902888516 |
|
11499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL17B |
0.431978902888516 |
|
11500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRHR1 |
0.431978902888516 |
|
11501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM215B |
0.431978902888516 |
|
11502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KANSL1 |
0.431978902888516 |
|
11503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A2 |
0.431978902888516 |
|
11504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A4P |
0.431978902888516 |
|
11505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A |
0.431978902888516 |
|
11506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPT |
0.431978902888516 |
|
11507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHM1 |
0.431978902888516 |
|
11508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL199P |
0.431978902888516 |
|
11509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL656P |
0.431978902888516 |
|
11510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL730P |
0.431978902888516 |
|
11511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL739P |
0.431978902888516 |
|
11512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPPL2C |
0.431978902888516 |
|
11513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STH |
0.431978902888516 |
|
11514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGCD |
0.432003448247905 |
|
11515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOXL2 |
0.432006422316191 |
|
11516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51M1 |
0.43201789758029 |
|
11517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR51J1 |
0.43201789758029 |
|
11518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIWIL2 |
0.432078361810559 |
|
11519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS19 |
0.432113998006845 |
|
11520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK1 |
0.4321165974514 |
|
11521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB8A |
0.43223850883103 |
|
11522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF570 |
0.432247091668755 |
|
11523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL26L1 |
0.432556117241514 |
|
11524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF502 |
0.432622752833516 |
|
11525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR564 |
0.432622752833516 |
|
11526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM42 |
0.432622752833516 |
|
11527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CES3 |
0.432699521035772 |
|
11528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf99 |
0.432714051083084 |
|
11529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDHR1 |
0.432714051083084 |
|
11530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDI2 |
0.43279417183879 |
|
11531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL402P |
0.433042989852961 |
|
11532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFKBID |
0.433042989852961 |
|
11533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf90 |
0.433062637697864 |
|
11534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFH |
0.433213544861734 |
|
11535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFHR1 |
0.433213544861734 |
|
11536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFHR2 |
0.433213544861734 |
|
11537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFHR3 |
0.433213544861734 |
|
11538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFHR4 |
0.433213544861734 |
|
11539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP222 |
0.433253230193118 |
|
11540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIT2 |
0.43340657951825 |
|
11541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4735 |
0.433419476131976 |
|
11542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WSCD2 |
0.433573835552683 |
|
11543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239013.1 |
0.433599640248915 |
|
11544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD8 |
0.433611524881005 |
|
11545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf78 |
0.433735087678918 |
|
11546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL13 |
0.433792667901545 |
|
11547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP215 |
0.433894585493816 |
|
11548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPAT |
0.433915093946582 |
|
11549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMA8 |
0.434108527170046 |
|
11550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF425 |
0.434236480858104 |
|
11551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCST |
0.434331439230333 |
|
11552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYROBP |
0.434331439230333 |
|
11553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL323P |
0.434348237300289 |
|
11554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNCA |
0.434355281654164 |
|
11555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAEA |
0.434409877025828 |
|
11556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRIPAK |
0.434409877025828 |
|
11557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UVSSA |
0.434409877025828 |
|
11558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
N4BP1 |
0.434422717949904 |
|
11559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFKB2 |
0.434474014403217 |
|
11560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSD |
0.434474014403217 |
|
11561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUEDC2 |
0.434474014403217 |
|
11562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL15 |
0.434474014403217 |
|
11563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR146B |
0.434474014403217 |
|
11564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf95 |
0.434474014403217 |
|
11565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBLN1 |
0.434532705080266 |
|
11566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR47 |
0.434541795847942 |
|
11567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCHP |
0.434574744203412 |
|
11568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGDIB |
0.434754351122613 |
|
11569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LONP2 |
0.434816379145851 |
|
11570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIAH1 |
0.434816379145851 |
|
11571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL54P |
0.434816379145851 |
|
11572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSUH2 |
0.434934674871483 |
|
11573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT18 |
0.434940312253258 |
|
11574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HR |
0.434940312253258 |
|
11575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REEP4 |
0.434940312253258 |
|
11576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGI3 |
0.434940312253258 |
|
11577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFTPC |
0.434940312253258 |
|
11578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00583 |
0.435219913017347 |
|
11579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS13C |
0.435236129991513 |
|
11580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAT1 |
0.435273510812962 |
|
11581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2Y1 |
0.435273510812962 |
|
11582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD10 |
0.435311768246703 |
|
11583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIWIL1 |
0.435311768246703 |
|
11584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIMBP2 |
0.435311768246703 |
|
11585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL534P |
0.435311768246703 |
|
11586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM89 |
0.435327080961057 |
|
11587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A6 |
0.435327080961057 |
|
11588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELSR3 |
0.435327080961057 |
|
11589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4793 |
0.435327080961057 |
|
11590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL503P |
0.43544924409463 |
|
11591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA62|ENSG00000201542.1 |
0.43544924409463 |
|
11592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP26 |
0.435473574487376 |
|
11593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU5F1B |
0.435494336306718 |
|
11594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCD1 |
0.43551611640243 |
|
11595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5J2 |
0.43551611640243 |
|
11596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF789 |
0.43551611640243 |
|
11597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF394 |
0.43551611640243 |
|
11598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZKSCAN5 |
0.43551611640243 |
|
11599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA21 |
0.435540305737698 |
|
11600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA4 |
0.435540305737698 |
|
11601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP391 |
0.435581146660288 |
|
11602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOLR2 |
0.435632168807684 |
|
11603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPPL1 |
0.435632168807684 |
|
11604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHOX2A |
0.435632168807684 |
|
11605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD13 |
0.435655148858203 |
|
11606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UOX |
0.435655148858203 |
|
11607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNASE2B |
0.435655148858203 |
|
11608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3B |
0.435861303975214 |
|
11609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPTL1 |
0.435892811227745 |
|
11610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD5 |
0.435935183309239 |
|
11611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBAC2 |
0.435935760098566 |
|
11612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC40 |
0.435977360257982 |
|
11613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GREB1L |
0.435991190850691 |
|
11614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F13B |
0.436000137978222 |
|
11615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPM |
0.436000137978222 |
|
11616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD77|ENSG00000212415.1 |
0.436101421915967 |
|
11617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP1 |
0.436139188229496 |
|
11618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD16 |
0.436139188229496 |
|
11619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00520 |
0.436177074909043 |
|
11620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL13AP3 |
0.436177074909043 |
|
11621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT7 |
0.436177410759715 |
|
11622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4454 |
0.436238258250041 |
|
11623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRP |
0.436238258250041 |
|
11624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL623P |
0.436238258250041 |
|
11625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF212 |
0.436241849444634 |
|
11626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF783 |
0.436241849444634 |
|
11627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA10 |
0.436420390265743 |
|
11628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA16 |
0.436420390265743 |
|
11629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA7 |
0.436420390265743 |
|
11630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA17 |
0.436420390265743 |
|
11631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA14 |
0.436420390265743 |
|
11632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA1 |
0.436426328802135 |
|
11633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTBS |
0.436426328802135 |
|
11634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf180 |
0.436426328802135 |
|
11635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKACB |
0.436493582419844 |
|
11636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA2|ENSG00000199959.1 |
0.436493582419844 |
|
11637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSD4 |
0.436522774517239 |
|
11638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMA4 |
0.436618812755771 |
|
11639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP53 |
0.436744359060007 |
|
11640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU3F3 |
0.436800998069674 |
|
11641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCT |
0.436846066315415 |
|
11642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAPC1 |
0.436872619657839 |
|
11643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX30 |
0.436903638288497 |
|
11644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM203A |
0.436990372249168 |
|
11645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MROH1 |
0.436990372249168 |
|
11646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCK5 |
0.436990372249168 |
|
11647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP39 |
0.436990372249168 |
|
11648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOP1 |
0.436990372249168 |
|
11649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf33 |
0.436990372249168 |
|
11650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf82 |
0.436990372249168 |
|
11651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD5 |
0.436990372249168 |
|
11652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPSF1 |
0.436990372249168 |
|
11653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYHR1 |
0.436990372249168 |
|
11654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGAT1 |
0.436990372249168 |
|
11655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM203B |
0.436990372249168 |
|
11656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL6 |
0.436990372249168 |
|
11657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXH1 |
0.436990372249168 |
|
11658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPT |
0.436990372249168 |
|
11659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSF1 |
0.436990372249168 |
|
11660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIFC2 |
0.436990372249168 |
|
11661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC14 |
0.436990372249168 |
|
11662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC24 |
0.436990372249168 |
|
11663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD3 |
0.436990372249168 |
|
11664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1234 |
0.436990372249168 |
|
11665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR939 |
0.436990372249168 |
|
11666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R16A |
0.436990372249168 |
|
11667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RECQL4 |
0.436990372249168 |
|
11668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL395P |
0.436990372249168 |
|
11669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL8 |
0.436990372249168 |
|
11670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCRT1 |
0.436990372249168 |
|
11671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCXA |
0.436990372249168 |
|
11672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCXB |
0.436990372249168 |
|
11673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A4 |
0.436990372249168 |
|
11674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC52A2 |
0.436990372249168 |
|
11675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM249 |
0.436990372249168 |
|
11676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TONSL |
0.436990372249168 |
|
11677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS28 |
0.436990372249168 |
|
11678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF16 |
0.436990372249168 |
|
11679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF250 |
0.436990372249168 |
|
11680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF251 |
0.436990372249168 |
|
11681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF252P |
0.436990372249168 |
|
11682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF34 |
0.436990372249168 |
|
11683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF517 |
0.436990372249168 |
|
11684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF7 |
0.436990372249168 |
|
11685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HES6 |
0.43714279261746 |
|
11686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPL |
0.437234211812082 |
|
11687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL24A1 |
0.437259615603119 |
|
11688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCHIP1 |
0.437278997285271 |
|
11689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL122P |
0.437521345142806 |
|
11690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB8B |
0.437521345142806 |
|
11691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAZ1B |
0.437550488462585 |
|
11692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC12 |
0.437573578166464 |
|
11693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LONRF3 |
0.437573578166464 |
|
11694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL621P |
0.437638771151809 |
|
11695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238342.1 |
0.437703892264343 |
|
11696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4763 |
0.437790026744311 |
|
11697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7A3 |
0.437790026744311 |
|
11698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7B |
0.437790026744311 |
|
11699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRNP |
0.437794149867566 |
|
11700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA10 |
0.437987655824998 |
|
11701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA11 |
0.437987655824998 |
|
11702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA5 |
0.437987655824998 |
|
11703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA6 |
0.437987655824998 |
|
11704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA7 |
0.437987655824998 |
|
11705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA8 |
0.437987655824998 |
|
11706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA9 |
0.437987655824998 |
|
11707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA12 |
0.437987655824998 |
|
11708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA13 |
0.437987655824998 |
|
11709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHAC1 |
0.437987655824998 |
|
11710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHAC2 |
0.437987655824998 |
|
11711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSPP1 |
0.438013477560853 |
|
11712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY5 |
0.438070174316195 |
|
11713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1 |
0.438070174316195 |
|
11714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3 |
0.438070174316195 |
|
11715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4 |
0.438070174316195 |
|
11716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDIA4 |
0.438070174316195 |
|
11717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF786 |
0.438070174316195 |
|
11718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAP1GAP2 |
0.438093924446628 |
|
11719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA20|ENSG00000206649.1 |
0.438098115873306 |
|
11720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIDT2 |
0.438123521789955 |
|
11721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAGLN |
0.438123521789955 |
|
11722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCSK7 |
0.438123521789955 |
|
11723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP19 |
0.438152673099401 |
|
11724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IZUMO4 |
0.438158842473804 |
|
11725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCD3 |
0.438207060628528 |
|
11726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACBD4 |
0.438207060628528 |
|
11727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf52 |
0.438360899988363 |
|
11728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THG1L |
0.438387143453952 |
|
11729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC27A2 |
0.438487617098126 |
|
11730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf76 |
0.438568386691553 |
|
11731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT8A |
0.438574506638066 |
|
11732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238605.1 |
0.438574506638066 |
|
11733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf24 |
0.438590103284907 |
|
11734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC15 |
0.438590103284907 |
|
11735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLYR1 |
0.438590657970839 |
|
11736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHB15 |
0.438594996195561 |
|
11737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf11 |
0.438620711149313 |
|
11738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA1 |
0.43862137386969 |
|
11739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA2 |
0.43862137386969 |
|
11740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA3 |
0.43862137386969 |
|
11741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA4 |
0.43862137386969 |
|
11742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MADD |
0.438685812779961 |
|
11743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTI2 |
0.438727953653497 |
|
11744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAK16 |
0.438727953653497 |
|
11745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDHB |
0.438736060755051 |
|
11746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PADI2 |
0.438736060755051 |
|
11747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA32|ENSG00000206776.1 |
0.438738537285146 |
|
11748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOV |
0.438738537285146 |
|
11749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPATCH2 |
0.43887351615416 |
|
11750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODF1 |
0.439016024391177 |
|
11751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB41 |
0.439035980739054 |
|
11752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MC5R |
0.439134938374635 |
|
11753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MC2R |
0.439134938374635 |
|
11754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUL1 |
0.439151778901771 |
|
11755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BATF3 |
0.439186254324917 |
|
11756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSL1 |
0.439186254324917 |
|
11757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239144.1 |
0.439237688002237 |
|
11758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPPL3 |
0.439286846100715 |
|
11759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP3D1 |
0.439338483894265 |
|
11760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASF2 |
0.439683021517533 |
|
11761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF80 |
0.439751170077336 |
|
11762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00694 |
0.439763491139258 |
|
11763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR4 |
0.43981880093708 |
|
11764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLB1 |
0.43981880093708 |
|
11765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRABP2 |
0.439897160201746 |
|
11766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSPO |
0.439905756102376 |
|
11767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL518P |
0.439943751734987 |
|
11768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYGS |
0.439965030166051 |
|
11769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBCCD1 |
0.439965030166051 |
|
11770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC59 |
0.439967869914218 |
|
11771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRXN1 |
0.440032840549312 |
|
11772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000253068.1 |
0.440042832583029 |
|
11773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDB1 |
0.440042832583029 |
|
11774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIOK1 |
0.440043046916107 |
|
11775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEXB |
0.440043845016815 |
|
11776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX18 |
0.44006141675068 |
|
11777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRY1 |
0.440082079014689 |
|
11778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAG3L2 |
0.440161970950962 |
|
11779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4A47 |
0.44035299405297 |
|
11780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C5 |
0.44035299405297 |
|
11781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB11 |
0.440361045595267 |
|
11782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYY2 |
0.44038942127479 |
|
11783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPY2 |
0.44038942127479 |
|
11784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THOC5 |
0.440434408621534 |
|
11785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC5B |
0.440459834504165 |
|
11786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC29A3 |
0.440459834504165 |
|
11787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238918.1 |
0.440459834504165 |
|
11788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD17 |
0.440494790856389 |
|
11789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD18 |
0.440494790856389 |
|
11790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP3 |
0.440509333098705 |
|
11791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM123 |
0.440564715610505 |
|
11792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB1B |
0.440576043566319 |
|
11793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNIH2 |
0.440576043566319 |
|
11794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIF1A |
0.440576043566319 |
|
11795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHA14 |
0.440603979151866 |
|
11796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABPB1 |
0.440605090249088 |
|
11797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000271819.1 |
0.440605090249088 |
|
11798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4712 |
0.440605090249088 |
|
11799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIEXF |
0.440839574355761 |
|
11800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAN |
0.440867902567887 |
|
11801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRM6 |
0.440882781957393 |
|
11802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AOAH |
0.440888109757486 |
|
11803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF454 |
0.440896749481633 |
|
11804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5B12 |
0.440903922270528 |
|
11805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4660 |
0.440911237580151 |
|
11806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF122 |
0.441033249030071 |
|
11807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CROCCP3 |
0.441058875624233 |
|
11808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLIT1 |
0.441212887715306 |
|
11809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00665 |
0.441275009332759 |
|
11810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCOLN2 |
0.44129667796158 |
|
11811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHG3 |
0.441306286690538 |
|
11812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITIH2 |
0.4413460251185 |
|
11813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIN |
0.4413460251185 |
|
11814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5C1 |
0.4413460251185 |
|
11815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP32 |
0.441351939653964 |
|
11816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBP |
0.441402129065296 |
|
11817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPAS4 |
0.44142010035296 |
|
11818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA43|ENSG00000201733.1 |
0.44142010035296 |
|
11819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL11 |
0.44142010035296 |
|
11820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS2 |
0.441442070429431 |
|
11821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R5A |
0.441458560033491 |
|
11822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1AR |
0.441473759688169 |
|
11823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSR3 |
0.441569717109405 |
|
11824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF13 |
0.441651975958179 |
|
11825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP3 |
0.441651975958179 |
|
11826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCUN1D2 |
0.441821972401601 |
|
11827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB1 |
0.441846872155239 |
|
11828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf39 |
0.441876140655013 |
|
11829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA5 |
0.442030297984191 |
|
11830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTBP |
0.442060511911525 |
|
11831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNTB1 |
0.442060511911525 |
|
11832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOT1L |
0.442075819002477 |
|
11833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC6 |
0.442264932357326 |
|
11834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERAS |
0.442264932357326 |
|
11835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCSK1N |
0.442264932357326 |
|
11836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL56P |
0.442287737161487 |
|
11837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WEE1 |
0.442287737161487 |
|
11838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238387.1 |
0.442287737161487 |
|
11839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLN |
0.442303021720897 |
|
11840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF395 |
0.442338047108605 |
|
11841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO16 |
0.442338047108605 |
|
11842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNL2 |
0.442345270712588 |
|
11843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNL1 |
0.442345270712588 |
|
11844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRFN1 |
0.442345270712588 |
|
11845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf53 |
0.442412410389221 |
|
11846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN2A |
0.442412410389221 |
|
11847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN2B |
0.442412410389221 |
|
11848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RP1 |
0.442534997565736 |
|
11849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXSR1 |
0.442543465100732 |
|
11850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A13 |
0.442543465100732 |
|
11851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A14 |
0.442543465100732 |
|
11852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGEL2 |
0.442595021431661 |
|
11853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KC1 |
0.442595021431661 |
|
11854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCLK3 |
0.442630159485529 |
|
11855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR19 |
0.442667353360695 |
|
11856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLLT4 |
0.442771213892378 |
|
11857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PADI3 |
0.442791479943789 |
|
11858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3972 |
0.442791479943789 |
|
11859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD52 |
0.442803474708753 |
|
11860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL852P |
0.442803474708753 |
|
11861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP402 |
0.442850942363237 |
|
11862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5B2 |
0.442941510326369 |
|
11863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN4 |
0.442951776365189 |
|
11864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBSCR27 |
0.442951776365189 |
|
11865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL21 |
0.443088935637064 |
|
11866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRLH |
0.443246156761795 |
|
11867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIF1A |
0.443307022231983 |
|
11868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFHR5 |
0.443334530034655 |
|
11869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF20A |
0.443362712112468 |
|
11870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC23 |
0.443362712112468 |
|
11871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM176B |
0.443397416933043 |
|
11872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM176A |
0.443397416933043 |
|
11873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2I |
0.44343292699232 |
|
11874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL6A2 |
0.443478411484904 |
|
11875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTCD |
0.443478411484904 |
|
11876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATC1L |
0.443478411484904 |
|
11877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSS |
0.443478411484904 |
|
11878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP36L1 |
0.443572610205278 |
|
11879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAGLA |
0.443573526718475 |
|
11880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDC |
0.443585096411464 |
|
11881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL494P |
0.443585096411464 |
|
11882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYND15 |
0.443706812743053 |
|
11883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPSM2 |
0.443854062886829 |
|
11884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238533.1 |
0.444012719947748 |
|
11885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDR16C6P |
0.444106898995836 |
|
11886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL151P |
0.444214439670264 |
|
11887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTAP |
0.444214439670264 |
|
11888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFDP1 |
0.444387814096157 |
|
11889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC24 |
0.444414201061831 |
|
11890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOA1BP |
0.444414201061831 |
|
11891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPATCH4 |
0.444414201061831 |
|
11892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAPLN2 |
0.444414201061831 |
|
11893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD6 |
0.444633950351912 |
|
11894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS3 |
0.444675009834597 |
|
11895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN11A |
0.444675735567885 |
|
11896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2CD4A |
0.444676976451529 |
|
11897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB6 |
0.444708948463879 |
|
11898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL224P |
0.444733098150395 |
|
11899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHLHE41 |
0.444958789470127 |
|
11900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD60|ENSG00000199321.1 |
0.444997605754575 |
|
11901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELF3 |
0.445121359870422 |
|
11902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIIAD1 |
0.445121359870422 |
|
11903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGO2 |
0.445148982366549 |
|
11904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF19 |
0.445182146484483 |
|
11905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYRM2 |
0.445235604846986 |
|
11906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238407.1 |
0.445265315436087 |
|
11907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPO5 |
0.445265315436087 |
|
11908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAPTM5 |
0.445276449315593 |
|
11909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MATN1 |
0.445276449315593 |
|
11910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4420 |
0.445276449315593 |
|
11911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC97 |
0.445435212329962 |
|
11912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRASLS5 |
0.445511681102089 |
|
11913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52E6 |
0.445683868559613 |
|
11914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10A5 |
0.44572656555468 |
|
11915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10A2 |
0.44572656555468 |
|
11916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC3 |
0.445784807356489 |
|
11917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RELL2 |
0.445784807356489 |
|
11918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCHSD1 |
0.445784807356489 |
|
11919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL546P |
0.445850047337711 |
|
11920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A9 |
0.445940101271737 |
|
11921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR17HG |
0.446079406132693 |
|
11922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMIGO2 |
0.446412759173773 |
|
11923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNL1 |
0.446570123578152 |
|
11924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP146 |
0.446570123578152 |
|
11925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLBD1 |
0.446574357810056 |
|
11926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK1IP1L |
0.446677400103226 |
|
11927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCOR3 |
0.446721168151647 |
|
11928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF5 |
0.446721168151647 |
|
11929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINS |
0.446997635918403 |
|
11930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN5A |
0.447051131649307 |
|
11931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP5 |
0.447156017294662 |
|
11932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD11B1L |
0.447170428111115 |
|
11933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PADI1 |
0.447330734245712 |
|
11934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS41 |
0.447429310272652 |
|
11935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA3|ENSG00000221719.1 |
0.447429310272652 |
|
11936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS21 |
0.447429310272652 |
|
11937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD2 |
0.447431903566177 |
|
11938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIS3L |
0.447469279756793 |
|
11939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52W1 |
0.447480112100709 |
|
11940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf42 |
0.447480112100709 |
|
11941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM160A2 |
0.447480112100709 |
|
11942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNGA4 |
0.447480112100709 |
|
11943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGDS |
0.447532798111301 |
|
11944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIS18BP1 |
0.447555882037216 |
|
11945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCKBR |
0.447570128933588 |
|
11946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALT1 |
0.447635116185843 |
|
11947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL41P |
0.447654081116738 |
|
11948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5708 |
0.447654081116738 |
|
11949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM161A |
0.447656477548283 |
|
11950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPNS1 |
0.447778745804257 |
|
11951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX7A1 |
0.447778745804257 |
|
11952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM3B |
0.447797800199434 |
|
11953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMIP |
0.44793924778172 |
|
11954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUZP2 |
0.447945281153406 |
|
11955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00643 |
0.447964032467837 |
|
11956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACVR2B |
0.448087623703164 |
|
11957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOG |
0.448087623703164 |
|
11958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RWDD1 |
0.448327073229742 |
|
11959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF548 |
0.448363346477192 |
|
11960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TATDN3 |
0.448421628917187 |
|
11961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf227 |
0.448421628917187 |
|
11962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLVCR1 |
0.448421628917187 |
|
11963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBBP8NL |
0.448467529951067 |
|
11964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIGD5 |
0.448495230052963 |
|
11965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A5 |
0.448615748754571 |
|
11966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTSJ1 |
0.448615748754571 |
|
11967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PORCN |
0.448615748754571 |
|
11968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBP |
0.448615748754571 |
|
11969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL569P |
0.448636159811151 |
|
11970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPRC1 |
0.448636682119952 |
|
11971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA20|ENSG00000206947.1 |
0.448818727960136 |
|
11972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAG2 |
0.448847847948645 |
|
11973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT14 |
0.448847847948645 |
|
11974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QTRT1 |
0.448880877084752 |
|
11975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDGA2 |
0.44898659994877 |
|
11976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PER2 |
0.448997841959396 |
|
11977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52B2 |
0.449018451978176 |
|
11978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL71P |
0.449019894766992 |
|
11979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC47A2 |
0.449046930977642 |
|
11980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH3A1 |
0.449046930977642 |
|
11981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00644 |
0.449184867813027 |
|
11982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52E4 |
0.449236925944212 |
|
11983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52E8 |
0.449236925944212 |
|
11984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYEOV |
0.449241771680741 |
|
11985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XYLB |
0.449321369679531 |
|
11986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHCBP1 |
0.449461555511183 |
|
11987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHSY1 |
0.449492726740688 |
|
11988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERP44 |
0.449610942868812 |
|
11989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL75P |
0.449610942868812 |
|
11990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR87 |
0.449641364779946 |
|
11991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTL |
0.449707092687673 |
|
11992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIBC2 |
0.449787659375749 |
|
11993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR638 |
0.449911158397084 |
|
11994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTTN |
0.449982661436166 |
|
11995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548F2 |
0.449989372299343 |
|
11996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4288 |
0.449996060081485 |
|
11997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP259 |
0.449996060081485 |
|
11998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC3 |
0.450045382446249 |
|
11999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PALD1 |
0.450046790385058 |
|
12000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPF |
0.450269837695237 |
|
12001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTPBP8 |
0.450301580768986 |
|
12002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf17 |
0.450301580768986 |
|
12003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5B3 |
0.450352270156505 |
|
12004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBFOX3 |
0.450413099044948 |
|
12005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00521 |
0.450529148542294 |
|
12006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA23 |
0.450613583643314 |
|
12007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLECL1 |
0.450624841606387 |
|
12008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD69 |
0.450624841606387 |
|
12009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REV3L |
0.450647191564067 |
|
12010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN7A |
0.450647920552797 |
|
12011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR617 |
0.450647920552797 |
|
12012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7D2 |
0.45066285576792 |
|
12013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00312 |
0.45069825018666 |
|
12014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM207A |
0.450772579578215 |
|
12015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00163 |
0.450772579578215 |
|
12016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00162 |
0.450772579578215 |
|
12017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL13RA1 |
0.450886410991529 |
|
12018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA35|ENSG00000239182.1 |
0.450886410991529 |
|
12019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAPC3 |
0.450939253085706 |
|
12020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSIP1 |
0.450939253085706 |
|
12021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL98P |
0.450939253085706 |
|
12022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1M1 |
0.450947684196298 |
|
12023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7G2 |
0.450947684196298 |
|
12024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAIP |
0.450988466884389 |
|
12025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBSCR28 |
0.451011791275053 |
|
12026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENC1 |
0.45110196729141 |
|
12027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VNN1 |
0.451102902083729 |
|
12028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VNN3 |
0.451102902083729 |
|
12029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VNN2 |
0.451102902083729 |
|
12030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC18B1 |
0.451102902083729 |
|
12031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF597 |
0.451194641060025 |
|
12032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA60 |
0.451194641060025 |
|
12033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB6 |
0.451273788241606 |
|
12034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLK |
0.451510059300895 |
|
12035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf49 |
0.451519633888539 |
|
12036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB17 |
0.45156039618532 |
|
12037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFLTD1 |
0.451620692582928 |
|
12038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPLA1 |
0.451662205173796 |
|
12039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf80 |
0.45167192296353 |
|
12040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM6 |
0.45167192296353 |
|
12041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHA1 |
0.45167192296353 |
|
12042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHA2 |
0.45167192296353 |
|
12043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHD |
0.45167192296353 |
|
12044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHE |
0.45167192296353 |
|
12045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHG1 |
0.45167192296353 |
|
12046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHG2 |
0.45167192296353 |
|
12047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHG3 |
0.45167192296353 |
|
12048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHG4 |
0.45167192296353 |
|
12049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHJ1 |
0.45167192296353 |
|
12050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHJ2 |
0.45167192296353 |
|
12051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHJ3 |
0.45167192296353 |
|
12052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHJ4 |
0.45167192296353 |
|
12053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHJ5 |
0.45167192296353 |
|
12054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHJ6 |
0.45167192296353 |
|
12055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGHM |
0.45167192296353 |
|
12056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0125 |
0.45167192296353 |
|
12057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00221 |
0.45167192296353 |
|
12058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00226 |
0.45167192296353 |
|
12059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP389 |
0.45167192296353 |
|
12060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM121 |
0.45167192296353 |
|
12061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4X2 |
0.451695751410337 |
|
12062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239038.1 |
0.451699392178099 |
|
12063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A5 |
0.45179256610041 |
|
12064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC61A2 |
0.451954538917059 |
|
12065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF113B |
0.451984171064636 |
|
12066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP8 |
0.451984171064636 |
|
12067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMP1 |
0.452177469803725 |
|
12068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE21 |
0.452233538357789 |
|
12069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAT1 |
0.452278862444504 |
|
12070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6Q1 |
0.452361392137859 |
|
12071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PELI3 |
0.4524255034112 |
|
12072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPP3 |
0.4524255034112 |
|
12073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX41 |
0.452561167567355 |
|
12074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS27 |
0.452580124377313 |
|
12075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRRM2 |
0.452580124377313 |
|
12076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R42 |
0.452641197923371 |
|
12077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA4 |
0.452670344176731 |
|
12078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMND5B |
0.452690150376967 |
|
12079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT2 |
0.452719410839468 |
|
12080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT1 |
0.452719410839468 |
|
12081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF1 |
0.452722390292075 |
|
12082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENGASE |
0.452722390292075 |
|
12083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4X1 |
0.452737385062601 |
|
12084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC30 |
0.452835842194601 |
|
12085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELOVL3 |
0.452861501008303 |
|
12086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITX3 |
0.452861501008303 |
|
12087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4B1 |
0.452865221977048 |
|
12088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOCS2 |
0.452980954080381 |
|
12089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB2 |
0.453069932842929 |
|
12090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf67 |
0.453069932842929 |
|
12091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INVS |
0.453141400417642 |
|
12092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC11 |
0.453150447672043 |
|
12093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM3 |
0.453175084031805 |
|
12094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR13 |
0.453175084031805 |
|
12095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WAS |
0.453175084031805 |
|
12096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUV39H1 |
0.453175084031805 |
|
12097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL863P |
0.453183477685186 |
|
12098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPS6 |
0.453225160895947 |
|
12099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL9A2 |
0.453238923364353 |
|
12100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAP2 |
0.453238923364353 |
|
12101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP69B |
0.453238923364353 |
|
12102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP69 |
0.453238923364353 |
|
12103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXO5 |
0.453238923364353 |
|
12104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EML1 |
0.45328778812803 |
|
12105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0E2 |
0.45332781298069 |
|
12106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF862 |
0.45332781298069 |
|
12107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP16 |
0.453352290389262 |
|
12108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R12A |
0.453449105486386 |
|
12109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf70 |
0.453473090253425 |
|
12110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252679.1 |
0.453473090253425 |
|
12111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239154.1 |
0.453473090253425 |
|
12112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAGE1 |
0.453534032958071 |
|
12113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP98 |
0.453611277651384 |
|
12114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERS6 |
0.453742024020036 |
|
12115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1D1 |
0.453745235275614 |
|
12116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP223 |
0.453745235275614 |
|
12117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239145.1 |
0.453745235275614 |
|
12118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4468 |
0.453745235275614 |
|
12119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238799.1 |
0.453758344531454 |
|
12120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFAS |
0.453831202912811 |
|
12121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK24 |
0.453848940388448 |
|
12122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000201465.1 |
0.453874707032206 |
|
12123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238984.1 |
0.453874707032206 |
|
12124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP5 |
0.453965658530755 |
|
12125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX17 |
0.453997176699213 |
|
12126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB49 |
0.45415874895646 |
|
12127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SZRD1 |
0.454163415125792 |
|
12128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT5 |
0.454171032747352 |
|
12129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT71 |
0.454171032747352 |
|
12130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT74 |
0.454171032747352 |
|
12131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT72 |
0.454171032747352 |
|
12132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT73 |
0.454171032747352 |
|
12133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF24 |
0.454181592719753 |
|
12134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF396 |
0.454181592719753 |
|
12135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCAT4 |
0.454213491074751 |
|
12136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA75|ENSG00000212620.1 |
0.454213491074751 |
|
12137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB39A |
0.454272269941295 |
|
12138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRCC3 |
0.454332953711492 |
|
12139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO1C1 |
0.454611959600387 |
|
12140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VEPH1 |
0.45462456122052 |
|
12141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN1A1 |
0.454686807362339 |
|
12142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5B17 |
0.454722161073017 |
|
12143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MST1R |
0.454813197843434 |
|
12144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MON1A |
0.454813197843434 |
|
12145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYD88 |
0.454817013001581 |
|
12146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD7 |
0.454857184190615 |
|
12147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238770.1 |
0.454857184190615 |
|
12148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF793 |
0.45495074976804 |
|
12149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2F2 |
0.455116107957332 |
|
12150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2F1 |
0.455116107957332 |
|
12151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6B1 |
0.455116107957332 |
|
12152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1377 |
0.455162816060414 |
|
12153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOLC1 |
0.455173948448626 |
|
12154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YAP1 |
0.455178476304213 |
|
12155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIRC2 |
0.455178476304213 |
|
12156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIRC3 |
0.455178476304213 |
|
12157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ247 |
0.455397130215946 |
|
12158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFBRAP1 |
0.455406291570809 |
|
12159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3679 |
0.455541833152203 |
|
12160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSN1S1 |
0.455552575240645 |
|
12161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG3 |
0.455615231580522 |
|
12162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAG3L1 |
0.455738399263407 |
|
12163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM73 |
0.455738399263407 |
|
12164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH1 |
0.455746207242023 |
|
12165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLTPD2 |
0.455766794396108 |
|
12166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM4SF5 |
0.455766794396108 |
|
12167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VMO1 |
0.455766794396108 |
|
12168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLD2 |
0.455766794396108 |
|
12169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB6 |
0.455766794396108 |
|
12170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNH5 |
0.455773175859719 |
|
12171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC117 |
0.455786265601086 |
|
12172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB2 |
0.455811218862708 |
|
12173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6C |
0.455842153698606 |
|
12174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0C |
0.455842153698606 |
|
12175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMDHD2 |
0.455842153698606 |
|
12176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEMP1 |
0.455842153698606 |
|
12177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3178 |
0.455842153698606 |
|
12178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSANTD3 |
0.455890998001629 |
|
12179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEFF1 |
0.455890998001629 |
|
12180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP363 |
0.455940029266691 |
|
12181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC24C |
0.455947472957192 |
|
12182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT11 |
0.455947472957192 |
|
12183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMRPP1 |
0.455947472957192 |
|
12184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRFIP1 |
0.456011045601166 |
|
12185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT7 |
0.456064774018689 |
|
12186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP70 |
0.456075673440474 |
|
12187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP229 |
0.456075673440474 |
|
12188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF648 |
0.456075673440474 |
|
12189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUD4 |
0.456112433271353 |
|
12190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA16B |
0.456187214332801 |
|
12191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM206 |
0.456187214332801 |
|
12192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NENF |
0.456187214332801 |
|
12193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHSG |
0.456199836222253 |
|
12194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FETUB |
0.456199836222253 |
|
12195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRG |
0.456199836222253 |
|
12196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252921.1 |
0.456270035054322 |
|
12197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF146 |
0.456299393066513 |
|
12198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYAR |
0.45631062268413 |
|
12199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VASH2 |
0.456368931159341 |
|
12200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDYL |
0.456490857271713 |
|
12201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NQO2 |
0.456532265352151 |
|
12202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM20B |
0.456560330763253 |
|
12203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR618 |
0.456616843206209 |
|
12204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4699 |
0.456616843206209 |
|
12205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5681A |
0.456666052750793 |
|
12206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00440 |
0.456716768062879 |
|
12207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVX2 |
0.456820032931327 |
|
12208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD13 |
0.456820032931327 |
|
12209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD12 |
0.456820032931327 |
|
12210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD10 |
0.456820032931327 |
|
12211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXD11 |
0.456820032931327 |
|
12212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR20A |
0.456847195659861 |
|
12213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR20B |
0.456847195659861 |
|
12214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR20C |
0.456847195659861 |
|
12215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR20D |
0.456847195659861 |
|
12216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR20E |
0.456847195659861 |
|
12217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSUN5P1 |
0.456910973151378 |
|
12218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HLF |
0.456974126573592 |
|
12219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHROOM3 |
0.456996180498273 |
|
12220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT6B |
0.456998854434202 |
|
12221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT6C |
0.456998854434202 |
|
12222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT75 |
0.456998854434202 |
|
12223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT6A |
0.456998854434202 |
|
12224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf40 |
0.457022578464839 |
|
12225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF7IP |
0.457132418667822 |
|
12226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKHD1 |
0.457151568826041 |
|
12227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf54 |
0.457184798352065 |
|
12228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVL |
0.457256037513112 |
|
12229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCG5 |
0.457336037364886 |
|
12230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATSL2 |
0.457396604669951 |
|
12231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPO8 |
0.457471360574664 |
|
12232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPRIN2 |
0.457471360574664 |
|
12233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FARP1 |
0.457475493671406 |
|
12234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT10 |
0.457528299997268 |
|
12235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMZ2 |
0.457544868215492 |
|
12236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR635 |
0.457544868215492 |
|
12237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC10B |
0.457563555823672 |
|
12238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4488 |
0.457563555823672 |
|
12239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJA3 |
0.45769428648311 |
|
12240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR56A3 |
0.457890937486899 |
|
12241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR52L1 |
0.457890937486899 |
|
12242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2E3 |
0.457925154473991 |
|
12243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRTM1 |
0.458006001282886 |
|
12244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1715 |
0.458043561313202 |
|
12245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBSN |
0.458062507672475 |
|
12246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2B |
0.458177298280294 |
|
12247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF354B |
0.458210298617731 |
|
12248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP2 |
0.458210298617731 |
|
12249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB2 |
0.458329730055367 |
|
12250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH2 |
0.458356307919625 |
|
12251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL178P |
0.458397612974393 |
|
12252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF397 |
0.458515346591354 |
|
12253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN30 |
0.458515346591354 |
|
12254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF271 |
0.458515346591354 |
|
12255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9Q2 |
0.458669548994767 |
|
12256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1S2 |
0.458669548994767 |
|
12257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1S1 |
0.458669548994767 |
|
12258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10Q1 |
0.458669548994767 |
|
12259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10W1 |
0.458669548994767 |
|
12260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00493 |
0.458688006334039 |
|
12261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA6 |
0.458737012145483 |
|
12262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLC1 |
0.458779584244176 |
|
12263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREBL2 |
0.458817288811027 |
|
12264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIMAP8 |
0.459144361185314 |
|
12265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIMAP7 |
0.459144361185314 |
|
12266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIMAP4 |
0.459144361185314 |
|
12267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL21 |
0.459240252480432 |
|
12268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YARS2 |
0.459241705517084 |
|
12269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL3 |
0.459242707818355 |
|
12270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTH1R |
0.459242707818355 |
|
12271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIN2B |
0.459477600270948 |
|
12272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR153 |
0.459501736167679 |
|
12273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4437 |
0.459515641459034 |
|
12274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCL1 |
0.459525205875028 |
|
12275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000207147.1 |
0.459551457393396 |
|
12276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P6 |
0.459674351251947 |
|
12277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000201245.1 |
0.459674351251947 |
|
12278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238305.1 |
0.459674351251947 |
|
12279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AZGP1P1 |
0.459698579498172 |
|
12280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAPDHS |
0.459728172524519 |
|
12281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM147 |
0.459728172524519 |
|
12282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP4A |
0.459728172524519 |
|
12283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANK3 |
0.45973813200276 |
|
12284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT82 |
0.459831322851802 |
|
12285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR63 |
0.459906457252824 |
|
12286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCOLN3 |
0.459906457252824 |
|
12287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPC1B |
0.459951814584356 |
|
12288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDAP1 |
0.459951814584356 |
|
12289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BUD31 |
0.459951814584356 |
|
12290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239133.1 |
0.459951814584356 |
|
12291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPSF4 |
0.459951814584356 |
|
12292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEKR1 |
0.459979204821576 |
|
12293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDELC2 |
0.460015782503877 |
|
12294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBF4 |
0.460075705951475 |
|
12295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERTAD4 |
0.460089381512905 |
|
12296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A10 |
0.460189007991032 |
|
12297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR365B |
0.460466699303955 |
|
12298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4725 |
0.460466699303955 |
|
12299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3144 |
0.460527961192613 |
|
12300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNNB1 |
0.460529159598587 |
|
12301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1S1 |
0.460623462053584 |
|
12302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4653 |
0.460623462053584 |
|
12303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VGF |
0.460623462053584 |
|
12304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT16 |
0.460623462053584 |
|
12305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOGAT3 |
0.460623462053584 |
|
12306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLOD3 |
0.460623462053584 |
|
12307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNHIT1 |
0.460623462053584 |
|
12308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN15 |
0.460623462053584 |
|
12309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIS1 |
0.460623462053584 |
|
12310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL26A1 |
0.460623462053584 |
|
12311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABL5 |
0.460623462053584 |
|
12312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL10 |
0.460623462053584 |
|
12313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYSMD4 |
0.460683817012603 |
|
12314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM1P46 |
0.460683817012603 |
|
12315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL484P |
0.460683817012603 |
|
12316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANTXR2 |
0.460698927504416 |
|
12317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM8 |
0.460698927504416 |
|
12318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF5 |
0.460698927504416 |
|
12319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP249 |
0.460717145501897 |
|
12320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL456P |
0.460717145501897 |
|
12321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL2 |
0.460784233385767 |
|
12322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRM1 |
0.460784233385767 |
|
12323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL36B |
0.460842916941407 |
|
12324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL36RN |
0.460842916941407 |
|
12325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1F10 |
0.460842916941407 |
|
12326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSC1A1 |
0.460902763744333 |
|
12327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRH3 |
0.460913332254046 |
|
12328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSPP |
0.460991871656221 |
|
12329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMP1 |
0.460991871656221 |
|
12330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00449 |
0.461186481735212 |
|
12331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM196A |
0.46127452667196 |
|
12332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK2G |
0.46137626019967 |
|
12333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS20 |
0.461457147701635 |
|
12334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNBP4 |
0.461464329745241 |
|
12335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR3C1 |
0.46170057033187 |
|
12336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALC |
0.461814313224315 |
|
12337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTG2 |
0.461906331140738 |
|
12338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P6 |
0.462000516036075 |
|
12339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4461 |
0.462077836056362 |
|
12340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAP2A |
0.462091368399869 |
|
12341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL9 |
0.462097753529588 |
|
12342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAP1 |
0.46227698055098 |
|
12343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PET112 |
0.46245609695195 |
|
12344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HES2 |
0.462560408922014 |
|
12345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4252 |
0.462560408922014 |
|
12346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS1R1 |
0.462594589284071 |
|
12347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL32 |
0.462753911902025 |
|
12348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA7A |
0.462753911902025 |
|
12349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGC3 |
0.462755860904447 |
|
12350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL68P |
0.462755860904447 |
|
12351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGC4 |
0.462755860904447 |
|
12352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDHGC5 |
0.462755860904447 |
|
12353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYBPC3 |
0.46277442333161 |
|
12354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP134 |
0.462796190458896 |
|
12355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY2C |
0.462796190458896 |
|
12356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BP2 |
0.46288376015404 |
|
12357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KMT2A |
0.462897686121402 |
|
12358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC28B |
0.462911956619904 |
|
12359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCC |
0.462911956619904 |
|
12360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCDC2B |
0.462911956619904 |
|
12361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM234 |
0.462911956619904 |
|
12362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3I |
0.462911956619904 |
|
12363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR9LP |
0.462911956619904 |
|
12364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R7 |
0.463067372118012 |
|
12365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R8 |
0.463067372118012 |
|
12366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADD1 |
0.46310562475843 |
|
12367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP8 |
0.463155891305111 |
|
12368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP395 |
0.463155891305111 |
|
12369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL360P |
0.463310038065337 |
|
12370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP320 |
0.463314142980106 |
|
12371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP297 |
0.463323427033925 |
|
12372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP298 |
0.463323427033925 |
|
12373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB8 |
0.463323427033925 |
|
12374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYND11 |
0.463323427033925 |
|
12375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIPAP1 |
0.463414485553926 |
|
12376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL139P |
0.463414485553926 |
|
12377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFE3 |
0.463414485553926 |
|
12378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC120 |
0.463414485553926 |
|
12379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAF2 |
0.463414485553926 |
|
12380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR45 |
0.463414485553926 |
|
12381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHKB |
0.463427187718421 |
|
12382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL9 |
0.463525872750682 |
|
12383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3162 |
0.4635890973013 |
|
12384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF565 |
0.463596559704666 |
|
12385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR56A1 |
0.463840834720353 |
|
12386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR56A4 |
0.463840834720353 |
|
12387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR56B4 |
0.463840834720353 |
|
12388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP329 |
0.463840834720353 |
|
12389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERGIC1 |
0.463859172113039 |
|
12390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3170 |
0.463999823683277 |
|
12391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA3 |
0.464071240549188 |
|
12392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID1A |
0.464073261105101 |
|
12393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL501P |
0.464073261105101 |
|
12394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK2 |
0.464155893275643 |
|
12395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF10B |
0.464226817426482 |
|
12396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCO5B |
0.464244780435423 |
|
12397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM78B |
0.464293929334795 |
|
12398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR921 |
0.464293929334795 |
|
12399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HES3 |
0.464380961048426 |
|
12400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLC2 |
0.464426039226595 |
|
12401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX10 |
0.464432148959204 |
|
12402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GHRHR |
0.464470351966535 |
|
12403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP166 |
0.464475139817244 |
|
12404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A29 |
0.4646548003097 |
|
12405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238818.1 |
0.464813292370234 |
|
12406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP64 |
0.464905632215908 |
|
12407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL72P |
0.464932638798996 |
|
12408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R60 |
0.464948849589201 |
|
12409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU6F2 |
0.464993387848005 |
|
12410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR3 |
0.464996095290828 |
|
12411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR1 |
0.464996095290828 |
|
12412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR4A3 |
0.465050426183799 |
|
12413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INO80 |
0.465060538853482 |
|
12414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS24 |
0.465119939807831 |
|
12415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF18A |
0.465148735434699 |
|
12416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB48 |
0.465185717432609 |
|
12417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMAA |
0.465216202451093 |
|
12418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL401P |
0.465258178611333 |
|
12419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL22 |
0.465262569089609 |
|
12420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD30B |
0.465320077309653 |
|
12421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL662P |
0.465320077309653 |
|
12422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROCK1 |
0.465320077309653 |
|
12423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA72|ENSG00000252158.1 |
0.465346421539223 |
|
12424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PACS2 |
0.465369520363679 |
|
12425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP779J2370 |
0.465377852312721 |
|
12426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKL2 |
0.465421500594289 |
|
12427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR193B |
0.465421500594289 |
|
12428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITIH5 |
0.465424151161286 |
|
12429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00670 |
0.465575048971162 |
|
12430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00968 |
0.465582141293722 |
|
12431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM5 |
0.465650964004543 |
|
12432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLSTN1 |
0.465652540158802 |
|
12433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY9 |
0.4656874913672 |
|
12434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K6 |
0.465708187965929 |
|
12435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCN3 |
0.465708187965929 |
|
12436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD164L2 |
0.465708187965929 |
|
12437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR3 |
0.465708187965929 |
|
12438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PENK |
0.465716554579497 |
|
12439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF3 |
0.465978435659869 |
|
12440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL512P |
0.465978435659869 |
|
12441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM71A |
0.465978435659869 |
|
12442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC7 |
0.466047231181775 |
|
12443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC14L4 |
0.466057144800176 |
|
12444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG6 |
0.466263916570491 |
|
12445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIP4K2A |
0.466263916570491 |
|
12446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM114 |
0.466305515441276 |
|
12447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212598.1 |
0.466399489049951 |
|
12448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP6 |
0.466407983136191 |
|
12449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRK1 |
0.466418455593444 |
|
12450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EML4 |
0.466422125041653 |
|
12451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR597 |
0.466512797419885 |
|
12452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF2B |
0.466524778431993 |
|
12453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD6IP |
0.466534976415336 |
|
12454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAPDC2 |
0.466565405005422 |
|
12455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC37L1 |
0.466565405005422 |
|
12456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC1 |
0.466617161542018 |
|
12457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT16 |
0.466627641537221 |
|
12458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMUB1 |
0.466634481686304 |
|
12459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP3 |
0.466634481686304 |
|
12460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ONECUT1 |
0.466646646028603 |
|
12461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB561 |
0.466650106131099 |
|
12462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACE |
0.466650106131099 |
|
12463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNH6 |
0.466650106131099 |
|
12464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP96 |
0.466743848592907 |
|
12465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDC4 |
0.466772675789342 |
|
12466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRN1L |
0.466772675789342 |
|
12467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R41 |
0.466871710096701 |
|
12468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snR65|ENSG00000252576.1 |
0.466879713602493 |
|
12469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252572.1 |
0.466879713602493 |
|
12470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIP |
0.46695168924736 |
|
12471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R39 |
0.46695168924736 |
|
12472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNE1 |
0.467089490537492 |
|
12473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYDC2 |
0.467094110044881 |
|
12474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC15P |
0.467117489986682 |
|
12475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUL5 |
0.467165568591395 |
|
12476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGR3 |
0.467200119326749 |
|
12477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEBP4 |
0.467200119326749 |
|
12478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL303P |
0.467200119326749 |
|
12479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOBTB2 |
0.467200119326749 |
|
12480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEUROD1 |
0.46726672487031 |
|
12481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM181A |
0.467269222799914 |
|
12482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4506 |
0.467269222799914 |
|
12483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R40 |
0.467304708236012 |
|
12484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBN1 |
0.467343912371069 |
|
12485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL754P |
0.467353364189323 |
|
12486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAT2 |
0.467424077547791 |
|
12487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL36AL |
0.467424077547791 |
|
12488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAAF2 |
0.467424077547791 |
|
12489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238501.1 |
0.46748687349911 |
|
12490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K13 |
0.467597734552963 |
|
12491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCL3 |
0.467654128086413 |
|
12492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238328.1 |
0.467654128086413 |
|
12493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM213A |
0.467783124221569 |
|
12494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9Q1 |
0.46787447753308 |
|
12495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARAP3 |
0.46789814914463 |
|
12496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZKSCAN7 |
0.467971058930438 |
|
12497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF660 |
0.467971058930438 |
|
12498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF197 |
0.467971058930438 |
|
12499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF35 |
0.467971058930438 |
|
12500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF10C |
0.467997246164321 |
|
12501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF10D |
0.467997246164321 |
|
12502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRF1 |
0.46802856234512 |
|
12503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC2B |
0.46802856234512 |
|
12504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCD3 |
0.468078015467783 |
|
12505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252241.1 |
0.468378337590425 |
|
12506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZPBP2 |
0.468402780563411 |
|
12507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXTL3 |
0.468423513214091 |
|
12508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO7P1 |
0.468426432612608 |
|
12509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf134 |
0.468426432612608 |
|
12510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FFAR2 |
0.468558297641961 |
|
12511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLXIPL |
0.468621897109987 |
|
12512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM3 |
0.468633330313111 |
|
12513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARFIP2 |
0.468633330313111 |
|
12514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM10B |
0.468633330313111 |
|
12515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNHD1 |
0.468633330313111 |
|
12516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP8 |
0.468633330313111 |
|
12517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REP15 |
0.468674084904801 |
|
12518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS35 |
0.468674084904801 |
|
12519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MANSC4 |
0.468674084904801 |
|
12520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXD2 |
0.468711792754215 |
|
12521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCBLD1 |
0.46871884545919 |
|
12522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AK3 |
0.468820857176389 |
|
12523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTLN |
0.468836101713269 |
|
12524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4799 |
0.468922707336484 |
|
12525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL254P |
0.468922707336484 |
|
12526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDPK1 |
0.46892356385084 |
|
12527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD5 |
0.46892356385084 |
|
12528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDPK2 |
0.46892356385084 |
|
12529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMPSTE24 |
0.46895255705341 |
|
12530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL676P |
0.469137549792231 |
|
12531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL30P11 |
0.469137549792231 |
|
12532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM167B |
0.469137585248312 |
|
12533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP199 |
0.469205836952532 |
|
12534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC21A |
0.469235162419865 |
|
12535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C13orf35 |
0.469235318374676 |
|
12536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVI2A |
0.469248724328645 |
|
12537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF2BPL |
0.469265383311495 |
|
12538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCKS |
0.469277537272938 |
|
12539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRD |
0.46940947955384 |
|
12540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000265369.2 |
0.469465859345175 |
|
12541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIK4 |
0.469495021036668 |
|
12542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF5 |
0.46956192150881 |
|
12543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA28 |
0.46956192150881 |
|
12544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP261 |
0.469643077111577 |
|
12545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRQ |
0.469643077111577 |
|
12546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMOX |
0.469759010780265 |
|
12547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRTDAP |
0.469774992465277 |
|
12548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMKN |
0.469774992465277 |
|
12549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGV |
0.469794118961658 |
|
12550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXM1 |
0.469829131779756 |
|
12551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TULP3 |
0.469829131779756 |
|
12552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4423 |
0.469917911165236 |
|
12553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYDE2 |
0.469917911165236 |
|
12554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf52 |
0.469917911165236 |
|
12555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL10 |
0.469917911165236 |
|
12556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA64|ENSG00000199566.1 |
0.469918366825283 |
|
12557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHCHD1 |
0.470040577252926 |
|
12558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSWIM8 |
0.470040577252926 |
|
12559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDST2 |
0.470040577252926 |
|
12560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HKR1 |
0.47004988525972 |
|
12561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBX2 |
0.470123887769991 |
|
12562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD15 |
0.470296393521761 |
|
12563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIT1 |
0.470296393521761 |
|
12564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53I13 |
0.470296393521761 |
|
12565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD13B |
0.470296393521761 |
|
12566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORO6 |
0.470296393521761 |
|
12567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRJ |
0.470344466876273 |
|
12568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEPTOR |
0.47037170864248 |
|
12569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKIP1 |
0.470528141027284 |
|
12570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D4B |
0.470619282249915 |
|
12571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NELFA |
0.470664289509817 |
|
12572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf48 |
0.470664289509817 |
|
12573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT8L |
0.470664289509817 |
|
12574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APH1B |
0.470857642443058 |
|
12575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLUH |
0.47098428968305 |
|
12576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1253 |
0.47098428968305 |
|
12577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL605P |
0.47098428968305 |
|
12578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP3 |
0.471198931652723 |
|
12579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2G |
0.471204328579856 |
|
12580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB3 |
0.471204328579856 |
|
12581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPLN |
0.471321884495204 |
|
12582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL17 |
0.471327295102758 |
|
12583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GVINP1 |
0.471327295102758 |
|
12584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2AG2 |
0.471327295102758 |
|
12585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2AG1 |
0.471327295102758 |
|
12586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6A2 |
0.471327295102758 |
|
12587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00467 |
0.471408605002498 |
|
12588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNB3 |
0.471479914891265 |
|
12589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A11 |
0.471504886656939 |
|
12590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBX1 |
0.47152547336158 |
|
12591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB10 |
0.47152547336158 |
|
12592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCA1P1 |
0.47152547336158 |
|
12593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCF2 |
0.47152547336158 |
|
12594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHPF2 |
0.47152547336158 |
|
12595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR671 |
0.47152547336158 |
|
12596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A13 |
0.471536163663205 |
|
12597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMC3 |
0.471536163663205 |
|
12598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPSN |
0.471536163663205 |
|
12599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPKOW |
0.471603367935065 |
|
12600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR151B |
0.471618873505988 |
|
12601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLOD5 |
0.471619282249196 |
|
12602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATA1 |
0.471619282249196 |
|
12603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZKSCAN1 |
0.471629647151417 |
|
12604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN21 |
0.471629647151417 |
|
12605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF3 |
0.471629647151417 |
|
12606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPS6 |
0.471629647151417 |
|
12607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM7 |
0.471629647151417 |
|
12608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR106B |
0.471629647151417 |
|
12609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR25 |
0.471629647151417 |
|
12610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR93 |
0.471629647151417 |
|
12611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP4M1 |
0.471629647151417 |
|
12612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF6 |
0.471629647151417 |
|
12613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNPY4 |
0.471629647151417 |
|
12614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBLAC1 |
0.471629647151417 |
|
12615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIDT1 |
0.471686447776254 |
|
12616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4494 |
0.471844570996483 |
|
12617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT11 |
0.471873507232822 |
|
12618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZYX |
0.471885659012789 |
|
12619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA1 |
0.471885659012789 |
|
12620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHB2 |
0.471917131658974 |
|
12621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSS3 |
0.472028923395368 |
|
12622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC17P |
0.472124655277463 |
|
12623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL1 |
0.472136090618331 |
|
12624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDCD1 |
0.472212579292317 |
|
12625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00941 |
0.472285783017726 |
|
12626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTK1 |
0.472372667906464 |
|
12627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM139 |
0.472372667906464 |
|
12628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP2 |
0.472372667906464 |
|
12629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL535P |
0.472372667906464 |
|
12630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL481P |
0.472372667906464 |
|
12631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCN1 |
0.472372667906464 |
|
12632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM131B |
0.472372667906464 |
|
12633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D25 |
0.47244504864909 |
|
12634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239017.1 |
0.47244504864909 |
|
12635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP165 |
0.472526213300872 |
|
12636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL274P |
0.472535799535236 |
|
12637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSEN1 |
0.472610830020415 |
|
12638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OAF |
0.472620075895289 |
|
12639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS3ST3A1 |
0.472642972779939 |
|
12640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF185 |
0.47266112560483 |
|
12641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1913 |
0.472666946621673 |
|
12642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOB3A |
0.472839762414985 |
|
12643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SART3 |
0.472892784305954 |
|
12644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISCU |
0.472892784305954 |
|
12645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT13 |
0.47299979233026 |
|
12646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASCL3 |
0.473123357731373 |
|
12647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM9B |
0.473123357731373 |
|
12648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86EP |
0.47320014356757 |
|
12649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL457P |
0.473240906950492 |
|
12650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRCIN1 |
0.473242112735362 |
|
12651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP104 |
0.473367925735688 |
|
12652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM29 |
0.473420658926046 |
|
12653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCBL2 |
0.473442812674189 |
|
12654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBMXL1 |
0.473442812674189 |
|
12655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBP3 |
0.473442812674189 |
|
12656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf68 |
0.473508220354592 |
|
12657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRAP1 |
0.473508220354592 |
|
12658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKSG61 |
0.473579107033003 |
|
12659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFPM1 |
0.473614918234584 |
|
12660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF1AD |
0.473635926231908 |
|
12661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBBP9 |
0.473664372590886 |
|
12662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC23B |
0.473664372590886 |
|
12663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF14 |
0.473679191384119 |
|
12664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA1 |
0.473718604737175 |
|
12665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZUFSP |
0.473801277232696 |
|
12666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPNA5 |
0.473801277232696 |
|
12667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR205HG |
0.473815676685703 |
|
12668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238763.1 |
0.473861027832199 |
|
12669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf113 |
0.473955241585837 |
|
12670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOP1 |
0.474021509798617 |
|
12671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM128 |
0.474021509798617 |
|
12672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSI1 |
0.474042121222142 |
|
12673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS27P25 |
0.474042121222142 |
|
12674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFX6 |
0.474103987318241 |
|
12675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE1A |
0.474131088453788 |
|
12676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHG5 |
0.474199136953412 |
|
12677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPC1 |
0.474202788395999 |
|
12678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRS4 |
0.474231586853905 |
|
12679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COBLL1 |
0.474240234608004 |
|
12680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP110 |
0.474240234608004 |
|
12681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP111 |
0.474240234608004 |
|
12682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1E |
0.474325041383415 |
|
12683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM119 |
0.474371683067522 |
|
12684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD3 |
0.474436983094598 |
|
12685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOS3 |
0.474448552281883 |
|
12686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG9B |
0.474448552281883 |
|
12687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB8 |
0.474448552281883 |
|
12688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASIC3 |
0.474448552281883 |
|
12689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK5 |
0.474448552281883 |
|
12690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A2 |
0.474448552281883 |
|
12691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FASTK |
0.474448552281883 |
|
12692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP164P1 |
0.474475639254313 |
|
12693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRF1 |
0.474764851963393 |
|
12694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH9A1 |
0.474834643474343 |
|
12695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM39B |
0.474908732230278 |
|
12696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5585 |
0.474908732230278 |
|
12697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSGA10IP |
0.474910493396706 |
|
12698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SART1 |
0.474910493396706 |
|
12699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN1B |
0.474989393494608 |
|
12700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR613 |
0.474989393494608 |
|
12701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4760 |
0.475153548100787 |
|
12702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIPA1L3 |
0.475168808769669 |
|
12703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UACA |
0.475246037014043 |
|
12704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM17B |
0.475349937146005 |
|
12705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PQBP1 |
0.475349937146005 |
|
12706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANGRF |
0.475377698601456 |
|
12707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL287P |
0.475509970077778 |
|
12708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF569 |
0.475525385363286 |
|
12709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBP5 |
0.475592839550502 |
|
12710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH20 |
0.475747744052988 |
|
12711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4D9 |
0.475945612017009 |
|
12712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7E24 |
0.47603435358767 |
|
12713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FERMT3 |
0.476085615448986 |
|
12714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB3A1 |
0.476126745533119 |
|
12715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAU2 |
0.476132652153253 |
|
12716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB1A1 |
0.476175086045086 |
|
12717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPA3 |
0.476209673747559 |
|
12718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFE2L2 |
0.476209673747559 |
|
12719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf16 |
0.476264645207058 |
|
12720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ178 |
0.47636687136603 |
|
12721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R3B |
0.476553660022693 |
|
12722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252543.1 |
0.476553660022693 |
|
12723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPT1 |
0.476575860972513 |
|
12724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT22 |
0.476575860972513 |
|
12725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC4 |
0.476575860972513 |
|
12726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VEGFB |
0.476575860972513 |
|
12727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP2 |
0.476575860972513 |
|
12728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCB3 |
0.476575860972513 |
|
12729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R14B |
0.476575860972513 |
|
12730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC25 |
0.476632743320695 |
|
12731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAND2 |
0.476650753931111 |
|
12732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGL1 |
0.476660919216686 |
|
12733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5580 |
0.476661954005481 |
|
12734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP4 |
0.476661954005481 |
|
12735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP109 |
0.476664540352721 |
|
12736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATC |
0.476693198657567 |
|
12737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIAP1 |
0.476693198657567 |
|
12738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF9 |
0.476693198657567 |
|
12739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNLL1 |
0.476693198657567 |
|
12740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGOHB |
0.4767581592627 |
|
12741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STYK1 |
0.4767581592627 |
|
12742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YBX3 |
0.4767581592627 |
|
12743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL398P |
0.476782076482324 |
|
12744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIMAP6 |
0.476796351685592 |
|
12745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIMAP2 |
0.476796351685592 |
|
12746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIMAP1 |
0.476796351685592 |
|
12747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIMAP5 |
0.476796351685592 |
|
12748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4306 |
0.477116864673945 |
|
12749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR18 |
0.477170196493609 |
|
12750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFT2D1 |
0.477170196493609 |
|
12751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPC1 |
0.477170196493609 |
|
12752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERI1 |
0.477185704341655 |
|
12753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUFY1 |
0.477264574478146 |
|
12754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX6A1 |
0.477284092024991 |
|
12755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBBP8 |
0.47738121324957 |
|
12756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP390 |
0.477549352503711 |
|
12757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf80 |
0.477571065632673 |
|
12758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00592 |
0.477571065632673 |
|
12759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT7 |
0.477571065632673 |
|
12760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT121P |
0.477571065632673 |
|
12761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESPN |
0.47769580710692 |
|
12762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF25 |
0.47769580710692 |
|
12763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLEC |
0.477705228259474 |
|
12764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAMP1 |
0.477765055248789 |
|
12765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R14A |
0.477844056285452 |
|
12766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AOC1 |
0.477893059075862 |
|
12767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2S3L |
0.477984017242571 |
|
12768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRAP1 |
0.477984017242571 |
|
12769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD93 |
0.478127373589649 |
|
12770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL46P |
0.478149044969086 |
|
12771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4452 |
0.47815011825516 |
|
12772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2A |
0.478166129777893 |
|
12773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKRF |
0.478166129777893 |
|
12774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTN1 |
0.478227618416242 |
|
12775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA12 |
0.478284091955548 |
|
12776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIGN |
0.478434036587874 |
|
12777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPPE |
0.478470246076629 |
|
12778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL296P |
0.478470246076629 |
|
12779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRTAP |
0.478470246076629 |
|
12780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUSD5 |
0.478470246076629 |
|
12781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548H4 |
0.478497578809311 |
|
12782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLN |
0.478534798423878 |
|
12783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00454 |
0.478714518382148 |
|
12784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SESTD1 |
0.478791457956008 |
|
12785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4715 |
0.479027703385536 |
|
12786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf55 |
0.479097529115604 |
|
12787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OVCH2 |
0.479110222121445 |
|
12788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10AB1P |
0.479110222121445 |
|
12789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL7B |
0.479129703974793 |
|
12790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBL2 |
0.479129703974793 |
|
12791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PVRL3 |
0.479227150887481 |
|
12792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00674 |
0.479246103584465 |
|
12793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A16P |
0.479246103584465 |
|
12794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA3A |
0.479248879236986 |
|
12795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRHPR |
0.479254955476367 |
|
12796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRX3 |
0.47926573445033 |
|
12797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDC8 |
0.47933032894162 |
|
12798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00871 |
0.479357492463718 |
|
12799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACY3 |
0.479444513695212 |
|
12800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH3B2 |
0.479444513695212 |
|
12801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf72 |
0.479444513695212 |
|
12802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOC2GP |
0.479444513695212 |
|
12803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86C2P |
0.479444513695212 |
|
12804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTP1 |
0.479444513695212 |
|
12805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFV1 |
0.479444513695212 |
|
12806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT8 |
0.479444513695212 |
|
12807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL59P |
0.479444513695212 |
|
12808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX10 |
0.479444513695212 |
|
12809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC93B1 |
0.479444513695212 |
|
12810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL606P |
0.479501625709637 |
|
12811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOZ1 |
0.479602240770323 |
|
12812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAFAH1B2 |
0.479678156955657 |
|
12813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAGE15 |
0.479791506718266 |
|
12814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAGE6 |
0.479791506718266 |
|
12815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM115A |
0.479791506718266 |
|
12816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM115C |
0.479791506718266 |
|
12817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAPBPL |
0.47985442107517 |
|
12818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MINK1 |
0.479945017395001 |
|
12819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC11C |
0.480108831105202 |
|
12820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM26D |
0.480210121185867 |
|
12821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPF3 |
0.480276685308294 |
|
12822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR345 |
0.480353606032274 |
|
12823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL523P |
0.480353606032274 |
|
12824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRA1 |
0.480407178420003 |
|
12825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAU |
0.480414782482093 |
|
12826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHP2 |
0.480558973798777 |
|
12827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1E1 |
0.480576513295519 |
|
12828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4A3 |
0.480627900018728 |
|
12829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD14 |
0.480627900018728 |
|
12830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGSH |
0.480627900018728 |
|
12831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A11 |
0.480627900018728 |
|
12832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCHE |
0.480647616927191 |
|
12833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRADA |
0.480657814394951 |
|
12834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC47 |
0.480657814394951 |
|
12835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX42 |
0.480657814394951 |
|
12836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCL |
0.480848798428911 |
|
12837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT5 |
0.480902692607465 |
|
12838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00880 |
0.481042194181673 |
|
12839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00881 |
0.481042194181673 |
|
12840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4526 |
0.481107594196304 |
|
12841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R1C |
0.481439891008468 |
|
12842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP113 |
0.481439891008468 |
|
12843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPH4A |
0.481452349663616 |
|
12844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRND |
0.481549674510102 |
|
12845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRNT |
0.481549674510102 |
|
12846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9I1 |
0.481608921598582 |
|
12847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF16 |
0.481674356880144 |
|
12848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH1A3 |
0.481678222229293 |
|
12849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRK1 |
0.481678222229293 |
|
12850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPTL5 |
0.481748824279703 |
|
12851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL647P |
0.481777579266611 |
|
12852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP61 |
0.481777579266611 |
|
12853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGPRD |
0.481781699473372 |
|
12854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGPRF |
0.481781699473372 |
|
12855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM200A |
0.481820727305132 |
|
12856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF655 |
0.481820727305132 |
|
12857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN25 |
0.481820727305132 |
|
12858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP3A5 |
0.481820727305132 |
|
12859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP3A4 |
0.481820727305132 |
|
12860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP3A43 |
0.481820727305132 |
|
12861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPL |
0.481862499985216 |
|
12862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM122A |
0.482004077889153 |
|
12863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A4A |
0.482041617038621 |
|
12864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A14 |
0.482041617038621 |
|
12865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A7 |
0.482041617038621 |
|
12866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC7 |
0.482133428976155 |
|
12867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRAC1 |
0.482133428976155 |
|
12868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAMD1C |
0.48215581810963 |
|
12869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL612P |
0.482258465640131 |
|
12870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC10 |
0.482290800685548 |
|
12871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP29 |
0.48236253918791 |
|
12872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUXA |
0.48236253918791 |
|
12873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252683.1 |
0.48236253918791 |
|
12874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZIM3 |
0.48236253918791 |
|
12875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF566 |
0.482374835952795 |
|
12876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BACE2 |
0.482385788399765 |
|
12877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMK2 |
0.482392321526296 |
|
12878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM25 |
0.482557192587386 |
|
12879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VGLL2 |
0.482562366973267 |
|
12880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPNA6 |
0.48258593196127 |
|
12881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP340 |
0.482629274138114 |
|
12882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU2F3 |
0.482637487619327 |
|
12883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM136 |
0.482637487619327 |
|
12884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPCN2 |
0.482781177915984 |
|
12885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM151A |
0.482884042761403 |
|
12886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED13 |
0.482988765973347 |
|
12887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIB1 |
0.483015100336009 |
|
12888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL590P |
0.483015100336009 |
|
12889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212604.1 |
0.483015393337428 |
|
12890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XIRP1 |
0.483085567493995 |
|
12891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CX3CR1 |
0.483085567493995 |
|
12892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR8 |
0.483085567493995 |
|
12893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOBP |
0.483085567493995 |
|
12894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR365A |
0.483178126816111 |
|
12895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLSPN |
0.483221430361261 |
|
12896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WTAPP1 |
0.483222726487411 |
|
12897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP10 |
0.483222726487411 |
|
12898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL240P |
0.48325184867359 |
|
12899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANBP17 |
0.483271925706126 |
|
12900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX47 |
0.483298623502639 |
|
12901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP219 |
0.483404131702091 |
|
12902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM111A |
0.483610728145318 |
|
12903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM109A |
0.483628462601281 |
|
12904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2B3 |
0.483628462601281 |
|
12905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO34 |
0.483751966005754 |
|
12906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHDRBS1 |
0.484002647102139 |
|
12907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVI2B |
0.484086189296852 |
|
12908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNL3 |
0.484101904186669 |
|
12909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNL4 |
0.484101904186669 |
|
12910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252447.1 |
0.484158364536879 |
|
12911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRA1B |
0.484186869442425 |
|
12912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC1 |
0.484186869442425 |
|
12913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPP14 |
0.484241273788258 |
|
12914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNAB2 |
0.484256281016953 |
|
12915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD51|ENSG00000202275.1 |
0.48431540144677 |
|
12916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDHR3 |
0.484317844071648 |
|
12917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPLKIP |
0.484344639028982 |
|
12918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM141 |
0.484408554916274 |
|
12919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1984 |
0.484408554916274 |
|
12920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABL6 |
0.484408554916274 |
|
12921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf172 |
0.484408554916274 |
|
12922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDF1 |
0.484408554916274 |
|
12923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAMDC4 |
0.484408554916274 |
|
12924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4292 |
0.484408554916274 |
|
12925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHPT1 |
0.484408554916274 |
|
12926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUS1 |
0.484455655873996 |
|
12927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED9 |
0.484584606167636 |
|
12928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALT7 |
0.484584606167636 |
|
12929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL157P |
0.484643388343573 |
|
12930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROX1 |
0.48469197699265 |
|
12931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX29 |
0.484738753539658 |
|
12932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5100 |
0.484844752044726 |
|
12933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA2018 |
0.484876583922625 |
|
12934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCAD1 |
0.484881098073867 |
|
12935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM162B |
0.484953553843 |
|
12936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRC6A |
0.484953553843 |
|
12937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP93 |
0.484968117464032 |
|
12938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKDCC |
0.484982453024035 |
|
12939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLUL |
0.484993953611233 |
|
12940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEDDM1 |
0.484993953611233 |
|
12941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCED1A |
0.485035184116666 |
|
12942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCCRP1 |
0.485052692347387 |
|
12943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCN |
0.485052692347387 |
|
12944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFHAS1 |
0.485094387585687 |
|
12945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MURC |
0.485169421371499 |
|
12946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP87 |
0.485169421371499 |
|
12947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PXDC1 |
0.485500212402687 |
|
12948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFRA2 |
0.485582405470337 |
|
12949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM22 |
0.485613598830224 |
|
12950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM9SF2 |
0.485630670156417 |
|
12951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNIP2 |
0.485678822328435 |
|
12952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS35 |
0.485679524652732 |
|
12953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORC6 |
0.485679524652732 |
|
12954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOLR1 |
0.485717701141633 |
|
12955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAD |
0.485769814523612 |
|
12956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR137 |
0.485769814523612 |
|
12957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYL1 |
0.485986124277627 |
|
12958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1200 |
0.48601653599242 |
|
12959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP4 |
0.486085604790705 |
|
12960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNTL5 |
0.486086836497182 |
|
12961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST9 |
0.4861526966726 |
|
12962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS16 |
0.486285929770394 |
|
12963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35F2 |
0.486321148047574 |
|
12964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCKIPSD |
0.486374599100034 |
|
12965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC171 |
0.486424525688064 |
|
12966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A3 |
0.486542410674323 |
|
12967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPXN |
0.486669440863248 |
|
12968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP91 |
0.486669440863248 |
|
12969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K7 |
0.486779662603999 |
|
12970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM64A |
0.486799422892045 |
|
12971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SWAP70 |
0.48694179811626 |
|
12972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf32 |
0.486945925155819 |
|
12973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS50 |
0.486983194542982 |
|
12974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS46 |
0.486983194542982 |
|
12975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS42 |
0.486983194542982 |
|
12976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS44 |
0.486983194542982 |
|
12977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS45 |
0.486983194542982 |
|
12978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP3 |
0.487059684033075 |
|
12979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCM |
0.487059684033075 |
|
12980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212187.1 |
0.487157589161766 |
|
12981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL79P |
0.487287832182467 |
|
12982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP24A1 |
0.487345414679194 |
|
12983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOK6 |
0.487374597420021 |
|
12984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CATSPER4 |
0.487588136547655 |
|
12985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM26E |
0.487615516369422 |
|
12986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARP6 |
0.487632451842418 |
|
12987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC49 |
0.487632451842418 |
|
12988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP10 |
0.487632451842418 |
|
12989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC3 |
0.487688142218724 |
|
12990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPAR3 |
0.487849555691103 |
|
12991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2G2 |
0.487973173736622 |
|
12992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUMO3 |
0.487973173736622 |
|
12993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTTG1IP |
0.487973173736622 |
|
12994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP373 |
0.487977514270378 |
|
12995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP37 |
0.488058369646748 |
|
12996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPACT |
0.488079934923765 |
|
12997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRH4 |
0.488079934923765 |
|
12998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CES4A |
0.488120676392625 |
|
12999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL543P |
0.488120676392625 |
|
13000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP15 |
0.488160353603525 |
|
13001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN23 |
0.488179266074174 |
|
13002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH1B1 |
0.488245337102226 |
|
13003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDHR4 |
0.488424826923653 |
|
13004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM212A |
0.488424826923653 |
|
13005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5193 |
0.488424826923653 |
|
13006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBA7 |
0.488424826923653 |
|
13007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBP1 |
0.488539386488268 |
|
13008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBP2 |
0.488539386488268 |
|
13009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBP7 |
0.488539386488268 |
|
13010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBP4 |
0.488539386488268 |
|
13011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMS1 |
0.488546622670237 |
|
13012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238732.1 |
0.488546622670237 |
|
13013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM132D |
0.488614199092444 |
|
13014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR45 |
0.488714452219262 |
|
13015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP116 |
0.488841641560646 |
|
13016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMFBP1 |
0.488881272666919 |
|
13017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCER1A |
0.488936988946881 |
|
13018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10J3 |
0.488936988946881 |
|
13019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD13 |
0.489016474051296 |
|
13020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf92 |
0.489310167640322 |
|
13021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDLIM7 |
0.48932667069343 |
|
13022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOK3 |
0.48932667069343 |
|
13023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX12 |
0.489387025505439 |
|
13024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R8 |
0.489387025505439 |
|
13025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA1 |
0.489387025505439 |
|
13026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRP |
0.48945805503166 |
|
13027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAX |
0.48945805503166 |
|
13028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPLX4 |
0.48945805503166 |
|
13029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMAN1 |
0.48945805503166 |
|
13030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG5P2 |
0.489473260980715 |
|
13031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGAG1 |
0.489473260980715 |
|
13032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH2 |
0.489484193447439 |
|
13033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2B |
0.489516192946018 |
|
13034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN2AIPNL |
0.489516192946018 |
|
13035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGST3 |
0.489532759652497 |
|
13036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP304 |
0.489541501117111 |
|
13037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSRB2 |
0.489541501117111 |
|
13038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXTL1 |
0.489569457685931 |
|
13039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A2 |
0.489569457685931 |
|
13040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM63 |
0.489569457685931 |
|
13041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDIK1L |
0.489569457685931 |
|
13042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM110D |
0.489569457685931 |
|
13043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF593 |
0.489569457685931 |
|
13044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNKSR1 |
0.489569457685931 |
|
13045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2L14 |
0.48959824702919 |
|
13046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL281P |
0.489703125626098 |
|
13047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf216 |
0.489703125626098 |
|
13048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPLP0P2 |
0.48979052261105 |
|
13049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR139 |
0.489816131243126 |
|
13050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOK7 |
0.489943950824945 |
|
13051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRPAP1 |
0.489943950824945 |
|
13052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf23 |
0.490126287798033 |
|
13053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTERFD3 |
0.490126287798033 |
|
13054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCNT1 |
0.490165749205013 |
|
13055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX2 |
0.490216343938891 |
|
13056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3161 |
0.490257615800416 |
|
13057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3611 |
0.490327058234448 |
|
13058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREM |
0.490327058234448 |
|
13059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA17|ENSG00000252190.1 |
0.490526456021616 |
|
13060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA18|ENSG00000252691.1 |
0.490526456021616 |
|
13061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJC3 |
0.490528590124293 |
|
13062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000222966.1 |
0.490528590124293 |
|
13063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AZGP1 |
0.490528590124293 |
|
13064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL11B |
0.490628427287186 |
|
13065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CWC22 |
0.490637261582459 |
|
13066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLT4 |
0.490772965377077 |
|
13067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAGPA |
0.490796920066633 |
|
13068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf89 |
0.490796920066633 |
|
13069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00272 |
0.490960859059307 |
|
13070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASEL |
0.490960859059307 |
|
13071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS16 |
0.490960859059307 |
|
13072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS8 |
0.490960859059307 |
|
13073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252559.1 |
0.490991390371832 |
|
13074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPACA5B |
0.491022500984653 |
|
13075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPACA5 |
0.491022500984653 |
|
13076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX6 |
0.491022500984653 |
|
13077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF182 |
0.491022500984653 |
|
13078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF630 |
0.491022500984653 |
|
13079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238473.1 |
0.491022500984653 |
|
13080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMMECR1 |
0.4910676964149 |
|
13081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548F4 |
0.491094709834283 |
|
13082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFBPL1 |
0.491202845255627 |
|
13083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UFL1 |
0.491216022320076 |
|
13084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHL5 |
0.491216022320076 |
|
13085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP112 |
0.491365217418105 |
|
13086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D24 |
0.491400537538475 |
|
13087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN3 |
0.491590011715336 |
|
13088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT5A |
0.491695972418456 |
|
13089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTA1 |
0.491735241724708 |
|
13090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCDN |
0.491862536190788 |
|
13091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFAP2E |
0.491862536190788 |
|
13092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB2 |
0.491862536190788 |
|
13093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNF4G |
0.491877708488396 |
|
13094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFPL4B |
0.491898769266359 |
|
13095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTX3 |
0.491923074919237 |
|
13096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREB3L2 |
0.492139564517706 |
|
13097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA18|ENSG00000252249.1 |
0.492184848355519 |
|
13098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP160 |
0.492272391227867 |
|
13099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF17 |
0.492278401519787 |
|
13100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF749 |
0.492278401519787 |
|
13101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR320C2 |
0.492496674087103 |
|
13102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCRIB |
0.492593440510747 |
|
13103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR937 |
0.492593440510747 |
|
13104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUF60 |
0.492593440510747 |
|
13105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRBP2 |
0.492593440510747 |
|
13106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP54 |
0.492676681017888 |
|
13107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK10 |
0.492698421269484 |
|
13108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF9 |
0.492745331346871 |
|
13109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL247P |
0.492753330496524 |
|
13110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL329P |
0.492784493192796 |
|
13111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QTRTD1 |
0.493077630029115 |
|
13112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSCAM |
0.493168817946822 |
|
13113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYZL1 |
0.493288015525255 |
|
13114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBN3 |
0.493365104789425 |
|
13115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUS7 |
0.493437860654619 |
|
13116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP1 |
0.49351833135433 |
|
13117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOPC |
0.493522437237906 |
|
13118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK33 |
0.493550707756315 |
|
13119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4417 |
0.493704386687486 |
|
13120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIK3 |
0.493704458942298 |
|
13121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL12 |
0.493743025182999 |
|
13122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDAH1 |
0.49375428507519 |
|
13123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBGCP3 |
0.493764704872842 |
|
13124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPFIBP2 |
0.493800031281036 |
|
13125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5R2 |
0.493800031281036 |
|
13126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCAT1 |
0.493848755195337 |
|
13127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A4 |
0.4939887251225 |
|
13128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL15 |
0.494096009785575 |
|
13129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC32P |
0.494096009785575 |
|
13130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC12 |
0.494136211530796 |
|
13131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF3 |
0.494225774482008 |
|
13132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST10 |
0.49426153134243 |
|
13133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL800P |
0.494316822150313 |
|
13134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRIP2 |
0.494502594480749 |
|
13135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRIP1 |
0.494502594480749 |
|
13136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXDC1 |
0.494519115404893 |
|
13137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP168 |
0.494616780744114 |
|
13138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53TG1 |
0.494642554434573 |
|
13139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CROT |
0.494642554434573 |
|
13140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP5A |
0.494687990937527 |
|
13141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF200 |
0.494715788600751 |
|
13142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRB |
0.494738633700178 |
|
13143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A9 |
0.494926529260061 |
|
13144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMA7 |
0.495124794681572 |
|
13145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SS18L1 |
0.495124794681572 |
|
13146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WRNIP1 |
0.495162279406948 |
|
13147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB5 |
0.495172796070482 |
|
13148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF12 |
0.495184220212697 |
|
13149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252170.1 |
0.495245558764089 |
|
13150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNRF3 |
0.495391730726839 |
|
13151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00448 |
0.495413924035746 |
|
13152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AURKC |
0.495605884535432 |
|
13153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF805 |
0.495605884535432 |
|
13154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRG2 |
0.495606714303909 |
|
13155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHFPL2 |
0.495646147104301 |
|
13156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COG5 |
0.495671184370008 |
|
13157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR22 |
0.495671184370008 |
|
13158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUS2L |
0.4956897231222 |
|
13159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAD10 |
0.495765199548589 |
|
13160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPEP3 |
0.495879399343262 |
|
13161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPEP2 |
0.495879399343262 |
|
13162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REXO2 |
0.496003352364317 |
|
13163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXPH5 |
0.496027153073851 |
|
13164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLL4 |
0.496037349091925 |
|
13165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RINT1 |
0.496110848927248 |
|
13166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB10 |
0.496110848927248 |
|
13167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMN |
0.496203190577065 |
|
13168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREBRF |
0.496513744649737 |
|
13169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BNIP1 |
0.496513744649737 |
|
13170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74|ENSG00000252917.1 |
0.49652153493983 |
|
13171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0141 |
0.496581226105631 |
|
13172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH12 |
0.496581226105631 |
|
13173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF14 |
0.496581226105631 |
|
13174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNPDA1 |
0.496581226105631 |
|
13175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R50 |
0.496590336046358 |
|
13176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL4A6 |
0.496795905962671 |
|
13177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUL2 |
0.496862323771694 |
|
13178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN7L1 |
0.496938291555236 |
|
13179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERPUD1 |
0.496954646330515 |
|
13180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CETP |
0.496954646330515 |
|
13181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2AE1 |
0.496958872697751 |
|
13182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM4 |
0.496958872697751 |
|
13183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHAC1 |
0.497082963219613 |
|
13184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP51 |
0.497097682530071 |
|
13185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRICKLE1 |
0.497133227288664 |
|
13186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP119 |
0.497240045938731 |
|
13187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX11G |
0.497301603446546 |
|
13188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf45 |
0.497301603446546 |
|
13189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF358 |
0.497301603446546 |
|
13190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY96 |
0.497558475130257 |
|
13191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS9 |
0.497600102682144 |
|
13192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP75 |
0.497805387127069 |
|
13193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1265 |
0.498072797956191 |
|
13194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR158 |
0.498158682106695 |
|
13195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA50 |
0.498276373735195 |
|
13196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1A |
0.498276373735195 |
|
13197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf55 |
0.498354475084884 |
|
13198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS2ST1 |
0.498379224930747 |
|
13199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCA3 |
0.498404743696263 |
|
13200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC4 |
0.498432727228932 |
|
13201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF207 |
0.498540164589061 |
|
13202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICMT |
0.498540164589061 |
|
13203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00337 |
0.498540164589061 |
|
13204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL45P |
0.498627659718535 |
|
13205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4724 |
0.498627659718535 |
|
13206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR193A |
0.498627659718535 |
|
13207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC7P |
0.498627659718535 |
|
13208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF852 |
0.498713693783412 |
|
13209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A38 |
0.498738484918761 |
|
13210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPSA |
0.498738484918761 |
|
13211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf57 |
0.498841992851075 |
|
13212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPUSD2 |
0.498841992851075 |
|
13213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESCO2 |
0.498847029994037 |
|
13214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPKAPK5 |
0.498854624645332 |
|
13215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF5 |
0.498854721712221 |
|
13216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF385B |
0.498938426378255 |
|
13217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VN1R1 |
0.498975105611806 |
|
13218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF419 |
0.498975105611806 |
|
13219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF772 |
0.498975105611806 |
|
13220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNK |
0.49906806742256 |
|
13221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238822.1 |
0.499079790093797 |
|
13222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1257 |
0.499115539554179 |
|
13223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00955 |
0.49914874725989 |
|
13224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNV1 |
0.49931642675186 |
|
13225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC7P |
0.499325613776963 |
|
13226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF264 |
0.499374760303199 |
|
13227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPP |
0.49939986789603 |
|
13228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN10 |
0.49966822404659 |
|
13229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA62|ENSG00000202363.1 |
0.499708991607404 |
|
13230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA6 |
0.499708991607404 |
|
13231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBR5 |
0.499724161551069 |
|
13232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC8P |
0.499724161551069 |
|
13233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL5 |
0.499783496463403 |
|
13234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD21 |
0.499783496463403 |
|
13235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA66|ENSG00000251795.1 |
0.499783496463403 |
|
13236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA66|ENSG00000207523.1 |
0.499783496463403 |
|
13237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000207022.1 |
0.499783496463403 |
|
13238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP164 |
0.49982176900005 |
|
13239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATOH1 |
0.49982176900005 |
|
13240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPBGL |
0.499826862643634 |
|
13241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARRB1 |
0.499826862643634 |
|
13242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A9 |
0.500042785802708 |
|
13243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NES |
0.500142342132233 |
|
13244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1407 |
0.500212503496711 |
|
13245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS1 |
0.500231087820142 |
|
13246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TERF1 |
0.50024736647763 |
|
13247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5B21 |
0.500339987579588 |
|
13248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH5 |
0.500380189607084 |
|
13249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00920 |
0.500380189607084 |
|
13250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPA0 |
0.500466260859081 |
|
13251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000272439.1 |
0.500592634737067 |
|
13252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC28 |
0.500783345009751 |
|
13253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFRA3 |
0.500825369741291 |
|
13254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PA2G4 |
0.500827774870771 |
|
13255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL41 |
0.500827774870771 |
|
13256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESYT1 |
0.500827774870771 |
|
13257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H10 |
0.500827774870771 |
|
13258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR874 |
0.500951680599295 |
|
13259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF460 |
0.500977675782609 |
|
13260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252505.1 |
0.501056037661526 |
|
13261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL15 |
0.501109896844334 |
|
13262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf200 |
0.50111527405721 |
|
13263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSD2 |
0.501255906224133 |
|
13264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF317 |
0.501434614323556 |
|
13265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB18 |
0.501511609877201 |
|
13266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEO1 |
0.501531015907739 |
|
13267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK6 |
0.501531015907739 |
|
13268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1260A |
0.501622041175589 |
|
13269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NGB |
0.501622041175589 |
|
13270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POMT2 |
0.501622041175589 |
|
13271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TACO1 |
0.501654555315445 |
|
13272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1B1 |
0.501946474913777 |
|
13273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB4 |
0.502009799738766 |
|
13274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS29 |
0.502150999743 |
|
13275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRR1 |
0.502150999743 |
|
13276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF10A |
0.502295189131958 |
|
13277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP7 |
0.502295189131958 |
|
13278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
R3HCC1 |
0.502295189131958 |
|
13279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTPD4 |
0.502295189131958 |
|
13280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGAX |
0.50238021430656 |
|
13281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGAD |
0.50238021430656 |
|
13282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL233P |
0.502441565446514 |
|
13283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFDN1 |
0.502526302965842 |
|
13284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBEGF |
0.502526302965842 |
|
13285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS11F |
0.502612314610284 |
|
13286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS11GP |
0.502612314610284 |
|
13287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSKH1 |
0.502707027903971 |
|
13288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTRL |
0.502707027903971 |
|
13289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB10 |
0.502707027903971 |
|
13290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCAT |
0.502707027903971 |
|
13291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A4 |
0.502707027903971 |
|
13292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPBAP1 |
0.502712854628693 |
|
13293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238480.1 |
0.502712854628693 |
|
13294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP90 |
0.502734682177922 |
|
13295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU109|ENSG00000252040.1 |
0.502734682177922 |
|
13296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU109|ENSG00000252640.1 |
0.502734682177922 |
|
13297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH3 |
0.502734682177922 |
|
13298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP108 |
0.502834326450943 |
|
13299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R20 |
0.502960295967756 |
|
13300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR65 |
0.503021572275144 |
|
13301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4293 |
0.503036140325452 |
|
13302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL5C |
0.503151071588594 |
|
13303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRK1 |
0.503155994520255 |
|
13304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRC4 |
0.503155994520255 |
|
13305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL29P30 |
0.503207955568767 |
|
13306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A12 |
0.503225130821094 |
|
13307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP3A7 |
0.503297116630227 |
|
13308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0319L |
0.503329007873396 |
|
13309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HGFAC |
0.503495813571982 |
|
13310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRB2 |
0.503601398352768 |
|
13311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRA6 |
0.503601398352768 |
|
13312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA2 |
0.503659127062296 |
|
13313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3PXD2A |
0.503690343701148 |
|
13314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POM121 |
0.503810800108955 |
|
13315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FYCO1 |
0.503846261961063 |
|
13316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCR6 |
0.503846261961063 |
|
13317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XCR1 |
0.503846261961063 |
|
13318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRG2 |
0.503935247477273 |
|
13319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC163P |
0.503939211839484 |
|
13320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMACHC |
0.503939211839484 |
|
13321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDX1 |
0.503939211839484 |
|
13322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC28A2 |
0.503940932141045 |
|
13323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGAM |
0.504048943344611 |
|
13324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RD3 |
0.50405753541068 |
|
13325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A37 |
0.504113158618273 |
|
13326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP50 |
0.504321242288963 |
|
13327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLYBL |
0.504438328951063 |
|
13328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRAP |
0.504448532088724 |
|
13329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2IRD2P1 |
0.504451555177854 |
|
13330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCF1B |
0.504451555177854 |
|
13331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSUN5P2 |
0.504451555177854 |
|
13332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSUN5 |
0.504451555177854 |
|
13333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAG3L3 |
0.504451555177854 |
|
13334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM50 |
0.504451555177854 |
|
13335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM74 |
0.504451555177854 |
|
13336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDAP1 |
0.504524406138123 |
|
13337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX10 |
0.504581668447449 |
|
13338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPP4 |
0.504653049377249 |
|
13339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADGB |
0.504673578383851 |
|
13340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A23 |
0.504788557404126 |
|
13341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAFAH2 |
0.504828666701524 |
|
13342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC18A1 |
0.504834590849911 |
|
13343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1B2 |
0.504834590849911 |
|
13344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LZTS1 |
0.504834590849911 |
|
13345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD9 |
0.505085046016487 |
|
13346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP424 |
0.505124343884529 |
|
13347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP425 |
0.505124343884529 |
|
13348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STC2 |
0.505180127887292 |
|
13349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLYATL2 |
0.505225365579713 |
|
13350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLYATL1P2 |
0.505225365579713 |
|
13351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP22 |
0.505368419262568 |
|
13352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC2 |
0.505368419262568 |
|
13353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HUS1B |
0.505368419262568 |
|
13354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF4 |
0.505368419262568 |
|
13355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN13 |
0.50537509434007 |
|
13356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRD3 |
0.505377706789784 |
|
13357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM23 |
0.505425028754274 |
|
13358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00358 |
0.505425843823176 |
|
13359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOLR3 |
0.50544307898152 |
|
13360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO1 |
0.505501768411235 |
|
13361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGPL1 |
0.505517349300906 |
|
13362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO42 |
0.50555465594053 |
|
13363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000251938.1 |
0.505559958394601 |
|
13364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FADD |
0.505623383904024 |
|
13365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZIC5 |
0.505628458680125 |
|
13366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZIC2 |
0.505628458680125 |
|
13367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00554 |
0.505628458680125 |
|
13368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEND5 |
0.505632357966493 |
|
13369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MXI1 |
0.505685220859225 |
|
13370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL42 |
0.505766497359658 |
|
13371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AK4 |
0.505838561778957 |
|
13372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548K |
0.505896045442438 |
|
13373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP3M1 |
0.505941220104574 |
|
13374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35G6 |
0.506014046292619 |
|
13375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2A |
0.506014046292619 |
|
13376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRB3 |
0.506076618574051 |
|
13377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMG4 |
0.506094468101514 |
|
13378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP95 |
0.506160948923609 |
|
13379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMURF2 |
0.506160948923609 |
|
13380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf116 |
0.506198579784297 |
|
13381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238401.1 |
0.506198579784297 |
|
13382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL27A |
0.506218359194797 |
|
13383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L5 |
0.506453352748414 |
|
13384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO1F |
0.506580245036359 |
|
13385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM168B |
0.506603816834407 |
|
13386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00605 |
0.50661085966055 |
|
13387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY5P1 |
0.506692773092286 |
|
13388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3165 |
0.506725492997553 |
|
13389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBLN1 |
0.506924543293973 |
|
13390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMI1 |
0.506924543293973 |
|
13391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD3 |
0.506924543293973 |
|
13392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf59 |
0.507113560719586 |
|
13393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTN3 |
0.507113560719586 |
|
13394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORC2 |
0.507134711239004 |
|
13395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM66 |
0.507143062692183 |
|
13396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA3|ENSG00000200983.1 |
0.507143062692183 |
|
13397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA45 |
0.507143062692183 |
|
13398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPM8 |
0.507208001695708 |
|
13399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRC1 |
0.507445764071451 |
|
13400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRC2 |
0.507445764071451 |
|
13401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRC3 |
0.507445764071451 |
|
13402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL797P |
0.507457628846753 |
|
13403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLPH |
0.507677569354091 |
|
13404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AQ |
0.50777774875731 |
|
13405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP8 |
0.507820107893378 |
|
13406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTF |
0.507957574923564 |
|
13407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLYAT |
0.507957574923564 |
|
13408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM26F |
0.508040049580815 |
|
13409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BANF1 |
0.50804341783938 |
|
13410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CST6 |
0.50804341783938 |
|
13411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CATSPER1 |
0.50804341783938 |
|
13412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251863.1 |
0.508073714835605 |
|
13413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL10L |
0.50807843084746 |
|
13414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC23 |
0.508134055691613 |
|
13415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD13A |
0.508141557562477 |
|
13416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000251944.1 |
0.508182568440454 |
|
13417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC16 |
0.508267192048541 |
|
13418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRP |
0.508408161401223 |
|
13419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP23 |
0.508408161401223 |
|
13420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCRL6 |
0.508408161401223 |
|
13421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPY6R |
0.508410706672007 |
|
13422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRTOMT |
0.508414165910838 |
|
13423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMTOR1 |
0.508414165910838 |
|
13424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238768.1 |
0.508414165910838 |
|
13425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC15 |
0.508414165910838 |
|
13426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17B |
0.508425178154569 |
|
13427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf34 |
0.508450106934414 |
|
13428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00459 |
0.50848374413901 |
|
13429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLN |
0.508489432235973 |
|
13430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7D4 |
0.508552194889516 |
|
13431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRT4 |
0.508564665953409 |
|
13432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G1B |
0.508564665953409 |
|
13433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf28 |
0.5086437117967 |
|
13434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL28 |
0.5086437117967 |
|
13435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM179B |
0.5086437117967 |
|
13436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD58 |
0.5086437117967 |
|
13437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP428 |
0.508697495845003 |
|
13438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00929 |
0.508994078872245 |
|
13439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS13A |
0.508997878526122 |
|
13440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000253041.1 |
0.509017374273514 |
|
13441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR143HG |
0.509030469142739 |
|
13442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR143 |
0.509030469142739 |
|
13443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR145 |
0.509030469142739 |
|
13444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELAC2 |
0.509100853552662 |
|
13445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3GLB1 |
0.509101186846921 |
|
13446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SQSTM1 |
0.509115992890895 |
|
13447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP150 |
0.509115992890895 |
|
13448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR885 |
0.509178540372277 |
|
13449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OAZ2 |
0.509222236052624 |
|
13450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR108 |
0.509324530288034 |
|
13451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIP10 |
0.509324530288034 |
|
13452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP262 |
0.509396328844602 |
|
13453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIT2 |
0.509565962082006 |
|
13454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPH1 |
0.509772515271957 |
|
13455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM193A |
0.509875561595016 |
|
13456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIBIN |
0.509935738419927 |
|
13457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP186 |
0.509980537617699 |
|
13458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS12 |
0.510012028445234 |
|
13459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RARRES3 |
0.510012028445234 |
|
13460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRASLS2 |
0.510012028445234 |
|
13461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G16 |
0.510012028445234 |
|
13462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATL3 |
0.510012028445234 |
|
13463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB32 |
0.51007765826969 |
|
13464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R9 |
0.510115071525711 |
|
13465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R10 |
0.510115071525711 |
|
13466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRH2 |
0.510115071525711 |
|
13467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC3L |
0.51015684680476 |
|
13468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBSPON |
0.510160569862769 |
|
13469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMD4 |
0.51018790111853 |
|
13470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP341 |
0.510248935654119 |
|
13471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP259 |
0.510248935654119 |
|
13472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTN4RL2 |
0.510248935654119 |
|
13473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL663P |
0.510279562793718 |
|
13474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX46 |
0.510308052544973 |
|
13475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD18 |
0.510311654625847 |
|
13476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGOL2 |
0.510311654625847 |
|
13477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL86P |
0.510328734813791 |
|
13478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3128 |
0.510363393864342 |
|
13479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238295.1 |
0.510363393864342 |
|
13480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL767P |
0.510484478806107 |
|
13481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf65 |
0.510529674068864 |
|
13482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A1 |
0.5106050432565 |
|
13483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPGAT1 |
0.510605775860629 |
|
13484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXER1 |
0.510616550535095 |
|
13485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC2 |
0.510929025152012 |
|
13486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM50B |
0.511119103102472 |
|
13487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM49A |
0.511242331117147 |
|
13488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCHFR |
0.511274098213951 |
|
13489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf62 |
0.511274098213951 |
|
13490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL6A3 |
0.511346420771339 |
|
13491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX1 |
0.511437098131716 |
|
13492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX3 |
0.511437098131716 |
|
13493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX4B |
0.511437098131716 |
|
13494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX4 |
0.511437098131716 |
|
13495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX9 |
0.511437098131716 |
|
13496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1RN |
0.511590831536831 |
|
13497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A40 |
0.511652641171249 |
|
13498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPF1 |
0.511839652605995 |
|
13499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATA5 |
0.511857860364946 |
|
13500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBX |
0.51191068698922 |
|
13501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL184P |
0.511974246896014 |
|
13502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRUNE2 |
0.512101788274089 |
|
13503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239111.1 |
0.512166408059186 |
|
13504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBPMS2 |
0.512322599237131 |
|
13505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1272 |
0.512322599237131 |
|
13506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCAM1P |
0.512347393560833 |
|
13507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSH1 |
0.512347393560833 |
|
13508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSH2 |
0.512347393560833 |
|
13509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSHL1 |
0.512347393560833 |
|
13510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GH2 |
0.512347393560833 |
|
13511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC141 |
0.512373456014164 |
|
13512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRH1 |
0.512374145739107 |
|
13513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R13 |
0.512374145739107 |
|
13514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIC3 |
0.512377735972635 |
|
13515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238761.1 |
0.512379659739078 |
|
13516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOK2 |
0.512451019688561 |
|
13517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CANX |
0.512619320658473 |
|
13518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBY3 |
0.512619320658473 |
|
13519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGB3P22 |
0.512619320658473 |
|
13520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAML1 |
0.512619320658473 |
|
13521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTC4S |
0.512619320658473 |
|
13522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAT4B |
0.512619320658473 |
|
13523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1229 |
0.512619320658473 |
|
13524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4297 |
0.512677921813415 |
|
13525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000200026.1 |
0.51278395196629 |
|
13526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A6E |
0.512846298825125 |
|
13527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AJAP1 |
0.512967979628562 |
|
13528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJD2 |
0.513184473122606 |
|
13529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTC1 |
0.513184473122606 |
|
13530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELMO1 |
0.513236013737312 |
|
13531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AOX1 |
0.51333667958209 |
|
13532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB9 |
0.513430460417118 |
|
13533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH20 |
0.513435931166953 |
|
13534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUMA1 |
0.513437966176379 |
|
13535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00379 |
0.513462028039058 |
|
13536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR9 |
0.513463285956092 |
|
13537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERGIC2 |
0.513520807186377 |
|
13538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB1 |
0.513604359210677 |
|
13539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4645 |
0.513604359210677 |
|
13540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBF1 |
0.513629596084009 |
|
13541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAOK1 |
0.513660142055573 |
|
13542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETBP1 |
0.51369524229977 |
|
13543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4319 |
0.51369524229977 |
|
13544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP10 |
0.51379586308263 |
|
13545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPL |
0.513865577467111 |
|
13546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF2 |
0.514036431071952 |
|
13547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC6 |
0.514155250216007 |
|
13548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEOX2 |
0.514185413309708 |
|
13549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC10A2 |
0.514205465347759 |
|
13550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H7A |
0.514224473824605 |
|
13551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPP2 |
0.514268375847897 |
|
13552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF143 |
0.514289667352963 |
|
13553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K3 |
0.514301177080415 |
|
13554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMD2 |
0.514301177080415 |
|
13555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTSJ3 |
0.514301177080415 |
|
13556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMC5 |
0.514301177080415 |
|
13557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCD2 |
0.514301177080415 |
|
13558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL805P |
0.514301177080415 |
|
13559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR1E |
0.514343620927327 |
|
13560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO10 |
0.514343620927327 |
|
13561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXN4 |
0.514370101589022 |
|
13562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3928 |
0.514430408661608 |
|
13563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCBD1 |
0.514481827955263 |
|
13564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000264043.2 |
0.514539643534094 |
|
13565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSH1 |
0.514539643534094 |
|
13566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR619 |
0.514539643534094 |
|
13567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAO |
0.514539643534094 |
|
13568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRF2 |
0.514601497999679 |
|
13569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAT1 |
0.514613691306294 |
|
13570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METAP1D |
0.514613691306294 |
|
13571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLX1 |
0.514717407103108 |
|
13572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLX2 |
0.514717407103108 |
|
13573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX6A2 |
0.514849620532261 |
|
13574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF843 |
0.514849620532261 |
|
13575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC5 |
0.514849620532261 |
|
13576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RX3 |
0.514850867639925 |
|
13577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRG3 |
0.514850867639925 |
|
13578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRG2 |
0.514850867639925 |
|
13579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC43A3 |
0.514850867639925 |
|
13580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRR |
0.515166774394504 |
|
13581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARN |
0.515167023261488 |
|
13582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR157 |
0.515377029276621 |
|
13583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCOR |
0.515382051036803 |
|
13584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC6 |
0.51538330520145 |
|
13585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U7|ENSG00000271841.1 |
0.515413481800569 |
|
13586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AURKA |
0.515443171095677 |
|
13587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSTF1 |
0.515443171095677 |
|
13588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4698 |
0.515446631524549 |
|
13589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPO7 |
0.515490249146778 |
|
13590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212321.1 |
0.51553500164891 |
|
13591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1F1 |
0.515600643780747 |
|
13592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIVM |
0.515609979146877 |
|
13593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC5 |
0.515609979146877 |
|
13594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL21EP |
0.515609979146877 |
|
13595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANBP10 |
0.515743338304824 |
|
13596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSNAXIP1 |
0.515743338304824 |
|
13597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPT |
0.515743338304824 |
|
13598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP11 |
0.515743338304824 |
|
13599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUTF2 |
0.515743338304824 |
|
13600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAK1 |
0.515763417210149 |
|
13601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB5 |
0.515787542602878 |
|
13602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL463P |
0.515787542602878 |
|
13603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIL3 |
0.515800876072289 |
|
13604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIF3L1 |
0.515800876072289 |
|
13605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRK4 |
0.515863431639928 |
|
13606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L7 |
0.515868003165127 |
|
13607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT86 |
0.515917898022764 |
|
13608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APBB1 |
0.515973356144822 |
|
13609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYBU |
0.515990896061583 |
|
13610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL638P |
0.516014823357148 |
|
13611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC34P |
0.516014823357148 |
|
13612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL284P |
0.516043246626063 |
|
13613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL6B |
0.516109241901086 |
|
13614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL6 |
0.516109241901086 |
|
13615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCC2 |
0.516109241901086 |
|
13616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAGE1 |
0.516184359400083 |
|
13617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA3 |
0.51619558304726 |
|
13618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARFGEF1 |
0.516229145136018 |
|
13619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHB3 |
0.5162313806528 |
|
13620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCA4 |
0.516258673820195 |
|
13621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCA3P |
0.516258673820195 |
|
13622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRD1 |
0.516343957643694 |
|
13623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX17 |
0.516606358895906 |
|
13624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERBB3 |
0.51667063640249 |
|
13625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLGAP5 |
0.516695539408109 |
|
13626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASS4 |
0.516709203974863 |
|
13627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238294.1 |
0.516709203974863 |
|
13628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPFFR2 |
0.516729563298184 |
|
13629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX5 |
0.516865665942289 |
|
13630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3064 |
0.516865665942289 |
|
13631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5047 |
0.516865665942289 |
|
13632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUOX1 |
0.516879634959469 |
|
13633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBBP1 |
0.517011166916087 |
|
13634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBPMS |
0.517011166916087 |
|
13635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf85 |
0.5171153302897 |
|
13636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD60 |
0.5171153302897 |
|
13637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP4R1L |
0.5171153302897 |
|
13638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239095.1 |
0.517199693523607 |
|
13639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf12 |
0.517329485938648 |
|
13640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIN2A |
0.517424902194209 |
|
13641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGEF1C |
0.517464924048036 |
|
13642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMD |
0.517478896689597 |
|
13643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIM2 |
0.517479753515447 |
|
13644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35A2 |
0.517479753515447 |
|
13645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUD5 |
0.517479753515447 |
|
13646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCND1 |
0.517479753515447 |
|
13647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCYAP1R1 |
0.51749960130361 |
|
13648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252078.1 |
0.51752638807054 |
|
13649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD248 |
0.517620241961618 |
|
13650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIN1 |
0.517620241961618 |
|
13651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRMS1 |
0.517620241961618 |
|
13652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT1 |
0.517620241961618 |
|
13653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL137P |
0.517743994510515 |
|
13654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD15 |
0.517743994510515 |
|
13655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOXRED1 |
0.517743994510515 |
|
13656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNG3 |
0.517875630461112 |
|
13657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF3C6 |
0.518057015391323 |
|
13658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238775.1 |
0.518057015391323 |
|
13659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPOCD1 |
0.518164964420535 |
|
13660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSIP1 |
0.518190467401005 |
|
13661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221455.1 |
0.518266578531262 |
|
13662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPGS2 |
0.518313859059699 |
|
13663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3 |
0.518432962137545 |
|
13664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK19 |
0.518532523762044 |
|
13665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SZT2 |
0.518713852013052 |
|
13666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNYL2 |
0.518745039119733 |
|
13667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR63 |
0.518753516703882 |
|
13668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKRIR |
0.518770866015638 |
|
13669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSFA2 |
0.518806899407313 |
|
13670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBSCR17 |
0.518812166079658 |
|
13671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2V2 |
0.518845626756492 |
|
13672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00620 |
0.518854606836506 |
|
13673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX22 |
0.518980795540376 |
|
13674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLD |
0.519245741569281 |
|
13675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX2 |
0.519257186032113 |
|
13676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSJ |
0.519299249569062 |
|
13677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH23 |
0.5193008178725 |
|
13678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY2 |
0.519311168723163 |
|
13679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK2D |
0.519346679889978 |
|
13680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTZ1 |
0.519435221530222 |
|
13681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED8 |
0.519435221530222 |
|
13682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN14 |
0.51949325421954 |
|
13683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTFDC1 |
0.519499775170375 |
|
13684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCNT7 |
0.519499775170375 |
|
13685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM209A |
0.519499775170375 |
|
13686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM209B |
0.519499775170375 |
|
13687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMD4A |
0.519575281757342 |
|
13688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP220 |
0.519751486541478 |
|
13689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR610 |
0.519754619704448 |
|
13690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A14 |
0.519813624903581 |
|
13691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4487 |
0.519850284835079 |
|
13692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RET |
0.519973927184769 |
|
13693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB11FIP4 |
0.520019178017007 |
|
13694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEAD4 |
0.520019388610546 |
|
13695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHNO1 |
0.520053706586312 |
|
13696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD10 |
0.520083484982953 |
|
13697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOP14 |
0.520083484982953 |
|
13698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHTKD1 |
0.520153362692755 |
|
13699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AK |
0.520153362692755 |
|
13700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000272507.1 |
0.520153362692755 |
|
13701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKN2 |
0.52022423981394 |
|
13702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX5 |
0.520272916035951 |
|
13703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP503 |
0.520272916035951 |
|
13704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA16|ENSG00000252404.1 |
0.520421022580662 |
|
13705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM181B |
0.520469535728902 |
|
13706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGD |
0.520559512467903 |
|
13707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMPD1 |
0.52058805051152 |
|
13708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAND1 |
0.520701236111384 |
|
13709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH4 |
0.520732511526622 |
|
13710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf87 |
0.520747100495848 |
|
13711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A33 |
0.520747269272873 |
|
13712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM201 |
0.520747269272873 |
|
13713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3CD |
0.520802758776131 |
|
13714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSE |
0.520897014282241 |
|
13715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP10L2 |
0.520906244246288 |
|
13716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf123 |
0.520906244246288 |
|
13717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR31 |
0.520906244246288 |
|
13718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP10 |
0.520906244246288 |
|
13719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL2 |
0.520906244246288 |
|
13720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC93A |
0.520906244246288 |
|
13721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252536.1 |
0.521016477834104 |
|
13722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFAP2C |
0.521016477834104 |
|
13723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL170P |
0.521016477834104 |
|
13724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN2 |
0.52109525101961 |
|
13725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCDBP |
0.521110299044974 |
|
13726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPX |
0.521110299044974 |
|
13727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM188B |
0.521143684621025 |
|
13728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP1 |
0.521143684621025 |
|
13729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP263 |
0.521345025448837 |
|
13730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF37 |
0.521362393339097 |
|
13731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC30A |
0.52155079551538 |
|
13732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM126B |
0.521851456105835 |
|
13733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR41 |
0.52196351007125 |
|
13734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTP |
0.52196351007125 |
|
13735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPX2 |
0.521970912241817 |
|
13736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB15 |
0.521970912241817 |
|
13737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD27|ENSG00000251699.1 |
0.522022388008914 |
|
13738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANK2 |
0.522035160652578 |
|
13739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKAIN3 |
0.522061979678502 |
|
13740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD63|ENSG00000251987.1 |
0.522084864831284 |
|
13741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF1L |
0.522198449235942 |
|
13742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCRL5 |
0.522199172721358 |
|
13743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCRL4 |
0.522199172721358 |
|
13744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R14 |
0.522220830419943 |
|
13745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00587 |
0.52222853496211 |
|
13746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAD5 |
0.522295844744909 |
|
13747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRM7 |
0.522378676977036 |
|
13748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf132 |
0.522514671300721 |
|
13749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM100 |
0.522540086370299 |
|
13750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238869.1 |
0.522814160487516 |
|
13751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC168 |
0.522814160487516 |
|
13752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00283 |
0.522814160487516 |
|
13753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX30 |
0.522814160487516 |
|
13754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDELC1 |
0.522814160487516 |
|
13755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ9 |
0.522875421626011 |
|
13756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF8 |
0.522875421626011 |
|
13757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCG2 |
0.522981441256331 |
|
13758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX7A2L |
0.523037615008158 |
|
13759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6ORF50 |
0.523044480329582 |
|
13760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF4B |
0.523044480329582 |
|
13761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM217A |
0.523044480329582 |
|
13762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252668.1 |
0.523044480329582 |
|
13763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf201 |
0.523044480329582 |
|
13764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECI2 |
0.523044480329582 |
|
13765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGPS |
0.52309079181207 |
|
13766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX4 |
0.523177477308643 |
|
13767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL25 |
0.523318316874741 |
|
13768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD96 |
0.52334116129147 |
|
13769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM153A |
0.523413546920633 |
|
13770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO1H |
0.523442522073809 |
|
13771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD10 |
0.523442522073809 |
|
13772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1208 |
0.52350388971911 |
|
13773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL694P |
0.523542001703564 |
|
13774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NETO2 |
0.523546618295313 |
|
13775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF7 |
0.523557110445332 |
|
13776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP23 |
0.523565650619543 |
|
13777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ILK |
0.523572394076893 |
|
13778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF10 |
0.523572394076893 |
|
13779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPP1 |
0.523572394076893 |
|
13780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCHS1 |
0.523572394076893 |
|
13781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA2D4 |
0.523572640580544 |
|
13782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1258 |
0.523675388164025 |
|
13783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPAS2 |
0.523773919808605 |
|
13784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTTN |
0.523798766834821 |
|
13785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KTN1 |
0.523845350033113 |
|
13786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP254 |
0.523890413992737 |
|
13787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX58 |
0.523960277952928 |
|
13788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OOSP1 |
0.524003384917984 |
|
13789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUOX |
0.524026377582868 |
|
13790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD2 |
0.524146137816139 |
|
13791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC31P |
0.524146137816139 |
|
13792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PACS1 |
0.524257864237631 |
|
13793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD75|ENSG00000221300.1 |
0.524262995414329 |
|
13794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP226 |
0.524324547167274 |
|
13795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY5P8 |
0.524394858428722 |
|
13796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR4 |
0.524500321593152 |
|
13797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMC1 |
0.524800002283041 |
|
13798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCK2 |
0.524820869902011 |
|
13799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC102B |
0.524924954484363 |
|
13800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADPRHL1 |
0.524954547643357 |
|
13801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGBL1 |
0.524992426359872 |
|
13802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMM2 |
0.525001260041149 |
|
13803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC30B |
0.525027933840178 |
|
13804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS3 |
0.525039140313736 |
|
13805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WIPF1 |
0.525077108545102 |
|
13806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL825P |
0.52511939236378 |
|
13807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF5B |
0.52511939236378 |
|
13808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR197 |
0.525138383737547 |
|
13809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YY1 |
0.525174749046967 |
|
13810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCO1 |
0.525189893494179 |
|
13811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA32|ENSG00000201384.1 |
0.525299592610082 |
|
13812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATS2L |
0.525354317601609 |
|
13813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL522P |
0.525407667266106 |
|
13814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LITAF |
0.525407667266106 |
|
13815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMTM7 |
0.525450977854388 |
|
13816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM210B |
0.525471920897487 |
|
13817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3A |
0.525501780967722 |
|
13818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf71 |
0.52551031564226 |
|
13819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM7 |
0.52551031564226 |
|
13820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFBI |
0.525573502488604 |
|
13821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYI |
0.525780043088487 |
|
13822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRF |
0.525780043088487 |
|
13823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R9A |
0.525870238035783 |
|
13824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PXK |
0.525975626255467 |
|
13825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00453 |
0.526004666656996 |
|
13826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00452 |
0.526004666656996 |
|
13827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00565 |
0.526004666656996 |
|
13828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOC3 |
0.526029610986339 |
|
13829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOA1 |
0.526029610986339 |
|
13830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD8BP |
0.526266833945523 |
|
13831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2G1P |
0.526283968632648 |
|
13832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNF1B |
0.526332423008022 |
|
13833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA43|ENSG00000202216.1 |
0.526459881504177 |
|
13834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4446 |
0.526497304398833 |
|
13835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOA4 |
0.526536066340435 |
|
13836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf186 |
0.526536575274182 |
|
13837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR10 |
0.526568263427887 |
|
13838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLGN2 |
0.526586015846455 |
|
13839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPEM1 |
0.526586015846455 |
|
13840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf74 |
0.526586015846455 |
|
13841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHL2 |
0.526688682962111 |
|
13842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A5 |
0.526740201295003 |
|
13843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A1 |
0.526740201295003 |
|
13844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMTM6 |
0.526756781263608 |
|
13845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548Q |
0.526764687377594 |
|
13846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDFIP1 |
0.526795139981493 |
|
13847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000212587.1 |
0.526851784047979 |
|
13848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC123 |
0.526882240505864 |
|
13849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSL1 |
0.526891996239926 |
|
13850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HELT |
0.526891996239926 |
|
13851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1430 |
0.526891996239926 |
|
13852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP2BP |
0.526891996239926 |
|
13853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3945 |
0.526891996239926 |
|
13854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4455 |
0.526891996239926 |
|
13855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A4 |
0.526891996239926 |
|
13856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX25 |
0.526891996239926 |
|
13857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM186 |
0.527034985952419 |
|
13858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL45 |
0.527164213291629 |
|
13859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR179 |
0.527164213291629 |
|
13860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOCS7 |
0.527164213291629 |
|
13861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL458P |
0.527164213291629 |
|
13862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238537.1 |
0.527237237639721 |
|
13863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PP13004 |
0.527287483195977 |
|
13864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL867P |
0.527323233215801 |
|
13865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL11P |
0.527358046192484 |
|
13866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEPR |
0.52744600464719 |
|
13867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF38 |
0.527473303640041 |
|
13868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A35 |
0.527502018954322 |
|
13869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEURL1B |
0.527524337073037 |
|
13870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5003 |
0.527524337073037 |
|
13871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NNMT |
0.527543079815725 |
|
13872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf54 |
0.527660211200006 |
|
13873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLU7 |
0.527660211200006 |
|
13874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTTG1 |
0.527660211200006 |
|
13875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR146A |
0.527660211200006 |
|
13876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3142 |
0.527660211200006 |
|
13877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESCO1 |
0.527726965169403 |
|
13878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL2 |
0.52786030544166 |
|
13879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP128 |
0.52786030544166 |
|
13880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLASP2 |
0.52786030544166 |
|
13881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEBL |
0.527948540803375 |
|
13882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSEN2 |
0.528020367354737 |
|
13883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP123 |
0.528020367354737 |
|
13884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf83 |
0.528020367354737 |
|
13885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKRN2 |
0.528020367354737 |
|
13886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA1 |
0.528111867501097 |
|
13887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGAT5 |
0.528123213176998 |
|
13888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPA2 |
0.528186267533151 |
|
13889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL375P |
0.528233025339763 |
|
13890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AOX2P |
0.528243768761452 |
|
13891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf50 |
0.528244508991252 |
|
13892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00324 |
0.528394419233806 |
|
13893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTC1 |
0.528394419233806 |
|
13894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGM |
0.528468856244695 |
|
13895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP12 |
0.528542617798211 |
|
13896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF18B |
0.528615078086935 |
|
13897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTM1 |
0.52870358529879 |
|
13898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTM2 |
0.52870358529879 |
|
13899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTM4 |
0.52870358529879 |
|
13900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC2A |
0.528705193818058 |
|
13901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC12A |
0.528705193818058 |
|
13902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC1B |
0.528705193818058 |
|
13903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC12B |
0.528705193818058 |
|
13904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC9A |
0.528705193818058 |
|
13905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC1A |
0.528705193818058 |
|
13906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP161 |
0.528705193818058 |
|
13907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC7A |
0.528705193818058 |
|
13908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLR1 |
0.528705193818058 |
|
13909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM52B |
0.528705193818058 |
|
13910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABARAPL1 |
0.528705193818058 |
|
13911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPP1 |
0.528756203121452 |
|
13912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB16 |
0.528805352590219 |
|
13913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB1 |
0.528892332880609 |
|
13914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD55 |
0.528954741239839 |
|
13915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7G1 |
0.529034380526516 |
|
13916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7G3 |
0.529034380526516 |
|
13917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENO1 |
0.529108405399148 |
|
13918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAL3ST3 |
0.529116294328509 |
|
13919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3B2 |
0.529116294328509 |
|
13920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238752.1 |
0.529116294328509 |
|
13921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00208 |
0.529185060073065 |
|
13922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL849P |
0.529231091276902 |
|
13923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LURAP1L |
0.529231091276902 |
|
13924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDL1 |
0.529274943726575 |
|
13925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR49 |
0.529294704505514 |
|
13926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD10 |
0.529294704505514 |
|
13927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINI1 |
0.529294704505514 |
|
13928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXPE1 |
0.529526630187828 |
|
13929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238724.1 |
0.529526630187828 |
|
13930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXPE4 |
0.529526630187828 |
|
13931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXR1 |
0.529557883703657 |
|
13932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf40 |
0.529655090284597 |
|
13933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAL2 |
0.529724939749384 |
|
13934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD96B |
0.529775986082712 |
|
13935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASXL3 |
0.529780185295705 |
|
13936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PWWP2A |
0.529827092146547 |
|
13937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP6 |
0.529827092146547 |
|
13938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF2 |
0.529827092146547 |
|
13939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00555 |
0.529889310238521 |
|
13940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPP2 |
0.529889310238521 |
|
13941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL21C |
0.529889310238521 |
|
13942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC85C |
0.529957888381365 |
|
13943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM2 |
0.530008968106084 |
|
13944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHLHE23 |
0.530016882592218 |
|
13945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00029 |
0.530016882592218 |
|
13946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAR1A |
0.530016882592218 |
|
13947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAR1B |
0.530016882592218 |
|
13948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YTHDF1 |
0.530016882592218 |
|
13949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST14 |
0.530263960714386 |
|
13950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM159B |
0.530320757393281 |
|
13951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM10 |
0.530329065828887 |
|
13952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPFIA1 |
0.530337072095438 |
|
13953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQR |
0.530386059610805 |
|
13954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF770 |
0.530386059610805 |
|
13955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf25 |
0.530493055818311 |
|
13956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF22 |
0.530493055818311 |
|
13957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP3CB |
0.530527356595284 |
|
13958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P4HA1 |
0.530698695266723 |
|
13959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UXS1 |
0.530740035327669 |
|
13960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNY |
0.530740631987086 |
|
13961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP5J |
0.530744630260747 |
|
13962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POC1A |
0.530805361026499 |
|
13963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF214 |
0.530862722835404 |
|
13964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP14 |
0.530862722835404 |
|
13965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBMXL2 |
0.530862722835404 |
|
13966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD1 |
0.530996774248006 |
|
13967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOD1 |
0.530997792021396 |
|
13968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238834.1 |
0.531010020921099 |
|
13969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXB2 |
0.531107904471903 |
|
13970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTERFD2 |
0.531118495595092 |
|
13971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTD1 |
0.531127109526218 |
|
13972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD6 |
0.531148914890977 |
|
13973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPH6 |
0.531213973952147 |
|
13974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P10 |
0.531269637888013 |
|
13975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF130 |
0.531282718426025 |
|
13976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL795P |
0.531312833123192 |
|
13977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP52 |
0.531351563822841 |
|
13978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM164 |
0.531394753455405 |
|
13979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM111B |
0.53141595699796 |
|
13980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3942 |
0.531427046862304 |
|
13981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT7B |
0.531552175409421 |
|
13982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP1B |
0.531561039958697 |
|
13983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4803 |
0.531561039958697 |
|
13984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMO4 |
0.531641794338632 |
|
13985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P28 |
0.531658160763664 |
|
13986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00434 |
0.531658160763664 |
|
13987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB8 |
0.531679519273418 |
|
13988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGO4 |
0.53173403635976 |
|
13989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GH1 |
0.531761829906259 |
|
13990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD79B |
0.531761829906259 |
|
13991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN4A |
0.531761829906259 |
|
13992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPY19L1 |
0.531824054419064 |
|
13993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM8 |
0.531861926597451 |
|
13994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPF2 |
0.531867792671977 |
|
13995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL20 |
0.531890014047614 |
|
13996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMN1 |
0.531890014047614 |
|
13997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THEMIS2 |
0.531894625995081 |
|
13998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239130.1 |
0.5319419280716 |
|
13999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCCA |
0.532104999251755 |
|
14000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD6 |
0.532111142348991 |
|
14001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOX2 |
0.532111142348991 |
|
14002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM107A |
0.532111142348991 |
|
14003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR29B2 |
0.532138654217372 |
|
14004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR29C |
0.532138654217372 |
|
14005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL16 |
0.532144950419944 |
|
14006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR141 |
0.5322442459944 |
|
14007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF220 |
0.532297055584913 |
|
14008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF9 |
0.532328563509894 |
|
14009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMTOR4 |
0.532340018611464 |
|
14010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf43 |
0.532340018611464 |
|
14011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAL3ST4 |
0.532340018611464 |
|
14012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4658 |
0.532340018611464 |
|
14013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPC2 |
0.532340018611464 |
|
14014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOGL |
0.532596982461587 |
|
14015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB22A |
0.532845741590374 |
|
14016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATA3 |
0.532925565032855 |
|
14017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPTN |
0.533017861318732 |
|
14018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A12 |
0.533029626522043 |
|
14019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A2 |
0.533029626522043 |
|
14020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDHB |
0.533067269135969 |
|
14021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP22 |
0.533199627907393 |
|
14022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL541P |
0.533222682090998 |
|
14023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JPH1 |
0.533441505407443 |
|
14024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH1A1 |
0.533459940209461 |
|
14025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGN2P46 |
0.533549849478077 |
|
14026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR72 |
0.53358006427691 |
|
14027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPNPEP1 |
0.53363036917169 |
|
14028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS7 |
0.533681523147623 |
|
14029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAMPT |
0.533784132747295 |
|
14030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUB |
0.533930969908515 |
|
14031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM214A |
0.533951093502716 |
|
14032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD3 |
0.533968308362112 |
|
14033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP31 |
0.533968308362112 |
|
14034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00378 |
0.533968308362112 |
|
14035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4689 |
0.53403112033019 |
|
14036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPHP4 |
0.53403112033019 |
|
14037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP200 |
0.534049373904124 |
|
14038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70G |
0.534096314888488 |
|
14039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K14 |
0.534219548192306 |
|
14040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP443 |
0.534219548192306 |
|
14041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFAM |
0.534417086999863 |
|
14042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U4|ENSG00000272160.1 |
0.534418151307936 |
|
14043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTAR1 |
0.534426152104121 |
|
14044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf72 |
0.534471958214371 |
|
14045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ICAM2 |
0.534471958214371 |
|
14046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDHD1 |
0.534484090706327 |
|
14047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEF2A |
0.534491577112421 |
|
14048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKP2 |
0.534704269728878 |
|
14049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGMO |
0.534729693429113 |
|
14050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A5 |
0.534786503318908 |
|
14051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2A25 |
0.534786503318908 |
|
14052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEAN1 |
0.535017782508973 |
|
14053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO16 |
0.535084722303911 |
|
14054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT9B |
0.535186346138724 |
|
14055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2D1 |
0.535208726041973 |
|
14056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2B4 |
0.535259949103559 |
|
14057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BICC1 |
0.535303155658989 |
|
14058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP196 |
0.535303155658989 |
|
14059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRGAP2 |
0.535491503776215 |
|
14060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL783P |
0.535538014510642 |
|
14061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMS2P3 |
0.535703954866012 |
|
14062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG1 |
0.53581189108119 |
|
14063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86A |
0.53581189108119 |
|
14064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP30 |
0.535891893389087 |
|
14065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP372 |
0.535891893389087 |
|
14066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALKBH2 |
0.535891893389087 |
|
14067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNG |
0.535891893389087 |
|
14068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACACB |
0.535891893389087 |
|
14069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELMOD1 |
0.535943015881038 |
|
14070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2A1 |
0.536039484581934 |
|
14071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT2A2 |
0.536039484581934 |
|
14072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF8 |
0.536173089499869 |
|
14073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATM |
0.53622209122119 |
|
14074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP153 |
0.536256802990556 |
|
14075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf72 |
0.536430400509659 |
|
14076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARHSP1 |
0.536430400509659 |
|
14077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP7 |
0.536430400509659 |
|
14078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE7A |
0.536569066898824 |
|
14079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRIN3 |
0.536651794996877 |
|
14080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNFT1 |
0.536680721894327 |
|
14081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEATR6 |
0.536680721894327 |
|
14082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4737 |
0.536680721894327 |
|
14083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1266 |
0.537010604824091 |
|
14084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A6 |
0.537035840497527 |
|
14085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE1 |
0.537123749487352 |
|
14086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD34 |
0.537136278625899 |
|
14087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4500 |
0.537176491045056 |
|
14088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLITRK5 |
0.537176491045056 |
|
14089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDM2 |
0.537198232232137 |
|
14090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIRREL |
0.537202343674371 |
|
14091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7E94P |
0.53728507151273 |
|
14092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF1C |
0.537312874552018 |
|
14093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT81 |
0.537325334513608 |
|
14094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT83 |
0.537325334513608 |
|
14095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT84 |
0.537325334513608 |
|
14096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT85 |
0.537325334513608 |
|
14097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2L10 |
0.537375246154669 |
|
14098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGFRN |
0.537390400506738 |
|
14099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYLK4 |
0.537463028888415 |
|
14100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIPL1 |
0.537474830753312 |
|
14101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNKS |
0.537520460595471 |
|
14102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX8 |
0.537523339867795 |
|
14103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT2 |
0.537595049976797 |
|
14104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAK2 |
0.537621737882707 |
|
14105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC1 |
0.537698645234425 |
|
14106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT9 |
0.537829503459511 |
|
14107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42BPB |
0.537885229748365 |
|
14108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL3 |
0.537907985011745 |
|
14109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP44 |
0.53799073959626 |
|
14110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOCS6 |
0.538103326648937 |
|
14111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUMB |
0.538105602549405 |
|
14112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNMB4 |
0.538158268332159 |
|
14113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IP6K2 |
0.538175089954961 |
|
14114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHB |
0.538322692461744 |
|
14115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPM |
0.538347016769039 |
|
14116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHLDB2 |
0.538382700230336 |
|
14117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD10 |
0.538382700230336 |
|
14118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAGLN3 |
0.538382700230336 |
|
14119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS7 |
0.538382700230336 |
|
14120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GP1BA |
0.53843308829859 |
|
14121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A11 |
0.53843308829859 |
|
14122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF167 |
0.53843308829859 |
|
14123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENO3 |
0.53843308829859 |
|
14124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFN1 |
0.53843308829859 |
|
14125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG7 |
0.53843308829859 |
|
14126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMTA2 |
0.53843308829859 |
|
14127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A7P |
0.538439264320591 |
|
14128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HECTD4 |
0.5384988765186 |
|
14129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYPN |
0.538507010617041 |
|
14130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2681 |
0.538529911236813 |
|
14131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4500HG |
0.538564577408261 |
|
14132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP8B4 |
0.538631390392262 |
|
14133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA6 |
0.538638572185106 |
|
14134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL171P |
0.538709623341936 |
|
14135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL784P |
0.538709623341936 |
|
14136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QL1 |
0.53871102400591 |
|
14137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SATB1 |
0.538719286530248 |
|
14138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf43 |
0.538753247281381 |
|
14139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORD |
0.538753247281381 |
|
14140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUOX2 |
0.538753247281381 |
|
14141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238892.1 |
0.538842250575544 |
|
14142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUOXA2 |
0.538867573387644 |
|
14143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCBD2 |
0.539040964529018 |
|
14144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CATSPER3 |
0.539040964529018 |
|
14145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITX1 |
0.539040964529018 |
|
14146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239065.1 |
0.539058927588286 |
|
14147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00599 |
0.539058927588286 |
|
14148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238496.1 |
0.539058927588286 |
|
14149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNB5 |
0.539094500319918 |
|
14150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC34A1 |
0.539100478013733 |
|
14151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F12 |
0.539100478013733 |
|
14152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRK6 |
0.539100478013733 |
|
14153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFN3 |
0.539100478013733 |
|
14154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCUBE2 |
0.539125921705054 |
|
14155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL344P |
0.539143200789639 |
|
14156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
T |
0.539170492582025 |
|
14157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00959 |
0.539181234305598 |
|
14158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR567 |
0.539277203267434 |
|
14159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VGLL3 |
0.539359649505233 |
|
14160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCMA |
0.539393405857639 |
|
14161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKS6 |
0.53942038530638 |
|
14162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P5 |
0.539465040383077 |
|
14163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P31 |
0.539465040383077 |
|
14164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3169 |
0.539465040383077 |
|
14165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR3 |
0.53957174948906 |
|
14166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFK |
0.539585017634041 |
|
14167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00473 |
0.539585281459678 |
|
14168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD45|ENSG00000231297.2 |
0.539585281459678 |
|
14169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1A1 |
0.539679679991795 |
|
14170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM76A |
0.539709956753436 |
|
14171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4675 |
0.539720342615298 |
|
14172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL2RA |
0.539736614947641 |
|
14173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT61A |
0.53974686908527 |
|
14174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAG5 |
0.53974686908527 |
|
14175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOPT1 |
0.53974686908527 |
|
14176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSMCE2 |
0.539822509170795 |
|
14177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYDC1 |
0.539898227397142 |
|
14178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM72 |
0.539898227397142 |
|
14179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCA2 |
0.540020618939874 |
|
14180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC52 |
0.540043068930105 |
|
14181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOJ |
0.540094814862082 |
|
14182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA59|ENSG00000252000.1 |
0.540117461308338 |
|
14183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK1A1 |
0.540121125736803 |
|
14184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4795 |
0.540121764136707 |
|
14185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUNDC3B |
0.540207580000228 |
|
14186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC52A1 |
0.540338393435315 |
|
14187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MNDA |
0.540348409464353 |
|
14188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUL4A |
0.540429223465338 |
|
14189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMP1 |
0.540429223465338 |
|
14190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRTP1 |
0.540429223465338 |
|
14191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX11 |
0.540550006653284 |
|
14192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238661.1 |
0.540550006653284 |
|
14193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf195 |
0.540571179223178 |
|
14194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPKAPK2 |
0.540606542799148 |
|
14195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL19 |
0.540606542799148 |
|
14196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL20 |
0.540606542799148 |
|
14197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR340 |
0.540738180959129 |
|
14198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCF2L |
0.540816028068894 |
|
14199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROZ |
0.540816028068894 |
|
14200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUOXA1 |
0.541072121288116 |
|
14201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEGF11 |
0.54109361072246 |
|
14202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3976 |
0.541103568974187 |
|
14203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM200C |
0.541103568974187 |
|
14204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB3 |
0.541127452089967 |
|
14205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNTA |
0.541158309081124 |
|
14206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252853.1 |
0.541209445151438 |
|
14207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP10 |
0.541247297575881 |
|
14208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF81 |
0.541395872895125 |
|
14209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW11 |
0.541399460927807 |
|
14210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB9 |
0.541399460927807 |
|
14211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK10 |
0.541399460927807 |
|
14212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00676 |
0.541540041166692 |
|
14213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRS2 |
0.541540041166692 |
|
14214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEGS2 |
0.541743592604196 |
|
14215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KNDC1 |
0.541879184759041 |
|
14216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTF1 |
0.541879184759041 |
|
14217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VENTX |
0.541879184759041 |
|
14218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR202 |
0.541879184759041 |
|
14219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM8 |
0.541879184759041 |
|
14220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBGCP2 |
0.541879184759041 |
|
14221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF511 |
0.541879184759041 |
|
14222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALY |
0.541879184759041 |
|
14223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAP1 |
0.541879184759041 |
|
14224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUOM |
0.541879184759041 |
|
14225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECHS1 |
0.541879184759041 |
|
14226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3944 |
0.541879184759041 |
|
14227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAOX |
0.541879184759041 |
|
14228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTG1 |
0.541879184759041 |
|
14229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2E1 |
0.541879184759041 |
|
14230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRG2B |
0.541879184759041 |
|
14231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRN |
0.541879184759041 |
|
14232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCE1 |
0.541879184759041 |
|
14233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AUTS2 |
0.541913112314009 |
|
14234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239128.1 |
0.542138415587637 |
|
14235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYRK3 |
0.542138642741414 |
|
14236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL633P |
0.542275712520139 |
|
14237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCTP |
0.542306662477139 |
|
14238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCK2 |
0.542459485378487 |
|
14239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4704 |
0.542581326671478 |
|
14240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SVOP |
0.542605898497073 |
|
14241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPT1 |
0.542690213296996 |
|
14242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RLF |
0.542690213296996 |
|
14243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCO2 |
0.542690213296996 |
|
14244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNE |
0.542731594986516 |
|
14245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf107 |
0.542731594986516 |
|
14246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF527 |
0.542735065794041 |
|
14247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALR1 |
0.542797947432269 |
|
14248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2D |
0.542871025515902 |
|
14249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYRP1 |
0.54288213674837 |
|
14250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000252049.1 |
0.542893558536901 |
|
14251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTF1A |
0.542893558536901 |
|
14252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPNA2 |
0.542909032921943 |
|
14253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRIP3 |
0.543030411732653 |
|
14254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEPROT |
0.543054761777681 |
|
14255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLAMF1 |
0.543142868290027 |
|
14256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD48 |
0.543142868290027 |
|
14257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLAMF7 |
0.543142868290027 |
|
14258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBF3 |
0.543177881699529 |
|
14259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000199727.1 |
0.543202108651105 |
|
14260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13A1 |
0.543303309415428 |
|
14261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC24A |
0.543311910517239 |
|
14262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP227 |
0.543319247806207 |
|
14263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMLG |
0.543319718192035 |
|
14264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A23 |
0.543336718095711 |
|
14265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAC1L |
0.543344961418325 |
|
14266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A3 |
0.543344961418325 |
|
14267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A2 |
0.543344961418325 |
|
14268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP3 |
0.543365567616898 |
|
14269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10T2 |
0.54339554987504 |
|
14270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACO1 |
0.543456738183858 |
|
14271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYLK3 |
0.543466362275143 |
|
14272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB3IP |
0.543489948689367 |
|
14273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYRFL |
0.543489948689367 |
|
14274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP271 |
0.543697328896416 |
|
14275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf98 |
0.543881210228718 |
|
14276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYCARD |
0.543881210228718 |
|
14277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIF |
0.543897799000975 |
|
14278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC24 |
0.543897799000975 |
|
14279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNG |
0.544008283599254 |
|
14280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A41 |
0.544029343940266 |
|
14281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4480 |
0.544175165763109 |
|
14282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM126A |
0.544178893504203 |
|
14283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF4 |
0.544270700099096 |
|
14284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL165P |
0.544325001195601 |
|
14285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC18 |
0.544325001195601 |
|
14286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSTF2T |
0.544459616507813 |
|
14287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC8 |
0.544460442262926 |
|
14288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4523 |
0.544473940920674 |
|
14289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT18 |
0.544604009009155 |
|
14290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMC2 |
0.5446741649794 |
|
14291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLGRKT |
0.544741982864027 |
|
14292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELK |
0.544817761418423 |
|
14293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLYATL1 |
0.54488325497133 |
|
14294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXXC5 |
0.544927034811602 |
|
14295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6K2 |
0.54501019955886 |
|
14296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6K3 |
0.54501019955886 |
|
14297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIP1 |
0.545084670154131 |
|
14298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JHDM1D |
0.545133016037418 |
|
14299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APBA1 |
0.545270450861973 |
|
14300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPACA7 |
0.545306899174939 |
|
14301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00411 |
0.545309325624227 |
|
14302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAR4 |
0.545333426347808 |
|
14303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNA4 |
0.545375707433308 |
|
14304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALKBH8 |
0.545388641851975 |
|
14305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMA5 |
0.545443773130277 |
|
14306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00355 |
0.54552567438418 |
|
14307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP11A |
0.545682781491573 |
|
14308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA7 |
0.545682781491573 |
|
14309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8K |
0.545682781491573 |
|
14310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8N |
0.545682781491573 |
|
14311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8O |
0.545682781491573 |
|
14312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL185P |
0.545682781491573 |
|
14313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL286P |
0.545682781491573 |
|
14314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL539P |
0.545682781491573 |
|
14315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA18|ENSG00000206849.1 |
0.545682781491573 |
|
14316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000206987.1 |
0.545682781491573 |
|
14317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULK4P1 |
0.545682781491573 |
|
14318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRP1 |
0.545756794565023 |
|
14319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5691 |
0.545782867482695 |
|
14320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR302E |
0.545797873217011 |
|
14321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMKLR1 |
0.545923004094975 |
|
14322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP12 |
0.545931714237923 |
|
14323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD3 |
0.545978633973062 |
|
14324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNAB3 |
0.545978633973062 |
|
14325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTROB |
0.545978633973062 |
|
14326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC1 |
0.545978633973062 |
|
14327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEFV |
0.54598445669637 |
|
14328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM125 |
0.546079034300246 |
|
14329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf210 |
0.546079034300246 |
|
14330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIE1 |
0.546079034300246 |
|
14331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPL |
0.546079034300246 |
|
14332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC20 |
0.546079034300246 |
|
14333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELOVL1 |
0.546079034300246 |
|
14334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED8 |
0.546079034300246 |
|
14335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238801.1 |
0.5461012071814 |
|
14336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPOPL |
0.546119056267005 |
|
14337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHYH |
0.546126856123362 |
|
14338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPHS1 |
0.546126856123362 |
|
14339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK2 |
0.546193826143798 |
|
14340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CATSPERD |
0.546296344358301 |
|
14341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF17 |
0.546361130368574 |
|
14342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCA2 |
0.546427928883337 |
|
14343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCA1 |
0.546427928883337 |
|
14344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MATR3 |
0.54657403384862 |
|
14345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD1A |
0.546597020182363 |
|
14346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD1C |
0.546597020182363 |
|
14347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERN1 |
0.546663498518285 |
|
14348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TATDN2 |
0.546762017792609 |
|
14349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFN |
0.546818902836759 |
|
14350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPN2 |
0.546818902836759 |
|
14351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPATCH3 |
0.546818902836759 |
|
14352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLAMF8 |
0.546883054876147 |
|
14353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf204 |
0.546883054876147 |
|
14354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD64|ENSG00000212161.1 |
0.546883054876147 |
|
14355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSIG8 |
0.546883054876147 |
|
14356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC19 |
0.546883054876147 |
|
14357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAGLN2 |
0.546883054876147 |
|
14358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTBP1 |
0.547000471815659 |
|
14359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238582.1 |
0.54700102384636 |
|
14360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYGEP |
0.54700102384636 |
|
14361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6K6 |
0.547033042792448 |
|
14362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf27A |
0.547095985515546 |
|
14363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf27B |
0.547095985515546 |
|
14364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL701P |
0.547095985515546 |
|
14365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIX6 |
0.547111124278636 |
|
14366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf82 |
0.547326248902855 |
|
14367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXPH2 |
0.547334177321519 |
|
14368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238807.1 |
0.547441866857823 |
|
14369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UST |
0.547483036012214 |
|
14370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf172 |
0.547540258905288 |
|
14371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRNP1 |
0.547540258905288 |
|
14372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM46B |
0.547540258905288 |
|
14373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf45 |
0.547595231122378 |
|
14374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D9B |
0.547595231122378 |
|
14375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4D6 |
0.547759866162093 |
|
14376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL36A |
0.547772600066833 |
|
14377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLX3 |
0.547848420731929 |
|
14378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL339P |
0.547848420731929 |
|
14379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000206909.1 |
0.547848420731929 |
|
14380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3671 |
0.547849558567138 |
|
14381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM24 |
0.548020723007693 |
|
14382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239123.1 |
0.548020723007693 |
|
14383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf70 |
0.548045788292209 |
|
14384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1207 |
0.548067955655002 |
|
14385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF9 |
0.548094580987364 |
|
14386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLAMF9 |
0.548094580987364 |
|
14387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPON2 |
0.54815119697957 |
|
14388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM7SF3 |
0.548159180799671 |
|
14389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED21 |
0.548159180799671 |
|
14390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf71 |
0.548159180799671 |
|
14391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LECT2 |
0.548250283145261 |
|
14392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL21 |
0.548250283145261 |
|
14393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX9 |
0.548435478042817 |
|
14394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSMD1 |
0.548453051250927 |
|
14395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA21|ENSG00000252835.1 |
0.548453051250927 |
|
14396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPC5 |
0.548460432230725 |
|
14397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10Z1 |
0.5485001067976 |
|
14398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTA1 |
0.5485001067976 |
|
14399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP286 |
0.548612958852953 |
|
14400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL4A1 |
0.548671240443667 |
|
14401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCOLN1 |
0.548768994075154 |
|
14402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPLA6 |
0.548768994075154 |
|
14403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNRC6A |
0.548848645070324 |
|
14404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1269B |
0.548865604413447 |
|
14405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC73 |
0.548899587844769 |
|
14406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2Z1 |
0.548953026181559 |
|
14407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBTD2 |
0.548999127363266 |
|
14408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA57|ENSG00000212529.1 |
0.548999127363266 |
|
14409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3PXD2B |
0.548999127363266 |
|
14410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKAP5 |
0.549137119492138 |
|
14411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212445.1 |
0.549257124174419 |
|
14412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSG1 |
0.549340946480067 |
|
14413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5692C1 |
0.549467768979071 |
|
14414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA81|ENSG00000252677.1 |
0.549553096405393 |
|
14415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00856 |
0.549645653078134 |
|
14416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA11P |
0.549701660094255 |
|
14417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5I |
0.549701660094255 |
|
14418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPLX1 |
0.549701660094255 |
|
14419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKQ |
0.549701660094255 |
|
14420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFRL1 |
0.549701660094255 |
|
14421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAK |
0.549701660094255 |
|
14422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDUA |
0.549701660094255 |
|
14423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD7 |
0.549701660094255 |
|
14424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR571 |
0.549701660094255 |
|
14425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL5 |
0.549701660094255 |
|
14426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCGF3 |
0.549701660094255 |
|
14427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE6B |
0.549701660094255 |
|
14428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGG |
0.549701660094255 |
|
14429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL358P |
0.549701660094255 |
|
14430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF212 |
0.549701660094255 |
|
14431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A1 |
0.549701660094255 |
|
14432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM175 |
0.549701660094255 |
|
14433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF141 |
0.549701660094255 |
|
14434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF595 |
0.549701660094255 |
|
14435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF718 |
0.549701660094255 |
|
14436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF721 |
0.549701660094255 |
|
14437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF732 |
0.549701660094255 |
|
14438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF876P |
0.549701660094255 |
|
14439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED11P |
0.549701660094255 |
|
14440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212458.1 |
0.549701660094255 |
|
14441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKBKE |
0.549703097697625 |
|
14442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf147 |
0.549703097697625 |
|
14443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00708 |
0.550038859201475 |
|
14444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTL9 |
0.550047756376902 |
|
14445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM222A |
0.550091746897936 |
|
14446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF17 |
0.550116396204053 |
|
14447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RELT |
0.550116396204053 |
|
14448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP11A |
0.550273260824197 |
|
14449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSRNP1 |
0.550320265243471 |
|
14450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F7 |
0.550488161115268 |
|
14451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F10 |
0.550488161115268 |
|
14452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCID2 |
0.550553455815152 |
|
14453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT7A |
0.550572938638329 |
|
14454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCRC1 |
0.550761832941311 |
|
14455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPO |
0.550784356784426 |
|
14456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL405P |
0.550991769601779 |
|
14457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL671P |
0.551015422717 |
|
14458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR123 |
0.55101946928941 |
|
14459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOBTB1 |
0.551039350954812 |
|
14460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP337 |
0.551250026124802 |
|
14461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA73|ENSG00000199977.1 |
0.55125238159111 |
|
14462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERS4 |
0.551259311114383 |
|
14463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf43 |
0.551366202684302 |
|
14464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK1 |
0.551429032115526 |
|
14465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RESP18 |
0.551688138508382 |
|
14466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNJL |
0.551826570289433 |
|
14467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL295P |
0.551826570289433 |
|
14468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAVER2 |
0.551945442751218 |
|
14469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD70 |
0.551946479987131 |
|
14470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF5 |
0.552067010069401 |
|
14471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf22 |
0.552074669126655 |
|
14472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGGT2 |
0.552323705456771 |
|
14473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf118 |
0.55234051950184 |
|
14474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR422A |
0.552345657675849 |
|
14475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPDZ |
0.552379680990085 |
|
14476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A11P |
0.552457135580037 |
|
14477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD30BP2 |
0.552457135580037 |
|
14478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAGE2 |
0.552457135580037 |
|
14479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F29P |
0.552457135580037 |
|
14480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3648 |
0.552457135580037 |
|
14481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3687 |
0.552457135580037 |
|
14482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTED |
0.552457135580037 |
|
14483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL52P |
0.552457135580037 |
|
14484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252199.1 |
0.552457135580037 |
|
14485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEKT4P2 |
0.552457135580037 |
|
14486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPTE |
0.552457135580037 |
|
14487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS9 |
0.552539244205453 |
|
14488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHROOM4 |
0.552600299866141 |
|
14489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS7BP |
0.552614273470058 |
|
14490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4D10 |
0.552755791110016 |
|
14491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC5 |
0.552756153543291 |
|
14492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf53 |
0.552756153543291 |
|
14493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF28 |
0.552783742735949 |
|
14494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC115 |
0.552906893752975 |
|
14495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC74B |
0.552906893752975 |
|
14496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F43P |
0.552906893752975 |
|
14497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMP4 |
0.552906893752975 |
|
14498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MZT2B |
0.552906893752975 |
|
14499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEF |
0.552906893752975 |
|
14500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN18 |
0.552906893752975 |
|
14501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMPD4 |
0.552906893752975 |
|
14502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA3E |
0.552906893752975 |
|
14503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD8 |
0.552925810085402 |
|
14504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL204P |
0.552951593637546 |
|
14505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKK1 |
0.553031545887574 |
|
14506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP12 |
0.553106203340241 |
|
14507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF7 |
0.553120435942502 |
|
14508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A51 |
0.553134107030134 |
|
14509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF26 |
0.553148078579558 |
|
14510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX36 |
0.553148078579558 |
|
14511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000271922.1 |
0.553148078579558 |
|
14512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR149 |
0.553148078579558 |
|
14513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU1F1 |
0.55334468882856 |
|
14514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPTX2 |
0.553363928581974 |
|
14515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBEC4 |
0.55343982413187 |
|
14516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF594 |
0.553493640681519 |
|
14517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH10 |
0.553505780764256 |
|
14518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P1 |
0.553608603726961 |
|
14519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP46 |
0.553638102650169 |
|
14520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDIM1 |
0.553667369264843 |
|
14521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPKC |
0.553704260064155 |
|
14522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPARG |
0.553766454313326 |
|
14523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5C1B |
0.553778155608746 |
|
14524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDH14 |
0.553778155608746 |
|
14525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD1D |
0.553885046866012 |
|
14526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PER1 |
0.553939517446531 |
|
14527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAMP2 |
0.553939517446531 |
|
14528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RLTPR |
0.553976302082532 |
|
14529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACD |
0.553976302082532 |
|
14530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf86 |
0.553976302082532 |
|
14531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENKD1 |
0.553976302082532 |
|
14532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARD6A |
0.553976302082532 |
|
14533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF304 |
0.554021361817228 |
|
14534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC39B |
0.554049195566455 |
|
14535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4D11 |
0.554065999309175 |
|
14536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YEATS4 |
0.554207319215597 |
|
14537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL804P |
0.554207319215597 |
|
14538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNTB |
0.554217675019097 |
|
14539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAX |
0.554217675019097 |
|
14540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4706 |
0.554217675019097 |
|
14541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEUROD6 |
0.55423273691355 |
|
14542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL6 |
0.554240876990203 |
|
14543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL10 |
0.554345421281267 |
|
14544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF232 |
0.554378065674394 |
|
14545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM167A |
0.55443468180101 |
|
14546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORBS2 |
0.55448473805349 |
|
14547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf135 |
0.554485205976762 |
|
14548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4999 |
0.554517068863395 |
|
14549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB11B |
0.554517068863395 |
|
14550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCRL1 |
0.554517222269882 |
|
14551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD5L |
0.554517222269882 |
|
14552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf64 |
0.554653717269429 |
|
14553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP262 |
0.554857311157883 |
|
14554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXN |
0.554875670587591 |
|
14555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMC1B |
0.554906814801324 |
|
14556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM7 |
0.554921059128095 |
|
14557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGSL1 |
0.554935782440419 |
|
14558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA6L |
0.554996971362676 |
|
14559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD6 |
0.555026988188355 |
|
14560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP276 |
0.555203319919116 |
|
14561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP2B |
0.555269837969252 |
|
14562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A1 |
0.555283586011682 |
|
14563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PM20D1 |
0.555479680589278 |
|
14564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP1 |
0.555486226003471 |
|
14565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP3 |
0.555486226003471 |
|
14566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLOC1S6 |
0.555514651072306 |
|
14567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYZ |
0.555528817681561 |
|
14568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCRTR1 |
0.555546641514683 |
|
14569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEF1 |
0.555546641514683 |
|
14570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL16A1 |
0.555546641514683 |
|
14571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD3 |
0.55559952677661 |
|
14572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS14 |
0.555618006693766 |
|
14573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBATA |
0.555618006693766 |
|
14574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAAO |
0.555659963500557 |
|
14575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL570P |
0.555776094810663 |
|
14576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD39|ENSG00000264997.1 |
0.555791338960401 |
|
14577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG16 |
0.555797348087505 |
|
14578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VMP1 |
0.555811020952837 |
|
14579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP20 |
0.555822083187285 |
|
14580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKINTL |
0.555866433049145 |
|
14581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEB1 |
0.555905002932907 |
|
14582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM70 |
0.555905002932907 |
|
14583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHYHIPL |
0.556035116239521 |
|
14584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00844 |
0.55607353866559 |
|
14585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC3 |
0.556078521656328 |
|
14586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MXD3 |
0.556098713964533 |
|
14587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB24 |
0.556098713964533 |
|
14588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRELID1 |
0.556098713964533 |
|
14589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMTC4 |
0.556149012350624 |
|
14590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STMN4 |
0.556200990655476 |
|
14591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378B |
0.556232325163425 |
|
14592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239129.1 |
0.556431120177563 |
|
14593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNN |
0.556511380046274 |
|
14594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC11 |
0.556511380046274 |
|
14595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD320 |
0.556524714375925 |
|
14596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL354P |
0.556553411389577 |
|
14597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPPL2A |
0.556553411389577 |
|
14598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRG1 |
0.556579987273035 |
|
14599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OIT3 |
0.556627469763469 |
|
14600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G12B |
0.556627469763469 |
|
14601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR6 |
0.556628903319264 |
|
14602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCSER2 |
0.556860134728865 |
|
14603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMBOX1 |
0.556896831234481 |
|
14604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICU1 |
0.55689725235806 |
|
14605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCRL3 |
0.557056474198536 |
|
14606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCRL2 |
0.557056474198536 |
|
14607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRIP2 |
0.557068356113353 |
|
14608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL24 |
0.55712851970918 |
|
14609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB5 |
0.557251761156911 |
|
14610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000253014.1 |
0.557283624621276 |
|
14611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238972.1 |
0.557315172104555 |
|
14612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000252774.1 |
0.557358151553609 |
|
14613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0101 |
0.557358151553609 |
|
14614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIP4 |
0.557358151553609 |
|
14615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL595P |
0.557358151553609 |
|
14616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL707P |
0.557358151553609 |
|
14617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITFG2 |
0.557430042663164 |
|
14618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHF |
0.557689978152999 |
|
14619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11|ENSG00000261709.2 |
0.557689978152999 |
|
14620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC14L5 |
0.557744213844713 |
|
14621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARRB2 |
0.557791721372427 |
|
14622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED11 |
0.557791721372427 |
|
14623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00852 |
0.557795196894839 |
|
14624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GHRLOS |
0.557795196894839 |
|
14625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GHRL |
0.557795196894839 |
|
14626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC13 |
0.557795196894839 |
|
14627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00348 |
0.557884655541581 |
|
14628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX27 |
0.557965448273085 |
|
14629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA24|ENSG00000207130.1 |
0.558048396129698 |
|
14630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB7A |
0.558048396129698 |
|
14631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD37 |
0.558164529422503 |
|
14632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UFSP2 |
0.558164529422503 |
|
14633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf47 |
0.558164529422503 |
|
14634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC110 |
0.558164529422503 |
|
14635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDLIM3 |
0.558164529422503 |
|
14636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOSR2 |
0.558319941279373 |
|
14637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHB1 |
0.558467397332301 |
|
14638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP210 |
0.558529114549839 |
|
14639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf131 |
0.55858572494199 |
|
14640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ00273 |
0.55858572494199 |
|
14641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL338P |
0.55858572494199 |
|
14642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCP |
0.55858572494199 |
|
14643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCG |
0.55858572494199 |
|
14644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGO |
0.55858572494199 |
|
14645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STOML2 |
0.55858572494199 |
|
14646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM214B |
0.55858572494199 |
|
14647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC29 |
0.558642116098465 |
|
14648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM208 |
0.558642116098465 |
|
14649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF4 |
0.558753917262247 |
|
14650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1A2 |
0.558900317165353 |
|
14651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF1B |
0.558915012026503 |
|
14652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1273D |
0.558915012026503 |
|
14653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL731P |
0.558915012026503 |
|
14654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL721P |
0.558915012026503 |
|
14655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYGB |
0.558980971220414 |
|
14656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYGA |
0.558980971220414 |
|
14657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf80 |
0.558980971220414 |
|
14658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPBP1 |
0.558998702576191 |
|
14659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WIBG |
0.559182304041138 |
|
14660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL15RA |
0.559427349151975 |
|
14661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF3 |
0.559481524152453 |
|
14662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP107 |
0.559515751890078 |
|
14663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35E3 |
0.559515751890078 |
|
14664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF239 |
0.559547664668315 |
|
14665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF485 |
0.559547664668315 |
|
14666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAHD1 |
0.559765567833249 |
|
14667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINE1 |
0.559770073888979 |
|
14668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSDMB |
0.559935631709888 |
|
14669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCK2 |
0.559954425765782 |
|
14670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINI2 |
0.560062257360477 |
|
14671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJA2 |
0.560088270527706 |
|
14672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM163 |
0.56021097305165 |
|
14673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA6 |
0.560213839498304 |
|
14674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA13 |
0.560213839498304 |
|
14675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA2 |
0.560213839498304 |
|
14676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA8 |
0.560213839498304 |
|
14677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNA1 |
0.560213839498304 |
|
14678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNE |
0.560213839498304 |
|
14679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR31 |
0.560213839498304 |
|
14680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD39|ENSG00000264379.1 |
0.560213839498304 |
|
14681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A6A |
0.560302134343918 |
|
14682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A4E |
0.560302134343918 |
|
14683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCN2 |
0.560359726433538 |
|
14684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDIA5 |
0.560437631031525 |
|
14685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252537.1 |
0.560466990974183 |
|
14686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLP1 |
0.56046722139469 |
|
14687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC5 |
0.56046722139469 |
|
14688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC2 |
0.560471468186756 |
|
14689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF152 |
0.560509188744792 |
|
14690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMCD1 |
0.560547051737468 |
|
14691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A4 |
0.560601758940522 |
|
14692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YBX2 |
0.560601758940522 |
|
14693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238900.1 |
0.560640179298913 |
|
14694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMOD2 |
0.560724265192273 |
|
14695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASL |
0.560724265192273 |
|
14696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLK |
0.56086893105938 |
|
14697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00838 |
0.560952250387139 |
|
14698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MILR1 |
0.560996918030876 |
|
14699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MASP2 |
0.561015497619995 |
|
14700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIP1 |
0.561065349852914 |
|
14701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL1 |
0.561076353257128 |
|
14702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAG |
0.561121142943927 |
|
14703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYGC |
0.561123120054265 |
|
14704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3M |
0.561144953945049 |
|
14705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDGF1P3 |
0.56116808580039 |
|
14706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNHIT6 |
0.561205522100249 |
|
14707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EZH2 |
0.561230309270957 |
|
14708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYGD |
0.561260503151257 |
|
14709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MROH2A |
0.561320087536454 |
|
14710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP232 |
0.561367829028469 |
|
14711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRIT1 |
0.561413566543592 |
|
14712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGR |
0.561531643152895 |
|
14713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00858 |
0.561531643152895 |
|
14714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL16 |
0.561615860823331 |
|
14715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIF |
0.561615860823331 |
|
14716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCN1 |
0.561615860823331 |
|
14717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BNIP3L |
0.561809297307145 |
|
14718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDAD1P1 |
0.561809297307145 |
|
14719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP57L1 |
0.56187808025875 |
|
14720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRA1A |
0.562083186807189 |
|
14721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA4 |
0.562107954259471 |
|
14722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRIT2 |
0.562117432408508 |
|
14723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRS2 |
0.562135688611945 |
|
14724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP195 |
0.56217139187252 |
|
14725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCND1 |
0.562199438514364 |
|
14726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPGDS |
0.562297141991439 |
|
14727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RXRG |
0.56237113026284 |
|
14728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFTUD2 |
0.562392042637878 |
|
14729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR607 |
0.562396451923877 |
|
14730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238313.1 |
0.562396942718353 |
|
14731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F31P |
0.562444953530101 |
|
14732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4784 |
0.562444953530101 |
|
14733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MZT2A |
0.562444953530101 |
|
14734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEE |
0.562444953530101 |
|
14735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA3D |
0.562444953530101 |
|
14736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC74A |
0.562444953530101 |
|
14737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHM1P |
0.562538090466453 |
|
14738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A48 |
0.562577782094039 |
|
14739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL9 |
0.562577782094039 |
|
14740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB2 |
0.5626477001919 |
|
14741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP86 |
0.562847462322789 |
|
14742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOB |
0.562847462322789 |
|
14743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYDIN |
0.562892197689938 |
|
14744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGFR |
0.562945730267135 |
|
14745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN7L3 |
0.562960126762689 |
|
14746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBTF |
0.562960126762689 |
|
14747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA20|ENSG00000252577.1 |
0.56296693646112 |
|
14748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERRFI1 |
0.563003780069434 |
|
14749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PXN |
0.563009389425032 |
|
14750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBFB |
0.563057495583829 |
|
14751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC4C |
0.563115524734734 |
|
14752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA11 |
0.563153660758343 |
|
14753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCUN1D5 |
0.563179273308528 |
|
14754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPD1P6 |
0.563217902539826 |
|
14755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1J |
0.563315130157963 |
|
14756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM19A3 |
0.563315130157963 |
|
14757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE4B |
0.563353562829315 |
|
14758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLG2 |
0.563487238106807 |
|
14759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KB1 |
0.563495159401041 |
|
14760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP301 |
0.56349549295529 |
|
14761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCU |
0.56350450104929 |
|
14762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO5C |
0.563508079762577 |
|
14763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDFY4 |
0.563509254135365 |
|
14764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT9 |
0.563754197782691 |
|
14765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL8 |
0.563754197782691 |
|
14766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRADD |
0.563754197782691 |
|
14767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSF4 |
0.563754197782691 |
|
14768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL3 |
0.563754197782691 |
|
14769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0895L |
0.563754197782691 |
|
14770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC3L1 |
0.563754197782691 |
|
14771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E2F4 |
0.563754197782691 |
|
14772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELMO3 |
0.563754197782691 |
|
14773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR328 |
0.563754197782691 |
|
14774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf67 |
0.563767406893827 |
|
14775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKE |
0.563767406893827 |
|
14776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGACT |
0.563788033614563 |
|
14777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM72A |
0.564068835403106 |
|
14778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WHSC1 |
0.564075408733106 |
|
14779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAC |
0.564093532468247 |
|
14780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR711 |
0.564121810397903 |
|
14781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TINAGL1 |
0.564168099609518 |
|
14782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP236 |
0.564208881740881 |
|
14783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL806P |
0.564383142562544 |
|
14784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL7A1 |
0.564439184906367 |
|
14785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC9 |
0.564485305063353 |
|
14786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CR1L |
0.56457349806686 |
|
14787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD46 |
0.56457349806686 |
|
14788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ10 |
0.564589187011231 |
|
14789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLFML1 |
0.564649830181919 |
|
14790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL7 |
0.56465948100708 |
|
14791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5D2 |
0.564676174096135 |
|
14792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGF2BP3 |
0.56473273091908 |
|
14793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1A1 |
0.56486300964984 |
|
14794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1A1OS |
0.56486300964984 |
|
14795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL9 |
0.564878285902082 |
|
14796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABAT |
0.565024398691439 |
|
14797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGN |
0.565038417831547 |
|
14798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRED3 |
0.565038417831547 |
|
14799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM60A |
0.565094285967332 |
|
14800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND1B |
0.565159002617356 |
|
14801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf49 |
0.565487471310263 |
|
14802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74|ENSG00000252213.1 |
0.565509222907478 |
|
14803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74A |
0.565509222907478 |
|
14804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYPL1 |
0.56562370255094 |
|
14805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB16 |
0.565687338814137 |
|
14806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMUB2 |
0.565687338814137 |
|
14807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RLN2 |
0.565750941561867 |
|
14808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RLN1 |
0.565750941561867 |
|
14809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD274 |
0.565750941561867 |
|
14810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD1LG2 |
0.565750941561867 |
|
14811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP235 |
0.565877626905906 |
|
14812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT6 |
0.565919626865796 |
|
14813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR766 |
0.565919626865796 |
|
14814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOWAHD |
0.565919626865796 |
|
14815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNED1 |
0.565956867386697 |
|
14816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYRM9 |
0.566020670809859 |
|
14817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTPBP4 |
0.566047238069947 |
|
14818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRBN |
0.566080231859081 |
|
14819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYSTM1 |
0.566142647534289 |
|
14820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGN |
0.56615213453659 |
|
14821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC41A1 |
0.566163254693918 |
|
14822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL31RA |
0.566342621388253 |
|
14823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP8 |
0.566357772888166 |
|
14824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL586P |
0.566442030511899 |
|
14825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTRH2 |
0.566481035712808 |
|
14826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND5B |
0.566505780632858 |
|
14827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS33A |
0.566560915044158 |
|
14828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD116|ENSG00000202498.1 |
0.566591388067026 |
|
14829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEND7 |
0.566711106747338 |
|
14830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF18 |
0.566711106747338 |
|
14831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GEN1 |
0.566761507410011 |
|
14832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTP4A2 |
0.566847427785012 |
|
14833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSGN1 |
0.566922583145148 |
|
14834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM222 |
0.566996920493598 |
|
14835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYTL1 |
0.566996920493598 |
|
14836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHAT |
0.567019708267382 |
|
14837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RP2 |
0.56714743623733 |
|
14838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf31 |
0.56714743623733 |
|
14839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPF3B |
0.567199549933373 |
|
14840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT6 |
0.567233862807589 |
|
14841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLN2 |
0.56728090194482 |
|
14842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACACA |
0.567295303495055 |
|
14843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9G4 |
0.567334737056288 |
|
14844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5G5P |
0.567334737056288 |
|
14845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGPD3 |
0.567403426223063 |
|
14846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1C1 |
0.567494794738739 |
|
14847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARP4B |
0.567602992258999 |
|
14848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAALADL2 |
0.567607721864648 |
|
14849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRB1 |
0.567630464866808 |
|
14850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPDR1 |
0.567708410325084 |
|
14851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME8 |
0.567708410325084 |
|
14852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKG1 |
0.567726814059702 |
|
14853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAD1 |
0.56774970304589 |
|
14854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACHD1 |
0.567760243099658 |
|
14855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4676 |
0.567815746644735 |
|
14856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF11 |
0.567855195796858 |
|
14857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM102 |
0.567855195796858 |
|
14858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH9 |
0.567926814851237 |
|
14859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB7L1 |
0.568012514675634 |
|
14860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF5A |
0.56813469665289 |
|
14861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPS2 |
0.56813469665289 |
|
14862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEURL4 |
0.56813469665289 |
|
14863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMAP1 |
0.568228695303965 |
|
14864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERI3 |
0.568228695303965 |
|
14865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD51B |
0.568442040919758 |
|
14866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf27 |
0.568633756376201 |
|
14867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPN1 |
0.568633756376201 |
|
14868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UIMC1 |
0.568638568983962 |
|
14869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KA2 |
0.568654486634899 |
|
14870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC3 |
0.568682753684274 |
|
14871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snR65|ENSG00000251901.1 |
0.568682753684274 |
|
14872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBD1 |
0.568690674634345 |
|
14873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70F |
0.568727219727007 |
|
14874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT2 |
0.568742424225165 |
|
14875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC10 |
0.568742424225165 |
|
14876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEST3 |
0.568742424225165 |
|
14877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC18 |
0.568964476279811 |
|
14878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4294 |
0.568964476279811 |
|
14879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSTM4 |
0.568964476279811 |
|
14880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5705 |
0.569100653276759 |
|
14881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B13 |
0.569100653276759 |
|
14882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B11 |
0.569100653276759 |
|
14883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL681P |
0.569100653276759 |
|
14884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD60|ENSG00000252692.1 |
0.5691483890971 |
|
14885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNKS1BP1 |
0.5692946187409 |
|
14886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSRP1 |
0.5692946187409 |
|
14887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238692.1 |
0.5692946187409 |
|
14888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238384.1 |
0.56931994200461 |
|
14889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PON2 |
0.56931994200461 |
|
14890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL743P |
0.569323789229105 |
|
14891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00470 |
0.569349521139271 |
|
14892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALS2CR12 |
0.56943608603407 |
|
14893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALS2CR11 |
0.569476618443149 |
|
14894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTER |
0.569588369439798 |
|
14895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR6 |
0.569734950634248 |
|
14896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR378C |
0.569859919217513 |
|
14897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5M1 |
0.569961164063013 |
|
14898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5AP2 |
0.569961164063013 |
|
14899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5AR1 |
0.569961164063013 |
|
14900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9G1 |
0.569961164063013 |
|
14901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBLL1 |
0.570041341652885 |
|
14902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A3 |
0.570041341652885 |
|
14903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD84 |
0.570045980673172 |
|
14904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP105 |
0.570088541725003 |
|
14905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIP1 |
0.570128939914796 |
|
14906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB6C |
0.57013967097697 |
|
14907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00364 |
0.570334709589529 |
|
14908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT9 |
0.570342444204137 |
|
14909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNASET2 |
0.570346664061236 |
|
14910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTSR1 |
0.570375519887167 |
|
14911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00659 |
0.570375519887167 |
|
14912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGBP |
0.570375519887167 |
|
14913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXPE2 |
0.570457437342373 |
|
14914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP300 |
0.570500812308965 |
|
14915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL698P |
0.570503352836058 |
|
14916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORMDL3 |
0.570505393491398 |
|
14917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBEAL2 |
0.570556067391924 |
|
14918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHGR1 |
0.570571707528662 |
|
14919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DISP2 |
0.570571707528662 |
|
14920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00594 |
0.570571707528662 |
|
14921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KNSTRN |
0.570571707528662 |
|
14922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RYR3 |
0.570630800788199 |
|
14923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252258.1 |
0.570675373518015 |
|
14924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL37 |
0.570994336936857 |
|
14925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSL4 |
0.571012045733989 |
|
14926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSL6 |
0.571012045733989 |
|
14927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF543 |
0.571061440024915 |
|
14928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL9A3 |
0.571108302310896 |
|
14929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCFL5 |
0.571108302310896 |
|
14930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP1B |
0.57123130056882 |
|
14931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP72 |
0.571246415553918 |
|
14932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE26 |
0.571274105823417 |
|
14933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPTL4 |
0.571317987442113 |
|
14934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD21 |
0.571351136847129 |
|
14935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3610 |
0.571351136847129 |
|
14936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLC1 |
0.571412304102988 |
|
14937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS3ST5 |
0.571583104313447 |
|
14938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL592P |
0.571607582372239 |
|
14939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA17P |
0.571617550712071 |
|
14940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA6 |
0.571731697302952 |
|
14941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTX4 |
0.571761101616475 |
|
14942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPEG1 |
0.571761101616475 |
|
14943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL42P |
0.571761101616475 |
|
14944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY5 |
0.571780192518826 |
|
14945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000251704.1 |
0.571850723348139 |
|
14946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XIRP2 |
0.571864904871855 |
|
14947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR133 |
0.57188412584366 |
|
14948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBOX1 |
0.571897322368699 |
|
14949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHDC2 |
0.572057941460384 |
|
14950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC22A |
0.572084566573583 |
|
14951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL12B |
0.572102730581965 |
|
14952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APCS |
0.572106052245133 |
|
14953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI6 |
0.572184983690332 |
|
14954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIRC7 |
0.572226035411835 |
|
14955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3196 |
0.572226035411835 |
|
14956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKAIN4 |
0.572226035411835 |
|
14957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARFGAP1 |
0.572226035411835 |
|
14958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4326 |
0.572226035411835 |
|
14959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMT1 |
0.572290013580043 |
|
14960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEXIM1 |
0.572290013580043 |
|
14961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEXIM2 |
0.572290013580043 |
|
14962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMNL1 |
0.572290013580043 |
|
14963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D5 |
0.572329721558603 |
|
14964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4796 |
0.572336499166451 |
|
14965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS2P45 |
0.572406354099515 |
|
14966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBAG9 |
0.572458739057545 |
|
14967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR585 |
0.572619978398265 |
|
14968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF11B |
0.572648577721949 |
|
14969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP286 |
0.572753192986077 |
|
14970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPSF6 |
0.572785696007691 |
|
14971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP299 |
0.57283833995458 |
|
14972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAS3 |
0.572949696723604 |
|
14973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHTF8 |
0.572949696723604 |
|
14974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEUROG1 |
0.572964671870033 |
|
14975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCL14 |
0.572964671870033 |
|
14976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RND3 |
0.572967651425911 |
|
14977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRAGD |
0.573133577470766 |
|
14978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPF2 |
0.573208479395069 |
|
14979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf30 |
0.573215219503084 |
|
14980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY1 |
0.573346383272509 |
|
14981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D28 |
0.573349428318208 |
|
14982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF286B |
0.573349428318208 |
|
14983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf79 |
0.573413674766131 |
|
14984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRABD2B |
0.573523756195684 |
|
14985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORAOV1 |
0.573617852935987 |
|
14986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP32 |
0.573641222424881 |
|
14987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G3 |
0.573662606641137 |
|
14988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INCA1 |
0.57366692473596 |
|
14989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GVQW1 |
0.573707866118463 |
|
14990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC7 |
0.57371139584952 |
|
14991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMTN |
0.57371139584952 |
|
14992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMBN |
0.57371139584952 |
|
14993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENAM |
0.57371139584952 |
|
14994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGJ |
0.57371139584952 |
|
14995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP3 |
0.57371139584952 |
|
14996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMD1 |
0.573887507514751 |
|
14997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALS2 |
0.573908526708577 |
|
14998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP7 |
0.574182516220418 |
|
14999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPEB4 |
0.574231503212958 |
|
15000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1A |
0.574253658588453 |
|
15001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPI1 |
0.574291854985866 |
|
15002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTM3 |
0.574353761487528 |
|
15003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPS8L3 |
0.574353761487528 |
|
15004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP202 |
0.574357277077532 |
|
15005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD29 |
0.574357783245348 |
|
15006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2B2 |
0.574434918642048 |
|
15007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM3D |
0.574510087480487 |
|
15008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C13 |
0.574671072452313 |
|
15009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL250P |
0.574719739261589 |
|
15010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TESC |
0.574746206040625 |
|
15011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL300P |
0.574759232650753 |
|
15012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4532 |
0.574853759716004 |
|
15013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPARCL1 |
0.574913639112409 |
|
15014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U7|ENSG00000272215.1 |
0.574984779681588 |
|
15015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL847P |
0.574995764252402 |
|
15016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSTM5 |
0.575037432118937 |
|
15017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLTK |
0.57503977126016 |
|
15018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAKD |
0.575106704458068 |
|
15019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATAD1 |
0.575138263647898 |
|
15020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIRH1A |
0.575286824821261 |
|
15021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H12C |
0.575379761891528 |
|
15022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDX |
0.575379761891528 |
|
15023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHACTR3 |
0.575470991797753 |
|
15024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB4A |
0.575495649847493 |
|
15025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPHAR |
0.575495649847493 |
|
15026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCSAP |
0.575495649847493 |
|
15027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHFM1 |
0.575517543861538 |
|
15028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA22 |
0.575558372245139 |
|
15029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR943 |
0.575558372245139 |
|
15030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD7 |
0.575625145600145 |
|
15031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB2A |
0.575653677057961 |
|
15032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPO6 |
0.575671238329387 |
|
15033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000200652.1 |
0.575671238329387 |
|
15034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNTB2 |
0.575837044861772 |
|
15035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf17 |
0.575937717601372 |
|
15036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACP6 |
0.576009055667527 |
|
15037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A12P |
0.576009055667527 |
|
15038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD34A |
0.576009055667527 |
|
15039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD35 |
0.576009055667527 |
|
15040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL9 |
0.576009055667527 |
|
15041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOLA1 |
0.576009055667527 |
|
15042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD160 |
0.576009055667527 |
|
15043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD1L |
0.576009055667527 |
|
15044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM72B |
0.576009055667527 |
|
15045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM72C |
0.576009055667527 |
|
15046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM72D |
0.576009055667527 |
|
15047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGR1A |
0.576009055667527 |
|
15048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGR1B |
0.576009055667527 |
|
15049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGR1C |
0.576009055667527 |
|
15050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMO5 |
0.576009055667527 |
|
15051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJA5 |
0.576009055667527 |
|
15052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJA8 |
0.576009055667527 |
|
15053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNRHR2 |
0.576009055667527 |
|
15054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR89A |
0.576009055667527 |
|
15055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR89B |
0.576009055667527 |
|
15056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR89C |
0.576009055667527 |
|
15057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HFE2 |
0.576009055667527 |
|
15058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H2AA3 |
0.576009055667527 |
|
15059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H2AA4 |
0.576009055667527 |
|
15060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H2AB |
0.576009055667527 |
|
15061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H2AC |
0.576009055667527 |
|
15062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H2BA |
0.576009055667527 |
|
15063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H2BE |
0.576009055667527 |
|
15064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H2BF |
0.576009055667527 |
|
15065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H3A |
0.576009055667527 |
|
15066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H3C |
0.576009055667527 |
|
15067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H3D |
0.576009055667527 |
|
15068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H4A |
0.576009055667527 |
|
15069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST2H4B |
0.576009055667527 |
|
15070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYDIN2 |
0.576009055667527 |
|
15071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA10 |
0.576009055667527 |
|
15072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00623 |
0.576009055667527 |
|
15073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00624 |
0.576009055667527 |
|
15074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIX1L |
0.576009055667527 |
|
15075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF10 |
0.576009055667527 |
|
15076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF11 |
0.576009055667527 |
|
15077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF12 |
0.576009055667527 |
|
15078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF14 |
0.576009055667527 |
|
15079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF15 |
0.576009055667527 |
|
15080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF16 |
0.576009055667527 |
|
15081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF20 |
0.576009055667527 |
|
15082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF24 |
0.576009055667527 |
|
15083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF8 |
0.576009055667527 |
|
15084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBPF9 |
0.576009055667527 |
|
15085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOTCH2NL |
0.576009055667527 |
|
15086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT17 |
0.576009055667527 |
|
15087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE4DIP |
0.576009055667527 |
|
15088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZK1P1 |
0.576009055667527 |
|
15089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZK1 |
0.576009055667527 |
|
15090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX11B |
0.576009055667527 |
|
15091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIAS3 |
0.576009055667527 |
|
15092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3C |
0.576009055667527 |
|
15093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3GL |
0.576009055667527 |
|
15094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIAL4A |
0.576009055667527 |
|
15095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIAL4B |
0.576009055667527 |
|
15096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIAL4C |
0.576009055667527 |
|
15097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIAL4D |
0.576009055667527 |
|
15098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIAL4G |
0.576009055667527 |
|
15099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAB2 |
0.576009055667527 |
|
15100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM8A |
0.576009055667527 |
|
15101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP88 |
0.576009055667527 |
|
15102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL261P |
0.576009055667527 |
|
15103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP57 |
0.576009055667527 |
|
15104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP58 |
0.576009055667527 |
|
15105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP59 |
0.576009055667527 |
|
15106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF115 |
0.576009055667527 |
|
15107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC22B |
0.576009055667527 |
|
15108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRGAP2B |
0.576009055667527 |
|
15109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNIP |
0.576009055667527 |
|
15110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY6 |
0.576022133206333 |
|
15111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMO1 |
0.576059495514893 |
|
15112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3CG |
0.576209623187653 |
|
15113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAR2B |
0.576209623187653 |
|
15114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBP1 |
0.576209623187653 |
|
15115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND5A |
0.576275783131065 |
|
15116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM41B |
0.576275783131065 |
|
15117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPA1P57 |
0.576356403532472 |
|
15118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO18 |
0.576464264308358 |
|
15119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP78 |
0.576557354380171 |
|
15120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF32 |
0.576565749421905 |
|
15121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH2 |
0.577049941431055 |
|
15122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF487 |
0.577114571749533 |
|
15123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOV10 |
0.577226774565702 |
|
15124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOC |
0.577226774565702 |
|
15125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR326 |
0.577272178715622 |
|
15126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL4 |
0.577294875620351 |
|
15127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAF1 |
0.577311060809099 |
|
15128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SVIP |
0.57736685717622 |
|
15129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP6 |
0.577520619250424 |
|
15130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSR |
0.577645614793752 |
|
15131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USF2 |
0.577645614793752 |
|
15132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAMP |
0.577645614793752 |
|
15133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL239P |
0.577891539144868 |
|
15134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238552.1 |
0.577921055138885 |
|
15135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSPN |
0.57794508225676 |
|
15136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX3 |
0.578004526306493 |
|
15137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC2 |
0.578117492172015 |
|
15138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF792 |
0.578144744932834 |
|
15139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC71L |
0.57827493064336 |
|
15140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT9 |
0.57831150414611 |
|
15141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P23 |
0.57833586604171 |
|
15142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1C4 |
0.578357020360037 |
|
15143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS3 |
0.57838676879779 |
|
15144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD15A |
0.57838676879779 |
|
15145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD15B |
0.57838676879779 |
|
15146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL35 |
0.57838676879779 |
|
15147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP192 |
0.578537619662892 |
|
15148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10V1 |
0.578537619662892 |
|
15149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPP19 |
0.578797042034721 |
|
15150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF17 |
0.578822335641926 |
|
15151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL479P |
0.578822335641926 |
|
15152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATOX1 |
0.578822518135652 |
|
15153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT2 |
0.578858338686916 |
|
15154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239058.1 |
0.579008454400214 |
|
15155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238931.1 |
0.579010594903394 |
|
15156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMZ2P1 |
0.5790490594938 |
|
15157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB4 |
0.579052979251314 |
|
15158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMNAT2 |
0.579393793862614 |
|
15159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK15 |
0.57941038644281 |
|
15160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABEP1 |
0.579438158083457 |
|
15161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRA5 |
0.579442065401619 |
|
15162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM237 |
0.57950195639455 |
|
15163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP6 |
0.579611859434669 |
|
15164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN8OS |
0.579672391602441 |
|
15165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP13 |
0.579774162873899 |
|
15166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL198P |
0.579808358264825 |
|
15167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL751P |
0.579922798178395 |
|
15168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA8 |
0.580032231781567 |
|
15169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP667F0711 |
0.580035668671617 |
|
15170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4794 |
0.580056648240621 |
|
15171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALOX12B |
0.580235719563477 |
|
15172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4314 |
0.580235719563477 |
|
15173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC5OS |
0.580315735520649 |
|
15174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GK2 |
0.580389360940505 |
|
15175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR61 |
0.580438931037794 |
|
15176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAI3 |
0.580438931037794 |
|
15177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6V |
0.580438931037794 |
|
15178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf56 |
0.580454936602618 |
|
15179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCB2 |
0.580454936602618 |
|
15180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD63 |
0.580454936602618 |
|
15181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00984 |
0.580454936602618 |
|
15182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf52 |
0.580454936602618 |
|
15183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP392 |
0.580454936602618 |
|
15184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTHLH |
0.580470201280095 |
|
15185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBLN2 |
0.580583879401681 |
|
15186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AV |
0.580583879401681 |
|
15187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NETO1 |
0.580583879401681 |
|
15188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP460 |
0.580583879401681 |
|
15189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF4 |
0.580587460880426 |
|
15190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFAIP2 |
0.58066275646351 |
|
15191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SESN1 |
0.580685124114503 |
|
15192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A6P1 |
0.580749821990104 |
|
15193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK9 |
0.580868802067408 |
|
15194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNA13 |
0.580880473466995 |
|
15195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD1B |
0.580913207207728 |
|
15196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODF2L |
0.580920888248681 |
|
15197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH7 |
0.580964931586812 |
|
15198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR551B |
0.581076358142232 |
|
15199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2AT4 |
0.581184816289285 |
|
15200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP349 |
0.581216968939333 |
|
15201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL772P |
0.581235985220851 |
|
15202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPP4 |
0.581259886680686 |
|
15203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDPD5 |
0.581407869261913 |
|
15204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB2 |
0.581453488907874 |
|
15205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITFG1 |
0.581523626994797 |
|
15206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBLN4 |
0.581528991375243 |
|
15207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP487 |
0.581528991375243 |
|
15208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MC3R |
0.581528991375243 |
|
15209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNC1LI1 |
0.58158569083899 |
|
15210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC16 |
0.581647190457221 |
|
15211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGMAT |
0.581647190457221 |
|
15212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL169P |
0.581955555311239 |
|
15213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL21P122 |
0.581998838226152 |
|
15214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2K4 |
0.581998838226152 |
|
15215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR744 |
0.581998838226152 |
|
15216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF39 |
0.582052548508589 |
|
15217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD127 |
0.582052548508589 |
|
15218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238652.1 |
0.582092706011692 |
|
15219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IBSP |
0.582092706011692 |
|
15220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEPE |
0.582092706011692 |
|
15221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238376.1 |
0.582178601554792 |
|
15222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KANK3 |
0.582191805802342 |
|
15223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REPS2 |
0.58220236336831 |
|
15224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMPR1A |
0.582308417300239 |
|
15225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC2 |
0.582463364438702 |
|
15226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPM7 |
0.582480747137386 |
|
15227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL5P |
0.582483144553325 |
|
15228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM19A1 |
0.58250599775838 |
|
15229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL774P |
0.582548194707026 |
|
15230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPR1 |
0.582626486117658 |
|
15231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASF1 |
0.582727280193246 |
|
15232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC40 |
0.582727280193246 |
|
15233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MECR |
0.582757518277834 |
|
15234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A10 |
0.58301077750319 |
|
15235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDI1 |
0.5830336956471 |
|
15236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDI2 |
0.5830336956471 |
|
15237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00200 |
0.5830336956471 |
|
15238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR37 |
0.5830336956471 |
|
15239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10K1 |
0.583118193894737 |
|
15240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10R2 |
0.583118193894737 |
|
15241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf76 |
0.583194351901251 |
|
15242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KSR1 |
0.583294390096847 |
|
15243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RP1L1 |
0.583501068185367 |
|
15244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4286 |
0.583501068185367 |
|
15245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf74 |
0.583501068185367 |
|
15246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP252 |
0.583501068185367 |
|
15247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252565.1 |
0.583501068185367 |
|
15248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX1 |
0.583503488822095 |
|
15249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM48 |
0.583503488822095 |
|
15250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL6 |
0.583709978607452 |
|
15251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP127 |
0.583741907901158 |
|
15252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB9 |
0.583749396151473 |
|
15253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA7 |
0.583848356418754 |
|
15254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL770P |
0.583852489928662 |
|
15255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN2A |
0.583951289214669 |
|
15256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAM |
0.583996262122585 |
|
15257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoR442|ENSG00000251959.1 |
0.583996262122585 |
|
15258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000272310.1 |
0.584016172331289 |
|
15259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRCP |
0.584030155783051 |
|
15260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238995.1 |
0.584030155783051 |
|
15261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM23 |
0.58406992127995 |
|
15262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC13 |
0.58406992127995 |
|
15263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC20 |
0.584160817055292 |
|
15264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTOR |
0.584191552238874 |
|
15265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPTL7 |
0.584191552238874 |
|
15266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNG1 |
0.584248716255385 |
|
15267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDB2 |
0.584407428149207 |
|
15268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP47 |
0.584477500738431 |
|
15269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf40 |
0.584509900636117 |
|
15270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACP2 |
0.584541393116425 |
|
15271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASA3 |
0.58458814452176 |
|
15272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC17 |
0.584679584062149 |
|
15273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRCAM |
0.584779706838614 |
|
15274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UROD |
0.584871032307035 |
|
15275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINT2 |
0.584942572376055 |
|
15276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9C1 |
0.584946819279375 |
|
15277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIFA |
0.584974177066905 |
|
15278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALPK1 |
0.584974177066905 |
|
15279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEUROG2 |
0.584974177066905 |
|
15280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548W |
0.584979716280646 |
|
15281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP405 |
0.584979716280646 |
|
15282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR3A |
0.585081981697832 |
|
15283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCH |
0.585150829540286 |
|
15284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf53 |
0.585181966770403 |
|
15285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHX9 |
0.585181966770403 |
|
15286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2B7P1 |
0.58524021539157 |
|
15287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2B6 |
0.58524021539157 |
|
15288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf87 |
0.585260986618924 |
|
15289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF19 |
0.58526933958533 |
|
15290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM188A |
0.585453413290516 |
|
15291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL22 |
0.585547365723221 |
|
15292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL20A1 |
0.585665805056566 |
|
15293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA4 |
0.585665805056566 |
|
15294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IVD |
0.585700277619473 |
|
15295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSB |
0.585808910784559 |
|
15296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB130|ENSG00000232948.1 |
0.585808910784559 |
|
15297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB130|ENSG00000233050.1 |
0.585808910784559 |
|
15298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB134 |
0.585808910784559 |
|
15299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB135 |
0.585808910784559 |
|
15300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEFB136 |
0.585808910784559 |
|
15301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM66A |
0.585808910784559 |
|
15302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM66D |
0.585808910784559 |
|
15303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86B1 |
0.585808910784559 |
|
15304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86B2 |
0.585808910784559 |
|
15305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FDFT1 |
0.585808910784559 |
|
15306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP253 |
0.585808910784559 |
|
15307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP254 |
0.585808910784559 |
|
15308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP17L2 |
0.585808910784559 |
|
15309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF705D |
0.585808910784559 |
|
15310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P8 |
0.585833925895502 |
|
15311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P27 |
0.585833925895502 |
|
15312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf21 |
0.585862924082078 |
|
15313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARP7 |
0.585862924082078 |
|
15314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR302A |
0.585862924082078 |
|
15315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR302B |
0.585862924082078 |
|
15316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR302C |
0.585862924082078 |
|
15317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR302D |
0.585862924082078 |
|
15318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR367 |
0.585862924082078 |
|
15319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP14 |
0.585898067032538 |
|
15320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212608.1 |
0.585965713431604 |
|
15321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PURA |
0.586049238864533 |
|
15322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGIP |
0.586049238864533 |
|
15323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAUS3 |
0.586070253887013 |
|
15324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAL1 |
0.586073458517105 |
|
15325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOB |
0.586122983536043 |
|
15326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD15 |
0.586122983536043 |
|
15327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238676.1 |
0.586179603972149 |
|
15328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALOX15B |
0.586179603972149 |
|
15329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN3A |
0.586241222626147 |
|
15330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL455P |
0.586241222626147 |
|
15331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMEL |
0.586295686668861 |
|
15332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK2 |
0.586295686668861 |
|
15333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A12 |
0.586409665678202 |
|
15334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELPLG |
0.586472854230976 |
|
15335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORO1C |
0.586472854230976 |
|
15336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP1 |
0.586482846663611 |
|
15337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPT2 |
0.586560509032818 |
|
15338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PON1 |
0.586612539496631 |
|
15339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PON3 |
0.586612539496631 |
|
15340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM198B |
0.58671299611624 |
|
15341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSWIM5 |
0.586739227584696 |
|
15342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAT6B |
0.586751622334426 |
|
15343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1D |
0.586901622113068 |
|
15344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP35 |
0.586905424891845 |
|
15345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB44 |
0.586946770466056 |
|
15346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC21 |
0.587008165549246 |
|
15347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CER1 |
0.587008165549246 |
|
15348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3GL2 |
0.587080668129246 |
|
15349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBED2 |
0.587104609866753 |
|
15350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP376 |
0.587309411562481 |
|
15351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL293P |
0.587326586859178 |
|
15352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSAT1 |
0.587405786271602 |
|
15353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY9 |
0.58749622101369 |
|
15354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD244 |
0.58749622101369 |
|
15355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITLN1 |
0.58749622101369 |
|
15356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH9 |
0.587607270846135 |
|
15357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAND4 |
0.587646003666093 |
|
15358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP10 |
0.587646003666093 |
|
15359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP4 |
0.587646003666093 |
|
15360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP9 |
0.587646003666093 |
|
15361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANTXRLP1 |
0.587646003666093 |
|
15362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANTXRL |
0.587646003666093 |
|
15363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA8L1 |
0.587646003666093 |
|
15364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA8L2 |
0.587646003666093 |
|
15365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA8 |
0.587646003666093 |
|
15366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASAH2C |
0.587646003666093 |
|
15367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMS1P1 |
0.587646003666093 |
|
15368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMS1P2 |
0.587646003666093 |
|
15369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf43 |
0.587646003666093 |
|
15370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM21B |
0.587646003666093 |
|
15371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM21C |
0.587646003666093 |
|
15372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM25B |
0.587646003666093 |
|
15373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM25E |
0.587646003666093 |
|
15374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM25G |
0.587646003666093 |
|
15375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM35BP |
0.587646003666093 |
|
15376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRIN2 |
0.587646003666093 |
|
15377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00842 |
0.587646003666093 |
|
15378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPY4R |
0.587646003666093 |
|
15379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN20A |
0.587646003666093 |
|
15380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBP3 |
0.587646003666093 |
|
15381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL248P |
0.587646003666093 |
|
15382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL453P |
0.587646003666093 |
|
15383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP310 |
0.587646003666093 |
|
15384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP311 |
0.587646003666093 |
|
15385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP312 |
0.587646003666093 |
|
15386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP313 |
0.587646003666093 |
|
15387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT15 |
0.587646003666093 |
|
15388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF488 |
0.587646003666093 |
|
15389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf33 |
0.58769659902385 |
|
15390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIF1B |
0.58769659902385 |
|
15391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK6 |
0.58769659902385 |
|
15392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238838.1 |
0.58769659902385 |
|
15393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf38 |
0.5876983322257 |
|
15394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00410 |
0.587797970987416 |
|
15395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS9 |
0.587823096920718 |
|
15396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL576P |
0.587823096920718 |
|
15397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPCS2 |
0.587823306139572 |
|
15398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA32 |
0.587833219358384 |
|
15399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKAPP1 |
0.587986317333412 |
|
15400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOXF2 |
0.587986317333412 |
|
15401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB33 |
0.587986317333412 |
|
15402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM255A |
0.587986317333412 |
|
15403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD8 |
0.588002272202576 |
|
15404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL781P |
0.588039735132808 |
|
15405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF4 |
0.588043900285933 |
|
15406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf141 |
0.588045522495903 |
|
15407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL36G |
0.588069295729153 |
|
15408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR155 |
0.58810299625439 |
|
15409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR625 |
0.588116734836067 |
|
15410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA64|ENSG00000238685.1 |
0.588280344421022 |
|
15411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMTN |
0.588283223911796 |
|
15412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFR1OP |
0.588329864356359 |
|
15413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3939 |
0.588329864356359 |
|
15414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARK3 |
0.588345182550552 |
|
15415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELP4 |
0.588372947280717 |
|
15416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEU3 |
0.588436154888995 |
|
15417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO2B1 |
0.588436154888995 |
|
15418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STXBP5 |
0.588446571590714 |
|
15419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCG |
0.588628085715935 |
|
15420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP129 |
0.588734620421958 |
|
15421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf35 |
0.588734620421958 |
|
15422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF4A |
0.58875827143386 |
|
15423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDPD2 |
0.58875827143386 |
|
15424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF10 |
0.588881706405984 |
|
15425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POP5 |
0.588881706405984 |
|
15426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABP1 |
0.588881706405984 |
|
15427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC119B |
0.588881706405984 |
|
15428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4700 |
0.588881706405984 |
|
15429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA1 |
0.589031397160773 |
|
15430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHDH |
0.589047019527313 |
|
15431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17RB |
0.589047019527313 |
|
15432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR8 |
0.589047019527313 |
|
15433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPP2 |
0.589151141686197 |
|
15434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IER2 |
0.589175190729841 |
|
15435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASRGL1 |
0.589345075632373 |
|
15436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238355.1 |
0.589393488969772 |
|
15437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35F3 |
0.589445759701163 |
|
15438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAN |
0.589507739436222 |
|
15439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR873 |
0.589582492447382 |
|
15440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR876 |
0.589582492447382 |
|
15441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP29 |
0.589629738332712 |
|
15442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD58 |
0.589669481367295 |
|
15443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AC |
0.589669481367295 |
|
15444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf56 |
0.589719156719258 |
|
15445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC4 |
0.589749373933606 |
|
15446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SACM1L |
0.589850065101861 |
|
15447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL145P |
0.589850065101861 |
|
15448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A20 |
0.589850065101861 |
|
15449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LZTFL1 |
0.589850065101861 |
|
15450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNT2 |
0.589882681055173 |
|
15451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBCA |
0.589893572665796 |
|
15452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP3B1 |
0.589893572665796 |
|
15453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFOD2 |
0.589947939861562 |
|
15454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFB1I1 |
0.589969407386731 |
|
15455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLUHP3 |
0.589969407386731 |
|
15456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF720 |
0.589969407386731 |
|
15457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA5B |
0.589976156741998 |
|
15458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL761P |
0.590049661239189 |
|
15459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239033.1 |
0.590117496408502 |
|
15460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTSCR1 |
0.590229023172156 |
|
15461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF18 |
0.590249094454592 |
|
15462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT7 |
0.5903246457956 |
|
15463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC178 |
0.590368292275898 |
|
15464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT1 |
0.590387176040451 |
|
15465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA76|ENSG00000266402.2 |
0.590418731044356 |
|
15466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD104 |
0.590418731044356 |
|
15467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ5 |
0.590421093126619 |
|
15468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOR2 |
0.590493242228832 |
|
15469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1324L |
0.590656370125863 |
|
15470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP27 |
0.590889290832832 |
|
15471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NACC1 |
0.590890215694262 |
|
15472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX10 |
0.590890215694262 |
|
15473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOS2 |
0.591025127829646 |
|
15474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL706P |
0.591089141464522 |
|
15475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF169 |
0.591156634891984 |
|
15476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOM1L1 |
0.591205626119338 |
|
15477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX11 |
0.591205626119338 |
|
15478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP338 |
0.591234225345967 |
|
15479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SARNP |
0.591239603719235 |
|
15480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD56|ENSG00000200112.1 |
0.591250658890381 |
|
15481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf44 |
0.591276844323027 |
|
15482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A9 |
0.591323058584948 |
|
15483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A2 |
0.59134408580646 |
|
15484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf58 |
0.59134408580646 |
|
15485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHSP |
0.59134408580646 |
|
15486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPNS3 |
0.591397277797241 |
|
15487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XKR6 |
0.591408260105986 |
|
15488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR598 |
0.591408260105986 |
|
15489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF7 |
0.591477243641202 |
|
15490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00507 |
0.591692889022395 |
|
15491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00508 |
0.591692889022395 |
|
15492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA5L1 |
0.59205891832685 |
|
15493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf48 |
0.59205891832685 |
|
15494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR147B |
0.59205891832685 |
|
15495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A4 |
0.59205891832685 |
|
15496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238583.1 |
0.59205891832685 |
|
15497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA41|ENSG00000207516.1 |
0.59205891832685 |
|
15498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK9 |
0.592159540415484 |
|
15499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFPT2 |
0.592159540415484 |
|
15500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRDL2 |
0.592167358128601 |
|
15501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD43|ENSG00000212277.1 |
0.592167358128601 |
|
15502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4696 |
0.592167358128601 |
|
15503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238402.1 |
0.592181813234269 |
|
15504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000251744.1 |
0.592285389951496 |
|
15505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAI2 |
0.592300270825823 |
|
15506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4254 |
0.592300270825823 |
|
15507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMER3 |
0.5924958667715 |
|
15508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL140P |
0.592551834510591 |
|
15509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDC1 |
0.592551834510591 |
|
15510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUM2 |
0.592551834510591 |
|
15511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4A11 |
0.592576728083557 |
|
15512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAP |
0.592613986895763 |
|
15513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX7 |
0.592630328512958 |
|
15514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PINX1 |
0.592630328512958 |
|
15515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPY2R |
0.592698347171543 |
|
15516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA76|ENSG00000252904.1 |
0.592758052920258 |
|
15517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTFR1 |
0.592774876648285 |
|
15518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM133B |
0.592885437162646 |
|
15519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUMF1 |
0.592930414727777 |
|
15520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLGN1 |
0.592988694851986 |
|
15521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL99P |
0.593094593275062 |
|
15522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT7P9 |
0.59314296431748 |
|
15523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYR61 |
0.593201937336721 |
|
15524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD81|ENSG00000199934.1 |
0.593201937336721 |
|
15525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOPORS |
0.59327768726355 |
|
15526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB6 |
0.59327768726355 |
|
15527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAT2 |
0.593313254916569 |
|
15528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSM2B |
0.593361694746843 |
|
15529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRC1L1 |
0.593410483359079 |
|
15530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRC1 |
0.593410483359079 |
|
15531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM236|ENSG00000148483.7 |
0.593410483359079 |
|
15532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM236|ENSG00000184040.7 |
0.593410483359079 |
|
15533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf47 |
0.593528736205355 |
|
15534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00618 |
0.593576134198165 |
|
15535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTCDNL1 |
0.593614690051831 |
|
15536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULK2 |
0.593648887230412 |
|
15537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF181 |
0.593674049381733 |
|
15538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPP21 |
0.593713511355612 |
|
15539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP512 |
0.593716852740997 |
|
15540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4758 |
0.593777497755278 |
|
15541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS21 |
0.593777497755278 |
|
15542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABLES2 |
0.593777497755278 |
|
15543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIA3 |
0.59379574861791 |
|
15544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKIB1 |
0.593844363303554 |
|
15545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMR1 |
0.59393084112002 |
|
15546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMR4P |
0.59393084112002 |
|
15547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD3L2 |
0.59393084112002 |
|
15548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD3L3 |
0.59393084112002 |
|
15549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD3L4 |
0.59393084112002 |
|
15550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD3L5 |
0.59393084112002 |
|
15551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF557 |
0.59393084112002 |
|
15552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH8 |
0.593972428243981 |
|
15553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC179 |
0.59403564330376 |
|
15554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBBX |
0.594084229762768 |
|
15555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC26 |
0.594155790536718 |
|
15556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3686 |
0.594155790536718 |
|
15557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDC |
0.594388862031383 |
|
15558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR0B2 |
0.594388862031383 |
|
15559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARNTL2 |
0.594432318574364 |
|
15560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLG3 |
0.594468388749655 |
|
15561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG3 |
0.594476987004692 |
|
15562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA73B |
0.594476987004692 |
|
15563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP281 |
0.594502651082551 |
|
15564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SC5D |
0.594583459880791 |
|
15565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2G1 |
0.594610495907044 |
|
15566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VRK1 |
0.594617316656728 |
|
15567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM201A |
0.594729863449262 |
|
15568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A10 |
0.595013926949314 |
|
15569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM83G |
0.595013926949314 |
|
15570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAPL |
0.595013926949314 |
|
15571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAP |
0.595013926949314 |
|
15572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD3A |
0.595013926949314 |
|
15573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD3C |
0.595013926949314 |
|
15574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD3D |
0.595013926949314 |
|
15575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DZIP1 |
0.595273525973698 |
|
15576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP285 |
0.595323713100279 |
|
15577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5692A1 |
0.595365821902826 |
|
15578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5692C2 |
0.595365821902826 |
|
15579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCM2 |
0.595365821902826 |
|
15580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL478P |
0.595365821902826 |
|
15581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL13P |
0.595365821902826 |
|
15582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX3X |
0.595397857480252 |
|
15583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL15P |
0.595397857480252 |
|
15584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEATR4 |
0.595398621271679 |
|
15585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf169 |
0.595398621271679 |
|
15586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GALT1 |
0.595436324683541 |
|
15587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOXF2B |
0.595465752337751 |
|
15588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH4 |
0.59557200417286 |
|
15589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXT2 |
0.595745532387352 |
|
15590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT6 |
0.595924126690532 |
|
15591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPA1 |
0.595937367855053 |
|
15592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D3F |
0.596043782048963 |
|
15593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D3 |
0.596043782048963 |
|
15594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNF |
0.596106208733897 |
|
15595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP60 |
0.596118907392564 |
|
15596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR65 |
0.596154338739271 |
|
15597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC103 |
0.596254561744744 |
|
15598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM187A |
0.596254561744744 |
|
15599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFAP |
0.596254561744744 |
|
15600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2A6 |
0.596265623453595 |
|
15601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2A7 |
0.596265623453595 |
|
15602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACCS |
0.596296423053138 |
|
15603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMPD2 |
0.596314906799201 |
|
15604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000201398.1 |
0.596349887263194 |
|
15605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA7 |
0.59636360942149 |
|
15606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM200B |
0.5963651847747 |
|
15607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF654 |
0.596500902717832 |
|
15608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A11 |
0.596535944317807 |
|
15609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP291 |
0.596553696752954 |
|
15610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPEP |
0.596601423357962 |
|
15611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB4A |
0.596724016781526 |
|
15612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYBBP1A |
0.59689320454185 |
|
15613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP6NL |
0.597036304879361 |
|
15614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAP1 |
0.59709275101036 |
|
15615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PATL1 |
0.597268526216997 |
|
15616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMB1 |
0.597311303346074 |
|
15617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000238297.1 |
0.597311303346074 |
|
15618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5584 |
0.597338863640964 |
|
15619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMA2 |
0.597396789546949 |
|
15620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT38 |
0.597430052700588 |
|
15621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT32 |
0.597430052700588 |
|
15622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT35 |
0.597430052700588 |
|
15623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT36 |
0.597430052700588 |
|
15624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT13 |
0.597430052700588 |
|
15625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT15 |
0.597430052700588 |
|
15626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT19 |
0.597430052700588 |
|
15627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00974 |
0.597430052700588 |
|
15628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT9 |
0.597430052700588 |
|
15629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT14 |
0.597430052700588 |
|
15630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGD5P1 |
0.597432041047726 |
|
15631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPRXL |
0.597432041047726 |
|
15632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASUN |
0.597457666310292 |
|
15633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDH1 |
0.597507724985065 |
|
15634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIKFYVE |
0.597507724985065 |
|
15635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMIZ1 |
0.597622528394771 |
|
15636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETS1 |
0.597659234421972 |
|
15637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRIT1 |
0.59771504219974 |
|
15638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS37B |
0.597767947815131 |
|
15639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4741 |
0.597768008218919 |
|
15640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM132C |
0.597800610467896 |
|
15641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD1E |
0.597824257301467 |
|
15642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABYR |
0.597969330418225 |
|
15643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP452 |
0.597969330418225 |
|
15644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC23 |
0.598059991488876 |
|
15645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLTC |
0.598060038739445 |
|
15646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238662.1 |
0.59815523588124 |
|
15647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOXF1 |
0.598178283999328 |
|
15648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT1 |
0.598201144401827 |
|
15649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT2 |
0.598201144401827 |
|
15650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT4 |
0.598201144401827 |
|
15651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRB3 |
0.598234145936124 |
|
15652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND1C |
0.598234145936124 |
|
15653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVI5 |
0.598457746546909 |
|
15654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP19 |
0.598598770439627 |
|
15655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCXD2 |
0.598616470567651 |
|
15656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESRG |
0.598695679375191 |
|
15657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC16P |
0.598866587880551 |
|
15658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A11 |
0.598868114250257 |
|
15659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOCD |
0.598984468345628 |
|
15660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6N1 |
0.599000806003578 |
|
15661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6N2 |
0.599000806003578 |
|
15662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBRS |
0.599004860993594 |
|
15663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR14 |
0.599004860993594 |
|
15664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM170B |
0.599102342576861 |
|
15665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL654P |
0.599231707828894 |
|
15666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF15 |
0.599265923470036 |
|
15667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGR |
0.599268899589839 |
|
15668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPIN2 |
0.599276589841547 |
|
15669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4693 |
0.59943194953763 |
|
15670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDI1 |
0.59943194953763 |
|
15671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPNS2 |
0.599445575826747 |
|
15672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCIMP |
0.599460901479331 |
|
15673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT8 |
0.5995012786074 |
|
15674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSDMA |
0.599531634232334 |
|
15675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD3 |
0.599531634232334 |
|
15676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIGD2 |
0.599644784524618 |
|
15677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP48 |
0.599648366054688 |
|
15678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL717P |
0.599713171740398 |
|
15679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDA |
0.599770149665549 |
|
15680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000200113.1 |
0.599802617240343 |
|
15681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TKTL1 |
0.599819369342791 |
|
15682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STMN1P1 |
0.599840008934877 |
|
15683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPS1 |
0.600030189992391 |
|
15684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDLBP |
0.600060430647897 |
|
15685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC6 |
0.600105569932231 |
|
15686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC5 |
0.600105569932231 |
|
15687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC3 |
0.600105569932231 |
|
15688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGY |
0.600105569932231 |
|
15689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYURF |
0.600105569932231 |
|
15690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAP1L5 |
0.600105569932231 |
|
15691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFIH1 |
0.600169198027691 |
|
15692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCA |
0.600169198027691 |
|
15693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYRK2 |
0.600189063028766 |
|
15694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA73|ENSG00000222145.1 |
0.600244144144581 |
|
15695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf41 |
0.600244206732017 |
|
15696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMRK1 |
0.600244206732017 |
|
15697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSTF1 |
0.600244206732017 |
|
15698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNASE1L1 |
0.600347684925336 |
|
15699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAZ |
0.600347684925336 |
|
15700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6AP1 |
0.600347684925336 |
|
15701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM50A |
0.600347684925336 |
|
15702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDI1 |
0.600347684925336 |
|
15703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT2 |
0.600496006807917 |
|
15704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNC2H1 |
0.600591964842737 |
|
15705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3622B |
0.600650870373912 |
|
15706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF599 |
0.600705066106187 |
|
15707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOS1AP |
0.600757657587301 |
|
15708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFR4 |
0.60088732432105 |
|
15709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC10 |
0.600891960958067 |
|
15710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX1 |
0.600907879332001 |
|
15711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP348 |
0.600964523914293 |
|
15712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212551.1 |
0.601126215570896 |
|
15713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4300 |
0.601128466547923 |
|
15714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUPL2 |
0.601269595018044 |
|
15715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPNMB |
0.601269595018044 |
|
15716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MALSU1 |
0.601269595018044 |
|
15717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000201376.1 |
0.601347134534757 |
|
15718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMX1 |
0.601347134534757 |
|
15719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00519 |
0.601347134534757 |
|
15720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00640 |
0.601347134534757 |
|
15721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1B |
0.601460742645196 |
|
15722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD18A |
0.601488413249647 |
|
15723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX18P3 |
0.601488413249647 |
|
15724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATA4 |
0.601581198405317 |
|
15725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf49 |
0.601581198405317 |
|
15726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEIL2 |
0.601581198405317 |
|
15727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP64 |
0.601615139057688 |
|
15728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL10 |
0.601629566401392 |
|
15729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD23|ENSG00000221139.1 |
0.601630464624734 |
|
15730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OC90 |
0.601652924940237 |
|
15731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHLA1 |
0.601652924940237 |
|
15732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTH2R |
0.601727729072066 |
|
15733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPYR1 |
0.601754738960931 |
|
15734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMTK2 |
0.601916135587603 |
|
15735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHLHA15 |
0.601916135587603 |
|
15736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TECPR1 |
0.601916135587603 |
|
15737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRI3 |
0.601916135587603 |
|
15738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAIAP2L1 |
0.601916135587603 |
|
15739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUPD1 |
0.601925802298359 |
|
15740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALT6 |
0.601947420932494 |
|
15741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF767 |
0.602043549114106 |
|
15742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK14 |
0.602094842240826 |
|
15743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIPF6 |
0.602103961457715 |
|
15744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL9R|ENSG00000124334.12 |
0.602119062163368 |
|
15745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRY3|ENSG00000168939.6 |
0.602119062163368 |
|
15746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAMP7|ENSG00000124333.10 |
0.602119062163368 |
|
15747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASH6P|ENSG00000182484.10 |
0.602119062163368 |
|
15748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASIR1|ENSG00000185203.7
|
0.602119062163368
|
|
15749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREB1 |
0.602170039635366 |
|
15750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOLH1 |
0.602254098953071 |
|
15751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DFNB59 |
0.602272569419545 |
|
15752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP7 |
0.602272569419545 |
|
15753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA3 |
0.602272569419545 |
|
15754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRANK1 |
0.602276266778908 |
|
15755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC4P |
0.602276266778908 |
|
15756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPM2AIP1 |
0.602276266778908 |
|
15757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLH1 |
0.602276266778908 |
|
15758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRFIP2 |
0.602276266778908 |
|
15759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238929.1 |
0.602276266778908 |
|
15760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF13B |
0.602333114008732 |
|
15761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRZB |
0.602386824860645 |
|
15762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL14EP |
0.60246779015711 |
|
15763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00841 |
0.602613658736998 |
|
15764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2B11 |
0.602628110871159 |
|
15765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2W5 |
0.602628110871159 |
|
15766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L4 |
0.602657800905771 |
|
15767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN32 |
0.602657800905771 |
|
15768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF174 |
0.602657800905771 |
|
15769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBIAD1 |
0.602807848040885 |
|
15770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL756P |
0.602855578394185 |
|
15771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548D2 |
0.602855578394185 |
|
15772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR190A |
0.602876606916078 |
|
15773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEG10 |
0.603077704895516 |
|
15774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL854P |
0.603090878610929 |
|
15775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCBP2 |
0.6030951483605 |
|
15776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR13 |
0.6030951483605 |
|
15777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K12 |
0.6030951483605 |
|
15778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TARBP2 |
0.6030951483605 |
|
15779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPFF |
0.6030951483605 |
|
15780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00977 |
0.603133998921331 |
|
15781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM5B |
0.603200117806318 |
|
15782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCAT6 |
0.603200117806318 |
|
15783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM84A |
0.60322612517667 |
|
15784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM71D |
0.603230772892597 |
|
15785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP28 |
0.603242801472469 |
|
15786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR3B |
0.603242801472469 |
|
15787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548G |
0.603253944950444 |
|
15788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHN1 |
0.603309344620884 |
|
15789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC10A6 |
0.603352155692676 |
|
15790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLD3 |
0.603355067747559 |
|
15791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF263 |
0.603430554743632 |
|
15792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIGD7 |
0.603430554743632 |
|
15793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF75A |
0.603430554743632 |
|
15794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2C1 |
0.603430554743632 |
|
15795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFX3 |
0.603540428058827 |
|
15796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252740.1 |
0.603564842218207 |
|
15797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP62 |
0.603564842218207 |
|
15798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP63 |
0.603564842218207 |
|
15799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFBR1 |
0.603665243746414 |
|
15800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL794P |
0.603665243746414 |
|
15801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD18B |
0.603900197007116 |
|
15802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMHR2 |
0.60393115100454 |
|
15803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX3P4 |
0.603947514984358 |
|
15804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP4 |
0.603947514984358 |
|
15805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKRA |
0.603956442494767 |
|
15806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF4 |
0.604023300669884 |
|
15807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL435P |
0.60405611102693 |
|
15808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5AN1 |
0.60405611102693 |
|
15809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf64 |
0.604114595697933 |
|
15810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUX2 |
0.604168892413544 |
|
15811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DR1 |
0.604178072930003 |
|
15812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF8L1 |
0.604213723214995 |
|
15813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABIF |
0.604229930897079 |
|
15814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL12 |
0.604229930897079 |
|
15815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252790.1 |
0.60436416032029 |
|
15816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZW10 |
0.604421982395044 |
|
15817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN25 |
0.604421982395044 |
|
15818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF4P4 |
0.604421982395044 |
|
15819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP46 |
0.60444751097201 |
|
15820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238975.1 |
0.604525478204402 |
|
15821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCE1 |
0.604561263672582 |
|
15822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP168 |
0.604605048883371 |
|
15823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPF |
0.604681064246706 |
|
15824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMG7 |
0.604766985718682 |
|
15825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCF2 |
0.604766985718682 |
|
15826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD38|ENSG00000207109.1 |
0.604769919294229 |
|
15827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUCKS1 |
0.604900086790246 |
|
15828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA72|ENSG00000201944.1 |
0.604900086790246 |
|
15829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B2M |
0.604902912440949 |
|
15830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM69 |
0.604902912440949 |
|
15831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP115 |
0.604908729485125 |
|
15832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLK1 |
0.604908729485125 |
|
15833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5M8 |
0.604927640522607 |
|
15834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5M11 |
0.604927640522607 |
|
15835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5M10 |
0.604927640522607 |
|
15836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBAP2 |
0.604975807235714 |
|
15837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4325 |
0.605068362043643 |
|
15838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPO11 |
0.605068362043643 |
|
15839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1D |
0.605111617610864 |
|
15840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K19 |
0.605113366858304 |
|
15841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238337.1 |
0.605113366858304 |
|
15842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXQ1 |
0.605353620728871 |
|
15843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXF2 |
0.605353620728871 |
|
15844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRAM2 |
0.605369131241917 |
|
15845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEPT1 |
0.605369131241917 |
|
15846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND2D |
0.605369131241917 |
|
15847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHIAP2 |
0.605369131241917 |
|
15848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHIA |
0.605369131241917 |
|
15849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAB1 |
0.605530715035858 |
|
15850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5DC2 |
0.605530715035858 |
|
15851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00681 |
0.605599790851162 |
|
15852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1456 |
0.605599790851162 |
|
15853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf69 |
0.605637478196866 |
|
15854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238970.1 |
0.605718264452586 |
|
15855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CISD1 |
0.605718264452586 |
|
15856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238624.1 |
0.605746594517985 |
|
15857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR35 |
0.605782222669148 |
|
15858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM3A |
0.605810630031145 |
|
15859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB5B |
0.605937759794205 |
|
15860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPD1 |
0.605956473160148 |
|
15861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR320C1 |
0.605956473160148 |
|
15862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNASE1L3 |
0.60595946715873 |
|
15863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR762 |
0.606003330390226 |
|
15864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTF1 |
0.606003330390226 |
|
15865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF18 |
0.606038000274366 |
|
15866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS5 |
0.606064793767113 |
|
15867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5M9 |
0.606109472126858 |
|
15868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPSAP2 |
0.606130670358727 |
|
15869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL627P |
0.606130670358727 |
|
15870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASNS |
0.606205019807617 |
|
15871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYHIN1 |
0.606219272469632 |
|
15872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CADM3 |
0.606219272469632 |
|
15873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DARC |
0.606219272469632 |
|
15874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC17 |
0.606301627627116 |
|
15875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PER3 |
0.606355171838174 |
|
15876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548H3 |
0.606530082687965 |
|
15877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC39C |
0.606577587936733 |
|
15878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP1 |
0.606783247143512 |
|
15879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACADS |
0.606964743796633 |
|
15880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTS2 |
0.607003164006128 |
|
15881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRU |
0.607010814432626 |
|
15882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCDC1 |
0.607098923831307 |
|
15883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD3 |
0.607241054299184 |
|
15884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPMK |
0.607325871691637 |
|
15885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROBO2 |
0.607327685395586 |
|
15886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRHR2 |
0.607357900104106 |
|
15887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP3 |
0.607365344139202 |
|
15888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP54 |
0.60748171220673 |
|
15889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM56 |
0.60748171220673 |
|
15890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALAS1 |
0.607506719356465 |
|
15891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP184 |
0.607567241301782 |
|
15892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD2 |
0.607614612402422 |
|
15893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252592.1 |
0.60770363155441 |
|
15894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITPNM2 |
0.60774716477679 |
|
15895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000207165.1 |
0.607750357015771 |
|
15896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXNA3 |
0.607750357015771 |
|
15897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAGE3 |
0.607750357015771 |
|
15898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBL4A |
0.607750357015771 |
|
15899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC10A3 |
0.607750357015771 |
|
15900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL697P |
0.607750357015771 |
|
15901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL742P |
0.607750357015771 |
|
15902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP225 |
0.60775709780215 |
|
15903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238598.1 |
0.607758610718855 |
|
15904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMD |
0.607803364415776 |
|
15905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLNA |
0.607803364415776 |
|
15906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLAMF6 |
0.607820281568401 |
|
15907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP354 |
0.607820408343191 |
|
15908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf128 |
0.607875404446617 |
|
15909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR320B1 |
0.608020987832332 |
|
15910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf137 |
0.608020987832332 |
|
15911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B7P2 |
0.608116963522642 |
|
15912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL19 |
0.608121061827926 |
|
15913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORAI3 |
0.608121061827926 |
|
15914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NABP2 |
0.608229517937139 |
|
15915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODF4 |
0.608240382226714 |
|
15916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF536 |
0.608264353083662 |
|
15917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCNXL4 |
0.608361977417292 |
|
15918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS7 |
0.608361977417292 |
|
15919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BZW1 |
0.608378479858941 |
|
15920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSU1P2 |
0.608381220194963 |
|
15921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TESK2 |
0.608483789818146 |
|
15922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP85 |
0.608673726787471 |
|
15923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
N6AMT1 |
0.608863378698723 |
|
15924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000208308.1 |
0.608904223445124 |
|
15925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPFFR1 |
0.608915938248066 |
|
15926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL399P |
0.608934840804217 |
|
15927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL232P |
0.608975794290335 |
|
15928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSGALNACT2 |
0.609293605266423 |
|
15929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGEF1A |
0.609293605266423 |
|
15930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC11P |
0.609293605266423 |
|
15931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXYD4 |
0.609293605266423 |
|
15932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSEN15 |
0.609340522360244 |
|
15933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPHOSPH9 |
0.609550840382632 |
|
15934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5M3 |
0.609686150726926 |
|
15935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL6 |
0.609810548624443 |
|
15936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC12 |
0.609874120068517 |
|
15937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D1B |
0.609900342973795 |
|
15938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP46A1 |
0.60992843096267 |
|
15939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf85 |
0.609938043322463 |
|
15940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP2 |
0.609991910015532 |
|
15941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR7 |
0.61005027965774 |
|
15942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBN1 |
0.61005027965774 |
|
15943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD1A |
0.610140320019732 |
|
15944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD3B7 |
0.610230522594696 |
|
15945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX1B |
0.610230522594696 |
|
15946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D3P2 |
0.610299726322963 |
|
15947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF170 |
0.610304904455009 |
|
15948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5AK2 |
0.610343870725167 |
|
15949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGT6 |
0.61040356416225 |
|
15950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS28 |
0.610478150463989 |
|
15951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNMT |
0.610530370120422 |
|
15952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238572.1 |
0.610571886359791 |
|
15953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSMCE1 |
0.61064739341651 |
|
15954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO5A |
0.610654251706809 |
|
15955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COLGALT2 |
0.610763325500153 |
|
15956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR489 |
0.610769814520933 |
|
15957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR653 |
0.610769814520933 |
|
15958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS14 |
0.610819598348961 |
|
15959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM16L |
0.610856511841557 |
|
15960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW10 |
0.610856511841557 |
|
15961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TVP23B |
0.610856511841557 |
|
15962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00989 |
0.610862043651159 |
|
15963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN10 |
0.61096421169367 |
|
15964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELSR2 |
0.610977664117497 |
|
15965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APPBP2 |
0.611013067603631 |
|
15966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AE2 |
0.611031849275903 |
|
15967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS8 |
0.611212350938109 |
|
15968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000271794.1 |
0.611220775191897 |
|
15969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCA7 |
0.611233028450261 |
|
15970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHSRP |
0.61125495121803 |
|
15971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3940 |
0.61125495121803 |
|
15972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000201945.1 |
0.611280677269006 |
|
15973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RX7 |
0.611280677269006 |
|
15974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RX4 |
0.611280677269006 |
|
15975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMKK2 |
0.611280677269006 |
|
15976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLPP |
0.611518971612808 |
|
15977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALKBH7 |
0.611518971612808 |
|
15978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2F1 |
0.611518971612808 |
|
15979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSPN |
0.611518971612808 |
|
15980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNF1A |
0.611541874896881 |
|
15981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD65|ENSG00000212264.1 |
0.611643329451455 |
|
15982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA4|ENSG00000252829.2 |
0.611674085516555 |
|
15983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVPLL |
0.611686102448119 |
|
15984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC144B |
0.611686102448119 |
|
15985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM106A |
0.611686102448119 |
|
15986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT16P1 |
0.611686102448119 |
|
15987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT17P2 |
0.611686102448119 |
|
15988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS9C |
0.611686102448119 |
|
15989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL639P |
0.611686102448119 |
|
15990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP32P2 |
0.611686102448119 |
|
15991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADARB2 |
0.611694704979794 |
|
15992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSF3 |
0.611697367314204 |
|
15993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD124 |
0.611697367314204 |
|
15994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC13B |
0.611799227908832 |
|
15995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf43 |
0.611860526479833 |
|
15996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OASL |
0.611860526479833 |
|
15997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238745.1 |
0.611954845569989 |
|
15998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP51A1 |
0.612013245271062 |
|
15999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRD1 |
0.612013245271062 |
|
16000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM178A |
0.612027366312498 |
|
16001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR940 |
0.612101980725029 |
|
16002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3677 |
0.612101980725029 |
|
16003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4717 |
0.612101980725029 |
|
16004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OACYLP |
0.612146358704266 |
|
16005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC24 |
0.612346938795743 |
|
16006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A9 |
0.612346938795743 |
|
16007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB6A |
0.612354413083671 |
|
16008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A9 |
0.612434226605899 |
|
16009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEPACAM2 |
0.612614918385074 |
|
16010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC132 |
0.612614918385074 |
|
16011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADRBK1 |
0.612648884782511 |
|
16012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238587.1 |
0.612782067245479 |
|
16013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA3 |
0.612787837279208 |
|
16014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM101A |
0.612838697546536 |
|
16015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMB4 |
0.612841558582404 |
|
16016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASZ1 |
0.612893980679116 |
|
16017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00700 |
0.612900511619983 |
|
16018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUS |
0.61301888908193 |
|
16019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR21 |
0.613118657889129 |
|
16020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABTB2 |
0.613219481194814 |
|
16021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL4A2 |
0.613295256042734 |
|
16022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT16 |
0.613447484175901 |
|
16023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC55 |
0.613464004518371 |
|
16024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APLNR |
0.613464004518371 |
|
16025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4419B |
0.613537445877971 |
|
16026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3612 |
0.613537445877971 |
|
16027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238895.1 |
0.613537445877971 |
|
16028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WISP1 |
0.613543902706126 |
|
16029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDRG1 |
0.613543902706126 |
|
16030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1K |
0.613583590778233 |
|
16031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNH7 |
0.613612718164249 |
|
16032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4705 |
0.613688639067845 |
|
16033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFR3A |
0.613732131767011 |
|
16034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALCR |
0.613784451070017 |
|
16035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP12 |
0.613786691820915 |
|
16036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF6 |
0.613786691820915 |
|
16037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECHDC3 |
0.613830854606985 |
|
16038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2R2 |
0.613945354643592 |
|
16039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNB1 |
0.613985797783377 |
|
16040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP244 |
0.61406121214657 |
|
16041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD2 |
0.61413393336894 |
|
16042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL12P38 |
0.614289396303413 |
|
16043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANP32AP1 |
0.614361674430286 |
|
16044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4X1 |
0.614405024373904 |
|
16045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM107B |
0.61449281353825 |
|
16046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM72 |
0.614495503360392 |
|
16047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf10 |
0.614495503360392 |
|
16048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA12|ENSG00000212342.1 |
0.614518507091827 |
|
16049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KSR2 |
0.614705907453765 |
|
16050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABP2 |
0.614912035401925 |
|
16051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO3 |
0.614967146935686 |
|
16052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL356P |
0.614969805408712 |
|
16053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAL1 |
0.615092618949113 |
|
16054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT11 |
0.615485281329534 |
|
16055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRM |
0.615495114901727 |
|
16056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC10 |
0.615495114901727 |
|
16057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251801.1 |
0.615538729840843 |
|
16058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM205CP |
0.615644126565566 |
|
16059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX40 |
0.615644298391541 |
|
16060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB3GAP1 |
0.61567655688534 |
|
16061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H3F3C |
0.615805645632292 |
|
16062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHIPL1 |
0.615919957768604 |
|
16063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF668 |
0.616203625652614 |
|
16064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS53 |
0.616203625652614 |
|
16065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF646 |
0.616203625652614 |
|
16066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VKORC1 |
0.616203625652614 |
|
16067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCKDK |
0.616203625652614 |
|
16068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE2 |
0.616248335009992 |
|
16069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAP1 |
0.616261899257301 |
|
16070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL352P |
0.616274210207931 |
|
16071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD13D |
0.616305546666214 |
|
16072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSH3 |
0.616305546666214 |
|
16073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL692P |
0.616384219545549 |
|
16074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAPTM4A |
0.616416718865519 |
|
16075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE10A |
0.616528405080405 |
|
16076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAK3 |
0.616567014563153 |
|
16077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEPRE1 |
0.616640857543368 |
|
16078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AR |
0.616808094757286 |
|
16079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTCF |
0.616825385412536 |
|
16080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRGX |
0.616832679513673 |
|
16081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRN1 |
0.616880448670787 |
|
16082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2355 |
0.616954838728977 |
|
16083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKFY1 |
0.617092814481762 |
|
16084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIM1L |
0.617163341747434 |
|
16085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD52 |
0.617163341747434 |
|
16086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL490P |
0.617163341747434 |
|
16087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF683 |
0.617163341747434 |
|
16088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL26 |
0.617283857838806 |
|
16089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF222 |
0.617283857838806 |
|
16090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPOCK1 |
0.617306493810477 |
|
16091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF4 |
0.617417654196584 |
|
16092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF3 |
0.617417654196584 |
|
16093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL147P |
0.617474012387011 |
|
16094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS3ST4 |
0.617492445704683 |
|
16095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNG4 |
0.61755719663223 |
|
16096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf177 |
0.617564983737249 |
|
16097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMTF1 |
0.617713634476353 |
|
16098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM243 |
0.617713634476353 |
|
16099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN19 |
0.61775353251602 |
|
16100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAMD1A |
0.617964616479632 |
|
16101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD11 |
0.617965386985393 |
|
16102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM95 |
0.617965386985393 |
|
16103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNK1 |
0.617965386985393 |
|
16104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KALRN |
0.617987299912106 |
|
16105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHD2 |
0.617995065093988 |
|
16106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP260 |
0.618263190730019 |
|
16107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE11A |
0.618381373451274 |
|
16108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0556 |
0.618391954780657 |
|
16109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL31 |
0.618393810332603 |
|
16110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP403 |
0.618395295366844 |
|
16111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4643 |
0.618487339051244 |
|
16112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD9 |
0.618508668108444 |
|
16113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARM1P1 |
0.618552762929609 |
|
16114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB3 |
0.618591719187244 |
|
16115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000252204.1 |
0.618598940008191 |
|
16116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL562P |
0.618702213864071 |
|
16117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM168A |
0.6187158427622 |
|
16118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN1A |
0.618886510933605 |
|
16119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP152 |
0.618886510933605 |
|
16120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD51 |
0.618957038479837 |
|
16121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMDN3 |
0.618957038479837 |
|
16122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFRP4 |
0.619059225805917 |
|
16123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMR3A |
0.619109249610567 |
|
16124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMR3B |
0.619109249610567 |
|
16125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROL1 |
0.619109249610567 |
|
16126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252657.1 |
0.619118377372467 |
|
16127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP66 |
0.619159266516588 |
|
16128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSM1 |
0.619181336304357 |
|
16129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAP2B |
0.619202460330822 |
|
16130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM215 |
0.619211987399009 |
|
16131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM4 |
0.619216108898859 |
|
16132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMD5 |
0.619224074276802 |
|
16133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CWF19L2 |
0.619264388436023 |
|
16134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL18 |
0.61932579979369 |
|
16135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHKG2 |
0.619338854237116 |
|
16136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf93 |
0.619338854237116 |
|
16137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP27 |
0.619345765994527 |
|
16138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR566 |
0.619413566958718 |
|
16139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R2A |
0.619438884438667 |
|
16140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLGAP1 |
0.619536777347626 |
|
16141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC21B |
0.619562482048766 |
|
16142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZRANB3 |
0.619595127279326 |
|
16143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1A4 |
0.619665724758819 |
|
16144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKZF2 |
0.619736847867547 |
|
16145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYTN |
0.619755291835512 |
|
16146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDH1B |
0.619755291835512 |
|
16147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FASTKD2 |
0.619755291835512 |
|
16148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSHB |
0.619772360799429 |
|
16149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL642P |
0.619772654438216 |
|
16150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT3 |
0.620251989206241 |
|
16151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAT8 |
0.620290324771548 |
|
16152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS8 |
0.620290324771548 |
|
16153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS36 |
0.620290324771548 |
|
16154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB4B |
0.620291638284297 |
|
16155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4708 |
0.620296275626131 |
|
16156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPPED2 |
0.620350765037835 |
|
16157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMAN2 |
0.6203793351766 |
|
16158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238565.1 |
0.620398465310825 |
|
16159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCP1A |
0.620398465310825 |
|
16160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL821P |
0.620398465310825 |
|
16161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC23 |
0.620402792933929 |
|
16162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERMAP |
0.620402792933929 |
|
16163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF691 |
0.620402792933929 |
|
16164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLRG1 |
0.620402909107974 |
|
16165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGB |
0.620402909107974 |
|
16166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGA |
0.620402909107974 |
|
16167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGG |
0.620402909107974 |
|
16168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRAT |
0.620402909107974 |
|
16169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM46 |
0.620402909107974 |
|
16170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPN1SW |
0.620407996812553 |
|
16171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC136 |
0.620407996812553 |
|
16172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLXIP |
0.620442614621189 |
|
16173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR31HG |
0.62044597822243 |
|
16174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM229B |
0.620463653673377 |
|
16175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX29 |
0.620701181747406 |
|
16176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPT1 |
0.620888702207421 |
|
16177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST3GAL1 |
0.620939683883744 |
|
16178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS1BP3 |
0.620967078287666 |
|
16179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF7 |
0.620998581939289 |
|
16180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF40 |
0.621041756894951 |
|
16181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED24 |
0.621042569457168 |
|
16182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFIB |
0.621186695530144 |
|
16183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2W |
0.621351285182942 |
|
16184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFC1B |
0.621360062086447 |
|
16185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFC1 |
0.621360062086447 |
|
16186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4F30P |
0.621360062086447 |
|
16187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEI |
0.621360062086447 |
|
16188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEJ |
0.621360062086447 |
|
16189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR148 |
0.621360062086447 |
|
16190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM30B |
0.621421858142726 |
|
16191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLK2 |
0.621427633528814 |
|
16192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRCAP |
0.621455919727474 |
|
16193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA30|ENSG00000206755.1 |
0.621455919727474 |
|
16194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIX1 |
0.62150408767693 |
|
16195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBK1 |
0.621775918291416 |
|
16196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf50 |
0.621785447580146 |
|
16197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL750P |
0.621910602821381 |
|
16198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC43 |
0.621937197797779 |
|
16199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT4 |
0.621937197797779 |
|
16200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIABLO |
0.621937197797779 |
|
16201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAP1 |
0.621961474078136 |
|
16202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF4 |
0.621969430152463 |
|
16203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CR2 |
0.622025256505044 |
|
16204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CR1 |
0.622025256505044 |
|
16205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238717.1 |
0.622050285194298 |
|
16206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPDL |
0.622072791975039 |
|
16207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUTYH |
0.622072791975039 |
|
16208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOE1 |
0.622072791975039 |
|
16209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238945.1 |
0.622072791975039 |
|
16210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIGYF1 |
0.622247454862613 |
|
16211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNB2 |
0.622247454862613 |
|
16212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL716P |
0.622272121959725 |
|
16213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10K2 |
0.6222871878823 |
|
16214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4451 |
0.622321918280795 |
|
16215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL601P |
0.622351957722775 |
|
16216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECSCR |
0.622369197105016 |
|
16217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238905.1 |
0.622388371636439 |
|
16218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00707 |
0.622440755738352 |
|
16219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLGLA |
0.622482264619322 |
|
16220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239041.1 |
0.6225546825658 |
|
16221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL2A |
0.622567180718065 |
|
16222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRC2 |
0.622567180718065 |
|
16223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP193 |
0.622665293941597 |
|
16224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF12 |
0.622703912058319 |
|
16225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SENP3 |
0.622703912058319 |
|
16226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF13 |
0.622703912058319 |
|
16227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BGRL3 |
0.62277882371685 |
|
16228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN11 |
0.62277882371685 |
|
16229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCHD2 |
0.622784122107367 |
|
16230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAT |
0.622784462613438 |
|
16231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGR2A |
0.622828054783567 |
|
16232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGR2B |
0.622828054783567 |
|
16233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGR2C |
0.622828054783567 |
|
16234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGR3A |
0.622828054783567 |
|
16235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCGR3B |
0.622828054783567 |
|
16236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA6 |
0.622828054783567 |
|
16237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL31P11 |
0.622828054783567 |
|
16238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A52 |
0.622837778018028 |
|
16239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTEN |
0.622863997294926 |
|
16240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1045 |
0.623141680864794 |
|
16241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R14C |
0.623146266087172 |
|
16242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00570 |
0.623150365518619 |
|
16243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMPK1 |
0.623186581980152 |
|
16244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD121B |
0.623300636571128 |
|
16245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000199392.1 |
0.623317015523679 |
|
16246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P26 |
0.623377381758595 |
|
16247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1M |
0.623418160178905 |
|
16248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIL1 |
0.62349871858918 |
|
16249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKB |
0.623583731923642 |
|
16250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMC1 |
0.623587980544534 |
|
16251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOA2 |
0.623666498642384 |
|
16252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5187 |
0.623666498642384 |
|
16253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR1I3 |
0.623666498642384 |
|
16254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM40L |
0.623666498642384 |
|
16255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCP4L1 |
0.623666498642384 |
|
16256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPZ |
0.623666498642384 |
|
16257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDHC |
0.623666498642384 |
|
16258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf192 |
0.623666498642384 |
|
16259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBMS3 |
0.623698662291011 |
|
16260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NISCH |
0.623861795256615 |
|
16261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GACAT1 |
0.623870635283757 |
|
16262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGPD4 |
0.623870635283757 |
|
16263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSF |
0.623887381122266 |
|
16264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM205B |
0.623892615720685 |
|
16265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA75|ENSG00000212580.1 |
0.62402080096357 |
|
16266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC12 |
0.624099206074689 |
|
16267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE28 |
0.624138929359095 |
|
16268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL589P |
0.624138929359095 |
|
16269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRG3 |
0.624201736967668 |
|
16270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP114 |
0.624231400789574 |
|
16271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MATN3 |
0.62436477154049 |
|
16272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH13 |
0.624432180683131 |
|
16273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOG |
0.624457429018326 |
|
16274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1328 |
0.624484672491358 |
|
16275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALT3 |
0.624504064386131 |
|
16276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPOX |
0.624504064386131 |
|
16277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS4 |
0.624504064386131 |
|
16278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFS2 |
0.624504064386131 |
|
16279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCER1G |
0.624504064386131 |
|
16280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL729P |
0.62455834870631 |
|
16281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP117 |
0.624795678090777 |
|
16282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX1 |
0.624806345490908 |
|
16283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDPD1 |
0.624815581875987 |
|
16284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL8A2 |
0.624825539016953 |
|
16285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUS4L |
0.624892582883784 |
|
16286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU109|ENSG00000238832.1 |
0.624892582883784 |
|
16287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A4 |
0.624892582883784 |
|
16288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5P2 |
0.625070554995356 |
|
16289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5P3 |
0.625070554995356 |
|
16290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5R1 |
0.625085909781357 |
|
16291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL5B |
0.625093295055945 |
|
16292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN7C |
0.625284547305932 |
|
16293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP339 |
0.625284547305932 |
|
16294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM53 |
0.625314961395026 |
|
16295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf228 |
0.625314961395026 |
|
16296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC3A |
0.625367175574467 |
|
16297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKACG |
0.62554636736876 |
|
16298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLFML2B |
0.625675083856319 |
|
16299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF14 |
0.625685554869961 |
|
16300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2J1 |
0.62569470061522 |
|
16301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL415P |
0.625851158372675 |
|
16302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TKT |
0.625868092992333 |
|
16303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAPK2 |
0.62596824639055 |
|
16304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM96A |
0.62596824639055 |
|
16305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238564.1 |
0.626005010364338 |
|
16306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMPH |
0.626117436996124 |
|
16307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5011 |
0.626136081358677 |
|
16308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HK3 |
0.626153946801473 |
|
16309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAP29 |
0.626166693532974 |
|
16310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELSR1 |
0.626185894905503 |
|
16311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBWD2 |
0.626206343119505 |
|
16312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM173 |
0.626341223206742 |
|
16313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP502 |
0.626399934764984 |
|
16314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2909 |
0.626409149839644 |
|
16315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADPRHL2 |
0.626421161408487 |
|
16316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCQ |
0.626533087022293 |
|
16317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BUD13 |
0.626590748503903 |
|
16318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00395 |
0.62660640492488 |
|
16319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAMP3 |
0.626726868644125 |
|
16320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGPAT4 |
0.626810108274408 |
|
16321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDTC1 |
0.626891437797729 |
|
16322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST7 |
0.626928987475943 |
|
16323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB13 |
0.626978106880986 |
|
16324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL445P |
0.626978106880986 |
|
16325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2U |
0.626991252105216 |
|
16326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAR1 |
0.627002525485544 |
|
16327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRH |
0.627002525485544 |
|
16328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRIT3 |
0.627002525485544 |
|
16329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKFN1 |
0.627017611537425 |
|
16330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS13 |
0.627078366199977 |
|
16331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNNBIP1 |
0.627162512059046 |
|
16332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASD1 |
0.627205664122042 |
|
16333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGCE |
0.627205664122042 |
|
16334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDS1 |
0.627266488041796 |
|
16335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF17 |
0.627323470764669 |
|
16336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX13 |
0.627371388041562 |
|
16337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL21R |
0.627435392030894 |
|
16338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF3C1 |
0.627435392030894 |
|
16339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000200191.1 |
0.627528502036981 |
|
16340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSC |
0.627528502036981 |
|
16341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEKT2 |
0.627624676347475 |
|
16342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR9 |
0.627666660520723 |
|
16343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TWF2 |
0.627666660520723 |
|
16344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf21 |
0.627738842960043 |
|
16345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP21 |
0.627789317399081 |
|
16346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJD3 |
0.627831749608461 |
|
16347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP441 |
0.627831749608461 |
|
16348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP507 |
0.62796429613976 |
|
16349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY4 |
0.62796429613976 |
|
16350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239155.1 |
0.628054663467613 |
|
16351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1B10 |
0.628055607997474 |
|
16352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1B15 |
0.628055607997474 |
|
16353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPGM |
0.628055607997474 |
|
16354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBX1 |
0.628075664009607 |
|
16355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIX3 |
0.628149406435416 |
|
16356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIX2 |
0.628149406435416 |
|
16357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP71 |
0.628294436104957 |
|
16358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRTM2 |
0.628478345852631 |
|
16359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP194 |
0.628478345852631 |
|
16360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPZA1 |
0.628512548579637 |
|
16361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSC2 |
0.628576803155741 |
|
16362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSC1 |
0.628576803155741 |
|
16363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM49B |
0.628580446489146 |
|
16364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM64C |
0.628580446489146 |
|
16365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000212455.1 |
0.62864453148808 |
|
16366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4443 |
0.628722555699398 |
|
16367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD16 |
0.628871413770108 |
|
16368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E2F6 |
0.628947302937786 |
|
16369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYBRD1 |
0.628978035455012 |
|
16370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS15 |
0.628992475675057 |
|
16371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A13 |
0.629014993832488 |
|
16372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPBP1L1 |
0.62903010187767 |
|
16373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNGT1 |
0.629041854763894 |
|
16374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00900 |
0.629278210882555 |
|
16375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM69 |
0.629368671238386 |
|
16376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPP |
0.629368671238386 |
|
16377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB4 |
0.62942898352333 |
|
16378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1P2 |
0.62943967762085 |
|
16379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSEL |
0.629447691028115 |
|
16380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CATSPERG |
0.629486036226638 |
|
16381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC39 |
0.629631001335621 |
|
16382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCHS2 |
0.629818859974119 |
|
16383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXNA2 |
0.629867770103169 |
|
16384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00948 |
0.629886150005994 |
|
16385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3157 |
0.629972477388333 |
|
16386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF518A |
0.629972477388333 |
|
16387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP9 |
0.63010035943328 |
|
16388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIR1 |
0.63010035943328 |
|
16389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCRN3 |
0.63010035943328 |
|
16390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PM20D2 |
0.630299751644856 |
|
16391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRR1 |
0.630299751644856 |
|
16392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000200492.1 |
0.630344758719624 |
|
16393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT81 |
0.63034895537149 |
|
16394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2278 |
0.630366064819684 |
|
16395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUFY3 |
0.63036669745037 |
|
16396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238318.1 |
0.63036669745037 |
|
16397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRSF1 |
0.63036669745037 |
|
16398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP404 |
0.63036688894143 |
|
16399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNNA1 |
0.630422939771068 |
|
16400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHI3L2 |
0.630443431537421 |
|
16401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD121A |
0.630488343383668 |
|
16402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM1L |
0.630552437396428 |
|
16403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR56 |
0.630607004958427 |
|
16404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR97 |
0.630607004958427 |
|
16405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC135 |
0.630607004958427 |
|
16406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KATNB1 |
0.630607004958427 |
|
16407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP123 |
0.630611105928794 |
|
16408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTF2 |
0.630611105928794 |
|
16409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74|ENSG00000252305.1 |
0.630879140053729 |
|
16410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAW1 |
0.630898919033421 |
|
16411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000272237.1 |
0.630898919033421 |
|
16412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL13 |
0.631027555919656 |
|
16413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP185 |
0.631132987071437 |
|
16414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDP |
0.631141940085812 |
|
16415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSG1L |
0.631147507486367 |
|
16416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPHN1 |
0.63121990170041 |
|
16417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF6 |
0.631361376464036 |
|
16418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT4 |
0.631379892726563 |
|
16419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRR2 |
0.631506091098084 |
|
16420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC6 |
0.631554438276988 |
|
16421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP26C1 |
0.631554438276988 |
|
16422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP26A1 |
0.631554438276988 |
|
16423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPM6 |
0.631566241753301 |
|
16424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1B1 |
0.63168000337241 |
|
16425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP13 |
0.631700593763161 |
|
16426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC3P |
0.631746488994118 |
|
16427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBL2 |
0.63175441765405 |
|
16428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPPR1 |
0.631871715567366 |
|
16429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00840 |
0.631873416379635 |
|
16430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL377P |
0.631950964229615 |
|
16431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL625P |
0.631950964229615 |
|
16432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYW1B |
0.631950964229615 |
|
16433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC2P |
0.632028758379471 |
|
16434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITRM1 |
0.632037767456396 |
|
16435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC3A1 |
0.632220412948396 |
|
16436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PREPL |
0.632220412948396 |
|
16437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4486 |
0.632341795555659 |
|
16438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA1|ENSG00000207407.1 |
0.632341795555659 |
|
16439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM40 |
0.632457188155702 |
|
16440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC5 |
0.63254879489617 |
|
16441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPN |
0.632767715553686 |
|
16442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXYD3 |
0.632767715553686 |
|
16443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GHITM |
0.632769118931468 |
|
16444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA64|ENSG00000238934.1 |
0.632895895794855 |
|
16445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UFC1 |
0.632895895794855 |
|
16446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA3 |
0.632972638430617 |
|
16447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAM1 |
0.633013555759779 |
|
16448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCSK5 |
0.633045149485373 |
|
16449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK38L |
0.633273100360927 |
|
16450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000209582.1 |
0.633302392399244 |
|
16451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF346 |
0.633311405348587 |
|
16452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP78 |
0.633474635119752 |
|
16453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3155A |
0.633474635119752 |
|
16454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf110 |
0.633536151863427 |
|
16455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XKR9 |
0.633622793101656 |
|
16456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCRLA |
0.633665698830878 |
|
16457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCRLB |
0.633665698830878 |
|
16458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL466P |
0.633665698830878 |
|
16459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFKP |
0.633768926220484 |
|
16460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRC5 |
0.63386390682721 |
|
16461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAOK3 |
0.634078547281002 |
|
16462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNGTT |
0.634195788489143 |
|
16463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF126P1 |
0.634195924381614 |
|
16464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPS1L1 |
0.634300522711235 |
|
16465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMS |
0.63439279317456 |
|
16466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL611P |
0.63439279317456 |
|
16467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP55 |
0.634464912919328 |
|
16468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A6 |
0.634467713527308 |
|
16469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP158 |
0.634673495032632 |
|
16470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX22 |
0.634826927314016 |
|
16471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIB |
0.634826927314016 |
|
16472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239140.1 |
0.634830394124025 |
|
16473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC14 |
0.634904738767605 |
|
16474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGN |
0.634989314713123 |
|
16475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB10 |
0.635164577172866 |
|
16476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM13C |
0.635262288590802 |
|
16477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD101 |
0.635322841788351 |
|
16478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTBL2 |
0.635359592214068 |
|
16479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP59 |
0.635390003355655 |
|
16480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERBB4 |
0.635416799456796 |
|
16481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VASH1 |
0.635453695062653 |
|
16482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EYA1 |
0.63561435298441 |
|
16483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PELP1 |
0.635651302644787 |
|
16484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELF4 |
0.635708721551638 |
|
16485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HN1L |
0.635715499393269 |
|
16486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00616 |
0.63572482490613 |
|
16487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNRC1 |
0.635760962943586 |
|
16488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL336P |
0.635760962943586 |
|
16489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF12 |
0.635760962943586 |
|
16490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF7 |
0.635765553344971 |
|
16491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA3G |
0.635765553344971 |
|
16492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNC1 |
0.635765553344971 |
|
16493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD6 |
0.635812072295674 |
|
16494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUDS3 |
0.635940719482013 |
|
16495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA3F |
0.636067600687506 |
|
16496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLBD2 |
0.636081309359602 |
|
16497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDS |
0.636081309359602 |
|
16498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDSL |
0.636081309359602 |
|
16499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHX5 |
0.636081309359602 |
|
16500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP104 |
0.636085288544671 |
|
16501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL661P |
0.636104132282237 |
|
16502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA72|ENSG00000206901.1 |
0.636141053950995 |
|
16503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A12 |
0.636164927276779 |
|
16504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNC1I2 |
0.636205961915538 |
|
16505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSC3 |
0.636321161635332 |
|
16506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3614 |
0.63648115850681 |
|
16507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3920 |
0.636656038208768 |
|
16508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RORB |
0.636874487538128 |
|
16509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1B |
0.636882843789196 |
|
16510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239052.1 |
0.636882843789196 |
|
16511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL755P |
0.636999055815307 |
|
16512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM69A |
0.63705964066453 |
|
16513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALOXE3 |
0.637287259937467 |
|
16514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HES7 |
0.637287259937467 |
|
16515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL25A1 |
0.637303842885554 |
|
16516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf82 |
0.637383879864469 |
|
16517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL720P |
0.637433485725649 |
|
16518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00619 |
0.63745866727114 |
|
16519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL493P |
0.637490518204464 |
|
16520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A1 |
0.637549435438295 |
|
16521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A2 |
0.637549435438295 |
|
16522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A3 |
0.637549435438295 |
|
16523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD20A4 |
0.637549435438295 |
|
16524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBWD3 |
0.637549435438295 |
|
16525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBWD5 |
0.637549435438295 |
|
16526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBWD6 |
0.637549435438295 |
|
16527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBWD7 |
0.637549435438295 |
|
16528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTNAP3B |
0.637549435438295 |
|
16529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTNAP3 |
0.637549435438295 |
|
16530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM27A |
0.637549435438295 |
|
16531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM27B |
0.637549435438295 |
|
16532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM27C |
0.637549435438295 |
|
16533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM27D1 |
0.637549435438295 |
|
16534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM27E1 |
0.637549435438295 |
|
16535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM27E2 |
0.637549435438295 |
|
16536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM27E3 |
0.637549435438295 |
|
16537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM74A1 |
0.637549435438295 |
|
16538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM74A2 |
0.637549435438295 |
|
16539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM74A3 |
0.637549435438295 |
|
16540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM74A4 |
0.637549435438295 |
|
16541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM74A5 |
0.637549435438295 |
|
16542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM74A6 |
0.637549435438295 |
|
16543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM95B1 |
0.637549435438295 |
|
16544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD4L2 |
0.637549435438295 |
|
16545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD4L3 |
0.637549435438295 |
|
16546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD4L4 |
0.637549435438295 |
|
16547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD4L5 |
0.637549435438295 |
|
16548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD4L6 |
0.637549435438295 |
|
16549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1299 |
0.637549435438295 |
|
16550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4477A |
0.637549435438295 |
|
16551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGM5P2 |
0.637549435438295 |
|
16552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL343P |
0.637549435438295 |
|
16553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL422P |
0.637549435438295 |
|
16554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL462P |
0.637549435438295 |
|
16555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL544P |
0.637549435438295 |
|
16556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL565P |
0.637549435438295 |
|
16557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL640P |
0.637549435438295 |
|
16558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL722P |
0.637549435438295 |
|
16559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL763P |
0.637549435438295 |
|
16560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL787P |
0.637549435438295 |
|
16561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP283 |
0.637549435438295 |
|
16562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP284 |
0.637549435438295 |
|
16563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252133.1 |
0.637549435438295 |
|
16564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252617.1 |
0.637549435438295 |
|
16565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252724.1 |
0.637549435438295 |
|
16566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252878.1 |
0.637549435438295 |
|
16567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31A1 |
0.637549435438295 |
|
16568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31A2 |
0.637549435438295 |
|
16569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31A3 |
0.637549435438295 |
|
16570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31A4 |
0.637549435438295 |
|
16571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31A5 |
0.637549435438295 |
|
16572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31A6 |
0.637549435438295 |
|
16573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31A7 |
0.637549435438295 |
|
16574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF658 |
0.637549435438295 |
|
16575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS27L |
0.637584516683604 |
|
16576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM17 |
0.637693570113585 |
|
16577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPLA |
0.637763485247739 |
|
16578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC80 |
0.637780919616966 |
|
16579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMPD2 |
0.637849181460088 |
|
16580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTN3 |
0.637899336193359 |
|
16581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC37 |
0.638116529234364 |
|
16582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000199927.1 |
0.638218657077461 |
|
16583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKK1 |
0.638272427195199 |
|
16584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4774 |
0.638327349643621 |
|
16585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COLEC12 |
0.638502032329635 |
|
16586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFKFB4 |
0.638536994530351 |
|
16587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOS1 |
0.638556564215173 |
|
16588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO21 |
0.638609522065122 |
|
16589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AK9 |
0.638630609133726 |
|
16590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF259 |
0.638642105039029 |
|
16591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOA5 |
0.638642105039029 |
|
16592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238348.1 |
0.638712727252088 |
|
16593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM6B |
0.638821630686395 |
|
16594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM88 |
0.638821630686395 |
|
16595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPP5 |
0.638825284364425 |
|
16596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF8L2 |
0.638841861416675 |
|
16597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf96 |
0.638858502936587 |
|
16598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAMP1 |
0.638860727919455 |
|
16599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP8B5P |
0.638863724743808 |
|
16600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH18A1 |
0.638868664743456 |
|
16601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATRIP |
0.638894978044723 |
|
16602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHISA5 |
0.638894978044723 |
|
16603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREX1 |
0.638894978044723 |
|
16604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYN2 |
0.639109594786335 |
|
16605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMP4 |
0.639109594786335 |
|
16606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOP2A |
0.639121160279932 |
|
16607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFBP4 |
0.639121160279932 |
|
16608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNS4 |
0.639121160279932 |
|
16609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSUN6 |
0.639124121140382 |
|
16610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00954 |
0.639231502931359 |
|
16611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALKBH3 |
0.639319611455654 |
|
16612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR211 |
0.63936376704659 |
|
16613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YPEL2 |
0.639466713342603 |
|
16614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4729 |
0.639466713342603 |
|
16615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRDMT1 |
0.639482194467597 |
|
16616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMPD3 |
0.63964968672809 |
|
16617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35B4 |
0.639722195990375 |
|
16618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADIPOR1 |
0.640097823928313 |
|
16619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL1A2 |
0.640244221167167 |
|
16620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC1A1 |
0.640256452036263 |
|
16621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL7A |
0.640323932632972 |
|
16622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPO7 |
0.640394315188253 |
|
16623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRI |
0.640505997662178 |
|
16624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4265 |
0.640539008626929 |
|
16625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL497P |
0.640608989089288 |
|
16626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212538.1 |
0.64063467732093 |
|
16627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP71 |
0.640787986004501 |
|
16628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOXL |
0.640805820216982 |
|
16629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMC5 |
0.640823879648328 |
|
16630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GADL1 |
0.640939304415473 |
|
16631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAG2 |
0.640947319937739 |
|
16632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULBP2 |
0.640966168768038 |
|
16633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAET1L |
0.640966168768038 |
|
16634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LACTB |
0.640983189143245 |
|
16635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEST1 |
0.640995486978888 |
|
16636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTH1 |
0.640995486978888 |
|
16637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLK |
0.641034132205508 |
|
16638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKDD1B |
0.641034132205508 |
|
16639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POC5 |
0.641034132205508 |
|
16640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFKFB3 |
0.641051055779246 |
|
16641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238438.1 |
0.641067119580527 |
|
16642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFPM2 |
0.641068760551807 |
|
16643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIA |
0.641205099289594 |
|
16644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC9 |
0.641315086038003 |
|
16645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSNAX |
0.641415039558933 |
|
16646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GID8 |
0.641440405941916 |
|
16647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC17A9 |
0.641440405941916 |
|
16648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C18orf56 |
0.641482734767054 |
|
16649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CETN1 |
0.641482734767054 |
|
16650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLUL1 |
0.641482734767054 |
|
16651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENOSF1 |
0.641482734767054 |
|
16652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP146 |
0.641482734767054 |
|
16653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYMS |
0.641482734767054 |
|
16654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YES1 |
0.641482734767054 |
|
16655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHF |
0.641495332929368 |
|
16656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRF1 |
0.641563761668842 |
|
16657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALN1 |
0.641699104720926 |
|
16658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8orf12 |
0.641708404037803 |
|
16659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBCK |
0.641713256635484 |
|
16660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIMP1 |
0.641713256635484 |
|
16661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIMD1 |
0.641713256635484 |
|
16662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1203 |
0.641831172686931 |
|
16663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSF3 |
0.64185799207201 |
|
16664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APRT |
0.64185799207201 |
|
16665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBFA2T3 |
0.64185799207201 |
|
16666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH15 |
0.64185799207201 |
|
16667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDT1 |
0.64185799207201 |
|
16668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTU2 |
0.64185799207201 |
|
16669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYBA |
0.64185799207201 |
|
16670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNS |
0.64185799207201 |
|
16671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17C |
0.64185799207201 |
|
16672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00304 |
0.64185799207201 |
|
16673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4722 |
0.64185799207201 |
|
16674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5189 |
0.64185799207201 |
|
16675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MVD |
0.64185799207201 |
|
16676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPN1L |
0.64185799207201 |
|
16677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIEZO1 |
0.64185799207201 |
|
16678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF166 |
0.64185799207201 |
|
16679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A31 |
0.64185799207201 |
|
16680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAI3 |
0.64185799207201 |
|
16681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC2L |
0.64185799207201 |
|
16682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H18 |
0.64185799207201 |
|
16683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF778 |
0.64185799207201 |
|
16684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLE2 |
0.642040370471092 |
|
16685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC30P |
0.642040370471092 |
|
16686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM229A |
0.642044835544696 |
|
16687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF5 |
0.642084438145136 |
|
16688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL581P |
0.642131600503364 |
|
16689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AWAT1 |
0.642131600503364 |
|
16690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFR1OP2 |
0.642138086518638 |
|
16691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP226 |
0.642143807087235 |
|
16692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221040.1 |
0.642220002733208 |
|
16693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAX |
0.642235721388233 |
|
16694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf54 |
0.642244528081056 |
|
16695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPA |
0.642244528081056 |
|
16696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL252P |
0.642245437506749 |
|
16697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBNA1BP2 |
0.64231581910598 |
|
16698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIDO1 |
0.642351024975362 |
|
16699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2D2 |
0.642359753180759 |
|
16700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTL |
0.642383521604376 |
|
16701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD109A |
0.642394060657928 |
|
16702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A9 |
0.642497853474634 |
|
16703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIP6 |
0.642497853474634 |
|
16704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRRT |
0.642497853474634 |
|
16705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACHE |
0.642497853474634 |
|
16706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UFSP1 |
0.642497853474634 |
|
16707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL549P |
0.642497853474634 |
|
16708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDYE3 |
0.64261025403206 |
|
16709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAG3L5P |
0.64261025403206 |
|
16710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDNF |
0.642626305714103 |
|
16711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA14 |
0.642626305714103 |
|
16712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUV39H2 |
0.642626305714103 |
|
16713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCLRE1C |
0.642626305714103 |
|
16714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEIG1 |
0.642626305714103 |
|
16715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCC1 |
0.64290212004191 |
|
16716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOOK3 |
0.643114000239986 |
|
16717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIOK3 |
0.643127317062604 |
|
16718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C18orf8 |
0.643127317062604 |
|
16719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFLAR |
0.64314736727763 |
|
16720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238695.1 |
0.643177853277157 |
|
16721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL108P |
0.643220853291803 |
|
16722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCN8 |
0.643221742120645 |
|
16723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCN15 |
0.643221742120645 |
|
16724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MXD4 |
0.643268882532426 |
|
16725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4800 |
0.643268882532426 |
|
16726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL283P |
0.64331765371124 |
|
16727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00314 |
0.643378923623487 |
|
16728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGO3 |
0.643498564939887 |
|
16729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP297 |
0.643510678425119 |
|
16730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALOX15 |
0.643542420986381 |
|
16731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCN1 |
0.643545461443167 |
|
16732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL387P |
0.643570954403641 |
|
16733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK11 |
0.643598647881293 |
|
16734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERBB2IP |
0.64362426492932 |
|
16735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIB2 |
0.643637559143854 |
|
16736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3125 |
0.643637559143854 |
|
16737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAB2 |
0.643745104264991 |
|
16738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC29 |
0.643746016872254 |
|
16739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARR3 |
0.643909133965324 |
|
16740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZD11 |
0.643909133965324 |
|
16741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB41 |
0.643909133965324 |
|
16742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAG3 |
0.643909260171592 |
|
16743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATS |
0.643909260171592 |
|
16744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PVRIG |
0.643909260171592 |
|
16745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP1 |
0.643913261222008 |
|
16746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4671 |
0.643934678722536 |
|
16747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO5A1 |
0.643969410031781 |
|
16748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4498 |
0.644031539440137 |
|
16749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPLP0 |
0.644031539440137 |
|
16750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5A2 |
0.644057817184987 |
|
16751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5A1 |
0.644057817184987 |
|
16752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM160A1 |
0.644146679678967 |
|
16753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNQ3 |
0.644159412735519 |
|
16754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULBP1 |
0.644217926140752 |
|
16755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC11P |
0.644241696677361 |
|
16756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A3 |
0.644405962338495 |
|
16757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0020 |
0.644418310993324 |
|
16758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEP1B |
0.644441028570238 |
|
16759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBCEL |
0.644457879513262 |
|
16760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BDNF |
0.644534396332163 |
|
16761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD1B |
0.644770210925849 |
|
16762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPD |
0.644770210925849 |
|
16763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD9 |
0.644770210925849 |
|
16764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR66 |
0.644770210925849 |
|
16765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5D1 |
0.644899287255586 |
|
16766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSD1 |
0.644943071963014 |
|
16767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM110 |
0.645054724912752 |
|
16768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC32 |
0.645091757636565 |
|
16769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB3C |
0.645125333030259 |
|
16770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HARBI1 |
0.645150680446589 |
|
16771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00505 |
0.645179837825825 |
|
16772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMBX1 |
0.645179837825825 |
|
16773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIA2 |
0.645274336256158 |
|
16774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTR |
0.645293476634968 |
|
16775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD8 |
0.64553580523446 |
|
16776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL451P |
0.645544444276705 |
|
16777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJD4 |
0.64555384107611 |
|
16778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB3BP |
0.645578076178511 |
|
16779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC3L4 |
0.645600350500232 |
|
16780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00677 |
0.645600350500232 |
|
16781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL8 |
0.645814870192707 |
|
16782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGAL |
0.645896860579344 |
|
16783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4518 |
0.645896860579344 |
|
16784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF747 |
0.645896860579344 |
|
16785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF768 |
0.645896860579344 |
|
16786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238625.1 |
0.646190069159128 |
|
16787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP447 |
0.646250396148285 |
|
16788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA8|ENSG00000207410.1 |
0.646250396148285 |
|
16789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX11 |
0.646269966051155 |
|
16790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VIM |
0.646427733002994 |
|
16791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST8SIA6 |
0.646427733002994 |
|
16792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF5 |
0.646531744462242 |
|
16793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A1 |
0.646641349523169 |
|
16794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARG2 |
0.646641749675118 |
|
16795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCP |
0.646659172374578 |
|
16796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUF2 |
0.646728237275553 |
|
16797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAC1 |
0.646742003900871 |
|
16798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMCN1 |
0.646769146132532 |
|
16799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238988.1 |
0.646783150973364 |
|
16800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238821.1 |
0.646845829485437 |
|
16801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP7 |
0.646925973937939 |
|
16802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252154.1 |
0.646925973937939 |
|
16803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL675P |
0.647009680730896 |
|
16804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP270 |
0.647009680730896 |
|
16805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGAE |
0.647021034085133 |
|
16806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOD1 |
0.647283993525166 |
|
16807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGCT |
0.647283993525166 |
|
16808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL745P |
0.647319170843896 |
|
16809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY8 |
0.647335275594459 |
|
16810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC86 |
0.647364732298615 |
|
16811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGDR2 |
0.647364732298615 |
|
16812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAET1K |
0.647403175765224 |
|
16813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL17RD |
0.647444197451731 |
|
16814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX12 |
0.647488312970838 |
|
16815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULBP3 |
0.647615286256232 |
|
16816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB18 |
0.647729105938766 |
|
16817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB6 |
0.647729105938766 |
|
16818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB5 |
0.647729105938766 |
|
16819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP234 |
0.647742974080253 |
|
16820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHIT1 |
0.647797485961923 |
|
16821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP115 |
0.647809999889929 |
|
16822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL12A |
0.647873103503985 |
|
16823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4479 |
0.647888278148531 |
|
16824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS6ST3 |
0.647908236389703 |
|
16825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR620 |
0.647942294047347 |
|
16826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000252693.1 |
0.648272016248875 |
|
16827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD200 |
0.648337839223097 |
|
16828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf183 |
0.648353119652414 |
|
16829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC162P |
0.648353119652414 |
|
16830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238474.1 |
0.648353119652414 |
|
16831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPGEF4 |
0.648387098378577 |
|
16832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCF11 |
0.649084392915929 |
|
16833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD42 |
0.649084392915929 |
|
16834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAP1B |
0.649133351372613 |
|
16835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP9 |
0.64925720208722 |
|
16836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA21|ENSG00000251866.1 |
0.64925720208722 |
|
16837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD51AP2 |
0.649282614903668 |
|
16838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSNL1 |
0.649282614903668 |
|
16839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG13 |
0.649286481567977 |
|
16840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STXBP4 |
0.649340100958187 |
|
16841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNRG |
0.649365127308263 |
|
16842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM25 |
0.649365221818698 |
|
16843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COIL |
0.649365221818698 |
|
16844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCPEP1 |
0.649365221818698 |
|
16845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUCLG2 |
0.649381683624203 |
|
16846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM43 |
0.649487176719021 |
|
16847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMI |
0.649487176719021 |
|
16848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFAIP6 |
0.649487176719021 |
|
16849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL124P |
0.649487176719021 |
|
16850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF860 |
0.649520247607719 |
|
16851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARS2 |
0.649597209636696 |
|
16852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LETM1 |
0.649707813751097 |
|
16853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A10 |
0.649731130753642 |
|
16854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A8 |
0.649731130753642 |
|
16855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A9 |
0.649731130753642 |
|
16856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A7 |
0.649731130753642 |
|
16857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A6 |
0.649731130753642 |
|
16858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A5 |
0.649731130753642 |
|
16859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A4 |
0.649731130753642 |
|
16860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000200545.1 |
0.649758488267998 |
|
16861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM183A |
0.649816888502025 |
|
16862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRK |
0.649854091443813 |
|
16863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB24 |
0.649937286522053 |
|
16864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETV6 |
0.64999869600595 |
|
16865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CC2D2B |
0.650015616560069 |
|
16866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNJ |
0.650015616560069 |
|
16867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHLPP1 |
0.650021472138748 |
|
16868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238907.1 |
0.650093277665569 |
|
16869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFE2L1 |
0.650104921285459 |
|
16870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4438 |
0.650160273120888 |
|
16871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UHMK1 |
0.650188961193206 |
|
16872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UAP1 |
0.650188961193206 |
|
16873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDR2 |
0.650188961193206 |
|
16874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL861P |
0.650188961193206 |
|
16875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B7 |
0.650188961193206 |
|
16876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00904 |
0.650230566272194 |
|
16877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF30 |
0.650230566272194 |
|
16878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB1 |
0.650269582614383 |
|
16879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNTT |
0.650332033107712 |
|
16880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS6 |
0.650364377394592 |
|
16881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRP10 |
0.650384786646086 |
|
16882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3F |
0.650384786646086 |
|
16883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIP2C |
0.650529286854752 |
|
16884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM187B |
0.650601432639999 |
|
16885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFRKB |
0.650737201630225 |
|
16886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JUP |
0.650859230402998 |
|
16887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF9 |
0.650903488997689 |
|
16888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD8 |
0.650970861878569 |
|
16889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4683 |
0.650970861878569 |
|
16890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A10 |
0.651072916843712 |
|
16891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A11 |
0.651072916843712 |
|
16892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A12 |
0.651072916843712 |
|
16893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A1 |
0.651072916843712 |
|
16894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A2 |
0.651072916843712 |
|
16895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A3 |
0.651072916843712 |
|
16896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A4 |
0.651072916843712 |
|
16897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A5 |
0.651072916843712 |
|
16898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A6 |
0.651072916843712 |
|
16899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A7 |
0.651072916843712 |
|
16900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A8 |
0.651072916843712 |
|
16901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47A9 |
0.651072916843712 |
|
16902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT47B1 |
0.651072916843712 |
|
16903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLUD2 |
0.651072916843712 |
|
16904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP141 |
0.651122021686268 |
|
16905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA5B2 |
0.651141529431066 |
|
16906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG3 |
0.651141529431066 |
|
16907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECE2 |
0.651141529431066 |
|
16908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1224 |
0.651141529431066 |
|
16909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK2N2 |
0.651141529431066 |
|
16910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4G1 |
0.651141529431066 |
|
16911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD66|ENSG00000212158.1 |
0.651141529431066 |
|
16912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM131A |
0.651141529431066 |
|
16913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCN2 |
0.651141529431066 |
|
16914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2H |
0.651141529431066 |
|
16915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THPO |
0.651141529431066 |
|
16916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRD |
0.651141529431066 |
|
16917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A3 |
0.651161015190773 |
|
16918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB3 |
0.651161015190773 |
|
16919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT1A1 |
0.651161015190773 |
|
16920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HJURP |
0.651161015190773 |
|
16921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSL3P1 |
0.651161015190773 |
|
16922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPALIN |
0.651371952653603 |
|
16923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLL2 |
0.651371952653603 |
|
16924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf123 |
0.65144887807111 |
|
16925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4469 |
0.651508261771746 |
|
16926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASAP1 |
0.651689440665604 |
|
16927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A8 |
0.651696809946495 |
|
16928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A18 |
0.651696809946495 |
|
16929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A15 |
0.651696809946495 |
|
16930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MS4A10 |
0.651696809946495 |
|
16931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238772.1 |
0.65173478649485 |
|
16932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAB39 |
0.651781690709511 |
|
16933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMILIN2 |
0.651973282844933 |
|
16934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX18 |
0.652009323627849 |
|
16935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETNPPL |
0.652032949134845 |
|
16936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP14 |
0.652050585525701 |
|
16937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPZ2 |
0.652099761747016 |
|
16938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR152 |
0.652099761747016 |
|
16939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRM3 |
0.652125120541638 |
|
16940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00690 |
0.652266557222264 |
|
16941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCERG1L |
0.652280148674208 |
|
16942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP2M1 |
0.652308274083935 |
|
16943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCF3 |
0.652308274083935 |
|
16944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TG |
0.652345413950176 |
|
16945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPC1 |
0.652359501519492 |
|
16946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF503 |
0.652391174938011 |
|
16947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA14 |
0.652403172488125 |
|
16948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSF5 |
0.65241574661298 |
|
16949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBXAS1 |
0.652465231975141 |
|
16950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT5 |
0.652522050075631 |
|
16951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP151 |
0.652522050075631 |
|
16952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM6 |
0.652676873032502 |
|
16953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL6IP4 |
0.652678303410706 |
|
16954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGFOD2 |
0.652678303410706 |
|
16955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238629.1 |
0.652751992547244 |
|
16956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK6 |
0.652776838188474 |
|
16957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSMD3 |
0.652953377615348 |
|
16958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR563 |
0.652964703359401 |
|
16959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB20 |
0.652967487460684 |
|
16960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPHKAP |
0.653199985176342 |
|
16961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCTS1 |
0.653209959513781 |
|
16962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1GALT1C1 |
0.653209959513781 |
|
16963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A7 |
0.65324931786741 |
|
16964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLA |
0.653287591095677 |
|
16965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP302 |
0.653290708831306 |
|
16966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC5 |
0.653476170703083 |
|
16967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2AB1P |
0.653476170703083 |
|
16968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DVL3 |
0.653476170703083 |
|
16969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR3C |
0.653476170703083 |
|
16970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR3D |
0.653476170703083 |
|
16971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR3E |
0.653476170703083 |
|
16972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL24 |
0.653476170703083 |
|
16973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL6 |
0.653476170703083 |
|
16974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00888 |
0.653476170703083 |
|
16975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP6D1 |
0.653476170703083 |
|
16976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4448 |
0.653476170703083 |
|
16977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARL |
0.653476170703083 |
|
16978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA4|ENSG00000251730.1 |
0.653476170703083 |
|
16979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000199363.1 |
0.653476170703083 |
|
16980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000201229.1 |
0.653476170703083 |
|
16981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA81|ENSG00000253092.1 |
0.653476170703083 |
|
16982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YEATS2 |
0.653476170703083 |
|
16983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACMSD |
0.65347787078435 |
|
16984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5590 |
0.65347787078435 |
|
16985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNT2 |
0.65347787078435 |
|
16986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf166 |
0.653540093359802 |
|
16987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR133A2 |
0.653540093359802 |
|
16988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO4A1 |
0.653540093359802 |
|
16989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00686 |
0.653540093359802 |
|
16990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM53A |
0.65364397890939 |
|
16991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRRA1 |
0.653706328176333 |
|
16992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEGR1 |
0.65411606416432 |
|
16993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDIT4 |
0.654183838627034 |
|
16994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000272262.1 |
0.654191961662606 |
|
16995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000253042.1 |
0.654191961662606 |
|
16996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY1A2 |
0.654220267821365 |
|
16997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC8 |
0.654254204717708 |
|
16998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4EBP2 |
0.654390942608268 |
|
16999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00559 |
0.65441579823357 |
|
17000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5orf20 |
0.654471381754404 |
|
17001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIFAB |
0.654471381754404 |
|
17002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4304 |
0.654497478233392 |
|
17003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL133P |
0.654497478233392 |
|
17004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB12 |
0.654591679496271 |
|
17005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FDX1 |
0.654611372509595 |
|
17006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM183CP |
0.654785091081096 |
|
17007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3148 |
0.654785091081096 |
|
17008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS41 |
0.654895370706793 |
|
17009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A5 |
0.654938266559258 |
|
17010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFY |
0.65573227083624 |
|
17011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM47B |
0.6557756474815 |
|
17012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO7 |
0.655867204223991 |
|
17013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SI |
0.655882270374689 |
|
17014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLITRK3 |
0.655882270374689 |
|
17015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238646.1 |
0.655912876132455 |
|
17016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP9X |
0.656132764728375 |
|
17017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTN1 |
0.656234462007824 |
|
17018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HVCN1 |
0.656234462007824 |
|
17019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC6 |
0.65636222207309 |
|
17020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF674 |
0.656437157388585 |
|
17021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELP6 |
0.656455922773486 |
|
17022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF664 |
0.656554403065135 |
|
17023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFAF4 |
0.656624816519824 |
|
17024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL509P |
0.656624816519824 |
|
17025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC3C |
0.656656209202884 |
|
17026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC4 |
0.656775812747662 |
|
17027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM187 |
0.656985965583047 |
|
17028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRAK1 |
0.656985965583047 |
|
17029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFMBT1 |
0.657015461306429 |
|
17030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TECTA |
0.65702977633393 |
|
17031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTN1 |
0.657038447414166 |
|
17032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1E2 |
0.657199941325862 |
|
17033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL7P |
0.657248358790453 |
|
17034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAZL |
0.657259944363867 |
|
17035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDK4 |
0.657298593246335 |
|
17036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL414P |
0.657304260375541 |
|
17037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSL1D1 |
0.657307680821906 |
|
17038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP87 |
0.657310513013327 |
|
17039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THBS1 |
0.657377132944801 |
|
17040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLD4 |
0.657382189155993 |
|
17041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC20A1 |
0.65740220859506 |
|
17042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5DC4 |
0.65740220859506 |
|
17043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGPD8 |
0.657441181414216 |
|
17044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA8 |
0.657604542662817 |
|
17045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITLN2 |
0.657701560553776 |
|
17046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HELZ |
0.657804709244948 |
|
17047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK39 |
0.657829663281376 |
|
17048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS3 |
0.657884525030749 |
|
17049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASQ1 |
0.658010745383066 |
|
17050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEA15 |
0.658010745383066 |
|
17051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCLK2 |
0.658021335528381 |
|
17052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf57 |
0.658067475790697 |
|
17053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SQRDL |
0.658107856182771 |
|
17054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR4 |
0.658188412527921 |
|
17055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZK1IP1 |
0.658604944687538 |
|
17056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC109B |
0.658616453953354 |
|
17057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf131 |
0.65866558962753 |
|
17058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL7C |
0.658837338200737 |
|
17059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4519 |
0.658837338200737 |
|
17060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF34 |
0.658842944652585 |
|
17061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOM1 |
0.658885013610388 |
|
17062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKAP2L |
0.658922413363914 |
|
17063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1A |
0.658922413363914 |
|
17064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA20|ENSG00000252778.1 |
0.658925001488875 |
|
17065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SECISBP2 |
0.658990293771437 |
|
17066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA2D3 |
0.659047397510208 |
|
17067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSPT1 |
0.65915198513013 |
|
17068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI16 |
0.659436067325557 |
|
17069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R7 |
0.659453922405822 |
|
17070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STIL |
0.659486015666942 |
|
17071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAND5 |
0.659509644936106 |
|
17072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL409P |
0.6596148293502 |
|
17073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MID1IP1 |
0.659676311823797 |
|
17074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4B |
0.659681790542386 |
|
17075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VTI1B |
0.659714578617703 |
|
17076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRA2A |
0.659865764667238 |
|
17077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST8 |
0.659897573894499 |
|
17078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL678P |
0.659912019561997 |
|
17079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPEPL1 |
0.660013064168939 |
|
17080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP266 |
0.660041511842648 |
|
17081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM2B |
0.66008920547308 |
|
17082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD164 |
0.660113361313052 |
|
17083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIL6 |
0.660113361313052 |
|
17084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMPD2 |
0.660113361313052 |
|
17085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICAL1 |
0.660113361313052 |
|
17086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA5 |
0.660236764400931 |
|
17087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFATC3 |
0.660301362251071 |
|
17088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESRP2 |
0.660301362251071 |
|
17089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G15 |
0.660301362251071 |
|
17090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A6 |
0.660301362251071 |
|
17091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A6OS |
0.660301362251071 |
|
17092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238343.1 |
0.660301362251071 |
|
17093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMPD3 |
0.660301362251071 |
|
17094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYAL4 |
0.660333681489035 |
|
17095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1CC |
0.66037651153115 |
|
17096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMA3 |
0.660453403081188 |
|
17097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIS3 |
0.660541647339499 |
|
17098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFAF2 |
0.660558009541422 |
|
17099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSKU |
0.660595716353482 |
|
17100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACER3 |
0.660595716353482 |
|
17101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT6 |
0.660595716353482 |
|
17102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN5 |
0.660595716353482 |
|
17103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OMP |
0.660595716353482 |
|
17104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO7A |
0.660595716353482 |
|
17105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSCR9 |
0.660690742925458 |
|
17106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSCR3 |
0.660690742925458 |
|
17107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW8 |
0.660823333364191 |
|
17108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM183B |
0.660864801375949 |
|
17109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRG3 |
0.661036715090372 |
|
17110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIBF1 |
0.661096971557783 |
|
17111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC14 |
0.661111091188604 |
|
17112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORMDL2 |
0.661111091188604 |
|
17113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL865P |
0.661186220968209 |
|
17114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2C3 |
0.661239120593348 |
|
17115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSU1 |
0.661422807942549 |
|
17116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PASK |
0.661544046887302 |
|
17117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF148 |
0.661623797989234 |
|
17118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELF5 |
0.661657457110396 |
|
17119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR708 |
0.661687260829834 |
|
17120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX6 |
0.661692994638409 |
|
17121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STT3B |
0.661696292894658 |
|
17122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIITA |
0.661882809296182 |
|
17123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX28 |
0.662023739954523 |
|
17124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFT1 |
0.66220135183445 |
|
17125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP261 |
0.662240314022545 |
|
17126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR176 |
0.662246443484397 |
|
17127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF1A2 |
0.662359076341128 |
|
17128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPDPF |
0.662359076341128 |
|
17129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN7A |
0.662451730938885 |
|
17130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPSS1 |
0.662734108752908 |
|
17131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC8A1 |
0.662743707074583 |
|
17132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL3 |
0.662753818402178 |
|
17133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL2 |
0.662753818402178 |
|
17134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMDS |
0.662799910702077 |
|
17135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SREK1IP1 |
0.662858038986702 |
|
17136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP11 |
0.662929843459915 |
|
17137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNB2 |
0.663009502572288 |
|
17138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221400.1 |
0.663074495261373 |
|
17139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BUB1B |
0.663355010662064 |
|
17140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJA1 |
0.663388039465465 |
|
17141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF1 |
0.663442483433849 |
|
17142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MT1HL1 |
0.663515531798319 |
|
17143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP195 |
0.663515531798319 |
|
17144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL39 |
0.663680299766135 |
|
17145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA69|ENSG00000206622.1 |
0.663680299766135 |
|
17146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDGFD |
0.663695260912773 |
|
17147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP7 |
0.663718656948202 |
|
17148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00696 |
0.663718656948202 |
|
17149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPM1 |
0.663772899088393 |
|
17150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU4F2 |
0.664004250806286 |
|
17151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAK2 |
0.66413084740806 |
|
17152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRADB |
0.66413084740806 |
|
17153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APTX |
0.664334139435244 |
|
17154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP206 |
0.664460111359149 |
|
17155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLX5 |
0.664493372581104 |
|
17156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACN9 |
0.664493372581104 |
|
17157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSG1 |
0.664505337879242 |
|
17158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF12 |
0.664579246403297 |
|
17159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP88 |
0.664610896944253 |
|
17160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPAIN |
0.664610896944253 |
|
17161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QBP |
0.664610896944253 |
|
17162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX33 |
0.664610896944253 |
|
17163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DERL2 |
0.664610896944253 |
|
17164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5582 |
0.6647182772595 |
|
17165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD67|ENSG00000252427.1 |
0.6647182772595 |
|
17166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD67|ENSG00000212135.1 |
0.6647182772595 |
|
17167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM78 |
0.664835709039036 |
|
17168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACCSL |
0.664853523542268 |
|
17169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD12 |
0.664866124968546 |
|
17170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENHO |
0.664900479544396 |
|
17171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAN1 |
0.664949255285513 |
|
17172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL614P |
0.664949864678447 |
|
17173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMS2 |
0.665290989734327 |
|
17174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST1 |
0.665334018867635 |
|
17175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL4R |
0.665335795865333 |
|
17176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NYX |
0.665377860804986 |
|
17177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00702 |
0.665455266945122 |
|
17178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABP4 |
0.665564931992846 |
|
17179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR152 |
0.665564931992846 |
|
17180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM134 |
0.665564931992846 |
|
17181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIP |
0.665564931992846 |
|
17182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITPNM1 |
0.665564931992846 |
|
17183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK2AP2 |
0.665564931992846 |
|
17184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL1A |
0.665647016693812 |
|
17185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGP |
0.665672260098434 |
|
17186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC3 |
0.665672260098434 |
|
17187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF609 |
0.66570349058451 |
|
17188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC24B |
0.66577378429163 |
|
17189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL55P |
0.66577378429163 |
|
17190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR576 |
0.66577378429163 |
|
17191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BET1 |
0.665775832528809 |
|
17192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGMS2 |
0.665850617391082 |
|
17193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP32 |
0.665862207991433 |
|
17194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THADA |
0.665868284327321 |
|
17195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf115 |
0.665963674410995 |
|
17196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL699P |
0.666005208446898 |
|
17197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COLEC10 |
0.666007175329304 |
|
17198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCYAP1 |
0.666122659977793 |
|
17199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM13A |
0.666255651310936 |
|
17200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA59|ENSG00000252870.1 |
0.666289494480708 |
|
17201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3923 |
0.666300967699611 |
|
17202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMC6 |
0.666307052337773 |
|
17203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN6 |
0.66636186734678 |
|
17204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCX |
0.66636186734678 |
|
17205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00890 |
0.66636186734678 |
|
17206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEPH |
0.666455357229654 |
|
17207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARF6 |
0.666656081618804 |
|
17208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIFO |
0.666765873119205 |
|
17209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGCP1 |
0.666765873119205 |
|
17210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OVGP1 |
0.666765873119205 |
|
17211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR77 |
0.666765873119205 |
|
17212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAP1A |
0.666765873119205 |
|
17213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL13B |
0.666827804480931 |
|
17214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX19 |
0.666827804480931 |
|
17215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU105C |
0.666865287820037 |
|
17216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP124 |
0.666883786972243 |
|
17217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP374 |
0.666896919122007 |
|
17218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA1 |
0.666924880974062 |
|
17219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF113A |
0.666924880974062 |
|
17220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGRMC1 |
0.666972747610468 |
|
17221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF15 |
0.667114383496477 |
|
17222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZXDC |
0.667114383496477 |
|
17223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UROC1 |
0.667114383496477 |
|
17224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf22 |
0.667114383496477 |
|
17225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST13 |
0.667114383496477 |
|
17226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP138 |
0.667114383496477 |
|
17227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNRD3NB |
0.667114383496477 |
|
17228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNRD3 |
0.667114383496477 |
|
17229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP210P1 |
0.667114383496477 |
|
17230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR37 |
0.667267564765144 |
|
17231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINH1 |
0.66728048738148 |
|
17232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP6 |
0.66728048738148 |
|
17233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR296 |
0.667310327106236 |
|
17234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR298 |
0.667310327106236 |
|
17235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAS |
0.667310327106236 |
|
17236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOGAT2 |
0.667369468115802 |
|
17237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WRN |
0.667495699215526 |
|
17238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPTN |
0.667532996629903 |
|
17239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APBA2 |
0.667654241711954 |
|
17240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP11B |
0.667654241711954 |
|
17241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRFAM7A |
0.667654241711954 |
|
17242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM189A1 |
0.667654241711954 |
|
17243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L7P |
0.667654241711954 |
|
17244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8F |
0.667654241711954 |
|
17245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8G |
0.667654241711954 |
|
17246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8H |
0.667654241711954 |
|
17247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8J |
0.667654241711954 |
|
17248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8M |
0.667654241711954 |
|
17249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8Q |
0.667654241711954 |
|
17250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8R |
0.667654241711954 |
|
17251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8T |
0.667654241711954 |
|
17252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC2P9 |
0.667654241711954 |
|
17253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDNL2 |
0.667654241711954 |
|
17254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL196P |
0.667654241711954 |
|
17255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL238P |
0.667654241711954 |
|
17256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL469P |
0.667654241711954 |
|
17257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL628P |
0.667654241711954 |
|
17258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL673P |
0.667654241711954 |
|
17259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL719P |
0.667654241711954 |
|
17260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL796P |
0.667654241711954 |
|
17261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL829P |
0.667654241711954 |
|
17262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL82P |
0.667654241711954 |
|
17263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TJP1 |
0.667654241711954 |
|
17264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000207430.1 |
0.667654241711954 |
|
17265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000207432.1 |
0.667654241711954 |
|
17266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000238519.1 |
0.667654241711954 |
|
17267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000252602.1 |
0.667654241711954 |
|
17268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULK4P2 |
0.667654241711954 |
|
17269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULK4P3 |
0.667654241711954 |
|
17270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WHAMMP2 |
0.667654241711954 |
|
17271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ278 |
0.667654241711954 |
|
17272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC12A8 |
0.667684660220445 |
|
17273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238520.1 |
0.667718198843357 |
|
17274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLX6 |
0.667872795327854 |
|
17275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKA |
0.66787932490202 |
|
17276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FARP2 |
0.66790010888126 |
|
17277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA77|ENSG00000221643.1 |
0.667924549719706 |
|
17278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF740 |
0.667970038997296 |
|
17279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf195 |
0.667989481471744 |
|
17280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTK6 |
0.667989481471744 |
|
17281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRMS |
0.667989481471744 |
|
17282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HELZ2 |
0.667989481471744 |
|
17283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMEB2 |
0.667989481471744 |
|
17284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD16B |
0.667989481471744 |
|
17285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARFRP1 |
0.667989481471744 |
|
17286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20ORF135 |
0.667989481471744 |
|
17287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf201 |
0.667989481471744 |
|
17288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC5 |
0.667989481471744 |
|
17289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIME1 |
0.667989481471744 |
|
17290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00176 |
0.667989481471744 |
|
17291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1914 |
0.667989481471744 |
|
17292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR647 |
0.667989481471744 |
|
17293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYT1 |
0.667989481471744 |
|
17294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPBWR2 |
0.667989481471744 |
|
17295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPRL1 |
0.667989481471744 |
|
17296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCMTD2 |
0.667989481471744 |
|
17297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF6 |
0.667989481471744 |
|
17298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS19 |
0.667989481471744 |
|
17299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTEL1 |
0.667989481471744 |
|
17300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD10 |
0.667989481471744 |
|
17301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A4RG |
0.667989481471744 |
|
17302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX18 |
0.667989481471744 |
|
17303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STMN3 |
0.667989481471744 |
|
17304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEA2 |
0.667989481471744 |
|
17305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF6B |
0.667989481471744 |
|
17306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPD52L2 |
0.667989481471744 |
|
17307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCKL1 |
0.667989481471744 |
|
17308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB46 |
0.667989481471744 |
|
17309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZGPAT |
0.667989481471744 |
|
17310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF512B |
0.667989481471744 |
|
17311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX52 |
0.667992961613474 |
|
17312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC7 |
0.668065003651531 |
|
17313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLG5 |
0.668258227345296 |
|
17314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPD6 |
0.668351049117535 |
|
17315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HESX1 |
0.668385459838583 |
|
17316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLS2 |
0.668408188615731 |
|
17317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIX4 |
0.668439315726397 |
|
17318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLT1D1 |
0.668678008753581 |
|
17319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC18 |
0.668950682210652 |
|
17320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3133 |
0.669125218094493 |
|
17321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK25 |
0.669125218094493 |
|
17322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG4B |
0.669125218094493 |
|
17323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOK |
0.669125218094493 |
|
17324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXXC11 |
0.669125218094493 |
|
17325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
D2HGDH |
0.669125218094493 |
|
17326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTYMK |
0.669125218094493 |
|
17327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAL3ST2 |
0.669125218094493 |
|
17328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ING5 |
0.669125218094493 |
|
17329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEU4 |
0.669125218094493 |
|
17330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD1 |
0.669125218094493 |
|
17331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP122 |
0.669125218094493 |
|
17332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP4 |
0.669125218094493 |
|
17333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL11 |
0.669225188868964 |
|
17334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA38B |
0.669225188868964 |
|
17335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2B4 |
0.669350220563265 |
|
17336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN23 |
0.669421661288408 |
|
17337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf100 |
0.669422678893118 |
|
17338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEPCE |
0.669425946551431 |
|
17339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R35 |
0.669425946551431 |
|
17340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf61 |
0.669425946551431 |
|
17341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL161P |
0.669425946551431 |
|
17342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSC22D4 |
0.669425946551431 |
|
17343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NYAP1 |
0.669425946551431 |
|
17344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL416P |
0.669425946551431 |
|
17345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGFG2 |
0.669425946551431 |
|
17346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRCH4 |
0.669425946551431 |
|
17347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAP25 |
0.669425946551431 |
|
17348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF259P1 |
0.66943324309422 |
|
17349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC23A1 |
0.669626036699115 |
|
17350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MZB1 |
0.669626036699115 |
|
17351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROB1 |
0.669626036699115 |
|
17352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA24 |
0.669626036699115 |
|
17353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT62 |
0.669742337885251 |
|
17354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UMPS |
0.669871249595411 |
|
17355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR544B |
0.669871249595411 |
|
17356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC16 |
0.669961966790363 |
|
17357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBLN2 |
0.670010964689538 |
|
17358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAOB |
0.670111950920218 |
|
17359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PILRA |
0.670321305262534 |
|
17360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCWPW1 |
0.670321305262534 |
|
17361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB7 |
0.670388079891874 |
|
17362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RARG |
0.670388079891874 |
|
17363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD5 |
0.670388079891874 |
|
17364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESPL1 |
0.670388079891874 |
|
17365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMKMT |
0.670415092608497 |
|
17366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP202 |
0.670425106112689 |
|
17367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH19 |
0.670511480113984 |
|
17368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH2 |
0.670587641480341 |
|
17369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL6IP1 |
0.670590721710507 |
|
17370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf85 |
0.670598744143463 |
|
17371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA4 |
0.670604443675215 |
|
17372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLRG2 |
0.670629048574273 |
|
17373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PWWP2B |
0.670679795235778 |
|
17374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHH2 |
0.670816285809363 |
|
17375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WAPAL |
0.670916884125157 |
|
17376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLGN |
0.670930845412437 |
|
17377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUSC7 |
0.67097344907965 |
|
17378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00853 |
0.671138554959597 |
|
17379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDHD1 |
0.671249541498403 |
|
17380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALX4 |
0.671260005293218 |
|
17381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX57 |
0.671284463033555 |
|
17382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO24 |
0.671336501102746 |
|
17383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOSPD3 |
0.671336501102746 |
|
17384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCOLCE |
0.671336501102746 |
|
17385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFR2 |
0.671336501102746 |
|
17386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTL6B |
0.671336501102746 |
|
17387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2U1 |
0.671350379227832 |
|
17388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HADH |
0.671350379227832 |
|
17389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELF2 |
0.671589114241961 |
|
17390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT12 |
0.67160779969237 |
|
17391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL15A1 |
0.67160779969237 |
|
17392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PWRN2 |
0.671661533896177 |
|
17393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL4P |
0.67186200217615 |
|
17394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SVOPL |
0.671953788068174 |
|
17395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000252188.1 |
0.671953788068174 |
|
17396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0A4 |
0.671953788068174 |
|
17397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM213 |
0.671953788068174 |
|
17398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAOA |
0.671986900763108 |
|
17399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD111|ENSG00000252230.1 |
0.672026689791016 |
|
17400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM66 |
0.672183030698984 |
|
17401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEPROTL1 |
0.672183030698984 |
|
17402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBOAT4 |
0.672183030698984 |
|
17403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCTN6 |
0.672183030698984 |
|
17404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGIP1 |
0.672203745417027 |
|
17405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MZT1 |
0.672253202199991 |
|
17406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BORA |
0.672253202199991 |
|
17407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3117 |
0.672298914084631 |
|
17408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP89 |
0.672301897075131 |
|
17409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD5 |
0.672311275436374 |
|
17410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4318 |
0.672391731763074 |
|
17411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1E |
0.672399877197604 |
|
17412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1D |
0.672451299821704 |
|
17413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT15 |
0.67246180890479 |
|
17414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNE |
0.672508883710476 |
|
17415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRBA |
0.672574987495233 |
|
17416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K1 |
0.672614225430573 |
|
17417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC8 |
0.672619345496331 |
|
17418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA9|ENSG00000252192.1 |
0.672619345496331 |
|
17419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSRC2 |
0.672619345496331 |
|
17420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KNTC1 |
0.672619345496331 |
|
17421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC5 |
0.672672416774767 |
|
17422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238559.1 |
0.672672416774767 |
|
17423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL376P |
0.672672416774767 |
|
17424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMP2 |
0.672748176487831 |
|
17425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSRB3 |
0.672999394539449 |
|
17426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252380.1 |
0.673054460993056 |
|
17427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELA2A |
0.673076054322344 |
|
17428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHH1 |
0.673162671647597 |
|
17429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGH |
0.673162671647597 |
|
17430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL222P |
0.673177467416557 |
|
17431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBNL2 |
0.673231707502144 |
|
17432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D3P5 |
0.673308051858253 |
|
17433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM135B |
0.673414599137388 |
|
17434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCF2L2 |
0.673438804865754 |
|
17435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR581 |
0.673555553111244 |
|
17436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239153.1 |
0.67358945806021 |
|
17437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRIG2 |
0.673602383244194 |
|
17438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAIP2 |
0.673685943304241 |
|
17439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLNK |
0.673728046265457 |
|
17440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LZIC |
0.673737250638311 |
|
17441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMNAT1 |
0.673737250638311 |
|
17442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP269 |
0.673737250638311 |
|
17443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5697 |
0.673737250638311 |
|
17444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSHZ3 |
0.673786155610343 |
|
17445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP4 |
0.67383443032641 |
|
17446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA9|ENSG00000199282.1 |
0.673859098179575 |
|
17447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELA2B |
0.673954792250883 |
|
17448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEF1 |
0.674160553684259 |
|
17449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4652 |
0.674262411483782 |
|
17450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBP7 |
0.674276982831681 |
|
17451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPE |
0.674282141124921 |
|
17452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KANSL1L |
0.674282141124921 |
|
17453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY2D |
0.674371421849789 |
|
17454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA10 |
0.674377203851957 |
|
17455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCFC1 |
0.674377203851957 |
|
17456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RENBP |
0.674377203851957 |
|
17457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NELL1 |
0.674388793227581 |
|
17458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TANGO6 |
0.674562839173558 |
|
17459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4Z1 |
0.674622566802237 |
|
17460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4A22 |
0.674622566802237 |
|
17461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL83P |
0.674651651073702 |
|
17462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCC2 |
0.674655684510454 |
|
17463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POT1 |
0.674717946040865 |
|
17464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN11 |
0.674765208008091 |
|
17465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL6 |
0.674765208008091 |
|
17466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP284 |
0.674827923568926 |
|
17467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD8 |
0.674901004957548 |
|
17468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A9 |
0.674996409610037 |
|
17469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10J4 |
0.675076043199564 |
|
17470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10J1 |
0.675076043199564 |
|
17471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF532 |
0.675102003190318 |
|
17472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA67|ENSG00000207094.1 |
0.675123594308902 |
|
17473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP377 |
0.675198803453072 |
|
17474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf65 |
0.675219200616135 |
|
17475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK2AP1 |
0.675219200616135 |
|
17476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP375 |
0.675219200616135 |
|
17477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00698 |
0.675227778804517 |
|
17478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00353 |
0.675239358903133 |
|
17479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5579 |
0.675314818256108 |
|
17480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGLN2 |
0.675398494980324 |
|
17481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf36 |
0.675408855404143 |
|
17482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BARX2 |
0.675415507633526 |
|
17483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL2BP |
0.675449425311747 |
|
17484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLLP |
0.675449425311747 |
|
17485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHIP |
0.675462715690657 |
|
17486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD17B |
0.675528859635697 |
|
17487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2S1 |
0.67573799483932 |
|
17488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5694 |
0.67573799483932 |
|
17489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP34 |
0.67574080495295 |
|
17490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR622 |
0.67574080495295 |
|
17491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC45A1 |
0.675806981864655 |
|
17492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOF |
0.675859284280513 |
|
17493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM10 |
0.675886337588297 |
|
17494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN1B |
0.675911023903722 |
|
17495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFPI2 |
0.67595200614448 |
|
17496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG11 |
0.67595200614448 |
|
17497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00359 |
0.676114221371815 |
|
17498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXGR1 |
0.676114221371815 |
|
17499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT4 |
0.676211824352005 |
|
17500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT79 |
0.676211824352005 |
|
17501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT78 |
0.676211824352005 |
|
17502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL870P |
0.676255213539454 |
|
17503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSPG5 |
0.676255213539454 |
|
17504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP248 |
0.676392685681735 |
|
17505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P13 |
0.676459742089817 |
|
17506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3184 |
0.676459742089817 |
|
17507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR423 |
0.676459742089817 |
|
17508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF112 |
0.676567639047649 |
|
17509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSG2 |
0.676686512654326 |
|
17510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP290 |
0.676772103793154 |
|
17511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAMDC2 |
0.676834278061861 |
|
17512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ40 |
0.676879073586345 |
|
17513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFBR2 |
0.67698254254583 |
|
17514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARNS1 |
0.676990736948194 |
|
17515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KB2 |
0.676990736948194 |
|
17516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORO1B |
0.676990736948194 |
|
17517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRCAP |
0.676990736948194 |
|
17518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZP1 |
0.67703565539341 |
|
17519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4789 |
0.677195668163596 |
|
17520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000271842.1 |
0.677195668163596 |
|
17521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP11 |
0.677208309034645 |
|
17522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM25A |
0.677208309034645 |
|
17523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ9 |
0.677316244193096 |
|
17524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2C |
0.677316244193096 |
|
17525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOK4 |
0.677316244193096 |
|
17526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AATF |
0.677319041939864 |
|
17527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3R1 |
0.677321946150569 |
|
17528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238306.1 |
0.677421104807171 |
|
17529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548I1 |
0.677530417443652 |
|
17530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM3 |
0.677601734585507 |
|
17531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L13 |
0.677623882319595 |
|
17532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1C4 |
0.67762949803589 |
|
17533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000251909.1 |
0.67762949803589 |
|
17534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VDAC2 |
0.677702159053137 |
|
17535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMTD1 |
0.677702159053137 |
|
17536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDAR |
0.677707088300286 |
|
17537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00589 |
0.677750870824803 |
|
17538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212195.1 |
0.677948505097907 |
|
17539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3HAV1 |
0.678019090857833 |
|
17540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMS1 |
0.678122291090319 |
|
17541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC138 |
0.678122291090319 |
|
17542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPRE2 |
0.678259172024097 |
|
17543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC4 |
0.678356748090294 |
|
17544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBNO1 |
0.678435469152246 |
|
17545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFX2 |
0.67849465817978 |
|
17546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHI3L1 |
0.678539521381171 |
|
17547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM212B |
0.678609902468852 |
|
17548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX20 |
0.678609902468852 |
|
17549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED5 |
0.67863699591288 |
|
17550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC2L |
0.678765110078423 |
|
17551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDPD4 |
0.678765658818388 |
|
17552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLT8D1 |
0.67878008856921 |
|
17553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPCS1 |
0.67878008856921 |
|
17554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK4 |
0.67878008856921 |
|
17555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITIH1 |
0.67878008856921 |
|
17556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITIH3 |
0.67878008856921 |
|
17557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITIH4 |
0.67878008856921 |
|
17558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUSTN1 |
0.67878008856921 |
|
17559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR605 |
0.678933421589691 |
|
17560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGB1P24 |
0.678934771097008 |
|
17561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC63 |
0.678965509271618 |
|
17562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL2 |
0.678965509271618 |
|
17563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOSL2 |
0.679072119074309 |
|
17564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAPT |
0.679096993905574 |
|
17565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC25A |
0.679151179223162 |
|
17566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERK |
0.679154518253404 |
|
17567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000272393.1 |
0.679231889480449 |
|
17568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3HAV1L |
0.679281961175051 |
|
17569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST6GAL2 |
0.679288605491463 |
|
17570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RWDD2B |
0.679435173199079 |
|
17571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP16 |
0.679435173199079 |
|
17572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCT8 |
0.679435173199079 |
|
17573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238339.1 |
0.679482483137188 |
|
17574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POP7 |
0.679527759410927 |
|
17575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPO |
0.679527759410927 |
|
17576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP446 |
0.679708887719162 |
|
17577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADORA1 |
0.67971224327151 |
|
17578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYBPH |
0.67971224327151 |
|
17579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPLB |
0.679748794763697 |
|
17580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR15 |
0.679785797976197 |
|
17581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR550A3 |
0.679785797976197 |
|
17582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL34 |
0.680012556400566 |
|
17583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSTC |
0.680012556400566 |
|
17584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL95P |
0.680068414654179 |
|
17585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL813P |
0.680068414654179 |
|
17586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM19A5 |
0.680233373337523 |
|
17587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A43 |
0.680417781858065 |
|
17588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROS1 |
0.680429470235407 |
|
17589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snosnR66 |
0.680490818689952 |
|
17590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AXIN2 |
0.680545457882465 |
|
17591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP14 |
0.680615430100498 |
|
17592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKAP |
0.680615430100498 |
|
17593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QL3 |
0.680704912060316 |
|
17594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTS |
0.680825150670954 |
|
17595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf34 |
0.680825150670954 |
|
17596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP265 |
0.680826525679545 |
|
17597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTDSPL2 |
0.680843861158917 |
|
17598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AVPR1B |
0.680853114469625 |
|
17599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC64 |
0.680982679166962 |
|
17600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000272464.1 |
0.680982679166962 |
|
17601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB35 |
0.680982679166962 |
|
17602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCN1L1 |
0.680982679166962 |
|
17603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSM3 |
0.680995684562503 |
|
17604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL18 |
0.681180372688385 |
|
17605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPR2 |
0.681182494114036 |
|
17606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC126 |
0.681258395921881 |
|
17607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB4 |
0.681291629973616 |
|
17608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HGD |
0.681291629973616 |
|
17609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABL3 |
0.681291629973616 |
|
17610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2E1 |
0.681291629973616 |
|
17611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00238 |
0.681320629810053 |
|
17612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX16 |
0.681493329200365 |
|
17613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYLTL1B |
0.681493329200365 |
|
17614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFF1 |
0.681543774969275 |
|
17615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPS1 |
0.681585128841723 |
|
17616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABBR2 |
0.681600032766141 |
|
17617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB30 |
0.681633739555288 |
|
17618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70E |
0.681633739555288 |
|
17619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLNC |
0.681638219337427 |
|
17620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1F |
0.681638219337427 |
|
17621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAZ2A |
0.681673028959392 |
|
17622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5B |
0.681673028959392 |
|
17623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKNOX2 |
0.681675859090304 |
|
17624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPR |
0.681694196698476 |
|
17625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HP |
0.681694196698476 |
|
17626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCUN1D1 |
0.681758105585147 |
|
17627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPPED1 |
0.681775876297378 |
|
17628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA27|ENSG00000199474.1 |
0.681775876297378 |
|
17629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA10 |
0.681843037612613 |
|
17630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNYL1 |
0.681866100820981 |
|
17631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSH2 |
0.681975611740799 |
|
17632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H8 |
0.682009426659184 |
|
17633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238951.1 |
0.682009426659184 |
|
17634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H6 |
0.682009426659184 |
|
17635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4B1 |
0.682041925367989 |
|
17636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XIAP |
0.682088958152351 |
|
17637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AK8 |
0.682173583316225 |
|
17638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRD2 |
0.682198588432157 |
|
17639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4301 |
0.682198588432157 |
|
17640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIRC2 |
0.682206545629499 |
|
17641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST7L |
0.682354903640472 |
|
17642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOU |
0.682454412004595 |
|
17643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEMF |
0.682587221315312 |
|
17644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCCC1 |
0.682600570995818 |
|
17645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMP3 |
0.682600570995818 |
|
17646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX38 |
0.68267169087399 |
|
17647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG1L |
0.682672015844583 |
|
17648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86JP |
0.682672015844583 |
|
17649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROPN1B |
0.682672015844583 |
|
17650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC41A3 |
0.682672015844583 |
|
17651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1549 |
0.682684133448043 |
|
17652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNL4B |
0.682688282840103 |
|
17653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP118 |
0.682725654682253 |
|
17654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4718 |
0.682857107857177 |
|
17655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4775 |
0.682907988447709 |
|
17656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD5 |
0.682907988447709 |
|
17657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYCNOS |
0.683002854063537 |
|
17658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYCN |
0.683002854063537 |
|
17659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL104P |
0.683002854063537 |
|
17660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA13 |
0.683014565569925 |
|
17661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL420P |
0.683180855955542 |
|
17662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA42|ENSG00000207502.1 |
0.683180855955542 |
|
17663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC174 |
0.683199146268305 |
|
17664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC26 |
0.683219361184856 |
|
17665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf55 |
0.68323746783282 |
|
17666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUC7L2 |
0.68323746783282 |
|
17667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM37 |
0.683466356832107 |
|
17668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR11 |
0.683466356832107 |
|
17669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP322 |
0.683598408766867 |
|
17670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBN2 |
0.683603296758729 |
|
17671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF629 |
0.683650280271538 |
|
17672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA12 |
0.683812956215771 |
|
17673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKA2 |
0.683845147627845 |
|
17674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL1 |
0.68390323600955 |
|
17675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LANCL1 |
0.68390323600955 |
|
17676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORN2 |
0.683910816764014 |
|
17677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX4 |
0.683920567002383 |
|
17678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPH3 |
0.683930079722241 |
|
17679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXNAD1 |
0.683930079722241 |
|
17680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NGF |
0.684005479134168 |
|
17681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VANGL1 |
0.684005479134168 |
|
17682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNV2 |
0.684092046550443 |
|
17683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC4 |
0.684125599030162 |
|
17684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORBS1 |
0.684366795615216 |
|
17685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGGBP1 |
0.68438752430442 |
|
17686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA4D |
0.684408184858321 |
|
17687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIGD1B |
0.684422590741146 |
|
17688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD59A |
0.684526124076699 |
|
17689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGES3 |
0.684526124076699 |
|
17690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL809P |
0.684526124076699 |
|
17691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP4 |
0.68457331216507 |
|
17692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEPREL4 |
0.684578496271952 |
|
17693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP10 |
0.684578496271952 |
|
17694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10X1 |
0.684593081824823 |
|
17695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6P1 |
0.684593081824823 |
|
17696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6Y1 |
0.684593081824823 |
|
17697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEOX1 |
0.684596388888317 |
|
17698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP275 |
0.684658953456158 |
|
17699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPO2 |
0.684658953456158 |
|
17700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR223 |
0.684851027256599 |
|
17701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSIG4 |
0.684851027256599 |
|
17702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2C9 |
0.684932316560388 |
|
17703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1CL1 |
0.685022736074976 |
|
17704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf41 |
0.685112153872838 |
|
17705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP276 |
0.685151360375137 |
|
17706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSC1 |
0.685164457865118 |
|
17707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDH11 |
0.685443859437821 |
|
17708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL369P |
0.685443859437821 |
|
17709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5092 |
0.685661311720324 |
|
17710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF7IP2 |
0.685796221110617 |
|
17711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA3B |
0.685996730598034 |
|
17712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSRP1 |
0.686095875576031 |
|
17713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf60 |
0.686177352015334 |
|
17714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR2F2 |
0.686245995858825 |
|
17715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1469 |
0.686245995858825 |
|
17716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSMEM2 |
0.686286288001192 |
|
17717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF8 |
0.686440583278357 |
|
17718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF831 |
0.68645904787027 |
|
17719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDN3 |
0.68645904787027 |
|
17720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL8B |
0.686553887385798 |
|
17721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOX |
0.686627020501731 |
|
17722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH5 |
0.686799800695887 |
|
17723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHEX |
0.686799800695887 |
|
17724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDE |
0.686799800695887 |
|
17725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF11 |
0.686799800695887 |
|
17726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL644P |
0.686799800695887 |
|
17727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCIN |
0.686822487895113 |
|
17728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA69|ENSG00000212206.1 |
0.686971397911917 |
|
17729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRBA2 |
0.686971397911917 |
|
17730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF19 |
0.686996176090941 |
|
17731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM109 |
0.686996176090941 |
|
17732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM132A |
0.686996176090941 |
|
17733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A16 |
0.687095090131917 |
|
17734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISPD |
0.68712087932039 |
|
17735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG7 |
0.687250521898938 |
|
17736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL15 |
0.687354305869722 |
|
17737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO7B |
0.687473210977656 |
|
17738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB5 |
0.68748218825409 |
|
17739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP266 |
0.687515071711467 |
|
17740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP14 |
0.687840951290922 |
|
17741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCH2 |
0.687906057816424 |
|
17742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35G5 |
0.687939711956459 |
|
17743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDH |
0.687939711956459 |
|
17744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF27 |
0.687962207561194 |
|
17745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC15A3 |
0.688007750125357 |
|
17746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5002 |
0.688041424468265 |
|
17747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITPNC1 |
0.688100794727486 |
|
17748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2E2 |
0.68812390189393 |
|
17749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM18 |
0.68812390189393 |
|
17750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMPER |
0.688134804150171 |
|
17751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHCHD3 |
0.688145768734728 |
|
17752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX19 |
0.688156416722614 |
|
17753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf91 |
0.688230207536669 |
|
17754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC27 |
0.688272334474701 |
|
17755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3RF1 |
0.688280400259775 |
|
17756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDEM3 |
0.688295448844389 |
|
17757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR9 |
0.68834856243497 |
|
17758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCP4 |
0.688372569049724 |
|
17759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GKAP1 |
0.688452371226918 |
|
17760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFS4 |
0.688509147190211 |
|
17761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB7 |
0.688557727857921 |
|
17762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR196A1 |
0.688557727857921 |
|
17763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDO |
0.688603569493536 |
|
17764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL617P |
0.688603569493536 |
|
17765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM9SF3 |
0.688668327883565 |
|
17766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPB8 |
0.688811933829582 |
|
17767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMLHE |
0.688851029346766 |
|
17768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRPPRC |
0.68887663540164 |
|
17769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNCB |
0.688968568436567 |
|
17770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4E1B |
0.688968568436567 |
|
17771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4281 |
0.688968568436567 |
|
17772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN17 |
0.688968568436567 |
|
17773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC5A |
0.688968568436567 |
|
17774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF2C |
0.689072427166261 |
|
17775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEST4 |
0.689072427166261 |
|
17776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD19 |
0.689072427166261 |
|
17777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLK3 |
0.689072427166261 |
|
17778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS8 |
0.689072427166261 |
|
17779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD38A |
0.689072427166261 |
|
17780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD38B |
0.689072427166261 |
|
17781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD46|ENSG00000200913.1 |
0.689072427166261 |
|
17782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD55 |
0.689072427166261 |
|
17783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTEX1D4 |
0.689072427166261 |
|
17784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFC5 |
0.689075194442051 |
|
17785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INMT |
0.689075832136876 |
|
17786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR606 |
0.689148193501649 |
|
17787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL164P |
0.689172977498556 |
|
17788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB5 |
0.689186134236776 |
|
17789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SATB2 |
0.689341015171863 |
|
17790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MINPP1 |
0.689366081808869 |
|
17791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRA8 |
0.689632001263133 |
|
17792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGBL3 |
0.689652394143273 |
|
17793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAPB |
0.689652605506033 |
|
17794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf83 |
0.689748025032958 |
|
17795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC19A3 |
0.689748025032958 |
|
17796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf49 |
0.68976888660834 |
|
17797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM140 |
0.68976888660834 |
|
17798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR91 |
0.68976888660834 |
|
17799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSL2 |
0.689851074502706 |
|
17800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8K3 |
0.689879769087333 |
|
17801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8K1 |
0.689879769087333 |
|
17802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD86 |
0.689903019994009 |
|
17803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPN3 |
0.689934287137888 |
|
17804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHML |
0.689934287137888 |
|
17805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
G6PD |
0.689938809928482 |
|
17806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA4B |
0.689957174109181 |
|
17807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A5 |
0.689968891176322 |
|
17808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3AP1 |
0.690063875207001 |
|
17809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP324 |
0.690063875207001 |
|
17810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL346P |
0.690065520964632 |
|
17811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRCC3 |
0.690103895980028 |
|
17812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIC2 |
0.690103895980028 |
|
17813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMC4 |
0.690103895980028 |
|
17814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAG1A |
0.690103895980028 |
|
17815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAG1B |
0.690103895980028 |
|
17816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTAG2 |
0.690103895980028 |
|
17817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKC1 |
0.690103895980028 |
|
17818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F8A1 |
0.690103895980028 |
|
17819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F8A2 |
0.690103895980028 |
|
17820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F8A3 |
0.690103895980028 |
|
17821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F8 |
0.690103895980028 |
|
17822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUNDC2 |
0.690103895980028 |
|
17823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAB3 |
0.690103895980028 |
|
17824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFB1 |
0.690103895980028 |
|
17825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFB2 |
0.690103895980028 |
|
17826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFB3 |
0.690103895980028 |
|
17827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPP1 |
0.690103895980028 |
|
17828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTCP1 |
0.690103895980028 |
|
17829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB39B |
0.690103895980028 |
|
17830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM9 |
0.690103895980028 |
|
17831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA36A |
0.690103895980028 |
|
17832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA56 |
0.690103895980028 |
|
17833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VBP1 |
0.690103895980028 |
|
17834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPN4 |
0.69011341201294 |
|
17835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A11 |
0.690121658823434 |
|
17836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM221A |
0.690212850677804 |
|
17837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5F1 |
0.690221517093125 |
|
17838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf162 |
0.690221517093125 |
|
17839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADORA3 |
0.690221517093125 |
|
17840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM247 |
0.690230927471801 |
|
17841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1E2 |
0.690230927471801 |
|
17842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK8 |
0.690244874153646 |
|
17843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC61B |
0.690251086722246 |
|
17844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE12 |
0.690416795373585 |
|
17845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARF4 |
0.690416795373585 |
|
17846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC26P |
0.690416795373585 |
|
17847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND6A |
0.690416795373585 |
|
17848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGEL1 |
0.690482763497181 |
|
17849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG2 |
0.690493190794014 |
|
17850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00167 |
0.69057883316382 |
|
17851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APLP2 |
0.69057883316382 |
|
17852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL22 |
0.690584717441153 |
|
17853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPAD1 |
0.69062672483531 |
|
17854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4A1 |
0.690659226465901 |
|
17855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA67|ENSG00000264772.2 |
0.690659226465901 |
|
17856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD10 |
0.690659226465901 |
|
17857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD68 |
0.690659226465901 |
|
17858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPDU1 |
0.690659226465901 |
|
17859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX15 |
0.690659226465901 |
|
17860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC20P |
0.690686529550085 |
|
17861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00529 |
0.690697834059912 |
|
17862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP17 |
0.690731912729554 |
|
17863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA12 |
0.690791090906754 |
|
17864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY2EP |
0.6908569019 |
|
17865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLSCR3 |
0.690859468652814 |
|
17866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM256 |
0.690859468652814 |
|
17867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR143 |
0.690927769869132 |
|
17868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2C19 |
0.691008489992717 |
|
17869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN9A |
0.691070714289163 |
|
17870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK12 |
0.69120238433565 |
|
17871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP43 |
0.69123162806313 |
|
17872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKBKG |
0.691310474938874 |
|
17873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATOH7 |
0.691314525200347 |
|
17874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHEK2P2 |
0.691418511262962 |
|
17875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT60 |
0.691418511262962 |
|
17876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYFIP1 |
0.691418511262962 |
|
17877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP547L112 |
0.691418511262962 |
|
17878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L1 |
0.691418511262962 |
|
17879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L2 |
0.691418511262962 |
|
17880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L6 |
0.691418511262962 |
|
17881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8DP |
0.691418511262962 |
|
17882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8EP |
0.691418511262962 |
|
17883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8I |
0.691418511262962 |
|
17884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA8S |
0.691418511262962 |
|
17885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC2P2 |
0.691418511262962 |
|
17886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC2P3 |
0.691418511262962 |
|
17887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1268A |
0.691418511262962 |
|
17888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBEAP1 |
0.691418511262962 |
|
17889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPA1 |
0.691418511262962 |
|
17890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPA2 |
0.691418511262962 |
|
17891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4M2 |
0.691418511262962 |
|
17892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4N4 |
0.691418511262962 |
|
17893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEB2 |
0.691418511262962 |
|
17894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POTEB |
0.691418511262962 |
|
17895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL106P |
0.691418511262962 |
|
17896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL400P |
0.691418511262962 |
|
17897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL495P |
0.691418511262962 |
|
17898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL536P |
0.691418511262962 |
|
17899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL545P |
0.691418511262962 |
|
17900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL584P |
0.691418511262962 |
|
17901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL759P |
0.691418511262962 |
|
17902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBGCP5 |
0.691418511262962 |
|
17903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WHAMMP3 |
0.691418511262962 |
|
17904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238960.1 |
0.691418511262962 |
|
17905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239083.1 |
0.691418511262962 |
|
17906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLD5 |
0.691472857995019 |
|
17907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00536 |
0.691546042999527 |
|
17908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252300.1 |
0.691557704060968 |
|
17909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRP9 |
0.691558260015623 |
|
17910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP3 |
0.691558260015623 |
|
17911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL682P |
0.691563348551647 |
|
17912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BNIP3 |
0.691656735807458 |
|
17913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIG4 |
0.691697478468046 |
|
17914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX4 |
0.691866224834668 |
|
17915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238992.1 |
0.691866224834668 |
|
17916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCG5 |
0.691897345723726 |
|
17917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCG8 |
0.691897345723726 |
|
17918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSH2 |
0.692029137873407 |
|
17919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P4 |
0.692032800835101 |
|
17920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIM2 |
0.692035428829942 |
|
17921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPLA8 |
0.692083519480642 |
|
17922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THAP5 |
0.692083519480642 |
|
17923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB9 |
0.692083519480642 |
|
17924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC11 |
0.692108054531856 |
|
17925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM183A |
0.692174231084909 |
|
17926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPFIA4 |
0.692174231084909 |
|
17927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOG |
0.692174231084909 |
|
17928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDB3 |
0.692175263461138 |
|
17929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFBP6 |
0.692186439474739 |
|
17930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOAT2 |
0.692186439474739 |
|
17931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRYD3 |
0.692186439474739 |
|
17932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TENC1 |
0.692186439474739 |
|
17933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH1 |
0.692298762291599 |
|
17934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYPA |
0.692379879793632 |
|
17935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYPB |
0.692379879793632 |
|
17936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYPE |
0.692379879793632 |
|
17937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPHN2 |
0.69239574476919 |
|
17938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLP2R |
0.692431326988883 |
|
17939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNC1I1 |
0.692470648325055 |
|
17940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R2D |
0.692584707766113 |
|
17941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NASP |
0.692596100688949 |
|
17942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCYRN1 |
0.692596185522056 |
|
17943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPCAM |
0.692596185522056 |
|
17944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP119 |
0.692596185522056 |
|
17945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR559 |
0.692596185522056 |
|
17946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB9 |
0.692629449178405 |
|
17947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MNAT1 |
0.692636052912737 |
|
17948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00669 |
0.692641202605768 |
|
17949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTN |
0.692673344168419 |
|
17950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252440.1 |
0.692735407644474 |
|
17951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10A3 |
0.692822619940648 |
|
17952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNC2LI1 |
0.692849809214815 |
|
17953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252359.1 |
0.692850508548397 |
|
17954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPB3 |
0.692922492133044 |
|
17955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRSAM1 |
0.69292877181664 |
|
17956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA23 |
0.692964426203336 |
|
17957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP84 |
0.693046393979763 |
|
17958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4429 |
0.693046393979763 |
|
17959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP85 |
0.693046393979763 |
|
17960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL674P |
0.693046393979763 |
|
17961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238371.1 |
0.693053790177246 |
|
17962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP182 |
0.693074759197001 |
|
17963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDN |
0.693076220936244 |
|
17964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM241 |
0.693124760973824 |
|
17965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RX1 |
0.693221868504898 |
|
17966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2A3 |
0.693221868504898 |
|
17967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP434 |
0.693221868504898 |
|
17968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEG1 |
0.693253164193169 |
|
17969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP137 |
0.693253164193169 |
|
17970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK8IP1 |
0.693276591816793 |
|
17971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf94 |
0.693276591816793 |
|
17972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SORL1 |
0.69334441455831 |
|
17973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP24 |
0.69361945295527 |
|
17974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSG4 |
0.693691420975958 |
|
17975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSG3 |
0.693691420975958 |
|
17976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSG2 |
0.693691420975958 |
|
17977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT76 |
0.693698759185983 |
|
17978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSDMC |
0.693757727114931 |
|
17979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM49B |
0.693757727114931 |
|
17980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000200075.1 |
0.693757727114931 |
|
17981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5194 |
0.693757727114931 |
|
17982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAI1 |
0.693800786665747 |
|
17983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A5 |
0.693803899911867 |
|
17984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM45B |
0.693816251295344 |
|
17985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAT1 |
0.693866161067377 |
|
17986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf71 |
0.6938832958558 |
|
17987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACADL |
0.693918455926893 |
|
17988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC6 |
0.693949343656058 |
|
17989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAET1E |
0.69396458285934 |
|
17990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAET1G |
0.69396458285934 |
|
17991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXE3 |
0.694038043878706 |
|
17992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP126 |
0.694039983398706 |
|
17993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLUD1 |
0.694076869917989 |
|
17994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KMO |
0.69420063292783 |
|
17995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CX3CL1 |
0.694224276180384 |
|
17996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10A6 |
0.694270310891941 |
|
17997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMKK1 |
0.694303283902691 |
|
17998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2B3 |
0.694355140678718 |
|
17999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP47 |
0.694355140678718 |
|
18000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HECTD3 |
0.694355140678718 |
|
18001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN18 |
0.694497357153542 |
|
18002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAKMIP3 |
0.694537835111785 |
|
18003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPYSL4 |
0.694537835111785 |
|
18004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK32C |
0.694537835111785 |
|
18005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP9 |
0.694569118314568 |
|
18006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238981.1 |
0.694643113795518 |
|
18007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTTNBP2NL |
0.694950321065652 |
|
18008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC61A1 |
0.695022918284129 |
|
18009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUVBL1 |
0.695022918284129 |
|
18010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf30 |
0.695118411333493 |
|
18011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA68|ENSG00000251715.1 |
0.695179782037269 |
|
18012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMSN1 |
0.695240260759355 |
|
18013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00498 |
0.695312476446362 |
|
18014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00499 |
0.695312476446362 |
|
18015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD80 |
0.695319214920077 |
|
18016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADPRH |
0.695319214920077 |
|
18017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA1A |
0.695319214920077 |
|
18018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL13 |
0.695325725133867 |
|
18019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NGRN |
0.695325725133867 |
|
18020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZAN |
0.695358445081004 |
|
18021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf49 |
0.695380528414392 |
|
18022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNFT2 |
0.695380528414392 |
|
18023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP11 |
0.695430554985368 |
|
18024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC13 |
0.695485887783561 |
|
18025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIPSL |
0.695567397511861 |
|
18026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLI1 |
0.69559947914635 |
|
18027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO3A1 |
0.695604283224289 |
|
18028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL117P |
0.695607725211115 |
|
18029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZRANB2 |
0.695660934347477 |
|
18030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf67 |
0.695721194017053 |
|
18031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238515.1 |
0.695721194017053 |
|
18032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF3 |
0.695835112350824 |
|
18033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMX1A |
0.695838191316421 |
|
18034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LATS1 |
0.695875126761845 |
|
18035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAM1 |
0.695913131797742 |
|
18036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A1 |
0.69591559481063 |
|
18037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8J1 |
0.695994007244469 |
|
18038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8U1 |
0.695994007244469 |
|
18039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC62 |
0.696028606002776 |
|
18040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF41 |
0.696077010877406 |
|
18041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf24 |
0.696077010877406 |
|
18042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf131 |
0.69614327351544 |
|
18043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSTA |
0.696153906668103 |
|
18044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP129 |
0.696224865668049 |
|
18045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHCHD4 |
0.696278429792312 |
|
18046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM43 |
0.696278429792312 |
|
18047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA9 |
0.696315754323239 |
|
18048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C12 |
0.696316335269089 |
|
18049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WBP11P1 |
0.696497900002925 |
|
18050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10J5 |
0.696514065855385 |
|
18051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F11R |
0.696535168776404 |
|
18052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCOC |
0.696544961735921 |
|
18053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC5 |
0.696693911832397 |
|
18054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SV2B |
0.696733318093086 |
|
18055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF12 |
0.69675461789132 |
|
18056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACBD7 |
0.696779704641593 |
|
18057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf111 |
0.696779704641593 |
|
18058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR718 |
0.69687365865676 |
|
18059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCRN1 |
0.69695055516535 |
|
18060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GARS |
0.697035780538265 |
|
18061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PILRB |
0.697075010293365 |
|
18062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA72|ENSG00000200355.1 |
0.697113903595602 |
|
18063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239141.1 |
0.697113903595602 |
|
18064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OMG |
0.697176824629013 |
|
18065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGC1 |
0.697328976065906 |
|
18066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGC2 |
0.697328976065906 |
|
18067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGJ1 |
0.697328976065906 |
|
18068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGJ2 |
0.697328976065906 |
|
18069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGJP1 |
0.697328976065906 |
|
18070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGJP2 |
0.697328976065906 |
|
18071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGJP |
0.697328976065906 |
|
18072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV10 |
0.697328976065906 |
|
18073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV11 |
0.697328976065906 |
|
18074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV1 |
0.697328976065906 |
|
18075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV2 |
0.697328976065906 |
|
18076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV3 |
0.697328976065906 |
|
18077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV4 |
0.697328976065906 |
|
18078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV5 |
0.697328976065906 |
|
18079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV8 |
0.697328976065906 |
|
18080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRGV9 |
0.697328976065906 |
|
18081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM4A |
0.697383828753883 |
|
18082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFG3L1P |
0.697386981882115 |
|
18083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf3 |
0.697386981882115 |
|
18084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK10 |
0.697386981882115 |
|
18085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPBD1 |
0.697386981882115 |
|
18086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHMP1A |
0.697386981882115 |
|
18087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE7 |
0.697386981882115 |
|
18088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBNDD1 |
0.697386981882115 |
|
18089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEF8 |
0.697386981882115 |
|
18090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPEP1 |
0.697386981882115 |
|
18091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM157C |
0.697386981882115 |
|
18092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCA |
0.697386981882115 |
|
18093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS8 |
0.697386981882115 |
|
18094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MC1R |
0.697386981882115 |
|
18095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM7 |
0.697386981882115 |
|
18096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL13 |
0.697386981882115 |
|
18097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD68 |
0.697386981882115 |
|
18098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA2L |
0.697386981882115 |
|
18099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA33 |
0.697386981882115 |
|
18100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPG7 |
0.697386981882115 |
|
18101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIRE2 |
0.697386981882115 |
|
18102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF25 |
0.697386981882115 |
|
18103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB3 |
0.697386981882115 |
|
18104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB8P7 |
0.697386981882115 |
|
18105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
URAHP |
0.697386981882115 |
|
18106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS9D1 |
0.697386981882115 |
|
18107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF276 |
0.697386981882115 |
|
18108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00567 |
0.697477635396663 |
|
18109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMG8 |
0.69748608611351 |
|
18110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPC |
0.697489589176722 |
|
18111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBNL1 |
0.697513761781878 |
|
18112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4428 |
0.697528681857884 |
|
18113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000252290.1 |
0.697528681857884 |
|
18114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFNB1 |
0.697572153087548 |
|
18115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS2 |
0.697582526920845 |
|
18116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXNB3 |
0.697733197595737 |
|
18117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDH3G |
0.697733197595737 |
|
18118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRPK3 |
0.697733197595737 |
|
18119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSR4 |
0.697733197595737 |
|
18120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZD4 |
0.697733197595737 |
|
18121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD36|ENSG00000251846.1 |
0.697733197595737 |
|
18122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1C7P |
0.697807105560209 |
|
18123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ1 |
0.697912570717613 |
|
18124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ5 |
0.697912570717613 |
|
18125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf45 |
0.697912570717613 |
|
18126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53AIP1 |
0.697912570717613 |
|
18127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL11 |
0.697920944421554 |
|
18128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP55 |
0.697983425486691 |
|
18129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB2B2 |
0.698054606023371 |
|
18130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4634 |
0.698067038456213 |
|
18131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSX2 |
0.698067038456213 |
|
18132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCA10 |
0.698142233421472 |
|
18133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLAH |
0.698256541430591 |
|
18134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH1L1 |
0.698382311216783 |
|
18135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U1|ENSG00000272020.1 |
0.698382311216783 |
|
18136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGLL |
0.698538747899867 |
|
18137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TENM3 |
0.698621971811955 |
|
18138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAMD4 |
0.698695208627103 |
|
18139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000207274.1 |
0.698755564901436 |
|
18140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO11 |
0.698815796412755 |
|
18141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHP1 |
0.698815979959877 |
|
18142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PURG |
0.699008331362488 |
|
18143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A4 |
0.69903743314339 |
|
18144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROSER2 |
0.699104136526171 |
|
18145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1263 |
0.69913156058563 |
|
18146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR720 |
0.69913156058563 |
|
18147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPSAP52 |
0.699179146958572 |
|
18148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1468 |
0.699200601441886 |
|
18149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRQ |
0.699206114162751 |
|
18150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCD |
0.699281455433516 |
|
18151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXD1 |
0.699333364583339 |
|
18152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN28A |
0.699400192443991 |
|
18153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4654 |
0.699468522453911 |
|
18154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR556 |
0.699468522453911 |
|
18155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf226 |
0.699468522453911 |
|
18156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf111 |
0.699468522453911 |
|
18157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC66 |
0.699522467942143 |
|
18158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERPUD2 |
0.699565049870472 |
|
18159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MECP2 |
0.699623831259965 |
|
18160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD15 |
0.699643199951027 |
|
18161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFSWAP |
0.699734465262957 |
|
18162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP378 |
0.699734465262957 |
|
18163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP17 |
0.699734465262957 |
|
18164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCP1 |
0.699740420288632 |
|
18165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSHB |
0.699740420288632 |
|
18166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA38|ENSG00000201042.1 |
0.69979499763068 |
|
18167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLIPR2 |
0.699795831318372 |
|
18168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A17P |
0.699843528280641 |
|
18169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL270P |
0.699843528280641 |
|
18170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALT2 |
0.699938872794807 |
|
18171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RECK |
0.700077916542917 |
|
18172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf56 |
0.700115497833186 |
|
18173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSTD1 |
0.700120508145362 |
|
18174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USF1 |
0.700120508145362 |
|
18175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP30 |
0.700120508145362 |
|
18176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PVRL4 |
0.700120508145362 |
|
18177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC9 |
0.700120508145362 |
|
18178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYYR1 |
0.700142957540798 |
|
18179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP139 |
0.700152674114432 |
|
18180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD12 |
0.700243449847261 |
|
18181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC44A1 |
0.700406196602658 |
|
18182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANBP2 |
0.700463392151314 |
|
18183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNRF2 |
0.700548500115971 |
|
18184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF11A |
0.700607371203391 |
|
18185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC1 |
0.700615796210377 |
|
18186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC6P1 |
0.700615796210377 |
|
18187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC6 |
0.700615796210377 |
|
18188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf45 |
0.700615796210377 |
|
18189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOPNL |
0.700615796210377 |
|
18190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0430 |
0.700615796210377 |
|
18191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR484 |
0.700615796210377 |
|
18192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPV17L |
0.700615796210377 |
|
18193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH11 |
0.700615796210377 |
|
18194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDE1 |
0.700615796210377 |
|
18195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOMO1 |
0.700615796210377 |
|
18196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOMO2 |
0.700615796210377 |
|
18197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOMO3 |
0.700615796210377 |
|
18198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPA1 |
0.700615796210377 |
|
18199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPA2 |
0.700615796210377 |
|
18200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPA3 |
0.700615796210377 |
|
18201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPA5 |
0.700615796210377 |
|
18202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPA7 |
0.700615796210377 |
|
18203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPA8 |
0.700615796210377 |
|
18204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPP1 |
0.700615796210377 |
|
18205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTAN1 |
0.700615796210377 |
|
18206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDXDC1 |
0.700615796210377 |
|
18207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD1P5 |
0.700615796210377 |
|
18208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD1P6 |
0.700615796210377 |
|
18209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G10 |
0.700615796210377 |
|
18210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL90P |
0.700615796210377 |
|
18211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS15A |
0.700615796210377 |
|
18212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRN3 |
0.700615796210377 |
|
18213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XYLT1 |
0.700615796210377 |
|
18214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD4A |
0.700659512840402 |
|
18215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIP1R |
0.700697305110476 |
|
18216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXC1 |
0.700724456337079 |
|
18217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXXC1P1 |
0.700758201481953 |
|
18218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANO5 |
0.700820415759273 |
|
18219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL297P |
0.701042586692725 |
|
18220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXYD1 |
0.701177370204617 |
|
18221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXYD7 |
0.701177370204617 |
|
18222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXYD5 |
0.701177370204617 |
|
18223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM2 |
0.701199495520008 |
|
18224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PODXL2 |
0.701199495520008 |
|
18225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABTB1 |
0.701199495520008 |
|
18226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL181P |
0.701264259461031 |
|
18227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00500 |
0.701288270580576 |
|
18228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMP1 |
0.701332893237048 |
|
18229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4769 |
0.701332893237048 |
|
18230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFP |
0.701332893237048 |
|
18231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELK1 |
0.701332893237048 |
|
18232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UXT |
0.701332893237048 |
|
18233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPRA1 |
0.701342074650664 |
|
18234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRTM2 |
0.701395439349651 |
|
18235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00940 |
0.701395439349651 |
|
18236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCP1B |
0.701395439349651 |
|
18237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSTL1 |
0.701412498660532 |
|
18238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDEL1 |
0.701440563553126 |
|
18239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR186 |
0.701462695405006 |
|
18240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL21A |
0.701566624939156 |
|
18241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSAD |
0.701637947174193 |
|
18242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDEM1 |
0.701672918310491 |
|
18243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD10 |
0.701769858589316 |
|
18244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2B3 |
0.701864234720943 |
|
18245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM58A |
0.701864234720943 |
|
18246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPU |
0.701949031172344 |
|
18247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A3 |
0.702058870732271 |
|
18248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL404P |
0.702058870732271 |
|
18249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RARA |
0.70209836132499 |
|
18250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL158P |
0.702134143574292 |
|
18251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLIN2 |
0.702134143574292 |
|
18252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDIA3 |
0.702155591209972 |
|
18253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELL3 |
0.702155591209972 |
|
18254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERF2 |
0.702155591209972 |
|
18255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYPK |
0.702155591209972 |
|
18256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1282 |
0.702155591209972 |
|
18257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERINC4 |
0.702155591209972 |
|
18258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFAP1 |
0.702155591209972 |
|
18259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR76 |
0.702155591209972 |
|
18260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD37|ENSG00000212377.1 |
0.702167566058345 |
|
18261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP461 |
0.702248947636637 |
|
18262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX20 |
0.702314605703452 |
|
18263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MERTK |
0.702501838793709 |
|
18264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM87B |
0.702501838793709 |
|
18265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548N |
0.7025152014098 |
|
18266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf71 |
0.702575080991417 |
|
18267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCRH |
0.70258878315709 |
|
18268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf66 |
0.702661392499873 |
|
18269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ00325 |
0.702661392499873 |
|
18270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL11 |
0.702687668072773 |
|
18271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADIRF |
0.702715955634485 |
|
18272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRHR |
0.70278737632032 |
|
18273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTPD1 |
0.702796479684908 |
|
18274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDH12 |
0.702813341227948 |
|
18275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252792.1 |
0.702813341227948 |
|
18276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL213P |
0.702813341227948 |
|
18277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL81P |
0.702854012755507 |
|
18278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFDN2 |
0.702957233991504 |
|
18279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPSS2 |
0.703017270457637 |
|
18280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN2 |
0.703096350841538 |
|
18281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7G |
0.703251195242912 |
|
18282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR82 |
0.703386868790305 |
|
18283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLYCTK |
0.703386868790305 |
|
18284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR135A1 |
0.703386868790305 |
|
18285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USB1 |
0.703415582787531 |
|
18286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF319 |
0.703415582787531 |
|
18287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEPP |
0.70371840805324 |
|
18288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSG2 |
0.703829860723324 |
|
18289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNS3 |
0.703852025601586 |
|
18290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATAD1 |
0.703915800281457 |
|
18291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFL1P1 |
0.703915800281457 |
|
18292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL78P |
0.703915800281457 |
|
18293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL17 |
0.704010214170343 |
|
18294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIAPIN1 |
0.704010214170343 |
|
18295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD74|ENSG00000201666.1 |
0.704041503237268 |
|
18296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLNS1A |
0.704157833526451 |
|
18297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL347P |
0.704226736022387 |
|
18298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00701 |
0.704372093595679 |
|
18299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OAS1 |
0.704389624881398 |
|
18300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OAS3 |
0.704389624881398 |
|
18301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BACH1 |
0.704404136381568 |
|
18302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM171 |
0.704423321895721 |
|
18303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM174 |
0.704423321895721 |
|
18304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM138B |
0.704425610485892 |
|
18305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABL2A |
0.704425610485892 |
|
18306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL23AP7 |
0.704425610485892 |
|
18307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASH2P |
0.704425610485892 |
|
18308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIT1 |
0.704490087428756 |
|
18309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEDD |
0.704490087428756 |
|
18310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTS4 |
0.704613991577527 |
|
18311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAV2 |
0.704648188171989 |
|
18312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF41 |
0.704653518814352 |
|
18313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CATSPER2P1 |
0.704960744120327 |
|
18314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CATSPER2 |
0.704960744120327 |
|
18315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKMT1A |
0.704960744120327 |
|
18316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKMT1B |
0.704960744120327 |
|
18317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRC |
0.704960744120327 |
|
18318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238494.1 |
0.704960744120327 |
|
18319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238535.1 |
0.704960744120327 |
|
18320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BFAR |
0.705025190693071 |
|
18321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1B4 |
0.705058698583102 |
|
18322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL436P |
0.705183475909343 |
|
18323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHCHD6 |
0.705408573279432 |
|
18324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLLN |
0.705412275810109 |
|
18325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM71 |
0.705495954887735 |
|
18326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF20L1 |
0.705495954887735 |
|
18327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC33P |
0.705516985005461 |
|
18328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD44 |
0.705693358521605 |
|
18329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX1 |
0.705693358521605 |
|
18330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00403 |
0.705693358521605 |
|
18331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00404 |
0.705693358521605 |
|
18332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00392 |
0.705717343032706 |
|
18333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKP1 |
0.705720451658959 |
|
18334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPM3 |
0.705771702880401 |
|
18335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD3NL |
0.70592311788938 |
|
18336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGT8 |
0.705978919422593 |
|
18337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIB1 |
0.706115309192303 |
|
18338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDPGP1 |
0.706115309192303 |
|
18339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXO3 |
0.706149123440316 |
|
18340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DESI2 |
0.706176719292674 |
|
18341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF12 |
0.706206748183946 |
|
18342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM35A |
0.706297051879164 |
|
18343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00863 |
0.706297051879164 |
|
18344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUTM2A |
0.706297051879164 |
|
18345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUTM2D |
0.706297051879164 |
|
18346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL733P |
0.706297051879164 |
|
18347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSRA |
0.706325231894044 |
|
18348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS51 |
0.706325231894044 |
|
18349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS55 |
0.706325231894044 |
|
18350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP9 |
0.706330327356584 |
|
18351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL687P |
0.706330327356584 |
|
18352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNCK |
0.706330327356584 |
|
18353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRH1 |
0.706386740113778 |
|
18354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCO2 |
0.706397329790449 |
|
18355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A6 |
0.706437089074537 |
|
18356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf101 |
0.706466197279963 |
|
18357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP61 |
0.706503278639473 |
|
18358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRRM4 |
0.706522212025391 |
|
18359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VENTXP1 |
0.70655113371921 |
|
18360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A14 |
0.706564068047282 |
|
18361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST8SIA2 |
0.706671482471992 |
|
18362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D10C |
0.706751708775203 |
|
18363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM133 |
0.706768784161591 |
|
18364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULF1 |
0.706877396832197 |
|
18365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPRY1 |
0.706890633095953 |
|
18366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNPO3 |
0.706918813873556 |
|
18367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC58 |
0.706925680595984 |
|
18368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM162A |
0.706925680595984 |
|
18369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR5B |
0.706925680595984 |
|
18370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A8 |
0.706950969254863 |
|
18371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAP31 |
0.706950969254863 |
|
18372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCD1 |
0.706950969254863 |
|
18373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS7C |
0.707035764160659 |
|
18374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBAL3 |
0.707075180045002 |
|
18375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NET1 |
0.707075180045002 |
|
18376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALML5 |
0.707075180045002 |
|
18377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALML3 |
0.707075180045002 |
|
18378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRMT3 |
0.707192994103969 |
|
18379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CABLES1 |
0.707221287220579 |
|
18380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00582 |
0.707264092251079 |
|
18381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2115 |
0.707310645276725 |
|
18382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPINK8 |
0.707310645276725 |
|
18383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD55 |
0.707345696197782 |
|
18384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3938 |
0.707414284666626 |
|
18385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIL |
0.707450140161066 |
|
18386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3D19 |
0.707502217800052 |
|
18387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKIL |
0.707714488310093 |
|
18388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL321P |
0.707720829060254 |
|
18389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2 |
0.707747508778786 |
|
18390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000238840.1 |
0.707783602543024 |
|
18391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1C2 |
0.707783602543024 |
|
18392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000239148.1 |
0.707783602543024 |
|
18393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00301 |
0.707852389663158 |
|
18394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTHL17 |
0.707854624819727 |
|
18395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF125 |
0.708058631316464 |
|
18396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF138 |
0.708058631316464 |
|
18397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238982.1 |
0.708058631316464 |
|
18398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP453 |
0.708058631316464 |
|
18399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13J1 |
0.708152595891348 |
|
18400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRCT1 |
0.708152595891348 |
|
18401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00961 |
0.708152595891348 |
|
18402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK10 |
0.708214977090095 |
|
18403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR550A1 |
0.708264908101396 |
|
18404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP350 |
0.708307224906795 |
|
18405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC51 |
0.708309935809196 |
|
18406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMA7 |
0.708309935809196 |
|
18407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREB3 |
0.7084422708116 |
|
18408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBA2 |
0.7084422708116 |
|
18409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL26 |
0.708470726386928 |
|
18410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAB3 |
0.708587966660172 |
|
18411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD4L1 |
0.708598313554066 |
|
18412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD1 |
0.708600506141853 |
|
18413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFHC2 |
0.708660868176696 |
|
18414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR17 |
0.708662697032103 |
|
18415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP500 |
0.708724827074255 |
|
18416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLN1 |
0.708783151860394 |
|
18417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000212273.1 |
0.708914173856279 |
|
18418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB2A1 |
0.708923034833782 |
|
18419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KNCN |
0.708924296405208 |
|
18420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKNK1 |
0.708924296405208 |
|
18421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOB3C |
0.708924296405208 |
|
18422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATPAF1 |
0.708924296405208 |
|
18423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB14 |
0.708924296405208 |
|
18424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX38 |
0.708924296405208 |
|
18425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D3A |
0.708950510942845 |
|
18426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CS |
0.709088902605854 |
|
18427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL583P |
0.70911987538166 |
|
18428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA77|ENSG00000221498.1 |
0.709121879293304 |
|
18429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP19 |
0.709121879293304 |
|
18430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZZEF1 |
0.709158220358182 |
|
18431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B9D1 |
0.709174989028233 |
|
18432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK7 |
0.709174989028233 |
|
18433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFAP4 |
0.709174989028233 |
|
18434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL12 |
0.709310654856254 |
|
18435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA65 |
0.709310654856254 |
|
18436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTR |
0.709395929420247 |
|
18437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF157 |
0.709464500956132 |
|
18438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11C |
0.709464500956132 |
|
18439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL817P |
0.709618540276688 |
|
18440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOQ |
0.709618540276688 |
|
18441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGF |
0.709618540276688 |
|
18442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRIPT |
0.709618540276688 |
|
18443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL118P |
0.709655274990858 |
|
18444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00678 |
0.709745342290869 |
|
18445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPHN |
0.709756144779049 |
|
18446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHCBP1L |
0.709794785801936 |
|
18447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NYAP2 |
0.709800377444967 |
|
18448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6 |
0.70986293057655 |
|
18449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM205A |
0.709993763347644 |
|
18450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHACTR4 |
0.710034061924221 |
|
18451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK1G1 |
0.710085862361948 |
|
18452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYRF |
0.710099594191141 |
|
18453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM258 |
0.710099594191141 |
|
18454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FADS2 |
0.710099594191141 |
|
18455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEN1 |
0.710099594191141 |
|
18456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR611 |
0.710099594191141 |
|
18457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FADS1 |
0.710099594191141 |
|
18458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1908 |
0.710099594191141 |
|
18459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FADS3 |
0.710099594191141 |
|
18460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB12 |
0.710112216137226 |
|
18461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB13 |
0.710112216137226 |
|
18462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB4 |
0.710112216137226 |
|
18463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB3 |
0.710112216137226 |
|
18464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GK |
0.710148933382966 |
|
18465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR591 |
0.710177496953597 |
|
18466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHISA6 |
0.710235741628261 |
|
18467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYLC2 |
0.710240504890712 |
|
18468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSN |
0.710241903969543 |
|
18469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOLL |
0.710256236679648 |
|
18470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX5 |
0.710327378256268 |
|
18471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIER3 |
0.710352446762934 |
|
18472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG13 |
0.710363008030343 |
|
18473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP1 |
0.710363008030343 |
|
18474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF408 |
0.710363008030343 |
|
18475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMT2 |
0.710400930192779 |
|
18476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPP38 |
0.710400930192779 |
|
18477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3672 |
0.710600054247424 |
|
18478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL19P |
0.710848235935532 |
|
18479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNASE1L2 |
0.710852460238414 |
|
18480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E4F1 |
0.710852460238414 |
|
18481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECI1 |
0.710852460238414 |
|
18482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNPS1 |
0.710852460238414 |
|
18483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1CA |
0.711056480225609 |
|
18484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOCS5 |
0.711178574167424 |
|
18485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCFD2 |
0.711178574167424 |
|
18486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC7A |
0.711178574167424 |
|
18487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALM2 |
0.711178574167424 |
|
18488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf61 |
0.711178574167424 |
|
18489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCSTN |
0.711229694687234 |
|
18490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHLH1 |
0.711229694687234 |
|
18491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VANGL2 |
0.711229694687234 |
|
18492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX8 |
0.711246426356588 |
|
18493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252189.1 |
0.711262471149068 |
|
18494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL785P |
0.71131298391237 |
|
18495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238729.1 |
0.71131298391237 |
|
18496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLB1 |
0.711350632904729 |
|
18497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD9 |
0.711415981096483 |
|
18498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD9L |
0.711415981096483 |
|
18499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMK1D |
0.711465451398686 |
|
18500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP216 |
0.711515230502934 |
|
18501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUSC2 |
0.711574292368467 |
|
18502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM166B |
0.711574292368467 |
|
18503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4667 |
0.711574292368467 |
|
18504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TESK1 |
0.711574292368467 |
|
18505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GADD45G |
0.711597058178929 |
|
18506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPG1 |
0.711610171942935 |
|
18507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDI2 |
0.711695330196943 |
|
18508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSD1L |
0.711725321757595 |
|
18509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238591.1 |
0.711740048738421 |
|
18510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB3IL1 |
0.711745484867845 |
|
18511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIFC3 |
0.711804432428223 |
|
18512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MREG |
0.71185699776952 |
|
18513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRID1 |
0.711999855382036 |
|
18514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF302 |
0.712172952091065 |
|
18515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL11RA |
0.712214584843133 |
|
18516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL27 |
0.712214584843133 |
|
18517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL19 |
0.712214584843133 |
|
18518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT17 |
0.712231316161446 |
|
18519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT42P |
0.712231316161446 |
|
18520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLAT |
0.712358836329871 |
|
18521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIH1D2 |
0.712358836329871 |
|
18522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf57 |
0.712358836329871 |
|
18523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM8B |
0.712358836329871 |
|
18524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1180 |
0.712412487271267 |
|
18525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FREM3 |
0.712432602094338 |
|
18526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCAR1 |
0.712436802731282 |
|
18527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCAR3 |
0.712436802731282 |
|
18528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENR |
0.712436802731282 |
|
18529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT4 |
0.712443972954481 |
|
18530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf47 |
0.712443972954481 |
|
18531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX14 |
0.712443972954481 |
|
18532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM179A |
0.712471397174864 |
|
18533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHEX |
0.712542256980465 |
|
18534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP25 |
0.712647588938345 |
|
18535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6AP2 |
0.712690815086292 |
|
18536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF248 |
0.712823758921363 |
|
18537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC3 |
0.712840883455087 |
|
18538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTX3L |
0.71291932049136 |
|
18539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP15 |
0.71291932049136 |
|
18540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM216 |
0.712952639716124 |
|
18541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPSF7 |
0.712952639716124 |
|
18542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDHAF2 |
0.712952639716124 |
|
18543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL23P |
0.712952639716124 |
|
18544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPN2 |
0.712966523264728 |
|
18545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
L1CAM |
0.712974178443749 |
|
18546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLST8 |
0.713019604773586 |
|
18547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRICD5 |
0.713019604773586 |
|
18548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGP |
0.713019604773586 |
|
18549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP54 |
0.713072117778549 |
|
18550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLIT3 |
0.713118526722749 |
|
18551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLIS3 |
0.713344165119596 |
|
18552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMBRA1 |
0.713381387293293 |
|
18553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC24A6 |
0.713420377208063 |
|
18554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP344 |
0.713494601872131 |
|
18555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AVPR2 |
0.713668378300215 |
|
18556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLQ |
0.713704221817083 |
|
18557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN20 |
0.713722477190001 |
|
18558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP488 |
0.713746769062381 |
|
18559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPI |
0.713746769062381 |
|
18560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM11 |
0.713746769062381 |
|
18561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC13 |
0.713746769062381 |
|
18562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHB4 |
0.713784427289396 |
|
18563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ3 |
0.713847023717431 |
|
18564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAQ |
0.714095492101729 |
|
18565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRG1 |
0.714264013035 |
|
18566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L8 |
0.714265810678941 |
|
18567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF141 |
0.714265810678941 |
|
18568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOTCH1 |
0.714269095896126 |
|
18569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHAD1 |
0.714293064934652 |
|
18570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFHD2 |
0.714293064934652 |
|
18571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTRC |
0.714293064934652 |
|
18572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD18|ENSG00000238503.1 |
0.714296863195083 |
|
18573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3681 |
0.714296863195083 |
|
18574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL815P |
0.714313056196671 |
|
18575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGI4 |
0.714697453868927 |
|
18576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL23R |
0.714753861855574 |
|
18577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf182 |
0.714767450214467 |
|
18578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRY2 |
0.71486275491956 |
|
18579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDARADD |
0.714883051341619 |
|
18580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35C1 |
0.714951392897687 |
|
18581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CADM1 |
0.715138428779998 |
|
18582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASR |
0.715160310747471 |
|
18583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VEZF1 |
0.715207697372819 |
|
18584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLMAP |
0.71521992015308 |
|
18585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDLIM1 |
0.715300923415129 |
|
18586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETV4 |
0.715335794730711 |
|
18587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWCE |
0.715467956361747 |
|
18588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf53 |
0.715493454165514 |
|
18589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM26 |
0.715552846129047 |
|
18590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAK6 |
0.715561945238108 |
|
18591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPG11 |
0.715591472389236 |
|
18592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PATL2 |
0.715591472389236 |
|
18593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCAR2 |
0.715956370046722 |
|
18594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB1D2 |
0.715993479390815 |
|
18595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM11 |
0.716032577452845 |
|
18596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM4SF20 |
0.716076606359952 |
|
18597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRBOX4 |
0.716192519500288 |
|
18598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRC1 |
0.716209160447854 |
|
18599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS33B |
0.716209160447854 |
|
18600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00606 |
0.716292820534045 |
|
18601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD14B |
0.7164319450396 |
|
18602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD14A |
0.7164319450396 |
|
18603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACY1 |
0.7164319450396 |
|
18604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL29 |
0.7164319450396 |
|
18605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf32 |
0.716514714447849 |
|
18606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCSER1 |
0.716565135851244 |
|
18607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL29P |
0.716571374911383 |
|
18608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA2|ENSG00000202343.1 |
0.716617240236205 |
|
18609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIL4 |
0.716633964388056 |
|
18610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GINM1 |
0.716633964388056 |
|
18611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAI2 |
0.716640286252855 |
|
18612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548X |
0.716720505317265 |
|
18613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPN1LW |
0.716727301923206 |
|
18614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPN1MW2 |
0.716727301923206 |
|
18615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPN1MW |
0.716727301923206 |
|
18616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX28P1 |
0.716727301923206 |
|
18617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX28P2 |
0.716727301923206 |
|
18618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX28 |
0.716727301923206 |
|
18619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53I11 |
0.716742192604409 |
|
18620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFR3 |
0.716803911161939 |
|
18621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P7 |
0.716946161549995 |
|
18622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR2D |
0.716946161549995 |
|
18623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMMECR1L |
0.716946161549995 |
|
18624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFDN5 |
0.716956002642558 |
|
18625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB2A2 |
0.716996560883738 |
|
18626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB1D4 |
0.716996560883738 |
|
18627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP318 |
0.71708170201972 |
|
18628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBLN7 |
0.717172213218447 |
|
18629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELAVL4 |
0.71717225853053 |
|
18630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APITD1 |
0.717180451184676 |
|
18631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORT |
0.717180451184676 |
|
18632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM47A |
0.717181635913145 |
|
18633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMOD |
0.717189477419394 |
|
18634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf26 |
0.717197729090307 |
|
18635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBAS |
0.717278287359117 |
|
18636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4791 |
0.717299172675292 |
|
18637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP239 |
0.717302271348563 |
|
18638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAM1 |
0.717371730118832 |
|
18639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238450.1 |
0.717371730118832 |
|
18640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LACTB2 |
0.717371730118832 |
|
18641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf37 |
0.717448243007401 |
|
18642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H1FX |
0.717448243007401 |
|
18643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4757 |
0.71755612759402 |
|
18644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSR1 |
0.71755612759402 |
|
18645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFB1M |
0.717572314541808 |
|
18646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOX3 |
0.717572314541808 |
|
18647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALU |
0.717572946918802 |
|
18648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF24 |
0.717587437751432 |
|
18649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM2A |
0.717635347345999 |
|
18650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB13 |
0.717946855480716 |
|
18651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCP2 |
0.717946855480716 |
|
18652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMMP1L |
0.717961929292965 |
|
18653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFTN1 |
0.718065843515588 |
|
18654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4790 |
0.718066404814094 |
|
18655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL553P |
0.718066404814094 |
|
18656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1C |
0.718136957849864 |
|
18657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1305 |
0.718280145734794 |
|
18658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR125B1 |
0.71832334007392 |
|
18659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLID |
0.71832334007392 |
|
18660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTG2 |
0.718324482325755 |
|
18661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAP130 |
0.718331402157719 |
|
18662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFRD2 |
0.718334090355822 |
|
18663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1CB |
0.718474528205234 |
|
18664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAX1 |
0.718548664285672 |
|
18665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212181.1 |
0.71858671530474 |
|
18666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000251740.1 |
0.718689451424971 |
|
18667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC29A2 |
0.718710169657835 |
|
18668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFT2D3 |
0.718901383909812 |
|
18669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR33 |
0.718901383909812 |
|
18670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB1D1 |
0.718934985780679 |
|
18671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU109|ENSG00000239197.1 |
0.718990908170927 |
|
18672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP40 |
0.719097081398703 |
|
18673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NALCN |
0.719311353447692 |
|
18674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYAL3 |
0.719336572658754 |
|
18675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYAL1 |
0.719336572658754 |
|
18676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT6 |
0.719336572658754 |
|
18677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238612.1 |
0.719402828377633 |
|
18678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAAH |
0.719431841652874 |
|
18679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ING1 |
0.719478439943625 |
|
18680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00346 |
0.719478439943625 |
|
18681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2C8 |
0.719618637259263 |
|
18682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A11 |
0.719623055175047 |
|
18683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAUS7 |
0.719731503083409 |
|
18684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TREX2 |
0.719731503083409 |
|
18685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BGN |
0.719731503083409 |
|
18686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAST2 |
0.719737476255991 |
|
18687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP303 |
0.719749708139223 |
|
18688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGFG1 |
0.719777971575295 |
|
18689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5703 |
0.719777971575295 |
|
18690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RANBP3 |
0.719941841674784 |
|
18691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5191 |
0.71996567813452 |
|
18692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf129 |
0.720067601384533 |
|
18693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHG1 |
0.720117122226245 |
|
18694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM208A |
0.720141383344853 |
|
18695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADM |
0.720166255471398 |
|
18696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKR1C3 |
0.720254701044867 |
|
18697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM2 |
0.720336339125426 |
|
18698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL14 |
0.720407467218874 |
|
18699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNPAT |
0.720468348381844 |
|
18700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP80 |
0.720468348381844 |
|
18701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOC8 |
0.720468348381844 |
|
18702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRTN |
0.720468348381844 |
|
18703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARS2 |
0.720483433302779 |
|
18704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFM2 |
0.720636622768923 |
|
18705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSA2 |
0.720636622768923 |
|
18706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM169A |
0.720636622768923 |
|
18707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STEAP1B |
0.720693237670197 |
|
18708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR62 |
0.720828766868674 |
|
18709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCBP4 |
0.720828766868674 |
|
18710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC24 |
0.720887461462567 |
|
18711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM171A1 |
0.720893469925808 |
|
18712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMTNL2 |
0.721089377688785 |
|
18713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FXR2 |
0.721089716716625 |
|
18714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238388.1 |
0.721117672305934 |
|
18715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKD |
0.721150095150734 |
|
18716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN7 |
0.72118922493989 |
|
18717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COA4 |
0.721486221231058 |
|
18718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAAF1 |
0.721486221231058 |
|
18719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALGDS |
0.721497737560152 |
|
18720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238657.1 |
0.721497737560152 |
|
18721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBGT1 |
0.721497737560152 |
|
18722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF33 |
0.721549524374626 |
|
18723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNIK |
0.721837264621555 |
|
18724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC90B |
0.722095887829697 |
|
18725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MITF |
0.722382600365381 |
|
18726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCND3 |
0.722411792592482 |
|
18727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOA2 |
0.722472581361878 |
|
18728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELOVL6 |
0.722482638463658 |
|
18729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRB |
0.722492398030049 |
|
18730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF9 |
0.722516018596106 |
|
18731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARK7 |
0.722516018596106 |
|
18732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST14 |
0.722556955430507 |
|
18733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFBR3 |
0.722624624547612 |
|
18734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THUMPD2 |
0.722697470089372 |
|
18735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP227 |
0.722708195570346 |
|
18736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFTA1P |
0.722784207975444 |
|
18737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00710 |
0.722784207975444 |
|
18738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252433.1 |
0.723016976281124 |
|
18739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHPK |
0.723027045850461 |
|
18740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPV1 |
0.723027045850461 |
|
18741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNS |
0.723027045850461 |
|
18742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC6 |
0.723027045850461 |
|
18743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RX5 |
0.723027045850461 |
|
18744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAX1BP3 |
0.723027045850461 |
|
18745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD5 |
0.723122878780239 |
|
18746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBRM1 |
0.723158334573009 |
|
18747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOC3L |
0.723165075215398 |
|
18748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THOC2 |
0.723277950161564 |
|
18749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMP |
0.723467235205266 |
|
18750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRGN |
0.72351327689638 |
|
18751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSIG2 |
0.72351327689638 |
|
18752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESAM |
0.72351327689638 |
|
18753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSANTD2 |
0.72351327689638 |
|
18754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238906.1 |
0.723718999375583 |
|
18755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD38|ENSG00000200733.1 |
0.723762732342379 |
|
18756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRBP |
0.723799531820844 |
|
18757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPRG1 |
0.723865049445441 |
|
18758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT2B |
0.723865156637399 |
|
18759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW12 |
0.723923338058417 |
|
18760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP4Z2P |
0.724027776426302 |
|
18761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC27P |
0.724055837611567 |
|
18762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMP2 |
0.72407413423454 |
|
18763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP35 |
0.724100094007631 |
|
18764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPY19L2P1 |
0.724108609087557 |
|
18765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCYT1B |
0.724165335646076 |
|
18766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SBF2 |
0.724209688534623 |
|
18767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDK1 |
0.72421763417032 |
|
18768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMTA1 |
0.724456135262362 |
|
18769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP12 |
0.724524357228479 |
|
18770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548X2 |
0.724676741461507 |
|
18771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROPN1 |
0.724741322988023 |
|
18772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIF1 |
0.724750568722682 |
|
18773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX29P2 |
0.724789883889842 |
|
18774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIAE |
0.724797934337884 |
|
18775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPA17 |
0.724797934337884 |
|
18776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H12B |
0.724823104199254 |
|
18777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC129 |
0.724900836781353 |
|
18778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAP |
0.725002840474937 |
|
18779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUL4B |
0.725029275011334 |
|
18780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000272179.1 |
0.725029275011334 |
|
18781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP17 |
0.725077211573796 |
|
18782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QRSL1 |
0.725228882013402 |
|
18783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IWS1 |
0.725461445034954 |
|
18784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC113 |
0.725499190047145 |
|
18785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS54 |
0.725499190047145 |
|
18786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTA1 |
0.725509552134558 |
|
18787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP133 |
0.725509552134558 |
|
18788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238350.1 |
0.725609998870064 |
|
18789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM192 |
0.725611470280081 |
|
18790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD53 |
0.725634702521762 |
|
18791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD92 |
0.725634702521762 |
|
18792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDYA |
0.725634702521762 |
|
18793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT61B |
0.725634702521762 |
|
18794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR43 |
0.725634702521762 |
|
18795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMRN2 |
0.725671429254054 |
|
18796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNCG |
0.725671429254054 |
|
18797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C20orf197 |
0.725827867801218 |
|
18798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC15A4 |
0.725886605195763 |
|
18799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX21 |
0.725976977374682 |
|
18800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL373P |
0.725976977374682 |
|
18801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1279 |
0.725976977374682 |
|
18802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSF1 |
0.726026555708735 |
|
18803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GP9 |
0.726054214181796 |
|
18804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252435.1 |
0.726054214181796 |
|
18805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238874.1 |
0.726054214181796 |
|
18806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ10A |
0.726060781841609 |
|
18807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM129B |
0.726066995048598 |
|
18808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADSS |
0.726166253942958 |
|
18809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5R1 |
0.726264912212572 |
|
18810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GEMIN6 |
0.726305781930416 |
|
18811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC102A |
0.726328720431695 |
|
18812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA11|ENSG00000253085.1 |
0.726467899225758 |
|
18813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEC1 |
0.726488896311925 |
|
18814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBF2 |
0.726510018530216 |
|
18815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPHS2 |
0.726510328961952 |
|
18816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTCFL |
0.726592493368072 |
|
18817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCK1 |
0.726592493368072 |
|
18818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBP1 |
0.726592493368072 |
|
18819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMEPA1 |
0.726592493368072 |
|
18820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMTM8 |
0.726625172484171 |
|
18821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDLRAD1 |
0.726712664869202 |
|
18822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM59 |
0.726712664869202 |
|
18823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4781 |
0.726712664869202 |
|
18824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEANC2 |
0.726712664869202 |
|
18825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K4 |
0.726723582503727 |
|
18826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPA1 |
0.726749737876616 |
|
18827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX1 |
0.72676753417012 |
|
18828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NELFCD |
0.72692865357632 |
|
18829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSZ |
0.72692865357632 |
|
18830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB1 |
0.72692865357632 |
|
18831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5E |
0.72692865357632 |
|
18832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLMO2 |
0.72692865357632 |
|
18833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTN4 |
0.726977109990803 |
|
18834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1P8 |
0.726987866551723 |
|
18835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUS3L |
0.726994452784838 |
|
18836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR22 |
0.726994452784838 |
|
18837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCNXL2 |
0.727097021036146 |
|
18838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238615.1 |
0.727115488621951 |
|
18839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00972 |
0.727158481858016 |
|
18840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EME2 |
0.727187178796883 |
|
18841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS34 |
0.727187178796883 |
|
18842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME3 |
0.727187178796883 |
|
18843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUBP2 |
0.727187178796883 |
|
18844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPSB3 |
0.727187178796883 |
|
18845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP193 |
0.727210163725678 |
|
18846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf183 |
0.727210163725678 |
|
18847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP84 |
0.727290016011469 |
|
18848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP238 |
0.727290016011469 |
|
18849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1C2 |
0.727363573701664 |
|
18850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1C2P1 |
0.727363573701664 |
|
18851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL508P |
0.72737332332697 |
|
18852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETF1 |
0.727461921779207 |
|
18853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD63|ENSG00000222937.1 |
0.727461921779207 |
|
18854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD63|ENSG00000206989.1 |
0.727461921779207 |
|
18855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIP4 |
0.727482772513319 |
|
18856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NACA |
0.727485638086825 |
|
18857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB14 |
0.727494539798276 |
|
18858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH2 |
0.727503066669901 |
|
18859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFALS |
0.727594136326695 |
|
18860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS37C |
0.727685740991732 |
|
18861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK31 |
0.727716367924344 |
|
18862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNL3 |
0.727750745619121 |
|
18863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD19B|ENSG00000238862.1 |
0.727750745619121 |
|
18864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD19B|ENSG00000252787.1 |
0.727750745619121 |
|
18865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD19|ENSG00000212493.1 |
0.727750745619121 |
|
18866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD19|ENSG00000222345.1 |
0.727750745619121 |
|
18867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD69 |
0.727750745619121 |
|
18868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS12 |
0.727974416806194 |
|
18869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD109B |
0.728048425643769 |
|
18870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALD1 |
0.728068672018559 |
|
18871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR7 |
0.728079450791007 |
|
18872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf80 |
0.728082220890702 |
|
18873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPNA1 |
0.728092539630368 |
|
18874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP9 |
0.728092539630368 |
|
18875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP173 |
0.728097204339205 |
|
18876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD65|ENSG00000212191.1 |
0.728097204339205 |
|
18877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC58 |
0.72811652337687 |
|
18878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD52 |
0.728148255233161 |
|
18879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP455 |
0.728151548345068 |
|
18880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F2 |
0.728185842384267 |
|
18881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM16 |
0.728214571714069 |
|
18882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIO1 |
0.728258274737863 |
|
18883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPB11 |
0.728258274737863 |
|
18884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC42 |
0.728258274737863 |
|
18885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238739.1 |
0.728280860918928 |
|
18886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL5RA |
0.728289272704466 |
|
18887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA43|ENSG00000253049.1 |
0.728289272704466 |
|
18888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRNT1 |
0.728289272704466 |
|
18889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPB41 |
0.728345748927314 |
|
18890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXR1 |
0.728437984101004 |
|
18891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VGLL4 |
0.728571691904527 |
|
18892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP499 |
0.72860096818029 |
|
18893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHLH2 |
0.728646753683552 |
|
18894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXB13 |
0.728685505497388 |
|
18895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3185 |
0.728685505497388 |
|
18896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAC |
0.728685505497388 |
|
18897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL6 |
0.728685505497388 |
|
18898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL125P |
0.728685505497388 |
|
18899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP42 |
0.728946192949119 |
|
18900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMD6 |
0.728947521938859 |
|
18901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTLA |
0.729091099845107 |
|
18902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KATNA1 |
0.729107184564315 |
|
18903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA6 |
0.72911487349566 |
|
18904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN11 |
0.729269100805019 |
|
18905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM4SF2 |
0.729345891015869 |
|
18906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE4B |
0.729441250207349 |
|
18907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE8B |
0.729561664540061 |
|
18908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCN3 |
0.729624863145684 |
|
18909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM252 |
0.72968111388237 |
|
18910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BARD1 |
0.729708629091401 |
|
18911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCN10 |
0.729732496164943 |
|
18912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCN6 |
0.729732496164943 |
|
18913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86DP |
0.729782042708904 |
|
18914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRG2C |
0.729782042708904 |
|
18915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00960 |
0.729782042708904 |
|
18916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1324 |
0.729782042708904 |
|
18917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4273 |
0.729782042708904 |
|
18918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL92P |
0.729782042708904 |
|
18919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF717 |
0.729782042708904 |
|
18920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR16 |
0.729881891881961 |
|
18921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP43 |
0.729881891881961 |
|
18922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIP |
0.72989379937131 |
|
18923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRYD4 |
0.72989379937131 |
|
18924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSPT2 |
0.730001898712324 |
|
18925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY5P3 |
0.730198353498853 |
|
18926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL22L1 |
0.730198353498853 |
|
18927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF5A2 |
0.730198353498853 |
|
18928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A2 |
0.730198353498853 |
|
18929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP3 |
0.730224345793461 |
|
18930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLK2 |
0.730275455801742 |
|
18931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACBD3 |
0.730341679617754 |
|
18932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUNX1 |
0.730348383188423 |
|
18933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF558 |
0.73041743315808 |
|
18934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR114 |
0.730605949950883 |
|
18935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT3 |
0.730610264621368 |
|
18936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGDR |
0.730634284789578 |
|
18937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGER2 |
0.730634284789578 |
|
18938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K7CL |
0.73067688361721 |
|
18939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212479.1 |
0.73067688361721 |
|
18940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARKD |
0.730694829201618 |
|
18941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT13 |
0.730880975922595 |
|
18942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL22A1 |
0.730884348053852 |
|
18943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCH1 |
0.731104145382868 |
|
18944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf38 |
0.731112004671062 |
|
18945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED14 |
0.731112004671062 |
|
18946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEFTY1 |
0.731228224556343 |
|
18947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYCR2 |
0.731228224556343 |
|
18948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEFTY2 |
0.731228224556343 |
|
18949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDE2 |
0.731228224556343 |
|
18950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNMA1 |
0.731266861296322 |
|
18951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VTCN1 |
0.731445360230473 |
|
18952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF3C4 |
0.731480716456943 |
|
18953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIXL1 |
0.73153532029191 |
|
18954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00675 |
0.731717938310935 |
|
18955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIRT |
0.731717938310935 |
|
18956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEXI |
0.731787278992335 |
|
18957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG7 |
0.731802841648453 |
|
18958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD11 |
0.731816083854642 |
|
18959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1C3 |
0.731841336727938 |
|
18960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00704 |
0.731915758587626 |
|
18961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00705 |
0.731915758587626 |
|
18962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIK2 |
0.731998335672429 |
|
18963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREB5 |
0.732162200983546 |
|
18964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB43 |
0.732202890539198 |
|
18965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISY1 |
0.732202890539198 |
|
18966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNBP |
0.732202890539198 |
|
18967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGOT |
0.732253614812223 |
|
18968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSIG10 |
0.732371538262008 |
|
18969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEBP1 |
0.732371538262008 |
|
18970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000212363.1 |
0.732664768094383 |
|
18971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCNT4 |
0.732664768094383 |
|
18972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THSD4 |
0.732704999358332 |
|
18973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMS1P5 |
0.732721117087452 |
|
18974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM25C |
0.732721117087452 |
|
18975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLUD1P2 |
0.732721117087452 |
|
18976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN20B |
0.732721117087452 |
|
18977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL527P |
0.732721117087452 |
|
18978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP314 |
0.732721117087452 |
|
18979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP315 |
0.732721117087452 |
|
18980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEUROG3 |
0.732831784454004 |
|
18981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DACT2 |
0.732832729631852 |
|
18982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMD1 |
0.732832729631852 |
|
18983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF25 |
0.732832729631852 |
|
18984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC40 |
0.732856732515418 |
|
18985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL242P |
0.732856732515418 |
|
18986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCMT1 |
0.733020890336689 |
|
18987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP243 |
0.733170033762872 |
|
18988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT5 |
0.733175250561821 |
|
18989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF689 |
0.733188721303532 |
|
18990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUBN |
0.733198003234421 |
|
18991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF589 |
0.733244547248777 |
|
18992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD2 |
0.73328475598597 |
|
18993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP6 |
0.733492820374942 |
|
18994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G12A |
0.733492820374942 |
|
18995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFI |
0.733492820374942 |
|
18996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGF |
0.733492820374942 |
|
18997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABRA |
0.733758302852311 |
|
18998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLNB |
0.733868150002672 |
|
18999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00703 |
0.734077559562068 |
|
19000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL27A1 |
0.734103676771761 |
|
19001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMOC2 |
0.734124695316398 |
|
19002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGMA |
0.734184322328736 |
|
19003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UVRAG |
0.734260023156055 |
|
19004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSBG2 |
0.7343397563182 |
|
19005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP167 |
0.73438445661582 |
|
19006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPH3A |
0.734399902010211 |
|
19007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPTF |
0.734403541298494 |
|
19008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL622P |
0.734403541298494 |
|
19009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf58 |
0.734403541298494 |
|
19010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOXA1 |
0.734622566465902 |
|
19011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000272272.1 |
0.734622566465902 |
|
19012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTPD8 |
0.734622566465902 |
|
19013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSMF |
0.734622566465902 |
|
19014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPLA7 |
0.734622566465902 |
|
19015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLTA |
0.734645659825608 |
|
19016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP112 |
0.734685366565918 |
|
19017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL48 |
0.734718535222625 |
|
19018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOS1 |
0.734811090094226 |
|
19019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAB2 |
0.734841981939262 |
|
19020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL234P |
0.734841981939262 |
|
19021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUMO4 |
0.734841981939262 |
|
19022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR670 |
0.734937022674338 |
|
19023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00930 |
0.734950398385275 |
|
19024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LLGL1 |
0.734955879748375 |
|
19025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLII |
0.734955879748375 |
|
19026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCR7 |
0.734955879748375 |
|
19027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOP3A |
0.734955879748375 |
|
19028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA77|ENSG00000221083.1 |
0.735002316267408 |
|
19029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H12D |
0.735099115901454 |
|
19030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASIC4 |
0.735123804939546 |
|
19031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHPF |
0.735123804939546 |
|
19032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM198 |
0.735123804939546 |
|
19033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3132 |
0.735123804939546 |
|
19034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL814P |
0.735217210232928 |
|
19035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFI1B |
0.735277709693397 |
|
19036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF3C5 |
0.735277709693397 |
|
19037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELP |
0.735277709693397 |
|
19038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEL |
0.735277709693397 |
|
19039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf166B |
0.735306290793676 |
|
19040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF43 |
0.735307936267176 |
|
19041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU2AF1 |
0.735318381788795 |
|
19042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETMAR |
0.735357042689082 |
|
19043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRIM1 |
0.735386528468041 |
|
19044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS10P7 |
0.735413146068347 |
|
19045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP451 |
0.735518060927317 |
|
19046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH3 |
0.735615687623281 |
|
19047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCO1 |
0.735615687623281 |
|
19048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIB1 |
0.735658529313236 |
|
19049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSRP1 |
0.735660077475017 |
|
19050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCR8 |
0.735673950350663 |
|
19051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFF |
0.735718602233542 |
|
19052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD115|ENSG00000212428.1 |
0.735747464919692 |
|
19053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADPRM |
0.735815649769674 |
|
19054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM220 |
0.735815649769674 |
|
19055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGOH2 |
0.735815649769674 |
|
19056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000201701.1 |
0.735826048887108 |
|
19057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR75 |
0.735882292038006 |
|
19058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNA14 |
0.73599003361531 |
|
19059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3175 |
0.736054464902208 |
|
19060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT222 |
0.736297354982228 |
|
19061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCE1 |
0.736297354982228 |
|
19062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT24 |
0.736297354982228 |
|
19063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BZRAP1 |
0.736502378697381 |
|
19064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR142 |
0.736502378697381 |
|
19065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4736 |
0.736502378697381 |
|
19066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUPT4H1 |
0.736502378697381 |
|
19067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL599P |
0.736607600059062 |
|
19068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARGFX |
0.736610200447366 |
|
19069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO40 |
0.736610200447366 |
|
19070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCLS1 |
0.736610200447366 |
|
19071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL172P |
0.736610200447366 |
|
19072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238670.1 |
0.736610200447366 |
|
19073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLE1 |
0.736823954075414 |
|
19074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GREB1 |
0.736832517864656 |
|
19075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF8 |
0.73687333973558 |
|
19076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGA3 |
0.736894052643249 |
|
19077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGA4 |
0.736894052643249 |
|
19078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGA5 |
0.736894052643249 |
|
19079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHDDS |
0.736918082041681 |
|
19080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGN2 |
0.736918082041681 |
|
19081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM208B |
0.737069022705141 |
|
19082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1161 |
0.737192958166092 |
|
19083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARG |
0.737219449052067 |
|
19084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPD1L |
0.737335355703666 |
|
19085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYVE1 |
0.73743882743427 |
|
19086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COA6 |
0.737440731293844 |
|
19087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4533 |
0.737479550022817 |
|
19088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AG2 |
0.737479550022817 |
|
19089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBS5 |
0.73750753681586 |
|
19090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPEB3 |
0.737558848504879 |
|
19091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP336 |
0.737560059534623 |
|
19092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD5 |
0.737598784043166 |
|
19093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL582P |
0.737679548637352 |
|
19094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR600HG |
0.737729559126639 |
|
19095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATF7 |
0.737753963729924 |
|
19096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RILPL1 |
0.737896818900058 |
|
19097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNC |
0.737904244240605 |
|
19098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK8IP3 |
0.73821634217023 |
|
19099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3177 |
0.73821634217023 |
|
19100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB11 |
0.738304485063141 |
|
19101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM10 |
0.738304485063141 |
|
19102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL41 |
0.738378058901211 |
|
19103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf88 |
0.738576894639253 |
|
19104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC42B |
0.738595201378709 |
|
19105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX54 |
0.738595201378709 |
|
19106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf52 |
0.738595201378709 |
|
19107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCD |
0.738595201378709 |
|
19108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAD9 |
0.738622039173289 |
|
19109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1257 |
0.738622039173289 |
|
19110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCC1 |
0.738622039173289 |
|
19111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5C3B |
0.738843124352627 |
|
19112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL10 |
0.738843124352627 |
|
19113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL871P |
0.738843124352627 |
|
19114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000239142.1 |
0.738868388042661 |
|
19115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF764 |
0.738886797053305 |
|
19116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF688 |
0.738886797053305 |
|
19117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF785 |
0.738886797053305 |
|
19118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548F1 |
0.739205346300572 |
|
19119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35D2 |
0.739302866516299 |
|
19120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTENP1 |
0.739329728872332 |
|
19121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL705P |
0.739351163442776 |
|
19122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNG5 |
0.739425077346774 |
|
19123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C4 |
0.739650176214262 |
|
19124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTC |
0.739680814682911 |
|
19125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF771 |
0.739839461893648 |
|
19126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239126.1 |
0.73988881021193 |
|
19127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF618 |
0.739889454191521 |
|
19128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMBP |
0.739889454191521 |
|
19129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGD5 |
0.739941914927825 |
|
19130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROBO3 |
0.74017629990406 |
|
19131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROBO4 |
0.74017629990406 |
|
19132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEPACAM |
0.74017629990406 |
|
19133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEPN1 |
0.74017629990406 |
|
19134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00189 |
0.740270978844997 |
|
19135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HLCS |
0.740277112038577 |
|
19136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP491 |
0.740277112038577 |
|
19137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST3GAL3 |
0.740519798879756 |
|
19138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF21A |
0.740572988846201 |
|
19139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT10 |
0.740578671115746 |
|
19140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOWAHC |
0.740578671115746 |
|
19141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TARDBP |
0.740601206909786 |
|
19142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAB21L3 |
0.740638045797247 |
|
19143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP20 |
0.740692827341609 |
|
19144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL96P |
0.740744969796677 |
|
19145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX30 |
0.740775368534337 |
|
19146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELK4 |
0.740832166068754 |
|
19147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM174B |
0.740879333718921 |
|
19148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPARA |
0.740900700893904 |
|
19149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTERF |
0.741055766196171 |
|
19150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D1A |
0.74124786593944 |
|
19151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM67 |
0.741350308238452 |
|
19152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNQ2 |
0.741424464626679 |
|
19153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5687 |
0.741436651335267 |
|
19154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP19 |
0.741509129908359 |
|
19155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMADHC |
0.741567181937552 |
|
19156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDHD |
0.741626764421204 |
|
19157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM153B |
0.741695168191104 |
|
19158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIMC1 |
0.741695168191104 |
|
19159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1191 |
0.741695168191104 |
|
19160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL10 |
0.741695168191104 |
|
19161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1271 |
0.741695168191104 |
|
19162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOP16 |
0.741695168191104 |
|
19163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIGD2A |
0.741695168191104 |
|
19164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLTB |
0.741695168191104 |
|
19165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAF2 |
0.741695168191104 |
|
19166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00943 |
0.741700375234652 |
|
19167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00944 |
0.741700375234652 |
|
19168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC45A3 |
0.741744291049488 |
|
19169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CWC27 |
0.741756699464777 |
|
19170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4777 |
0.741799487673252 |
|
19171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX2 |
0.741814893408338 |
|
19172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAREM |
0.74182852248266 |
|
19173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL32 |
0.741842166363366 |
|
19174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ILDR1 |
0.741911394455391 |
|
19175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHX8 |
0.741930384249021 |
|
19176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAL1 |
0.741949946556319 |
|
19177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCX3B |
0.741949946556319 |
|
19178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNI1 |
0.742017903725555 |
|
19179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHLDA3 |
0.742017903725555 |
|
19180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POPDC2 |
0.742064100674904 |
|
19181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX17 |
0.742064100674904 |
|
19182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAATS1 |
0.742064100674904 |
|
19183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR1I2 |
0.742064100674904 |
|
19184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00845 |
0.742080801096934 |
|
19185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL762P |
0.742083341475728 |
|
19186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL397P |
0.742083341475728 |
|
19187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR156 |
0.742083341475728 |
|
19188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf156 |
0.742095126807181 |
|
19189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEMGN |
0.742095126807181 |
|
19190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAZN |
0.742152300373908 |
|
19191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAS1L |
0.74219199310653 |
|
19192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGB1 |
0.742230012212889 |
|
19193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP23 |
0.742304749415188 |
|
19194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIP2 |
0.742428225116744 |
|
19195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL21 |
0.742458282264701 |
|
19196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDB1 |
0.742478480541386 |
|
19197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAK |
0.742478480541386 |
|
19198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB561A3 |
0.742478480541386 |
|
19199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM138 |
0.742478480541386 |
|
19200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPAP1 |
0.742501999567919 |
|
19201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALB2 |
0.742602882608058 |
|
19202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF23 |
0.742602882608058 |
|
19203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF19 |
0.742602882608058 |
|
19204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTBN5 |
0.742627811019819 |
|
19205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC9 |
0.742740248264353 |
|
19206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC8 |
0.742740248264353 |
|
19207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM9B |
0.742801850434728 |
|
19208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP103 |
0.742858411891119 |
|
19209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEK2 |
0.74286316398976 |
|
19210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIK1 |
0.742933072302563 |
|
19211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2L11 |
0.742944688678642 |
|
19212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM45 |
0.743032869707097 |
|
19213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00693 |
0.743107472634281 |
|
19214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000252993.1 |
0.743129686069144 |
|
19215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HELLS |
0.743348488905426 |
|
19216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2C18 |
0.743348488905426 |
|
19217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00290 |
0.743382114130989 |
|
19218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC15 |
0.743547644260172 |
|
19219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC37A2 |
0.743547644260172 |
|
19220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM218 |
0.743547644260172 |
|
19221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT18P59 |
0.743547644260172 |
|
19222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL12RB2 |
0.743598750625415 |
|
19223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC38 |
0.743638320255397 |
|
19224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP4K5 |
0.7436525390217 |
|
19225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EAF2 |
0.743689776281116 |
|
19226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC15A2 |
0.743689776281116 |
|
19227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM38B |
0.743698025365419 |
|
19228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2E2 |
0.743708245043894 |
|
19229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCWPW2 |
0.743874371661496 |
|
19230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMS22L |
0.743909475211892 |
|
19231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238849.1 |
0.744079215600854 |
|
19232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATA6 |
0.744234032178817 |
|
19233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238594.1 |
0.744266725603605 |
|
19234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPP25L |
0.744332105881806 |
|
19235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCTN3 |
0.744332105881806 |
|
19236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID3C |
0.744332105881806 |
|
19237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALT |
0.744332105881806 |
|
19238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGMAR1 |
0.744332105881806 |
|
19239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAST |
0.744433671762509 |
|
19240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP442 |
0.744433671762509 |
|
19241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3J |
0.744435974418341 |
|
19242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP7 |
0.744572393758201 |
|
19243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP8 |
0.744572393758201 |
|
19244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM21D |
0.744572393758201 |
|
19245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM25D |
0.744572393758201 |
|
19246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP316 |
0.744572393758201 |
|
19247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74|ENSG00000223182.1 |
0.744572393758201 |
|
19248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM23B |
0.744572393758201 |
|
19249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM39A |
0.744668705985083 |
|
19250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POGLUT1 |
0.744668705985083 |
|
19251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMMDC1 |
0.744668705985083 |
|
19252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTFR |
0.744754208485155 |
|
19253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf92 |
0.744999714984941 |
|
19254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf93 |
0.744999714984941 |
|
19255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4491 |
0.744999714984941 |
|
19256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGPAT2 |
0.745041295627795 |
|
19257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGFL7 |
0.745041295627795 |
|
19258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR126 |
0.745041295627795 |
|
19259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGC4771 |
0.745237738109128 |
|
19260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTMA |
0.745237738109128 |
|
19261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AARD |
0.745271428190607 |
|
19262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDPF1 |
0.745360638157013 |
|
19263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKDREJ |
0.745360638157013 |
|
19264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGER3 |
0.745430410711368 |
|
19265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CADM2 |
0.745488752709846 |
|
19266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERBP1 |
0.745520003402845 |
|
19267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL306P |
0.745588723142321 |
|
19268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRO |
0.745674771772022 |
|
19269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS7 |
0.74590776149434 |
|
19270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT8 |
0.74597907108892 |
|
19271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC6 |
0.745982289086738 |
|
19272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR615 |
0.745982289086738 |
|
19273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD31 |
0.746036977895447 |
|
19274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMU |
0.746101052280192 |
|
19275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1E1 |
0.746104694128184 |
|
19276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR3A3 |
0.746104694128184 |
|
19277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1E2 |
0.746104694128184 |
|
19278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPA |
0.746104694128184 |
|
19279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPV3 |
0.746104694128184 |
|
19280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBAP1 |
0.746106657496639 |
|
19281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP282 |
0.746106657496639 |
|
19282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPA |
0.746200394067403 |
|
19283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR301A |
0.746333054307684 |
|
19284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSRNP3 |
0.746340078002062 |
|
19285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL2 |
0.746410375235872 |
|
19286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL4A3BP |
0.746527130421711 |
|
19287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGCR |
0.746527130421711 |
|
19288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP27 |
0.74656169878739 |
|
19289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP100 |
0.746625926634128 |
|
19290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL834P |
0.746625926634128 |
|
19291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR601 |
0.746657946211999 |
|
19292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR64 |
0.746663203347678 |
|
19293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC73 |
0.746666013765205 |
|
19294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR454 |
0.746680820579315 |
|
19295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf127 |
0.746793943474586 |
|
19296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRT2 |
0.746799792317204 |
|
19297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRT3 |
0.746799792317204 |
|
19298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP279 |
0.746799792317204 |
|
19299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRIM1 |
0.746844331369449 |
|
19300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARFGAP2 |
0.746883825019817 |
|
19301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PACSIN3 |
0.746883825019817 |
|
19302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGED4B |
0.746944509166494 |
|
19303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGED4 |
0.746944509166494 |
|
19304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11D |
0.746944509166494 |
|
19305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11E |
0.746944509166494 |
|
19306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCE |
0.747063551693572 |
|
19307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf76 |
0.747088674836285 |
|
19308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00173 |
0.747111411694949 |
|
19309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDNRB |
0.747144297033363 |
|
19310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL810P |
0.747144297033363 |
|
19311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF1 |
0.747185188809168 |
|
19312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXE1 |
0.747389885644046 |
|
19313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL275P |
0.7473949624399 |
|
19314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC40A1 |
0.747402684210354 |
|
19315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPB41L4B |
0.747512913437233 |
|
19316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GALT2 |
0.747538151002875 |
|
19317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR2E3 |
0.747620438501112 |
|
19318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf36 |
0.747631626111512 |
|
19319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT4 |
0.747664091653354 |
|
19320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf67 |
0.747698797919606 |
|
19321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC41 |
0.747710897292726 |
|
19322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKZF1 |
0.747767798815738 |
|
19323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLB1L |
0.747767798815738 |
|
19324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK16 |
0.747767798815738 |
|
19325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA4A |
0.747767798815738 |
|
19326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBA4B |
0.747767798815738 |
|
19327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHDC1 |
0.747889788602981 |
|
19328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA3D |
0.747923830771142 |
|
19329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WIF1 |
0.747926177268809 |
|
19330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARX |
0.748067772448028 |
|
19331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL91P |
0.748067772448028 |
|
19332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTSE1 |
0.748133484998923 |
|
19333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RILPL2 |
0.748182402101047 |
|
19334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIM2 |
0.748270637571858 |
|
19335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA22 |
0.748309704233268 |
|
19336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL786P |
0.748358369919141 |
|
19337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3908 |
0.748373266714324 |
|
19338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED2 |
0.748373266714324 |
|
19339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX55 |
0.748373266714324 |
|
19340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA9|ENSG00000206897.1 |
0.748373266714324 |
|
19341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB2 |
0.74842882746117 |
|
19342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCCD1 |
0.74846566948913 |
|
19343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC15 |
0.74849950333721 |
|
19344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX19 |
0.748597392231062 |
|
19345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLA1 |
0.748722728948014 |
|
19346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACER1 |
0.748778163302094 |
|
19347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM15 |
0.748925207589693 |
|
19348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1A1 |
0.749099671379978 |
|
19349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2A1 |
0.749099671379978 |
|
19350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN2L |
0.749099671379978 |
|
19351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD19 |
0.749099671379978 |
|
19352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3C |
0.749099671379978 |
|
19353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAT |
0.749099671379978 |
|
19354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4517 |
0.749099671379978 |
|
19355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4721 |
0.749099671379978 |
|
19356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFATC2IP |
0.749099671379978 |
|
19357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB8 |
0.749099671379978 |
|
19358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB9 |
0.749099671379978 |
|
19359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABEP2 |
0.749099671379978 |
|
19360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRN3P2 |
0.749099671379978 |
|
19361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2B1 |
0.749099671379978 |
|
19362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA43|ENSG00000252461.1 |
0.749099671379978 |
|
19363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPNS1 |
0.749099671379978 |
|
19364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUFM |
0.749099671379978 |
|
19365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238352.1 |
0.749099671379978 |
|
19366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238684.1 |
0.749099671379978 |
|
19367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238699.1 |
0.749099671379978 |
|
19368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDRT15 |
0.749113126887357 |
|
19369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDRT1 |
0.749113126887357 |
|
19370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDRT4 |
0.749113126887357 |
|
19371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDRT7 |
0.749113126887357 |
|
19372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDRT8 |
0.749113126887357 |
|
19373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS3ST3B1 |
0.749113126887357 |
|
19374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4731 |
0.749113126887357 |
|
19375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMP22 |
0.749113126887357 |
|
19376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL792P |
0.749113126887357 |
|
19377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74|ENSG00000252129.1 |
0.749113126887357 |
|
19378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEKT3 |
0.749113126887357 |
|
19379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TVP23C |
0.749113126887357 |
|
19380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238806.1 |
0.749113126887357 |
|
19381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ME2 |
0.749203164180633 |
|
19382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELAC1 |
0.749203164180633 |
|
19383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBR4 |
0.749340719605121 |
|
19384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED13L |
0.749453845897281 |
|
19385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF79 |
0.74945807851806 |
|
19386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCHD1 |
0.749471454312387 |
|
19387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3665 |
0.749671546612958 |
|
19388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLAIN1 |
0.749671546612958 |
|
19389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUD7A |
0.749713819612125 |
|
19390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIS3L2 |
0.749729123703648 |
|
19391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIA4 |
0.749773867444917 |
|
19392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CETN2 |
0.749821734772615 |
|
19393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSAG1 |
0.749821734772615 |
|
19394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSAG2 |
0.749821734772615 |
|
19395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSAG3 |
0.749821734772615 |
|
19396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSAG4 |
0.749821734772615 |
|
19397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA12 |
0.749821734772615 |
|
19398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA1 |
0.749821734772615 |
|
19399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA2B |
0.749821734772615 |
|
19400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA2 |
0.749821734772615 |
|
19401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA3 |
0.749821734772615 |
|
19402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA6 |
0.749821734772615 |
|
19403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSDHL |
0.749821734772615 |
|
19404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMA3 |
0.749821734772615 |
|
19405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMA5 |
0.749821734772615 |
|
19406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMA6A |
0.749821734772615 |
|
19407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMA6B |
0.749821734772615 |
|
19408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMA6C |
0.749821734772615 |
|
19409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMA6D |
0.749821734772615 |
|
19410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL190P |
0.749821734772615 |
|
19411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL667P |
0.749821734772615 |
|
19412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP92 |
0.749821734772615 |
|
19413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF185 |
0.749821734772615 |
|
19414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF275 |
0.749821734772615 |
|
19415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239037.1 |
0.749821734772615 |
|
19416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP32 |
0.749852710395164 |
|
19417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB16 |
0.749898969294427 |
|
19418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC18 |
0.749944315579363 |
|
19419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PWRN1 |
0.750053866731016 |
|
19420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000200538.1 |
0.750175577777862 |
|
19421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIPPLY3 |
0.750220039258948 |
|
19422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSH6 |
0.750351312348796 |
|
19423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G4A |
0.750444340457533 |
|
19424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSUN4 |
0.750653369028575 |
|
19425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP273 |
0.750761210428489 |
|
19426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCAS2 |
0.750772554514403 |
|
19427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL167P |
0.750828561556208 |
|
19428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLM |
0.750872261269679 |
|
19429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM129A |
0.750884444335074 |
|
19430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGAT2 |
0.750970397415274 |
|
19431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC4P |
0.751028196118586 |
|
19432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP35 |
0.751062969618975 |
|
19433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRA3 |
0.751099968999272 |
|
19434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK4 |
0.751107034191375 |
|
19435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSK3B |
0.751193644099886 |
|
19436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA11 |
0.751273863146669 |
|
19437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPS |
0.751273863146669 |
|
19438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VMAC |
0.751273863146669 |
|
19439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNKL |
0.751724828101014 |
|
19440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf91 |
0.751724828101014 |
|
19441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC154 |
0.751724828101014 |
|
19442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF175 |
0.751781684553087 |
|
19443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFRP2 |
0.751781684553087 |
|
19444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR767 |
0.751791334541182 |
|
19445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK1 |
0.751945672713584 |
|
19446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4427 |
0.751945672713584 |
|
19447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG9 |
0.751946891870223 |
|
19448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FDXACB1 |
0.751946891870223 |
|
19449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf1 |
0.751946891870223 |
|
19450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIS12 |
0.752080552290735 |
|
19451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE20 |
0.752249803337104 |
|
19452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H3F3A |
0.752279794834612 |
|
19453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNURF |
0.752297599969716 |
|
19454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD64|ENSG00000270704.2 |
0.752297599969716 |
|
19455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD108 |
0.752297599969716 |
|
19456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLK4 |
0.752371160198263 |
|
19457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DACH1 |
0.752520807237565 |
|
19458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGGT1 |
0.752782346115869 |
|
19459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL206P |
0.752782346115869 |
|
19460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1280 |
0.75285717482171 |
|
19461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR204 |
0.752894802392323 |
|
19462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA73|ENSG00000253090.1 |
0.752933520784159 |
|
19463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSHR |
0.752979591548108 |
|
19464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK2A2 |
0.753033699971318 |
|
19465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL645P |
0.753033699971318 |
|
19466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRA10AC1 |
0.75303967267096 |
|
19467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238327.1 |
0.753148481633535 |
|
19468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0B |
0.753268353816244 |
|
19469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD18|ENSG00000200677.1 |
0.753341563898614 |
|
19470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC16A |
0.753602582309463 |
|
19471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT2 |
0.753745158846539 |
|
19472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC9 |
0.753977920205793 |
|
19473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEKT5 |
0.754214480123354 |
|
19474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN33 |
0.754281359089846 |
|
19475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMO |
0.754281359089846 |
|
19476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238522.1 |
0.754339970391109 |
|
19477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHMT1 |
0.754457756631808 |
|
19478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAE1 |
0.754681431472751 |
|
19479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L3 |
0.754681431472751 |
|
19480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM38 |
0.754681431472751 |
|
19481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAD4 |
0.754694451805565 |
|
19482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL695P |
0.754694451805565 |
|
19483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEX3C |
0.754694451805565 |
|
19484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4266 |
0.754694881565046 |
|
19485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME6 |
0.754704134706358 |
|
19486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIH |
0.755011942086287 |
|
19487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN2A2 |
0.755168622319441 |
|
19488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDDC3 |
0.755168622319441 |
|
19489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5C3AP1 |
0.755170408370508 |
|
19490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN4 |
0.75552792723086 |
|
19491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHMT1 |
0.755654138954986 |
|
19492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR602 |
0.755654138954986 |
|
19493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3134 |
0.75579592162945 |
|
19494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM69B |
0.755884676978891 |
|
19495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCM6 |
0.756047669654317 |
|
19496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF10 |
0.756095822773539 |
|
19497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK7 |
0.756122775220983 |
|
19498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLLT1 |
0.756137153954999 |
|
19499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXADR |
0.756153806439911 |
|
19500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AW |
0.756158827101661 |
|
19501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAG |
0.756233825853383 |
|
19502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF4 |
0.756282656496687 |
|
19503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD4 |
0.756382608069964 |
|
19504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRVI1 |
0.75642429108996 |
|
19505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MND1 |
0.756433458571575 |
|
19506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAD1 |
0.756466393307609 |
|
19507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GORASP2 |
0.756466393307609 |
|
19508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDGFC |
0.756474906840025 |
|
19509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTX4 |
0.756478962388675 |
|
19510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM204 |
0.756478962388675 |
|
19511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM192A |
0.756527762273901 |
|
19512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP1LC3B2 |
0.756537100480883 |
|
19513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTR9 |
0.756702891041716 |
|
19514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D12 |
0.756785880839566 |
|
19515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL365P |
0.756905674808046 |
|
19516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTG4 |
0.756911316538085 |
|
19517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf88 |
0.756911316538085 |
|
19518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR34B |
0.756911316538085 |
|
19519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR34C |
0.756911316538085 |
|
19520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAYN |
0.756911316538085 |
|
19521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGP1 |
0.756948873038854 |
|
19522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSMP |
0.756948873038854 |
|
19523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF44 |
0.757015736862913 |
|
19524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDHR2 |
0.757015736862913 |
|
19525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL684P |
0.757015736862913 |
|
19526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRIN1 |
0.757015736862913 |
|
19527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WSB2 |
0.757263262653474 |
|
19528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APPL1 |
0.757334891098909 |
|
19529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB14 |
0.757334891098909 |
|
19530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHR |
0.757531728945854 |
|
19531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000199473.1 |
0.757531728945854 |
|
19532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252291.1 |
0.757861519827285 |
|
19533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM233 |
0.757869694138064 |
|
19534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP197 |
0.757869694138064 |
|
19535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAB1 |
0.757869694138064 |
|
19536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD54L |
0.758413215565995 |
|
19537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNRH1 |
0.758462024272155 |
|
19538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD9 |
0.758462024272155 |
|
19539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCA2 |
0.758462024272155 |
|
19540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WIPF3 |
0.758489138355184 |
|
19541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000251926.1 |
0.758600643423965 |
|
19542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCAR1 |
0.758600643423965 |
|
19543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRIP1 |
0.758636178056626 |
|
19544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FASTKD1 |
0.758674091593654 |
|
19545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCB1 |
0.758696248246777 |
|
19546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM14E |
0.758771446167328 |
|
19547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00113 |
0.758773918902279 |
|
19548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPD8 |
0.758791456927628 |
|
19549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3124 |
0.758791456927628 |
|
19550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR11L1 |
0.758791456927628 |
|
19551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13G1 |
0.758791456927628 |
|
19552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR14A16 |
0.758791456927628 |
|
19553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR14A2 |
0.758791456927628 |
|
19554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR14C36 |
0.758791456927628 |
|
19555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR14I1 |
0.758791456927628 |
|
19556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR14K1 |
0.758791456927628 |
|
19557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1C1 |
0.758791456927628 |
|
19558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2AJ1 |
0.758791456927628 |
|
19559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2AK2 |
0.758791456927628 |
|
19560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2G6 |
0.758791456927628 |
|
19561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2L13 |
0.758791456927628 |
|
19562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2L2 |
0.758791456927628 |
|
19563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2L3 |
0.758791456927628 |
|
19564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2L5 |
0.758791456927628 |
|
19565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2L8 |
0.758791456927628 |
|
19566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2M2 |
0.758791456927628 |
|
19567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2M3 |
0.758791456927628 |
|
19568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2M4 |
0.758791456927628 |
|
19569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2M5 |
0.758791456927628 |
|
19570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2M7 |
0.758791456927628 |
|
19571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T10 |
0.758791456927628 |
|
19572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T11 |
0.758791456927628 |
|
19573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T12 |
0.758791456927628 |
|
19574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T1 |
0.758791456927628 |
|
19575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T27 |
0.758791456927628 |
|
19576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T29 |
0.758791456927628 |
|
19577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T2 |
0.758791456927628 |
|
19578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T33 |
0.758791456927628 |
|
19579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T34 |
0.758791456927628 |
|
19580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T35 |
0.758791456927628 |
|
19581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T3 |
0.758791456927628 |
|
19582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T4 |
0.758791456927628 |
|
19583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T5 |
0.758791456927628 |
|
19584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T6 |
0.758791456927628 |
|
19585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T7 |
0.758791456927628 |
|
19586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2T8 |
0.758791456927628 |
|
19587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2W3 |
0.758791456927628 |
|
19588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6F1 |
0.758791456927628 |
|
19589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGBD2 |
0.758791456927628 |
|
19590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BP5L |
0.758791456927628 |
|
19591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM58 |
0.758791456927628 |
|
19592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF672 |
0.758791456927628 |
|
19593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF692 |
0.758791456927628 |
|
19594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCC |
0.758898989522431 |
|
19595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AAMDC |
0.758982084805109 |
|
19596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC42P |
0.759141362926526 |
|
19597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNS |
0.75922936854772 |
|
19598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238592.1 |
0.75922936854772 |
|
19599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2S2 |
0.759293665900954 |
|
19600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D30 |
0.759359170424268 |
|
19601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PALLD |
0.759362308204785 |
|
19602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB11 |
0.759556360585413 |
|
19603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4694 |
0.759636815185449 |
|
19604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP166 |
0.759678053223614 |
|
19605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL437P |
0.759695337585558 |
|
19606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSR2 |
0.759803305743334 |
|
19607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAI2 |
0.759867717088377 |
|
19608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCP3 |
0.759905545501827 |
|
19609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOLPP1 |
0.759992579646154 |
|
19610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRAT |
0.759992579646154 |
|
19611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGFEM1P |
0.76018619518452 |
|
19612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G4B |
0.76032405411178 |
|
19613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP393 |
0.76032405411178 |
|
19614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEMD3 |
0.760377706497415 |
|
19615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC25C |
0.760383538537127 |
|
19616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPGEF1 |
0.760515085143473 |
|
19617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOWAHB |
0.760590764344484 |
|
19618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGLN1 |
0.760641868295697 |
|
19619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4310 |
0.760681826455721 |
|
19620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2A2 |
0.760779172611023 |
|
19621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGED1 |
0.760829985938682 |
|
19622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD74|ENSG00000201025.1 |
0.760967330607027 |
|
19623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD74|ENSG00000200891.1 |
0.761131516838579 |
|
19624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKRN3 |
0.761185873256838 |
|
19625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEL2 |
0.761185873256838 |
|
19626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAMM41 |
0.761281498850788 |
|
19627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR320D2 |
0.761516202992523 |
|
19628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXB1 |
0.761516202992523 |
|
19629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXB2 |
0.761516202992523 |
|
19630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXNA1 |
0.7615785199368 |
|
19631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238746.1 |
0.761772304704207 |
|
19632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTPBP10 |
0.762055024200421 |
|
19633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EYA3 |
0.762081871902453 |
|
19634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf53 |
0.762112458945898 |
|
19635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGDHL |
0.762112458945898 |
|
19636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00864 |
0.762131318731253 |
|
19637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP36L2 |
0.762343713095719 |
|
19638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB2 |
0.762395313579289 |
|
19639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB3 |
0.762395313579289 |
|
19640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB4 |
0.762395313579289 |
|
19641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB1 |
0.762395313579289 |
|
19642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR0B1 |
0.762395313579289 |
|
19643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOA4 |
0.762467650185151 |
|
19644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A14 |
0.762489797297007 |
|
19645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P19 |
0.762489797297007 |
|
19646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF385A |
0.762490830531684 |
|
19647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC8P |
0.762588480797916 |
|
19648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRIQ3 |
0.762588480797916 |
|
19649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FPGT |
0.762588480797916 |
|
19650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OAS2 |
0.762696953593134 |
|
19651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A16 |
0.7627567674879 |
|
19652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT39 |
0.762757594568823 |
|
19653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT40 |
0.762757594568823 |
|
19654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP7 |
0.762782111425088 |
|
19655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC6 |
0.762890265276685 |
|
19656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FURIN |
0.762916641680643 |
|
19657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FES |
0.762916641680643 |
|
19658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10A7 |
0.762930823645042 |
|
19659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUPV3L1 |
0.762946795934252 |
|
19660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HKDC1 |
0.762946795934252 |
|
19661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00354 |
0.762981751276889 |
|
19662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EP400 |
0.76298882851465 |
|
19663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAK1 |
0.763033914429129 |
|
19664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD21 |
0.763106783079038 |
|
19665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf20 |
0.763124039425285 |
|
19666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAT |
0.763196932675841 |
|
19667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OBSL1 |
0.763201925598606 |
|
19668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INHA |
0.763201925598606 |
|
19669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP213 |
0.763201925598606 |
|
19670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK11IP |
0.763201925598606 |
|
19671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGO1 |
0.763205175297431 |
|
19672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA16|ENSG00000201467.1 |
0.763216002603585 |
|
19673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBR3 |
0.763248976755596 |
|
19674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXNA4 |
0.763305453646757 |
|
19675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSR |
0.763325127494527 |
|
19676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN8 |
0.763325127494527 |
|
19677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR646 |
0.763642870535303 |
|
19678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MXRA5 |
0.763645177971237 |
|
19679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf24 |
0.763741224007855 |
|
19680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF13 |
0.763760947630079 |
|
19681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP1LC3C |
0.763816148234867 |
|
19682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R21 |
0.763889946772424 |
|
19683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DFFA |
0.764028396033917 |
|
19684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CMC1 |
0.764217758824054 |
|
19685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AZI2 |
0.764217758824054 |
|
19686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A7 |
0.764257402566922 |
|
19687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238316.1 |
0.764288747104168 |
|
19688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00607 |
0.764340557804432 |
|
19689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE5A |
0.764365363733589 |
|
19690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11|ENSG00000221245.1 |
0.764365363733589 |
|
19691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FN1 |
0.764431761367324 |
|
19692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASQ2 |
0.764475784420064 |
|
19693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A1 |
0.764581353810233 |
|
19694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TET1 |
0.764600020614138 |
|
19695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCML1 |
0.764742289634789 |
|
19696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH12 |
0.764938286693117 |
|
19697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR587 |
0.764944055538104 |
|
19698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT3 |
0.764945045152391 |
|
19699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO3 |
0.764975540581822 |
|
19700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AE1 |
0.765025321358282 |
|
19701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1278 |
0.765075632929853 |
|
19702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00446 |
0.765103273434781 |
|
19703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf10 |
0.76510349151227 |
|
19704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AAAS |
0.76510349151227 |
|
19705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRGN |
0.765123015742825 |
|
19706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS26A |
0.765123015742825 |
|
19707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THRSP |
0.765123453414974 |
|
19708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFC2 |
0.765123453414974 |
|
19709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG8 |
0.765123453414974 |
|
19710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCHL5 |
0.765183817598714 |
|
19711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL735P |
0.765193243778345 |
|
19712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEFSEC |
0.765234555196983 |
|
19713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR1B |
0.765347410590608 |
|
19714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIG |
0.765483969056116 |
|
19715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCTPP1 |
0.765582538960266 |
|
19716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA42|ENSG00000199787.1 |
0.765582538960266 |
|
19717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLCO2A1 |
0.765605699171248 |
|
19718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERICH2 |
0.765632252689543 |
|
19719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C74 |
0.765643061715406 |
|
19720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238969.1 |
0.765645314165373 |
|
19721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN12 |
0.765666857022637 |
|
19722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VLDLR |
0.76570152799809 |
|
19723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDA2R |
0.76571253890122 |
|
19724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCA |
0.765719002825837 |
|
19725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHCHD5 |
0.765758756371898 |
|
19726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGBL4 |
0.765806774988432 |
|
19727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REXO4 |
0.765952473613356 |
|
19728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHL1 |
0.766073147677776 |
|
19729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTN6 |
0.766073147677776 |
|
19730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP144 |
0.766073147677776 |
|
19731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL120P |
0.766073147677776 |
|
19732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUFY2 |
0.766105476647723 |
|
19733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNA2 |
0.766105476647723 |
|
19734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP319 |
0.766105476647723 |
|
19735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00849 |
0.766105476647723 |
|
19736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL602P |
0.766180275644941 |
|
19737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX50 |
0.766246884486722 |
|
19738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNGB1 |
0.766348609787655 |
|
19739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL801P |
0.76636885513557 |
|
19740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4459 |
0.76636885513557 |
|
19741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS11 |
0.766393351755685 |
|
19742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRM1 |
0.766393351755685 |
|
19743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R1B |
0.766452816493766 |
|
19744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD59 |
0.766510645638725 |
|
19745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC2 |
0.766574120081712 |
|
19746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238663.1 |
0.766601743012446 |
|
19747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATIC |
0.766601743012446 |
|
19748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf9 |
0.766656538510596 |
|
19749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA5 |
0.766687838952653 |
|
19750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITM2C |
0.766712985227671 |
|
19751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR55 |
0.766712985227671 |
|
19752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNT2 |
0.767030176135255 |
|
19753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAD1 |
0.767030176135255 |
|
19754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR802 |
0.767159638248358 |
|
19755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF8 |
0.767175562273325 |
|
19756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWC2L |
0.767273870110382 |
|
19757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB8 |
0.767406270352967 |
|
19758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GATA2 |
0.767406270352967 |
|
19759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000243321.2 |
0.767562717309963 |
|
19760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A6 |
0.767721305361367 |
|
19761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8B12 |
0.767779892245337 |
|
19762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8A1 |
0.767779892245337 |
|
19763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGD4 |
0.767878818671153 |
|
19764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR346 |
0.768138128432336 |
|
19765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD23B |
0.768201073867629 |
|
19766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP11 |
0.768215060698366 |
|
19767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A12 |
0.768245937628256 |
|
19768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD81|ENSG00000223213.1 |
0.768328158637367 |
|
19769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD28 |
0.768531265936903 |
|
19770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC32 |
0.76858764996893 |
|
19771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSM2A |
0.768662435458971 |
|
19772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF367 |
0.76889469668782 |
|
19773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HABP4 |
0.76889469668782 |
|
19774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIER1 |
0.768900549550583 |
|
19775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ12 |
0.768913327272083 |
|
19776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FH |
0.768922172701688 |
|
19777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PANX3 |
0.769011855641545 |
|
19778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBRG1 |
0.769011855641545 |
|
19779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP352 |
0.769011855641545 |
|
19780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAG1 |
0.769021220928847 |
|
19781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBA1 |
0.769202699713378 |
|
19782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INE1 |
0.769202699713378 |
|
19783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK16 |
0.769202699713378 |
|
19784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXO1 |
0.769270620035349 |
|
19785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNC4 |
0.769319499059879 |
|
19786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf54 |
0.769402060260371 |
|
19787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf163 |
0.769432797503547 |
|
19788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD14 |
0.769438134360406 |
|
19789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR78 |
0.769537409572858 |
|
19790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABO |
0.769589087276764 |
|
19791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGC4294 |
0.76961028556377 |
|
19792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX16 |
0.76961028556377 |
|
19793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD82 |
0.769646507857448 |
|
19794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DISC1 |
0.769765143447373 |
|
19795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL390P |
0.769800710740786 |
|
19796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPA1 |
0.769800710740786 |
|
19797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP434E1119 |
0.769805172993844 |
|
19798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPR2 |
0.769811622174237 |
|
19799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG8 |
0.769811622174237 |
|
19800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM221B |
0.769811622174237 |
|
19801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HINT2 |
0.769811622174237 |
|
19802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCP2 |
0.769935860738999 |
|
19803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB5RL |
0.769935860738999 |
|
19804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM33 |
0.770048866382824 |
|
19805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNPY2 |
0.770096914343785 |
|
19806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKL1 |
0.770131672048951 |
|
19807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP72 |
0.770134363746605 |
|
19808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF2 |
0.770134363746605 |
|
19809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AD |
0.770138980503197 |
|
19810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIPK2 |
0.770180565153756 |
|
19811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM8B |
0.770257712474502 |
|
19812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf72 |
0.770284714295802 |
|
19813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM71F1 |
0.770343161659691 |
|
19814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM71F2 |
0.770343161659691 |
|
19815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HILPDA |
0.770343161659691 |
|
19816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL2B |
0.770343161659691 |
|
19817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP242 |
0.770343161659691 |
|
19818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP243 |
0.770343161659691 |
|
19819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULK1 |
0.770401516323932 |
|
19820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUS1 |
0.770402767051129 |
|
19821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA49 |
0.770402767051129 |
|
19822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP45 |
0.770454787348229 |
|
19823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLE4 |
0.770513240594223 |
|
19824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PJA1 |
0.770684505510796 |
|
19825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00269 |
0.770684505510796 |
|
19826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5089 |
0.770865626755027 |
|
19827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPRML |
0.770865626755027 |
|
19828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1976 |
0.770880160869598 |
|
19829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP50 |
0.770922911244174 |
|
19830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3H |
0.77092668390848 |
|
19831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDST4 |
0.770982231950878 |
|
19832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPM2 |
0.77103125694169 |
|
19833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRWD1 |
0.771077545316712 |
|
19834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP133 |
0.771204881267625 |
|
19835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD72 |
0.771306282569331 |
|
19836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIT1 |
0.771306282569331 |
|
19837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF39 |
0.771306282569331 |
|
19838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC107 |
0.771306282569331 |
|
19839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMRP |
0.771306282569331 |
|
19840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA9 |
0.771306282569331 |
|
19841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL22P |
0.771306282569331 |
|
19842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DFNB31 |
0.77135196304796 |
|
19843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGBD3 |
0.771572749712279 |
|
19844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF2 |
0.771603199852216 |
|
19845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR1A |
0.771701836114403 |
|
19846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCF1 |
0.771784132146107 |
|
19847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AWAT2 |
0.771996148077655 |
|
19848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGAT2L6 |
0.771996148077655 |
|
19849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGBP1 |
0.771996148077655 |
|
19850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR676 |
0.771996148077655 |
|
19851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTUD6A |
0.771996148077655 |
|
19852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF150 |
0.77210573078963 |
|
19853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEIL3 |
0.772117786538942 |
|
19854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGA |
0.772117786538942 |
|
19855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP172 |
0.772117786538942 |
|
19856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP253 |
0.772126475325022 |
|
19857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNPPD1 |
0.772187127671271 |
|
19858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM134A |
0.772187127671271 |
|
19859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAND2B |
0.772187127671271 |
|
19860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB6 |
0.772187127671271 |
|
19861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG9A |
0.772187127671271 |
|
19862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WSB1 |
0.772235391553473 |
|
19863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TROVE2 |
0.772282659452284 |
|
19864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCP1 |
0.772284808451364 |
|
19865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM47C |
0.772311327938594 |
|
19866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGM5 |
0.772312768710175 |
|
19867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB11 |
0.772321898760053 |
|
19868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX14 |
0.772429381910616 |
|
19869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL228P |
0.772436705345598 |
|
19870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BHLHE40 |
0.772600856824516 |
|
19871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APCDD1L |
0.772646293005227 |
|
19872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE6C |
0.772709960666379 |
|
19873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRIF1 |
0.772846456620819 |
|
19874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMELESS |
0.772848842408212 |
|
19875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTSL3 |
0.772852846565328 |
|
19876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP267 |
0.772873939431511 |
|
19877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4299 |
0.772931748737676 |
|
19878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEP |
0.772943984302442 |
|
19879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM28 |
0.772943984302442 |
|
19880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRT4 |
0.772943984302442 |
|
19881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMPDH1 |
0.772943984302442 |
|
19882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP183 |
0.772951831319704 |
|
19883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS6 |
0.773006310000585 |
|
19884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A3 |
0.773006310000585 |
|
19885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHM3 |
0.773296772296756 |
|
19886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDK3 |
0.773305124297625 |
|
19887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2G2 |
0.773344413159746 |
|
19888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2G3 |
0.773344413159746 |
|
19889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIT |
0.773617340082411 |
|
19890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1178 |
0.773617340082411 |
|
19891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRBD1 |
0.773737049900231 |
|
19892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP15 |
0.773824666202256 |
|
19893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFTUD1P1 |
0.77389103384485 |
|
19894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCCB |
0.773940321566676 |
|
19895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASAH2B |
0.774034195976775 |
|
19896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPOT |
0.774252002040778 |
|
19897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBK1 |
0.774252002040778 |
|
19898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RWDD4 |
0.774313937313621 |
|
19899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STOX2 |
0.774313937313621 |
|
19900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC11 |
0.774313937313621 |
|
19901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL28P |
0.774313937313621 |
|
19902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF2 |
0.774313937313621 |
|
19903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD79 |
0.774313937313621 |
|
19904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASP3 |
0.774313937313621 |
|
19905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC111 |
0.774313937313621 |
|
19906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLF1IP |
0.774313937313621 |
|
19907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCC |
0.774316174182552 |
|
19908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00310 |
0.774353310415548 |
|
19909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDH2 |
0.77439986626718 |
|
19910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B12 |
0.774635689870944 |
|
19911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGI1 |
0.774763198246537 |
|
19912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3RF3 |
0.774805636770701 |
|
19913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35G1 |
0.774902028461829 |
|
19914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13F1 |
0.774948943833578 |
|
19915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR593 |
0.774956795845816 |
|
19916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NARS2 |
0.77498100326335 |
|
19917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAN2 |
0.775052551028354 |
|
19918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL23A |
0.775052551028354 |
|
19919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAT2 |
0.775052551028354 |
|
19920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOF |
0.775052551028354 |
|
19921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRX2 |
0.775440713551965 |
|
19922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212391.1 |
0.775803236595141 |
|
19923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL112P |
0.775848328698326 |
|
19924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000199713.1 |
0.775848328698326 |
|
19925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCGB1B2P |
0.776078858797588 |
|
19926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM14 |
0.776093434593784 |
|
19927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4508 |
0.776122429137201 |
|
19928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPEG |
0.776300070668946 |
|
19929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMPPA |
0.776300070668946 |
|
19930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548C |
0.776331376524417 |
|
19931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF26B |
0.776443689827308 |
|
19932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSF1 |
0.776446044468647 |
|
19933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00305 |
0.776555309666689 |
|
19934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO2 |
0.776687311480754 |
|
19935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO44 |
0.776687311480754 |
|
19936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO6 |
0.776687311480754 |
|
19937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAD2L2 |
0.776687311480754 |
|
19938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRAXIN |
0.776687311480754 |
|
19939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOH |
0.77670705408358 |
|
19940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM120A |
0.776768485436332 |
|
19941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STYXL1 |
0.776768485436332 |
|
19942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL6ST |
0.77687925651148 |
|
19943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238326.1 |
0.77687925651148 |
|
19944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP1 |
0.776905902644574 |
|
19945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNER |
0.777227713632691 |
|
19946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C6 |
0.777368357840391 |
|
19947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C1 |
0.777368357840391 |
|
19948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORN3 |
0.777481582224794 |
|
19949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPH7 |
0.777582009023561 |
|
19950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL41 |
0.777582009023561 |
|
19951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL294P |
0.777645991469934 |
|
19952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL4A4 |
0.777729193470103 |
|
19953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL4A3 |
0.777729193470103 |
|
19954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYCP2 |
0.77779291336614 |
|
19955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM217B |
0.77779291336614 |
|
19956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R3D |
0.77779291336614 |
|
19957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDH26 |
0.77779291336614 |
|
19958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10P1 |
0.777978135930607 |
|
19959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTNA |
0.778075261067613 |
|
19960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC173 |
0.778392335377723 |
|
19961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL23 |
0.778392335377723 |
|
19962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHOSPHO2 |
0.778392335377723 |
|
19963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000206961.1 |
0.778392335377723 |
|
19964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSB |
0.778392335377723 |
|
19965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL5 |
0.778392335377723 |
|
19966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252981.1 |
0.778392335377723 |
|
19967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP444 |
0.778853727734098 |
|
19968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL819P |
0.779106542734544 |
|
19969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROBO1 |
0.779219961038404 |
|
19970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOSTRIN |
0.779245195734413 |
|
19971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPC25 |
0.779245195734413 |
|
19972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
G6PC2 |
0.779245195734413 |
|
19973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF15 |
0.779336587046282 |
|
19974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP459 |
0.779389193628552 |
|
19975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBDD1 |
0.779424817938036 |
|
19976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R12B |
0.779497946476526 |
|
19977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNK3 |
0.779536842316255 |
|
19978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000206853.1 |
0.77958398319164 |
|
19979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP1 |
0.77967138085952 |
|
19980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSMB |
0.779688958433766 |
|
19981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORC4 |
0.779713299717324 |
|
19982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM98B |
0.779726328466345 |
|
19983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBMS2 |
0.779753446861956 |
|
19984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OBP2B |
0.779858265877368 |
|
19985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WIPF2 |
0.779877988933021 |
|
19986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLI2 |
0.779892113802884 |
|
19987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4522 |
0.780197746675998 |
|
19988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPIP5K1 |
0.780242827859153 |
|
19989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCF1 |
0.780425497063439 |
|
19990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR455 |
0.780480782083897 |
|
19991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATL2 |
0.780670875802773 |
|
19992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHROOM2 |
0.780683372708932 |
|
19993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KYNU |
0.780711551323129 |
|
19994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCTD |
0.780759336671079 |
|
19995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM92A1P2 |
0.780759336671079 |
|
19996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP67 |
0.780759336671079 |
|
19997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252048.1 |
0.780759336671079 |
|
19998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238319.1 |
0.780759336671079 |
|
19999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3152 |
0.780951891651544 |
|
20000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP258 |
0.780951891651544 |
|
20001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC24A2 |
0.781018744424833 |
|
20002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD46|ENSG00000201009.1 |
0.781029717155128 |
|
20003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP121 |
0.781050546043708 |
|
20004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL20 |
0.781050546043708 |
|
20005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL826P |
0.781077901798273 |
|
20006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORAI1 |
0.781116301742662 |
|
20007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC48 |
0.78121042316443 |
|
20008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL659P |
0.781247427284664 |
|
20009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP293 |
0.781247427284664 |
|
20010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00402 |
0.781252960639045 |
|
20011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY1P5 |
0.781252960639045 |
|
20012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00347 |
0.781252960639045 |
|
20013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBF4B |
0.781285350759927 |
|
20014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM11 |
0.781285350759927 |
|
20015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJC1 |
0.781285350759927 |
|
20016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTSL1 |
0.781301090027771 |
|
20017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252852.1 |
0.781425386121264 |
|
20018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYRK1A |
0.781590976856571 |
|
20019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD98 |
0.781672927149836 |
|
20020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212214.1 |
0.781706861287189 |
|
20021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NANS |
0.781816539290915 |
|
20022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM14 |
0.781816539290915 |
|
20023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORO2A |
0.781816539290915 |
|
20024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D2 |
0.781816539290915 |
|
20025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORMDL1 |
0.781818919655694 |
|
20026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238530.1 |
0.781891334410371 |
|
20027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1G1 |
0.781891334410371 |
|
20028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf91 |
0.781891334410371 |
|
20029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53 |
0.782192421167763 |
|
20030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMPDL3B |
0.782360508851038 |
|
20031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XKR8 |
0.782360508851038 |
|
20032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYAB |
0.782397926362913 |
|
20033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPB2 |
0.782397926362913 |
|
20034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf52 |
0.782397926362913 |
|
20035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIXDC1 |
0.782397926362913 |
|
20036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP351 |
0.782397926362913 |
|
20037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2B1 |
0.782686372591255 |
|
20038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0A2 |
0.782686372591255 |
|
20039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2H3 |
0.782686372591255 |
|
20040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTN2 |
0.782686372591255 |
|
20041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR30B |
0.782784190384343 |
|
20042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR30D |
0.782784190384343 |
|
20043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UNC45A |
0.782785450789852 |
|
20044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHN2 |
0.782844493974554 |
|
20045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5S |
0.782864295989501 |
|
20046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPVL |
0.782890466753186 |
|
20047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM47 |
0.782900426121241 |
|
20048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSTM1 |
0.782931931139028 |
|
20049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB7 |
0.783053905321344 |
|
20050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLD1 |
0.783213792340062 |
|
20051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PP13439 |
0.783213792340062 |
|
20052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM212 |
0.783213792340062 |
|
20053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238359.1 |
0.783213792340062 |
|
20054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNDC3B |
0.783213792340062 |
|
20055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL141P |
0.783213792340062 |
|
20056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GHSR |
0.783213792340062 |
|
20057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFSF10 |
0.783213792340062 |
|
20058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00381 |
0.783260967392669 |
|
20059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAF1 |
0.783424648879538 |
|
20060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSTN |
0.783581080321525 |
|
20061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF11 |
0.783760749088177 |
|
20062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALM |
0.78377019617271 |
|
20063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF7 |
0.78377019617271 |
|
20064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3E |
0.783783295714085 |
|
20065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRMT7 |
0.783894620238714 |
|
20066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP258 |
0.78392319211606 |
|
20067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARAF |
0.784014632925951 |
|
20068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYN1 |
0.784014632925951 |
|
20069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDSR |
0.784123793507181 |
|
20070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS4B |
0.784123793507181 |
|
20071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNLL2 |
0.784210202209225 |
|
20072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4D1 |
0.784210202209225 |
|
20073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4D2 |
0.784210202209225 |
|
20074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL736P |
0.784237659010663 |
|
20075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM129 |
0.784238893161845 |
|
20076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TACC3 |
0.784238893161845 |
|
20077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHBG |
0.784241009146533 |
|
20078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000251860.1 |
0.784241009146533 |
|
20079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAT2 |
0.784241009146533 |
|
20080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1B2 |
0.784241009146533 |
|
20081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALCOCO1 |
0.784262108916311 |
|
20082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL15 |
0.784299648028127 |
|
20083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3R3 |
0.784555488265161 |
|
20084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRH2 |
0.784640829889977 |
|
20085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX31 |
0.784889010631065 |
|
20086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYAL2 |
0.784904080498254 |
|
20087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WRAP53 |
0.78495308131784 |
|
20088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFNB3 |
0.78495308131784 |
|
20089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL29P2 |
0.78495308131784 |
|
20090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT3 |
0.785182911964861 |
|
20091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT5 |
0.785182911964861 |
|
20092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT6 |
0.785182911964861 |
|
20093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TACR2 |
0.785193105996638 |
|
20094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STOX1 |
0.785232883766652 |
|
20095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM155B |
0.785252253699808 |
|
20096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRTA2 |
0.785346599067763 |
|
20097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARTN |
0.785488048755618 |
|
20098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPO13 |
0.785488048755618 |
|
20099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGR |
0.785502142349541 |
|
20100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POR |
0.785518094805336 |
|
20101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A13 |
0.785716115956301 |
|
20102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2T |
0.785726856553597 |
|
20103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP321 |
0.785855627781032 |
|
20104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIN2A |
0.785920826011661 |
|
20105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIN2B |
0.785920826011661 |
|
20106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR1F |
0.786078364137523 |
|
20107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNA2 |
0.786115883172983 |
|
20108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBL4B |
0.786128372904454 |
|
20109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB2 |
0.786295942929147 |
|
20110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB10 |
0.786295942929147 |
|
20111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKP4 |
0.786384555795748 |
|
20112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNG1 |
0.786402364344405 |
|
20113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNPNAT1 |
0.786514904447602 |
|
20114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD83 |
0.786558922950732 |
|
20115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYLK |
0.786860932466733 |
|
20116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP147 |
0.786929146423373 |
|
20117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP288 |
0.787066035766318 |
|
20118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANHX |
0.787164431258539 |
|
20119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKLE2 |
0.787164431258539 |
|
20120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHFR |
0.787164431258539 |
|
20121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA3 |
0.787164431258539 |
|
20122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRCOL1 |
0.787164431258539 |
|
20123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RX2 |
0.787164431258539 |
|
20124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGAM5 |
0.787164431258539 |
|
20125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLE |
0.787164431258539 |
|
20126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PXMP2 |
0.787164431258539 |
|
20127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP379 |
0.787164431258539 |
|
20128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC12P |
0.787164431258539 |
|
20129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF10 |
0.787164431258539 |
|
20130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF140 |
0.787164431258539 |
|
20131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF268 |
0.787164431258539 |
|
20132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF26 |
0.787164431258539 |
|
20133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF605 |
0.787164431258539 |
|
20134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF84 |
0.787164431258539 |
|
20135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF891 |
0.787164431258539 |
|
20136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNA3 |
0.787178176226667 |
|
20137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCN7 |
0.787224024387691 |
|
20138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TELO2 |
0.787224024387691 |
|
20139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT140 |
0.787224024387691 |
|
20140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTL7B |
0.787258680356548 |
|
20141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTL7A |
0.787258680356548 |
|
20142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC53 |
0.787359536306944 |
|
20143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf173 |
0.787359536306944 |
|
20144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYZ |
0.787359536306944 |
|
20145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYW3 |
0.787359536306944 |
|
20146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPATCH11 |
0.787494994492756 |
|
20147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACER2 |
0.787598125836018 |
|
20148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN3L |
0.787678349454479 |
|
20149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAP43 |
0.787700153130455 |
|
20150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10AG1 |
0.787732228680047 |
|
20151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4A15 |
0.787732228680047 |
|
20152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4A16 |
0.787732228680047 |
|
20153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4A5 |
0.787732228680047 |
|
20154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C11 |
0.787732228680047 |
|
20155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C15 |
0.787732228680047 |
|
20156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C16 |
0.787732228680047 |
|
20157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C46 |
0.787732228680047 |
|
20158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4C6 |
0.787732228680047 |
|
20159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4P4 |
0.787732228680047 |
|
20160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4S2 |
0.787732228680047 |
|
20161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5AS1 |
0.787732228680047 |
|
20162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5D13 |
0.787732228680047 |
|
20163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5D14 |
0.787732228680047 |
|
20164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5D16 |
0.787732228680047 |
|
20165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5D18 |
0.787732228680047 |
|
20166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5F1 |
0.787732228680047 |
|
20167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5I1 |
0.787732228680047 |
|
20168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5J2 |
0.787732228680047 |
|
20169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5L1 |
0.787732228680047 |
|
20170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5L2 |
0.787732228680047 |
|
20171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5T2 |
0.787732228680047 |
|
20172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5W2 |
0.787732228680047 |
|
20173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8H2 |
0.787732228680047 |
|
20174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8H3 |
0.787732228680047 |
|
20175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8I2 |
0.787732228680047 |
|
20176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8J3 |
0.787732228680047 |
|
20177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8K5 |
0.787732228680047 |
|
20178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM48 |
0.787732228680047 |
|
20179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM51HP |
0.787732228680047 |
|
20180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM51 |
0.787732228680047 |
|
20181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP77 |
0.787733311730523 |
|
20182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP292 |
0.787733311730523 |
|
20183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A15 |
0.78775700149562 |
|
20184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35F5 |
0.787781979628637 |
|
20185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4782 |
0.787781979628637 |
|
20186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX3P2 |
0.787814806839873 |
|
20187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDC80 |
0.787814806839873 |
|
20188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU109|ENSG00000238575.1 |
0.787814806839873 |
|
20189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238425.1 |
0.787814806839873 |
|
20190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPH2 |
0.787825873693345 |
|
20191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP7D3 |
0.787827659452659 |
|
20192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM163B |
0.787870469003517 |
|
20193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBH |
0.787870469003517 |
|
20194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPK1B |
0.787919831399863 |
|
20195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRTN |
0.787955147782842 |
|
20196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LANCL3 |
0.788139700027124 |
|
20197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS7 |
0.788226688380696 |
|
20198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCC1 |
0.788232178988528 |
|
20199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
R3HDM1 |
0.788239955213656 |
|
20200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAP2A |
0.78838761805085 |
|
20201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUCNR1 |
0.788411984962357 |
|
20202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBLD |
0.788480613048944 |
|
20203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPH3 |
0.788480613048944 |
|
20204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP4 |
0.788550234297035 |
|
20205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALAD |
0.78859054522955 |
|
20206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf43 |
0.78859054522955 |
|
20207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLE3 |
0.78859054522955 |
|
20208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATPAF2 |
0.788678608203129 |
|
20209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SV2C |
0.78869550935353 |
|
20210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKL4 |
0.788797139771117 |
|
20211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA67|ENSG00000252473.1 |
0.788797139771117 |
|
20212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABGAP1 |
0.788841209592737 |
|
20213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMEB1 |
0.78891755028695 |
|
20214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA24|ENSG00000252777.1 |
0.78891755028695 |
|
20215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCKAP1 |
0.789031725084138 |
|
20216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D26 |
0.789049486938688 |
|
20217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF286A |
0.789049486938688 |
|
20218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP436 |
0.789049486938688 |
|
20219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC10A7 |
0.789129926173916 |
|
20220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAM1L1 |
0.789162663644143 |
|
20221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL37 |
0.789195780455422 |
|
20222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM51 |
0.789275093268543 |
|
20223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDM4 |
0.789292902998701 |
|
20224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALT4 |
0.789315783222155 |
|
20225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP31 |
0.789315783222155 |
|
20226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPGEF5 |
0.789330462472146 |
|
20227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP157 |
0.789437611647336 |
|
20228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADPGK |
0.789543434029046 |
|
20229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP4K3 |
0.789636006130543 |
|
20230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YTHDF2 |
0.789639435698904 |
|
20231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMDN2 |
0.789674205728018 |
|
20232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP332 |
0.789691255723529 |
|
20233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3174 |
0.789740401279052 |
|
20234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL664P |
0.789767757281437 |
|
20235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERO1LB |
0.789788261361778 |
|
20236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252638.1 |
0.789788261361778 |
|
20237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT6 |
0.789809347971636 |
|
20238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN15 |
0.789818223374109 |
|
20239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMPRSS15 |
0.789923770124059 |
|
20240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QSER1 |
0.789989910531822 |
|
20241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBG1 |
0.7901148072962 |
|
20242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSR |
0.790171756984378 |
|
20243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBS12 |
0.790222361121289 |
|
20244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF2 |
0.790222361121289 |
|
20245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA5 |
0.790222361121289 |
|
20246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD51C |
0.79022294686261 |
|
20247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN1 |
0.790344169092453 |
|
20248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POMGNT1 |
0.790344169092453 |
|
20249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LURAP1 |
0.790344169092453 |
|
20250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSBN1 |
0.790357746599419 |
|
20251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN22 |
0.790357746599419 |
|
20252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGN1 |
0.790375942478454 |
|
20253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238556.1 |
0.790375942478454 |
|
20254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCSAML |
0.79038854595349 |
|
20255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL144P |
0.790393798530959 |
|
20256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR34 |
0.790393798530959 |
|
20257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR82 |
0.790393798530959 |
|
20258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf63 |
0.790416471099487 |
|
20259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPLL |
0.790470011682707 |
|
20260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R15B |
0.790523679527602 |
|
20261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASAL1 |
0.790645482158347 |
|
20262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLBP |
0.79087818330784 |
|
20263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf141 |
0.790896401983584 |
|
20264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCNL1 |
0.790896401983584 |
|
20265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGDS |
0.790896401983584 |
|
20266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf142 |
0.790896401983584 |
|
20267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIC3 |
0.790896401983584 |
|
20268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA2 |
0.790896401983584 |
|
20269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf139 |
0.790896401983584 |
|
20270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUT7 |
0.790896401983584 |
|
20271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCEL |
0.790918183485996 |
|
20272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P7 |
0.790918183485996 |
|
20273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC16A |
0.790962657760662 |
|
20274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAGH |
0.791121640398555 |
|
20275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEPDC7 |
0.791203121641425 |
|
20276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS8 |
0.79159974753039 |
|
20277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTN4IP1 |
0.791624633924767 |
|
20278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STYX |
0.791898167194646 |
|
20279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEATR1 |
0.791905271613775 |
|
20280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF804A |
0.792234628399616 |
|
20281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GXYLT2 |
0.792249196523567 |
|
20282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF33A |
0.792435455379969 |
|
20283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF37A |
0.792435455379969 |
|
20284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPLX2 |
0.792507735404725 |
|
20285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3C2B |
0.792569964810797 |
|
20286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMSD |
0.792577383215009 |
|
20287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB8 |
0.792577383215009 |
|
20288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG12 |
0.792706071254411 |
|
20289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PECR |
0.792912748419885 |
|
20290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUBP1 |
0.792940991957374 |
|
20291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TVP23A |
0.792940991957374 |
|
20292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5010 |
0.792956676393459 |
|
20293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAGLU |
0.792956676393459 |
|
20294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGI3 |
0.792975205905074 |
|
20295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDCD2 |
0.793171466948918 |
|
20296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMMR |
0.793171466948918 |
|
20297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAT2B |
0.793171466948918 |
|
20298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYND19 |
0.793284142769854 |
|
20299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARRDC1 |
0.793284142769854 |
|
20300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf37 |
0.793284142769854 |
|
20301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239171.1 |
0.793363195886377 |
|
20302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2CD3 |
0.793378788238152 |
|
20303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THEG5 |
0.793407037836874 |
|
20304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRB14 |
0.793438792580557 |
|
20305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13C4 |
0.793690867766421 |
|
20306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13C3 |
0.793690867766421 |
|
20307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THOC3 |
0.793703317044795 |
|
20308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL335P |
0.793779930011808 |
|
20309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1109 |
0.793779930011808 |
|
20310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAD1 |
0.793779930011808 |
|
20311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL2 |
0.793779930011808 |
|
20312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL21 |
0.793779930011808 |
|
20313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDR1 |
0.793863879156385 |
|
20314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF462 |
0.794003134022811 |
|
20315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR577 |
0.794269886959293 |
|
20316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF5L |
0.794375104697904 |
|
20317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
URB2 |
0.794375104697904 |
|
20318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBR3 |
0.794513418520258 |
|
20319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOPEY2 |
0.794513418520258 |
|
20320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL73P |
0.794513418520258 |
|
20321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS9 |
0.794634696337472 |
|
20322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELMOD2 |
0.794886629982473 |
|
20323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL152P |
0.794886629982473 |
|
20324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL442P |
0.794921632560722 |
|
20325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC42 |
0.795032132902996 |
|
20326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP18 |
0.795049127254819 |
|
20327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCT |
0.795049283535031 |
|
20328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC4 |
0.795108207260819 |
|
20329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HELB |
0.795120804744149 |
|
20330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238528.1 |
0.795120804744149 |
|
20331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX15 |
0.795303163922776 |
|
20332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAV1 |
0.795339721440385 |
|
20333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5094 |
0.795425922135138 |
|
20334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5009 |
0.795425922135138 |
|
20335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf38 |
0.795425922135138 |
|
20336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX10 |
0.795473572745945 |
|
20337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCL |
0.795543712053147 |
|
20338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXNB1 |
0.795576477199154 |
|
20339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D9 |
0.795659776884212 |
|
20340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLX |
0.795771281980593 |
|
20341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238570.1 |
0.795896420461963 |
|
20342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIPK3 |
0.79598486417662 |
|
20343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX53 |
0.796040449892303 |
|
20344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRAMP1L |
0.796053383062201 |
|
20345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQGAP2 |
0.796294361347678 |
|
20346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH10 |
0.796495540718957 |
|
20347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL129P |
0.796495540718957 |
|
20348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL418P |
0.796654410088679 |
|
20349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBL1X |
0.796664190020674 |
|
20350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRD1 |
0.796761116114353 |
|
20351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239026.1 |
0.796761116114353 |
|
20352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SFXN1 |
0.796761116114353 |
|
20353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP148 |
0.796761116114353 |
|
20354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR569 |
0.796854153193331 |
|
20355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG16L1 |
0.797043733768739 |
|
20356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX3 |
0.797068779005758 |
|
20357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B1 |
0.7971563379703 |
|
20358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COASY |
0.7971563379703 |
|
20359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00161 |
0.797185584203209 |
|
20360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf112 |
0.79721733735248 |
|
20361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCAT7 |
0.797406820814287 |
|
20362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBP2 |
0.797406820814287 |
|
20363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR15L |
0.797798318640968 |
|
20364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HHLA3 |
0.797818853574243 |
|
20365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL32P |
0.797848575339024 |
|
20366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDHD1 |
0.797880739266938 |
|
20367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4767 |
0.797880739266938 |
|
20368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR651 |
0.797880739266938 |
|
20369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPLA4 |
0.797880739266938 |
|
20370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STS |
0.797880739266938 |
|
20371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCX2 |
0.797880739266938 |
|
20372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCX3A |
0.797880739266938 |
|
20373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VCX |
0.797880739266938 |
|
20374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00709 |
0.797901436181212 |
|
20375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8G |
0.79792139422289 |
|
20376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW5 |
0.79792139422289 |
|
20377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCN12 |
0.79792139422289 |
|
20378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRSF11 |
0.798064831490934 |
|
20379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD13C |
0.798064831490934 |
|
20380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDH2 |
0.798097784398113 |
|
20381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP94 |
0.798267638115808 |
|
20382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4329 |
0.798288507575532 |
|
20383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP6 |
0.798478028871305 |
|
20384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASAH2 |
0.798478028871305 |
|
20385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM21A |
0.798478028871305 |
|
20386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00843 |
0.798478028871305 |
|
20387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMRPP4 |
0.798478028871305 |
|
20388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP317 |
0.798478028871305 |
|
20389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGMS1 |
0.798478028871305 |
|
20390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA74|ENSG00000223111.1 |
0.798478028871305 |
|
20391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM23 |
0.798478028871305 |
|
20392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRA2 |
0.798556808670067 |
|
20393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCB |
0.798556808670067 |
|
20394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOSPD2 |
0.798556808670067 |
|
20395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF2 |
0.798576330284572 |
|
20396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASNSD1 |
0.798661646724042 |
|
20397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKAR |
0.798661646724042 |
|
20398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB10 |
0.798734450548533 |
|
20399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP78 |
0.798734450548533 |
|
20400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSGEPL1 |
0.799003781584798 |
|
20401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMSAP2 |
0.799043471324605 |
|
20402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPY19L2 |
0.799120161648149 |
|
20403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH15 |
0.799152621119818 |
|
20404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMTOR5 |
0.799174774834118 |
|
20405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROK1 |
0.799174774834118 |
|
20406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC7 |
0.799233708042334 |
|
20407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL7A |
0.799255982220353 |
|
20408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD24 |
0.799255982220353 |
|
20409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD36A |
0.799255982220353 |
|
20410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD36B |
0.799255982220353 |
|
20411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD36C |
0.799255982220353 |
|
20412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SURF1 |
0.799255982220353 |
|
20413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SURF2 |
0.799255982220353 |
|
20414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SURF4 |
0.799255982220353 |
|
20415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf96 |
0.799255982220353 |
|
20416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS13 |
0.799255982220353 |
|
20417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACFD1 |
0.799255982220353 |
|
20418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A6 |
0.799255982220353 |
|
20419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM8C |
0.799255982220353 |
|
20420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTSL2 |
0.799255982220353 |
|
20421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238733.1 |
0.799292630134097 |
|
20422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IYD |
0.799740757589044 |
|
20423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238656.1 |
0.79974645213163 |
|
20424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA6 |
0.799775313437301 |
|
20425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPTC |
0.799842654681693 |
|
20426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf28 |
0.800076158338068 |
|
20427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUSC2 |
0.800187347295475 |
|
20428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A8 |
0.800211192717347 |
|
20429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP3S2 |
0.800252763253487 |
|
20430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP445 |
0.800352946560064 |
|
20431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SASH1 |
0.800357473378902 |
|
20432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BSPRY |
0.800410196087408 |
|
20433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA27|ENSG00000252459.1 |
0.800505504401362 |
|
20434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMP15 |
0.800505646863726 |
|
20435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL363P |
0.800554943506571 |
|
20436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHFPL1 |
0.80058613625855 |
|
20437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD1 |
0.800654042892201 |
|
20438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA33|ENSG00000252045.1 |
0.800660813804204 |
|
20439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2053 |
0.800775830138779 |
|
20440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDCA7L |
0.800866757912896 |
|
20441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPC3 |
0.800949004708946 |
|
20442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPN3 |
0.800949004708946 |
|
20443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM216A |
0.800949004708946 |
|
20444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS29 |
0.800949004708946 |
|
20445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD50|ENSG00000202335.1 |
0.800949004708946 |
|
20446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD9B |
0.800949004708946 |
|
20447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0355 |
0.801189140017615 |
|
20448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR2C |
0.801214759506717 |
|
20449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD9A |
0.801227910065143 |
|
20450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL4 |
0.801277537712598 |
|
20451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM120B |
0.801303368477374 |
|
20452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf64 |
0.801314695069684 |
|
20453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGFR |
0.801339234960726 |
|
20454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP23 |
0.801339234960726 |
|
20455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRNAU1AP |
0.801339323661399 |
|
20456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD99 |
0.801339323661399 |
|
20457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2117 |
0.801405339188222 |
|
20458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2AP1 |
0.801501530656879 |
|
20459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPJ |
0.801525958042032 |
|
20460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70C |
0.80159858059728 |
|
20461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP128 |
0.80159858059728 |
|
20462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHAT |
0.801631106452097 |
|
20463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC18A3 |
0.801631106452097 |
|
20464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR2B |
0.801688931319957 |
|
20465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLIS1 |
0.801690146095607 |
|
20466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL538P |
0.801834442650121 |
|
20467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIN1P1 |
0.801834442650121 |
|
20468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00393 |
0.802013508315183 |
|
20469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TENM1 |
0.802116756429224 |
|
20470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL769P |
0.802253869492891 |
|
20471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKNA |
0.802507005833437 |
|
20472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FREM1 |
0.802517890543654 |
|
20473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA58|ENSG00000201003.1 |
0.802648923238152 |
|
20474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL13A1 |
0.802792797917004 |
|
20475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA4 |
0.80285012277704 |
|
20476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR137C |
0.802923409131515 |
|
20477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L11 |
0.802994929911935 |
|
20478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP41 |
0.803261050328114 |
|
20479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABARAPL3 |
0.803310076722503 |
|
20480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF774 |
0.803310076722503 |
|
20481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC16 |
0.803326776189374 |
|
20482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRN |
0.803360683916869 |
|
20483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGR3 |
0.803379988678467 |
|
20484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPX |
0.803421988632982 |
|
20485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL559P |
0.803425756717345 |
|
20486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NGEF |
0.803532718424285 |
|
20487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2 |
0.803614453174778 |
|
20488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL419P |
0.803682034051749 |
|
20489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN9 |
0.803769185144104 |
|
20490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238545.1 |
0.803769185144104 |
|
20491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMS1 |
0.803862910321828 |
|
20492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL449P |
0.80394998678099 |
|
20493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPZ1 |
0.803978094480619 |
|
20494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THSD7B |
0.804027560891061 |
|
20495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM110B |
0.804095906800373 |
|
20496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BUB1 |
0.804158414542604 |
|
20497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239094.1 |
0.804191359431643 |
|
20498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4753 |
0.804243836815124 |
|
20499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGPRX2 |
0.804309118200763 |
|
20500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELF3 |
0.804345581844026 |
|
20501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRELP |
0.80442837736869 |
|
20502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM219A |
0.804631000646833 |
|
20503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF25 |
0.804663220111996 |
|
20504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NID1 |
0.804670439977495 |
|
20505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR137B |
0.804670439977495 |
|
20506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDA |
0.804705337812202 |
|
20507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRY1 |
0.804778257239818 |
|
20508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F2RL2 |
0.804828865986206 |
|
20509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORM1 |
0.804935626684194 |
|
20510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORM2 |
0.804935626684194 |
|
20511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIATL1 |
0.80501694211563 |
|
20512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHCYL1 |
0.805034418127567 |
|
20513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX8 |
0.805252705919069 |
|
20514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4505 |
0.805264869565464 |
|
20515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000200536.1 |
0.805321196250958 |
|
20516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM15 |
0.805321196250958 |
|
20517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A4 |
0.805321196250958 |
|
20518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TANC1 |
0.805332095096977 |
|
20519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1B |
0.805437156789414 |
|
20520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL10 |
0.805655562119733 |
|
20521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROR1 |
0.805657789484013 |
|
20522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEATR5B |
0.805710542406854 |
|
20523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13C8 |
0.805791697406913 |
|
20524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHDRBS3 |
0.805826049966366 |
|
20525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EBLN2 |
0.805852653083933 |
|
20526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPIN1 |
0.805941466855162 |
|
20527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4262 |
0.805941466855162 |
|
20528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QPCT |
0.805962482394172 |
|
20529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00577 |
0.806293099991978 |
|
20530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP188 |
0.806373008206077 |
|
20531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3GLB2 |
0.806373008206077 |
|
20532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM73B |
0.806373008206077 |
|
20533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252388.1 |
0.806379889978964 |
|
20534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL651P |
0.806424934531496 |
|
20535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA6|ENSG00000251791.1 |
0.806450543890953 |
|
20536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP17A|ENSG00000197976.6 |
0.806540388569443 |
|
20537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSD |
0.806540388569443 |
|
20538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSE |
0.806540388569443 |
|
20539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSF |
0.806540388569443 |
|
20540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSH |
0.806540388569443 |
|
20541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASMTL|ENSG00000169093.10 |
0.806540388569443 |
|
20542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASMT|ENSG00000196433.6 |
0.806540388569443 |
|
20543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD99P1|ENSG00000223773.2 |
0.806540388569443 |
|
20544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD99|ENSG00000002586.13 |
0.806540388569443 |
|
20545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRLF2|ENSG00000205755.6 |
0.806540388569443 |
|
20546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSF2RA|ENSG00000198223.9 |
0.806540388569443 |
|
20547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRSX|ENSG00000169084.8 |
0.806540388569443 |
|
20548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTPBP6|ENSG00000178605.8 |
0.806540388569443 |
|
20549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYG2 |
0.806540388569443 |
|
20550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL3RA|ENSG00000185291.6 |
0.806540388569443 |
|
20551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00102|ENSG00000230542.1 |
0.806540388569443 |
|
20552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00106|ENSG00000236871.2 |
0.806540388569443 |
|
20553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00685|ENSG00000226179.1 |
0.806540388569443 |
|
20554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3690|ENSG00000265658.1 |
0.806540388569443 |
|
20555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY8|ENSG00000182162.5 |
0.806540388569443 |
|
20556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCXD1|ENSG00000182378.8 |
0.806540388569443 |
|
20557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R3B|ENSG00000167393.12 |
0.806540388569443 |
|
20558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL355P|ENSG00000265350.1 |
0.806540388569443 |
|
20559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL578P |
0.806540388569443 |
|
20560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP498|ENSG00000223274.1 |
0.806540388569443 |
|
20561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHOX|ENSG00000185960.8 |
0.806540388569443 |
|
20562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A6|ENSG00000169100.8 |
0.806540388569443 |
|
20563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XG |
0.806540388569443 |
|
20564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBED1|ENSG00000214717.4 |
0.806540388569443 |
|
20565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000251848.1 |
0.806540388569443 |
|
20566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B6 |
0.806547093163912 |
|
20567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF21B |
0.806591408050739 |
|
20568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1S |
0.806591408050739 |
|
20569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASCL5 |
0.806591408050739 |
|
20570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM9 |
0.806591408050739 |
|
20571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFN1 |
0.806591408050739 |
|
20572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P8 |
0.806901280112132 |
|
20573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA14A |
0.806942192596688 |
|
20574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBR1 |
0.80694724963561 |
|
20575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP264 |
0.807131576858212 |
|
20576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISCA1 |
0.807131576858212 |
|
20577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC6 |
0.807131576858212 |
|
20578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA8 |
0.807218941439024 |
|
20579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRB2 |
0.807219356319057 |
|
20580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTSR2 |
0.807296266484034 |
|
20581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548S |
0.807296266484034 |
|
20582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MID1 |
0.807301180690067 |
|
20583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TARBP1 |
0.80733483527965 |
|
20584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA5 |
0.807336232237251 |
|
20585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00924 |
0.807762729161289 |
|
20586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf27 |
0.807799542005105 |
|
20587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AJ2 |
0.807799542005105 |
|
20588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRPX |
0.807799542005105 |
|
20589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYTL5 |
0.807799542005105 |
|
20590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNPEP |
0.807811662629259 |
|
20591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DES |
0.807811662629259 |
|
20592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD7 |
0.807954617320054 |
|
20593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC2A8 |
0.808032059881753 |
|
20594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K2 |
0.808082781392136 |
|
20595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4783 |
0.808082781392136 |
|
20596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROC |
0.808082781392136 |
|
20597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1202 |
0.808084338960939 |
|
20598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4666B |
0.80811961017737 |
|
20599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HACE1 |
0.808193044714124 |
|
20600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA10 |
0.808450017352051 |
|
20601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGAV |
0.808536437719805 |
|
20602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA20|ENSG00000201660.1 |
0.808740127005566 |
|
20603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTN2 |
0.808948901751199 |
|
20604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM5 |
0.80907477756847 |
|
20605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf153 |
0.809314728402253 |
|
20606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A3 |
0.809414557997995 |
|
20607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLM1 |
0.809431396193034 |
|
20608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD4 |
0.809581824593758 |
|
20609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX51 |
0.809693389554589 |
|
20610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT9 |
0.809693389554589 |
|
20611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOC4L |
0.809693389554589 |
|
20612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNLS |
0.809801678096518 |
|
20613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA35 |
0.809846240872627 |
|
20614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC7 |
0.809861095750596 |
|
20615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAF12 |
0.810101008051228 |
|
20616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB42 |
0.810101008051228 |
|
20617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPON1 |
0.810108213581964 |
|
20618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT11 |
0.81035447234311 |
|
20619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212182.1 |
0.810360659356801 |
|
20620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
A1CF |
0.810397331648523 |
|
20621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13C9 |
0.810488937341602 |
|
20622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13D1 |
0.810488937341602 |
|
20623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPSNAP3A |
0.810488937341602 |
|
20624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIPSNAP3B |
0.810488937341602 |
|
20625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCA1 |
0.810488937341602 |
|
20626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHISA9 |
0.810508725021595 |
|
20627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212434.1 |
0.810640567962197 |
|
20628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252566.1 |
0.810980549177502 |
|
20629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XK |
0.811014081084498 |
|
20630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13C2 |
0.81106187905351 |
|
20631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13C5 |
0.81106187905351 |
|
20632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KA1 |
0.811205872865477 |
|
20633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL679P |
0.811205872865477 |
|
20634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR23B |
0.811274603276997 |
|
20635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR27B |
0.811274603276997 |
|
20636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3074 |
0.811274603276997 |
|
20637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIM1 |
0.811311507888496 |
|
20638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM74 |
0.811435083325039 |
|
20639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHX1 |
0.811610192659963 |
|
20640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCN4 |
0.811642621677572 |
|
20641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WWC3 |
0.811642621677572 |
|
20642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GINS3 |
0.81171643869618 |
|
20643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRN |
0.811718193541703 |
|
20644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS1 |
0.811736416365607 |
|
20645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EP400NL |
0.811791731524254 |
|
20646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V1G3 |
0.811825804889519 |
|
20647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239077.1 |
0.81187298670696 |
|
20648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTR3 |
0.81187298670696 |
|
20649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252946.1 |
0.81222430298085 |
|
20650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD276 |
0.812258143122117 |
|
20651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf59 |
0.812258143122117 |
|
20652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0922 |
0.812267116121762 |
|
20653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR2 |
0.812267116121762 |
|
20654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMI2 |
0.812458326910827 |
|
20655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238409.1 |
0.812458326910827 |
|
20656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7A2 |
0.812465931930344 |
|
20657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIP5K1B |
0.812555393869193 |
|
20658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA21|ENSG00000251805.1 |
0.81258575165955 |
|
20659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf106 |
0.812620037889142 |
|
20660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYLPF |
0.812706545939124 |
|
20661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEPT1 |
0.812706545939124 |
|
20662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF48 |
0.812706545939124 |
|
20663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548H2 |
0.812710363692997 |
|
20664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMMP2L |
0.812772788978316 |
|
20665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM171B |
0.812776769579258 |
|
20666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLITRK6 |
0.812816128703517 |
|
20667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HK1 |
0.812831631302622 |
|
20668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFRC |
0.812990927883427 |
|
20669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LBH |
0.813358221122622 |
|
20670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPO |
0.813381037873888 |
|
20671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGRRF1 |
0.81342044997531 |
|
20672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD3L1 |
0.813428253943422 |
|
20673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP289 |
0.813576851249538 |
|
20674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4504 |
0.813578602962555 |
|
20675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK5RAP3 |
0.813582157802223 |
|
20676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP10 |
0.813701552653756 |
|
20677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf35 |
0.813830582321805 |
|
20678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBG2 |
0.813845210030252 |
|
20679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCR10 |
0.813845210030252 |
|
20680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTNAP1 |
0.813845210030252 |
|
20681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHH3 |
0.813845210030252 |
|
20682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STX8 |
0.813879133379774 |
|
20683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR634 |
0.813999342268582 |
|
20684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTX1 |
0.814032392044328 |
|
20685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGA2 |
0.814044360939778 |
|
20686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP11L1 |
0.814077287769481 |
|
20687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR1D1 |
0.814091579189278 |
|
20688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL29 |
0.814108271971416 |
|
20689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC6L2 |
0.814120449118376 |
|
20690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4268 |
0.814129712604436 |
|
20691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf191 |
0.814388390672271 |
|
20692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMP15 |
0.81439128976596 |
|
20693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DARS |
0.814475776841946 |
|
20694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMUG1 |
0.814478686991529 |
|
20695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNMA1 |
0.814534809529159 |
|
20696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELMSAN1 |
0.814534809529159 |
|
20697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC17 |
0.814576339882146 |
|
20698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5T1 |
0.814596721212433 |
|
20699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8H1 |
0.814596721212433 |
|
20700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM2 |
0.814600111517258 |
|
20701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPAS1 |
0.814650425211996 |
|
20702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT223P |
0.814755093153409 |
|
20703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT25 |
0.814755093153409 |
|
20704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238804.1 |
0.814831031943539 |
|
20705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIP |
0.814831031943539 |
|
20706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGF2BP1 |
0.814831031943539 |
|
20707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPCS3 |
0.814836550165103 |
|
20708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE1C |
0.814885346064168 |
|
20709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EZH1 |
0.814929218425637 |
|
20710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP289 |
0.815045632687688 |
|
20711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00092 |
0.815045632687688 |
|
20712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B3 |
0.815045632687688 |
|
20713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCML2 |
0.815072922951056 |
|
20714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf57 |
0.815094993875586 |
|
20715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00471 |
0.815094993875586 |
|
20716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMUR1 |
0.815094993875586 |
|
20717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL5A2 |
0.81526193565483 |
|
20718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3129 |
0.81526193565483 |
|
20719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THRA |
0.815265447804937 |
|
20720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf66 |
0.815325454173192 |
|
20721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS11P6 |
0.815325454173192 |
|
20722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA2D1 |
0.815407489625154 |
|
20723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU11 |
0.81557812683383 |
|
20724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR148B |
0.815656265558623 |
|
20725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL744P |
0.815656265558623 |
|
20726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR84 |
0.815656265558623 |
|
20727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPRIN1 |
0.81575691476231 |
|
20728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX20 |
0.815780297228727 |
|
20729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VIT |
0.815823099170274 |
|
20730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDOC1 |
0.816101586238618 |
|
20731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCA5L |
0.816227417379366 |
|
20732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BGR |
0.816227417379366 |
|
20733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOSTDC1 |
0.816262869315993 |
|
20734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOS2 |
0.816313784143737 |
|
20735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR2C2 |
0.816336338663039 |
|
20736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS25 |
0.816336338663039 |
|
20737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC10 |
0.816377287651533 |
|
20738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR196A2 |
0.816377287651533 |
|
20739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMPD1 |
0.816385932859929 |
|
20740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL432P |
0.816385932859929 |
|
20741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRAS |
0.816385932859929 |
|
20742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGI2 |
0.816415013048235 |
|
20743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAL2 |
0.816533591415802 |
|
20744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBDD2 |
0.816694265257828 |
|
20745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC146 |
0.816723861326872 |
|
20746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238416.1 |
0.816737056771697 |
|
20747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GALNT2 |
0.816757310862823 |
|
20748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACLY |
0.81693741541622 |
|
20749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP287 |
0.816999616727164 |
|
20750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTAFR |
0.817038877022777 |
|
20751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKTN |
0.817121080430143 |
|
20752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00476 |
0.817227333036241 |
|
20753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP434H0512 |
0.817227333036241 |
|
20754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP1B1 |
0.817300364861929 |
|
20755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMS3L |
0.817306232046788 |
|
20756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMS3|ENSG00000256977.6 |
0.817306232046788 |
|
20757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIMS3|ENSG00000257207.4 |
0.817306232046788 |
|
20758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00116 |
0.817306232046788 |
|
20759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MALL |
0.817306232046788 |
|
20760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4267 |
0.817306232046788 |
|
20761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4436B1 |
0.817306232046788 |
|
20762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4436B2 |
0.817306232046788 |
|
20763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPHP1 |
0.817306232046788 |
|
20764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGPD5 |
0.817306232046788 |
|
20765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGPD6 |
0.817306232046788 |
|
20766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf56 |
0.817378378505574 |
|
20767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238440.1 |
0.817378378505574 |
|
20768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEZ2 |
0.817417647363532 |
|
20769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FERMT2 |
0.817435327803518 |
|
20770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf88 |
0.817474388646804 |
|
20771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC14B |
0.817539949435249 |
|
20772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AAED1 |
0.817539949435249 |
|
20773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL747P |
0.817543424541011 |
|
20774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNKSR2 |
0.817597536836462 |
|
20775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GNT7 |
0.817654696153481 |
|
20776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA75|ENSG00000206885.1 |
0.817654696153481 |
|
20777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD20 |
0.817654696153481 |
|
20778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD82 |
0.817654696153481 |
|
20779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP136 |
0.817831627221374 |
|
20780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP1A |
0.818091051449768 |
|
20781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC8 |
0.818175044418247 |
|
20782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSL5 |
0.818246661078883 |
|
20783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD12 |
0.81825790019726 |
|
20784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRG1 |
0.81825790019726 |
|
20785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLN5 |
0.81825790019726 |
|
20786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL3 |
0.81825790019726 |
|
20787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMC3IP |
0.818347370839349 |
|
20788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3937 |
0.818411780730349 |
|
20789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF330 |
0.818422386906333 |
|
20790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC60 |
0.818495244968709 |
|
20791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42EP3 |
0.818564588573783 |
|
20792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00211 |
0.818564588573783 |
|
20793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMG1 |
0.818621047498788 |
|
20794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOM1L2 |
0.818647114932161 |
|
20795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHX1 |
0.81887595948656 |
|
20796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM63A |
0.81887595948656 |
|
20797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF12L2 |
0.818923055583339 |
|
20798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU109|ENSG00000238754.1 |
0.818981653307373 |
|
20799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL808P |
0.818986022918985 |
|
20800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FFAR4 |
0.819026277457593 |
|
20801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBP4 |
0.819026277457593 |
|
20802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCEH1 |
0.819345512543277 |
|
20803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTX2 |
0.819380992178204 |
|
20804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POMZP3 |
0.819380992178204 |
|
20805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPK3B |
0.819380992178204 |
|
20806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPGEFL1 |
0.819651049049519 |
|
20807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WWC2 |
0.819691618353573 |
|
20808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4439 |
0.819695140213632 |
|
20809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALX3 |
0.819747909982324 |
|
20810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA3E |
0.819786320448186 |
|
20811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOMM20 |
0.819801126476682 |
|
20812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM34 |
0.819801126476682 |
|
20813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA14B |
0.819801126476682 |
|
20814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SURF6 |
0.819886162093337 |
|
20815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED22 |
0.819886162093337 |
|
20816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2AK4 |
0.820069981131428 |
|
20817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRP14 |
0.820069981131428 |
|
20818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
7SK|ENSG00000232512.2 |
0.820188420447304 |
|
20819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2Z |
0.820236632900675 |
|
20820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRIP1 |
0.820389434144586 |
|
20821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHTF18 |
0.820550084424958 |
|
20822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG13 |
0.820550084424958 |
|
20823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR662 |
0.820550084424958 |
|
20824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSLNL |
0.820550084424958 |
|
20825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSLN |
0.820550084424958 |
|
20826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR25 |
0.820550084424958 |
|
20827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPUSD1 |
0.820550084424958 |
|
20828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXP1 |
0.820680612865923 |
|
20829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANP32B |
0.820842765083784 |
|
20830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUNDC1 |
0.820914759034861 |
|
20831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL291P |
0.820914759034861 |
|
20832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRM3 |
0.820943458498208 |
|
20833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLN3 |
0.821039218260654 |
|
20834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOBR |
0.821039218260654 |
|
20835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL27 |
0.821039218260654 |
|
20836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC101 |
0.821039218260654 |
|
20837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASC3 |
0.821117426062855 |
|
20838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LACE1 |
0.821183039821025 |
|
20839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYMP |
0.821186891874002 |
|
20840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNA10 |
0.821186891874002 |
|
20841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM9A |
0.821284148172431 |
|
20842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED18 |
0.82139127662948 |
|
20843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR25 |
0.821435564148942 |
|
20844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STEAP3 |
0.821555968938756 |
|
20845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP1 |
0.821643097460174 |
|
20846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INCENP |
0.82172321358964 |
|
20847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H2AFY2 |
0.822004151702787 |
|
20848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIFM2 |
0.822004151702787 |
|
20849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYSND1 |
0.822004151702787 |
|
20850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAR1A |
0.822004151702787 |
|
20851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPS7B |
0.82201238862466 |
|
20852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS13D |
0.822061976847219 |
|
20853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf203 |
0.822118249493027 |
|
20854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA59A |
0.822187794089374 |
|
20855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED12L |
0.8222507280353 |
|
20856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP145 |
0.8222507280353 |
|
20857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR171 |
0.8222507280353 |
|
20858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY14 |
0.8222507280353 |
|
20859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR122 |
0.822296566882218 |
|
20860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WTIP |
0.822400339642717 |
|
20861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNH8 |
0.822465411066518 |
|
20862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO36 |
0.822493740109773 |
|
20863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIP12 |
0.822493740109773 |
|
20864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR7 |
0.822587281216139 |
|
20865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR582 |
0.822786426152584 |
|
20866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIAM2 |
0.822878815809117 |
|
20867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCL24 |
0.822885731425329 |
|
20868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL212P |
0.822911580537512 |
|
20869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPB1 |
0.822911580537512 |
|
20870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00588 |
0.82299720571604 |
|
20871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF1 |
0.823083120848949 |
|
20872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMYND10 |
0.823083120848949 |
|
20873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPRL2 |
0.823083120848949 |
|
20874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYB561D2 |
0.823083120848949 |
|
20875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM115 |
0.823083120848949 |
|
20876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL499P |
0.823141145483489 |
|
20877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCLAT1 |
0.823152583220889 |
|
20878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXP2 |
0.823237851955328 |
|
20879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FHL1 |
0.823825076808672 |
|
20880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH11 |
0.823909525463873 |
|
20881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM5 |
0.823989692219758 |
|
20882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIRT1 |
0.824036481343172 |
|
20883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR87 |
0.824098317284773 |
|
20884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY13 |
0.824098317284773 |
|
20885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P2RY12 |
0.824098317284773 |
|
20886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF10 |
0.824098317284773 |
|
20887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5186 |
0.824098317284773 |
|
20888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL220P |
0.824292544242841 |
|
20889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSANTD4 |
0.824345167682739 |
|
20890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AASDHPPT |
0.824354992343025 |
|
20891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP385 |
0.824423744515582 |
|
20892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A6 |
0.824554999494191 |
|
20893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239080.1 |
0.824554999494191 |
|
20894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
API5 |
0.824621290360521 |
|
20895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARS |
0.824668266327169 |
|
20896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDIT3 |
0.824668266327169 |
|
20897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD6 |
0.824668266327169 |
|
20898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR616 |
0.824668266327169 |
|
20899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCTN2 |
0.824668266327169 |
|
20900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP75 |
0.824806506318445 |
|
20901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA20|ENSG00000251861.1 |
0.824806506318445 |
|
20902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD3B1 |
0.825307531258864 |
|
20903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1H |
0.825312885715165 |
|
20904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS29P |
0.825312885715165 |
|
20905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPSAB1 |
0.825312885715165 |
|
20906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPSB2 |
0.825312885715165 |
|
20907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPSD1 |
0.825312885715165 |
|
20908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPSG1 |
0.825312885715165 |
|
20909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCB5 |
0.825571543573888 |
|
20910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4792 |
0.825579906266563 |
|
20911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSBP3 |
0.825865801848679 |
|
20912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00903 |
0.825900676453313 |
|
20913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAV1 |
0.825934724657676 |
|
20914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL452P |
0.825934724657676 |
|
20915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL710P |
0.825948289185912 |
|
20916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL312P |
0.825982164391018 |
|
20917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF5A |
0.825982164391018 |
|
20918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIP4K2C |
0.825982164391018 |
|
20919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRAGA |
0.825989962388411 |
|
20920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAUS6 |
0.825989962388411 |
|
20921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA8 |
0.825989962388411 |
|
20922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP237 |
0.82608376920895 |
|
20923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKS1 |
0.826221046177974 |
|
20924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFE2 |
0.826402195131619 |
|
20925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4G2 |
0.826467551121581 |
|
20926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD97 |
0.826467551121581 |
|
20927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAO2 |
0.826509551675968 |
|
20928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35D1 |
0.826637817979568 |
|
20929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MANEA |
0.826678576863056 |
|
20930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FERD3L |
0.826705907324464 |
|
20931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3146 |
0.826705907324464 |
|
20932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TWIST1 |
0.826705907324464 |
|
20933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TWISTNB |
0.826705907324464 |
|
20934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCR4 |
0.826781374159477 |
|
20935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000202377.1 |
0.827023006993981 |
|
20936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYM |
0.827046209921124 |
|
20937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHPN2 |
0.827069640854611 |
|
20938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP247 |
0.827079744846922 |
|
20939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBED3 |
0.827251354908856 |
|
20940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000201674.1 |
0.827320653298459 |
|
20941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL93P |
0.827320653298459 |
|
20942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD30 |
0.827320653298459 |
|
20943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SESN2 |
0.827344070237602 |
|
20944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX3 |
0.827346027835306 |
|
20945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS23 |
0.827488550422466 |
|
20946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMOT |
0.827594078434338 |
|
20947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL266P |
0.827594078434338 |
|
20948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238899.1 |
0.827818770486708 |
|
20949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD26P1 |
0.828056624026927 |
|
20950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoR442|ENSG00000252203.1 |
0.8281410291001 |
|
20951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239000.1 |
0.8281410291001 |
|
20952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPGR |
0.828166257932524 |
|
20953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252050.1 |
0.828166257932524 |
|
20954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4788 |
0.828229288490392 |
|
20955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHTF1 |
0.828247823850576 |
|
20956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK5 |
0.828356131983578 |
|
20957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTD |
0.828483787598193 |
|
20958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEPD |
0.828583178936783 |
|
20959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRNP35 |
0.82860323875551 |
|
20960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS38 |
0.828857453671615 |
|
20961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT9A |
0.828857453671615 |
|
20962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5008 |
0.828857453671615 |
|
20963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATPIF1 |
0.828921155110504 |
|
20964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP22 |
0.828939738735702 |
|
20965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL406P |
0.829147018878328 |
|
20966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAB2 |
0.829147878502368 |
|
20967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAT6 |
0.829147878502368 |
|
20968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB6 |
0.829155020212295 |
|
20969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDLRAD3 |
0.82919960930615 |
|
20970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRS1 |
0.829279956833105 |
|
20971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5702 |
0.829309423314889 |
|
20972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1231 |
0.829438005777489 |
|
20973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPO9 |
0.829438005777489 |
|
20974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHISA4 |
0.829438005777489 |
|
20975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf62 |
0.829485748257916 |
|
20976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPY19L2P4 |
0.829485748257916 |
|
20977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STEAP1 |
0.829485748257916 |
|
20978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STEAP2 |
0.829485748257916 |
|
20979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF804B |
0.829485748257916 |
|
20980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1S3 |
0.829502837333988 |
|
20981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC1 |
0.829630582407022 |
|
20982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC8 |
0.829690562010002 |
|
20983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBRSL1 |
0.829690562010002 |
|
20984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00865 |
0.829705692525747 |
|
20985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLA1 |
0.829727322668728 |
|
20986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4651 |
0.830019894919645 |
|
20987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF645 |
0.83002920823342 |
|
20988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTF2 |
0.830091326767333 |
|
20989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR942 |
0.830091326767333 |
|
20990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM45 |
0.830091326767333 |
|
20991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF507 |
0.830140045342812 |
|
20992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFIT1B |
0.830267675615492 |
|
20993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFIT1 |
0.830267675615492 |
|
20994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFIT5 |
0.830267675615492 |
|
20995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPPB |
0.830331288410646 |
|
20996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB6 |
0.830408751239122 |
|
20997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB26 |
0.830408751239122 |
|
20998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PANK1 |
0.83050578161852 |
|
20999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1471 |
0.830606421239928 |
|
21000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPPC |
0.830606421239928 |
|
21001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00632 |
0.830696585845912 |
|
21002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABL1 |
0.830871572139683 |
|
21003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WRB |
0.83096259095388 |
|
21004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD3 |
0.830962667705168 |
|
21005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPRM |
0.831329567640153 |
|
21006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN3 |
0.831385325167564 |
|
21007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STOM |
0.831422535117075 |
|
21008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF20B |
0.831451044632283 |
|
21009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBTPS2 |
0.831464139662977 |
|
21010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YY2 |
0.831464139662977 |
|
21011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL328P |
0.831573983008697 |
|
21012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL47 |
0.831602767942067 |
|
21013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB5 |
0.831602767942067 |
|
21014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239096.1 |
0.831602767942067 |
|
21015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADORA2B |
0.831634813399488 |
|
21016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSWIM7 |
0.831634813399488 |
|
21017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC19 |
0.831634813399488 |
|
21018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRM8 |
0.831776272656864 |
|
21019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND4C |
0.83187884687615 |
|
21020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GALT5 |
0.831996580295597 |
|
21021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF5 |
0.831996580295597 |
|
21022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252175.1 |
0.831997787375037 |
|
21023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM120C |
0.831997787375037 |
|
21024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN2AIP |
0.832143067181763 |
|
21025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239116.1 |
0.832143067181763 |
|
21026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP21 |
0.832143656911502 |
|
21027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGTRAP |
0.832210317361964 |
|
21028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf167 |
0.832210317361964 |
|
21029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTHFR |
0.832210317361964 |
|
21030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCN6 |
0.832210317361964 |
|
21031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPPA |
0.832210317361964 |
|
21032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MECOM |
0.832322697238837 |
|
21033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP6V0A1 |
0.832662050507852 |
|
21034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WWTR1 |
0.83266212607486 |
|
21035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WSCD1 |
0.832685566177983 |
|
21036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL467P |
0.832689963540663 |
|
21037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ING2 |
0.832701585789919 |
|
21038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NIN |
0.832814596141979 |
|
21039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN22 |
0.832865224509497 |
|
21040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN24 |
0.832865224509497 |
|
21041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238596.1 |
0.832865224509497 |
|
21042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXLNG |
0.832870977326899 |
|
21043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBBP7 |
0.832870977326899 |
|
21044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP143 |
0.832926808729361 |
|
21045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ13 |
0.832967846824993 |
|
21046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPTC7 |
0.83312396165796 |
|
21047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPKP3 |
0.833314009343196 |
|
21048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPM1 |
0.833314520237177 |
|
21049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR9K2 |
0.83348202966282 |
|
21050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR28 |
0.833657991825728 |
|
21051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCLO |
0.833731231588837 |
|
21052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ7 |
0.833775777507824 |
|
21053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP81 |
0.833777990469333 |
|
21054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRRM3 |
0.833875879812349 |
|
21055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTG3 |
0.833898791852084 |
|
21056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP191 |
0.834044897965262 |
|
21057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00474 |
0.834086191003167 |
|
21058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPP10 |
0.834138210546484 |
|
21059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KISS1 |
0.834146259137804 |
|
21060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLT1A |
0.834146259137804 |
|
21061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP283 |
0.834285111372031 |
|
21062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF3CL |
0.834289650763956 |
|
21063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB7 |
0.834289650763956 |
|
21064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238703.1 |
0.834289650763956 |
|
21065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QL2 |
0.834311146423883 |
|
21066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL468P |
0.834311146423883 |
|
21067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CREB3L1 |
0.834511092467129 |
|
21068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FP15737 |
0.834579336429071 |
|
21069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP5E |
0.834595180905047 |
|
21070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC6P |
0.834628300555731 |
|
21071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPN |
0.834678787408268 |
|
21072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AI |
0.834689597226765 |
|
21073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBP1 |
0.834751407679398 |
|
21074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP135 |
0.834874714388261 |
|
21075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM19A4 |
0.834919008149955 |
|
21076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238935.1 |
0.834947548243437 |
|
21077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENPP6 |
0.834999985248082 |
|
21078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFHD1 |
0.835068211791195 |
|
21079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2CB |
0.835214895429748 |
|
21080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL359P |
0.835383337733364 |
|
21081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSTD2 |
0.835485709014959 |
|
21082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPF |
0.835520246797845 |
|
21083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPK |
0.835520246797845 |
|
21084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL504P |
0.835645412639412 |
|
21085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCF5 |
0.835645412639412 |
|
21086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1A2 |
0.835779183444528 |
|
21087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00333 |
0.835975233989285 |
|
21088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239170.1 |
0.836093000365822 |
|
21089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSM5 |
0.836107364858456 |
|
21090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBC |
0.836127549525256 |
|
21091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5188 |
0.836127549525256 |
|
21092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL588P |
0.83615047484603 |
|
21093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBTD1 |
0.836301054759227 |
|
21094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUCL1 |
0.836321732253213 |
|
21095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2E1 |
0.836527060541726 |
|
21096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKIRAS1 |
0.836527060541726 |
|
21097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL15 |
0.836527060541726 |
|
21098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASSF3 |
0.836546297294471 |
|
21099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAV2 |
0.836547045732853 |
|
21100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00094 |
0.836547045732853 |
|
21101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRD3 |
0.836547045732853 |
|
21102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD2BP2 |
0.836681624026839 |
|
21103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D10B |
0.836681624026839 |
|
21104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG2 |
0.836834138767452 |
|
21105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL11 |
0.836844365997651 |
|
21106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RERE |
0.8370706222944 |
|
21107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSRM |
0.837146561351257 |
|
21108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMC2 |
0.837228402091624 |
|
21109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM196 |
0.837267425295825 |
|
21110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS6ST1 |
0.83753677076938 |
|
21111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1QTNF8 |
0.837631769859084 |
|
21112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD1 |
0.837636103584333 |
|
21113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUEDC1 |
0.837655992854751 |
|
21114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD53 |
0.837718688583782 |
|
21115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM159 |
0.838066648055538 |
|
21116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STEAP4 |
0.838107447049501 |
|
21117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC25 |
0.838168822619283 |
|
21118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4668 |
0.83822428815234 |
|
21119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT2 |
0.838245052286971 |
|
21120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCF2 |
0.838282444704666 |
|
21121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB12 |
0.838457380217188 |
|
21122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRGUK |
0.838458849485079 |
|
21123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFAF7 |
0.838502865809703 |
|
21124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKD3 |
0.838502865809703 |
|
21125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAMP2 |
0.83865552289435 |
|
21126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS25 |
0.83865552289435 |
|
21127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNK4 |
0.83865552289435 |
|
21128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COA3 |
0.83865552289435 |
|
21129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYPC |
0.838660410040735 |
|
21130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D13 |
0.838671886373329 |
|
21131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNMT3A |
0.838676940961122 |
|
21132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL8 |
0.838795369009807 |
|
21133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF2A |
0.838963250082539 |
|
21134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf76 |
0.839116691005079 |
|
21135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBI |
0.839116691005079 |
|
21136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL714P |
0.839143141657589 |
|
21137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC13 |
0.839164731898597 |
|
21138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM214 |
0.839298772911569 |
|
21139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGBL5 |
0.839298772911569 |
|
21140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSTR5 |
0.839346061353336 |
|
21141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALPPL2 |
0.839475501673341 |
|
21142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALPP |
0.839475501673341 |
|
21143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECEL1P2 |
0.839475501673341 |
|
21144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALPI |
0.839475501673341 |
|
21145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECEL1 |
0.839475501673341 |
|
21146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRSS56 |
0.839475501673341 |
|
21147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRND |
0.839475501673341 |
|
21148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNG |
0.839475501673341 |
|
21149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK4 |
0.839504965971703 |
|
21150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YWHAG |
0.839505541655504 |
|
21151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLK1 |
0.8396858181928 |
|
21152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238567.1 |
0.8396858181928 |
|
21153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAS |
0.839702413221466 |
|
21154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT6B1 |
0.83989821608086 |
|
21155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEBPZ |
0.83989821608086 |
|
21156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKX |
0.840009115960806 |
|
21157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYM |
0.840081892014227 |
|
21158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR64 |
0.840159108349894 |
|
21159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHKA2 |
0.840159108349894 |
|
21160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL48P |
0.840159108349894 |
|
21161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARSG |
0.840470265518761 |
|
21162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB5 |
0.840504964387067 |
|
21163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGGF1 |
0.840551175876162 |
|
21164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU83B |
0.840640988027543 |
|
21165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1551 |
0.840695912101192 |
|
21166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC23A3 |
0.84079781665264 |
|
21167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX5 |
0.840823450603083 |
|
21168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIGYF2 |
0.840882351339414 |
|
21169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf82 |
0.840882351339414 |
|
21170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4327 |
0.840952505620891 |
|
21171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL7B |
0.840956951437576 |
|
21172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA7 |
0.840956951437576 |
|
21173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLOC1S1 |
0.840956951437576 |
|
21174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPA |
0.84098886522271 |
|
21175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA47 |
0.840999896585086 |
|
21176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JMJD8 |
0.841146569104537 |
|
21177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STUB1 |
0.841146569104537 |
|
21178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR24 |
0.841146569104537 |
|
21179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf195 |
0.841368149505266 |
|
21180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC33 |
0.841517247325501 |
|
21181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf117 |
0.84161927966438 |
|
21182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC16 |
0.84161927966438 |
|
21183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOR2A |
0.84161927966438 |
|
21184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP489 |
0.841691441407032 |
|
21185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNNA3 |
0.841692628909126 |
|
21186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST6GALNAC3 |
0.841711787144314 |
|
21187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASXL2 |
0.841721451596275 |
|
21188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMFB |
0.84181342466967 |
|
21189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOD |
0.841824833261051 |
|
21190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00969 |
0.841824833261051 |
|
21191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR570 |
0.841824833261051 |
|
21192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC20 |
0.841824833261051 |
|
21193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUC4 |
0.841824833261051 |
|
21194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R2 |
0.841824833261051 |
|
21195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL773P |
0.841824833261051 |
|
21196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC24P |
0.841824833261051 |
|
21197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDHAP1 |
0.841824833261051 |
|
21198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNK2 |
0.841824833261051 |
|
21199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALNT2 |
0.841925703651745 |
|
21200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPRD1 |
0.84201342285468 |
|
21201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMF1 |
0.842062954935638 |
|
21202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP60 |
0.842246946724587 |
|
21203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1301 |
0.842253339693792 |
|
21204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IHH |
0.842313238317537 |
|
21205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3131 |
0.842313238317537 |
|
21206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL764P |
0.842313238317537 |
|
21207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL6A4P1 |
0.842593326452081 |
|
21208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DGKZ |
0.842601455398291 |
|
21209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRM4 |
0.842601455398291 |
|
21210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDK |
0.842601455398291 |
|
21211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4688 |
0.842601455398291 |
|
21212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM198B |
0.8428844909276 |
|
21213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM144 |
0.8428844909276 |
|
21214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC108 |
0.842948636405457 |
|
21215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR375 |
0.842948636405457 |
|
21216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAP2 |
0.843038911821676 |
|
21217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD4 |
0.8430580456728 |
|
21218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT122 |
0.8430580456728 |
|
21219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSPG4P5 |
0.843131999390497 |
|
21220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L4 |
0.843131999390497 |
|
21221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L5 |
0.843131999390497 |
|
21222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL331P |
0.843131999390497 |
|
21223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL417P |
0.843131999390497 |
|
21224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2Q2P1 |
0.843131999390497 |
|
21225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP5 |
0.843152821981658 |
|
21226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNIH |
0.843236453555752 |
|
21227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GZMA |
0.84349049830356 |
|
21228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERP1 |
0.843520216254963 |
|
21229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2A |
0.843520216254963 |
|
21230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELT |
0.843520216254963 |
|
21231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIAH2 |
0.843520216254963 |
|
21232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM188B2 |
0.843520216254963 |
|
21233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLRN1 |
0.843520216254963 |
|
21234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM134C |
0.843617560844908 |
|
21235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00158 |
0.843799524970238 |
|
21236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238314.1 |
0.843799524970238 |
|
21237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA4 |
0.843853311845296 |
|
21238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2I |
0.84393729221481 |
|
21239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1228 |
0.844003560377003 |
|
21240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFEC |
0.844076716840249 |
|
21241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H15 |
0.844115593532915 |
|
21242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP1A1 |
0.84422927262304 |
|
21243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL32P3 |
0.844319527918105 |
|
21244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA7B |
0.844319527918105 |
|
21245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCKAP1L |
0.844516229985153 |
|
21246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCHD1 |
0.844531380598644 |
|
21247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00222 |
0.844608486599545 |
|
21248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFASC |
0.844647553845654 |
|
21249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LACRT |
0.844785706235206 |
|
21250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAIAP3 |
0.844790537232705 |
|
21251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNPTG |
0.844790537232705 |
|
21252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSR3 |
0.844790537232705 |
|
21253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHODL |
0.844827974208671 |
|
21254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKK2 |
0.844831840415803 |
|
21255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN28B |
0.844894981295816 |
|
21256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1226 |
0.845018815726665 |
|
21257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEND3 |
0.845100583163634 |
|
21258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR160 |
0.845107677078718 |
|
21259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHC3 |
0.845107677078718 |
|
21260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCTP2 |
0.845146098988345 |
|
21261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXD3 |
0.845236139668528 |
|
21262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINB5 |
0.845242590692183 |
|
21263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSC22D2 |
0.845453489881724 |
|
21264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCI |
0.845486589089744 |
|
21265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPCN1 |
0.845571645252753 |
|
21266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND2C |
0.845600092385166 |
|
21267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00901 |
0.845613715594317 |
|
21268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMC7 |
0.845631321209787 |
|
21269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL299P |
0.845671136529167 |
|
21270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXND1 |
0.845681204406034 |
|
21271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL752P |
0.845681204406034 |
|
21272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAHD1 |
0.845774877210306 |
|
21273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEIOB |
0.845774877210306 |
|
21274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA8|ENSG00000207100.1 |
0.84579631884864 |
|
21275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IER3IP1 |
0.845809175721188 |
|
21276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKOR2 |
0.845809175721188 |
|
21277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4527 |
0.845809175721188 |
|
21278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP187 |
0.845848799066817 |
|
21279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT6 |
0.845865954067945 |
|
21280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC14 |
0.846009566603457 |
|
21281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYADML |
0.846034668876763 |
|
21282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A3P1 |
0.846081770791676 |
|
21283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRTB1 |
0.846081770791676 |
|
21284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
L2HGDH |
0.846271102630445 |
|
21285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EOGT |
0.846466394454292 |
|
21286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNPEP |
0.846513379949026 |
|
21287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYH1 |
0.846545044896994 |
|
21288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP4R2 |
0.846624512045171 |
|
21289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4478 |
0.846627796429666 |
|
21290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA8 |
0.846627796429666 |
|
21291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORN5 |
0.846627796429666 |
|
21292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR630 |
0.846635966340204 |
|
21293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPP30 |
0.846756312507637 |
|
21294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDC1 |
0.846825560691223 |
|
21295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG12 |
0.846900093078011 |
|
21296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD12B |
0.847011856517852 |
|
21297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF180 |
0.847060162516868 |
|
21298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM4SF4 |
0.847234084684004 |
|
21299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMF1 |
0.847265355569023 |
|
21300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3136 |
0.847265355569023 |
|
21301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBA3 |
0.847265355569023 |
|
21302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP102 |
0.847300159439906 |
|
21303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCC1 |
0.847300209298183 |
|
21304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUPR1 |
0.847370546633679 |
|
21305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REN |
0.847398181782039 |
|
21306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238851.1 |
0.847435567172795 |
|
21307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA7|ENSG00000206913.1 |
0.847533415502011 |
|
21308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR592 |
0.84757911555262 |
|
21309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGL2 |
0.847655036105361 |
|
21310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1RAPL1 |
0.847945045322977 |
|
21311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM177 |
0.847968336325346 |
|
21312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REEP2 |
0.84802552055026 |
|
21313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGR1 |
0.84802552055026 |
|
21314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY3P3 |
0.848176305996897 |
|
21315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL732P |
0.848410904025913 |
|
21316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1587 |
0.848410904025913 |
|
21317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFN2 |
0.848643167063417 |
|
21318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHO |
0.848737913848163 |
|
21319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
H1FOO |
0.848737913848163 |
|
21320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ6 |
0.848780713273932 |
|
21321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHX6 |
0.848847445413155 |
|
21322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM18 |
0.848847445413155 |
|
21323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRRF |
0.848847445413155 |
|
21324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAPC4 |
0.848851844035941 |
|
21325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDCCAG3 |
0.848851844035941 |
|
21326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PMPCA |
0.848851844035941 |
|
21327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPE |
0.848942070089018 |
|
21328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC12 |
0.848955096828647 |
|
21329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL394P |
0.848955096828647 |
|
21330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVA1C |
0.849000520664883 |
|
21331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MMGT1 |
0.849030828999365 |
|
21332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RYR2 |
0.849095433954261 |
|
21333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DENND1A |
0.849506210844537 |
|
21334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00276 |
0.849657218564636 |
|
21335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN13 |
0.849878737279948 |
|
21336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGR2 |
0.849878737279948 |
|
21337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLG |
0.849899742885414 |
|
21338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP107 |
0.850014166067711 |
|
21339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR1D2 |
0.850503082876626 |
|
21340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC11 |
0.850525104030195 |
|
21341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBED5 |
0.851078194383589 |
|
21342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFAND6 |
0.851085697024745 |
|
21343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000251881.1 |
0.851085697024745 |
|
21344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAH |
0.851085697024745 |
|
21345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APOO |
0.851177395943624 |
|
21346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf58 |
0.851177395943624 |
|
21347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCVRN |
0.851256162924271 |
|
21348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESM1 |
0.851345543068465 |
|
21349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GZMK |
0.851345543068465 |
|
21350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD10 |
0.851366042699193 |
|
21351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA35|ENSG00000208839.1 |
0.851433227293658 |
|
21352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR764 |
0.851433227293658 |
|
21353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1912 |
0.851433227293658 |
|
21354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLOD1 |
0.851442168024853 |
|
21355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00691 |
0.851471342847548 |
|
21356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THRB |
0.851471342847548 |
|
21357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMA4 |
0.851513232130714 |
|
21358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA5 |
0.851513232130714 |
|
21359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL668P |
0.851533363715171 |
|
21360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC3B |
0.851534598885244 |
|
21361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM9 |
0.85154282302271 |
|
21362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM157B |
0.85161990662619 |
|
21363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBBP5 |
0.85161990662619 |
|
21364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf106 |
0.85166451992292 |
|
21365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4515 |
0.85182295982827 |
|
21366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP170 |
0.85188229145684 |
|
21367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDCCAG8 |
0.85188229145684 |
|
21368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4677 |
0.85188229145684 |
|
21369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAT1 |
0.851921751084947 |
|
21370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAPGEF2 |
0.851956628676935 |
|
21371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGR6 |
0.852111973444546 |
|
21372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WLS |
0.85215488323963 |
|
21373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FTSJD1 |
0.852164481343079 |
|
21374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRAGB |
0.852194519962364 |
|
21375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRAK3 |
0.852267050773684 |
|
21376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPM6A |
0.852307431494442 |
|
21377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P2 |
0.852463598333288 |
|
21378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000212149.1 |
0.852463598333288 |
|
21379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP8 |
0.852516813901293 |
|
21380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTNL10 |
0.852803590389232 |
|
21381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST3H2A |
0.852803590389232 |
|
21382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST3H2BB |
0.852803590389232 |
|
21383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIST3H3 |
0.852803590389232 |
|
21384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4666A |
0.852803590389232 |
|
21385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S10 |
0.852803590389232 |
|
21386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S11 |
0.852803590389232 |
|
21387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S12 |
0.852803590389232 |
|
21388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S13 |
0.852803590389232 |
|
21389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S14 |
0.852803590389232 |
|
21390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S15 |
0.852803590389232 |
|
21391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S16 |
0.852803590389232 |
|
21392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S17 |
0.852803590389232 |
|
21393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S1 |
0.852803590389232 |
|
21394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S2 |
0.852803590389232 |
|
21395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S3 |
0.852803590389232 |
|
21396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S4 |
0.852803590389232 |
|
21397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S5 |
0.852803590389232 |
|
21398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S6 |
0.852803590389232 |
|
21399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S7 |
0.852803590389232 |
|
21400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S8 |
0.852803590389232 |
|
21401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5S9 |
0.852803590389232 |
|
21402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP18 |
0.852803590389232 |
|
21403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP19 |
0.852803590389232 |
|
21404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF187 |
0.852803590389232 |
|
21405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000206878.1 |
0.852803590389232 |
|
21406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM11 |
0.852803590389232 |
|
21407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM17 |
0.852803590389232 |
|
21408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTPCR |
0.852826316531965 |
|
21409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP11B |
0.852828494434743 |
|
21410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYST |
0.852857723629217 |
|
21411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1537 |
0.852857723629217 |
|
21412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAB1 |
0.852952642332188 |
|
21413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZP3 |
0.852971688220433 |
|
21414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG4 |
0.853002947222679 |
|
21415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYCBPAP |
0.853120034885069 |
|
21416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDH5 |
0.853157606902678 |
|
21417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD63 |
0.853157606902678 |
|
21418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDF11 |
0.853157606902678 |
|
21419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00846 |
0.853264171982825 |
|
21420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP10L |
0.853264171982825 |
|
21421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21ORF59 |
0.853264171982825 |
|
21422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf59 |
0.853264171982825 |
|
21423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLL1 |
0.853457082536755 |
|
21424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF710 |
0.853472275445764 |
|
21425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEUROD4 |
0.853504149165029 |
|
21426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT33A |
0.853504606031578 |
|
21427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT33B |
0.853504606031578 |
|
21428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT31 |
0.853504606031578 |
|
21429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT34 |
0.853504606031578 |
|
21430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT37 |
0.853504606031578 |
|
21431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL229P |
0.853545053251044 |
|
21432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN2B |
0.853628478680577 |
|
21433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP7A1 |
0.853628478680577 |
|
21434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDST3 |
0.853654386351616 |
|
21435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG8 |
0.853654386351616 |
|
21436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB18 |
0.853855529119752 |
|
21437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL148P |
0.853855529119752 |
|
21438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC13 |
0.853927921848163 |
|
21439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP63 |
0.853927921848163 |
|
21440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHQ1 |
0.853982669500715 |
|
21441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYGL |
0.854047737982671 |
|
21442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPYSL2 |
0.854101470079314 |
|
21443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN1 |
0.854156174445515 |
|
21444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL21D |
0.854172776689498 |
|
21445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLGN4X |
0.854348910597134 |
|
21446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP490 |
0.854648252541489 |
|
21447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAGHL |
0.854689266721244 |
|
21448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NARFL |
0.854689266721244 |
|
21449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5T3 |
0.854777872806782 |
|
21450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF3C |
0.854798826055434 |
|
21451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238811.1 |
0.85479892713963 |
|
21452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR112 |
0.854865857461322 |
|
21453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOT2 |
0.854886631876727 |
|
21454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL143P |
0.854886631876727 |
|
21455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGARP |
0.85507514677947 |
|
21456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNL3L |
0.855190629679282 |
|
21457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C18orf32 |
0.855316276866629 |
|
21458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1539 |
0.855316276866629 |
|
21459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL17 |
0.855316276866629 |
|
21460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD58C |
0.855316276866629 |
|
21461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD58A |
0.855316276866629 |
|
21462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD58B |
0.855316276866629 |
|
21463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPG |
0.855316276866629 |
|
21464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL776P |
0.855348426136477 |
|
21465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100Z |
0.85542171593249 |
|
21466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC36P |
0.85542171593249 |
|
21467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRHBP |
0.85542171593249 |
|
21468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELF2 |
0.855440696482215 |
|
21469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL382P |
0.855440696482215 |
|
21470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL311P |
0.855440696482215 |
|
21471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP188 |
0.855487472331795 |
|
21472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPN3 |
0.855541221856665 |
|
21473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA20 |
0.855541221856665 |
|
21474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSI2 |
0.855581953542386 |
|
21475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP471 |
0.855595755879815 |
|
21476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf21 |
0.855692270596642 |
|
21477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA1 |
0.855703922664371 |
|
21478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOTAIRM1 |
0.855703922664371 |
|
21479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA2 |
0.855703922664371 |
|
21480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA3 |
0.855703922664371 |
|
21481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA4 |
0.855703922664371 |
|
21482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA5 |
0.855703922664371 |
|
21483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA6 |
0.855703922664371 |
|
21484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA7 |
0.855703922664371 |
|
21485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA9 |
0.855703922664371 |
|
21486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA10 |
0.855703922664371 |
|
21487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR196B |
0.855703922664371 |
|
21488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA11 |
0.855703922664371 |
|
21489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXA13 |
0.855703922664371 |
|
21490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOTTIP |
0.855703922664371 |
|
21491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EVX1 |
0.855703922664371 |
|
21492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf13 |
0.855712822073711 |
|
21493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM195A |
0.855712822073711 |
|
21494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR90 |
0.855712822073711 |
|
21495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFIKKN1 |
0.855712822073711 |
|
21496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHOT2 |
0.855712822073711 |
|
21497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBDL1 |
0.855712822073711 |
|
21498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238701.1 |
0.855737030421241 |
|
21499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHCGR |
0.855754631398027 |
|
21500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD1 |
0.855812819408865 |
|
21501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASKIN1 |
0.855812819408865 |
|
21502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4516 |
0.855812819408865 |
|
21503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB26 |
0.855812819408865 |
|
21504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD60|ENSG00000206630.1 |
0.855812819408865 |
|
21505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF7 |
0.855812819408865 |
|
21506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGRP1 |
0.855865398667087 |
|
21507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf53 |
0.855865398667087 |
|
21508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCD |
0.855957486516634 |
|
21509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPCL1 |
0.856009484242112 |
|
21510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF10 |
0.856009484242112 |
|
21511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF11 |
0.856009484242112 |
|
21512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF12 |
0.856009484242112 |
|
21513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF13 |
0.856009484242112 |
|
21514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF14 |
0.856009484242112 |
|
21515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF15 |
0.856009484242112 |
|
21516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF16 |
0.856009484242112 |
|
21517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF17 |
0.856009484242112 |
|
21518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF18 |
0.856009484242112 |
|
21519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF19 |
0.856009484242112 |
|
21520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF1 |
0.856009484242112 |
|
21521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF21 |
0.856009484242112 |
|
21522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF22 |
0.856009484242112 |
|
21523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF2 |
0.856009484242112 |
|
21524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF3 |
0.856009484242112 |
|
21525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF4 |
0.856009484242112 |
|
21526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF5 |
0.856009484242112 |
|
21527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF6 |
0.856009484242112 |
|
21528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF7 |
0.856009484242112 |
|
21529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF8 |
0.856009484242112 |
|
21530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF9 |
0.856009484242112 |
|
21531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATL1 |
0.856025880482682 |
|
21532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF782 |
0.85608442453719 |
|
21533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP296 |
0.856301934946866 |
|
21534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4E2 |
0.856441248102462 |
|
21535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHA4 |
0.856449836563184 |
|
21536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNNI3K |
0.856451135711547 |
|
21537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTPD5 |
0.856483906270445 |
|
21538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR17 |
0.856515914414681 |
|
21539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAREML |
0.856545588242709 |
|
21540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOLK |
0.856571024761168 |
|
21541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRPN |
0.856619515032469 |
|
21542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EI24 |
0.856645732085974 |
|
21543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIGD1 |
0.85666981463315 |
|
21544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5001 |
0.85666981463315 |
|
21545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF8 |
0.856726942612859 |
|
21546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf104 |
0.856758587708236 |
|
21547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC43 |
0.856758587708236 |
|
21548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA2013 |
0.856847536414753 |
|
21549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGBD5 |
0.856905369441713 |
|
21550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACADM |
0.856913254128015 |
|
21551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS5 |
0.856926325096217 |
|
21552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4759 |
0.856926325096217 |
|
21553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC92 |
0.857150672195888 |
|
21554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH10OS |
0.857150672195888 |
|
21555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP74 |
0.857159795135703 |
|
21556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNPO |
0.857305841313693 |
|
21557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSEN2 |
0.857393056686842 |
|
21558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCL |
0.857490042911535 |
|
21559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239121.1 |
0.857507693744994 |
|
21560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC38A7 |
0.857507693744994 |
|
21561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP147 |
0.857561871066118 |
|
21562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GADD45A |
0.857575992338044 |
|
21563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBA2 |
0.857628000190615 |
|
21564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSG1 |
0.857762667100447 |
|
21565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTM |
0.857955079338452 |
|
21566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4674 |
0.857955867418375 |
|
21567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABGGTB |
0.85803577833324 |
|
21568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD45C |
0.85803577833324 |
|
21569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD45A |
0.85803577833324 |
|
21570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD45B |
0.85803577833324 |
|
21571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000201516.1 |
0.858131981885998 |
|
21572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXPH4 |
0.85813584633804 |
|
21573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHMT2 |
0.85813584633804 |
|
21574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HADHA |
0.858142927492416 |
|
21575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRC |
0.85817560318957 |
|
21576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1549L |
0.858247566866058 |
|
21577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM14A |
0.858413850425766 |
|
21578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMO2 |
0.85841788261707 |
|
21579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYCBP2 |
0.858524383309524 |
|
21580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4270 |
0.858577397948815 |
|
21581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL110P |
0.858577397948815 |
|
21582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDHD2 |
0.858657053434058 |
|
21583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238329.1 |
0.858694761907094 |
|
21584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI44 |
0.858740062759845 |
|
21585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP224 |
0.858950141568776 |
|
21586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM206A |
0.858976724975944 |
|
21587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTNNAL1 |
0.858976724975944 |
|
21588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM245 |
0.858976724975944 |
|
21589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR32 |
0.858976724975944 |
|
21590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MESP2 |
0.859010737557125 |
|
21591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOCS1 |
0.859022236375794 |
|
21592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNP2 |
0.859022236375794 |
|
21593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRM3 |
0.859022236375794 |
|
21594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212228.1 |
0.859022236375794 |
|
21595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRM2 |
0.859022236375794 |
|
21596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRM1 |
0.859022236375794 |
|
21597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R17 |
0.859123437291102 |
|
21598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238433.1 |
0.859204292897686 |
|
21599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IKBKAP |
0.859228994235838 |
|
21600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG6 |
0.859335030298625 |
|
21601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB7 |
0.859335030298625 |
|
21602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL488P |
0.859335030298625 |
|
21603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLEU2L |
0.859335030298625 |
|
21604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPE65 |
0.859375632284581 |
|
21605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEPDC1 |
0.859446935885431 |
|
21606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOST |
0.859447393708913 |
|
21607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf40 |
0.859488159463993 |
|
21608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM103A1 |
0.859488159463993 |
|
21609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTH |
0.859552150324295 |
|
21610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A14 |
0.859579255771326 |
|
21611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf61 |
0.859579255771326 |
|
21612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf91 |
0.859718193307952 |
|
21613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMELX |
0.859750835380706 |
|
21614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AX |
0.859750835380706 |
|
21615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPE |
0.859904864993923 |
|
21616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53BP1 |
0.859941830758414 |
|
21617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR5C1 |
0.859967605115287 |
|
21618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1K1 |
0.859967605115287 |
|
21619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ONECUT2 |
0.860012191313018 |
|
21620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A7 |
0.860027373512767 |
|
21621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APP |
0.86003712904226 |
|
21622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1L6 |
0.860110173937957 |
|
21623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL16 |
0.860123806259865 |
|
21624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METRN |
0.860123806259865 |
|
21625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC78 |
0.860123806259865 |
|
21626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM173A |
0.860123806259865 |
|
21627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf64 |
0.860287827867258 |
|
21628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABPA |
0.860334352109773 |
|
21629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf3 |
0.860361075801505 |
|
21630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNLT3 |
0.86070827848834 |
|
21631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM194A |
0.860898031329673 |
|
21632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC44A5 |
0.860926653084757 |
|
21633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AADACL3 |
0.860956136879169 |
|
21634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238771.1 |
0.860956136879169 |
|
21635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf158 |
0.860956136879169 |
|
21636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP110 |
0.860992853149351 |
|
21637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP140 |
0.860992853149351 |
|
21638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP140L |
0.860992853149351 |
|
21639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCBP1 |
0.861088888847827 |
|
21640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOD1L2 |
0.86113799062808 |
|
21641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC5 |
0.861655876810024 |
|
21642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OMA1 |
0.861974797550362 |
|
21643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GARNL3 |
0.862103861489549 |
|
21644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT18 |
0.862286022758582 |
|
21645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC4 |
0.862421428156418 |
|
21646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB33B |
0.862485359217413 |
|
21647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSWIM6 |
0.862770413725896 |
|
21648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP11C |
0.862850142088758 |
|
21649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf66 |
0.862850142088758 |
|
21650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR505 |
0.862850142088758 |
|
21651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL727P |
0.862850142088758 |
|
21652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC23P |
0.862850142088758 |
|
21653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA18|ENSG00000252719.1 |
0.862850142088758 |
|
21654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238485.1 |
0.862850142088758 |
|
21655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEB3B |
0.862860315924268 |
|
21656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEB3CL2 |
0.862860315924268 |
|
21657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEB3CL |
0.862860315924268 |
|
21658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEB3C |
0.862860315924268 |
|
21659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPO11 |
0.862921532887335 |
|
21660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BEND2 |
0.862952076641068 |
|
21661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMS |
0.863082088502672 |
|
21662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXT1 |
0.863167964958122 |
|
21663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VEGFC |
0.863187908728716 |
|
21664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA67|ENSG00000207027.1 |
0.863205270075009 |
|
21665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCHR2 |
0.863292107218316 |
|
21666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF4 |
0.863304734038954 |
|
21667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCUN1D3 |
0.863400028785911 |
|
21668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN13 |
0.863448666312621 |
|
21669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238802.1 |
0.863487751053139 |
|
21670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF17 |
0.863487751053139 |
|
21671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCLT1 |
0.863487751053139 |
|
21672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC72 |
0.863555554195103 |
|
21673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKMY2 |
0.863555554195103 |
|
21674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BZW2 |
0.863555554195103 |
|
21675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC14A2 |
0.863567893676107 |
|
21676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KATNAL2 |
0.863576692688102 |
|
21677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC68 |
0.863627482288066 |
|
21678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRIP2 |
0.864083695183763 |
|
21679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMKR1 |
0.864083695183763 |
|
21680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSL1 |
0.864146635594486 |
|
21681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GABRE |
0.864194212630485 |
|
21682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR224 |
0.864194212630485 |
|
21683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR452 |
0.864194212630485 |
|
21684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf95 |
0.864289480390792 |
|
21685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPKB |
0.864289480390792 |
|
21686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPECC1 |
0.864452737763154 |
|
21687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACPP |
0.864513769203758 |
|
21688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALCOCO2 |
0.864545174806588 |
|
21689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA68|ENSG00000212565.1 |
0.864545174806588 |
|
21690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5G1 |
0.864545174806588 |
|
21691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HACL1 |
0.864612626237635 |
|
21692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PITX2 |
0.864653723571569 |
|
21693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLFM1 |
0.864662435084294 |
|
21694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL3A1 |
0.864740264801223 |
|
21695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RS1 |
0.865071821918331 |
|
21696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZP2 |
0.86517350081802 |
|
21697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKS4B |
0.86517350081802 |
|
21698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCAF12L1 |
0.865223444060184 |
|
21699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RC3H2 |
0.865323732473297 |
|
21700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACA64|ENSG00000239005.1 |
0.865324426803872 |
|
21701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4768 |
0.865369495883627 |
|
21702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHS |
0.865369495883627 |
|
21703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238764.1 |
0.865369495883627 |
|
21704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P16 |
0.865393849035981 |
|
21705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD6 |
0.865487901613713 |
|
21706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKL5 |
0.865571205147842 |
|
21707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3713 |
0.865614913104047 |
|
21708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPHB1 |
0.865680666277323 |
|
21709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHCYL2 |
0.865789685828771 |
|
21710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL13RA2 |
0.865838231908542 |
|
21711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRCH2 |
0.865838231908542 |
|
21712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUZP4 |
0.865838231908542 |
|
21713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBMXL3 |
0.865838231908542 |
|
21714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA35|ENSG00000271907.1 |
0.865838231908542 |
|
21715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PID1 |
0.865846735472695 |
|
21716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP165 |
0.865911983835441 |
|
21717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP457 |
0.865946029715552 |
|
21718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUBP1 |
0.865983572506029 |
|
21719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJB4 |
0.865983572506029 |
|
21720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNI |
0.866052646982761 |
|
21721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIATL2 |
0.866059099710707 |
|
21722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUTM2G |
0.866059099710707 |
|
21723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSV |
0.866059099710707 |
|
21724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZP4 |
0.866059624725291 |
|
21725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP27C1 |
0.866090661255727 |
|
21726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC3 |
0.866090661255727 |
|
21727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAR1 |
0.866130571902733 |
|
21728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPATCH1 |
0.866228754209533 |
|
21729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR88 |
0.866228754209533 |
|
21730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1245A |
0.86627928167849 |
|
21731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME1 |
0.866288451657368 |
|
21732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME2 |
0.866288451657368 |
|
21733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf18 |
0.86631178799273 |
|
21734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEMK1 |
0.86631178799273 |
|
21735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BVES |
0.866341708363329 |
|
21736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POPDC3 |
0.866341708363329 |
|
21737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST20 |
0.866347124532197 |
|
21738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15ORF37 |
0.866347124532197 |
|
21739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf37 |
0.866347124532197 |
|
21740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA16 |
0.866423840179665 |
|
21741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR550A2 |
0.866459956674863 |
|
21742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COG2 |
0.866509919384781 |
|
21743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRC2B |
0.866512085911065 |
|
21744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AADACL2 |
0.866578577256141 |
|
21745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AADAC |
0.866578577256141 |
|
21746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS27 |
0.866647743599024 |
|
21747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP88 |
0.866680675038941 |
|
21748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYKK |
0.866701505886251 |
|
21749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PREP |
0.866720406692359 |
|
21750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSMO1 |
0.866883360869389 |
|
21751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST8SIA3 |
0.866967655660124 |
|
21752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDRG4 |
0.866994238116012 |
|
21753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCMT1 |
0.86700984394313 |
|
21754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL557P |
0.86700984394313 |
|
21755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM6A |
0.867041053471089 |
|
21756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRRS1L |
0.867078390838233 |
|
21757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIRAS3 |
0.867279357580203 |
|
21758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238744.1 |
0.867515036410272 |
|
21759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AQP8 |
0.867602834989571 |
|
21760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZKSCAN2 |
0.867602834989571 |
|
21761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D4 |
0.867701446254399 |
|
21762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A9 |
0.867708941461596 |
|
21763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP22 |
0.867708941461596 |
|
21764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP63 |
0.867732692586223 |
|
21765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL34 |
0.867943117590309 |
|
21766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNPO1 |
0.867975424540761 |
|
21767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4804 |
0.867975424540761 |
|
21768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCHO2 |
0.867975424540761 |
|
21769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP13 |
0.867978216020503 |
|
21770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX5L |
0.867978216020503 |
|
21771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL482P |
0.86804340958548 |
|
21772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC144A |
0.868123924096795 |
|
21773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL620P |
0.868123924096795 |
|
21774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT16P2 |
0.868123924096795 |
|
21775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT17P1 |
0.868123924096795 |
|
21776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP32P1 |
0.868123924096795 |
|
21777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY1A3 |
0.86815262194937 |
|
21778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUCY1B3 |
0.86815262194937 |
|
21779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASIC5 |
0.86815262194937 |
|
21780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDO2 |
0.86815262194937 |
|
21781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSO |
0.86815262194937 |
|
21782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGFL6 |
0.86816939812781 |
|
21783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP20 |
0.86816939812781 |
|
21784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCEANC |
0.86816939812781 |
|
21785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB9A |
0.86816939812781 |
|
21786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAPPC2 |
0.86816939812781 |
|
21787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8B2 |
0.868177363249018 |
|
21788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AVL9 |
0.868183945212304 |
|
21789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNE1 |
0.868194687593797 |
|
21790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNE2 |
0.868194687593797 |
|
21791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM11 |
0.868194687593797 |
|
21792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11|ENSG00000221398.1 |
0.868194687593797 |
|
21793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDX4 |
0.86819855251902 |
|
21794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA46|ENSG00000207493.1 |
0.868216760058163 |
|
21795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA50|ENSG00000206952.2 |
0.868216760058163 |
|
21796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP3 |
0.868316471667723 |
|
21797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5G2 |
0.868346198846206 |
|
21798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSDE1 |
0.868369422586294 |
|
21799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR107 |
0.868450351205066 |
|
21800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI44L |
0.868548246620319 |
|
21801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1262 |
0.868657204002407 |
|
21802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNDBP1 |
0.868771162267656 |
|
21803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP343 |
0.868915791257945 |
|
21804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCHL3 |
0.868973418666818 |
|
21805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000206637.1 |
0.869009066964719 |
|
21806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3911 |
0.869027809817207 |
|
21807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTRH1 |
0.869027809817207 |
|
21808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC180 |
0.86908416631262 |
|
21809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMO7 |
0.869226863743298 |
|
21810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BICD1 |
0.869308811049023 |
|
21811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AADACL4 |
0.869347903580614 |
|
21812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP55 |
0.869434568933058 |
|
21813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC148 |
0.869442810321703 |
|
21814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX60 |
0.869550091285876 |
|
21815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf198 |
0.869678611501887 |
|
21816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238543.1 |
0.869842400276021 |
|
21817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238481.1 |
0.869842400276021 |
|
21818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC4 |
0.869846388365242 |
|
21819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf177 |
0.869846388365242 |
|
21820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARS2 |
0.869846388365242 |
|
21821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC22 |
0.869846388365242 |
|
21822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCC2 |
0.869951090752826 |
|
21823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC31A1 |
0.870046509902527 |
|
21824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC26 |
0.870046509902527 |
|
21825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF4 |
0.870046509902527 |
|
21826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF183 |
0.870046509902527 |
|
21827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR31 |
0.870046509902527 |
|
21828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMPX |
0.870048467574972 |
|
21829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAPL1 |
0.870205968353492 |
|
21830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM53C |
0.870339951340473 |
|
21831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETD6 |
0.870369955843467 |
|
21832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNOT1 |
0.870369955843467 |
|
21833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTATIP2 |
0.870385795230818 |
|
21834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN4 |
0.870397173267449 |
|
21835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSRP3 |
0.870611847471978 |
|
21836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARVA |
0.870618169430507 |
|
21837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A12 |
0.870702684795363 |
|
21838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC144NL |
0.870823974362856 |
|
21839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BARHL1 |
0.870834599888106 |
|
21840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GART |
0.870841032219857 |
|
21841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212539.1 |
0.870844641994825 |
|
21842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPNE4 |
0.871040825237002 |
|
21843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRIG1 |
0.871072148962101 |
|
21844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROCK1P1 |
0.871087001227361 |
|
21845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THOC1 |
0.871087001227361 |
|
21846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP14 |
0.871087001227361 |
|
21847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARB1 |
0.871104942573379 |
|
21848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRCC5 |
0.871150517664279 |
|
21849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIN1 |
0.871293146386978 |
|
21850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHEJ1 |
0.871330023555934 |
|
21851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTBD1 |
0.871671342682926 |
|
21852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRN2 |
0.871721500287081 |
|
21853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT45A1 |
0.871730074818013 |
|
21854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT45A2 |
0.871730074818013 |
|
21855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT45A3 |
0.871730074818013 |
|
21856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT45A4 |
0.871730074818013 |
|
21857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT45A5 |
0.871730074818013 |
|
21858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CT45A6 |
0.871730074818013 |
|
21859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf48 |
0.871730074818013 |
|
21860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX26B |
0.871730074818013 |
|
21861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00086 |
0.871730074818013 |
|
21862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP515 |
0.871730074818013 |
|
21863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAGE1 |
0.871730074818013 |
|
21864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF449 |
0.871730074818013 |
|
21865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF75D |
0.871730074818013 |
|
21866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP323 |
0.871982060584338 |
|
21867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDHD3 |
0.872078459672265 |
|
21868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DUSP3 |
0.872226171557374 |
|
21869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP1A2 |
0.872333010439202 |
|
21870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C68 |
0.872577495704594 |
|
21871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX41 |
0.872638888195401 |
|
21872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOTCH2 |
0.872670490107093 |
|
21873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCL1 |
0.872670965412003 |
|
21874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMPD4 |
0.872676728633161 |
|
21875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00933 |
0.872710032610668 |
|
21876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL132P |
0.872847046267439 |
|
21877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000251802.1 |
0.872847046267439 |
|
21878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBA5 |
0.872961494486318 |
|
21879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB10 |
0.873021238622085 |
|
21880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCRN4L |
0.873095968195425 |
|
21881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYBB |
0.873098076988063 |
|
21882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SVEP1 |
0.873105802388955 |
|
21883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMAN1L |
0.873180658796151 |
|
21884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPLX3 |
0.873180658796151 |
|
21885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TESPA1 |
0.873197661437794 |
|
21886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238920.1 |
0.873216637629077 |
|
21887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRED1 |
0.873267722963993 |
|
21888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIPA1L2 |
0.873301309426615 |
|
21889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1S2 |
0.87341452489704 |
|
21890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00351 |
0.873467334418283 |
|
21891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMRT1 |
0.873521940499943 |
|
21892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238475.1 |
0.873545679312012 |
|
21893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESR1 |
0.873716427904461 |
|
21894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPME1 |
0.873816663054902 |
|
21895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
P4HA3 |
0.873816663054902 |
|
21896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STXBP1 |
0.873829705311789 |
|
21897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL609P |
0.874010534768322 |
|
21898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNL1 |
0.874040753980622 |
|
21899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252646.1 |
0.874059113691282 |
|
21900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT11 |
0.874059113691282 |
|
21901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM151A |
0.874059113691282 |
|
21902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHD4 |
0.874255693583264 |
|
21903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALK |
0.874286184234082 |
|
21904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGS2 |
0.874337509873685 |
|
21905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C12orf61 |
0.874354846675394 |
|
21906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7I |
0.874354846675394 |
|
21907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM27 |
0.874359926484278 |
|
21908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA5BP1 |
0.874359926484278 |
|
21909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CA5B |
0.874359926484278 |
|
21910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA7|ENSG00000200620.1 |
0.874359926484278 |
|
21911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZRSR2 |
0.874359926484278 |
|
21912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPD2 |
0.874421585313019 |
|
21913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1911 |
0.874608959086562 |
|
21914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDP1 |
0.874653468161363 |
|
21915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRG4 |
0.874690127717348 |
|
21916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPR |
0.874690127717348 |
|
21917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf27 |
0.874690127717348 |
|
21918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCLM |
0.874690127717348 |
|
21919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDC |
0.874690127717348 |
|
21920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP22 |
0.874761533295727 |
|
21921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GIPC2 |
0.874920385039261 |
|
21922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDRT15L2 |
0.874940996657863 |
|
21923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAD11 |
0.874956446325963 |
|
21924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPHP3 |
0.874956446325963 |
|
21925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACKR4 |
0.874956446325963 |
|
21926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP156 |
0.875195534715306 |
|
21927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF9 |
0.875195547946841 |
|
21928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAML3 |
0.875217655694107 |
|
21929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STON1 |
0.875240110857563 |
|
21930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2A1L |
0.875240110857563 |
|
21931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTRL |
0.87529281248917 |
|
21932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIKE1 |
0.875365332757695 |
|
21933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE2B |
0.87537595440525 |
|
21934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE1A |
0.87537595440525 |
|
21935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE1B |
0.87537595440525 |
|
21936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE2 |
0.87537595440525 |
|
21937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548F5 |
0.875389838123728 |
|
21938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4770 |
0.875458271201663 |
|
21939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP2K3 |
0.875563871744672 |
|
21940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C19orf40 |
0.875586207508126 |
|
21941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO3B |
0.875758358815566 |
|
21942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC170 |
0.875819190999152 |
|
21943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCF2 |
0.876072467936297 |
|
21944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEDD4L |
0.876105397557586 |
|
21945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERI2 |
0.876204670947036 |
|
21946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD56|ENSG00000200377.1 |
0.876365283028668 |
|
21947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT3A |
0.876477518908229 |
|
21948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARF1 |
0.876477518908229 |
|
21949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3620 |
0.876477518908229 |
|
21950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf35 |
0.876477518908229 |
|
21951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL55 |
0.876477518908229 |
|
21952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GJC2 |
0.876477518908229 |
|
21953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUK1 |
0.876477518908229 |
|
21954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf148 |
0.876477518908229 |
|
21955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IBA57 |
0.876477518908229 |
|
21956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R4 |
0.876737865633841 |
|
21957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4466 |
0.876929467096806 |
|
21958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQGAP1 |
0.877260165230361 |
|
21959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF14 |
0.877273020825511 |
|
21960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIPF1 |
0.877314167598841 |
|
21961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8B4 |
0.877433613734786 |
|
21962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8B8 |
0.877433613734786 |
|
21963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSDL2 |
0.877436335533324 |
|
21964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf147 |
0.877436335533324 |
|
21965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOA1 |
0.877503255370991 |
|
21966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNA3 |
0.877557200534524 |
|
21967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHRNB4 |
0.877557200534524 |
|
21968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf169 |
0.877668266392711 |
|
21969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM166A |
0.877668266392711 |
|
21970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDOR1 |
0.877668266392711 |
|
21971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF208 |
0.877668266392711 |
|
21972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF224 |
0.877668266392711 |
|
21973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC34A3 |
0.877668266392711 |
|
21974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM203 |
0.877668266392711 |
|
21975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPRN |
0.877668266392711 |
|
21976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBB4B |
0.877668266392711 |
|
21977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGTR2 |
0.877742528101153 |
|
21978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A26 |
0.877850058877998 |
|
21979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB40C |
0.877866154642251 |
|
21980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EOMES |
0.877955222038277 |
|
21981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MROH7 |
0.877960624582496 |
|
21982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR21 |
0.878057186676659 |
|
21983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA2D2 |
0.878165123413508 |
|
21984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APIP |
0.878192134359486 |
|
21985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC4H2 |
0.878210768019605 |
|
21986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239046.1 |
0.878249478850626 |
|
21987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKIV2L2 |
0.878295569541528 |
|
21988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFCP2L1 |
0.878309185581123 |
|
21989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIAS2 |
0.878363644611045 |
|
21990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM81 |
0.878475333768668 |
|
21991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D3C |
0.878519409752816 |
|
21992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCR2 |
0.8787372012159 |
|
21993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RQCD1 |
0.87893314264628 |
|
21994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNF8 |
0.878960750527169 |
|
21995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCR5 |
0.879060660427588 |
|
21996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD22 |
0.879086073517256 |
|
21997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKM |
0.879119532627836 |
|
21998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM169 |
0.87937394504317 |
|
21999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OBSCN |
0.879461082676952 |
|
22000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8B3 |
0.879507439636159 |
|
22001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPP7 |
0.879577590768093 |
|
22002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238824.1 |
0.879577590768093 |
|
22003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPM |
0.879646849152227 |
|
22004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM44 |
0.879670180193075 |
|
22005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C3 |
0.879758060045151 |
|
22006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C75 |
0.879758060045151 |
|
22007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMC2 |
0.879765277361514 |
|
22008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP4 |
0.879803126001199 |
|
22009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1183 |
0.879803126001199 |
|
22010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCMT2 |
0.879844011270131 |
|
22011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAL |
0.879844011270131 |
|
22012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAV1 |
0.879903789932682 |
|
22013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EN1 |
0.879976469552952 |
|
22014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf173 |
0.880167371022697 |
|
22015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NELFB |
0.880167371022697 |
|
22016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC46A2 |
0.880284838664449 |
|
22017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGST2 |
0.880377172806886 |
|
22018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRARP |
0.880410848980473 |
|
22019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOR4A |
0.880410848980473 |
|
22020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMF |
0.880508504025279 |
|
22021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf114 |
0.880525453183175 |
|
22022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENDOG |
0.880525453183175 |
|
22023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCBL1 |
0.880525453183175 |
|
22024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC8A |
0.880525453183175 |
|
22025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDPN |
0.88060303962566 |
|
22026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP134 |
0.880626204244102 |
|
22027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTD1 |
0.880935043211769 |
|
22028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BECN1 |
0.880935043211769 |
|
22029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSME3 |
0.880935043211769 |
|
22030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AOC2 |
0.880935043211769 |
|
22031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AOC3 |
0.880935043211769 |
|
22032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AOC4P |
0.880935043211769 |
|
22033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00671 |
0.880935043211769 |
|
22034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
G6PC |
0.880935043211769 |
|
22035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR85 |
0.881193098992238 |
|
22036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf105 |
0.881257945315082 |
|
22037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPY |
0.881257945315082 |
|
22038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYY |
0.881257945315082 |
|
22039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1298 |
0.881265196787173 |
|
22040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM168 |
0.881323638293674 |
|
22041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AACS |
0.881362799992784 |
|
22042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIMT1 |
0.881475662362333 |
|
22043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GREM2 |
0.881571988298976 |
|
22044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFC1 |
0.881645046862712 |
|
22045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGM1 |
0.881666243054479 |
|
22046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL130P |
0.881666243054479 |
|
22047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARV1 |
0.881797365823997 |
|
22048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM89A |
0.881797365823997 |
|
22049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1182 |
0.881797365823997 |
|
22050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDOA |
0.881970296883597 |
|
22051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPHD1 |
0.881970296883597 |
|
22052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOLA2B |
0.881970296883597 |
|
22053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BOLA2 |
0.881970296883597 |
|
22054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf54 |
0.881970296883597 |
|
22055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf92 |
0.881970296883597 |
|
22056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDIPT |
0.881970296883597 |
|
22057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CORO1A |
0.881970296883597 |
|
22058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOC2A |
0.881970296883597 |
|
22059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM57B |
0.881970296883597 |
|
22060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDPD3 |
0.881970296883597 |
|
22061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIRIP3 |
0.881970296883597 |
|
22062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INO80E |
0.881970296883597 |
|
22063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCTD13 |
0.881970296883597 |
|
22064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF22 |
0.881970296883597 |
|
22065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPK3 |
0.881970296883597 |
|
22066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAZ |
0.881970296883597 |
|
22067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MVP |
0.881970296883597 |
|
22068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAGR1 |
0.881970296883597 |
|
22069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP4C |
0.881970296883597 |
|
22070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRT2 |
0.881970296883597 |
|
22071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QPRT |
0.881970296883597 |
|
22072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP127 |
0.881970296883597 |
|
22073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEZ6L2 |
0.881970296883597 |
|
22074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLX1A |
0.881970296883597 |
|
22075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLX1B |
0.881970296883597 |
|
22076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPN |
0.881970296883597 |
|
22077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1A3 |
0.881970296883597 |
|
22078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SULT1A4 |
0.881970296883597 |
|
22079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAOK2 |
0.881970296883597 |
|
22080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX6 |
0.881970296883597 |
|
22081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM219 |
0.881970296883597 |
|
22082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YPEL3 |
0.881970296883597 |
|
22083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZG16 |
0.881970296883597 |
|
22084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238639.1 |
0.881970296883597 |
|
22085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239114.1 |
0.881970296883597 |
|
22086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239193.1 |
0.881970296883597 |
|
22087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP183 |
0.882002327826458 |
|
22088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPO |
0.882049462306773 |
|
22089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00862 |
0.882154239644346 |
|
22090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3123 |
0.882276395723435 |
|
22091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPP3 |
0.882292085082931 |
|
22092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD300LG |
0.882292085082931 |
|
22093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPP2 |
0.882292085082931 |
|
22094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM215A |
0.882292085082931 |
|
22095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf60 |
0.882320772664978 |
|
22096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBX1 |
0.88235725615413 |
|
22097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHCG |
0.882441550446185 |
|
22098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID3B |
0.882469523463905 |
|
22099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD62A |
0.882562785447627 |
|
22100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD62B |
0.882562785447627 |
|
22101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POMT1 |
0.882562785447627 |
|
22102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCK1 |
0.882562785447627 |
|
22103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00885 |
0.882612702536668 |
|
22104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAD2 |
0.882630191524794 |
|
22105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf64 |
0.882642534690868 |
|
22106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRCRB4D |
0.882646871631013 |
|
22107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITSN1 |
0.882654899596324 |
|
22108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL159P |
0.882657996004371 |
|
22109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPD1 |
0.882743888840519 |
|
22110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPE1 |
0.882743888840519 |
|
22111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HUWE1 |
0.882890130344591 |
|
22112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00317 |
0.882945844145195 |
|
22113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRP9 |
0.883077145590706 |
|
22114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRG4 |
0.883090072932091 |
|
22115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP10 |
0.883137286977403 |
|
22116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLL1 |
0.883188681773211 |
|
22117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM120B |
0.883188681773211 |
|
22118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4644 |
0.883188681773211 |
|
22119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED30 |
0.883220894261846 |
|
22120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR5A2 |
0.883243629671949 |
|
22121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSC2 |
0.88334011568885 |
|
22122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1225 |
0.88334011568885 |
|
22123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDHX |
0.883379241175149 |
|
22124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM225A |
0.883563238706144 |
|
22125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM225B |
0.883563238706144 |
|
22126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFP37 |
0.883563238706144 |
|
22127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF883 |
0.883563238706144 |
|
22128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SARDH |
0.883714493391268 |
|
22129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL216P |
0.883750914811184 |
|
22130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP125 |
0.883750914811184 |
|
22131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2AK2 |
0.883951187983655 |
|
22132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STXBP5L |
0.884015945848033 |
|
22133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM19 |
0.884103451290647 |
|
22134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP1 |
0.884155449479872 |
|
22135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PALM2 |
0.884214817956237 |
|
22136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALGPS1 |
0.884232609307396 |
|
22137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPTL2 |
0.884232609307396 |
|
22138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMOD1 |
0.88425989441095 |
|
22139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIMM17A |
0.88425989441095 |
|
22140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2A1 |
0.884271956828693 |
|
22141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIBCH |
0.884345198590427 |
|
22142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC12P |
0.88436818501771 |
|
22143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP2 |
0.884440506233406 |
|
22144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LONRF1 |
0.884452396367214 |
|
22145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC27 |
0.884674010847153 |
|
22146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GID4 |
0.884894588100584 |
|
22147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTEX1D1 |
0.88509328658754 |
|
22148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM50B |
0.885268951665434 |
|
22149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMIM10 |
0.885370995637799 |
|
22150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM127C |
0.885370995637799 |
|
22151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM127A |
0.885370995637799 |
|
22152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM127B |
0.885370995637799 |
|
22153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00087 |
0.885370995637799 |
|
22154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00633 |
0.885370995637799 |
|
22155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDILT |
0.885414665045092 |
|
22156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP11A1 |
0.885423082730966 |
|
22157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC19 |
0.885462622400172 |
|
22158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCC1 |
0.885548944656548 |
|
22159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARF5 |
0.885548944656548 |
|
22160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSCN3 |
0.885548944656548 |
|
22161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR155HG |
0.885581922983602 |
|
22162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00515 |
0.885581922983602 |
|
22163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSWIM2 |
0.885635460932219 |
|
22164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTSF1 |
0.885711235165902 |
|
22165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000251800.1 |
0.885874230317968 |
|
22166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5J |
0.885929492675195 |
|
22167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD90 |
0.886091125724703 |
|
22168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGFBP3 |
0.88610230631758 |
|
22169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LARP1B |
0.886106610981622 |
|
22170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGRMC2 |
0.886106610981622 |
|
22171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC13 |
0.886110921982201 |
|
22172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VGLL1 |
0.886245339354861 |
|
22173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR934 |
0.886245339354861 |
|
22174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBQLN1 |
0.886417553992046 |
|
22175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D27 |
0.88643631118962 |
|
22176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF13B |
0.88643631118962 |
|
22177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOZ2 |
0.886580469004474 |
|
22178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL227P |
0.886590347996887 |
|
22179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL392P |
0.886597384460657 |
|
22180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LAMC3 |
0.886621684939279 |
|
22181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5O |
0.886651040446043 |
|
22182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL740P |
0.886651040446043 |
|
22183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD8 |
0.886708550419042 |
|
22184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf29 |
0.886708550419042 |
|
22185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAM2 |
0.886749893401833 |
|
22186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPSB4 |
0.886766256705725 |
|
22187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACPL2 |
0.886766256705725 |
|
22188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB38 |
0.886766256705725 |
|
22189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR139 |
0.886809647647227 |
|
22190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBBP6 |
0.886864736851534 |
|
22191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPI |
0.88696951379572 |
|
22192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD2L |
0.88696951379572 |
|
22193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL154P |
0.88696951379572 |
|
22194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG5 |
0.887078010020539 |
|
22195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL47P |
0.887078010020539 |
|
22196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBED6 |
0.887165525641554 |
|
22197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEMD1 |
0.887174531812463 |
|
22198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6A |
0.887215511220617 |
|
22199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISLR2 |
0.887215511220617 |
|
22200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL429P |
0.887215511220617 |
|
22201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLG1 |
0.887322195946284 |
|
22202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTL6A |
0.887440013644789 |
|
22203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISLR |
0.887445697096789 |
|
22204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STRA6 |
0.887445697096789 |
|
22205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA15 |
0.88750659944294 |
|
22206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC13 |
0.887519139091832 |
|
22207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA4L2 |
0.887607130159955 |
|
22208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLSCR2 |
0.887655100093913 |
|
22209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL153P |
0.887669867550955 |
|
22210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTCD2 |
0.887669867550955 |
|
22211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELTD1 |
0.887692942867741 |
|
22212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAB2IP |
0.887738551598147 |
|
22213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMER1 |
0.887787438629216 |
|
22214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSN |
0.887827024427273 |
|
22215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCOR1 |
0.887939688327182 |
|
22216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN8 |
0.887980314029104 |
|
22217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFX |
0.8880111384371 |
|
22218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA4|ENSG00000202434.1 |
0.888049285433226 |
|
22219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR944 |
0.88808369566043 |
|
22220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LEPREL1 |
0.88808369566043 |
|
22221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL486P |
0.88808369566043 |
|
22222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIN1 |
0.888156558710094 |
|
22223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANAPC2 |
0.888156558710094 |
|
22224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC26 |
0.888156558710094 |
|
22225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3621 |
0.888156558710094 |
|
22226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSNA1 |
0.888156558710094 |
|
22227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM210 |
0.888156558710094 |
|
22228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIN3 |
0.888215098437412 |
|
22229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLE1 |
0.888334695073425 |
|
22230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGT |
0.888407277219875 |
|
22231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00649 |
0.888533884618081 |
|
22232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3H11A |
0.888638011600853 |
|
22233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RFTN2 |
0.888666916959557 |
|
22234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXW2 |
0.888703868871301 |
|
22235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD5 |
0.888703868871301 |
|
22236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF19 |
0.888703868871301 |
|
22237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF1 |
0.888703868871301 |
|
22238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGAP2 |
0.888707708085784 |
|
22239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN31 |
0.888707708085784 |
|
22240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK4 |
0.888707708085784 |
|
22241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBBP5 |
0.88874846097577 |
|
22242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR297 |
0.888767904681954 |
|
22243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRCC6BP1 |
0.888800152520319 |
|
22244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP65 |
0.888800152520319 |
|
22245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CASK |
0.888936690568959 |
|
22246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF169 |
0.889013191439581 |
|
22247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTAN1 |
0.889126095646973 |
|
22248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR34 |
0.889126095646973 |
|
22249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAPDC3 |
0.88915310030252 |
|
22250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF510 |
0.889172378478693 |
|
22251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC31A2 |
0.889181050524589 |
|
22252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP15 |
0.889181050524589 |
|
22253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP89 |
0.889230126337784 |
|
22254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH9 |
0.889279909936638 |
|
22255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP27B1 |
0.889279909936638 |
|
22256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL1 |
0.889279909936638 |
|
22257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL21B |
0.889279909936638 |
|
22258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSFM |
0.889279909936638 |
|
22259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf67 |
0.889372955713996 |
|
22260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRAMEF20 |
0.889430584537902 |
|
22261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL39P5 |
0.889440934741457 |
|
22262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AMOTL2 |
0.889440934741457 |
|
22263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFRD1 |
0.889450067208258 |
|
22264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSMEM1 |
0.889450067208258 |
|
22265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGPS1 |
0.8895040059069 |
|
22266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf46 |
0.889505894690758 |
|
22267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RXFP1 |
0.889588103102158 |
|
22268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCN4 |
0.889610369869867 |
|
22269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKAP2 |
0.889680300128799 |
|
22270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNIP2 |
0.889937590363093 |
|
22271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf45 |
0.889937590363093 |
|
22272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADNP2 |
0.889979214715329 |
|
22273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTDP1 |
0.889979214715329 |
|
22274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSBP1L1 |
0.889979214715329 |
|
22275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNG2 |
0.889979214715329 |
|
22276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFATC1 |
0.889979214715329 |
|
22277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARD6G |
0.889979214715329 |
|
22278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PQLC1 |
0.889979214715329 |
|
22279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBFADN |
0.889979214715329 |
|
22280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBFA |
0.889979214715329 |
|
22281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNL4A |
0.889979214715329 |
|
22282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSAD1 |
0.890129852722554 |
|
22283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC20B |
0.890249404753679 |
|
22284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX37 |
0.890261871367028 |
|
22285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD63|ENSG00000252112.1 |
0.890265964533471 |
|
22286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IREB2 |
0.890364102701847 |
|
22287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL516P |
0.890389455179149 |
|
22288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4673 |
0.890480797008493 |
|
22289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STOML1 |
0.890500011439922 |
|
22290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN2 |
0.890572851982419 |
|
22291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIIP |
0.890607027378926 |
|
22292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL649P |
0.890607027378926 |
|
22293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00308 |
0.890615602139066 |
|
22294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE8A |
0.890733893852837 |
|
22295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238571.1 |
0.890785390237939 |
|
22296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE4D |
0.890806672202383 |
|
22297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMIGD1 |
0.890871666741182 |
|
22298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR514A1 |
0.890916079300613 |
|
22299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR514A2 |
0.890916079300613 |
|
22300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR514A3 |
0.890916079300613 |
|
22301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEFM |
0.890958244096433 |
|
22302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEFL |
0.890958244096433 |
|
22303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HUNK |
0.890969853099983 |
|
22304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238546.1 |
0.890981500012263 |
|
22305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM37 |
0.891035037026861 |
|
22306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF281 |
0.891213818686565 |
|
22307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KL1 |
0.891234698680176 |
|
22308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYRM1 |
0.891255707122234 |
|
22309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPVP1 |
0.891326536420672 |
|
22310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL163P |
0.891490254062341 |
|
22311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN1B1 |
0.891490646106957 |
|
22312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD62 |
0.891490646106957 |
|
22313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAC3 |
0.891549292552326 |
|
22314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEBPA |
0.891573253895333 |
|
22315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00928 |
0.891672268181203 |
|
22316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARNT2 |
0.891735005568822 |
|
22317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFN2 |
0.891863848712482 |
|
22318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR513C |
0.891888845088835 |
|
22319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR513B |
0.891888845088835 |
|
22320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR513A1 |
0.891888845088835 |
|
22321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR513A2 |
0.891888845088835 |
|
22322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR506 |
0.891888845088835 |
|
22323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR507 |
0.891888845088835 |
|
22324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR508 |
0.891888845088835 |
|
22325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHYHD1 |
0.891910970472989 |
|
22326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BLMH |
0.891976096693129 |
|
22327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SON |
0.892024576385332 |
|
22328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP38 |
0.892227321956095 |
|
22329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACOT9 |
0.892265153800845 |
|
22330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMG1 |
0.892285865363935 |
|
22331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7A1 |
0.892326766033548 |
|
22332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7DHG |
0.892326766033548 |
|
22333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7F1 |
0.892326766033548 |
|
22334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7D |
0.892326766033548 |
|
22335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238792.1 |
0.892326766033548 |
|
22336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRGAP1 |
0.892341975006857 |
|
22337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCD4 |
0.892511774384022 |
|
22338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AVPR1A |
0.892539119441876 |
|
22339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNE3 |
0.892568687747181 |
|
22340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL367P |
0.892618146295693 |
|
22341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS3ST6 |
0.892618146295693 |
|
22342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSRB1 |
0.892618146295693 |
|
22343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL3L |
0.892618146295693 |
|
22344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFB10 |
0.892618146295693 |
|
22345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBL3 |
0.892618146295693 |
|
22346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACE2 |
0.892703342600848 |
|
22347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB11 |
0.892703342600848 |
|
22348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB9 |
0.892703342600848 |
|
22349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BMX |
0.892703342600848 |
|
22350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIGF |
0.892703342600848 |
|
22351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGA |
0.892703342600848 |
|
22352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIR |
0.892703342600848 |
|
22353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOB4 |
0.892794276245883 |
|
22354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HECW2 |
0.89280238837297 |
|
22355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC13P |
0.892810113744518 |
|
22356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD28|ENSG00000212295.1 |
0.892890877007846 |
|
22357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN9 |
0.892906723220685 |
|
22358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP79 |
0.892906723220685 |
|
22359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKN3 |
0.892967460049523 |
|
22360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC12 |
0.892967460049523 |
|
22361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZER1 |
0.892967460049523 |
|
22362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239055.1 |
0.892967460049523 |
|
22363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EAF1 |
0.892979901075296 |
|
22364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COLQ |
0.892979901075296 |
|
22365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP287 |
0.893140958536642 |
|
22366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD95|ENSG00000200969.1 |
0.893140958536642 |
|
22367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31D5P |
0.893140958536642 |
|
22368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31D4 |
0.893140958536642 |
|
22369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31D3 |
0.893140958536642 |
|
22370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31D1 |
0.893140958536642 |
|
22371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAZF1 |
0.893164249177513 |
|
22372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL22P19 |
0.893227070019926 |
|
22373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRI3BP |
0.893237565663105 |
|
22374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF151 |
0.89327552485399 |
|
22375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS2 |
0.89327552485399 |
|
22376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNHG9 |
0.89327552485399 |
|
22377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA10 |
0.89327552485399 |
|
22378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA64|ENSG00000207405.1 |
0.89327552485399 |
|
22379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORC3 |
0.893318111699495 |
|
22380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHAF1B |
0.893318111699495 |
|
22381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UGCG |
0.893474355782624 |
|
22382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOB1 |
0.89365065030044 |
|
22383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM194B |
0.893670499970894 |
|
22384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTN2 |
0.893723864989828 |
|
22385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3B1 |
0.893836459666986 |
|
22386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IVNS1ABP |
0.893875107867747 |
|
22387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLX4 |
0.894010175026455 |
|
22388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLITRK1 |
0.894046671331623 |
|
22389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP237 |
0.894344775015185 |
|
22390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP505 |
0.894348101339167 |
|
22391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL560P |
0.894391630695264 |
|
22392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEAD1 |
0.894496557814319 |
|
22393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL5A |
0.894523345398907 |
|
22394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDSUB1 |
0.89457169686476 |
|
22395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL150P |
0.894627942966259 |
|
22396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK10 |
0.894675772962514 |
|
22397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A7 |
0.894675772962514 |
|
22398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL859P |
0.894675772962514 |
|
22399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238568.1 |
0.894699823718417 |
|
22400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2S3 |
0.894776112530724 |
|
22401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKT3 |
0.894854729616869 |
|
22402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFIA |
0.894869905772007 |
|
22403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS3 |
0.894938678500909 |
|
22404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC18P |
0.894938678500909 |
|
22405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM5C |
0.894977599319458 |
|
22406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBCE |
0.894985243136016 |
|
22407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAA2 |
0.894994560883802 |
|
22408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA17|ENSG00000251992.1 |
0.894994560883802 |
|
22409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA17|ENSG00000267322.1 |
0.894994560883802 |
|
22410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA18|ENSG00000252139.1 |
0.894994560883802 |
|
22411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KY |
0.895028176727988 |
|
22412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP141 |
0.895028176727988 |
|
22413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNGT2 |
0.895111684836561 |
|
22414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABI3 |
0.895111684836561 |
|
22415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL393P |
0.895135756953236 |
|
22416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GMNC |
0.895327640686187 |
|
22417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3915 |
0.895477570287138 |
|
22418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ10B |
0.895541125984651 |
|
22419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PML |
0.895580881049892 |
|
22420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ5 |
0.89560712952279 |
|
22421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IER5L |
0.895629775351188 |
|
22422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C10orf107 |
0.895650574444507 |
|
22423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSTF3 |
0.895670293855469 |
|
22424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSTN |
0.895735852143532 |
|
22425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTS2B |
0.895735852143532 |
|
22426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP8B1 |
0.895805388413141 |
|
22427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNST |
0.895822517215477 |
|
22428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCCPDH |
0.895822517215477 |
|
22429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000252011.1 |
0.895822517215477 |
|
22430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252495.1 |
0.895822517215477 |
|
22431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFB2M |
0.895822517215477 |
|
22432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCF3 |
0.896041491923583 |
|
22433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MET |
0.896122667512902 |
|
22434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM154A |
0.89617076580563 |
|
22435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZXDB |
0.89622219072961 |
|
22436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE6D |
0.896294429122554 |
|
22437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FANCI |
0.896368563001858 |
|
22438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLG |
0.896368563001858 |
|
22439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLOD2 |
0.896375150888093 |
|
22440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLSCR4 |
0.896375150888093 |
|
22441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STC1 |
0.896406402064835 |
|
22442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3R5 |
0.896452800133913 |
|
22443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIAM1 |
0.896463252610128 |
|
22444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPDC1 |
0.896539621468793 |
|
22445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000251979.1 |
0.896814164692543 |
|
22446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKUB1 |
0.896841327346047 |
|
22447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR578 |
0.896883579866486 |
|
22448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRN3 |
0.89696683349347 |
|
22449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238922.1 |
0.89696683349347 |
|
22450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNC |
0.897013797166549 |
|
22451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM13 |
0.897013797166549 |
|
22452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL20RB |
0.897108633651824 |
|
22453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM211A |
0.89717418954468 |
|
22454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF624 |
0.89717418954468 |
|
22455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB39 |
0.897357667100308 |
|
22456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAC3 |
0.897357667100308 |
|
22457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSTD3 |
0.897364307842978 |
|
22458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMC6 |
0.897418389351939 |
|
22459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PART1 |
0.897490258994355 |
|
22460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLK4 |
0.897519636209821 |
|
22461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR2E1 |
0.897585283501034 |
|
22462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBX2P1 |
0.897585782317612 |
|
22463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UAP1L1 |
0.897621459275654 |
|
22464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP516 |
0.89762746808859 |
|
22465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MDFIC |
0.897649654755085 |
|
22466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAXC |
0.897727867351269 |
|
22467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD2 |
0.897747571344719 |
|
22468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP114 |
0.897748434506055 |
|
22469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR561 |
0.897748434506055 |
|
22470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCNN1G |
0.897834147256595 |
|
22471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPV2 |
0.897961921287724 |
|
22472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTRHD1 |
0.898077465367731 |
|
22473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPO |
0.898077465367731 |
|
22474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCY3 |
0.898077465367731 |
|
22475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF287 |
0.898097706621901 |
|
22476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNS1 |
0.898156075891647 |
|
22477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL65P |
0.898241420206092 |
|
22478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOGAT1 |
0.898256738098226 |
|
22479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ3 |
0.898397783363113 |
|
22480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNISR |
0.898397783363113 |
|
22481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP45 |
0.898397783363113 |
|
22482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCCS |
0.898541527520332 |
|
22483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP131 |
0.89868405676841 |
|
22484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TENM4 |
0.898688704908925 |
|
22485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00478 |
0.898747455793221 |
|
22486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZRN3 |
0.898997633618888 |
|
22487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OS9 |
0.899013455150567 |
|
22488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH10 |
0.899077289651729 |
|
22489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PARP6 |
0.899086548905011 |
|
22490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CELF6 |
0.899086548905011 |
|
22491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAMD2 |
0.899151128640022 |
|
22492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEO1 |
0.89917355293831 |
|
22493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238436.1 |
0.899174224332829 |
|
22494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD30A |
0.899201366169464 |
|
22495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCS1L |
0.899209029025296 |
|
22496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF25 |
0.899209029025296 |
|
22497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK36 |
0.899209029025296 |
|
22498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R3C |
0.899277535983225 |
|
22499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf66 |
0.899422747017409 |
|
22500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBWD1 |
0.899422747017409 |
|
22501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK8 |
0.899422747017409 |
|
22502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM138C |
0.899422747017409 |
|
22503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD4 |
0.899422747017409 |
|
22504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KANK1 |
0.899422747017409 |
|
22505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL412P |
0.899422747017409 |
|
22506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA68|ENSG00000201407.1 |
0.899424129456773 |
|
22507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5682 |
0.899454035543728 |
|
22508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECT2 |
0.89962206694359 |
|
22509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD28|ENSG00000252284.1 |
0.899756923290446 |
|
22510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF40A |
0.899766441689119 |
|
22511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MALT1 |
0.899778775271918 |
|
22512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC16A7 |
0.899821701103218 |
|
22513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGL |
0.90000386257347 |
|
22514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1288 |
0.90000386257347 |
|
22515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPV |
0.90000386257347 |
|
22516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31E1 |
0.900045496225198 |
|
22517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA31C1 |
0.900045496225198 |
|
22518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK20 |
0.900045496225198 |
|
22519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000271923.1 |
0.900045496225198 |
|
22520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERCC8 |
0.900102597928031 |
|
22521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTH |
0.900235316019161 |
|
22522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMOD1 |
0.90025434637469 |
|
22523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDCBP |
0.900379796963549 |
|
22524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
R3HDM2 |
0.900484236531702 |
|
22525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAV2 |
0.900624447859846 |
|
22526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL39 |
0.90068094161513 |
|
22527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPCDC |
0.90073602569595 |
|
22528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBB |
0.900795563073787 |
|
22529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AT |
0.900876283600536 |
|
22530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AK5 |
0.900958225984587 |
|
22531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNT1 |
0.901008969018714 |
|
22532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPRE3 |
0.901022151623639 |
|
22533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST6GALNAC4 |
0.901112055475362 |
|
22534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIP5KL1 |
0.901112055475362 |
|
22535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP73 |
0.901118809347793 |
|
22536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR5 |
0.901193981434847 |
|
22537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OFD1 |
0.901209115968302 |
|
22538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF366 |
0.901226064494998 |
|
22539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX3 |
0.901227563405566 |
|
22540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238974.1 |
0.901227563405566 |
|
22541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP212 |
0.901227563405566 |
|
22542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT16P3 |
0.901442840253409 |
|
22543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LGALS9B |
0.901442840253409 |
|
22544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOS2P3 |
0.901442840253409 |
|
22545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00622 |
0.901448325059393 |
|
22546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF697 |
0.901448325059393 |
|
22547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPRC5B |
0.901614445957132 |
|
22548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKS2 |
0.901668865282616 |
|
22549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3153 |
0.901668865282616 |
|
22550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKAP1 |
0.901796458899864 |
|
22551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX21 |
0.901841029595847 |
|
22552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239188.1 |
0.901882453578456 |
|
22553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRTC3 |
0.901957288991277 |
|
22554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD7 |
0.901980713468436 |
|
22555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST4 |
0.901998166560063 |
|
22556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD14 |
0.902094156251045 |
|
22557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf52 |
0.902103546368011 |
|
22558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDR2 |
0.902103546368011 |
|
22559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EEF2K |
0.902103546368011 |
|
22560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF6 |
0.902103546368011 |
|
22561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL9 |
0.902103546368011 |
|
22562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB3 |
0.902103546368011 |
|
22563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB4 |
0.902103546368011 |
|
22564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPIPB5 |
0.902103546368011 |
|
22565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOA |
0.902103546368011 |
|
22566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDZD9 |
0.902103546368011 |
|
22567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3E |
0.902103546368011 |
|
22568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL245P |
0.902103546368011 |
|
22569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRN3P1 |
0.902103546368011 |
|
22570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRN3P3 |
0.902103546368011 |
|
22571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA6|ENSG00000252798.1 |
0.902103546368011 |
|
22572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDR42E2 |
0.902103546368011 |
|
22573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMG1P1 |
0.902103546368011 |
|
22574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UQCRC2 |
0.902103546368011 |
|
22575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA3A |
0.902103546368011 |
|
22576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238712.1 |
0.902103546368011 |
|
22577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238954.1 |
0.902103546368011 |
|
22578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239172.1 |
0.902103546368011 |
|
22579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000238963.1 |
0.90215901767178 |
|
22580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC9 |
0.902334361512107 |
|
22581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPEF1 |
0.902362770767646 |
|
22582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MON2 |
0.90245095377664 |
|
22583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM12 |
0.902484860106984 |
|
22584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC2 |
0.902484860106984 |
|
22585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCL2L15 |
0.90259012977983 |
|
22586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4513 |
0.902614495503013 |
|
22587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAX1BP1 |
0.902772651903638 |
|
22588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXN4 |
0.902784819033236 |
|
22589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP81 |
0.902784819033236 |
|
22590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD14 |
0.902786202041723 |
|
22591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBR1 |
0.902786202041723 |
|
22592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NGFR |
0.9028635802286 |
|
22593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXPH3 |
0.9028635802286 |
|
22594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239135.1 |
0.902866740882689 |
|
22595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC38 |
0.902959874375004 |
|
22596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK2A3 |
0.903073988230184 |
|
22597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3GL3 |
0.903096728175942 |
|
22598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
A4GNT |
0.903220549022635 |
|
22599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DZIP1L |
0.903220549022635 |
|
22600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBR1 |
0.903220549022635 |
|
22601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARMC8 |
0.903220549022635 |
|
22602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME9 |
0.903220549022635 |
|
22603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENTPD2 |
0.903332931067988 |
|
22604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAPCD2 |
0.903332931067988 |
|
22605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANPEP |
0.903405901851446 |
|
22606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL6IP5 |
0.903446925254495 |
|
22607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMOD3 |
0.903446925254495 |
|
22608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP513 |
0.903459162017348 |
|
22609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UTP14A |
0.903459162017348 |
|
22610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA20|ENSG00000252722.1 |
0.903523662925258 |
|
22611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM9C |
0.90373767613836 |
|
22612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXL4 |
0.90377234263178 |
|
22613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSK |
0.903805715068383 |
|
22614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN7 |
0.903830536411267 |
|
22615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A36 |
0.903856377622889 |
|
22616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU3F2 |
0.903925597949867 |
|
22617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNKS2 |
0.90394983006645 |
|
22618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENG |
0.903957214996687 |
|
22619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP296 |
0.903957214996687 |
|
22620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AK1 |
0.903957214996687 |
|
22621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4672 |
0.903957214996687 |
|
22622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST6GALNAC6 |
0.903957214996687 |
|
22623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL487P |
0.90396401923887 |
|
22624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD2 |
0.903971837969003 |
|
22625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R3A |
0.903986629722477 |
|
22626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZEB2 |
0.903990380219504 |
|
22627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MESP1 |
0.904119745411026 |
|
22628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM78A |
0.90413406075183 |
|
22629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP4B1 |
0.904165490069023 |
|
22630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCLRE1B |
0.904165490069023 |
|
22631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTHFD1L |
0.90418417072918 |
|
22632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP121 |
0.904287552236233 |
|
22633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP279 |
0.904287552236233 |
|
22634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPOP |
0.904307296319146 |
|
22635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIPK1 |
0.904339585862713 |
|
22636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLFML3 |
0.904339585862713 |
|
22637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCTR |
0.904417988573107 |
|
22638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238891.1 |
0.904599845089151 |
|
22639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP136 |
0.904608003853438 |
|
22640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA51|ENSG00000207171.1 |
0.904633797426446 |
|
22641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMSB4X |
0.904726409229864 |
|
22642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM3B |
0.904736487798596 |
|
22643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNGR2 |
0.904747158692483 |
|
22644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A17 |
0.904806306381347 |
|
22645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROX2 |
0.904844650532823 |
|
22646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLST |
0.904844650532823 |
|
22647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRROS |
0.904889984390288 |
|
22648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGX |
0.904889984390288 |
|
22649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP19 |
0.904889984390288 |
|
22650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFI2 |
0.904889984390288 |
|
22651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCBP2 |
0.904889984390288 |
|
22652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAK2 |
0.904889984390288 |
|
22653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGZ |
0.904889984390288 |
|
22654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SENP5 |
0.904889984390288 |
|
22655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U4|ENSG00000272359.1 |
0.904889984390288 |
|
22656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F2R |
0.904931938347557 |
|
22657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F2RL1 |
0.904931938347557 |
|
22658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL208P |
0.904931938347557 |
|
22659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238688.1 |
0.904931938347557 |
|
22660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snR65|ENSG00000253036.1 |
0.905213185959038 |
|
22661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INHBC |
0.90532798613236 |
|
22662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INHBE |
0.90532798613236 |
|
22663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLI1 |
0.90532798613236 |
|
22664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP9 |
0.90532798613236 |
|
22665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTX3 |
0.90532798613236 |
|
22666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF25 |
0.90532798613236 |
|
22667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B4GALNT1 |
0.90532798613236 |
|
22668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC26A10 |
0.90532798613236 |
|
22669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARIH1 |
0.905452046181243 |
|
22670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPT2 |
0.905778944238643 |
|
22671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUTM2F |
0.905784018747414 |
|
22672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAP47 |
0.905791084576675 |
|
22673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH18 |
0.905918932596418 |
|
22674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP9 |
0.906027287556153 |
|
22675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FUBP3 |
0.906172724950997 |
|
22676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN14 |
0.906179794027425 |
|
22677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00963 |
0.906369168641862 |
|
22678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP6 |
0.906377785315004 |
|
22679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA16|ENSG00000252329.1 |
0.906451545374024 |
|
22680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238852.1 |
0.906473654672609 |
|
22681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZIC4 |
0.906585846289929 |
|
22682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGA1P4 |
0.906675777988844 |
|
22683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SET |
0.906675777988844 |
|
22684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238330.1 |
0.906691438219351 |
|
22685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCA1 |
0.906758576997831 |
|
22686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP2R3A |
0.906788017391677 |
|
22687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX60L |
0.906800027377577 |
|
22688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4447 |
0.906834035093664 |
|
22689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GULP1 |
0.906857466571321 |
|
22690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT10 |
0.906868179320277 |
|
22691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THBS2 |
0.906896207023282 |
|
22692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSL3P |
0.906999336613836 |
|
22693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSTYK |
0.907063930414306 |
|
22694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUP214 |
0.907376300445193 |
|
22695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL15 |
0.907404239733218 |
|
22696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIRREL3 |
0.907575813941911 |
|
22697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGR2 |
0.907602180233213 |
|
22698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEU2 |
0.907681318262644 |
|
22699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE1B |
0.907721165802456 |
|
22700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R1A |
0.907721165802456 |
|
22701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLYCAM1 |
0.907721165802456 |
|
22702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKSG68 |
0.90792446013016 |
|
22703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF484 |
0.90793292042411 |
|
22704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GP2 |
0.90803034146314 |
|
22705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UMOD |
0.90803034146314 |
|
22706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATAD2B |
0.908073786213785 |
|
22707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD12 |
0.90823977730701 |
|
22708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSC |
0.908323745556629 |
|
22709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CH25H |
0.908404487402599 |
|
22710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNB4 |
0.908500095256044 |
|
22711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA4L |
0.908512095066428 |
|
22712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAM2 |
0.908545602919597 |
|
22713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN17 |
0.908607459241306 |
|
22714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00307 |
0.908607459241306 |
|
22715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBL1XR1 |
0.908695086471538 |
|
22716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMN2 |
0.908753184382901 |
|
22717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoZ185 |
0.908850345370107 |
|
22718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRH |
0.90885379029967 |
|
22719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID4B |
0.908913715289564 |
|
22720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf185 |
0.90935615432262 |
|
22721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZXDA |
0.909383706022608 |
|
22722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDR9C7 |
0.909414848034344 |
|
22723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA64|ENSG00000252441.1 |
0.909558927030112 |
|
22724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK9 |
0.909655611422006 |
|
22725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3960 |
0.909655611422006 |
|
22726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FPGS |
0.909655611422006 |
|
22727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS3ST2 |
0.909777405185972 |
|
22728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL44 |
0.909802198072219 |
|
22729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM1P34 |
0.909889054520014 |
|
22730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6C |
0.909889054520014 |
|
22731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6D |
0.909889054520014 |
|
22732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL327P |
0.909889054520014 |
|
22733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL489P |
0.909889054520014 |
|
22734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBR1 |
0.910230280886477 |
|
22735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TES |
0.910359415631791 |
|
22736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A31 |
0.910431180155681 |
|
22737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP362 |
0.910489443688534 |
|
22738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LLPH |
0.910489443688534 |
|
22739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMBIM4 |
0.910489443688534 |
|
22740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR107 |
0.910616072314081 |
|
22741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL310P |
0.910669392416507 |
|
22742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK18 |
0.910707359607654 |
|
22743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RARB |
0.910791104840067 |
|
22744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1468 |
0.910814028726383 |
|
22745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGD1 |
0.910819634436795 |
|
22746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPX8 |
0.910911746956627 |
|
22747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR449A |
0.910911746956627 |
|
22748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR449B |
0.910911746956627 |
|
22749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR449C |
0.910911746956627 |
|
22750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALG1L2 |
0.911127466956334 |
|
22751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM86HP |
0.911127466956334 |
|
22752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP179 |
0.911160289180302 |
|
22753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM73A |
0.911175907518732 |
|
22754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEXN |
0.911175907518732 |
|
22755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL188P |
0.911193854255696 |
|
22756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf84 |
0.911218440710255 |
|
22757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHOSPHO1 |
0.911222855284641 |
|
22758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP211 |
0.911231490485691 |
|
22759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM1 |
0.911231490485691 |
|
22760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FARSB |
0.911253436137997 |
|
22761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNJ1 |
0.911297510802153 |
|
22762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF13 |
0.911337505330375 |
|
22763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT23 |
0.911440564352372 |
|
22764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPC3 |
0.911446030644732 |
|
22765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC59 |
0.911485735719493 |
|
22766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSF2 |
0.911485735719493 |
|
22767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHAD |
0.911485735719493 |
|
22768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GBE1 |
0.911488888860321 |
|
22769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAGE2B |
0.911637901469866 |
|
22770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAGE2 |
0.911637901469866 |
|
22771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC3 |
0.911822622887522 |
|
22772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOMER2 |
0.911828936844347 |
|
22773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2113 |
0.912005736155088 |
|
22774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TDRD12 |
0.912019790851907 |
|
22775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLS3 |
0.912119789950689 |
|
22776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NSMAF |
0.912154522177511 |
|
22777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
E2F8 |
0.912304091377331 |
|
22778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSBN1L |
0.912504049626364 |
|
22779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDAC9 |
0.912504518269832 |
|
22780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC70 |
0.912524954740464 |
|
22781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN12 |
0.912529895988162 |
|
22782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A3R2 |
0.912559743778539 |
|
22783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTHL1 |
0.912559743778539 |
|
22784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL712P |
0.912584614456004 |
|
22785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB1 |
0.912598820782492 |
|
22786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP38 |
0.912639446271683 |
|
22787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SASH3 |
0.912642825771565 |
|
22788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP211 |
0.912669176921441 |
|
22789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP126 |
0.912702089163622 |
|
22790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNPR |
0.912712655611687 |
|
22791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL505P |
0.912771147384098 |
|
22792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HDGFRP3 |
0.91277257578497 |
|
22793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL6 |
0.912786497151628 |
|
22794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP267 |
0.91282713679557 |
|
22795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JMJD4 |
0.912849405408936 |
|
22796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM122B |
0.912968049304655 |
|
22797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP21 |
0.913090024817729 |
|
22798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REG4 |
0.913180194238763 |
|
22799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000252582.1 |
0.91321869877733 |
|
22800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCND2 |
0.913312405192664 |
|
22801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM6SF1 |
0.913352317439962 |
|
22802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCAN1 |
0.913413058180028 |
|
22803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC50 |
0.913468153661913 |
|
22804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLIC6 |
0.913538188252114 |
|
22805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00160 |
0.913538188252114 |
|
22806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ULK3 |
0.913599310997256 |
|
22807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SDPR |
0.913636509524631 |
|
22808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL703P |
0.913752507829955 |
|
22809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP150 |
0.913752507829955 |
|
22810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR891A |
0.913984445078282 |
|
22811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDFY1 |
0.914124080682073 |
|
22812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGK |
0.914125322161543 |
|
22813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTA2 |
0.914127668491748 |
|
22814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMDEC1 |
0.914154386665341 |
|
22815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FZD2 |
0.914263629544468 |
|
22816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C70 |
0.914407854678674 |
|
22817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1284 |
0.914571199177722 |
|
22818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM7 |
0.914741116781822 |
|
22819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAN |
0.914877494067691 |
|
22820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAPLN3 |
0.914877494067691 |
|
22821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFGE8 |
0.914877494067691 |
|
22822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAMLD1 |
0.914912168714691 |
|
22823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRTM3 |
0.914931035580054 |
|
22824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEB |
0.914953565476008 |
|
22825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX2 |
0.914962710672985 |
|
22826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX2B |
0.914962710672985 |
|
22827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF652 |
0.914995127794551 |
|
22828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHB |
0.914995127794551 |
|
22829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPM6B |
0.915057601420163 |
|
22830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP51 |
0.915123738372961 |
|
22831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3BP5 |
0.915132863422453 |
|
22832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf30 |
0.915182139465867 |
|
22833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00892 |
0.915205463073001 |
|
22834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD40LG |
0.915205463073001 |
|
22835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGEF6 |
0.915205463073001 |
|
22836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL837P |
0.915261129381446 |
|
22837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238985.1 |
0.915261129381446 |
|
22838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT26 |
0.915275552824371 |
|
22839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT27 |
0.915275552824371 |
|
22840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT28 |
0.915275552824371 |
|
22841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT10 |
0.915275552824371 |
|
22842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM99 |
0.915275552824371 |
|
22843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT12 |
0.915275552824371 |
|
22844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRT20 |
0.915275552824371 |
|
22845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOTAIR |
0.915435217877935 |
|
22846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000253004.1 |
0.915557859630549 |
|
22847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST6GALNAC5 |
0.915562081513807 |
|
22848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTAF1 |
0.915637320635822 |
|
22849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGM7 |
0.915667975816167 |
|
22850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
F9 |
0.915818019449096 |
|
22851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEH1 |
0.915819075713049 |
|
22852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR4A2 |
0.915853269195427 |
|
22853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAT10 |
0.915864888508127 |
|
22854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADCK3 |
0.915876469634418 |
|
22855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAS1 |
0.915999138401664 |
|
22856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf170 |
0.915999138401664 |
|
22857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRMT1L |
0.916044995702154 |
|
22858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SWT1 |
0.916044995702154 |
|
22859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3714 |
0.916118117531166 |
|
22860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OCRL |
0.916165967189867 |
|
22861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APLN |
0.916165967189867 |
|
22862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COG7 |
0.916176964546526 |
|
22863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAV1 |
0.916291307517094 |
|
22864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHGDH |
0.916406454929432 |
|
22865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGCS2 |
0.916406454929432 |
|
22866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZSCAN29 |
0.916431171903688 |
|
22867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TUBGCP4 |
0.916431171903688 |
|
22868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPA2 |
0.916431273603264 |
|
22869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM202 |
0.916508552216958 |
|
22870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XPNPEP2 |
0.916586849193259 |
|
22871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DET1 |
0.916669352678359 |
|
22872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1179 |
0.916669352678359 |
|
22873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AEN |
0.916669352678359 |
|
22874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISG20 |
0.916669352678359 |
|
22875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C5 |
0.916687783074617 |
|
22876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGM2L1 |
0.916725291425151 |
|
22877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AL |
0.916725291425151 |
|
22878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR125B2 |
0.916770522175471 |
|
22879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNKSR3 |
0.91678053693921 |
|
22880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR27 |
0.916786228434194 |
|
22881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX29 |
0.916824380772253 |
|
22882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF821 |
0.916830623459782 |
|
22883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IST1 |
0.916830623459782 |
|
22884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESRRB |
0.916922327010805 |
|
22885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGB3 |
0.916928574109346 |
|
22886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLXDC2 |
0.916985407934986 |
|
22887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPP2 |
0.917087297194206 |
|
22888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR181A1 |
0.917243703799584 |
|
22889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR181B1 |
0.917243703799584 |
|
22890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTM1 |
0.917265259850962 |
|
22891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212421.1 |
0.917304166957166 |
|
22892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR888 |
0.917394029923136 |
|
22893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR890 |
0.917394029923136 |
|
22894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR892A |
0.917394029923136 |
|
22895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR892B |
0.917394029923136 |
|
22896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR891B |
0.917394029923136 |
|
22897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP77 |
0.917511497919239 |
|
22898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN7 |
0.917561918253128 |
|
22899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL46 |
0.917572293230247 |
|
22900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS11 |
0.917572293230247 |
|
22901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRIG3 |
0.917612796222996 |
|
22902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAA38 |
0.91775309072905 |
|
22903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GEMIN8 |
0.917931496116861 |
|
22904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HGF |
0.917947978872985 |
|
22905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAMSAP1 |
0.917949840612274 |
|
22906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBAC1 |
0.917949840612274 |
|
22907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALPK2 |
0.917970212612126 |
|
22908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP238 |
0.918046747384852 |
|
22909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3666 |
0.918046747384852 |
|
22910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP2 |
0.918132786290718 |
|
22911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPB42 |
0.918217635343437 |
|
22912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM62 |
0.918217635343437 |
|
22913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD7 |
0.918237134503409 |
|
22914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAAH2 |
0.918297957772072 |
|
22915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACTRT1 |
0.918337276785822 |
|
22916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf58 |
0.918407707975374 |
|
22917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHCR24 |
0.918457542414704 |
|
22918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DAPK1 |
0.918533238448681 |
|
22919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf211 |
0.918581493864915 |
|
22920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP331 |
0.918608330484018 |
|
22921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLCL2 |
0.918751053680789 |
|
22922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPZA2 |
0.918769028443881 |
|
22923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL713P |
0.918781376898183 |
|
22924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEC1 |
0.918807299054401 |
|
22925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEC3 |
0.918807299054401 |
|
22926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXA1 |
0.918807299054401 |
|
22927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXA2 |
0.918807299054401 |
|
22928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXC |
0.918807299054401 |
|
22929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXD |
0.918807299054401 |
|
22930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF410 |
0.918813011185469 |
|
22931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM161B |
0.918813011185469 |
|
22932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000251999.1 |
0.919007797398643 |
|
22933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDNK |
0.919331524084109 |
|
22934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR5A1 |
0.919457548251688 |
|
22935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TACSTD2 |
0.919472200711932 |
|
22936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CISH |
0.919518907730807 |
|
22937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL799P |
0.919537942422281 |
|
22938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB12 |
0.919537942422281 |
|
22939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00884 |
0.919701718779287 |
|
22940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM44 |
0.919701718779287 |
|
22941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000200222.1 |
0.919822467930835 |
|
22942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFHB |
0.9198582589025 |
|
22943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AHCTF1 |
0.919898693962887 |
|
22944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR147A |
0.92000326247622 |
|
22945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238336.1 |
0.920075026418947 |
|
22946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1958 |
0.920137308207091 |
|
22947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN16 |
0.920211756940975 |
|
22948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM207 |
0.920211756940975 |
|
22949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL1RAP |
0.920211756940975 |
|
22950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC27 |
0.920291251135739 |
|
22951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XYLT2 |
0.920369800984677 |
|
22952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL27 |
0.920369800984677 |
|
22953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EME1 |
0.920369800984677 |
|
22954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000253009.1 |
0.920599078809478 |
|
22955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR106A |
0.920641197289046 |
|
22956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR18B |
0.920641197289046 |
|
22957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR19B2 |
0.920641197289046 |
|
22958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR20B |
0.920641197289046 |
|
22959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR363 |
0.920641197289046 |
|
22960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR92A2 |
0.920641197289046 |
|
22961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238815.1 |
0.920648032079613 |
|
22962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM132B |
0.920659073341318 |
|
22963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO5B |
0.920833804094203 |
|
22964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2R1 |
0.920855176887421 |
|
22965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1L4 |
0.920892869024148 |
|
22966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAD54L2 |
0.920909984089989 |
|
22967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC29P |
0.920909984089989 |
|
22968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00692 |
0.92112264493628 |
|
22969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HES1 |
0.921326684478825 |
|
22970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL215P |
0.921326684478825 |
|
22971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD56|ENSG00000200753.1 |
0.921354357298525 |
|
22972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIS18A |
0.921472249440372 |
|
22973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MACC1 |
0.921480907327568 |
|
22974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GP5 |
0.921536275000719 |
|
22975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP13A3 |
0.921536275000719 |
|
22976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHST2 |
0.921539927519388 |
|
22977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIF1L |
0.921588960082853 |
|
22978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL314P |
0.921647622745971 |
|
22979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOXHD1 |
0.921672549634359 |
|
22980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR2K2 |
0.921685485551984 |
|
22981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP294 |
0.921685485551984 |
|
22982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR99A |
0.921736097967182 |
|
22983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7C |
0.921736097967182 |
|
22984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC28 |
0.921881852977688 |
|
22985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35B1 |
0.921887308537897 |
|
22986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDC42BPA |
0.921893433445411 |
|
22987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNFRSF1B |
0.921904344946035 |
|
22988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252969.1 |
0.921904344946035 |
|
22989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOP2B |
0.922075557770166 |
|
22990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4442 |
0.922075557770166 |
|
22991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP235 |
0.922141328594421 |
|
22992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL7 |
0.922204549565869 |
|
22993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEX11A |
0.922382606993065 |
|
22994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR93 |
0.922382606993065 |
|
22995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU6ATAC |
0.922444987312987 |
|
22996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4632 |
0.922539979615044 |
|
22997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KBTBD2 |
0.922571153150001 |
|
22998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP1 |
0.922629025838428 |
|
22999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPRBP |
0.922630647158973 |
|
23000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED27 |
0.922655557085396 |
|
23001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX4 |
0.922758486421924 |
|
23002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF496 |
0.922894127937134 |
|
23003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA7A |
0.922909163879628 |
|
23004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT16 |
0.922944205617599 |
|
23005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM3C |
0.922944205617599 |
|
23006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST8SIA5 |
0.922977684110943 |
|
23007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD6 |
0.923191214339781 |
|
23008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLK3 |
0.923194795293868 |
|
23009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EDC3 |
0.923194795293868 |
|
23010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM28 |
0.923351407810029 |
|
23011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAA2 |
0.923412154591926 |
|
23012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf168 |
0.923412154591926 |
|
23013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSM12 |
0.923456253115774 |
|
23014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
G6PC3 |
0.923456253115774 |
|
23015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTTNBP2 |
0.923495449989052 |
|
23016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf145 |
0.923604768987847 |
|
23017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00971 |
0.923816371298937 |
|
23018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGDIG |
0.923905297308509 |
|
23019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AXIN1 |
0.923905297308509 |
|
23020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf11 |
0.923905297308509 |
|
23021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN15 |
0.923905297308509 |
|
23022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX11L10 |
0.923905297308509 |
|
23023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DECR2 |
0.923905297308509 |
|
23024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBA1 |
0.923905297308509 |
|
23025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBA2 |
0.923905297308509 |
|
23026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBM |
0.923905297308509 |
|
23027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBQ1 |
0.923905297308509 |
|
23028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBZ |
0.923905297308509 |
|
23029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITFG3 |
0.923905297308509 |
|
23030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUC7L |
0.923905297308509 |
|
23031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3176 |
0.923905297308509 |
|
23032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5587 |
0.923905297308509 |
|
23033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPG |
0.923905297308509 |
|
23034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL28 |
0.923905297308509 |
|
23035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NHLRC4 |
0.923905297308509 |
|
23036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NME4 |
0.923905297308509 |
|
23037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPRL3 |
0.923905297308509 |
|
23038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDIA2 |
0.923905297308509 |
|
23039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIGQ |
0.923905297308509 |
|
23040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLR3K |
0.923905297308509 |
|
23041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB11FIP3 |
0.923905297308509 |
|
23042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS11 |
0.923905297308509 |
|
23043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RHBDF1 |
0.923905297308509 |
|
23044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNRNP25 |
0.923905297308509 |
|
23045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM8A |
0.923905297308509 |
|
23046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASH4P |
0.923905297308509 |
|
23047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WASIR2 |
0.923905297308509 |
|
23048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5692A2 |
0.923919995723103 |
|
23049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBQLN2 |
0.92392739335361 |
|
23050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIPA |
0.923974165104269 |
|
23051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF678 |
0.924096204301143 |
|
23052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD59|ENSG00000252517.1 |
0.924120716487248 |
|
23053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL6A4P2 |
0.9241340497715 |
|
23054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM43A |
0.924341110133785 |
|
23055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGTA1P |
0.924362363980023 |
|
23056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL187P |
0.924362363980023 |
|
23057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C2 |
0.924550555442804 |
|
23058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INIP |
0.924630182432736 |
|
23059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX30 |
0.924630182432736 |
|
23060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP151 |
0.924689839648502 |
|
23061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SKA1 |
0.924729937996757 |
|
23062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLAC1 |
0.924761066274243 |
|
23063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNTN |
0.924806222953723 |
|
23064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC11 |
0.924867059898134 |
|
23065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP458 |
0.924867059898134 |
|
23066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR181A1HG |
0.924971453004952 |
|
23067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR37L1 |
0.925134381862837 |
|
23068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL8A |
0.925134381862837 |
|
23069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00159 |
0.925426528099881 |
|
23070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPK |
0.925550389404186 |
|
23071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH3 |
0.925563008352824 |
|
23072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ING3 |
0.925678267747111 |
|
23073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP240 |
0.925678267747111 |
|
23074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP241 |
0.925678267747111 |
|
23075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRS3 |
0.925734685112262 |
|
23076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTATSF1 |
0.925734685112262 |
|
23077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP26 |
0.925825536406485 |
|
23078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC13 |
0.925927353381421 |
|
23079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOXC12 |
0.925927353381421 |
|
23080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBS9 |
0.925949118869365 |
|
23081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NR6A1 |
0.925976134387499 |
|
23082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ROR2 |
0.926022945958241 |
|
23083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTNG2 |
0.926035126168331 |
|
23084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P22 |
0.926155989114287 |
|
23085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WFIKKN2 |
0.926305882963883 |
|
23086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POMC |
0.926529106571207 |
|
23087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD1 |
0.926589905464858 |
|
23088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXXC1 |
0.926589905464858 |
|
23089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNP |
0.926662958522576 |
|
23090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC7 |
0.926662958522576 |
|
23091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP125 |
0.926682970901919 |
|
23092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR4 |
0.926682970901919 |
|
23093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBS4 |
0.926691376288944 |
|
23094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIRC1 |
0.926722611216602 |
|
23095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC3HC1 |
0.926781601576795 |
|
23096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf36 |
0.926874126339053 |
|
23097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR8 |
0.927006771481916 |
|
23098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLDN18 |
0.927183124715235 |
|
23099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAXBP1 |
0.92732020430819 |
|
23100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PP2D1 |
0.927407857387976 |
|
23101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAT2B |
0.927407857387976 |
|
23102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD40 |
0.927448200053346 |
|
23103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRICKLE2 |
0.927519348202177 |
|
23104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5C3A |
0.927601548940743 |
|
23105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM228A |
0.927713069370871 |
|
23106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL5A1 |
0.927731143874352 |
|
23107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3689A |
0.927731143874352 |
|
23108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3689B |
0.927731143874352 |
|
23109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3689C |
0.927731143874352 |
|
23110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3689D1 |
0.927731143874352 |
|
23111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3689D2 |
0.927731143874352 |
|
23112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3689E |
0.927731143874352 |
|
23113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3689F |
0.927731143874352 |
|
23114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCN2 |
0.927731143874352 |
|
23115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCN1 |
0.927731143874352 |
|
23116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMD6 |
0.927779061942224 |
|
23117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238626.1 |
0.927795621974873 |
|
23118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL658P |
0.927844381987975 |
|
23119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTPS2 |
0.927844381987975 |
|
23120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AM |
0.927844381987975 |
|
23121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S100G |
0.927844381987975 |
|
23122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE1C |
0.927870235131439 |
|
23123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE1D |
0.927870235131439 |
|
23124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE1E |
0.927870235131439 |
|
23125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRG2 |
0.927889388107182 |
|
23126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CKS1B|ENSG00000268942.1 |
0.927942701928675 |
|
23127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGBL1 |
0.927967457990504 |
|
23128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MGA |
0.927969792511519 |
|
23129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR626 |
0.927969792511519 |
|
23130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP335 |
0.927974091485459 |
|
23131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3135A |
0.927985267506977 |
|
23132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00958 |
0.928012838247306 |
|
23133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
URB1 |
0.928198611259767 |
|
23134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL109P |
0.928198611259767 |
|
23135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA80 |
0.928198611259767 |
|
23136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf119 |
0.928198611259767 |
|
23137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTF1 |
0.928242289814162 |
|
23138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBMX |
0.92824853210222 |
|
23139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD61|ENSG00000206979.1 |
0.92824853210222 |
|
23140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR101 |
0.92824853210222 |
|
23141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RP9P |
0.928347024261651 |
|
23142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP9 |
0.928347024261651 |
|
23143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD9 |
0.928392100033723 |
|
23144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00610 |
0.928392100033723 |
|
23145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf91 |
0.928433330154727 |
|
23146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCNN1B |
0.928505263833871 |
|
23147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP23 |
0.928505263833871 |
|
23148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARNTL |
0.928703021308247 |
|
23149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRVP |
0.928734253054041 |
|
23150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX14 |
0.928781498058146 |
|
23151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEZ1 |
0.928819953000639 |
|
23152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP142 |
0.928859291213901 |
|
23153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR448 |
0.928956531257511 |
|
23154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSP90AA6P |
0.928990764875878 |
|
23155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF142 |
0.929048760605987 |
|
23156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3927 |
0.929115602037046 |
|
23157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPOCK3 |
0.929184702512472 |
|
23158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSIP2 |
0.929500659933667 |
|
23159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000212581.1 |
0.929500659933667 |
|
23160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXN5 |
0.92968750928445 |
|
23161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RDH16 |
0.929693560262862 |
|
23162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPCEF1 |
0.929698218330109 |
|
23163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR182 |
0.929727331792218 |
|
23164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HBCBP |
0.929727331792218 |
|
23165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1343 |
0.929751160216051 |
|
23166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRPR |
0.929870748806688 |
|
23167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEB17 |
0.929870748806688 |
|
23168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00303 |
0.92993212026899 |
|
23169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP132 |
0.929961424965883 |
|
23170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRM2 |
0.929961424965883 |
|
23171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCF6 |
0.929961424965883 |
|
23172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR514B |
0.930000069900024 |
|
23173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR510 |
0.930000069900024 |
|
23174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGPP2 |
0.930050148339985 |
|
23175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGB1P5 |
0.930054592880078 |
|
23176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSPG4P12 |
0.930060973749483 |
|
23177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL428P |
0.930060973749483 |
|
23178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBNL3 |
0.930324128675049 |
|
23179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAIF1 |
0.930325960929869 |
|
23180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NXNL2 |
0.930377140371383 |
|
23181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252299.1 |
0.93037922563739 |
|
23182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGPRX1 |
0.930562091183595 |
|
23183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMYD3 |
0.930823724456505 |
|
23184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP2C1 |
0.930854862003569 |
|
23185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A6 |
0.93092829876175 |
|
23186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR61 |
0.930986200568725 |
|
23187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIGLEC15 |
0.931090550746227 |
|
23188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INTU |
0.931296788812112 |
|
23189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYAP1 |
0.931339894846957 |
|
23190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAGS |
0.931415204459061 |
|
23191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM101 |
0.931415204459061 |
|
23192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221044.1 |
0.931415204459061 |
|
23193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP228 |
0.931453708407981 |
|
23194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRABP1 |
0.931485112818152 |
|
23195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCO |
0.931491468993192 |
|
23196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf39 |
0.931511732575476 |
|
23197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOS |
0.931535569857085 |
|
23198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JDP2 |
0.931618922462664 |
|
23199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBMS1 |
0.931621338127881 |
|
23200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HECTD2 |
0.931634684196122 |
|
23201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLIG2 |
0.931696853736203 |
|
23202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE5 |
0.931739005078705 |
|
23203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL856P |
0.931820519921457 |
|
23204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNDC1 |
0.931856929359264 |
|
23205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLMP |
0.931967152364628 |
|
23206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00320 |
0.932074825366908 |
|
23207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASEF |
0.932111181481634 |
|
23208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RYK |
0.932114783372379 |
|
23209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FECH |
0.932268379360649 |
|
23210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239079.1 |
0.932299334778543 |
|
23211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRTAM |
0.932357364268047 |
|
23212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF13 |
0.932412562742858 |
|
23213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL591P |
0.932478992866331 |
|
23214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238368.1 |
0.93255376576045 |
|
23215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP149 |
0.932616590947386 |
|
23216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DONSON |
0.932686070089218 |
|
23217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYZL1 |
0.932686070089218 |
|
23218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP12 |
0.932696562040585 |
|
23219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPRIP |
0.932698569415255 |
|
23220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLD6 |
0.932698569415255 |
|
23221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLCN |
0.932698569415255 |
|
23222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD19P |
0.932725399365226 |
|
23223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf37 |
0.932746522743557 |
|
23224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf63 |
0.932821155937325 |
|
23225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BSX |
0.932821155937325 |
|
23226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA8 |
0.932821155937325 |
|
23227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD14E |
0.932821155937325 |
|
23228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD14C |
0.932821155937325 |
|
23229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD14D |
0.932821155937325 |
|
23230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PYDC2 |
0.93286796223764 |
|
23231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP277 |
0.932869031783183 |
|
23232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTDC1 |
0.932986722957343 |
|
23233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAM2 |
0.933031986925798 |
|
23234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO15A |
0.93307385818492 |
|
23235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALKBH5 |
0.93307385818492 |
|
23236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2B2 |
0.933077328486651 |
|
23237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MLH3 |
0.933077328486651 |
|
23238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACYP1 |
0.933077328486651 |
|
23239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZC2HC1C |
0.933077328486651 |
|
23240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK9 |
0.933077328486651 |
|
23241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLSCR1 |
0.933120360761953 |
|
23242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLSCR5 |
0.933120360761953 |
|
23243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR7 |
0.933151648137321 |
|
23244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TLR8 |
0.933151648137321 |
|
23245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM102A |
0.933213689804536 |
|
23246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YLPM1 |
0.933263059890426 |
|
23247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL1A1 |
0.933271273688603 |
|
23248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCG2 |
0.933375500334814 |
|
23249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICALCL |
0.933375770851828 |
|
23250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGF |
0.933379209554815 |
|
23251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPB41L5 |
0.933400502794163 |
|
23252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM185B |
0.933400502794163 |
|
23253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIBADH |
0.933488776985178 |
|
23254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITSN2 |
0.933508407802763 |
|
23255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00466 |
0.933552155573776 |
|
23256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP49 |
0.933552155573776 |
|
23257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMAD7 |
0.933695402043708 |
|
23258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR562 |
0.933803766065375 |
|
23259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTN3 |
0.933845662641469 |
|
23260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYTL3 |
0.933876556688796 |
|
23261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBASH3B |
0.934120615708317 |
|
23262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238691.1 |
0.934193174329877 |
|
23263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RXRA |
0.934223268560396 |
|
23264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238341.1 |
0.934273006706661 |
|
23265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKI67IP |
0.934273006706661 |
|
23266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf62 |
0.934336085984054 |
|
23267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000207098.1 |
0.934336085984054 |
|
23268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPM2 |
0.934345989188398 |
|
23269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INHBB |
0.934361749902136 |
|
23270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RALB |
0.934445029121934 |
|
23271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA16|ENSG00000252923.1 |
0.93447753864021 |
|
23272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR135B |
0.934490411686423 |
|
23273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN7 |
0.934498222571111 |
|
23274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL434P |
0.934498222571111 |
|
23275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL738P |
0.934498222571111 |
|
23276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF168 |
0.934498222571111 |
|
23277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LSAMP |
0.934503280347771 |
|
23278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLJ14816 |
0.93450351378871 |
|
23279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000201810.1 |
0.934628094403128 |
|
23280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP5D |
0.93475304703706 |
|
23281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4743 |
0.934874287231642 |
|
23282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAT1 |
0.935180769567335 |
|
23283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT14 |
0.935183743524152 |
|
23284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MICAL2 |
0.935360983369733 |
|
23285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPYSL5 |
0.935421069108939 |
|
23286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFR3B |
0.935437637333122 |
|
23287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCGF5 |
0.935451573362044 |
|
23288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD5|ENSG00000272166.1 |
0.935676893937845 |
|
23289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC150 |
0.935682837154509 |
|
23290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSN |
0.935723662370592 |
|
23291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238618.1 |
0.935864764446089 |
|
23292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF11 |
0.935864764446089 |
|
23293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAST |
0.935931016138301 |
|
23294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM156A |
0.935942100373899 |
|
23295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM156B |
0.935942100373899 |
|
23296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XAGE3 |
0.935942100373899 |
|
23297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA48|ENSG00000212383.1 |
0.936063810827116 |
|
23298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH3KBP1 |
0.936090357115531 |
|
23299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LYPD6B |
0.936121913418537 |
|
23300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXR2 |
0.936121978079828 |
|
23301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5704 |
0.936221406619423 |
|
23302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JUN |
0.936249669188201 |
|
23303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3R4 |
0.93634521656657 |
|
23304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MCIDAS |
0.93645201142507 |
|
23305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNO |
0.93645201142507 |
|
23306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC7A10 |
0.936481009285494 |
|
23307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNKD |
0.936534900779922 |
|
23308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM61 |
0.936578536158139 |
|
23309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BSND |
0.936578536158139 |
|
23310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCSK9 |
0.936578536158139 |
|
23311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00927 |
0.936674007350302 |
|
23312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP20 |
0.936713391892261 |
|
23313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL370P |
0.936713391892261 |
|
23314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAC4 |
0.936787716829088 |
|
23315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSX7 |
0.936800909961153 |
|
23316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP504 |
0.936800909961153 |
|
23317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP170P1 |
0.936802809060301 |
|
23318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM108 |
0.937155972754456 |
|
23319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR26A2 |
0.937184769190612 |
|
23320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNE4 |
0.937218611824461 |
|
23321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNUPN |
0.937326953236654 |
|
23322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IMP3 |
0.937326953236654 |
|
23323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX33 |
0.937326953236654 |
|
23324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF133 |
0.937332988078774 |
|
23325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF148 |
0.937332988078774 |
|
23326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00870 |
0.937419966600727 |
|
23327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX13 |
0.937469518059808 |
|
23328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETNK2 |
0.937469518059808 |
|
23329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00502 |
0.937535493929954 |
|
23330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTBP3 |
0.937701882314084 |
|
23331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL57P |
0.937701882314084 |
|
23332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP295 |
0.937701882314084 |
|
23333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00877 |
0.93772289599379 |
|
23334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIM1 |
0.937734355345179 |
|
23335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252883.1 |
0.93797725389713 |
|
23336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4669 |
0.938043072543886 |
|
23337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGES3L |
0.938109725723185 |
|
23338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUNDC1 |
0.938109725723185 |
|
23339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL27 |
0.938109725723185 |
|
23340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFI35 |
0.938109725723185 |
|
23341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VAT1 |
0.938109725723185 |
|
23342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RND2 |
0.938109725723185 |
|
23343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPAR1 |
0.938192550400085 |
|
23344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLEC19A |
0.938254115875282 |
|
23345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYT17 |
0.938260651769277 |
|
23346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf152 |
0.938319761940024 |
|
23347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC8 |
0.938319761940024 |
|
23348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXN |
0.938319761940024 |
|
23349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPED1 |
0.938362706139425 |
|
23350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP472 |
0.938368941394357 |
|
23351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HADHB |
0.93836995921729 |
|
23352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDSS2 |
0.938610609919192 |
|
23353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf23 |
0.938652583091119 |
|
23354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR23C |
0.938652583091119 |
|
23355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTMR1 |
0.93880585367423 |
|
23356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00578 |
0.938839877312159 |
|
23357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA18|ENSG00000200288.1 |
0.938839877312159 |
|
23358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAT7 |
0.938923970887442 |
|
23359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODF2 |
0.939005535871745 |
|
23360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSL3 |
0.939037608429426 |
|
23361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMC5 |
0.939149858253224 |
|
23362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC14A1 |
0.939201431220483 |
|
23363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf171 |
0.939248283966296 |
|
23364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD6L |
0.939265349351326 |
|
23365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3R6 |
0.939265349351326 |
|
23366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA73|ENSG00000201816.1 |
0.939278149749092 |
|
23367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DEPDC1B |
0.939285281346298 |
|
23368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOD2 |
0.93947802564689 |
|
23369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WTAP |
0.93947802564689 |
|
23370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAT2 |
0.93947802564689 |
|
23371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA20|ENSG00000207392.1 |
0.93947802564689 |
|
23372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD5 |
0.939624149322911 |
|
23373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMC3 |
0.939624149322911 |
|
23374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRON |
0.93967031878006 |
|
23375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD116|ENSG00000252985.1 |
0.93967031878006 |
|
23376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXN3 |
0.939739053038396 |
|
23377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD99L2 |
0.939743122985312 |
|
23378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF3C3 |
0.939848648283564 |
|
23379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf66 |
0.939848648283564 |
|
23380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIRC3 |
0.940167326278973 |
|
23381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BFSP2 |
0.940170405629765 |
|
23382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238991.1 |
0.940460423297811 |
|
23383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB5A |
0.940501957494626 |
|
23384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA3 |
0.940513419894693 |
|
23385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA1 |
0.940548675833047 |
|
23386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HEXA |
0.940707044818638 |
|
23387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2H |
0.940707189546187 |
|
23388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFDP3 |
0.940734680952289 |
|
23389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOPBP1 |
0.940775518026971 |
|
23390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000252805.1 |
0.940781599626415 |
|
23391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NARS |
0.94082040933862 |
|
23392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDV3 |
0.940873898537071 |
|
23393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN1L |
0.941004392135604 |
|
23394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP9B |
0.941084779706039 |
|
23395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAX3 |
0.94110050706889 |
|
23396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC140 |
0.94110050706889 |
|
23397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC14P |
0.941237737768629 |
|
23398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000237002.2 |
0.941269485964703 |
|
23399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAMPTL |
0.941269485964703 |
|
23400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC39A |
0.941328404841181 |
|
23401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPB1 |
0.941392856210658 |
|
23402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAD2L1 |
0.941430487639948 |
|
23403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXN2 |
0.941447935649529 |
|
23404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5688 |
0.941490898808428 |
|
23405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB17 |
0.941518827580176 |
|
23406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PGAP1 |
0.941524520603709 |
|
23407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB8 |
0.941568635902199 |
|
23408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4529 |
0.941587318666648 |
|
23409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM45B |
0.941605234996173 |
|
23410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4744 |
0.941627764769443 |
|
23411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STK17B |
0.941650085903272 |
|
23412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239161.1 |
0.941650085903272 |
|
23413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL820P |
0.941650085903272 |
|
23414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA33|ENSG00000201827.1 |
0.941660330299872 |
|
23415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP15 |
0.941708982035141 |
|
23416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC39A10 |
0.941785699025113 |
|
23417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFP1 |
0.941854929831148 |
|
23418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P20 |
0.941891272845645 |
|
23419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP268 |
0.941891272845645 |
|
23420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TEX264 |
0.941973237522639 |
|
23421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF512 |
0.94197719690936 |
|
23422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC121 |
0.94197719690936 |
|
23423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPN1 |
0.94197719690936 |
|
23424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA36|ENSG00000206731.1 |
0.94197719690936 |
|
23425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUPT7L |
0.94197719690936 |
|
23426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRPRB |
0.941979702379357 |
|
23427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB6B |
0.941979702379357 |
|
23428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RYBP |
0.941987358896729 |
|
23429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYSM1 |
0.942012944784652 |
|
23430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC176 |
0.942078542063954 |
|
23431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALDH6A1 |
0.942078542063954 |
|
23432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALPK3 |
0.942112459069396 |
|
23433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC28A1 |
0.942112459069396 |
|
23434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL530P |
0.942148334132916 |
|
23435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR5BP |
0.942267237922792 |
|
23436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPKBP1 |
0.942287815742788 |
|
23437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JMJD7 |
0.942287815742788 |
|
23438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM4SF19 |
0.942412249751067 |
|
23439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEBPG |
0.942542176992363 |
|
23440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOX6 |
0.942543938824499 |
|
23441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSPG4 |
0.942613673022923 |
|
23442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ODF3L1 |
0.942613673022923 |
|
23443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM1P35 |
0.942613673022923 |
|
23444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBR2 |
0.942757886400744 |
|
23445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XDH |
0.942879471940934 |
|
23446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
7SK|ENSG00000271814.1 |
0.943033912099752 |
|
23447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL290P |
0.943036679989302 |
|
23448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TXNDC12 |
0.943036679989302 |
|
23449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KTI12 |
0.943036679989302 |
|
23450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BTF3L4 |
0.943036679989302 |
|
23451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPDYE4 |
0.9432990914705 |
|
23452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT11 |
0.943309184669406 |
|
23453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THUMPD1 |
0.9433536244783 |
|
23454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY4P18 |
0.94341171731281 |
|
23455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB3B |
0.943455873036465 |
|
23456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP47 |
0.943499955873813 |
|
23457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKK3 |
0.943499955873813 |
|
23458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB43 |
0.943563089582064 |
|
23459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CUL3 |
0.943604861239191 |
|
23460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP239 |
0.94370491584404 |
|
23461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf62 |
0.943719259890637 |
|
23462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNPO2 |
0.94378584383539 |
|
23463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC93 |
0.943885575371827 |
|
23464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF1AX |
0.943940915697685 |
|
23465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS6KA3 |
0.943940915697685 |
|
23466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID5B |
0.943942787210839 |
|
23467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OIP5 |
0.943966050115608 |
|
23468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH4 |
0.944002932241875 |
|
23469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETS2 |
0.944043754738992 |
|
23470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALCB |
0.944077359199647 |
|
23471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALCA |
0.944077359199647 |
|
23472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDHA1 |
0.944127211367359 |
|
23473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf49 |
0.944149183154336 |
|
23474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THOC7 |
0.944149183154336 |
|
23475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC10P |
0.944245377113373 |
|
23476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC5P |
0.944245377113373 |
|
23477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1255B1 |
0.944257680640172 |
|
23478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PASD1 |
0.944260325621006 |
|
23479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUSD1 |
0.944269477635289 |
|
23480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFTUD1 |
0.944289525071889 |
|
23481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP1G1 |
0.944340584689043 |
|
23482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD71 |
0.944340584689043 |
|
23483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AAMP |
0.944365517231174 |
|
23484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPBAR1 |
0.944365517231174 |
|
23485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL111P |
0.944399910133992 |
|
23486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP7D2 |
0.94445576441231 |
|
23487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZZZ3 |
0.944494304194716 |
|
23488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AVIL |
0.944655793466339 |
|
23489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP27A1 |
0.944802589291114 |
|
23490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR173 |
0.944853926510111 |
|
23491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM19A2 |
0.944963645968646 |
|
23492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3167 |
0.944974963555262 |
|
23493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH7 |
0.945136547473095 |
|
23494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAF8 |
0.945145783847545 |
|
23495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MUSK |
0.945160217447361 |
|
23496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000200496.1 |
0.945201659645861 |
|
23497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4493 |
0.945201659645861 |
|
23498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP140 |
0.94523883086604 |
|
23499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TF |
0.94523883086604 |
|
23500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHRS7B |
0.945286781592592 |
|
23501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM11 |
0.945286781592592 |
|
23502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL426P |
0.945286781592592 |
|
23503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf103 |
0.945286781592592 |
|
23504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZIC3 |
0.945350385999835 |
|
23505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL325P |
0.945350385999835 |
|
23506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PODN |
0.945351934861145 |
|
23507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD302 |
0.945356050633144 |
|
23508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LY75 |
0.945356050633144 |
|
23509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LUC7L3 |
0.945560966600871 |
|
23510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD77|ENSG00000212279.2 |
0.945565694416204 |
|
23511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP33 |
0.945581411918137 |
|
23512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM122C |
0.945584612699403 |
|
23513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MOSPD1 |
0.945584612699403 |
|
23514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP212 |
0.945735861066954 |
|
23515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA62|ENSG00000272015.1 |
0.945735900213044 |
|
23516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AASS |
0.945844209872921 |
|
23517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00483 |
0.945912378391045 |
|
23518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
METTL14 |
0.946010184939 |
|
23519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSD2 |
0.946049254251868 |
|
23520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WHAMM |
0.946049254251868 |
|
23521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR38 |
0.946074904990934 |
|
23522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL35 |
0.946074904990934 |
|
23523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPC5L |
0.946074904990934 |
|
23524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDKN2C |
0.946110943502975 |
|
23525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DBC1 |
0.946120743087703 |
|
23526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM228B |
0.946194064004731 |
|
23527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFN4 |
0.946194064004731 |
|
23528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPSR1 |
0.946406153468605 |
|
23529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1296 |
0.946485494844545 |
|
23530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF277 |
0.946561491515961 |
|
23531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA58|ENSG00000249020.1 |
0.946563374923921 |
|
23532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBP |
0.946636418226838 |
|
23533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD2 |
0.946636418226838 |
|
23534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL258P |
0.946721558067676 |
|
23535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHEK1 |
0.946797544756682 |
|
23536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACRV1 |
0.946797544756682 |
|
23537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PATE1 |
0.946797544756682 |
|
23538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PATE2 |
0.946797544756682 |
|
23539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PATE3 |
0.946797544756682 |
|
23540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YPEL5 |
0.946887092727852 |
|
23541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D21 |
0.946964555738418 |
|
23542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCORL1 |
0.946980561978277 |
|
23543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6B |
0.94701752290828 |
|
23544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL485P |
0.94701752290828 |
|
23545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL853P |
0.94701752290828 |
|
23546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HIGD2B |
0.94701752290828 |
|
23547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPT1 |
0.947187859023762 |
|
23548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR113 |
0.947187859023762 |
|
23549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DRC1 |
0.947187859023762 |
|
23550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOF |
0.947187859023762 |
|
23551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM154B |
0.947233325562791 |
|
23552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WARS2 |
0.947349674180148 |
|
23553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGES2 |
0.947401553443479 |
|
23554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCN2 |
0.947401553443479 |
|
23555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMCO1 |
0.947438798109539 |
|
23556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR53 |
0.947438798109539 |
|
23557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO45 |
0.947438798109539 |
|
23558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN14 |
0.947614063849091 |
|
23559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP90 |
0.947614063849091 |
|
23560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EHD3 |
0.947614063849091 |
|
23561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4289 |
0.947829927163035 |
|
23562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNA1G |
0.947897684364226 |
|
23563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMNL2 |
0.947986270202586 |
|
23564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA19|ENSG00000251822.1 |
0.94803014198054 |
|
23565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMI1 |
0.948137300378105 |
|
23566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK7 |
0.948532107638968 |
|
23567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCS1 |
0.948535685916296 |
|
23568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRCA1 |
0.948548085297268 |
|
23569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA64|ENSG00000207187.1 |
0.948563477332143 |
|
23570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL16 |
0.948578124240322 |
|
23571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELF4 |
0.948593925978116 |
|
23572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIFM1 |
0.948593925978116 |
|
23573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TANK |
0.94871183451653 |
|
23574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2R1 |
0.948784974413831 |
|
23575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPHL1P |
0.948820885392707 |
|
23576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM4SF18 |
0.948820885392707 |
|
23577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSL |
0.94891462896754 |
|
23578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERPINE2 |
0.94893626265004 |
|
23579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL3 |
0.948941182147435 |
|
23580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MED9 |
0.948957168160072 |
|
23581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASD1 |
0.948957168160072 |
|
23582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEMT |
0.948957168160072 |
|
23583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTRF |
0.949077371095931 |
|
23584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP224 |
0.949088976947521 |
|
23585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB27B |
0.949106301055926 |
|
23586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACSBG1 |
0.949142930935432 |
|
23587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJA4 |
0.949142930935432 |
|
23588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTDSP2 |
0.94920671945411 |
|
23589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZYG11B |
0.949258078600309 |
|
23590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INSIG2 |
0.949278817876039 |
|
23591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERGEF |
0.949281463124917 |
|
23592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIZ1 |
0.94939633171657 |
|
23593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPY19L3 |
0.949409265541074 |
|
23594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUFY4 |
0.949420103598948 |
|
23595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB15 |
0.949451591734779 |
|
23596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPUSD4 |
0.949501418227034 |
|
23597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM118B |
0.949501418227034 |
|
23598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C13orf45 |
0.949599448433936 |
|
23599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00561 |
0.949599448433936 |
|
23600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AARSD1 |
0.949741534699899 |
|
23601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL423P |
0.949768000613768 |
|
23602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35G2 |
0.949869718465364 |
|
23603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCK1 |
0.949869718465364 |
|
23604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNM1 |
0.949887027479656 |
|
23605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA2 |
0.949887027479656 |
|
23606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NID2 |
0.949894153474994 |
|
23607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB33A |
0.949933523149791 |
|
23608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP399 |
0.950000118079032 |
|
23609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1H |
0.950045673289434 |
|
23610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM124B |
0.950246834900754 |
|
23611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPA |
0.950249821678962 |
|
23612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC35F6 |
0.950249821678962 |
|
23613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPC2 |
0.950263446567093 |
|
23614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCK |
0.950268663780765 |
|
23615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARPC2 |
0.950279197871104 |
|
23616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DTNB |
0.950325572643431 |
|
23617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238885.1 |
0.950350312463417 |
|
23618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN12 |
0.950455512777705 |
|
23619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD17C |
0.950558208213917 |
|
23620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238939.1 |
0.950613879597317 |
|
23621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB2 |
0.950613879597317 |
|
23622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT16P |
0.950632951911764 |
|
23623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT16 |
0.950632951911764 |
|
23624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TYRO3 |
0.950655339858152 |
|
23625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD3B2 |
0.950704358031739 |
|
23626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR549 |
0.950764799852047 |
|
23627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP53 |
0.950814258767445 |
|
23628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252372.1 |
0.950896993252707 |
|
23629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMR1NB |
0.95090885062578 |
|
23630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMBIM1 |
0.950956550623293 |
|
23631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238736.1 |
0.950956550623293 |
|
23632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NBR1 |
0.950998697440468 |
|
23633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SELRC1 |
0.951084110703923 |
|
23634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL302P |
0.951165422114461 |
|
23635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR181A2HG |
0.951165422114461 |
|
23636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR181A2 |
0.951165422114461 |
|
23637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR181B2 |
0.951165422114461 |
|
23638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS9 |
0.951173468589273 |
|
23639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASTE1 |
0.951224156425531 |
|
23640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL62P |
0.951246876528956 |
|
23641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP120 |
0.951281668917224 |
|
23642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA33|ENSG00000202283.1 |
0.951342476679621 |
|
23643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF800 |
0.951426156483566 |
|
23644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA75|ENSG00000212593.1 |
0.951465614346297 |
|
23645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FMR1 |
0.951543363976971 |
|
23646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf120 |
0.951545596034698 |
|
23647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF10 |
0.951545596034698 |
|
23648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTE3 |
0.951545596034698 |
|
23649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDHAL6CP |
0.951564310803524 |
|
23650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL475P |
0.951689214216546 |
|
23651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf87 |
0.951689214216546 |
|
23652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COQ4 |
0.951846336710037 |
|
23653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC27A4 |
0.951846336710037 |
|
23654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
URM1 |
0.951846336710037 |
|
23655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CERCAM |
0.951846336710037 |
|
23656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAPPA |
0.951857507062672 |
|
23657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO1B |
0.952040019575536 |
|
23658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6X1 |
0.952051990236384 |
|
23659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6M1 |
0.952051990236384 |
|
23660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PROK2 |
0.95209226690749 |
|
23661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL271P |
0.95209226690749 |
|
23662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPT2 |
0.952148675575903 |
|
23663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf123 |
0.952148675575903 |
|
23664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGOH |
0.952148675575903 |
|
23665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX59 |
0.952224984374696 |
|
23666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF385D |
0.952229823656065 |
|
23667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1827 |
0.952256529096506 |
|
23668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G4E |
0.952256613027095 |
|
23669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGRF1 |
0.952269469243376 |
|
23670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFIT2 |
0.952368571707182 |
|
23671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFIT3 |
0.952368571707182 |
|
23672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMB7 |
0.952395006652339 |
|
23673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGOL1 |
0.952416217349716 |
|
23674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA10 |
0.952485583695073 |
|
23675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HTR7 |
0.952600807885086 |
|
23676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBC1D2B |
0.952611602315429 |
|
23677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBKBP1 |
0.952670806361564 |
|
23678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3CA |
0.952709571847048 |
|
23679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000201957.1 |
0.952709571847048 |
|
23680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNMB3 |
0.952709571847048 |
|
23681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF639 |
0.952709571847048 |
|
23682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFN1 |
0.952709571847048 |
|
23683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNB4 |
0.952709571847048 |
|
23684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP31 |
0.952717397582261 |
|
23685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRAP |
0.952717769443508 |
|
23686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC144CP |
0.952738164485959 |
|
23687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL17P |
0.952738164485959 |
|
23688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U6|ENSG00000266839.2 |
0.952738164485959 |
|
23689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UPF3AP2 |
0.952738164485959 |
|
23690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP32P3 |
0.952738164485959 |
|
23691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4313 |
0.952776281739432 |
|
23692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL319P |
0.952776281739432 |
|
23693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAGE3 |
0.952804807972241 |
|
23694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FJX1 |
0.952823065242415 |
|
23695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf16 |
0.952827853921873 |
|
23696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR27 |
0.952849209450463 |
|
23697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KPNB1 |
0.952849492788646 |
|
23698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR5L |
0.953017209884407 |
|
23699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP456 |
0.95302670774559 |
|
23700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKSG52 |
0.95303144641301 |
|
23701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00945 |
0.953058645865 |
|
23702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLIG1 |
0.953058645865 |
|
23703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF483 |
0.953064610657473 |
|
23704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGR1 |
0.953064610657473 |
|
23705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1276 |
0.953067385129314 |
|
23706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548AP |
0.953067385129314 |
|
23707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MANF |
0.953258129250385 |
|
23708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM15B |
0.953258129250385 |
|
23709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRP8 |
0.953275678942343 |
|
23710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANXA5 |
0.953925247380809 |
|
23711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM155 |
0.953925247380809 |
|
23712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB6 |
0.954030470237103 |
|
23713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA67|ENSG00000212395.1 |
0.954053914617767 |
|
23714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPRIPL2 |
0.954100760092755 |
|
23715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX18 |
0.954110731442429 |
|
23716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1273C |
0.954146120968255 |
|
23717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0368 |
0.954186937678967 |
|
23718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGM5 |
0.954363885429362 |
|
23719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM60 |
0.95452509399609 |
|
23720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC11A |
0.954614097697512 |
|
23721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF592 |
0.954614097697512 |
|
23722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO1A |
0.954672695150421 |
|
23723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOXO1 |
0.954719871004649 |
|
23724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GFER |
0.954719871004649 |
|
23725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNGR3 |
0.954719871004649 |
|
23726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPW |
0.954719871004649 |
|
23727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF598 |
0.954719871004649 |
|
23728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL219P |
0.954719871004649 |
|
23729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EXOSC9 |
0.954743309635978 |
|
23730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNA2 |
0.954743309635978 |
|
23731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BBS7 |
0.954743309635978 |
|
23732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC3 |
0.954743309635978 |
|
23733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF365 |
0.95499355475115 |
|
23734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPKAPK3 |
0.955003362422289 |
|
23735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4787 |
0.955003362422289 |
|
23736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238902.1 |
0.955079435698368 |
|
23737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DLX3 |
0.955178107150154 |
|
23738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP70 |
0.955257445543113 |
|
23739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCR2P1 |
0.955362836777936 |
|
23740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCR2 |
0.955362836777936 |
|
23741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLS |
0.955379033986065 |
|
23742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAT4 |
0.955379033986065 |
|
23743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAMP2 |
0.955421041056744 |
|
23744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPP25 |
0.955421041056744 |
|
23745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAMP5 |
0.955421041056744 |
|
23746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITIH6 |
0.955430857405867 |
|
23747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NGLY1 |
0.955562220302249 |
|
23748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AKAP13 |
0.955567449745417 |
|
23749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM225 |
0.955594861852151 |
|
23750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8D4 |
0.955594861852151 |
|
23751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR26B |
0.95561979330546 |
|
23752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239098.1 |
0.955645873451349 |
|
23753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPY |
0.955645873451349 |
|
23754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR100 |
0.95566046185987 |
|
23755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP48 |
0.955689088499012 |
|
23756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLSTN2 |
0.955712175959317 |
|
23757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VIL1 |
0.955731449431605 |
|
23758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP37 |
0.955731449431605 |
|
23759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL430P |
0.955743334513536 |
|
23760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP234 |
0.955772452048769 |
|
23761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDE3B |
0.955809598006852 |
|
23762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR199B |
0.955819557728141 |
|
23763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3154 |
0.955819557728141 |
|
23764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXCR1 |
0.955822762332453 |
|
23765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238453.1 |
0.955839641693089 |
|
23766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP33 |
0.955906322342755 |
|
23767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS17 |
0.956048813410035 |
|
23768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1L1 |
0.956058030875975 |
|
23769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1L3 |
0.956058030875975 |
|
23770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00925 |
0.956064168096145 |
|
23771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238428.1 |
0.956173593320786 |
|
23772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK5R2 |
0.956270810917349 |
|
23773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00608 |
0.956270810917349 |
|
23774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CRYBA2 |
0.956270810917349 |
|
23775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEV |
0.956270810917349 |
|
23776 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf69 |
0.956338728985148 |
|
23777 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOD1 |
0.956446148953984 |
|
23778 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAF4 |
0.956446148953984 |
|
23779 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA81|ENSG00000238390.1 |
0.956446148953984 |
|
23780 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SETX |
0.956532432893519 |
|
23781 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAP3K15 |
0.956591142759293 |
|
23782 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCDC160 |
0.956698598298905 |
|
23783 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INPP4B |
0.956796577652637 |
|
23784 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL542P |
0.956875825521061 |
|
23785 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10G4 |
0.95691310654329 |
|
23786 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10G9 |
0.95691310654329 |
|
23787 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM194A |
0.957008137675492 |
|
23788 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTDSP1 |
0.957028511553098 |
|
23789 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF6 |
0.957040210287461 |
|
23790 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPRT1 |
0.957040210287461 |
|
23791 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR450A1 |
0.957040210287461 |
|
23792 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR450A2 |
0.957040210287461 |
|
23793 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR450B |
0.957040210287461 |
|
23794 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR503HG |
0.957040210287461 |
|
23795 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR542 |
0.957040210287461 |
|
23796 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR503 |
0.957040210287461 |
|
23797 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00629 |
0.957040210287461 |
|
23798 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CACNG3 |
0.957079082840176 |
|
23799 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA1|ENSG00000201541.1 |
0.957079082840176 |
|
23800 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LIN52 |
0.957115119888082 |
|
23801 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF4E3 |
0.957122155402795 |
|
23802 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAA2 |
0.957156340188076 |
|
23803 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP333 |
0.957156340188076 |
|
23804 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR504 |
0.957208686207221 |
|
23805 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8A |
0.957219053458315 |
|
23806 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C8B |
0.957219053458315 |
|
23807 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A1 |
0.957273679047742 |
|
23808 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP42 |
0.957318600897445 |
|
23809 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR4D5 |
0.957321289874476 |
|
23810 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6T1 |
0.957321289874476 |
|
23811 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10S1 |
0.957321289874476 |
|
23812 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDS |
0.957378312795816 |
|
23813 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00893 |
0.957378312795816 |
|
23814 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf40A |
0.957378312795816 |
|
23815 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf40B |
0.957378312795816 |
|
23816 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSFX1 |
0.957378312795816 |
|
23817 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSFX2 |
0.957378312795816 |
|
23818 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA11 |
0.957378312795816 |
|
23819 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA8 |
0.957378312795816 |
|
23820 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA9B |
0.957378312795816 |
|
23821 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEA9 |
0.957378312795816 |
|
23822 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM185A |
0.957378312795816 |
|
23823 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf70 |
0.957406970503764 |
|
23824 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00242 |
0.957406970503764 |
|
23825 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00574 |
0.957406970503764 |
|
23826 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ESYT3 |
0.957414362174076 |
|
23827 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZIC1 |
0.957547409370875 |
|
23828 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM117A |
0.957713868040148 |
|
23829 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSL3 |
0.957783337038009 |
|
23830 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM46C |
0.957793766457066 |
|
23831 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM104B |
0.957967984396438 |
|
23832 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L10 |
0.957967984396438 |
|
23833 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAGE5 |
0.957967984396438 |
|
23834 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNAP |
0.958000389578184 |
|
23835 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSCR10 |
0.958073874843456 |
|
23836 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST7 |
0.958154621604559 |
|
23837 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3139 |
0.958161963873104 |
|
23838 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP105 |
0.95821345972256 |
|
23839 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP23P1 |
0.958288641254603 |
|
23840 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC2P4 |
0.958288641254603 |
|
23841 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC2P5 |
0.958288641254603 |
|
23842 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HERC2P8 |
0.958288641254603 |
|
23843 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00273 |
0.958288641254603 |
|
23844 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP406 |
0.958288641254603 |
|
23845 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP407 |
0.958288641254603 |
|
23846 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP408 |
0.958288641254603 |
|
23847 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP409 |
0.958288641254603 |
|
23848 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP410 |
0.958288641254603 |
|
23849 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP413 |
0.958288641254603 |
|
23850 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP415 |
0.958288641254603 |
|
23851 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP416 |
0.958288641254603 |
|
23852 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP417 |
0.958288641254603 |
|
23853 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP418 |
0.958288641254603 |
|
23854 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP419 |
0.958288641254603 |
|
23855 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP420 |
0.958288641254603 |
|
23856 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP421 |
0.958288641254603 |
|
23857 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP422 |
0.958288641254603 |
|
23858 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP423 |
0.958288641254603 |
|
23859 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC6A10P |
0.958288641254603 |
|
23860 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53TG3B |
0.958288641254603 |
|
23861 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53TG3C |
0.958288641254603 |
|
23862 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53TG3D |
0.958288641254603 |
|
23863 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53TG3 |
0.958288641254603 |
|
23864 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF267 |
0.958288641254603 |
|
23865 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAQR9 |
0.958292350452052 |
|
23866 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U2SURP |
0.958292350452052 |
|
23867 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A39 |
0.958360660734528 |
|
23868 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRN |
0.958360660734528 |
|
23869 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM171A2 |
0.958360660734528 |
|
23870 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGA2B |
0.958360660734528 |
|
23871 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAND2P |
0.958399047783202 |
|
23872 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR73 |
0.958399047783202 |
|
23873 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMB |
0.958399047783202 |
|
23874 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZFYVE9 |
0.958470478771019 |
|
23875 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZDHHC14 |
0.958547687589193 |
|
23876 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BNC1 |
0.958817635773211 |
|
23877 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC18P |
0.958818807157256 |
|
23878 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPATCH2L |
0.958819414552343 |
|
23879 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238581.1 |
0.958906482361412 |
|
23880 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNU4ATAC |
0.958990518570592 |
|
23881 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOF |
0.959000685535499 |
|
23882 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSCR8 |
0.959047899544486 |
|
23883 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM4SF1 |
0.959115195017185 |
|
23884 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL807P |
0.959492747662223 |
|
23885 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD6 |
0.959510214237701 |
|
23886 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C18orf54 |
0.959510214237701 |
|
23887 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPN2 |
0.959523676195387 |
|
23888 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPRZ1 |
0.9595523495992 |
|
23889 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MBD2 |
0.959737388547229 |
|
23890 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA37 |
0.959737388547229 |
|
23891 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POLI |
0.959737388547229 |
|
23892 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IL10RB |
0.959836717286869 |
|
23893 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAMBPL1 |
0.959841396657763 |
|
23894 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00887 |
0.959915620912981 |
|
23895 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC15 |
0.959915620912981 |
|
23896 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL788P |
0.959934065335645 |
|
23897 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPA4 |
0.959958807541727 |
|
23898 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CADPS2 |
0.960631433131749 |
|
23899 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNBP1 |
0.960970419653545 |
|
23900 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CC2D1B |
0.961024202705644 |
|
23901 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ORC1 |
0.961024202705644 |
|
23902 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPF38A |
0.961024202705644 |
|
23903 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239063.1 |
0.961024202705644 |
|
23904 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BCOR |
0.961414231866751 |
|
23905 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDHAL6A |
0.961447479989721 |
|
23906 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSG101 |
0.961447479989721 |
|
23907 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NKIRAS2 |
0.961450722380936 |
|
23908 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL214P |
0.961490541600176 |
|
23909 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252961.1 |
0.961495070233555 |
|
23910 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFIL3 |
0.961524763447918 |
|
23911 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GUSBP5 |
0.961552630212033 |
|
23912 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL571P |
0.961581845018389 |
|
23913 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SALL3 |
0.961672529929521 |
|
23914 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AUH |
0.961717606519928 |
|
23915 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FSTL5 |
0.961731983173016 |
|
23916 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLASP1 |
0.961904570133317 |
|
23917 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GSAP |
0.961939088773457 |
|
23918 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAT5B |
0.961961748978459 |
|
23919 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAT5A |
0.961961748978459 |
|
23920 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3159 |
0.961999016897698 |
|
23921 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDHA |
0.961999016897698 |
|
23922 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LDHC |
0.961999016897698 |
|
23923 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC1A7 |
0.962175380571138 |
|
23924 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP171 |
0.962212728245087 |
|
23925 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC51A |
0.962261075309832 |
|
23926 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCYT1A |
0.962261075309832 |
|
23927 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC37A5P |
0.962305221860409 |
|
23928 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC25 |
0.962305221860409 |
|
23929 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNG10 |
0.962305221860409 |
|
23930 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP149 |
0.962467040842772 |
|
23931 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFAP3L |
0.962502674042439 |
|
23932 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXD3 |
0.962542044891596 |
|
23933 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCTEX1D2 |
0.962571144586386 |
|
23934 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STT3A |
0.962644936259481 |
|
23935 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF8 |
0.962660545388959 |
|
23936 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG9 |
0.962714319819157 |
|
23937 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHL25 |
0.962760201724876 |
|
23938 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STAT3 |
0.962794826221932 |
|
23939 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGED2 |
0.962849848661811 |
|
23940 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11|ENSG00000221716.1 |
0.962849848661811 |
|
23941 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA11|ENSG00000221750.1 |
0.962849848661811 |
|
23942 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PFKFB1 |
0.962849848661811 |
|
23943 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MORF4L1 |
0.962898693624571 |
|
23944 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD44 |
0.962905989288372 |
|
23945 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ELOVL7 |
0.962923408875206 |
|
23946 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRD5A2 |
0.962961507077424 |
|
23947 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETFDH |
0.962979288540673 |
|
23948 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000271817.1 |
0.962979288540673 |
|
23949 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPID |
0.962979288540673 |
|
23950 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
POU4F1 |
0.963133286241717 |
|
23951 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF219 |
0.963133286241717 |
|
23952 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNK2 |
0.963137239807974 |
|
23953 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGGY |
0.963211659485545 |
|
23954 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASZ1 |
0.963212032572544 |
|
23955 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBL7 |
0.963244015586 |
|
23956 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK1 |
0.963466604870083 |
|
23957 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFA5 |
0.963500964144986 |
|
23958 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP90 |
0.963523729438245 |
|
23959 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U1|ENSG00000271739.1 |
0.963565120973713 |
|
23960 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMRPP3 |
0.963575818265146 |
|
23961 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CLCN3 |
0.963578642375628 |
|
23962 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf27 |
0.963578642375628 |
|
23963 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD77|ENSG00000212347.2 |
0.963926862199818 |
|
23964 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4785 |
0.964060436715614 |
|
23965 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGEC2 |
0.964069824725541 |
|
23966 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C17orf51 |
0.964220892171915 |
|
23967 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM27L |
0.964220892171915 |
|
23968 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTND1P15 |
0.964220892171915 |
|
23969 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRNR2L1 |
0.964220892171915 |
|
23970 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBBP4 |
0.964220892171915 |
|
23971 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf54 |
0.964232635256009 |
|
23972 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQUB |
0.964290684122908 |
|
23973 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UEVLD |
0.964421443756955 |
|
23974 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2H1 |
0.964597573959712 |
|
23975 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10G8 |
0.964623138961557 |
|
23976 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10G7 |
0.964623138961557 |
|
23977 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCDH10 |
0.96466428864084 |
|
23978 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACVR1C |
0.964693213320345 |
|
23979 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL253P |
0.96484289877604 |
|
23980 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP514 |
0.964953761846242 |
|
23981 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MST4 |
0.964953761846242 |
|
23982 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMD7 |
0.964953761846242 |
|
23983 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT2 |
0.964971662305504 |
|
23984 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00484 |
0.964984496854214 |
|
23985 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RRAS2 |
0.965020049711665 |
|
23986 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBM26 |
0.965149922394886 |
|
23987 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDFIP2 |
0.965149922394886 |
|
23988 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATG4C |
0.96531829350631 |
|
23989 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf58 |
0.965358090831835 |
|
23990 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP144 |
0.965358090831835 |
|
23991 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL35P |
0.965389741876291 |
|
23992 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLITRK4 |
0.965444677718761 |
|
23993 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDCD5 |
0.965673194284232 |
|
23994 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA68|ENSG00000201388.1 |
0.965673194284232 |
|
23995 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C11orf74 |
0.965857850601156 |
|
23996 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C76 |
0.965870697026007 |
|
23997 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC1A2 |
0.965874033396639 |
|
23998 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4797 |
0.965900238175917 |
|
23999 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238491.1 |
0.965900238175917 |
|
24000 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BDH1 |
0.965900238175917 |
|
24001 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HS6ST2 |
0.965940536134311 |
|
24002 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SGCA |
0.96601701738609 |
|
24003 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HILS1 |
0.96601701738609 |
|
24004 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTIF |
0.966034373497844 |
|
24005 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SHC3 |
0.966069785712092 |
|
24006 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A25 |
0.966113839364075 |
|
24007 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPRM1 |
0.966156458177459 |
|
24008 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CFTR |
0.966230382816037 |
|
24009 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KNOP1 |
0.966232459193769 |
|
24010 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD74|ENSG00000200206.1 |
0.966260617676723 |
|
24011 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ15 |
0.966281808833217 |
|
24012 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP1 |
0.966330230141665 |
|
24013 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP5A1 |
0.966331738851517 |
|
24014 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAUS1 |
0.966331738851517 |
|
24015 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NINJ1 |
0.966463594395212 |
|
24016 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPP6 |
0.966479520334696 |
|
24017 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OXSM |
0.96661779137678 |
|
24018 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C16orf62 |
0.966649639272458 |
|
24019 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCNG2 |
0.966677564068507 |
|
24020 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8D1 |
0.966679911419713 |
|
24021 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DPY30 |
0.966688698297864 |
|
24022 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR8D2 |
0.966802521360077 |
|
24023 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADO |
0.967043452562921 |
|
24024 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4330 |
0.967368790967136 |
|
24025 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR50 |
0.967368790967136 |
|
24026 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDE1 |
0.967415396964885 |
|
24027 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CCP110 |
0.967415396964885 |
|
24028 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM29 |
0.967449313204827 |
|
24029 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEGF9 |
0.967594469772633 |
|
24030 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPVF |
0.967664481775687 |
|
24031 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPS5 |
0.967704244257589 |
|
24032 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT6 |
0.967802741599868 |
|
24033 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WNT10A |
0.967802741599868 |
|
24034 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBKS |
0.967848952668117 |
|
24035 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CTSH |
0.967860861318514 |
|
24036 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERO1L |
0.967896016790732 |
|
24037 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00894 |
0.967923508203046 |
|
24038 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL5 |
0.967978615669258 |
|
24039 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JMJD1C |
0.967983590388138 |
|
24040 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EGR2 |
0.967997800989513 |
|
24041 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SND1 |
0.96809580584644 |
|
24042 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP222 |
0.968105183312314 |
|
24043 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGD3 |
0.968108610936821 |
|
24044 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXN2 |
0.968118287062426 |
|
24045 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASA2 |
0.968152394389899 |
|
24046 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VMA21 |
0.968289618867461 |
|
24047 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB7C |
0.968440187904003 |
|
24048 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYP2J2 |
0.968445171244566 |
|
24049 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HOOK1 |
0.968468174988262 |
|
24050 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKAG3 |
0.968485321136756 |
|
24051 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHLPP2 |
0.968763855700079 |
|
24052 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70D |
0.968763855700079 |
|
24053 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPATCH8 |
0.968860762591755 |
|
24054 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238608.1 |
0.96889288959923 |
|
24055 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252256.1 |
0.96889288959923 |
|
24056 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIB2 |
0.968916989536153 |
|
24057 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IDH3A |
0.968916989536153 |
|
24058 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR144 |
0.968919867121472 |
|
24059 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL13AP17 |
0.968987884669648 |
|
24060 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C18orf25 |
0.969083522287132 |
|
24061 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEFF2 |
0.96912371331929 |
|
24062 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAND2 |
0.969159401118574 |
|
24063 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZBTB34 |
0.969184022543097 |
|
24064 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMD4B |
0.969219597499675 |
|
24065 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP102 |
0.969240656632587 |
|
24066 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAF1 |
0.969390826492991 |
|
24067 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAG1 |
0.969467009405546 |
|
24068 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAG2 |
0.969467009405546 |
|
24069 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAMR1 |
0.969475048964438 |
|
24070 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC28A3 |
0.969486488293436 |
|
24071 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRAF6 |
0.969588966053801 |
|
24072 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VWA5A |
0.969661144306238 |
|
24073 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR10D3 |
0.969661144306238 |
|
24074 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RLBP1 |
0.969693664362353 |
|
24075 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF7 |
0.970019708602711 |
|
24076 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLIN1 |
0.970019708602711 |
|
24077 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PODXL |
0.970026682185534 |
|
24078 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NAB1 |
0.970123561969712 |
|
24079 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYCS |
0.970227473551 |
|
24080 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf31 |
0.970227473551 |
|
24081 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTN1 |
0.970563003705916 |
|
24082 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNMB2 |
0.970752758443456 |
|
24083 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP148 |
0.970752758443456 |
|
24084 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT13 |
0.970942014790068 |
|
24085 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CARD9 |
0.970978048572834 |
|
24086 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DKFZP434A062 |
0.970978048572834 |
|
24087 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNLZ |
0.970978048572834 |
|
24088 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPSM1 |
0.970978048572834 |
|
24089 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHX3 |
0.970978048572834 |
|
24090 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QSOX2 |
0.970978048572834 |
|
24091 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MSH4 |
0.971016324051708 |
|
24092 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DFNA5 |
0.971022224149409 |
|
24093 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL4D |
0.971026174175665 |
|
24094 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00854 |
0.971026174175665 |
|
24095 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00910 |
0.971026174175665 |
|
24096 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM106A |
0.971026174175665 |
|
24097 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAH7 |
0.971136094958381 |
|
24098 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCAL1 |
0.971247433772897 |
|
24099 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DIRAS2 |
0.971362293340622 |
|
24100 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TICRR |
0.971402961627595 |
|
24101 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DOCK3 |
0.97141639797257 |
|
24102 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238999.1 |
0.971522226502696 |
|
24103 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRO |
0.971562568912073 |
|
24104 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ETFA |
0.971569258612553 |
|
24105 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISL2 |
0.971569258612553 |
|
24106 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3916 |
0.971571615488865 |
|
24107 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP82 |
0.971571615488865 |
|
24108 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAM30 |
0.971637507940967 |
|
24109 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XXYLT1 |
0.97173707624232 |
|
24110 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3137 |
0.97173707624232 |
|
24111 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL36P |
0.97173707624232 |
|
24112 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM32 |
0.971890605937264 |
|
24113 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF202 |
0.971915557633724 |
|
24114 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHX58 |
0.971944985277337 |
|
24115 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KAT2A |
0.971944985277337 |
|
24116 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPB9 |
0.971944985277337 |
|
24117 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF385C |
0.972040397827475 |
|
24118 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINGO1 |
0.972047665846163 |
|
24119 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QRFP |
0.972099464560659 |
|
24120 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED10 |
0.972225919750104 |
|
24121 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP245 |
0.972295583848284 |
|
24122 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FATE1 |
0.972302549650623 |
|
24123 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNGA2 |
0.972302549650623 |
|
24124 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASCC3 |
0.972307991632619 |
|
24125 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FGF12 |
0.972484540874353 |
|
24126 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAB5C |
0.972495411031387 |
|
24127 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNH4 |
0.972495411031387 |
|
24128 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HCRT |
0.972495411031387 |
|
24129 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GHDC |
0.972495411031387 |
|
24130 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPC4 |
0.972553719341315 |
|
24131 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC63 |
0.972645015890633 |
|
24132 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOBP |
0.972651934182792 |
|
24133 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCML4 |
0.972651934182792 |
|
24134 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NACC2 |
0.972796255719276 |
|
24135 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACVR1 |
0.972933030269441 |
|
24136 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSNK1A1P1 |
0.97293958916624 |
|
24137 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPS3 |
0.973057641433837 |
|
24138 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CP |
0.973057641433837 |
|
24139 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CYTIP |
0.973086035211681 |
|
24140 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGPRX3 |
0.973274719695294 |
|
24141 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRGPRX4 |
0.973274719695294 |
|
24142 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAA4 |
0.973274719695294 |
|
24143 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP334 |
0.973274719695294 |
|
24144 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAA1 |
0.973274719695294 |
|
24145 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTY2D1 |
0.973367416275708 |
|
24146 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEC24D |
0.97348617853215 |
|
24147 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RP9 |
0.973547361539105 |
|
24148 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252706.1 |
0.973547361539105 |
|
24149 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP229 |
0.973547361539105 |
|
24150 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR2114 |
0.973628720651064 |
|
24151 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM86A |
0.973748539025826 |
|
24152 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF22 |
0.973748539025826 |
|
24153 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL775P |
0.973819382213445 |
|
24154 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF670 |
0.973912960172748 |
|
24155 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF695 |
0.973912960172748 |
|
24156 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPI |
0.973970367071689 |
|
24157 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM219B |
0.973970367071689 |
|
24158 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COX5A |
0.973970367071689 |
|
24159 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GYG1 |
0.973993592523235 |
|
24160 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HLTF |
0.973993592523235 |
|
24161 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL351P |
0.974061912994632 |
|
24162 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SRPR |
0.974061912994632 |
|
24163 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXRED1 |
0.974061912994632 |
|
24164 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TIRAP |
0.974061912994632 |
|
24165 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238855.1 |
0.974061912994632 |
|
24166 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC46 |
0.974117936995927 |
|
24167 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCRN2 |
0.974117936995927 |
|
24168 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SP6 |
0.974117936995927 |
|
24169 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPA5 |
0.974171316130851 |
|
24170 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPA1 |
0.974171316130851 |
|
24171 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SWI5 |
0.974446998892629 |
|
24172 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SENP8 |
0.974530297865655 |
|
24173 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CHP2 |
0.974555384756609 |
|
24174 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTLL4 |
0.974600936227414 |
|
24175 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK11 |
0.974764391221826 |
|
24176 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000212511.1 |
0.97481572146891 |
|
24177 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NABP1 |
0.974912931478266 |
|
24178 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATXN7 |
0.974995117840884 |
|
24179 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BATF |
0.975040819014935 |
|
24180 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FLVCR2 |
0.975040819014935 |
|
24181 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SH2D7 |
0.975088932580559 |
|
24182 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPCML |
0.975099485681418 |
|
24183 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AADAT |
0.975106717799457 |
|
24184 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAS2R16 |
0.975172223273225 |
|
24185 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRAMD1B |
0.975303593382744 |
|
24186 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCN3B |
0.975303593382744 |
|
24187 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUAK2 |
0.975533903517536 |
|
24188 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DSCR4 |
0.975603356522882 |
|
24189 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNP1 |
0.975623947225678 |
|
24190 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRUB2 |
0.975700090919493 |
|
24191 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00501 |
0.975754390856255 |
|
24192 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP52 |
0.975754390856255 |
|
24193 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NFE2L3 |
0.975872742021165 |
|
24194 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCARNA15|ENSG00000252690.2 |
0.975896853908505 |
|
24195 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRG3 |
0.975955747024673 |
|
24196 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPEPPS |
0.975995694803909 |
|
24197 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEMO1 |
0.976026223251753 |
|
24198 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF124 |
0.976070372777383 |
|
24199 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMX1B |
0.976112291435104 |
|
24200 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPAP2B |
0.976137344318598 |
|
24201 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SIN3A |
0.976249139363301 |
|
24202 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC8A |
0.976303188075399 |
|
24203 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FIBCD1 |
0.976306213221777 |
|
24204 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCP1 |
0.976392979968702 |
|
24205 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA29 |
0.976392979968702 |
|
24206 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN2C1 |
0.976405940589639 |
|
24207 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEIS2 |
0.976453621856509 |
|
24208 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNE1 |
0.976465430385448 |
|
24209 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
STARD9 |
0.976482415637943 |
|
24210 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
QRFPR |
0.976560338101371 |
|
24211 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP225 |
0.976596823756559 |
|
24212 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO5 |
0.97660961824315 |
|
24213 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTRF1L |
0.97660961824315 |
|
24214 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPRY2 |
0.97665718981566 |
|
24215 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAPKAP1 |
0.976800314142853 |
|
24216 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRDM5 |
0.97684439928655 |
|
24217 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DMD |
0.976851945557408 |
|
24218 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAN1A2 |
0.976961343451482 |
|
24219 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TPH1 |
0.97704535690707 |
|
24220 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAAL1 |
0.97704535690707 |
|
24221 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAA3P |
0.97704535690707 |
|
24222 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239025.1 |
0.977104351065861 |
|
24223 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDAN1 |
0.977104351065861 |
|
24224 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC9A9 |
0.977142334382307 |
|
24225 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00184 |
0.977151995809555 |
|
24226 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA70|ENSG00000252014.1 |
0.977222437475471 |
|
24227 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDK5RAP2 |
0.977361785734529 |
|
24228 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFBP2 |
0.977580923535723 |
|
24229 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000239044.1 |
0.97760144674867 |
|
24230 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RASGRP3 |
0.977706593452849 |
|
24231 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTBP2 |
0.977828156752791 |
|
24232 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCPS |
0.977865117402769 |
|
24233 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf41 |
0.977906553701102 |
|
24234 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAP2C |
0.9779367370782 |
|
24235 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANP32BP1 |
0.977962094033628 |
|
24236 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COMMD4 |
0.977962094033628 |
|
24237 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ6 |
0.97798565918999 |
|
24238 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AFF2 |
0.978118913990084 |
|
24239 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1B1 |
0.978180096595965 |
|
24240 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00052 |
0.978290119371257 |
|
24241 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRIK2 |
0.978407079462911 |
|
24242 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEIL1 |
0.978413152722285 |
|
24243 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR631 |
0.978413152722285 |
|
24244 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP281 |
0.978434544966261 |
|
24245 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERMN |
0.978434544966261 |
|
24246 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP91 |
0.978438324530035 |
|
24247 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP92 |
0.978438324530035 |
|
24248 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAT3 |
0.978454943147197 |
|
24249 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP400 |
0.978486025359418 |
|
24250 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GCKR |
0.978573097640356 |
|
24251 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM98A |
0.978679584448919 |
|
24252 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUCB2 |
0.978720106418385 |
|
24253 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4711 |
0.978850028907335 |
|
24254 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM242 |
0.978854005777101 |
|
24255 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRPS2 |
0.978934740147419 |
|
24256 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA40|ENSG00000212266.1 |
0.979106920232374 |
|
24257 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA84 |
0.979130701571927 |
|
24258 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NOL8 |
0.979130701571927 |
|
24259 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASPN |
0.979130701571927 |
|
24260 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CENPP |
0.979130701571927 |
|
24261 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECM2 |
0.979130701571927 |
|
24262 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4670 |
0.979130701571927 |
|
24263 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OGN |
0.979130701571927 |
|
24264 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OMD |
0.979130701571927 |
|
24265 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGFBP5 |
0.979147492131729 |
|
24266 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL447P |
0.979266999955272 |
|
24267 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4291 |
0.97942297597393 |
|
24268 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IARS |
0.979542032345768 |
|
24269 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NLRC4 |
0.979674756081719 |
|
24270 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNC1 |
0.979691223583824 |
|
24271 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP31 |
0.979751267609039 |
|
24272 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARL6IP6 |
0.979773374884056 |
|
24273 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBFD1 |
0.979833015235022 |
|
24274 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMG20A |
0.979905608452147 |
|
24275 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC13A1 |
0.979910653341558 |
|
24276 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf33 |
0.979991428361088 |
|
24277 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TBX15 |
0.980161921384352 |
|
24278 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP246 |
0.980256291155823 |
|
24279 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP189 |
0.980426463236443 |
|
24280 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD27 |
0.980528464211589 |
|
24281 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPAL2 |
0.98053795667863 |
|
24282 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LPA |
0.98053795667863 |
|
24283 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
YIPF4 |
0.980561530098857 |
|
24284 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf47 |
0.980588227283336 |
|
24285 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL869P |
0.980591975584077 |
|
24286 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPANXN1 |
0.9806101306572 |
|
24287 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL37A |
0.980688841571199 |
|
24288 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS26B |
0.980758171520589 |
|
24289 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
THYN1 |
0.980758171520589 |
|
24290 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACAD8 |
0.980758171520589 |
|
24291 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
B3GAT1 |
0.980758171520589 |
|
24292 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLB1L2 |
0.980758171520589 |
|
24293 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLB1L3 |
0.980758171520589 |
|
24294 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAGI1 |
0.980868592239424 |
|
24295 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC11A1 |
0.980893600712295 |
|
24296 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSGA13 |
0.98094510811948 |
|
24297 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLF14 |
0.98094510811948 |
|
24298 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA25|ENSG00000200991.1 |
0.980950442498484 |
|
24299 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNDIG1L |
0.980999239865249 |
|
24300 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPC2 |
0.980999239865249 |
|
24301 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4709 |
0.980999239865249 |
|
24302 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ISCA2 |
0.980999239865249 |
|
24303 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FRMD3 |
0.981019422697924 |
|
24304 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGTR1 |
0.981194751857936 |
|
24305 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNAR1 |
0.981212747928459 |
|
24306 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNK3 |
0.981293420463151 |
|
24307 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM92 |
0.981389291012038 |
|
24308 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
S1PR3 |
0.98142069850021 |
|
24309 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR184 |
0.98142755422089 |
|
24310 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NEK6 |
0.981532052971083 |
|
24311 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR29A |
0.981581721547148 |
|
24312 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR29B1 |
0.981581721547148 |
|
24313 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL18 |
0.981636531000221 |
|
24314 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PNLDC1 |
0.981636531000221 |
|
24315 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZMAT3 |
0.981645141169714 |
|
24316 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL789P |
0.981675909673927 |
|
24317 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GANC |
0.981744144092916 |
|
24318 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAPN3 |
0.981744144092916 |
|
24319 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLITRK2 |
0.981945121723083 |
|
24320 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM257 |
0.981945121723083 |
|
24321 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPTLC1 |
0.982215958052042 |
|
24322 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP242 |
0.982303397978558 |
|
24323 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT5 |
0.982310198527614 |
|
24324 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OST4 |
0.982318032060936 |
|
24325 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SUSD3 |
0.982408333987522 |
|
24326 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR182 |
0.982502981484764 |
|
24327 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR183 |
0.982502981484764 |
|
24328 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR96 |
0.982502981484764 |
|
24329 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAMD14 |
0.982505014594662 |
|
24330 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R9B |
0.982505014594662 |
|
24331 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VRTN |
0.982552568248868 |
|
24332 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYO9A |
0.982602133402775 |
|
24333 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFPI |
0.982615277392981 |
|
24334 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BAZ2B |
0.982708897357491 |
|
24335 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U8|ENSG00000212144.1 |
0.982720194828374 |
|
24336 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IRF2BP2 |
0.982720194828374 |
|
24337 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf89 |
0.982763125816579 |
|
24338 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRF1 |
0.98287546840253 |
|
24339 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP244 |
0.98287546840253 |
|
24340 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEST |
0.982970676482302 |
|
24341 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR335 |
0.982970676482302 |
|
24342 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HNRNPA2B1 |
0.983006407468265 |
|
24343 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CBX3 |
0.983006407468265 |
|
24344 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IPPK |
0.983008047955527 |
|
24345 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MAS1 |
0.98303324266869 |
|
24346 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00939 |
0.983076449845529 |
|
24347 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4697 |
0.983104302028064 |
|
24348 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF9B |
0.983104302028064 |
|
24349 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
JAM3 |
0.983104302028064 |
|
24350 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCAPD3 |
0.983104302028064 |
|
24351 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BARX1 |
0.983113906506652 |
|
24352 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4290 |
0.983230137354206 |
|
24353 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RCN2 |
0.983334770238063 |
|
24354 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00613 |
0.983488401991206 |
|
24355 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MESDC2 |
0.983512054305029 |
|
24356 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4422 |
0.983628036060632 |
|
24357 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERG |
0.983628834876816 |
|
24358 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPDC1 |
0.983629855155657 |
|
24359 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LHX2 |
0.983774980569385 |
|
24360 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP13A5 |
0.98378256915234 |
|
24361 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP13A4 |
0.98378256915234 |
|
24362 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OPA1 |
0.98378256915234 |
|
24363 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPYL2 |
0.983822451697303 |
|
24364 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GDAP2 |
0.983835583286097 |
|
24365 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SEMA3C |
0.983861894256724 |
|
24366 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
L1TD1 |
0.983920238937468 |
|
24367 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HRASLS |
0.983985102106497 |
|
24368 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMARCA5 |
0.984020219644117 |
|
24369 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4421 |
0.984031377027525 |
|
24370 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KANK4 |
0.984043876274428 |
|
24371 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL33 |
0.984046376043987 |
|
24372 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3692 |
0.984164366432756 |
|
24373 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMCN2 |
0.984172500193361 |
|
24374 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ACVR2A |
0.984311291600485 |
|
24375 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3973 |
0.984423213228159 |
|
24376 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ADAMTS7 |
0.98454306378636 |
|
24377 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPEB1 |
0.984574067037962 |
|
24378 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DHODH |
0.984605847847753 |
|
24379 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD50 |
0.984612260118182 |
|
24380 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252088.1 |
0.984637155582633 |
|
24381 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTKN2 |
0.984640323377182 |
|
24382 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GGA2 |
0.984655116610127 |
|
24383 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EARS2 |
0.984655116610127 |
|
24384 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf129 |
0.984656488523655 |
|
24385 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIN1 |
0.984663486252117 |
|
24386 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRAS |
0.984776171038964 |
|
24387 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
XRN1 |
0.984796410998148 |
|
24388 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PBX3 |
0.984938589511549 |
|
24389 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAT |
0.985023434685451 |
|
24390 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARVELD3 |
0.985023434685451 |
|
24391 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000252609.1 |
0.98502598382011 |
|
24392 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PATE4 |
0.985030203169284 |
|
24393 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM209 |
0.985060674941749 |
|
24394 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SSMEM1 |
0.985060674941749 |
|
24395 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP217 |
0.985218185423326 |
|
24396 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX10 |
0.985237924754637 |
|
24397 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRKCB |
0.985258015017573 |
|
24398 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1Q1 |
0.985285290416141 |
|
24399 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PABPC4L |
0.985431790630331 |
|
24400 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR221 |
0.98546634711228 |
|
24401 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR222 |
0.98546634711228 |
|
24402 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM120A |
0.985539959261045 |
|
24403 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PDK2 |
0.985564935611959 |
|
24404 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYL4 |
0.98558244594128 |
|
24405 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP170 |
0.985617163405091 |
|
24406 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM42 |
0.985685609944812 |
|
24407 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTMAP5 |
0.985823415768193 |
|
24408 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HYLS1 |
0.985846034034945 |
|
24409 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PUS3 |
0.985846034034945 |
|
24410 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FCF1 |
0.985849950860425 |
|
24411 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA7|ENSG00000222604.1 |
0.985849950860425 |
|
24412 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF165 |
0.985870149768531 |
|
24413 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP24 |
0.985874344701334 |
|
24414 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GNAI1 |
0.985908150195817 |
|
24415 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTRK3 |
0.985931720564532 |
|
24416 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUDT19 |
0.985944581659532 |
|
24417 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00114 |
0.986062025965793 |
|
24418 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DYNLT1 |
0.986112828740601 |
|
24419 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C21orf49 |
0.986115797824496 |
|
24420 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RMND1 |
0.986212316917974 |
|
24421 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EFCAB13 |
0.98623748737971 |
|
24422 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GK5 |
0.986241178088665 |
|
24423 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCD4 |
0.986260147204414 |
|
24424 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN5 |
0.986457686925537 |
|
24425 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM181 |
0.986507239448349 |
|
24426 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR98 |
0.986530356984647 |
|
24427 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIRLET7F2 |
0.986530356984647 |
|
24428 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFNAR2 |
0.986679687237783 |
|
24429 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL507P |
0.986917568724815 |
|
24430 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RUNDC3A |
0.986917568724815 |
|
24431 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000221496.1 |
0.986917568724815 |
|
24432 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2NL |
0.987033229308483 |
|
24433 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAPVD1 |
0.987060050627818 |
|
24434 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BICD2 |
0.987267396966284 |
|
24435 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GAB1 |
0.987300174243847 |
|
24436 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRG4 |
0.987375143243401 |
|
24437 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CSPG4P8 |
0.987463137563936 |
|
24438 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L10|ENSG00000205281.6 |
0.987463137563936 |
|
24439 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L10|ENSG00000254374.2 |
0.987463137563936 |
|
24440 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L9|ENSG00000196648.6 |
0.987463137563936 |
|
24441 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GOLGA6L9|ENSG00000197978.8 |
0.987463137563936 |
|
24442 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL256P |
0.987463137563936 |
|
24443 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL410P |
0.987463137563936 |
|
24444 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL61P |
0.987463137563936 |
|
24445 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS17 |
0.987463137563936 |
|
24446 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2Q2P2 |
0.987463137563936 |
|
24447 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2Q2P3 |
0.987463137563936 |
|
24448 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP6C |
0.987478306367592 |
|
24449 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RABEPK |
0.987478306367592 |
|
24450 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSPA5 |
0.987478306367592 |
|
24451 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RAI1 |
0.987507215560906 |
|
24452 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL173P |
0.987507443970135 |
|
24453 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FEZF1 |
0.987591938127773 |
|
24454 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ALAS2 |
0.987611633161471 |
|
24455 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
APEX2 |
0.987611633161471 |
|
24456 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBE2Q2 |
0.987636333990977 |
|
24457 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL510P |
0.987636333990977 |
|
24458 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO22 |
0.987636333990977 |
|
24459 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLT6D1 |
0.987643138598166 |
|
24460 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCN9 |
0.987858377195347 |
|
24461 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SOHLH1 |
0.987858377195347 |
|
24462 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CNTNAP5 |
0.987952273518168 |
|
24463 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KLHDC10 |
0.9879574892521 |
|
24464 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR33B |
0.988010490640196 |
|
24465 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SREBF1 |
0.988010490640196 |
|
24466 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RGS9BP |
0.988117897203941 |
|
24467 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPX7 |
0.988120193502368 |
|
24468 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSTPIP1 |
0.988129444007313 |
|
24469 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP517 |
0.988170506093395 |
|
24470 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA63|ENSG00000199633.1 |
0.988190900008583 |
|
24471 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD44 |
0.988209667602528 |
|
24472 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSTPIP2 |
0.988281624085926 |
|
24473 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF106 |
0.988470456384282 |
|
24474 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNAP23 |
0.988470456384282 |
|
24475 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRRC57 |
0.988470456384282 |
|
24476 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRRX2 |
0.988543391765136 |
|
24477 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0087 |
0.988554933382045 |
|
24478 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C7orf71 |
0.988554933382045 |
|
24479 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATR |
0.988565827628078 |
|
24480 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL45P2 |
0.988630278889534 |
|
24481 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZCCHC11 |
0.988670629851754 |
|
24482 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTBK2 |
0.988731802782253 |
|
24483 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AREL1 |
0.988733353815228 |
|
24484 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP26 |
0.988783878749437 |
|
24485 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITPKA |
0.988857514556873 |
|
24486 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UBXN2A |
0.988885726579893 |
|
24487 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL610P |
0.988885726579893 |
|
24488 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MFSD2B |
0.988885726579893 |
|
24489 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf44 |
0.988885726579893 |
|
24490 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FKBP1B |
0.988885726579893 |
|
24491 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TNIP3 |
0.988928126119918 |
|
24492 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G4D |
0.988933842607432 |
|
24493 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA26|ENSG00000212624.1 |
0.988976152297642 |
|
24494 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAPER |
0.988985515340379 |
|
24495 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMCO5A |
0.989010680455648 |
|
24496 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MEX3B |
0.989013582074272 |
|
24497 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM159A |
0.989062823587249 |
|
24498 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAT4 |
0.989086107553563 |
|
24499 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AP3B2 |
0.989187910266645 |
|
24500 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPS15 |
0.989218708859912 |
|
24501 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf16 |
0.989501889115362 |
|
24502 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMEM87A |
0.989554314115307 |
|
24503 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4263 |
0.989590646688515 |
|
24504 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGF2R |
0.989640625261278 |
|
24505 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AIRN |
0.989640625261278 |
|
24506 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf62 |
0.989844982551619 |
|
24507 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CD36 |
0.989902157790097 |
|
24508 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GLRA3 |
0.989990540711165 |
|
24509 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNT7 |
0.990121773302463 |
|
24510 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR548T |
0.990121773302463 |
|
24511 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HMGB2 |
0.990121773302463 |
|
24512 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SAP30 |
0.990121773302463 |
|
24513 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCRG1 |
0.990121773302463 |
|
24514 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL6A6 |
0.990258734991189 |
|
24515 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00564 |
0.990260146509101 |
|
24516 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PEAK1 |
0.990358767247413 |
|
24517 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TGFB3 |
0.990380492210127 |
|
24518 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EPG5 |
0.990430329111737 |
|
24519 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238679.1 |
0.990471158241999 |
|
24520 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM218A |
0.990480528046167 |
|
24521 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM61 |
0.990480528046167 |
|
24522 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP387 |
0.990580910087548 |
|
24523 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf1 |
0.990580910087548 |
|
24524 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHF2 |
0.990595573039196 |
|
24525 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TM2D1 |
0.990649306811782 |
|
24526 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TFDP2 |
0.990711119998162 |
|
24527 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VSX2 |
0.990740219054038 |
|
24528 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP106 |
0.99107332649266 |
|
24529 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ITGB3 |
0.991148509907094 |
|
24530 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TULP4 |
0.991170260707723 |
|
24531 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYNJ2 |
0.991198670847548 |
|
24532 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USH1C |
0.991215332516188 |
|
24533 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OTOG |
0.991215332516188 |
|
24534 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYOD1 |
0.991215332516188 |
|
24535 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
INADL |
0.991326144734868 |
|
24536 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS13 |
0.991326713291416 |
|
24537 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD14A |
0.991326713291416 |
|
24538 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD14B |
0.991326713291416 |
|
24539 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPL10 |
0.991343830465342 |
|
24540 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3C2A |
0.991392052196245 |
|
24541 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COL6A5 |
0.991396607212117 |
|
24542 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA0226 |
0.991411115659139 |
|
24543 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR922 |
0.991411115659139 |
|
24544 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FYTTD1 |
0.991411115659139 |
|
24545 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LRCH3 |
0.991411115659139 |
|
24546 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD18DP |
0.991411115659139 |
|
24547 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM157A |
0.991411115659139 |
|
24548 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQCG |
0.991411115659139 |
|
24549 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LMLN |
0.991411115659139 |
|
24550 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPL35A |
0.991411115659139 |
|
24551 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCGEM1 |
0.991512987549122 |
|
24552 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRD1 |
0.99159449951843 |
|
24553 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR761 |
0.99159449951843 |
|
24554 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MVB12B |
0.991703774819393 |
|
24555 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CIB4 |
0.99173976035481 |
|
24556 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NCR3LG1 |
0.991797352572937 |
|
24557 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLS1 |
0.991820368539938 |
|
24558 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP25 |
0.991820368539938 |
|
24559 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRPC1 |
0.991820368539938 |
|
24560 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PCOLCE2 |
0.991820368539938 |
|
24561 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP143 |
0.991846713655522 |
|
24562 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASS1 |
0.991888016494342 |
|
24563 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238298.1 |
0.991888016494342 |
|
24564 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SF3B14 |
0.991909934221516 |
|
24565 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TP53I3 |
0.991909934221516 |
|
24566 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CDON |
0.991994925932751 |
|
24567 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTPN9 |
0.992006181855367 |
|
24568 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HAUS2 |
0.992097935129834 |
|
24569 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMED3 |
0.992137536300361 |
|
24570 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1024 |
0.992137536300361 |
|
24571 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPIN4 |
0.992164033047835 |
|
24572 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
REEP3 |
0.992177733603 |
|
24573 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIF5C |
0.992248377481286 |
|
24574 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MTHFS |
0.992394647948071 |
|
24575 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C15orf27 |
0.992452809749721 |
|
24576 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PALB2 |
0.992485908105596 |
|
24577 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KCNJ11 |
0.992506052626282 |
|
24578 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABCC8 |
0.992578131725427 |
|
24579 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00475 |
0.992603079801516 |
|
24580 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238860.1 |
0.992629905569467 |
|
24581 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PHTF2 |
0.992692703500745 |
|
24582 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLA2G4F |
0.992700897943369 |
|
24583 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf50 |
0.992708925593731 |
|
24584 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238996.1 |
0.992710889835996 |
|
24585 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP124 |
0.992723409875338 |
|
24586 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL724P |
0.992723409875338 |
|
24587 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM54 |
0.992744269707146 |
|
24588 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
UCN |
0.992744269707146 |
|
24589 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP501 |
0.992745744396534 |
|
24590 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP41 |
0.992771389502593 |
|
24591 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C14orf166 |
0.992816047580372 |
|
24592 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPS17L |
0.992873522946958 |
|
24593 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DCTN5 |
0.992910183040639 |
|
24594 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLK1 |
0.992910183040639 |
|
24595 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1J2 |
0.992924205721058 |
|
24596 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1J4 |
0.992924205721058 |
|
24597 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1N1 |
0.992924205721058 |
|
24598 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1J1 |
0.992936210271303 |
|
24599 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRBF2 |
0.993049614114851 |
|
24600 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GRK7 |
0.99310221944787 |
|
24601 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATP1B3 |
0.99310221944787 |
|
24602 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TCF23 |
0.993103720575743 |
|
24603 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MARCH1 |
0.993151778332759 |
|
24604 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGES |
0.993191726920932 |
|
24605 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DDX25 |
0.993235388527485 |
|
24606 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL9 |
0.993248651655593 |
|
24607 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORA31|ENSG00000251838.1 |
0.993270565033635 |
|
24608 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VPS39 |
0.993271169371478 |
|
24609 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR627 |
0.993271169371478 |
|
24610 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
USP20 |
0.993312795851293 |
|
24611 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL180P |
0.993319353992744 |
|
24612 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP291 |
0.993433249408551 |
|
24613 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDNF |
0.993764829852307 |
|
24614 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP137 |
0.993764829852307 |
|
24615 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
AGTPBP1 |
0.993807207597252 |
|
24616 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSBPL3 |
0.993811719902115 |
|
24617 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KIAA1199 |
0.993845506871285 |
|
24618 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR148A |
0.993870295638078 |
|
24619 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANGPTL3 |
0.99387411196176 |
|
24620 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPM1G |
0.99389349018757 |
|
24621 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NRBP1 |
0.99389349018757 |
|
24622 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KRTCAP3 |
0.99389349018757 |
|
24623 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTK |
0.993964545336154 |
|
24624 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RPAP1 |
0.993964545336154 |
|
24625 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NUSAP1 |
0.994042828349883 |
|
24626 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFAF1 |
0.994042828349883 |
|
24627 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RTF1 |
0.994042828349883 |
|
24628 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1N2 |
0.99407586159944 |
|
24629 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR1L8 |
0.99407586159944 |
|
24630 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT43 |
0.994191497537484 |
|
24631 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNF7 |
0.994241422950816 |
|
24632 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LOXL1 |
0.994253302808598 |
|
24633 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PKD1L3 |
0.994278971326134 |
|
24634 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOR1B |
0.994312693515171 |
|
24635 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A1 |
0.994422448482367 |
|
24636 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARHGAP36 |
0.99446440215689 |
|
24637 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OSTCP1 |
0.994472007671653 |
|
24638 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C6orf99 |
0.994472007671653 |
|
24639 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PPP1R26 |
0.994614143245955 |
|
24640 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf116 |
0.994614143245955 |
|
24641 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS2 |
0.994614143245955 |
|
24642 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LCN1 |
0.994614143245955 |
|
24643 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OBP2A |
0.994614143245955 |
|
24644 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PAEP |
0.994614143245955 |
|
24645 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNY5P4 |
0.994674567462069 |
|
24646 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL665P |
0.994897599469473 |
|
24647 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ENOX2 |
0.994964568690511 |
|
24648 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCAI |
0.995054688343743 |
|
24649 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PTGS1 |
0.995132151092137 |
|
24650 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EZR |
0.99513520307997 |
|
24651 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C3orf72 |
0.995282193640496 |
|
24652 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FOXL2 |
0.995282193640496 |
|
24653 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR23A |
0.995282193640496 |
|
24654 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR23B |
0.995282193640496 |
|
24655 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PRR23C |
0.995282193640496 |
|
24656 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MKLN1 |
0.99530187350732 |
|
24657 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ANKRD34C |
0.995306325849646 |
|
24658 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CPA3 |
0.995457394694581 |
|
24659 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SCP2 |
0.99550420645243 |
|
24660 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NDUFAB1 |
0.995529989257489 |
|
24661 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPAG17 |
0.995580024024307 |
|
24662 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MRPS22 |
0.995602641910865 |
|
24663 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KDM5C |
0.995604769458432 |
|
24664 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CALCRL |
0.995693293461697 |
|
24665 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IFT172 |
0.995728702410367 |
|
24666 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FNDC4 |
0.995728702410367 |
|
24667 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NTRK2 |
0.995849027959042 |
|
24668 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A3 |
0.995908195520113 |
|
24669 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAIM |
0.995970505230882 |
|
24670 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZYG11A |
0.996038151908278 |
|
24671 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ECHDC2 |
0.996038151908278 |
|
24672 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1273F |
0.996038151908278 |
|
24673 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR5095 |
0.996038151908278 |
|
24674 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR1273G |
0.996038151908278 |
|
24675 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BPESC1 |
0.996041788345253 |
|
24676 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPB2 |
0.996041788345253 |
|
24677 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00331 |
0.996154092013155 |
|
24678 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NT5M |
0.996179779583131 |
|
24679 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TOR1A |
0.996185118168515 |
|
24680 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C9orf78 |
0.996185118168515 |
|
24681 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
WDR3 |
0.996208013799131 |
|
24682 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF669 |
0.996217513825603 |
|
24683 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C1orf229 |
0.996217513825603 |
|
24684 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SKP43 |
0.996321464152788 |
|
24685 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SYK |
0.996388600386415 |
|
24686 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SMC1A |
0.996443479828335 |
|
24687 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RIBC1 |
0.996443479828335 |
|
24688 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HSD17B10 |
0.996443479828335 |
|
24689 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C4orf3 |
0.996451522790904 |
|
24690 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FABP2 |
0.996451522790904 |
|
24691 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL30P |
0.996576883885346 |
|
24692 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR6C65 |
0.996638861033329 |
|
24693 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP56 |
0.996649147794677 |
|
24694 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FAM120AOS |
0.996655441430528 |
|
24695 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SPATA19 |
0.996711896565586 |
|
24696 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL278P |
0.996840394547446 |
|
24697 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC22A2 |
0.996844559047356 |
|
24698 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
snoU13|ENSG00000238693.1 |
0.996859867106609 |
|
24699 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BRE |
0.996863489075105 |
|
24700 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
BIRC6 |
0.996956884246642 |
|
24701 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OLFML2A |
0.996989386832449 |
|
24702 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EMILIN1 |
0.997073588458411 |
|
24703 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
KHK |
0.997073588458411 |
|
24704 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CGREF1 |
0.997073588458411 |
|
24705 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ABHD1 |
0.997073588458411 |
|
24706 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PREB |
0.997073588458411 |
|
24707 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf53 |
0.997073588458411 |
|
24708 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR3918 |
0.997080651772625 |
|
24709 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PSMA1 |
0.997103270432179 |
|
24710 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPY1R |
0.997170515772099 |
|
24711 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NPY5R |
0.997170515772099 |
|
24712 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC4A1AP |
0.997188065003105 |
|
24713 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ST3GAL4 |
0.99719237768325 |
|
24714 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MB21D2 |
0.997199270144744 |
|
24715 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TRIM60 |
0.997392514233668 |
|
24716 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPB1 |
0.997430975468454 |
|
24717 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GALNTL6 |
0.997497220563121 |
|
24718 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PLEKHA7 |
0.997639593393025 |
|
24719 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LTBP1 |
0.997746231295382 |
|
24720 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SERAC1 |
0.997779568508654 |
|
24721 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF2H5 |
0.997779568508654 |
|
24722 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL191P |
0.997923172757685 |
|
24723 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBP2 |
0.99799729588324 |
|
24724 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBP1 |
0.99799729588324 |
|
24725 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASTN2 |
0.99814201092495 |
|
24726 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPG2 |
0.998164217050247 |
|
24727 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ASB6 |
0.998215483393399 |
|
24728 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
PIK3CB |
0.998231363001984 |
|
24729 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RSPH3 |
0.998299925005993 |
|
24730 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TAGAP |
0.998299925005993 |
|
24731 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RN7SL205P |
0.998396335420337 |
|
24732 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RNA5SP223 |
0.998425781295199 |
|
24733 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR7E14P |
0.998454405385284 |
|
24734 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IQSEC2 |
0.998540610531217 |
|
24735 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
NMNAT3 |
0.998580918951275 |
|
24736 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
U3|ENSG00000202233.1 |
0.998621495043944 |
|
24737 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX9 |
0.99862307013048 |
|
24738 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TSPAN3 |
0.998713699643513 |
|
24739 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TKTL2 |
0.998775371312573 |
|
24740 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TMA16 |
0.998775371312573 |
|
24741 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
IGSF1 |
0.998798321051635 |
|
24742 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
OR13H1 |
0.998798321051635 |
|
24743 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MYCT1 |
0.998798591117427 |
|
24744 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
VIP |
0.998798591117427 |
|
24745 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ARID1B |
0.998802077058978 |
|
24746 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
COPS3 |
0.998804852616099 |
|
24747 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC5A6 |
0.99904078061216 |
|
24748 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ATRAID |
0.99904078061216 |
|
24749 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
DNAJC5G |
0.99904078061216 |
|
24750 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CAD |
0.999048885599491 |
|
24751 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC30A3 |
0.999048885599491 |
|
24752 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4514 |
0.999233662970244 |
|
24753 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MESDC1 |
0.999233662970244 |
|
24754 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF280C |
0.999253665475436 |
|
24755 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
FBXO8 |
0.999272464928139 |
|
24756 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CEP44 |
0.999272464928139 |
|
24757 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SLC25A14 |
0.999425079923629 |
|
24758 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GPR119 |
0.999425079923629 |
|
24759 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
RBMX2 |
0.999425079923629 |
|
24760 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
LINC00486 |
0.99948741109127 |
|
24761 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4765 |
0.99948741109127 |
|
24762 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR558 |
0.99948741109127 |
|
24763 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNORD112|ENSG00000252502.1 |
0.99948741109127 |
|
24764 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
TTC27 |
0.99948741109127 |
|
24765 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ERN2 |
0.999489410177159 |
|
24766 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
C2orf70 |
0.999631652245986 |
|
24767 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MPV17 |
0.999641620865844 |
|
24768 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
GTF3C2 |
0.999641620865844 |
|
24769 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
EIF2B4 |
0.999641620865844 |
|
24770 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
SNX17 |
0.999641620865844 |
|
24771 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
ZNF513 |
0.999641620865844 |
|
24772 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
MIR4276 |
0.999815307747154 |
|
24773 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
HPGD |
0.999815307747154 |
|
24774 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf51A |
0.999913339744748 |
|
24775 |
Ovarian serous cystadenocarcinoma (OV) |
Paclitaxel |
CXorf51B |
0.999913339744748 |
|